data_2m19_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m19 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 0' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 65.3 p . . . . . 0 C--O 1.244 0.767 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -108.06 167.5 9.95 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.887 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -120.84 133.48 55.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.7 mt -126.13 142.36 51.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.333 0.653 . . . . 0.0 109.945 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 45.5 tt0 -88.73 102.68 15.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.42 HD12 HD22 ' A' ' 37' ' ' LEU . 30.1 mt -93.76 104.0 16.11 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtp85 -94.4 117.83 30.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.775 -176.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.4 138.12 43.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.864 0.866 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.28 156.2 48.01 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 109.56 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 61.55 -131.24 0.69 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.77 1.228 . . . . 0.0 111.64 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.2 m -58.38 -46.89 85.46 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 123.346 0.658 . . . . 0.0 111.215 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -58.6 -26.38 63.62 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.042 0.537 . . . . 0.0 111.548 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -70.89 -50.47 34.65 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.096 0.558 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -74.26 -25.62 59.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.375 0.422 . . . . 0.0 111.932 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 44' ' ' LEU . 48.1 t -59.29 -54.99 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.672 0.789 . . . . 0.0 110.036 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.478 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 94.4 t -72.59 -24.59 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.204 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.06 10.91 62.74 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.017 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -141.32 136.04 31.14 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.49 -22.06 21.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.035 0.534 . . . . 0.0 112.253 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 15.0 m -155.59 134.31 11.91 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 17.4 pt -131.27 176.66 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.209 1.004 . . . . 0.0 109.143 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -125.07 112.84 16.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.71 157.44 15.9 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 0.0 109.436 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -117.94 105.54 12.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.81 172.36 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 16.9 t70 -70.68 157.58 37.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -63.81 -27.74 69.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.06 0.544 . . . . 0.0 111.495 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.24 -23.82 37.77 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.032 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 129.6 40.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 110.586 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -110.81 -179.36 3.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.152 0.581 . . . . 0.0 110.774 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.413 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 39.6 t -51.52 -35.78 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.299 1.04 . . . . 0.0 111.981 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.604 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -65.81 -41.95 95.37 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 123.865 0.728 . . . . 0.0 114.011 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.81 -37.22 84.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.221 0.608 . . . . 0.0 110.765 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.13 -59.58 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.73 0.812 . . . . 0.0 110.543 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.5 pp -65.86 -30.46 71.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 117.776 0.262 . . . . 0.0 111.501 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HA ' HD11 ' A' ' 49' ' ' ILE . 10.4 tpt180 -54.55 -48.13 72.38 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.147 0.499 . . . . 0.0 110.713 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -75.48 -32.46 60.58 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.865 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -57.28 -39.35 75.51 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.54 0.736 . . . . 0.0 112.683 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 1.4 pp20? -73.53 -29.51 62.5 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 120.664 0.269 . . . . 0.0 111.63 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.18 -22.39 66.92 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.096 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -92.64 -57.71 2.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.777 0.799 . . . . 0.0 109.789 174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.478 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 98.6 m-85 -99.83 116.8 32.74 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.954 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.33 -34.29 77.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.061 0.944 . . . . 0.0 111.052 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.01 -8.66 64.98 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.719 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.648 ' HB3' HD12 ' A' ' 48' ' ' LEU . 57.8 mt -105.54 -9.62 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.851 0.861 . . . . 0.0 111.507 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.87 121.27 10.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.105 0.562 . . . . 0.0 111.953 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.1 -33.85 3.93 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -86.17 2.68 45.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.34 -5.82 8.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.054 0.941 . . . . 0.0 111.043 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' A' ' 35' ' ' ARG . 35.0 mt -132.31 128.78 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.499 1.119 . . . . 0.0 108.823 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -129.83 113.04 14.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.063 0.545 . . . . 0.0 109.724 168.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.56 30.7 20.16 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.893 0.877 . . . . 0.0 112.215 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.33 75.01 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.208 -0.774 . . . . 0.0 114.373 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.6 -174.57 2.68 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.085 0.943 . . . . 0.0 109.466 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG12 HD22 ' A' ' 34' ' ' LEU . 17.5 m -67.47 -56.94 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-O 117.764 -1.112 . . . . 0.0 112.098 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.509 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 13.4 tppt? 151.1 139.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 C-N-CA 124.956 1.302 . . . . 0.0 108.923 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.509 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 25.5 Cg_endo -59.89 134.08 54.7 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.112 2.542 . . . . 0.0 111.752 167.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 73.48 -14.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.98 1.312 . . . . 0.0 114.441 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 1.4 p -67.2 136.39 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 15.9 m120 -107.67 103.46 12.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 HG21 HG22 ' A' ' 67' ' ' VAL . 3.5 m -120.72 142.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.795 0.838 . . . . 0.0 109.288 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.0 mp -129.19 172.15 11.73 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.403 1.481 . . . . 0.0 109.979 -165.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HB3' HG11 ' A' ' 67' ' ' VAL . 18.4 tptp -165.14 106.13 0.79 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 56.3 35.31 25.6 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-O 122.065 0.936 . . . . 0.0 109.711 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.04 -13.4 57.08 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.639 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -90.73 117.76 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.9 tt0 -72.4 103.65 3.52 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.206 0.602 . . . . 0.0 110.25 -174.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG11 ' HB3' ' A' ' 62' ' ' LYS . 13.0 m -67.66 -0.7 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 58' ' ' VAL . 5.3 m -67.39 -27.28 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 118.073 0.397 . . . . 0.0 110.526 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -82.05 -16.4 50.26 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.953 0.901 . . . . 0.0 111.118 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.5 -150.34 0.4 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.343 1.057 . . . . 0.0 109.354 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.31 108.37 3.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.442 0.697 . . . . 0.0 111.098 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.25 -42.57 18.59 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.653 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.604 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.8 mmt -78.24 -38.55 42.65 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.36 0.664 . . . . 0.0 112.412 -174.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.22 79.46 1.54 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.553 0.692 . . . . 0.0 111.535 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 t -81.72 -75.43 0.29 Allowed 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.707 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -177.45 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -164.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 77' ' ' LEU . 9.5 mt -72.65 118.31 15.41 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.238 0.926 . . . . 0.0 111.83 -166.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 42.6 m-20 -119.71 173.91 6.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.157 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.3 146.91 52.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.134 0.573 . . . . 0.0 112.277 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 14.86 67.17 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.164 -0.926 . . . . 0.0 114.19 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 2.2 t70 -72.89 179.67 3.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.316 0.558 . . . . 0.0 110.307 -177.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.56 100.08 3.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.047 0.539 . . . . 0.0 110.834 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.2 t -87.77 106.9 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.1 m -91.72 141.88 28.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.57 143.15 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 121.683 0.754 . . . . 0.0 110.189 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 12.8 m-85 -134.92 135.32 22.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.442 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 30.4 Cg_endo -61.49 161.92 22.53 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.361 2.708 . . . . 0.0 112.783 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 42.4 Cg_endo . . . . . 0 C--N 1.38 2.186 0 C-N-CA 122.052 1.835 . . . . 0.0 112.525 -174.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.137 0.494 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -141.21 128.87 21.51 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.357 1.063 . . . . 0.0 109.351 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.21 135.72 35.21 Favored 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 123.512 0.725 . . . . 0.0 109.065 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.36 132.62 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.215 0.606 . . . . 0.0 110.105 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 66.0 tt0 -88.82 95.9 10.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.464 HD12 HD22 ' A' ' 37' ' ' LEU . 46.1 mt -92.9 103.79 16.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 95.6 mtt180 -91.3 117.96 30.09 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.642 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.55 141.86 37.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -133.75 159.76 39.62 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.245 0.618 . . . . 0.0 109.563 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 58.3 -130.69 1.32 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.436 1.094 . . . . 0.0 112.1 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.431 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 81.3 m -55.68 -49.19 73.61 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 123.914 0.885 . . . . 0.0 111.188 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -59.78 -27.58 66.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.803 0.441 . . . . 0.0 111.283 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -52.6 27.07 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.605 0.362 . . . . 0.0 111.006 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.13 -21.07 60.79 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.436 0.46 . . . . 0.0 111.652 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.509 HG12 ' HG ' ' A' ' 44' ' ' LEU . 46.1 t -62.76 -53.89 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.444 0.698 . . . . 0.0 110.47 169.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.445 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 93.1 t -73.76 -21.68 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.572 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.95 11.19 62.9 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.699 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -142.54 142.56 32.24 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -95.68 -8.12 35.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.465 0.306 . . . . 0.0 111.737 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 2.1 m -158.47 128.16 5.82 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.491 1.116 . . . . 0.0 108.495 170.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.426 HG12 ' HB2' ' A' ' 5' ' ' LEU . 11.3 pt -119.03 171.03 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.599 0.76 . . . . 0.0 108.999 173.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.05 112.38 20.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.496 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -93.39 177.3 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.647 1.179 . . . . 0.0 109.77 171.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -156.79 105.35 2.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 171.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.93 172.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.46 1.104 . . . . 0.0 108.618 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.88 160.46 30.63 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.415 0.286 . . . . 0.0 110.402 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.7 -14.95 59.47 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -81.31 -16.05 53.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 152.22 43.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.568 0.747 . . . . 0.0 110.712 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.1 p -136.17 -174.49 3.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.834 1.253 . . . . 0.0 108.727 174.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.1 t -50.51 -36.32 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 C-N-CA 124.185 0.994 . . . . 0.0 112.238 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.12 62.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.844 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.43 -30.13 69.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.421 0.688 . . . . 0.0 110.791 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.72 -60.42 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.357 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.6 pp -66.25 -30.09 70.46 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.565 0.346 . . . . 0.0 111.616 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.489 ' HA ' HD11 ' A' ' 49' ' ' ILE . 12.0 tpt180 -50.56 -49.86 55.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.549 0.74 . . . . 0.0 111.042 169.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 35.0 t -76.09 -32.59 59.3 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.05 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.7 mm? -56.77 -36.69 70.11 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.199 0.6 . . . . 0.0 112.597 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.3 pt-20 -73.6 -26.64 60.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.8 62.31 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.303 0.641 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.496 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 16.8 mm-40 -89.52 -58.08 2.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.587 0.755 . . . . 0.0 109.864 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.445 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 97.9 m-85 -102.14 122.2 43.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.32 -171.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.19 -29.12 67.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.599 0.759 . . . . 0.0 111.941 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.8 -4.38 85.33 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.644 0.59 . . . . 0.0 113.47 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.589 ' HB3' HD13 ' A' ' 48' ' ' LEU . 67.2 mt -106.3 -0.98 23.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.479 0.711 . . . . 0.0 111.335 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.89 120.89 14.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.68 -2.5 53.88 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 170.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.9 ptp180 -107.9 4.0 24.87 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.235 1.014 . . . . 0.0 111.122 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.589 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -126.57 -2.24 6.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.186 0.994 . . . . 0.0 110.56 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.489 HD11 ' HA ' ' A' ' 35' ' ' ARG . 27.7 mt -131.53 137.15 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.757 1.223 . . . . 0.0 108.552 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -148.64 114.78 5.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.87 31.17 21.02 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.981 1.312 . . . . 0.0 112.374 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.412 ' O ' ' HE2' ' A' ' 73' ' ' MET . . . 84.39 -10.12 62.39 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.536 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -94.33 -174.84 3.47 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.261 1.031 . . . . 0.0 109.017 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.468 HG12 HD21 ' A' ' 34' ' ' LEU . 27.4 m -64.94 -55.81 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.31 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? 150.84 132.71 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 125.526 1.53 . . . . 0.0 108.492 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.85 135.05 53.5 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 122.947 2.431 . . . . 0.0 111.507 165.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 82.95 -17.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.306 1.442 . . . . 0.0 113.578 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.447 HG23 ' HD3' ' A' ' 88' ' ' PRO . 2.0 p -73.16 139.39 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.582 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.5 m120 -106.12 103.71 13.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.83 131.11 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.162 0.585 . . . . 0.0 109.618 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.5 mp -123.01 143.24 50.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.476 1.11 . . . . 0.0 109.986 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 2.2 tptm -112.98 105.26 13.28 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.45 55.88 8.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.282 1.433 . . . . 0.0 111.994 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.54 -14.34 30.35 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.801 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -97.43 114.07 25.85 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 117.566 0.683 . . . . 0.0 109.212 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.2 tt0 -70.3 112.37 6.58 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 75' ' ' THR . 35.4 m -72.44 -1.27 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 113.397 -174.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 m -70.21 -13.36 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.818 0.447 . . . . 0.0 111.422 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -93.81 -18.78 21.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.635 0.774 . . . . 0.0 110.904 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.96 -152.9 0.52 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.117 0.967 . . . . 0.0 109.076 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.09 112.84 1.66 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.068 0.547 . . . . 0.0 110.956 172.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.33 -46.77 8.72 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.412 ' HE2' ' O ' ' A' ' 52' ' ' GLY . 76.0 mmm -80.32 -38.92 29.68 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.829 0.852 . . . . 0.0 112.32 -172.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.85 74.31 1.46 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.475 0.655 . . . . 0.0 111.48 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.448 HG23 HG13 ' A' ' 67' ' ' VAL . 1.7 t -81.31 -69.94 0.57 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.498 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' H ' HG21 ' A' ' 75' ' ' THR . . . -177.05 33.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.846 0.858 . . . . 0.0 110.485 -164.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.1 tp -75.66 138.61 41.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.709 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -151.04 -176.13 5.42 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.743 1.217 . . . . 0.0 107.978 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.88 144.43 50.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 118.432 0.56 . . . . 0.0 111.203 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.75 5.17 63.68 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.912 0.768 . . . . 0.0 114.566 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.598 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.9 m-20 -84.35 135.66 34.21 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.241 0.521 . . . . 0.0 112.117 -171.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -92.64 124.6 36.78 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.827 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.7 t -108.1 106.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.5 m -94.34 106.0 17.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.157 0.583 . . . . 0.0 110.186 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 m -106.58 145.46 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.005 0.907 . . . . 0.0 111.039 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 8.2 m-85 -131.23 139.69 36.24 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 175.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 46.4 Cg_endo -65.91 168.49 15.26 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.485 2.79 . . . . 0.0 112.631 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HD3' HG23 ' A' ' 58' ' ' VAL . 74.3 Cg_endo . . . . . 0 C--N 1.368 1.581 0 C-N-CA 121.077 1.185 . . . . 0.0 109.372 170.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.24 0.543 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptm -102.94 118.76 37.53 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.476 1.51 . . . . 0.0 110.54 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -86.53 126.49 34.49 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.451 HD12 HD21 ' A' ' 77' ' ' LEU . 27.1 mt -128.46 130.19 47.2 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.288 0.635 . . . . 0.0 110.149 -167.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -88.75 97.74 11.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.42 HD11 HD21 ' A' ' 37' ' ' LEU . 24.3 mt -93.49 103.52 15.71 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 90.0 mtt180 -92.26 117.69 30.14 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.061 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.07 140.1 38.76 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.811 0.844 . . . . 0.0 109.633 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -131.94 158.4 41.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.054 0.542 . . . . 0.0 110.054 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.21 -127.44 1.27 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.069 1.347 . . . . 0.0 111.93 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.36 -47.02 87.87 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.662 0.785 . . . . 0.0 111.204 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -58.06 -29.57 65.51 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.096 0.558 . . . . 0.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.62 -54.32 20.68 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.002 0.521 . . . . 0.0 110.937 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 -20.05 60.43 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 123.62 0.575 . . . . 0.0 111.858 -174.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.467 HG12 ' HG ' ' A' ' 44' ' ' LEU . 41.6 t -60.69 -54.36 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.37 0.668 . . . . 0.0 110.142 168.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.423 HG12 ' HG3' ' A' ' 17' ' ' GLN . 60.4 t -73.26 -21.22 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.367 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.7 11.29 65.53 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.359 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.423 ' HG3' HG12 ' A' ' 15' ' ' VAL . 15.0 mt-30 -140.23 143.46 36.02 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.993 0.917 . . . . 0.0 109.051 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -92.93 -15.09 26.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.492 0.717 . . . . 0.0 111.694 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -156.58 138.06 13.98 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.2 pt -130.99 174.51 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.015 0.926 . . . . 0.0 108.545 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.54 111.92 17.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 163.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.411 ' CH2' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -89.62 176.85 6.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 108.743 169.256 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -155.8 111.74 3.07 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.809 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 m -113.62 177.68 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.412 1.085 . . . . 0.0 108.169 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -59.85 148.95 32.86 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.376 0.535 . . . . 0.0 110.533 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.09 -10.22 59.38 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.77 -20.25 43.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.682 0.793 . . . . 0.0 110.952 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 160.98 23.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.122 0.969 . . . . 0.0 112.377 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -138.39 -176.32 4.42 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.766 1.226 . . . . 0.0 109.437 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.3 t -51.33 -35.84 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.205 1.002 . . . . 0.0 111.471 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.74 -43.54 59.21 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.772 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -64.72 -31.37 72.57 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.447 0.699 . . . . 0.0 110.985 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.22 -60.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.86 0.864 . . . . 0.0 110.63 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.578 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.4 pp -65.62 -30.03 70.69 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.469 0.481 . . . . 0.0 111.173 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.567 ' HA ' HD11 ' A' ' 49' ' ' ILE . 21.9 tpt180 -53.1 -50.51 64.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.681 0.753 . . . . 0.0 111.695 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.8 m -75.27 -31.92 60.88 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.593 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 5' ' ' LEU . 2.5 mm? -56.14 -46.9 79.07 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.323 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.49 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.1 pt-20 -67.78 -26.87 66.31 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.757 0.253 . . . . 0.0 111.486 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.98 -23.93 67.36 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.455 0.472 . . . . 0.0 111.465 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -101.03 -59.55 1.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.158 0.504 . . . . 0.0 110.503 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -86.01 120.72 27.71 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.314 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.56 -33.12 74.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.992 0.917 . . . . 0.0 110.798 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.09 2.85 83.02 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.578 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 48' ' ' LEU . 71.5 mt -115.02 6.15 15.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.352 0.661 . . . . 0.0 110.725 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -72.26 121.45 19.42 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -173.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.58 68.06 Favored Glycine 0 C--N 1.357 1.742 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.504 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 13.5 ptp180 -119.59 -4.78 10.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.031 0.932 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.578 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -119.25 -3.84 10.52 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.189 1.395 . . . . 0.0 109.886 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 35' ' ' ARG . 75.5 mt -132.41 140.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.931 1.293 . . . . 0.0 108.156 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.67 126.96 5.25 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 61.55 30.85 18.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.761 1.224 . . . . 0.0 111.543 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.03 -4.98 56.15 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.666 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -106.59 -174.27 2.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.497 0.719 . . . . 0.0 109.455 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -59.37 -55.67 22.17 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 CA-C-O 117.689 -1.148 . . . . 0.0 112.483 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 12.5 tppt? 150.59 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 125.173 1.389 . . . . 0.0 108.057 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.447 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 11.4 Cg_endo -52.6 124.71 15.86 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.969 2.446 . . . . 0.0 111.947 168.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 74.74 2.59 4.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.639 1.176 . . . . 0.0 113.821 170.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 p -77.63 132.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 19.5 m120 -98.35 103.89 15.88 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.83 141.44 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.574 0.749 . . . . 0.0 109.692 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -131.17 140.62 49.96 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.173 1.389 . . . . 0.0 109.556 -166.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 16.0 tptm -105.46 105.63 15.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 166.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.7 t30 57.12 36.35 27.47 Favored 'General case' 0 CA--C 1.562 1.418 0 O-C-N 124.168 0.918 . . . . 0.0 111.366 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.3 -10.46 74.83 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -94.26 109.96 21.74 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.0 tt0 -68.62 106.25 2.54 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.032 0.533 . . . . 0.0 110.754 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.518 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 16.1 m -69.2 -1.23 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -174.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 m -68.06 -21.74 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-N 117.773 0.261 . . . . 0.0 111.237 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -87.55 -19.4 27.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.339 0.655 . . . . 0.0 110.656 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.0 -153.09 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.382 1.073 . . . . 0.0 109.718 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.73 108.4 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.579 0.752 . . . . 0.0 110.582 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.518 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -71.89 -49.63 22.03 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.589 -0.278 . . . . 0.0 113.122 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.5 -39.68 37.46 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.68 75.6 1.48 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.348 0.594 . . . . 0.0 110.903 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -76.65 -60.79 2.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.239 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.18 33.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.569 1.148 . . . . 0.0 109.657 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.451 HD21 HD12 ' A' ' 3' ' ' LEU . 42.5 tp -74.98 114.84 13.92 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -120.1 -176.7 3.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.676 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -66.5 144.14 56.65 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.364 0.666 . . . . 0.0 111.101 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.92 8.97 85.22 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.946 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.576 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 70.4 m-20 -97.75 144.56 27.25 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.786 0.834 . . . . 0.0 111.599 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.28 141.96 27.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.67 0.788 . . . . 0.0 111.116 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.08 107.39 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.232 1.013 . . . . 0.0 108.311 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.642 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 49.4 m -90.6 139.05 31.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.691 0.796 . . . . 0.0 109.268 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.16 142.43 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.124 0.874 . . . . 0.0 110.624 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 20.5 m-85 -129.79 135.99 28.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.41 164.02 19.05 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.329 2.686 . . . . 0.0 112.16 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.369 1.628 0 C-N-CA 121.364 1.376 . . . . 0.0 110.287 175.744 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -122.71 146.03 47.86 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.506 0.722 . . . . 0.0 109.944 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.57 135.2 33.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 HD21 ' A' ' 77' ' ' LEU . 20.6 mt -134.12 133.54 41.2 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.32 0.648 . . . . 0.0 109.399 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -88.89 107.79 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 37' ' ' LEU . 24.6 mt -94.79 104.03 15.93 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 92.4 mtt180 -92.05 118.13 30.5 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.825 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.7 139.6 40.03 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.807 0.843 . . . . 0.0 109.283 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.43 154.95 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.195 0.598 . . . . 0.0 109.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 61.85 -128.9 0.72 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.813 1.245 . . . . 0.0 112.074 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.3 m -62.39 -41.5 98.69 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 123.731 0.813 . . . . 0.0 111.381 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -63.33 -25.18 68.18 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.225 0.61 . . . . 0.0 111.383 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -71.55 -53.18 14.63 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.411 0.684 . . . . 0.0 111.189 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -71.18 -23.37 62.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.013 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.495 HG11 ' HG ' ' A' ' 44' ' ' LEU . 19.8 t -60.87 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.555 0.693 . . . . 0.0 111.043 170.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.74 -21.97 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.323 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.48 12.48 77.22 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.567 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -143.36 143.82 31.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.774 1.229 . . . . 0.0 109.016 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -94.62 -18.47 21.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.622 0.369 . . . . 0.0 111.732 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -154.86 127.96 8.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.899 0.88 . . . . 0.0 108.663 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.17 170.02 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.955 0.902 . . . . 0.0 109.086 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.82 112.35 20.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -96.93 179.67 4.87 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 108.848 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -157.06 106.17 2.19 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.15 179.97 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.427 1.091 . . . . 0.0 108.391 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.71 150.14 24.31 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.489 0.715 . . . . 0.0 111.511 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.91 -20.82 62.45 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.149 0.579 . . . . 0.0 111.741 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.89 -23.82 20.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.238 0.615 . . . . 0.0 110.724 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.29 128.06 35.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.465 0.306 . . . . 0.0 110.286 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.2 p -107.25 -174.68 2.59 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.496 0.719 . . . . 0.0 111.175 -172.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 78.9 t -51.85 -38.24 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.164 0.985 . . . . 0.0 112.25 -173.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -64.44 -42.39 97.62 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 123.728 0.643 . . . . 0.0 113.27 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -69.24 -30.42 68.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.57 0.748 . . . . 0.0 110.956 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.0 t -64.88 -60.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.476 0.71 . . . . 0.0 110.452 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.472 HD21 HG12 ' A' ' 54' ' ' VAL . 1.9 pp -63.94 -30.3 71.39 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.183 0.447 . . . . 0.0 111.337 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.511 ' HA ' HD13 ' A' ' 49' ' ' ILE . 8.8 tpt85 -53.71 -47.02 70.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.046 0.538 . . . . 0.0 110.831 169.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 m -74.84 -32.94 62.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.22 0.608 . . . . 0.0 111.78 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.5 HD22 HD11 ' A' ' 5' ' ' LEU . 3.9 mm? -58.18 -35.36 71.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -78.57 -25.91 45.46 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.173 0.442 . . . . 0.0 111.394 176.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -16.07 62.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.652 0.781 . . . . 0.0 111.513 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -100.87 -59.36 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.404 0.681 . . . . 0.0 110.181 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.07 119.47 34.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.676 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.09 -30.29 70.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.858 0.463 . . . . 0.0 110.599 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -72.22 -12.28 76.03 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.597 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.604 ' HB3' HD12 ' A' ' 48' ' ' LEU . 97.7 mt -109.84 -0.43 18.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 111.026 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -62.02 121.08 12.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.444 0.698 . . . . 0.0 112.433 -172.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.12 -22.87 3.43 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -91.18 10.69 26.01 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.393 1.077 . . . . 0.0 111.856 -173.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -130.0 -5.98 4.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.34 1.056 . . . . 0.0 110.9 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 35' ' ' ARG . 67.4 mt -131.78 130.6 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.676 1.19 . . . . 0.0 108.195 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.37 126.13 22.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.951 0.5 . . . . 0.0 110.0 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.1 t70 54.81 31.33 15.39 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.552 1.141 . . . . 0.0 112.315 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.41 -13.74 53.94 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.692 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.35 -176.96 3.45 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.815 0.846 . . . . 0.0 109.008 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.472 HG12 HD21 ' A' ' 34' ' ' LEU . 16.6 m -64.47 -56.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.836 -1.078 . . . . 0.0 112.333 -173.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? 155.17 133.14 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 124.705 1.202 . . . . 0.0 109.287 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.79 134.48 47.13 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.519 2.812 . . . . 0.0 111.383 168.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 77.85 -15.11 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.778 1.631 . . . . 0.0 113.52 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.13 145.37 13.0 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -114.24 103.88 11.54 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.05 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.071 0.948 . . . . 0.0 108.663 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -117.15 151.51 36.7 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 20.8 tptp -124.24 104.37 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.392 1.477 . . . . 0.0 107.203 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 50.75 38.63 20.0 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.648 1.179 . . . . 0.0 111.15 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.1 80.82 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.374 -0.83 . . . . 0.0 115.107 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -103.61 110.15 22.1 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 118.021 0.911 . . . . 0.0 109.424 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.4 tt0 -66.55 112.28 4.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.497 0.719 . . . . 0.0 110.885 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.557 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 31.0 m -68.01 -0.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.41 -18.18 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 118.182 0.446 . . . . 0.0 110.669 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -92.73 -10.52 36.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.141 0.976 . . . . 0.0 111.396 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.66 -155.67 0.62 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.019 0.928 . . . . 0.0 109.081 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -66.92 111.01 3.56 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.008 0.523 . . . . 0.0 111.492 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.557 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -73.21 -50.32 12.89 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.223 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.49 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.5 mmt -71.15 -36.56 72.09 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.576 0.75 . . . . 0.0 112.79 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.39 81.67 1.41 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.749 0.785 . . . . 0.0 111.525 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -79.37 0.14 Allowed 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.961 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.96 33.11 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.132 0.573 . . . . 0.0 110.035 -168.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.518 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 18.0 tp -74.72 123.25 24.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.928 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.69 168.08 17.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.98 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.92 135.16 55.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.124 0.57 . . . . 0.0 111.29 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.26 18.97 73.04 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.54 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.12 169.98 12.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.736 0.414 . . . . 0.0 110.092 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.48 98.45 4.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.415 0.686 . . . . 0.0 110.519 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -86.36 107.88 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.65 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 53.6 m -87.04 152.23 22.56 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.91 0.484 . . . . 0.0 109.934 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m -144.56 146.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-O 121.635 0.731 . . . . 0.0 109.939 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 11.3 m-85 -136.81 140.34 31.56 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.19 169.08 9.84 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.796 2.998 . . . . 0.0 112.501 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 C--N 1.379 2.154 0 C-N-CA 121.159 1.239 . . . . 0.0 110.627 177.697 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 0' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 69.7 p . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.247 0.07 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 26.9 ptt? -102.84 129.62 49.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 110.583 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.05 136.52 33.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.5 mt -131.82 134.3 45.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 100.32 13.1 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.78 104.16 16.25 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.529 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 52.9 mtp180 -91.0 116.83 29.09 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.757 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.434 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 96.0 m-85 -103.79 138.81 39.88 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 109.241 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -130.77 157.88 41.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.645 0.778 . . . . 0.0 109.072 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.46 -132.72 0.8 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.443 1.097 . . . . 0.0 112.563 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.6 m -58.09 -42.3 85.34 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 124.16 0.984 . . . . 0.0 111.876 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.434 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 11.3 m-30 -62.66 -34.37 76.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.83 0.452 . . . . 0.0 111.224 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -38.38 88.02 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.536 0.523 . . . . 0.0 110.089 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.35 -43.96 84.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.986 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.49 HG12 ' HG ' ' A' ' 44' ' ' LEU . 69.4 t -57.22 -51.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.703 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.69 -26.6 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.453 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 11.4 71.25 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.144 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -138.46 145.72 41.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -86.91 -25.01 24.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.05 0.54 . . . . 0.0 112.038 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -156.39 123.13 5.17 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.184 0.993 . . . . 0.0 108.372 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.83 173.39 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.664 0.786 . . . . 0.0 109.353 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.57 112.09 18.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -95.4 177.15 5.93 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.599 1.16 . . . . 0.0 108.689 171.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -157.11 106.79 2.22 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.153 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.24 168.88 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 26.4 t70 -71.75 155.22 40.7 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.93 -14.63 61.91 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.59 0.756 . . . . 0.0 112.708 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -80.14 -16.91 53.9 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.122 0.569 . . . . 0.0 109.909 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.6 163.88 27.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.778 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.1 p -133.48 -175.39 3.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.563 1.145 . . . . 0.0 109.126 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.38 -37.93 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.051 0.94 . . . . 0.0 111.176 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.83 -42.48 69.92 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.567 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.45 -36.38 78.1 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.3 0.64 . . . . 0.0 111.033 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -62.76 -60.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.511 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.482 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.9 -30.45 71.44 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.466 0.306 . . . . 0.0 111.233 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.6 tpt180 -54.71 -49.21 71.26 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.187 0.595 . . . . 0.0 111.603 170.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 m -75.85 -31.27 59.24 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.736 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.03 -46.84 75.31 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.543 0.737 . . . . 0.0 112.373 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.6 pt-20 -65.5 -26.4 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.05 -22.25 62.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.113 0.565 . . . . 0.0 111.211 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -100.36 -59.43 1.71 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.682 0.753 . . . . 0.0 109.413 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -86.83 104.0 15.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.352 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.3 -17.55 63.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.384 0.674 . . . . 0.0 111.329 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -74.99 -12.65 83.21 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.304 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.605 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.6 mt -101.62 0.65 36.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.483 0.713 . . . . 0.0 110.918 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.38 121.35 14.65 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.54 70.42 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.229 -0.896 . . . . 0.0 115.213 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.534 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 2.3 ptp180 -117.91 -12.24 10.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.858 0.863 . . . . 0.0 111.13 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -107.41 -3.27 19.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.41 1.084 . . . . 0.0 110.477 172.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 35' ' ' ARG . 21.1 mt -134.47 136.5 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.911 1.284 . . . . 0.0 109.0 171.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' ' HZ2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -132.47 108.2 8.98 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 167.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 53.56 31.55 12.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.032 0.933 . . . . 0.0 112.903 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.6 2.25 67.68 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.52 -178.88 3.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 164.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.59 -55.54 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.152 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.534 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 14.2 tppt? 150.54 132.27 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.534 0 C-N-CA 125.443 1.497 . . . . 0.0 109.054 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.88 132.85 54.53 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 122.951 2.434 . . . . 0.0 111.679 167.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 78.93 -12.18 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.286 1.434 . . . . 0.0 113.94 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 68' ' ' VAL . 1.2 p -73.18 139.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.607 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.13 104.49 13.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG11 HG12 ' A' ' 85' ' ' VAL . 2.9 m -119.16 119.1 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.487 0.715 . . . . 0.0 109.289 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -112.38 131.24 55.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.491 1.116 . . . . 0.0 110.615 -172.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HB3' HG12 ' A' ' 67' ' ' VAL . 17.2 tptp -107.57 109.51 21.18 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.63 1.572 . . . . 0.0 108.116 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 56.38 35.42 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.763 0.792 . . . . 0.0 110.667 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.0 -0.07 87.49 Favored Glycine 0 CA--C 1.543 1.804 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.617 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -107.47 112.56 25.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.651 0.78 . . . . 0.0 109.913 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.4 tt0 -67.14 105.19 1.62 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.913 0.885 . . . . 0.0 110.98 -173.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 62' ' ' LYS . 17.1 m -69.33 -0.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 58' ' ' VAL . 17.4 m -67.72 -21.19 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 117.924 0.329 . . . . 0.0 111.152 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -84.73 -17.47 38.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.88 0.872 . . . . 0.0 111.204 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -138.15 -151.27 0.38 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.241 1.016 . . . . 0.0 109.769 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' O ' ' HB ' ' A' ' 75' ' ' THR . 1.4 m-20 -63.93 108.5 1.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.026 0.53 . . . . 0.0 111.167 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.25 -42.2 15.65 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.842 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.531 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.3 mmt -77.82 -39.88 42.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.399 0.679 . . . . 0.0 112.334 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.77 77.66 1.47 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.102 0.477 . . . . 0.0 111.461 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 71' ' ' ASP . 4.0 t -81.49 -67.91 0.74 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.003 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 179.84 33.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.346 0.658 . . . . 0.0 111.184 -164.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.453 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 31.0 tp -73.45 135.41 44.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.244 0.545 . . . . 0.0 110.692 -164.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.6 166.19 24.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.998 -165.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 34.4 t70 -65.52 143.6 57.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.382 0.673 . . . . 0.0 111.769 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.33 75.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.627 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.69 137.12 33.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 117.455 0.628 . . . . 0.0 111.249 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -96.39 94.99 7.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.766 0.426 . . . . 0.0 109.953 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 t -86.89 106.36 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.635 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 54.8 m -82.61 150.07 27.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.401 0.681 . . . . 0.0 110.035 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.418 HG12 HG11 ' A' ' 60' ' ' VAL . 23.0 m -145.9 141.84 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.601 0.715 . . . . 0.0 109.686 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.607 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 10.9 m-85 -133.68 132.09 21.53 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 22.0 Cg_endo -59.41 165.66 8.94 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.647 2.898 . . . . 0.0 113.256 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--N 1.374 1.884 0 C-N-CA 121.532 1.488 . . . . 0.0 110.676 175.929 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 46.5 p . . . . . 0 C--O 1.237 0.399 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -123.87 141.81 51.69 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.304 0.642 . . . . 0.0 110.055 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -107.73 113.16 26.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.699 0.399 . . . . 0.0 110.265 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 18.1 mt -102.64 142.09 34.38 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.257 1.023 . . . . 0.0 110.825 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.34 97.06 10.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.39 103.49 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.6 mtp180 -96.07 116.39 28.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.698 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -103.68 137.27 41.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.83 0.852 . . . . 0.0 109.18 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -129.17 159.59 35.54 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.574 0.75 . . . . 0.0 109.102 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.512 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.44 -133.6 1.07 Allowed 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.12 0.968 . . . . 0.0 112.239 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 14' ' ' VAL . 31.3 m -59.89 -40.92 90.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.618 0.767 . . . . 0.0 112.235 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -63.22 -29.08 70.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.772 0.26 . . . . 0.0 111.02 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.509 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 54.4 ttp85 -66.77 -53.58 31.59 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.391 0.676 . . . . 0.0 111.552 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.76 -27.9 67.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.401 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.435 HG13 ' HG ' ' A' ' 44' ' ' LEU . 45.6 t -62.19 -53.07 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.593 0.757 . . . . 0.0 111.046 173.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.439 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.1 t -70.64 -24.16 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.294 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.51 11.06 71.87 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.587 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -142.53 135.74 28.61 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 21.0 ptmt -83.69 -24.36 31.3 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.539 0.336 . . . . 0.0 111.773 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -155.52 135.69 13.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.2 172.68 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.739 0.816 . . . . 0.0 109.846 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 3' ' ' LEU . 82.8 m-85 -123.18 113.4 18.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.403 0.621 . . . . 0.0 109.51 170.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.426 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -103.01 139.53 38.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.153 1.381 . . . . 0.0 109.51 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -107.95 106.63 16.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.25 -179.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.326 1.05 . . . . 0.0 109.116 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.22 154.75 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.127 0.571 . . . . 0.0 109.894 173.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.36 -37.69 86.64 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.076 0.95 . . . . 0.0 112.25 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.83 -13.04 59.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.42 0.688 . . . . 0.0 110.705 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 142.87 57.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.878 0.471 . . . . 0.0 109.903 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 p -118.83 -176.93 3.2 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.9 t -53.09 -35.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.125 0.97 . . . . 0.0 111.504 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.78 59.64 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.36 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.0 -33.13 72.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.384 0.673 . . . . 0.0 110.804 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.26 -60.38 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.304 1.042 . . . . 0.0 110.946 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.578 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.9 pp -65.33 -30.11 70.92 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 123.239 0.337 . . . . 0.0 111.704 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.524 ' HA ' HD11 ' A' ' 49' ' ' ILE . 1.3 ppt_? -64.49 -36.55 84.55 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.077 0.465 . . . . 0.0 109.994 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.9 m -75.6 -33.67 60.58 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.622 0.769 . . . . 0.0 111.769 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.96 -37.86 88.77 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.064 0.546 . . . . 0.0 112.358 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -70.66 -28.55 64.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.832 0.348 . . . . 0.0 111.609 176.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.94 -24.49 62.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.158 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 12.8 mm-40 -88.13 -59.64 2.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.634 0.731 . . . . 0.0 109.726 174.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 97.1 m-85 -98.45 118.29 34.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.114 -170.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.78 -28.67 68.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.139 0.976 . . . . 0.0 110.654 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.7 -9.55 86.97 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 119.411 -0.661 . . . . 0.0 113.844 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.6 ' HB3' HD13 ' A' ' 48' ' ' LEU . 84.0 mt -95.9 -6.92 38.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.657 0.729 . . . . 0.0 111.127 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.22 124.61 22.62 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.6 0.76 . . . . 0.0 112.906 -171.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.96 8.51 86.81 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 115.135 0.814 . . . . 0.0 115.135 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.3 OUTLIER -125.1 -22.37 4.44 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 117.404 0.602 . . . . 0.0 111.973 -174.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -96.55 -0.23 49.11 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.774 0.43 . . . . 0.0 110.704 172.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.524 HD11 ' HA ' ' A' ' 35' ' ' ARG . 57.4 mt -135.41 145.66 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.173 1.389 . . . . 0.0 108.634 171.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 15.4 tp10 -157.74 127.85 6.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.967 0.907 . . . . 0.0 108.96 168.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.6 t70 56.87 31.31 19.42 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.493 1.14 . . . . 0.0 111.373 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.88 -14.26 38.59 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 114.743 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -94.89 -174.06 3.16 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 117.83 0.815 . . . . 0.0 110.053 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 34' ' ' LEU . 18.2 m -59.93 -54.71 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.772 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HA ' ' HB3' ' A' ' 50' ' ' GLU . 9.6 tppt? 150.44 137.0 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 C-N-CA 126.304 1.841 . . . . 0.0 108.112 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.76 125.6 19.18 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.038 164.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 81.19 -9.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.403 1.481 . . . . 0.0 113.939 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 55' ' ' LYS . 5.2 p -69.52 129.21 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.599 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -94.92 103.27 15.14 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 m -121.55 131.14 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 6.7 mp -123.87 141.73 51.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.065 0.946 . . . . 0.0 110.645 -168.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HE3' HD11 ' A' ' 77' ' ' LEU . 15.0 tptm -111.84 105.14 13.52 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.177 1.391 . . . . 0.0 107.835 168.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.11 35.61 25.25 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.45 1.1 . . . . 0.0 111.402 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.65 -14.21 64.65 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 114.342 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -89.09 107.66 19.16 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.896 0.848 . . . . 0.0 109.595 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.6 tt0 -65.34 106.85 1.46 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.102 0.561 . . . . 0.0 110.024 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.7 m -69.73 -1.71 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.33 -22.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.501 0.591 . . . . 0.0 110.917 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 66' ' ' GLU . 60.0 m-70 -84.05 -12.12 55.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.548 0.739 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.58 -153.04 0.44 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.568 1.147 . . . . 0.0 109.318 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.16 108.46 0.9 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.675 0.39 . . . . 0.0 110.687 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.7 -47.9 14.03 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.371 0.42 . . . . 0.0 112.358 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 90.1 mmm -80.31 -36.78 33.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.307 0.643 . . . . 0.0 112.221 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.98 76.81 1.52 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.906 -0.496 . . . . 0.0 111.715 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 t -81.46 -69.33 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.994 0.518 . . . . 0.0 112.393 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -179.0 34.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.507 0.723 . . . . 0.0 111.064 -163.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.468 HD11 ' HE3' ' A' ' 62' ' ' LYS . 40.4 tp -74.25 141.45 45.37 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.22 0.608 . . . . 0.0 111.502 -169.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -154.78 175.92 13.12 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.947 0.899 . . . . 0.0 109.567 -170.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.16 143.59 43.18 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.199 0.909 . . . . 0.0 111.78 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.88 2.51 65.31 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.297 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.78 134.9 33.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.781 0.832 . . . . 0.0 110.09 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.38 106.14 17.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.109 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.16 107.23 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.2 m -96.44 106.38 18.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.499 0.72 . . . . 0.0 110.303 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.66 140.78 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 3.5 m-85 -129.6 134.97 26.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 42.3 Cg_endo -65.54 166.19 20.5 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.202 2.602 . . . . 0.0 112.634 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--N 1.366 1.499 0 C-N-CA 121.079 1.186 . . . . 0.0 109.199 170.118 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 0' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 47.3 p . . . . . 0 C--O 1.234 0.26 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.471 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 24.9 ptt? -104.23 132.23 50.71 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.024 0.93 . . . . 0.0 110.673 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -87.15 135.19 33.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -128.61 136.59 50.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.309 0.643 . . . . 0.0 110.654 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -88.93 95.98 10.53 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.65 103.91 16.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.0 mtp180 -94.34 117.18 29.73 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -103.13 139.71 38.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.777 0.831 . . . . 0.0 109.29 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -133.89 158.86 42.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.379 0.672 . . . . 0.0 109.852 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 87' ' ' PRO . . . 61.02 -130.75 0.78 Allowed 'General case' 0 CA--C 1.565 1.527 0 O-C-N 124.363 1.039 . . . . 0.0 111.37 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.431 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 97.7 m -60.57 -48.08 83.34 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.662 0.665 . . . . 0.0 111.647 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.87 -24.7 53.63 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.817 0.447 . . . . 0.0 111.623 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.418 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -70.43 -53.39 16.63 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.294 0.637 . . . . 0.0 111.027 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 -22.29 59.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.864 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.453 HG12 ' HG ' ' A' ' 44' ' ' LEU . 42.8 t -59.43 -52.82 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.244 0.618 . . . . 0.0 110.342 168.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.444 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 93.8 t -75.13 -22.31 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.51 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.418 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 73.38 11.48 79.83 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.52 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -142.92 146.6 34.17 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.143 0.977 . . . . 0.0 108.58 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -90.12 -19.99 23.65 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.852 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.4 m -155.18 131.99 10.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.03 0.932 . . . . 0.0 108.716 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 pt -123.58 175.38 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.025 0.93 . . . . 0.0 108.64 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.88 112.25 15.76 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 167.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 -178.53 4.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.221 1.409 . . . . 0.0 109.629 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -156.1 111.48 2.95 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.39 174.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.8 p-10 -71.51 158.79 35.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.268 0.94 . . . . 0.0 110.322 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.67 -19.86 61.35 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.388 0.675 . . . . 0.0 112.088 -172.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.85 -21.12 37.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.476 0.31 . . . . 0.0 110.175 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 162.09 28.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.413 0.685 . . . . 0.0 111.216 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -137.86 -174.07 3.68 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.855 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -50.6 -37.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 125.626 1.57 . . . . 0.0 112.107 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.605 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.87 -38.61 65.28 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.299 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -66.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.232 0.613 . . . . 0.0 110.548 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.8 -60.41 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.572 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.87 -30.46 71.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.503 0.321 . . . . 0.0 110.982 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.549 ' HA ' HD11 ' A' ' 49' ' ' ILE . 26.0 tpt85 -52.91 -51.7 60.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.404 0.682 . . . . 0.0 111.507 171.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.1 m -75.99 -32.1 59.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.708 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.3 mm? -52.13 -48.57 64.77 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.723 0.809 . . . . 0.0 112.34 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 3.6 pt-20 -64.95 -26.31 68.25 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.0 -20.22 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.135 0.574 . . . . 0.0 111.104 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.35 -57.9 2.14 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.0 m-85 -91.82 108.55 20.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.84 -173.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.62 -22.0 65.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.353 0.661 . . . . 0.0 111.587 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.496 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.56 -8.68 87.14 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.028 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.647 ' HB3' HD12 ' A' ' 48' ' ' LEU . 88.9 mt -105.14 -6.89 19.46 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.699 0.799 . . . . 0.0 111.041 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.89 122.28 15.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.722 0.809 . . . . 0.0 113.142 -171.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.53 2.84 51.86 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 2.3 ptp180 -113.85 -4.37 13.33 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.647 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -114.5 -2.71 13.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.794 . . . . 0.0 110.357 174.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 35' ' ' ARG . 46.8 mt -135.26 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.99 1.316 . . . . 0.0 109.201 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 19.8 mm-40 -143.69 123.84 13.71 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.119 0.968 . . . . 0.0 109.15 160.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.35 30.87 20.18 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 124.353 1.061 . . . . 0.0 112.109 168.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.86 3.12 88.22 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 114.989 0.756 . . . . 0.0 114.989 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -116.41 -175.44 2.75 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.019 0.928 . . . . 0.0 108.702 170.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 m -63.2 -55.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.876 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 9.6 tppt? 153.22 139.69 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.377 0 C-N-CA 125.091 1.356 . . . . 0.0 109.062 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 22.2 Cg_endo -60.8 128.38 25.44 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.825 2.35 . . . . 0.0 111.928 166.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 77.83 -1.69 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.337 1.455 . . . . 0.0 113.912 171.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 3.1 p -76.4 153.71 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 13.2 m120 -118.24 104.76 11.1 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.8 129.48 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.468 0.707 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 6.9 mp -121.66 140.18 52.62 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.803 1.241 . . . . 0.0 111.899 -166.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.479 ' NZ ' ' HB2' ' A' ' 63' ' ' ASN . 0.5 OUTLIER -119.34 107.56 13.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.824 1.249 . . . . 0.0 108.29 171.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 65.0 t30 60.36 34.78 20.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.666 1.186 . . . . 0.0 110.328 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.87 -14.97 61.81 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.522 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -94.27 111.66 23.4 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.42 0.61 . . . . 0.0 109.896 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.8 tt0 -67.89 108.36 2.99 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.851 0.86 . . . . 0.0 110.886 -173.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.05 -1.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.795 1.638 . . . . 0.0 114.552 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 m -71.16 -23.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.188 0.449 . . . . 0.0 110.582 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 66' ' ' GLU . 74.9 m-70 -88.72 -15.97 33.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.732 0.813 . . . . 0.0 110.828 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.39 -140.7 0.17 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.699 1.199 . . . . 0.0 108.789 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.81 119.02 25.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.746 1.157 . . . . 0.0 110.806 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.29 -43.12 39.87 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.688 0.617 . . . . 0.0 112.817 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.605 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.4 mmt -81.46 -39.95 24.06 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.73 69.26 1.03 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.401 0.62 . . . . 0.0 111.774 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 t -74.49 -67.82 0.59 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.98 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -174.99 33.7 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 110.887 -165.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.11 139.29 42.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.188 0.195 . . . . 0.0 110.851 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 33.9 t70 -144.32 -176.06 4.88 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.729 0.811 . . . . 0.0 108.835 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 30.8 t70 -70.19 147.8 49.4 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.422 0.556 . . . . 0.0 111.852 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.86 66.53 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.386 -0.824 . . . . 0.0 113.301 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 3.6 t0 -94.76 127.65 40.9 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 122.568 0.347 . . . . 0.0 110.608 -168.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.17 115.85 23.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.151 0.58 . . . . 0.0 111.438 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.75 106.99 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.8 m -84.09 147.96 27.08 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -142.45 147.08 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.696 0.76 . . . . 0.0 109.792 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.486 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.8 m-85 -133.82 142.77 44.83 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 9' ' ' ALA . 40.3 Cg_endo -64.82 168.5 13.39 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.222 2.615 . . . . 0.0 111.374 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 48.4 Cg_endo . . . . . 0 C--N 1.371 1.751 0 C-N-CA 120.645 0.897 . . . . 0.0 111.249 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 0' ' ' THR . . . . . 0.518 ' HB ' ' HD2' ' A' ' 23' ' ' ARG . 2.6 p . . . . . 0 C--O 1.241 0.648 0 CA-C-O 121.285 0.564 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.778 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -109.08 121.84 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.788 0.435 . . . . 0.0 110.135 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.51 146.66 28.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.527 0.731 . . . . 0.0 111.153 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 42.9 tt0 -88.72 95.45 10.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.1 103.94 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.677 -0.639 . . . . 0.0 109.47 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 13.1 mtp180 -95.18 117.05 29.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.739 -176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -106.4 135.69 47.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.451 1.101 . . . . 0.0 108.926 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.75 160.46 31.64 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.12 0.568 . . . . 0.0 109.844 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.44 -121.03 1.22 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.994 1.318 . . . . 0.0 112.198 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.522 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 87.9 m -70.37 -44.56 67.83 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.866 0.866 . . . . 0.0 111.329 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -58.8 -28.43 65.97 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.636 0.374 . . . . 0.0 110.962 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 47.6 ttp180 -65.85 -52.17 52.71 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.75 0.656 . . . . 0.0 111.185 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.91 -27.11 60.88 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.481 0.488 . . . . 0.0 111.739 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG13 ' HG ' ' A' ' 44' ' ' LEU . 39.2 t -59.08 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.474 0.709 . . . . 0.0 110.541 170.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 17' ' ' GLN . 96.7 t -74.66 -22.36 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.963 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 11.39 63.35 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.769 0.7 . . . . 0.0 112.891 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.49 ' NE2' HG21 ' A' ' 20' ' ' ILE . 17.3 mt-30 -145.74 138.15 25.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.303 1.041 . . . . 0.0 108.312 -166.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 21.8 ptmt -100.92 -29.22 12.33 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 m -154.9 113.62 3.57 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.49 HG21 ' NE2' ' A' ' 17' ' ' GLN . 26.7 pt -121.63 170.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.205 0.602 . . . . 0.0 110.806 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -111.47 125.21 53.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.4 ' CH2' HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -121.89 123.18 41.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.122 0.969 . . . . 0.0 108.853 -176.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.518 ' HD2' ' HB ' ' A' ' 0' ' ' THR . 6.6 tpp85 -83.08 106.95 15.31 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.07 -179.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 0.0 109.526 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.23 159.7 24.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.394 0.677 . . . . 0.0 110.613 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.22 -26.03 68.33 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 110.522 168.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -80.24 -22.94 41.23 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.34 1.056 . . . . 0.0 110.553 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.24 43.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.294 0.637 . . . . 0.0 110.592 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 p -137.75 -174.64 3.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.118 0.967 . . . . 0.0 108.643 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 t -51.09 -35.96 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.996 0.918 . . . . 0.0 111.535 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.6 -45.5 76.38 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.175 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.37 -35.37 78.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.951 0.9 . . . . 0.0 111.113 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.28 -60.79 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.16 0.984 . . . . 0.0 110.805 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.531 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 1.9 pp -67.39 -30.08 69.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.19 0.306 . . . . 0.0 111.404 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.511 ' HA ' HD13 ' A' ' 49' ' ' ILE . 20.8 tpt180 -55.57 -49.74 71.93 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.376 0.608 . . . . 0.0 111.218 170.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -73.96 -32.48 63.49 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.148 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -57.28 -39.05 74.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.441 0.696 . . . . 0.0 112.42 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 7.1 pt-20 -75.67 -28.51 58.73 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 117.874 0.307 . . . . 0.0 111.691 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.64 -34.52 78.42 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.08 0.467 . . . . 0.0 110.467 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -79.0 -59.1 2.91 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.366 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 95.9 m-85 -99.21 122.03 41.85 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.799 -168.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.08 -40.66 96.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.052 0.941 . . . . 0.0 110.926 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 -16.37 64.27 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.323 -0.709 . . . . 0.0 114.218 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.562 ' O ' HD21 ' A' ' 48' ' ' LEU . 64.1 mt -95.39 -13.5 24.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.686 0.795 . . . . 0.0 111.833 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.548 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.07 120.8 9.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.52 -28.14 5.99 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.549 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 12.4 ptm180 -90.89 3.17 55.26 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -168.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.562 HD21 ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -127.15 2.65 6.45 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.355 0.662 . . . . 0.0 110.962 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 35' ' ' ARG . 69.6 mt -135.63 129.13 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.52 1.128 . . . . 0.0 108.352 170.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 1.2 tm-20 -150.62 128.59 11.79 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.0 t70 61.08 30.31 19.4 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.449 1.1 . . . . 0.0 110.85 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.51 -13.55 6.31 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.798 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.78 -173.41 2.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.915 0.886 . . . . 0.0 109.361 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 60' ' ' VAL . 17.0 m -60.23 -57.07 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.536 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.992 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 56' ' ' PRO . 12.8 tppt? 150.39 137.84 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 C-N-CA 124.986 1.314 . . . . 0.0 109.862 -175.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.501 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 42.8 Cg_endo -65.91 141.31 64.27 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 123.435 2.756 . . . . 0.0 111.773 163.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 82.25 -23.78 0.2 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.768 1.627 . . . . 0.0 112.532 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.12 141.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.9 m120 -111.87 104.58 12.89 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 54' ' ' VAL . 2.7 m -115.93 140.64 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.639 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -132.22 146.94 52.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.796 1.239 . . . . 0.0 110.012 -166.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.661 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 17.9 tptm -106.08 104.54 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 164.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.87 41.41 32.05 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.314 1.046 . . . . 0.0 111.838 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.44 -11.53 71.89 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-N 115.244 -0.889 . . . . 0.0 114.551 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -99.87 106.43 18.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tt0 -64.11 114.2 4.02 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.162 0.985 . . . . 0.0 111.63 -170.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.8 m -73.78 -2.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -172.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 m -72.67 -7.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 118.24 0.473 . . . . 0.0 111.361 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -96.69 -16.66 20.81 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.877 0.871 . . . . 0.0 110.958 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.84 -154.01 0.58 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.676 1.19 . . . . 0.0 109.208 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.2 m-20 -61.36 108.59 0.96 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.88 -48.54 33.23 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.484 0.49 . . . . 0.0 112.228 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.9 mmm -80.76 -37.97 29.46 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.003 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.04 66.13 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -172.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -70.09 -70.19 0.31 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.449 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.99 35.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -159.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.78 135.9 43.57 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.644 -0.66 . . . . 0.0 112.566 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.52 175.17 9.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.538 1.535 . . . . 0.0 108.151 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.66 141.26 53.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.771 0.714 . . . . 0.0 111.039 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.75 -15.14 27.34 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.619 -0.718 . . . . 0.0 114.381 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.661 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 50.9 m-20 -69.37 134.15 48.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.313 0.645 . . . . 0.0 111.618 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.21 142.6 27.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.03 107.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 165.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.0 m -94.06 130.12 40.33 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 0.0 109.151 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.437 HG12 HG12 ' A' ' 60' ' ' VAL . 23.0 m -130.53 138.73 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.722 0.692 . . . . 0.0 110.605 -174.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 64.1 m-85 -122.3 135.53 25.59 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.522 ' HG3' ' H ' ' A' ' 10' ' ' THR . 27.4 Cg_endo -58.96 168.04 4.89 Favored 'Trans proline' 0 C--N 1.364 1.369 0 C-N-CA 123.953 3.102 . . . . 0.0 114.075 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo . . . . . 0 C--N 1.378 2.098 0 C-N-CA 122.345 2.03 . . . . 0.0 111.374 174.1 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 0' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 36.8 p . . . . . 0 C--O 1.241 0.609 0 CA-C-O 120.915 0.388 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.459 ' HE2' HD12 ' A' ' 3' ' ' LEU . 24.8 ptt? -147.21 132.95 18.92 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -83.81 141.11 31.6 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.459 HD12 ' HE2' ' A' ' 1' ' ' MET . 27.5 mt -141.64 129.79 22.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 109.514 -172.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -88.86 101.16 13.77 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 mt -94.98 108.1 20.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 27.9 mtm180 -97.87 117.42 32.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.782 0.833 . . . . 0.0 109.743 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -102.51 135.15 44.66 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.332 1.053 . . . . 0.0 108.877 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -130.69 161.24 32.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.89 0.476 . . . . 0.0 110.069 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.44 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 59.08 -120.9 1.1 Allowed 'General case' 0 CA--C 1.564 1.506 0 O-C-N 124.509 1.131 . . . . 0.0 111.873 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.7 m -71.98 -41.61 67.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.302 0.641 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -60.52 -26.66 67.03 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.579 0.351 . . . . 0.0 110.864 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -47.52 69.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.57 0.748 . . . . 0.0 111.086 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.14 -22.99 59.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.541 HG12 ' HG ' ' A' ' 44' ' ' LEU . 74.8 t -60.33 -55.44 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 171.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.5 -20.42 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.06 11.85 83.98 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.417 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -163.94 158.26 19.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.695 0.798 . . . . 0.0 110.66 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -85.05 -19.67 31.6 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 9.6 m -152.55 147.78 26.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 pt -137.07 174.02 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.399 1.08 . . . . 0.0 108.762 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -122.58 113.16 18.9 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 167.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.405 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -98.49 172.63 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.896 1.279 . . . . 0.0 109.377 171.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -153.68 106.12 2.86 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.291 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.36 173.2 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.22 1.408 . . . . 0.0 108.474 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 34.0 t70 -66.2 161.26 22.43 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.978 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.22 -22.48 59.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.124 0.57 . . . . 0.0 111.745 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -81.0 -16.43 53.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.68 0.392 . . . . 0.0 110.65 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.86 151.49 41.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.324 0.65 . . . . 0.0 109.61 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.4 p -130.39 -174.74 3.43 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.901 0.881 . . . . 0.0 109.954 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.0 t -50.84 -37.04 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 124.578 1.151 . . . . 0.0 111.479 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.87 -39.78 64.5 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.802 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.26 -31.7 71.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.933 0.493 . . . . 0.0 110.52 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.74 -59.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.542 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 54' ' ' VAL . 1.7 pp -64.26 -31.15 72.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.799 0.272 . . . . 0.0 111.093 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.481 ' HA ' HD11 ' A' ' 49' ' ' ILE . 9.1 tpt180 -51.77 -50.25 61.07 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.264 0.554 . . . . 0.0 111.353 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -75.82 -32.02 59.63 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.313 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.94 -39.06 68.48 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.2 pt-20 -73.95 -29.71 62.14 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.65 0.262 . . . . 0.0 111.63 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.69 65.51 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.57 0.748 . . . . 0.0 110.895 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.405 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 21.4 mm-40 -95.39 -58.71 2.06 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.431 1.092 . . . . 0.0 109.944 172.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.89 116.0 28.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.09 -30.49 70.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.953 0.901 . . . . 0.0 110.541 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.9 -20.17 77.49 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.956 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HB3' HD11 ' A' ' 48' ' ' LEU . 63.1 mt -99.3 -1.66 38.41 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.713 0.805 . . . . 0.0 111.842 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.14 120.43 10.31 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.5 -7.64 17.79 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -100.16 4.57 44.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.029 0.914 . . . . 0.0 111.328 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.0 -5.96 8.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.579 1.152 . . . . 0.0 110.605 -177.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 35' ' ' ARG . 55.3 mt -133.02 138.6 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.681 1.193 . . . . 0.0 108.569 169.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 8.5 tp10 -144.9 124.87 13.51 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.649 0.78 . . . . 0.0 109.102 169.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.4 t70 58.95 31.79 21.66 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.432 1.093 . . . . 0.0 111.728 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 73' ' ' MET . . . 87.44 -14.74 57.17 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.168 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.09 -174.44 2.54 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.858 0.863 . . . . 0.0 109.185 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HD22 ' A' ' 34' ' ' LEU . 34.0 m -62.83 -54.97 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 CA-C-O 118.11 -0.947 . . . . 0.0 112.829 -170.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 11.5 tppt? 151.61 139.61 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.388 0 C-N-CA 125.789 1.635 . . . . 0.0 107.879 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.473 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 21.9 Cg_endo -58.58 125.57 18.73 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.83 2.353 . . . . 0.0 111.636 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 73.41 1.4 3.97 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.66 1.184 . . . . 0.0 113.944 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.43 HG22 ' HD3' ' A' ' 88' ' ' PRO . 5.1 p -74.28 117.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.6 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 5.1 m-20 -80.83 103.62 10.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.506 HG13 HG11 ' A' ' 85' ' ' VAL . 2.9 m -123.73 131.98 72.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -175.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.683 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 3.7 mp -121.88 172.14 8.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.254 1.022 . . . . 0.0 111.208 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 16.7 tptp -159.53 108.68 1.84 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.462 ' HB2' ' HZ2' ' A' ' 62' ' ' LYS . 9.7 t-20 54.85 34.42 21.99 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.798 0.839 . . . . 0.0 110.237 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.9 13.98 82.51 Favored Glycine 0 C--N 1.352 1.465 0 N-CA-C 115.005 0.762 . . . . 0.0 115.005 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -119.67 121.25 38.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.797 0.839 . . . . 0.0 108.802 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.6 tt0 -75.91 110.14 10.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.405 0.682 . . . . 0.0 110.677 -171.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.5 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 17.5 m -70.54 -0.96 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -174.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 m -70.25 -16.5 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 118.104 0.411 . . . . 0.0 110.885 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -95.33 1.15 54.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.1 0.96 . . . . 0.0 111.26 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.47 -153.84 0.44 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.795 0.838 . . . . 0.0 109.773 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.54 108.58 0.99 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.0 0.52 . . . . 0.0 111.314 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.5 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -67.37 -50.6 43.29 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.568 0.543 . . . . 0.0 113.627 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.4 ' HE3' ' O ' ' A' ' 52' ' ' GLY . 79.1 mmm -80.48 -39.64 27.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.089 0.556 . . . . 0.0 111.821 -170.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.84 76.62 1.54 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.912 0.863 . . . . 0.0 111.058 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.474 HG21 ' HG2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -81.64 -71.61 0.47 Allowed 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.149 177.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.16 34.67 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.599 0.76 . . . . 0.0 110.931 -163.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.534 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 21.0 tp -73.86 149.89 41.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.991 0.424 . . . . 0.0 110.54 -170.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.5 171.7 19.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 109.297 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.1 p-10 -70.39 146.62 50.29 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.347 0.659 . . . . 0.0 112.059 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.95 16.31 63.88 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.254 -0.885 . . . . 0.0 114.019 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.74 163.15 24.71 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.498 0.649 . . . . 0.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.38 95.33 4.43 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.638 0.732 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.8 t -86.53 138.56 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.919 1.288 . . . . 0.0 109.142 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.683 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 17.9 m -117.25 161.25 19.8 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.459 0.572 . . . . 0.0 110.653 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.506 HG11 HG13 ' A' ' 60' ' ' VAL . 35.3 m -146.79 141.73 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.196 0.998 . . . . 0.0 109.197 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.6 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 7.5 m-85 -135.28 133.7 20.79 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 175.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 23.6 Cg_endo -60.92 155.87 47.22 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.067 2.511 . . . . 0.0 112.565 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HD3' HG22 ' A' ' 58' ' ' VAL . 97.8 Cg_endo . . . . . 0 C--N 1.367 1.536 0 C-N-CA 122.565 2.177 . . . . 0.0 111.869 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 54.9 p . . . . . 0 C--O 1.238 0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.594 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.0 ptt? -105.34 135.97 45.74 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.823 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.85 129.75 41.71 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.657 0.783 . . . . 0.0 109.005 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 143.78 50.49 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.074 0.397 . . . . 0.0 111.221 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 36.1 tt0 -89.53 101.15 13.83 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.69 104.44 16.54 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 25.4 mtp180 -91.38 118.8 30.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.17 136.06 45.37 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.988 0.915 . . . . 0.0 109.387 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.66 161.56 30.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.083 0.553 . . . . 0.0 109.851 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.45 -129.92 1.33 Allowed 'General case' 0 CA--C 1.561 1.366 0 O-C-N 124.359 1.037 . . . . 0.0 111.238 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -64.04 -40.62 96.71 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 123.394 0.677 . . . . 0.0 111.747 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.478 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -67.54 -49.05 65.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.236 0.615 . . . . 0.0 110.626 -178.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.92 -18.03 60.95 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.82 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.448 HG13 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -66.02 -54.43 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.178 0.513 . . . . 0.0 110.253 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.55 -17.35 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.884 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.478 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 70.71 11.95 69.81 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.536 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -140.07 138.14 35.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.798 1.239 . . . . 0.0 109.146 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -82.68 -21.09 35.05 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.733 0.646 . . . . 0.0 110.707 172.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 11.6 m -154.65 149.81 26.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.628 1.171 . . . . 0.0 108.799 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 15.5 pt -135.26 178.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.129 0.972 . . . . 0.0 109.055 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -125.81 112.22 15.77 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.403 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -96.38 179.1 5.14 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.98 1.312 . . . . 0.0 109.921 174.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.0 ttp-105 -157.23 107.07 2.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.219 0.533 . . . . 0.0 109.942 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.84 176.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.684 1.194 . . . . 0.0 109.141 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -54.3 144.97 18.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.348 1.059 . . . . 0.0 110.014 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.99 -31.86 71.86 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.63 -7.51 59.6 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.593 0.757 . . . . 0.0 111.498 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.73 159.84 29.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.766 0.426 . . . . 0.0 109.853 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.8 p -130.96 179.2 6.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.986 0.515 . . . . 0.0 110.715 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.57 -35.79 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.609 1.164 . . . . 0.0 112.137 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.573 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.71 -37.47 67.01 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.741 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.46 -36.76 84.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.449 0.7 . . . . 0.0 110.927 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.14 -59.98 3.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.612 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD23 HG13 ' A' ' 54' ' ' VAL . 2.5 pp -63.7 -30.45 71.55 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.933 0.333 . . . . 0.0 111.315 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.488 ' HA ' HD13 ' A' ' 49' ' ' ILE . 22.4 tpt180 -53.4 -48.73 68.42 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.004 0.431 . . . . 0.0 111.511 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.21 -32.8 61.29 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.533 0.333 . . . . 0.0 111.547 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 3.1 mm? -56.08 -34.54 66.08 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.6 0.76 . . . . 0.0 112.837 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -76.8 -26.09 54.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.91 -30.75 65.69 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.936 0.494 . . . . 0.0 110.51 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.403 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 15.8 mm-40 -79.79 -58.92 2.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.212 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.4 118.25 36.26 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.718 -169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.09 -28.55 67.45 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.106 0.562 . . . . 0.0 110.192 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.21 -2.29 82.94 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.861 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB3' HD12 ' A' ' 48' ' ' LEU . 87.4 mt -114.65 2.84 14.61 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.578 0.689 . . . . 0.0 110.3 171.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.6 123.62 23.58 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.964 0.505 . . . . 0.0 111.886 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.85 8.19 87.75 Favored Glycine 0 N--CA 1.48 1.625 0 N-CA-C 115.176 0.831 . . . . 0.0 115.176 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.484 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.9 ptp180 -125.96 2.16 7.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.744 0.818 . . . . 0.0 111.422 -173.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.577 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -128.5 -8.89 5.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.427 1.091 . . . . 0.0 110.724 -176.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.488 HD13 ' HA ' ' A' ' 35' ' ' ARG . 31.2 mt -130.26 132.49 65.01 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 C-N-CA 124.867 1.267 . . . . 0.0 108.653 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.32 108.45 8.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.395 0.678 . . . . 0.0 109.798 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.2 t70 57.56 31.29 20.09 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.293 1.037 . . . . 0.0 111.666 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.0 0.66 71.1 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.6 -174.69 2.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.085 0.942 . . . . 0.0 108.721 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG13 HD23 ' A' ' 34' ' ' LEU . 15.0 m -65.1 -56.3 16.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 CA-C-O 117.537 -1.22 . . . . 0.0 112.015 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.2 tppt? 151.18 136.32 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 C-N-CA 124.667 1.187 . . . . 0.0 108.746 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.86 128.12 27.81 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.936 2.424 . . . . 0.0 111.08 164.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 82.42 -14.82 0.73 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.349 1.46 . . . . 0.0 114.251 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -70.12 126.46 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.4 m120 -94.82 103.45 15.34 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -120.68 134.23 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.095 0.474 . . . . 0.0 109.94 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 7.1 mp -119.59 171.68 8.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.885 1.274 . . . . 0.0 111.738 -170.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.57 ' HZ3' ' HB2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -158.16 104.2 1.86 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.776 -177.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.57 ' HB2' ' HZ3' ' A' ' 62' ' ' LYS . 15.3 t-20 56.47 36.47 27.61 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.455 1.102 . . . . 0.0 110.243 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.58 -13.24 67.13 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.719 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -97.41 119.9 36.79 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.413 0.685 . . . . 0.0 109.936 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 25.3 tt0 -79.55 106.47 11.6 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.769 -173.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -68.51 -1.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.374 1.469 . . . . 0.0 114.489 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.47 -21.61 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 117.857 0.299 . . . . 0.0 111.169 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -87.25 -19.34 28.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.979 0.912 . . . . 0.0 110.791 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.81 -139.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.612 1.165 . . . . 0.0 108.423 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.2 109.42 17.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.953 0.797 . . . . 0.0 110.206 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.85 -38.77 65.53 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.354 0.409 . . . . 0.0 112.871 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.573 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.9 mmt -81.58 -37.17 28.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.26 77.57 1.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 t -81.51 -66.5 0.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.27 33.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 -165.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.62 141.81 46.54 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.844 -0.535 . . . . 0.0 111.144 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.43 -175.98 4.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.313 1.045 . . . . 0.0 108.909 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.0 p30 -80.02 148.86 30.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.087 0.555 . . . . 0.0 111.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.67 61.75 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.708 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.34 141.97 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.19 0.596 . . . . 0.0 111.566 -170.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.61 109.84 22.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.88 0.472 . . . . 0.0 110.854 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -100.23 107.09 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.448 0.699 . . . . 0.0 109.285 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 61.4 m -87.07 148.13 25.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.121 0.569 . . . . 0.0 109.934 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 m -143.37 148.31 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.346 0.659 . . . . 0.0 110.241 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 25.5 m-85 -136.7 135.72 20.71 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 23.7 Cg_endo -59.71 164.47 11.5 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 124.012 3.141 . . . . 0.0 113.505 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.38 2.203 0 C-N-CA 122.297 1.998 . . . . 0.0 112.804 -178.595 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 62.8 p . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.491 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 21.4 ptt? -116.34 133.62 55.81 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.001 0.92 . . . . 0.0 110.976 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.91 132.99 36.08 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.214 1.006 . . . . 0.0 110.139 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.3 mt -132.64 139.07 47.58 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.515 0.726 . . . . 0.0 110.437 -168.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -89.37 102.32 14.99 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.496 HD11 HD23 ' A' ' 37' ' ' LEU . 36.4 mt -93.24 104.07 16.28 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.541 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 12.4 mtp180 -95.58 117.9 31.3 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.993 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.67 138.33 44.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.915 0.886 . . . . 0.0 109.76 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -132.01 156.07 46.9 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.307 0.643 . . . . 0.0 109.32 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.36 -128.12 1.72 Allowed 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.845 1.258 . . . . 0.0 112.818 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 84.8 m -55.92 -49.59 73.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.148 0.979 . . . . 0.0 111.862 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -64.19 -23.12 67.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.685 0.394 . . . . 0.0 111.006 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.593 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -69.21 -48.25 62.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.187 0.595 . . . . 0.0 110.962 178.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -22.78 59.38 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.379 0.424 . . . . 0.0 111.675 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.538 HG13 ' HG ' ' A' ' 44' ' ' LEU . 78.5 t -59.64 -56.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.594 0.711 . . . . 0.0 110.587 170.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.0 t -73.78 -22.07 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.376 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.593 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 71.01 11.05 69.52 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.938 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -142.37 145.33 33.76 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.848 0.859 . . . . 0.0 109.21 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -19.32 29.59 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.572 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 13.6 m -155.0 139.93 17.28 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 162.98 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.129 0.972 . . . . 0.0 108.882 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.0 112.75 24.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -103.37 178.05 4.67 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.447 1.499 . . . . 0.0 109.514 174.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -157.61 110.56 2.46 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.792 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.02 179.89 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.72 150.93 18.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.332 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.89 -35.0 69.62 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.524 1.129 . . . . 0.0 111.438 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.93 -13.3 59.02 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.768 0.827 . . . . 0.0 110.375 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 166.96 4.96 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.972 0.909 . . . . 0.0 111.353 172.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.8 p -135.98 -177.62 4.78 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.604 0.762 . . . . 0.0 110.1 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 77' ' ' LEU . 80.2 t -52.01 -37.84 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 C-N-CA 123.8 0.84 . . . . 0.0 110.757 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.63 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.49 -37.98 69.23 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.449 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.89 -29.82 68.18 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.046 0.539 . . . . 0.0 110.624 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.8 t -65.36 -60.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.577 0.751 . . . . 0.0 110.202 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.0 -30.31 71.4 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.794 0.27 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HA ' HD12 ' A' ' 49' ' ' ILE . 19.7 tpt180 -52.83 -46.96 67.99 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.28 0.562 . . . . 0.0 111.388 169.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.5 m -75.03 -32.43 61.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.708 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.496 HD23 HD11 ' A' ' 5' ' ' LEU . 3.5 mm? -59.18 -31.9 69.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.456 ' HB3' HD23 ' A' ' 48' ' ' LEU . 16.6 pt-20 -77.74 -28.48 50.76 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.426 0.557 . . . . 0.0 111.365 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.74 72.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.0 0.52 . . . . 0.0 111.084 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -85.96 -58.8 2.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.506 0.723 . . . . 0.0 110.58 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 95.0 m-85 -95.12 116.32 28.58 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.632 -171.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.99 -32.74 74.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.161 0.985 . . . . 0.0 111.225 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.483 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.69 -5.76 83.91 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.673 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.646 ' HB3' HD11 ' A' ' 48' ' ' LEU . 58.4 mt -106.56 3.04 26.58 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.573 0.687 . . . . 0.0 111.444 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.86 121.04 14.61 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 5.88 59.67 Favored Glycine 0 C--N 1.358 1.782 0 N-CA-C 115.773 1.069 . . . . 0.0 115.773 171.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.7 ptp180 -113.12 5.15 16.95 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.017 0.927 . . . . 0.0 111.337 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -126.27 -8.74 6.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.708 1.203 . . . . 0.0 110.36 -178.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 35' ' ' ARG . 33.5 mt -128.78 137.28 57.7 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 125.266 1.426 . . . . 0.0 108.402 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 16.1 mm-40 -128.9 107.95 10.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.525 0.73 . . . . 0.0 109.416 160.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 52.91 41.56 31.96 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.009 1.323 . . . . 0.0 112.873 171.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -7.1 78.03 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.988 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -110.5 -174.8 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.83 0.815 . . . . 0.0 109.1 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -70.14 -56.39 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.013 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 tppt? 152.49 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.434 0 C-N-CA 124.919 1.288 . . . . 0.0 109.392 -175.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.435 ' HD2' ' HG3' ' A' ' 50' ' ' GLU . 36.5 Cg_endo -63.11 131.91 34.42 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.077 2.518 . . . . 0.0 111.724 166.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 m170 76.73 -2.93 2.61 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 124.859 1.264 . . . . 0.0 113.682 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 1.4 p -75.9 154.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.2 m120 -121.03 103.56 9.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 HG21 ' A' ' 67' ' ' VAL . 4.4 m -117.0 147.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.755 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.1 mp -132.13 172.51 12.3 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.052 1.341 . . . . 0.0 110.375 -163.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 17.6 tptp -157.82 105.33 1.99 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.143 1.377 . . . . 0.0 107.534 -172.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.92 35.02 14.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.484 1.114 . . . . 0.0 110.744 -168.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.76 -14.18 59.06 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.361 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -83.63 116.67 22.73 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.91 0.855 . . . . 0.0 110.087 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 23.0 tt0 -73.85 107.07 5.86 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.068 -171.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.51 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.2 m -75.52 -0.98 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 58' ' ' VAL . 17.1 m -70.62 -14.98 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.946 0.794 . . . . 0.0 111.342 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -85.38 -27.17 26.01 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.628 0.771 . . . . 0.0 110.722 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -130.3 -152.22 0.5 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.119 0.968 . . . . 0.0 109.868 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.28 108.91 1.72 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.206 0.602 . . . . 0.0 111.334 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.51 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.63 -43.1 12.45 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.774 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.63 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.5 mmt -74.52 -39.49 62.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.121 0.569 . . . . 0.0 111.957 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.3 79.02 1.39 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.195 0.521 . . . . 0.0 111.496 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.2 t -81.78 -62.35 1.66 Allowed 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.882 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 176.06 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.67 1.188 . . . . 0.0 110.034 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 30' ' ' VAL . 1.2 tm? -73.91 113.68 11.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.55 0.74 . . . . 0.0 110.727 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.82 -178.19 4.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.229 1.411 . . . . 0.0 109.516 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.2 p-10 -66.42 150.36 49.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 112.362 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.21 13.43 64.75 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.239 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.85 156.99 33.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 117.446 0.623 . . . . 0.0 111.176 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.541 ' HB1' ' HD2' ' A' ' 6' ' ' ARG . . . -115.63 94.31 4.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.438 0.695 . . . . 0.0 109.297 171.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.26 106.37 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 48.9 m -93.11 146.35 23.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.376 0.671 . . . . 0.0 109.718 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 m -140.94 141.79 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.693 0.759 . . . . 0.0 110.199 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.7 m-85 -128.7 136.67 29.5 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.433 ' HG3' ' H ' ' A' ' 10' ' ' THR . 54.5 Cg_endo -62.75 169.37 8.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.165 3.243 . . . . 0.0 112.792 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 12.8 Cg_exo . . . . . 0 C--N 1.381 2.256 0 N-CA-C 108.962 -1.207 . . . . 0.0 108.962 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.8 ptt? -132.65 145.22 50.9 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.826 0.85 . . . . 0.0 109.443 174.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.33 113.42 26.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.996 0.519 . . . . 0.0 110.473 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.403 HD13 HD12 ' A' ' 77' ' ' LEU . 21.8 mt -104.6 143.53 32.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.858 0.863 . . . . 0.0 111.018 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.53 101.09 13.77 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.58 0.352 . . . . 0.0 110.146 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.2 mt -93.8 105.55 17.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.26 0.552 . . . . 0.0 110.332 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 61.4 mtp180 -91.5 124.18 35.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.62 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -112.32 137.82 49.93 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.561 0.745 . . . . 0.0 109.013 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -132.5 161.16 34.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.874 0.47 . . . . 0.0 110.454 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 56.28 -128.03 1.97 Allowed 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.631 1.172 . . . . 0.0 112.16 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m -59.5 -49.79 76.42 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.778 0.831 . . . . 0.0 111.609 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -59.8 -24.05 63.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.937 0.495 . . . . 0.0 111.352 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 ttp85 -68.71 -51.05 45.7 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.57 -21.85 60.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.529 0.332 . . . . 0.0 111.257 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.431 HG11 ' HG ' ' A' ' 44' ' ' LEU . 76.0 t -61.12 -55.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 0.0 110.07 170.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -77.87 -16.86 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.723 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.56 11.73 62.84 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.088 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -139.75 146.96 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.006 0.922 . . . . 0.0 110.007 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -104.36 -19.04 14.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.013 0.925 . . . . 0.0 110.998 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.5 m -153.74 138.36 16.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.949 0.9 . . . . 0.0 108.971 165.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.8 pt -133.37 178.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.821 0.848 . . . . 0.0 109.734 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -125.09 112.84 16.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.89 132.64 51.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 108.54 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -96.8 112.74 24.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 m -113.61 -179.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.83 166.26 22.62 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.019 0.372 . . . . 0.0 110.548 174.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.63 -31.58 72.86 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.625 0.77 . . . . 0.0 112.377 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.86 -17.16 51.62 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.828 0.451 . . . . 0.0 110.832 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 147.14 37.04 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.724 0.81 . . . . 0.0 112.183 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' A' ' 74' ' ' ALA . 74.5 p -134.03 -174.64 3.6 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.942 0.897 . . . . 0.0 109.097 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.0 t -52.36 -42.06 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.65 0.78 . . . . 0.0 111.464 -175.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.63 94.77 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.363 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.09 -34.43 76.41 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.262 0.553 . . . . 0.0 110.45 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.95 -57.8 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.246 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.625 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.2 pp -70.07 -30.66 67.96 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -64.94 -35.29 80.67 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.715 0.689 . . . . 0.0 110.49 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -75.84 -33.04 60.02 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.422 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -61.89 -39.43 91.95 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.935 0.494 . . . . 0.0 111.722 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 4.8 pt-20 -73.11 -26.26 61.17 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.95 63.72 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.077 0.551 . . . . 0.0 111.328 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -96.5 -59.19 1.87 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.943 0.878 . . . . 0.0 109.306 173.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -95.83 106.95 19.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.094 -171.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.38 -27.04 69.03 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.202 0.601 . . . . 0.0 111.048 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.58 -5.01 62.69 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.826 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.638 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.7 mt -111.3 -6.86 14.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.377 0.671 . . . . 0.0 111.481 172.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.3 120.03 8.51 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.56 5.66 56.51 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -96.62 -32.78 12.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.579 0.751 . . . . 0.0 109.583 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -98.13 2.03 48.15 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.219 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.22 139.0 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.603 1.161 . . . . 0.0 109.469 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.55 129.76 11.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.64 31.11 12.05 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.144 1.378 . . . . 0.0 112.035 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.62 -9.72 41.73 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.127 -0.818 . . . . 0.0 114.76 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -93.67 -174.42 3.46 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.179 0.989 . . . . 0.0 108.902 168.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.479 HG13 HD22 ' A' ' 34' ' ' LEU . 28.6 m -64.14 -55.32 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.417 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HG2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 tppt? 153.6 137.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 C-N-CA 125.175 1.39 . . . . 0.0 109.491 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.27 128.35 29.77 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.665 2.91 . . . . 0.0 111.981 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 76.35 -6.73 1.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.5 1.52 . . . . 0.0 113.874 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.17 141.85 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 18.0 m120 -111.8 104.13 12.43 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.417 HG22 HG11 ' A' ' 54' ' ' VAL . 4.9 m -113.34 136.05 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -127.74 148.53 50.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.036 1.334 . . . . 0.0 110.209 -168.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -112.38 105.43 13.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 59.44 35.87 23.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.059 0.944 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.08 -13.79 65.28 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.765 -0.652 . . . . 0.0 114.247 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -90.45 102.14 14.87 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.6 tt0 -64.79 106.2 1.16 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.859 0.864 . . . . 0.0 111.015 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.87 -1.35 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 66' ' ' GLU . 15.2 m -70.83 -12.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 118.09 0.405 . . . . 0.0 111.554 171.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -93.63 -20.97 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.569 0.748 . . . . 0.0 110.779 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.62 -153.14 0.54 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.604 1.162 . . . . 0.0 109.076 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.442 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.0 m-20 -59.64 109.34 0.89 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.266 0.626 . . . . 0.0 111.116 172.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.98 -46.33 7.15 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 123.321 0.388 . . . . 0.0 112.246 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 89.4 mmm -80.73 -20.16 43.41 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.427 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -161.44 79.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.898 0.317 . . . . 0.0 111.614 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -76.58 -74.97 0.21 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -176.68 35.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.492 0.317 . . . . 0.0 111.572 -164.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.403 HD12 HD13 ' A' ' 3' ' ' LEU . 18.2 mt -73.7 150.13 41.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.553 0.692 . . . . 0.0 112.435 -170.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -154.23 179.7 8.72 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.723 1.609 . . . . 0.0 107.628 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 31.9 t70 -63.99 129.33 39.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.019 0.528 . . . . 0.0 111.906 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.96 6.22 82.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.133 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.01 122.22 27.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.602 0.761 . . . . 0.0 111.413 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.67 125.08 32.19 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.252 0.621 . . . . 0.0 111.734 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.36 107.63 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.684 0.794 . . . . 0.0 109.721 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.666 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.0 m -85.83 152.1 23.28 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.394 0.677 . . . . 0.0 110.191 175.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.49 147.0 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.418 0.628 . . . . 0.0 109.946 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 42.3 m-85 -135.33 134.24 21.14 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 174.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 29.8 Cg_endo -59.42 164.64 10.61 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.841 3.028 . . . . 0.0 114.025 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HG3' ' HG2' ' A' ' 55' ' ' LYS . 15.4 Cg_exo . . . . . 0 C--N 1.38 2.215 0 C-N-CA 122.662 2.241 . . . . 0.0 111.166 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 0' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 25' ' ' ASP . 29.7 p . . . . . 0 C--O 1.238 0.499 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.501 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 23.7 ptt? -114.63 132.01 56.52 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.581 1.153 . . . . 0.0 110.695 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -84.42 128.57 34.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.275 0.63 . . . . 0.0 109.533 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.476 HD12 ' HE1' ' A' ' 1' ' ' MET . 25.3 mt -127.46 137.08 52.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.475 0.71 . . . . 0.0 110.467 -173.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -89.69 101.54 14.23 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.3 mt -93.33 107.42 19.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtt-85 -96.31 120.45 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.302 1.041 . . . . 0.0 109.778 -176.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.44 134.42 50.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.515 1.126 . . . . 0.0 109.251 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -128.68 162.55 27.09 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.979 0.512 . . . . 0.0 109.904 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 60.8 -122.6 0.91 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.493 1.117 . . . . 0.0 111.497 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.416 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 54.5 m -68.94 -45.77 69.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 111.408 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -57.19 -27.91 62.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.03 0.532 . . . . 0.0 111.335 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -64.57 -53.6 45.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.538 0.735 . . . . 0.0 111.34 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -21.76 60.43 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.345 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.483 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -61.71 -49.99 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.026 0.531 . . . . 0.0 110.606 169.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.94 -15.5 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.728 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.68 83.32 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.049 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -166.93 155.76 10.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.218 1.007 . . . . 0.0 110.156 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -89.75 -13.27 37.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 8.8 m -155.22 147.53 23.85 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.193 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -140.78 172.22 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.61 1.164 . . . . 0.0 108.703 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -118.35 112.78 20.47 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -92.1 -179.19 5.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.832 1.253 . . . . 0.0 108.937 167.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -156.73 110.16 2.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 176.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.363 1.065 . . . . 0.0 108.472 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.429 ' HA ' HG21 ' A' ' 0' ' ' THR . 6.9 t70 -68.76 157.1 37.08 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 122.995 0.518 . . . . 0.0 110.031 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.68 -18.69 60.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.715 0.406 . . . . 0.0 110.728 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.39 -23.83 37.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.297 0.639 . . . . 0.0 109.723 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.52 147.87 47.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.476 0.71 . . . . 0.0 109.668 171.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -132.08 -174.37 3.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.263 1.025 . . . . 0.0 109.8 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.457 ' N ' HD13 ' A' ' 77' ' ' LEU . 2.3 p -50.72 -36.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.644 1.178 . . . . 0.0 112.646 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -71.05 -41.02 61.48 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.379 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 35' ' ' ARG . 17.8 t70 -70.9 -29.49 65.57 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.792 0.296 . . . . 0.0 110.521 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.7 t -59.37 -60.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.455 0.702 . . . . 0.0 109.831 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 HG12 ' A' ' 54' ' ' VAL . 2.4 pp -66.57 -30.76 71.14 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 123.11 0.257 . . . . 0.0 111.334 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.5 tpt180 -56.0 -46.65 78.66 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.36 0.6 . . . . 0.0 111.629 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -75.2 -32.97 61.35 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.356 0.662 . . . . 0.0 111.773 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -56.45 -45.03 81.04 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.701 0.801 . . . . 0.0 112.152 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 9.5 pt-20 -64.16 -29.8 70.9 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.61 0.569 . . . . 0.0 112.283 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.86 -22.67 67.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.957 0.503 . . . . 0.0 111.63 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -97.13 -57.97 2.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.008 0.909 . . . . 0.0 109.169 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.65 105.47 17.84 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.807 -173.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.3 -32.14 72.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.393 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.917 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.642 ' HB3' HD12 ' A' ' 48' ' ' LEU . 81.5 mt -103.09 -11.66 17.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.863 0.865 . . . . 0.0 111.271 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -57.28 121.55 10.41 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.366 0.667 . . . . 0.0 112.517 -173.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.59 -19.93 8.31 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 171.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.76 0.72 57.47 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.466 0.633 . . . . 0.0 111.655 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.642 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -124.02 5.58 8.62 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 110.29 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 35' ' ' ARG . 17.5 mt -140.75 142.47 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 124.639 1.176 . . . . 0.0 109.244 172.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -145.76 116.68 7.76 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.463 0.705 . . . . 0.0 110.125 164.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 55.92 31.56 18.07 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.221 1.008 . . . . 0.0 111.826 172.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.39 82.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -106.9 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.096 0.948 . . . . 0.0 108.785 165.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.513 HG12 HD23 ' A' ' 34' ' ' LEU . 15.8 m -64.29 -55.39 21.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 CA-C-O 117.595 -1.193 . . . . 0.0 112.13 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? 150.02 132.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 C-N-CA 125.212 1.405 . . . . 0.0 107.601 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -61.11 140.61 90.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.727 2.285 . . . . 0.0 111.593 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 80.16 -21.33 0.33 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.509 1.524 . . . . 0.0 113.504 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 p -72.61 152.51 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 15.9 m120 -119.89 103.83 9.67 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.3 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.461 0.704 . . . . 0.0 109.55 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.6 mp -121.12 131.29 54.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.925 1.29 . . . . 0.0 110.725 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -105.59 111.73 24.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.15 0.98 . . . . 0.0 109.057 171.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.4 t30 57.3 34.83 25.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.594 1.158 . . . . 0.0 110.577 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -4.51 86.04 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.41 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -102.37 114.23 28.23 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.944 0.897 . . . . 0.0 109.157 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 18.3 tt0 -70.63 110.26 5.36 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.363 0.665 . . . . 0.0 111.292 -171.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.02 -1.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.2 m -68.3 -19.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.109 0.413 . . . . 0.0 111.527 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -85.39 -16.26 40.42 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.924 0.89 . . . . 0.0 110.963 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.24 -152.72 0.44 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.42 1.088 . . . . 0.0 109.334 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.61 108.2 0.94 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.957 0.503 . . . . 0.0 110.551 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.01 -29.06 24.07 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.794 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.537 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.5 mmt -80.85 -37.94 29.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.503 0.721 . . . . 0.0 112.147 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.78 85.34 1.17 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 t -82.01 -70.79 0.52 Allowed 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.554 0.742 . . . . 0.0 112.271 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 179.77 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.458 1.103 . . . . 0.0 110.209 -163.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.29 114.86 13.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -116.85 179.76 3.92 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.359 0.664 . . . . 0.0 110.433 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 7.8 p-10 -73.09 142.32 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.56 0.744 . . . . 0.0 111.286 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.63 18.3 78.54 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.314 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -96.61 141.78 29.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.439 0.696 . . . . 0.0 111.785 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.54 109.35 22.12 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.167 0.987 . . . . 0.0 110.711 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.13 107.29 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.2 m -83.92 150.49 25.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.77 0.828 . . . . 0.0 110.093 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.12 145.63 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.466 0.706 . . . . 0.0 109.491 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 19.4 m-85 -137.33 135.06 19.02 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 29.3 Cg_endo -61.2 165.61 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 123.96 3.107 . . . . 0.0 113.688 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 C--N 1.378 2.107 0 C-N-CA 122.608 2.205 . . . . 0.0 112.491 178.338 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -147.27 145.64 29.47 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.586 0.754 . . . . 0.0 109.495 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -89.3 141.11 28.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.67 138.15 44.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.575 0.75 . . . . 0.0 109.264 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -89.37 104.5 17.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.2 mt -93.72 104.26 16.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 79.9 mtt180 -92.05 117.39 29.79 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.533 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.54 137.59 42.16 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.907 0.883 . . . . 0.0 109.227 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -130.22 160.55 33.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.896 0.478 . . . . 0.0 110.59 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.402 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 57.95 -119.0 1.1 Allowed 'General case' 0 CA--C 1.56 1.332 0 O-C-N 124.783 1.302 . . . . 0.0 112.238 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.519 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 8.6 m -70.99 -47.45 58.78 Favored 'General case' 0 C--N 1.361 1.067 0 CA-C-N 118.415 0.552 . . . . 0.0 110.437 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -58.04 -26.61 62.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.051 0.54 . . . . 0.0 111.056 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -66.55 -54.42 23.85 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.223 0.609 . . . . 0.0 111.386 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -17.64 60.87 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.635 0.585 . . . . 0.0 111.797 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.4 t -63.44 -55.06 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.391 0.676 . . . . 0.0 109.654 169.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.44 -16.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.441 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 17.28 80.23 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.491 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -166.77 150.82 7.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.018 0.927 . . . . 0.0 110.321 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -91.23 -22.21 20.72 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -154.75 136.87 14.73 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -130.03 176.82 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.031 0.933 . . . . 0.0 109.144 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.5 111.44 16.82 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.11 177.4 5.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.001 1.32 . . . . 0.0 109.111 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -156.54 108.11 2.46 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 m -112.75 179.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.846 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -55.97 148.62 16.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.421 0.688 . . . . 0.0 110.364 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -66.55 -26.1 66.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.517 0.327 . . . . 0.0 111.413 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.45 -24.64 36.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.952 0.501 . . . . 0.0 110.56 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.47 129.2 39.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.345 0.658 . . . . 0.0 111.16 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.1 p -111.92 -172.97 2.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.324 1.049 . . . . 0.0 110.372 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -50.82 -41.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 123.771 0.828 . . . . 0.0 111.804 -170.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.35 94.85 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.65 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.11 -33.26 75.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.264 0.625 . . . . 0.0 111.582 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.03 -59.75 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.675 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.571 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.1 pp -68.89 -30.71 69.27 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.4 ppt_? -67.35 -34.3 77.02 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.907 0.776 . . . . 0.0 111.204 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.1 m -75.58 -32.45 60.36 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.007 175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -59.08 -49.57 77.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.918 0.487 . . . . 0.0 111.213 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -67.25 -25.31 66.02 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -20.84 66.52 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 123.345 0.403 . . . . 0.0 110.973 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -96.91 -58.72 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.782 0.801 . . . . 0.0 109.41 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.85 111.13 22.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.339 -170.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.77 -26.93 67.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.638 0.775 . . . . 0.0 110.116 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.54 -17.48 68.84 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.501 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' HD22 ' A' ' 48' ' ' LEU . 82.4 mt -103.2 -13.98 16.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.888 0.875 . . . . 0.0 111.683 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.16 121.21 10.75 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.28 11.94 79.69 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 11.3 ptm180 -120.58 -21.19 6.84 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.54 0.67 . . . . 0.0 111.318 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -101.85 8.42 41.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.031 0.533 . . . . 0.0 110.219 170.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 35' ' ' ARG . 43.2 mt -140.89 142.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.079 1.351 . . . . 0.0 108.87 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 1.6 tm-20 -154.83 123.69 6.2 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.09 31.04 17.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.413 1.085 . . . . 0.0 111.589 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.57 -4.07 75.36 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.592 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HA ' ' SD ' ' A' ' 73' ' ' MET . 3.7 pt-20 -106.36 -174.07 2.45 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.82 0.81 . . . . 0.0 109.681 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.8 -54.7 30.12 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.165 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? 149.45 137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 C-N-CA 126.503 1.921 . . . . 0.0 106.982 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 18.6 Cg_endo -56.54 129.08 32.81 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.802 2.335 . . . . 0.0 111.174 166.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 76.35 -6.26 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.877 1.271 . . . . 0.0 113.957 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 68' ' ' VAL . 1.9 p -73.69 143.79 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.81 104.69 13.35 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.18 137.25 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.228 0.611 . . . . 0.0 109.599 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.7 mp -126.89 142.73 51.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.835 1.254 . . . . 0.0 110.85 -166.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -114.06 109.21 18.08 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.474 1.11 . . . . 0.0 108.208 166.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.33 35.65 23.26 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.074 0.94 . . . . 0.0 110.349 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.25 -14.7 60.2 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.819 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -87.64 109.03 19.37 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.481 ' HG2' HG23 ' A' ' 68' ' ' VAL . 17.4 tt0 -67.44 105.09 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.453 0.701 . . . . 0.0 110.334 -173.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.48 -1.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.481 HG23 ' HG2' ' A' ' 66' ' ' GLU . 20.2 m -73.7 -10.27 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 122.593 0.357 . . . . 0.0 111.364 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -87.15 -25.54 24.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.534 0.733 . . . . 0.0 110.452 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.22 -150.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.074 0.95 . . . . 0.0 109.808 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.21 107.89 0.54 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.685 0.394 . . . . 0.0 111.055 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -86.22 -30.35 22.74 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.684 0.615 . . . . 0.0 111.954 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.52 ' HA ' ' HE3' ' A' ' 73' ' ' MET . 20.7 mmt -81.45 -34.9 31.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.078 0.551 . . . . 0.0 111.79 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.36 81.48 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 t -81.02 -67.76 0.75 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -173.5 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -163.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.32 144.09 44.65 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.68 -175.08 5.18 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.395 1.478 . . . . 0.0 107.817 -174.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.3 143.08 52.15 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.891 0.476 . . . . 0.0 111.186 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.0 69.6 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 114.806 0.682 . . . . 0.0 114.806 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.99 118.28 22.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.033 0.533 . . . . 0.0 111.665 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.55 104.03 14.19 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.523 0.729 . . . . 0.0 111.147 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 t -93.27 106.56 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 50.8 m -86.95 148.9 25.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.731 0.812 . . . . 0.0 109.539 176.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.42 146.33 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.814 0.816 . . . . 0.0 109.692 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 21.9 m-85 -132.38 144.55 53.51 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 173.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HG3' ' H ' ' A' ' 10' ' ' THR . 34.3 Cg_endo -63.48 169.11 10.22 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.517 2.811 . . . . 0.0 112.124 169.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 38.8 Cg_endo . . . . . 0 C--N 1.376 1.995 0 C-N-CA 121.218 1.278 . . . . 0.0 110.661 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 0' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 24.6 p . . . . . 0 C--O 1.241 0.632 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.05 136.91 54.88 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.411 1.084 . . . . 0.0 110.068 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -91.74 141.37 28.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.405 0.682 . . . . 0.0 110.14 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.43 138.9 45.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.466 1.106 . . . . 0.0 110.606 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.3 103.98 16.57 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.508 0.723 . . . . 0.0 109.089 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.413 HD11 HD21 ' A' ' 37' ' ' LEU . 29.9 mt -93.31 103.62 15.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 74.7 mtt180 -91.09 119.75 31.49 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.58 1.152 . . . . 0.0 109.434 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -108.11 140.35 41.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.25 1.02 . . . . 0.0 108.759 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -132.38 160.55 36.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.138 0.575 . . . . 0.0 109.585 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.41 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 59.72 -125.28 1.18 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.685 1.194 . . . . 0.0 112.706 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 27.6 m -68.02 -46.8 70.19 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.369 0.668 . . . . 0.0 111.14 -178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -57.31 -26.57 61.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.31 0.644 . . . . 0.0 111.633 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.489 ' HD3' ' HG2' ' A' ' 18' ' ' LYS . 7.0 tmm_? -68.66 -53.14 24.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.415 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -18.77 60.59 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.424 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.6 t -64.34 -48.12 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.251 0.548 . . . . 0.0 110.216 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 17' ' ' GLN . 88.4 t -78.87 -21.7 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.863 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.64 20.04 75.34 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.227 -175.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.499 ' HB2' HG13 ' A' ' 15' ' ' VAL . 13.8 mm100 -148.07 139.21 23.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.86 1.264 . . . . 0.0 109.111 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 26.3 mtmt -85.01 -21.32 29.51 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.891 0.744 . . . . 0.0 109.925 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -154.08 148.7 26.35 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.336 1.054 . . . . 0.0 108.814 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -135.84 168.03 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.473 1.109 . . . . 0.0 108.386 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.04 113.16 25.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.425 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -100.15 178.29 4.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.055 1.342 . . . . 0.0 109.373 171.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -157.44 107.33 2.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.549 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.32 173.21 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.347 1.059 . . . . 0.0 108.229 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.3 p-10 -67.86 160.46 28.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.093 0.473 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.26 -19.69 59.58 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.346 0.659 . . . . 0.0 111.522 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -80.76 -19.34 45.11 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.536 0.734 . . . . 0.0 109.155 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.73 154.65 39.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 0.0 110.775 172.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 p -134.23 -174.7 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.619 1.168 . . . . 0.0 109.862 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.94 -37.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 124.551 1.14 . . . . 0.0 111.878 -175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -68.76 -42.25 80.15 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.298 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.72 -35.15 77.22 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.421 0.688 . . . . 0.0 110.895 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.15 -61.1 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.797 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.15 -30.71 71.65 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.662 0.21 . . . . 0.0 110.728 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -53.68 -48.39 69.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.919 0.487 . . . . 0.0 111.562 172.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.1 m -75.8 -31.61 59.5 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.803 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD21 HD11 ' A' ' 5' ' ' LEU . 2.1 mm? -54.11 -41.08 67.9 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.741 0.816 . . . . 0.0 112.824 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 12.2 pt-20 -71.56 -28.11 63.62 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.13 68.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.102 0.561 . . . . 0.0 110.277 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 4.9 mm-40 -86.04 -59.37 2.32 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.832 0.853 . . . . 0.0 109.783 175.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.2 m-85 -99.58 119.81 38.66 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.672 -168.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.29 -29.01 67.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.791 0.837 . . . . 0.0 110.902 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.87 -0.23 80.68 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.072 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.65 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.6 mt -115.78 1.58 13.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 111.092 173.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.03 122.39 19.28 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.44 76.56 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.555 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 9.8 ptp180 -118.29 4.47 11.89 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.641 0.776 . . . . 0.0 111.827 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.65 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -125.92 -8.08 6.64 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.498 1.119 . . . . 0.0 110.443 -178.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.1 mt -132.73 136.87 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.877 1.271 . . . . 0.0 108.297 167.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -149.64 124.19 9.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.36 31.52 21.01 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.669 1.187 . . . . 0.0 111.937 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.02 -14.46 53.12 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.531 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -99.16 -174.84 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.962 0.881 . . . . 0.0 109.058 171.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.42 -55.11 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 118.104 -0.95 . . . . 0.0 111.723 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.6 tppt? 154.88 135.11 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.037 0 C-N-CA 124.714 1.206 . . . . 0.0 108.956 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 26.7 Cg_endo -60.45 135.55 61.91 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.929 2.419 . . . . 0.0 111.336 165.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 79.45 -12.49 1.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.135 1.374 . . . . 0.0 113.569 174.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 1.9 p -75.81 152.12 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.8 104.12 9.62 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.465 HG21 HG23 ' A' ' 67' ' ' VAL . 5.3 m -122.1 146.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.261 0.624 . . . . 0.0 109.873 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.3 mp -127.64 172.08 11.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.073 1.349 . . . . 0.0 110.971 -167.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 19.4 tptp -162.51 105.58 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 t30 54.99 35.57 24.96 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.053 0.941 . . . . 0.0 110.096 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.03 -14.69 61.36 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.784 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -88.89 118.77 28.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.374 0.67 . . . . 0.0 110.094 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.7 tt0 -72.44 103.01 3.34 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.477 0.486 . . . . 0.0 109.713 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.541 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 14.3 m -69.73 -1.07 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -173.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.3 m -69.91 -16.21 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.31 0.505 . . . . 0.0 111.317 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -91.09 -10.72 40.99 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.383 0.673 . . . . 0.0 111.324 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.84 -152.4 0.42 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.189 0.996 . . . . 0.0 109.595 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.17 108.35 2.65 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.1 0.56 . . . . 0.0 110.409 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.541 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -81.62 -38.59 13.84 Favored Glycine 0 C--N 1.341 0.846 0 O-C-N 123.378 0.424 . . . . 0.0 112.594 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.516 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.8 mmt -80.19 -36.36 35.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 112.647 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.19 77.65 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.432 HG21 ' HG2' ' A' ' 62' ' ' LYS . 1.4 t -82.15 -74.62 0.33 Allowed 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.802 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.22 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.143 0.577 . . . . 0.0 111.472 -161.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 24.3 tp -74.22 144.74 44.59 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.761 0.315 . . . . 0.0 111.347 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -156.21 168.76 26.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.295 1.038 . . . . 0.0 109.464 -168.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.87 149.97 48.56 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.948 0.499 . . . . 0.0 111.839 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.39 63.84 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.841 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -82.74 155.41 24.3 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.169 0.484 . . . . 0.0 109.863 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 99.06 6.68 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 123.287 0.635 . . . . 0.0 109.617 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -86.44 106.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.4 m -90.87 146.5 23.86 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 123.168 0.587 . . . . 0.0 109.506 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.27 144.76 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -128.83 141.19 40.82 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.433 ' HG3' ' H ' ' A' ' 10' ' ' THR . 41.6 Cg_endo -63.79 168.4 11.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.762 2.975 . . . . 0.0 112.519 175.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 15.7 Cg_endo . . . . . 0 C--N 1.378 2.088 0 C-N-CA 121.234 1.289 . . . . 0.0 111.198 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 C--O 1.24 0.557 0 CA-C-O 121.107 0.479 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.481 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.9 ptt? -101.72 140.4 36.05 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.781 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -95.22 130.59 41.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.292 0.637 . . . . 0.0 109.797 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 77' ' ' LEU . 24.4 mt -124.44 138.73 54.33 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.646 0.779 . . . . 0.0 110.45 -169.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 45.5 tt0 -89.32 102.64 15.31 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.86 103.7 16.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 30.1 mtm180 -92.32 117.62 30.09 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.393 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.33 138.49 42.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 109.464 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.72 155.38 48.95 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.335 0.654 . . . . 0.0 109.7 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 60.75 -126.75 0.96 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.144 1.378 . . . . 0.0 111.99 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.7 m -63.97 -43.03 96.98 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 123.34 0.656 . . . . 0.0 111.127 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -60.98 -27.69 68.47 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.574 0.35 . . . . 0.0 111.072 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 55.3 ttp180 -67.5 -53.33 29.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.321 0.648 . . . . 0.0 111.396 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -20.42 60.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.111 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.508 HG12 ' HG ' ' A' ' 44' ' ' LEU . 40.6 t -61.5 -47.74 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.559 0.695 . . . . 0.0 110.294 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.75 -20.54 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.905 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.53 16.36 71.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.041 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -143.19 139.4 30.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.553 1.141 . . . . 0.0 109.841 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 22.3 ptmt -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.754 0.659 . . . . 0.0 110.521 172.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -156.92 145.43 19.74 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.465 174.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.12 173.24 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.344 1.057 . . . . 0.0 109.089 172.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -118.73 112.76 20.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.8 -179.64 4.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.276 1.43 . . . . 0.0 109.388 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -157.36 105.75 2.11 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.82 172.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -59.21 148.33 32.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.175 0.59 . . . . 0.0 111.285 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -61.94 -27.31 68.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 111.29 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -80.3 -24.99 39.61 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 110.24 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.89 37.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.02 0.528 . . . . 0.0 109.639 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.3 p -103.14 -173.87 2.42 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.596 0.758 . . . . 0.0 110.799 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 77' ' ' LEU . 87.9 t -50.84 -37.03 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 124.204 1.002 . . . . 0.0 111.493 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.605 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.3 -38.38 71.19 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.97 -31.02 69.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.297 0.639 . . . . 0.0 110.879 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.32 -60.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.172 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.514 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.7 pp -64.63 -30.16 71.18 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.192 0.308 . . . . 0.0 111.204 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.521 ' HA ' HD13 ' A' ' 49' ' ' ILE . 16.6 tpt180 -51.41 -49.97 60.57 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.462 0.705 . . . . 0.0 111.242 168.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 m -75.36 -32.31 60.81 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.653 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 3.8 mm? -58.26 -35.31 71.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.187 0.595 . . . . 0.0 112.498 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.493 ' HB3' HD22 ' A' ' 48' ' ' LEU . 7.8 pt-20 -76.84 -27.45 55.12 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.324 0.511 . . . . 0.0 111.673 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.92 64.7 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.776 0.43 . . . . 0.0 111.01 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -90.23 -59.82 2.09 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.574 0.702 . . . . 0.0 110.158 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -92.28 126.54 37.4 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.602 -168.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.99 -35.67 69.55 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.689 0.796 . . . . 0.0 110.023 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.18 -4.19 86.18 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.957 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.591 ' HB3' HD12 ' A' ' 48' ' ' LEU . 56.9 mt -106.82 -3.67 20.12 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.934 0.867 . . . . 0.0 111.485 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.02 121.4 14.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.87 12.02 67.2 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.354 0.902 . . . . 0.0 115.354 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.44 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -118.26 0.44 11.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.005 0.922 . . . . 0.0 110.743 179.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.591 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -122.8 -5.42 8.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.524 1.13 . . . . 0.0 109.831 177.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 35' ' ' ARG . 37.0 mt -130.67 135.17 60.87 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.108 1.363 . . . . 0.0 108.398 169.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HG2' ' HZ3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -145.84 126.35 14.13 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 166.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 56.11 31.29 17.92 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.604 1.162 . . . . 0.0 111.947 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.01 -14.38 57.32 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.27 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.59 -174.6 2.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.402 HG12 HD21 ' A' ' 34' ' ' LEU . 27.8 m -63.51 -55.88 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.153 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 11.3 tppt? 151.5 137.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.075 0 C-N-CA 125.122 1.369 . . . . 0.0 108.901 -176.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 131.13 31.48 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 C-N-CA 123.042 2.495 . . . . 0.0 111.836 165.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 79.38 -11.72 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.585 1.554 . . . . 0.0 114.167 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -69.34 142.99 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.622 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 16.4 m120 -110.2 103.36 12.04 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG11 HG12 ' A' ' 85' ' ' VAL . 3.7 m -121.3 129.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.537 0.735 . . . . 0.0 109.307 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 2.1 mp -121.06 139.39 53.38 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.435 1.094 . . . . 0.0 110.413 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 12.9 tptm -110.5 114.65 28.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.17 35.12 21.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.032 0.933 . . . . 0.0 110.993 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.05 -4.93 81.79 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.998 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -100.35 116.01 31.32 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 11.3 tt0 -70.28 107.11 3.59 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.635 0.584 . . . . 0.0 109.774 -173.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.71 -1.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.48 -19.35 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 122.662 0.385 . . . . 0.0 111.168 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -90.26 -5.24 56.55 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.668 0.787 . . . . 0.0 111.235 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.01 -149.35 0.29 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 109.327 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.24 108.84 3.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.266 0.626 . . . . 0.0 110.605 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.23 -43.4 20.95 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 122.999 0.187 . . . . 0.0 112.641 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.605 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.6 mmt -76.91 -40.26 47.94 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.195 0.598 . . . . 0.0 111.775 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.37 78.75 1.52 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 t -80.8 -65.99 0.94 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.654 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 175.57 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.918 0.887 . . . . 0.0 110.462 -163.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 30' ' ' VAL . 47.2 tp -73.89 136.64 43.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.639 0.375 . . . . 0.0 110.412 -175.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -149.93 -177.46 5.92 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 122.805 0.442 . . . . 0.0 110.013 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.481 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 33.6 t70 -64.4 144.93 56.81 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.794 0.838 . . . . 0.0 112.917 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.35 -7.19 12.42 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.455 -0.793 . . . . 0.0 114.793 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.456 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 4.9 m-20 -78.44 142.07 37.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.762 0.825 . . . . 0.0 112.431 -169.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -97.64 111.16 23.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.036 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.17 107.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.709 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 12.9 m -85.57 147.04 26.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.985 0.514 . . . . 0.0 109.986 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.444 HG12 HG11 ' A' ' 60' ' ' VAL . 33.0 m -141.93 140.6 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.602 0.715 . . . . 0.0 109.584 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 6.6 m-85 -129.92 137.79 31.67 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 37.1 Cg_endo -63.44 162.67 26.48 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.151 2.567 . . . . 0.0 112.594 176.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 C--N 1.37 1.68 0 C-N-CA 121.509 1.472 . . . . 0.0 111.17 177.864 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 0' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 20.9 p . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.543 ' HE1' HD22 ' A' ' 3' ' ' LEU . 27.0 ptt? -96.06 143.54 27.12 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.826 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -93.34 126.87 38.69 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.904 0.882 . . . . 0.0 109.046 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.543 HD22 ' HE1' ' A' ' 1' ' ' MET . 0.4 OUTLIER -124.11 148.98 46.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.946 0.498 . . . . 0.0 109.988 -175.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 31.1 tt0 -97.42 113.51 25.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 170.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.2 mt -101.39 112.29 24.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 51.9 mtt180 -99.94 117.17 33.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.187 0.995 . . . . 0.0 108.796 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.55 137.61 45.28 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.952 0.901 . . . . 0.0 109.256 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -131.6 159.7 37.48 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.93 0.492 . . . . 0.0 109.814 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 59.21 -120.6 1.07 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 124.779 1.232 . . . . 0.0 112.337 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -71.92 -45.41 61.29 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 123.082 0.553 . . . . 0.0 110.442 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -55.34 -30.0 59.42 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.195 0.598 . . . . 0.0 110.972 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HD2' ' HG2' ' A' ' 18' ' ' LYS . 50.8 ttp180 -66.72 -55.24 15.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.84 0.856 . . . . 0.0 111.726 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -16.93 60.91 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.934 -174.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.466 HG13 ' HG ' ' A' ' 44' ' ' LEU . 40.1 t -65.54 -55.87 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.28 0.632 . . . . 0.0 109.689 168.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.2 t -74.54 -17.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.612 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.7 11.61 73.3 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.701 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -139.48 144.29 37.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.198 0.999 . . . . 0.0 109.144 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' HD2' ' A' ' 12' ' ' ARG . 22.0 mtmm -86.31 -21.05 27.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.746 0.419 . . . . 0.0 109.909 174.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 14.7 m -154.05 146.51 24.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.377 1.071 . . . . 0.0 109.216 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 23.2 pt -141.52 170.61 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 109.7 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -112.83 113.07 24.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.47 -179.53 4.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.579 1.151 . . . . 0.0 109.843 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.441 ' HG2' ' HB ' ' A' ' 0' ' ' THR . 60.7 ttp180 -157.4 106.43 2.14 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.829 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.46 169.37 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.215 171.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 27.8 t70 -61.8 154.09 26.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.936 0.494 . . . . 0.0 111.039 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.24 -32.42 71.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.014 0.926 . . . . 0.0 111.833 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -81.01 -22.6 39.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.958 0.903 . . . . 0.0 111.362 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 153.72 37.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.28 0.632 . . . . 0.0 110.66 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -130.48 -175.07 3.53 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 97.8 t -51.81 -37.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.951 0.9 . . . . 0.0 111.648 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.95 65.92 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.005 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.27 -33.79 76.64 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.272 0.629 . . . . 0.0 110.296 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.88 -60.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.813 0.845 . . . . 0.0 110.317 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.484 HD23 HG11 ' A' ' 54' ' ' VAL . 2.6 pp -64.66 -30.74 71.76 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.134 0.424 . . . . 0.0 111.579 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HA ' HD11 ' A' ' 49' ' ' ILE . 17.3 tpt180 -50.96 -48.59 61.0 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.157 0.583 . . . . 0.0 110.956 168.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 m -74.65 -32.5 62.29 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.187 0.595 . . . . 0.0 111.436 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 4.1 mm? -59.74 -34.29 72.76 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 48' ' ' LEU . 5.6 pt-20 -76.89 -28.57 55.41 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.718 0.69 . . . . 0.0 111.124 173.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.05 -32.7 72.37 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.039 0.536 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -83.99 -58.0 2.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.526 0.73 . . . . 0.0 110.474 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -96.38 127.33 42.28 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.587 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.28 -45.68 90.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.131 0.973 . . . . 0.0 110.697 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.11 7.1 54.34 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.423 -0.808 . . . . 0.0 114.021 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.585 ' HB3' HD13 ' A' ' 48' ' ' LEU . 74.3 mt -115.97 5.26 13.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.615 0.707 . . . . 0.0 111.167 172.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -69.89 120.94 16.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.27 -8.09 26.97 Favored Glycine 0 C--N 1.359 1.847 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -100.08 4.13 44.45 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.355 1.062 . . . . 0.0 111.403 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.585 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -128.66 -8.87 5.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.257 1.023 . . . . 0.0 110.855 -177.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.454 HD11 ' HA ' ' A' ' 35' ' ' ARG . 51.5 mt -125.22 132.52 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.598 1.159 . . . . 0.0 107.967 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.17 117.65 13.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.919 0.488 . . . . 0.0 109.731 167.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.2 t70 55.54 30.85 15.98 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.05 -14.83 63.4 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.616 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -97.31 -174.01 2.82 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.883 0.842 . . . . 0.0 108.885 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.484 HG11 HD23 ' A' ' 34' ' ' LEU . 13.8 m -65.5 -56.83 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.788 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 150.81 135.97 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.003 0 C-N-CA 125.078 1.351 . . . . 0.0 109.176 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.49 137.51 51.02 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.84 2.36 . . . . 0.0 110.972 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 77.9 -11.94 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.325 1.45 . . . . 0.0 113.61 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 p -73.56 138.94 20.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.658 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.6 m120 -104.67 103.55 13.21 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.54 HG11 HG11 ' A' ' 85' ' ' VAL . 4.2 m -122.93 135.38 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -126.19 155.62 41.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.349 1.059 . . . . 0.0 110.639 -166.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.509 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 13.3 tptm -123.49 104.51 9.11 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.554 1.142 . . . . 0.0 107.975 169.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 t30 52.64 37.69 24.07 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.062 1.345 . . . . 0.0 111.702 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 19.61 43.79 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.871 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -133.27 105.49 7.01 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 16.0 tt0 -62.85 109.31 1.4 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.331 1.052 . . . . 0.0 110.918 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -69.95 -1.48 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -68.16 -22.53 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 117.935 0.334 . . . . 0.0 110.824 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -86.38 -15.87 39.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.865 0.866 . . . . 0.0 111.151 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.75 -153.14 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.247 1.019 . . . . 0.0 109.289 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.25 113.5 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.077 0.551 . . . . 0.0 110.538 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.3 -50.29 12.79 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.718 0.636 . . . . 0.0 112.734 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.3 mmm -79.94 -36.83 35.7 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.345 0.658 . . . . 0.0 111.692 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.43 77.95 1.65 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.571 0.701 . . . . 0.0 111.008 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.29 -71.4 0.47 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.836 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' H ' HG21 ' A' ' 75' ' ' THR . . . -173.75 28.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.912 0.885 . . . . 0.0 110.962 -164.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -75.33 144.06 42.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.175 0.59 . . . . 0.0 111.574 -168.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -157.51 -176.02 5.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.066 0.546 . . . . 0.0 110.1 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 28.3 t70 -63.88 140.53 58.88 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.035 0.934 . . . . 0.0 111.338 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 -7.09 57.87 Favored Glycine 0 C--N 1.344 1.023 0 O-C-N 123.834 0.709 . . . . 0.0 114.421 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.509 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 78.1 m-20 -79.55 133.9 36.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -170.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.32 105.66 17.63 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.446 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.2 137.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.9 m -118.12 154.83 31.46 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.441 0.564 . . . . 0.0 110.2 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.54 HG11 HG11 ' A' ' 60' ' ' VAL . 34.6 m -145.1 143.92 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.751 0.82 . . . . 0.0 110.152 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.658 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 18.1 m-85 -135.08 133.75 21.08 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.426 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 22.0 Cg_endo -59.89 160.96 19.93 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 123.325 2.684 . . . . 0.0 112.867 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 C--N 1.377 2.059 0 C-N-CA 121.945 1.764 . . . . 0.0 111.745 -178.664 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 34.3 p . . . . . 0 C--O 1.241 0.624 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.469 ' HE1' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -113.76 151.44 31.96 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.481 0.712 . . . . 0.0 110.391 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.11 137.96 50.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.602 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.469 HD12 ' HE1' ' A' ' 1' ' ' MET . 11.6 mt -124.23 149.25 46.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.685 0.794 . . . . 0.0 109.855 -176.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -89.2 106.86 18.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.26 112.65 24.57 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 39.8 mtp180 -104.64 118.02 35.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.716 0.806 . . . . 0.0 109.297 -170.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 136.67 45.47 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.924 0.89 . . . . 0.0 109.325 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -132.45 160.74 35.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.79 0.436 . . . . 0.0 110.104 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.06 -117.77 0.82 Allowed 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.892 1.277 . . . . 0.0 112.389 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.536 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 46.7 m -69.69 -47.52 62.91 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 123.632 0.773 . . . . 0.0 110.494 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -59.46 -24.36 63.49 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.986 0.515 . . . . 0.0 111.224 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -50.36 53.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.731 0.813 . . . . 0.0 111.291 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -16.91 60.89 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.537 HG12 ' HG ' ' A' ' 44' ' ' LEU . 72.6 t -65.36 -53.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.626 0.726 . . . . 0.0 110.205 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.85 -16.73 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.633 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.74 11.52 85.15 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.414 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.97 158.84 10.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.84 0.856 . . . . 0.0 110.807 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -94.76 -9.42 34.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.0 m -152.65 143.08 22.63 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.41 175.82 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.223 1.009 . . . . 0.0 109.119 174.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.49 112.96 16.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.36 135.91 44.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.303 1.041 . . . . 0.0 110.038 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -104.13 106.18 16.6 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.1 175.7 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.542 1.137 . . . . 0.0 108.226 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.46 164.52 26.54 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.627 0.371 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -76.95 -15.46 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.53 -24.33 36.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.879 0.472 . . . . 0.0 110.35 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.06 58.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.901 0.881 . . . . 0.0 111.463 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.3 p -128.27 -174.39 3.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.475 1.11 . . . . 0.0 109.725 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.81 -33.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 123.973 0.909 . . . . 0.0 112.093 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.58 -50.05 51.67 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.053 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -61.59 -29.55 70.11 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.174 0.59 . . . . 0.0 111.583 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.45 -60.62 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.31 1.044 . . . . 0.0 110.541 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.3 pp -74.14 -31.06 62.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.2 ppt_? -67.12 -31.85 72.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.67 0.668 . . . . 0.0 111.176 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -76.67 -34.11 58.24 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.607 0.763 . . . . 0.0 112.333 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -59.91 -38.96 83.81 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 122.974 0.509 . . . . 0.0 111.86 -176.449 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -68.28 -37.41 80.64 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.345 0.403 . . . . 0.0 111.765 175.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.54 -28.96 69.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.506 0.723 . . . . 0.0 111.447 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -82.72 -58.83 2.72 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.043 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.22 112.56 24.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.813 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.93 -31.3 70.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.579 0.751 . . . . 0.0 110.55 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -73.31 -6.39 69.56 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.419 -0.809 . . . . 0.0 114.064 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.59 ' HB3' HD11 ' A' ' 48' ' ' LEU . 68.0 mt -113.26 2.29 15.51 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.675 0.738 . . . . 0.0 111.141 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.9 120.74 13.62 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.27 -28.67 2.6 Favored Glycine 0 C--N 1.359 1.826 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 5.6 ptp180 -83.29 9.24 11.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.904 1.282 . . . . 0.0 112.693 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -132.26 9.85 4.45 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.94 0.896 . . . . 0.0 110.931 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.1 mt -141.41 140.75 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.296 1.038 . . . . 0.0 109.315 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HG2' ' HZ1' ' A' ' 55' ' ' LYS . 16.6 mm-40 -139.71 110.41 6.74 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.302 0.641 . . . . 0.0 110.317 163.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t70 56.6 36.14 27.16 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.475 1.11 . . . . 0.0 111.894 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.04 27.52 62.13 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.139 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.63 -177.4 4.17 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 161.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 HD23 ' A' ' 34' ' ' LEU . 17.1 m -66.5 -56.09 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 117.588 -1.196 . . . . 0.0 112.297 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HZ1' ' HG2' ' A' ' 50' ' ' GLU . 5.9 tppt? 149.58 134.27 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.243 0 C-N-CA 126.06 1.744 . . . . 0.0 108.616 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.417 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 19.5 Cg_endo -58.91 133.34 53.02 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.061 2.507 . . . . 0.0 112.184 165.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 81.03 -26.99 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.861 1.664 . . . . 0.0 113.107 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.76 120.44 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -95.41 104.71 16.62 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 85' ' ' VAL . 1.7 m -109.37 146.39 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.287 0.635 . . . . 0.0 109.55 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.5 mp -132.7 170.66 14.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.971 1.308 . . . . 0.0 110.243 -164.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HE2' HD23 ' A' ' 77' ' ' LEU . 20.9 tptp -162.28 105.43 1.14 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 55.82 34.76 24.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.16 0.981 . . . . 0.0 109.832 -171.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.93 -13.58 48.05 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 114.492 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -87.16 119.28 27.23 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.922 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 24.3 tt0 -78.53 104.47 9.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.224 0.61 . . . . 0.0 111.13 -168.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.454 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.1 m -70.87 -1.32 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -170.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.1 m -68.6 -19.78 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.39 0.541 . . . . 0.0 110.898 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -92.53 -29.38 16.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.019 0.927 . . . . 0.0 110.843 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.79 -150.74 0.47 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.143 0.977 . . . . 0.0 109.406 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.04 108.31 2.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.955 0.502 . . . . 0.0 110.955 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.454 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -83.15 -37.79 12.09 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 123.32 0.387 . . . . 0.0 112.273 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.531 ' HA ' ' HE3' ' A' ' 73' ' ' MET . 14.1 mmt -79.73 -38.39 33.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.653 0.781 . . . . 0.0 111.917 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.73 83.96 1.29 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.47 -75.26 0.29 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.724 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.4 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -163.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.448 HD23 ' HE2' ' A' ' 62' ' ' LYS . 15.4 mt -73.68 143.65 46.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.865 0.84 . . . . 0.0 112.554 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -151.1 169.3 22.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.751 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.9 135.07 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 122.13 -0.356 . . . . 0.0 111.217 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 16.58 80.54 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.82 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.2 157.43 21.64 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.421 0.611 . . . . 0.0 109.563 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.75 106.03 11.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.268 0.627 . . . . 0.0 111.143 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -86.92 137.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 69.5 m -118.62 151.82 37.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.44 HG13 HG12 ' A' ' 60' ' ' VAL . 10.3 m -142.27 148.3 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 121.404 0.621 . . . . 0.0 110.196 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -136.3 140.71 33.53 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.536 ' HG3' ' H ' ' A' ' 10' ' ' THR . 53.6 Cg_endo -64.28 168.83 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.254 3.303 . . . . 0.0 112.417 174.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 C--N 1.382 2.329 0 C-N-CA 121.077 1.185 . . . . 0.0 111.385 -178.725 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.198 0.523 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' A' ' 26' ' ' ASP . 13.2 ptm -122.31 111.71 17.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.412 1.085 . . . . 0.0 109.722 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.32 121.43 28.87 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 77' ' ' LEU . 21.4 mt -123.93 135.21 53.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.562 0.745 . . . . 0.0 110.027 -169.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.11 98.45 11.77 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.413 HD12 HD21 ' A' ' 37' ' ' LEU . 21.9 mt -94.83 104.8 16.71 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.122 . . . . 0.0 110.529 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 41.3 mtp180 -101.06 117.33 34.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.408 0.683 . . . . 0.0 109.414 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -101.76 140.22 36.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.049 0.939 . . . . 0.0 109.357 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.5 157.11 43.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.096 0.558 . . . . 0.0 110.137 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.66 -122.29 1.09 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.775 1.23 . . . . 0.0 112.861 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.454 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 92.0 m -64.78 -48.07 75.83 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 123.757 0.823 . . . . 0.0 111.042 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -60.03 -24.52 64.59 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.819 0.448 . . . . 0.0 111.467 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -72.46 -47.58 47.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.932 0.493 . . . . 0.0 111.288 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -74.16 -19.11 60.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.53 0.332 . . . . 0.0 111.698 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG12 ' HG ' ' A' ' 44' ' ' LEU . 53.0 t -67.35 -52.55 40.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.67 0.788 . . . . 0.0 110.483 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.486 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 95.6 t -73.88 -22.18 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.526 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.07 11.44 63.66 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.885 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -146.46 136.99 23.97 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -170.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HD2' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -87.71 -14.71 39.09 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -155.5 137.82 14.84 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.709 0.804 . . . . 0.0 109.315 177.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.45 140.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -88.92 112.45 23.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.86 170.97 9.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.55 1.14 . . . . 0.0 108.928 170.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -157.02 108.47 2.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.704 0.764 . . . . 0.0 109.466 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.57 -179.56 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.766 1.627 . . . . 0.0 108.364 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.99 160.19 30.09 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.412 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 5.3 p-10 -69.83 -8.08 45.33 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.694 0.797 . . . . 0.0 113.043 -170.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.35 -14.44 57.25 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.719 0.807 . . . . 0.0 112.26 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.95 129.47 36.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.696 0.398 . . . . 0.0 111.133 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p -109.63 -179.59 3.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -54.02 -32.66 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.081 0.952 . . . . 0.0 112.368 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.63 -40.51 58.88 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.741 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.7 -32.24 73.41 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.163 0.481 . . . . 0.0 110.45 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.21 -60.08 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.678 0.611 . . . . 0.0 110.408 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.467 HD22 HG11 ' A' ' 54' ' ' VAL . 2.6 pp -66.91 -30.08 70.14 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 123.331 0.394 . . . . 0.0 111.166 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HA ' HD13 ' A' ' 49' ' ' ILE . 18.3 tpt85 -56.28 -48.38 76.72 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.061 0.544 . . . . 0.0 111.518 170.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -75.88 -31.75 59.37 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.047 0.539 . . . . 0.0 111.442 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 5' ' ' LEU . 1.5 mm? -56.59 -44.81 81.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.706 0.803 . . . . 0.0 112.406 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -65.68 -25.64 67.42 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.157 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.7 -21.65 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.655 0.597 . . . . 0.0 111.238 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -98.68 -59.09 1.81 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 122.877 0.471 . . . . 0.0 109.781 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 91.9 m-85 -89.66 117.45 28.54 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.882 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.01 -35.39 81.04 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.742 0.817 . . . . 0.0 111.481 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.88 -2.13 75.74 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.754 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.619 ' HB3' HD13 ' A' ' 48' ' ' LEU . 58.0 mt -103.94 -15.57 15.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.46 0.704 . . . . 0.0 110.893 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.48 120.65 9.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.779 0.832 . . . . 0.0 112.59 -171.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.62 74.04 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 115.489 0.955 . . . . 0.0 115.489 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.55 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 3.1 ptp180 -118.71 -0.06 11.37 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.539 0.736 . . . . 0.0 111.713 -176.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.22 -3.05 11.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.738 0.815 . . . . 0.0 110.185 173.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 35' ' ' ARG . 41.2 mt -133.44 137.19 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.019 1.328 . . . . 0.0 108.195 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -135.96 108.39 7.37 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t70 57.92 32.2 21.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.636 1.174 . . . . 0.0 112.557 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.43 1.2 69.17 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 115.084 0.793 . . . . 0.0 115.084 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.08 -174.91 2.63 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 117.849 0.824 . . . . 0.0 109.392 165.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG11 HD22 ' A' ' 34' ' ' LEU . 17.8 m -65.76 -55.42 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.601 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.5 tppt? 150.21 138.09 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 C-N-CA 125.576 1.55 . . . . 0.0 107.956 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.479 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 19.6 Cg_endo -56.07 129.19 33.57 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 123.009 2.473 . . . . 0.0 110.619 166.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 74.86 -4.79 2.29 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.997 1.319 . . . . 0.0 114.28 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -74.99 131.9 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.1 m120 -100.9 103.58 14.76 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.43 137.28 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.267 0.627 . . . . 0.0 109.765 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 7.4 mp -118.87 169.23 10.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.113 1.365 . . . . 0.0 111.09 -169.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -163.77 106.0 0.95 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.478 -177.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.517 ' HB2' ' HZ3' ' A' ' 62' ' ' LYS . 7.5 t-20 59.21 38.12 23.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.188 1.395 . . . . 0.0 109.721 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.96 -14.6 48.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.619 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -93.79 119.12 32.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.445 0.622 . . . . 0.0 109.565 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 22.4 tt0 -75.18 109.46 8.69 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.064 0.459 . . . . 0.0 109.765 -174.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.6 m -71.4 -0.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.72 -19.91 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.186 0.448 . . . . 0.0 110.978 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -88.3 -19.65 26.46 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.737 0.815 . . . . 0.0 110.794 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.34 -148.34 0.36 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.692 1.197 . . . . 0.0 109.262 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.3 108.95 6.46 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.003 0.521 . . . . 0.0 110.57 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.6 -37.64 22.94 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 113.903 0.321 . . . . 0.0 113.903 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 82.8 mmm -81.62 -26.75 34.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.99 85.35 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 118.177 0.444 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.43 HG21 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.81 -73.15 0.4 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.073 0.549 . . . . 0.0 112.192 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.43 ' H ' HG21 ' A' ' 75' ' ' THR . . . -173.19 33.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.815 0.846 . . . . 0.0 110.557 -164.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 3' ' ' LEU . 41.4 tp -74.35 123.54 24.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.495 0.318 . . . . 0.0 110.154 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 7.0 t70 -116.82 178.24 4.41 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.5 147.69 49.09 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.359 0.663 . . . . 0.0 111.035 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.21 10.82 70.06 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.548 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -82.6 177.67 8.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.451 0.701 . . . . 0.0 110.896 -174.228 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.69 109.11 9.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.293 0.637 . . . . 0.0 110.866 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.47 137.65 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 108.734 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 75.3 m -121.04 154.23 36.33 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -142.88 147.64 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.624 0.726 . . . . 0.0 110.141 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 14.9 m-85 -133.51 140.23 36.28 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HG3' ' H ' ' A' ' 10' ' ' THR . 58.7 Cg_endo -66.36 168.38 16.3 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.711 2.94 . . . . 0.0 112.3 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 C--N 1.377 2.04 0 C-N-CA 121.395 1.397 . . . . 0.0 110.869 177.001 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.244 0.77 0 CA-C-O 120.974 0.416 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.6 ptt? -149.86 124.02 9.48 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.773 0.829 . . . . 0.0 109.547 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -85.27 113.65 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.031 0.932 . . . . 0.0 109.107 -175.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.404 HD12 ' HE1' ' A' ' 1' ' ' MET . 27.3 mt -115.46 134.5 55.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.391 0.676 . . . . 0.0 110.931 -171.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 65.1 tt0 -89.17 103.09 15.74 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.8 mt -93.84 105.3 17.33 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.4 mtt180 -91.9 117.0 29.39 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.749 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.431 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m-85 -103.44 136.09 43.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.976 0.91 . . . . 0.0 109.248 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.01 161.41 29.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.225 0.61 . . . . 0.0 109.537 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.459 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.41 -133.27 0.93 Allowed 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.604 1.162 . . . . 0.0 112.354 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.2 m -55.76 -44.03 77.26 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 124.324 1.05 . . . . 0.0 111.819 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.431 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 10.8 m-30 -63.1 -33.09 74.71 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.076 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -41.57 91.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.642 0.377 . . . . 0.0 110.273 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -67.91 -35.86 79.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.806 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.467 HG12 ' HG ' ' A' ' 44' ' ' LEU . 64.6 t -60.46 -56.31 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.257 0.623 . . . . 0.0 110.617 174.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.26 -17.15 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.42 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.98 11.52 70.08 Favored Glycine 0 C--N 1.35 1.313 0 C-N-CA 123.578 0.608 . . . . 0.0 113.682 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -160.7 142.45 12.33 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.232 1.013 . . . . 0.0 110.149 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -85.83 -22.16 27.74 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.952 0.901 . . . . 0.0 113.38 -167.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.2 m -150.18 133.09 16.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 18.1 pt -129.98 171.88 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.997 . . . . 0.0 108.928 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -116.95 112.17 20.63 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 163.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -89.96 -179.05 5.62 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.91 1.284 . . . . 0.0 108.772 164.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -155.73 113.89 3.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.68 -179.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.52 156.74 35.97 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.723 0.409 . . . . 0.0 110.353 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.56 -24.96 53.56 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.262 0.625 . . . . 0.0 111.049 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.65 -14.39 56.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.86 0.864 . . . . 0.0 110.558 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 166.07 23.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.257 0.623 . . . . 0.0 110.836 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.8 p -132.2 -177.47 4.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.594 0.758 . . . . 0.0 110.815 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.414 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.8 p -57.35 -35.85 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.617 1.167 . . . . 0.0 111.553 175.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.62 -38.52 78.26 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.553 0.533 . . . . 0.0 113.221 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.71 -33.17 75.04 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.284 0.634 . . . . 0.0 110.491 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.0 -60.19 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.702 0.801 . . . . 0.0 110.528 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.0 pp -65.07 -30.61 71.58 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.88 0.309 . . . . 0.0 111.316 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -54.47 -47.31 73.1 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.239 0.616 . . . . 0.0 111.368 170.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 36.1 t -75.9 -32.64 59.74 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.093 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 2.3 mm? -58.04 -35.8 71.84 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.69 0.796 . . . . 0.0 112.954 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -77.79 -30.02 51.11 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 120.737 0.303 . . . . 0.0 111.462 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.19 -26.41 67.39 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.929 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 36' ' ' SER . 6.1 mm-40 -90.76 -56.28 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.026 0.93 . . . . 0.0 110.191 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -95.73 122.66 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.187 -170.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.92 -35.82 81.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.043 0.937 . . . . 0.0 110.774 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.476 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.67 -2.11 90.6 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.919 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.563 ' HB3' HD13 ' A' ' 48' ' ' LEU . 85.0 mt -109.88 5.24 22.33 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.868 0.834 . . . . 0.0 110.885 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.34 121.46 17.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.971 0.508 . . . . 0.0 112.177 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.54 -24.65 6.28 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 12.3 ptp180 -90.25 7.5 37.93 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.69 1.196 . . . . 0.0 112.505 -171.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.563 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.06 -7.1 3.47 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.135 0.974 . . . . 0.0 111.088 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.89 127.7 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.509 1.123 . . . . 0.0 108.416 169.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -127.51 108.84 11.15 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.175 0.59 . . . . 0.0 110.162 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 t70 53.02 39.53 29.63 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.581 1.152 . . . . 0.0 112.007 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.2 -14.53 65.05 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.195 -0.911 . . . . 0.0 115.369 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -102.21 -175.32 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.286 1.043 . . . . 0.0 109.223 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.421 HG13 HD21 ' A' ' 34' ' ' LEU . 15.8 m -69.02 -57.56 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.07 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.486 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 15.4 tppt? 153.74 135.22 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 CA-C-N 119.683 1.129 . . . . 0.0 109.786 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.486 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 17.1 Cg_endo -56.07 135.25 68.9 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 123.319 2.68 . . . . 0.0 111.879 165.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 76.28 -15.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.565 1.546 . . . . 0.0 113.947 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.76 146.36 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.5 m120 -121.13 103.87 9.34 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG11 HG11 ' A' ' 85' ' ' VAL . 3.2 m -116.17 131.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.53 0.732 . . . . 0.0 109.531 -177.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -120.41 133.9 55.35 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.209 1.403 . . . . 0.0 110.297 -171.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -105.62 105.62 15.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 59.32 35.13 23.16 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.097 0.959 . . . . 0.0 111.13 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.92 -14.31 63.7 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.426 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -93.73 105.92 17.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.837 0.855 . . . . 0.0 109.41 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 26.1 tt0 -70.88 104.83 3.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.602 0.761 . . . . 0.0 111.174 -168.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.448 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 23.4 m -71.65 -0.95 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.89 -22.69 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.806 170.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -86.71 -28.55 23.02 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.772 0.829 . . . . 0.0 110.803 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HG ' ' HA ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -117.6 -153.74 0.54 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.383 1.073 . . . . 0.0 109.503 177.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.26 107.89 1.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.888 0.475 . . . . 0.0 110.186 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.448 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -80.2 -34.1 30.58 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.031 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.459 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.7 mmt -82.15 -39.11 23.72 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.2 82.48 1.6 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.29 0.566 . . . . 0.0 111.631 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 t -81.34 -72.87 0.41 Allowed 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.135 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.55 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.955 0.902 . . . . 0.0 110.414 -161.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -74.03 123.0 23.52 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -167.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.71 175.21 5.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.148 0.979 . . . . 0.0 109.989 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 11.1 p-10 -72.89 146.73 45.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.458 0.703 . . . . 0.0 111.949 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 15.15 73.1 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.396 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.31 171.45 13.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.098 0.559 . . . . 0.0 111.332 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.52 94.78 3.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 170.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.89 107.39 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 74.2 m -85.68 155.01 21.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 110.402 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.432 HG11 HG11 ' A' ' 60' ' ' VAL . 32.8 m -146.35 145.49 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 109.673 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 29.9 m-85 -132.38 136.62 28.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 32.5 Cg_endo -61.04 168.91 6.68 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.971 3.114 . . . . 0.0 113.432 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 C--N 1.376 2.016 0 C-N-CA 121.103 1.202 . . . . 0.0 110.328 172.929 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.561 0 N-CA-C 112.124 -0.39 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -85.51 161.26 35.21 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.202 -0.359 . . . . 0.0 112.202 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -87.03 -174.25 48.98 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-O 119.804 -0.442 . . . . 0.0 112.262 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? 57.46 87.51 0.06 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.731 1.213 . . . . 0.0 109.708 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' -2' ' ' LYS . 13.0 m-20 -130.28 37.4 3.88 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.926 0.891 . . . . 0.0 110.261 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . 0.537 ' HA ' HG23 ' A' ' 0' ' ' THR . 1.7 m-85 -84.81 69.26 10.7 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 122.034 0.921 . . . . 0.0 110.991 -169.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.629 ' HZ1' ' HB3' ' A' ' -2' ' ' LYS . 0.0 OUTLIER -150.82 179.98 7.76 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.272 -176.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' -2' ' ' LYS . 23.1 t70 -101.48 169.03 9.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 27.9 t70 72.68 150.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.841 1.256 . . . . 0.0 111.722 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.37 -178.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.006 0.922 . . . . 0.0 110.443 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.73 135.5 46.81 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.463 -0.773 . . . . 0.0 109.492 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.629 ' HB3' ' HZ1' ' A' ' -7' ' ' LYS . 0.0 OUTLIER -167.46 -35.95 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.621 0.768 . . . . 0.0 110.068 -178.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 69.51 29.92 71.32 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.781 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.537 HG23 ' HA ' ' A' ' -8' ' ' TYR . 65.3 p -88.55 141.57 28.41 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -108.06 167.5 9.95 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.887 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -120.84 133.48 55.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.7 mt -126.13 142.36 51.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.333 0.653 . . . . 0.0 109.945 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 45.5 tt0 -88.73 102.68 15.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.42 HD12 HD22 ' A' ' 37' ' ' LEU . 30.1 mt -93.76 104.0 16.11 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtp85 -94.4 117.83 30.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.775 -176.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.4 138.12 43.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.864 0.866 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.28 156.2 48.01 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 109.56 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 61.55 -131.24 0.69 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.77 1.228 . . . . 0.0 111.64 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.2 m -58.38 -46.89 85.46 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 123.346 0.658 . . . . 0.0 111.215 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -58.6 -26.38 63.62 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.042 0.537 . . . . 0.0 111.548 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -70.89 -50.47 34.65 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.096 0.558 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -74.26 -25.62 59.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.375 0.422 . . . . 0.0 111.932 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 44' ' ' LEU . 48.1 t -59.29 -54.99 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.672 0.789 . . . . 0.0 110.036 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.478 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 94.4 t -72.59 -24.59 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.204 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.06 10.91 62.74 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.017 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -141.32 136.04 31.14 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.49 -22.06 21.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.035 0.534 . . . . 0.0 112.253 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 15.0 m -155.59 134.31 11.91 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 17.4 pt -131.27 176.66 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.209 1.004 . . . . 0.0 109.143 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -125.07 112.84 16.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.71 157.44 15.9 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 0.0 109.436 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -117.94 105.54 12.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.81 172.36 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 16.9 t70 -70.68 157.58 37.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -63.81 -27.74 69.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.06 0.544 . . . . 0.0 111.495 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.24 -23.82 37.77 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.032 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 129.6 40.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 110.586 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -110.81 -179.36 3.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.152 0.581 . . . . 0.0 110.774 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.413 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 39.6 t -51.52 -35.78 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.299 1.04 . . . . 0.0 111.981 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.604 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -65.81 -41.95 95.37 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 123.865 0.728 . . . . 0.0 114.011 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.81 -37.22 84.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.221 0.608 . . . . 0.0 110.765 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.13 -59.58 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.73 0.812 . . . . 0.0 110.543 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.5 pp -65.86 -30.46 71.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 117.776 0.262 . . . . 0.0 111.501 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HA ' HD11 ' A' ' 49' ' ' ILE . 10.4 tpt180 -54.55 -48.13 72.38 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.147 0.499 . . . . 0.0 110.713 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -75.48 -32.46 60.58 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.865 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -57.28 -39.35 75.51 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.54 0.736 . . . . 0.0 112.683 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 1.4 pp20? -73.53 -29.51 62.5 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 120.664 0.269 . . . . 0.0 111.63 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.18 -22.39 66.92 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.096 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -92.64 -57.71 2.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.777 0.799 . . . . 0.0 109.789 174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.478 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 98.6 m-85 -99.83 116.8 32.74 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.954 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.33 -34.29 77.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.061 0.944 . . . . 0.0 111.052 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.01 -8.66 64.98 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.719 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.648 ' HB3' HD12 ' A' ' 48' ' ' LEU . 57.8 mt -105.54 -9.62 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.851 0.861 . . . . 0.0 111.507 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.87 121.27 10.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.105 0.562 . . . . 0.0 111.953 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.1 -33.85 3.93 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -86.17 2.68 45.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.34 -5.82 8.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.054 0.941 . . . . 0.0 111.043 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' A' ' 35' ' ' ARG . 35.0 mt -132.31 128.78 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.499 1.119 . . . . 0.0 108.823 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -129.83 113.04 14.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.063 0.545 . . . . 0.0 109.724 168.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.56 30.7 20.16 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.893 0.877 . . . . 0.0 112.215 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.33 75.01 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.208 -0.774 . . . . 0.0 114.373 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.6 -174.57 2.68 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.085 0.943 . . . . 0.0 109.466 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG12 HD22 ' A' ' 34' ' ' LEU . 17.5 m -67.47 -56.94 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-O 117.764 -1.112 . . . . 0.0 112.098 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.509 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 13.4 tppt? 151.1 139.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 C-N-CA 124.956 1.302 . . . . 0.0 108.923 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.509 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 25.5 Cg_endo -59.89 134.08 54.7 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.112 2.542 . . . . 0.0 111.752 167.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 73.48 -14.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.98 1.312 . . . . 0.0 114.441 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 1.4 p -67.2 136.39 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 15.9 m120 -107.67 103.46 12.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 HG21 HG22 ' A' ' 67' ' ' VAL . 3.5 m -120.72 142.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.795 0.838 . . . . 0.0 109.288 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.0 mp -129.19 172.15 11.73 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.403 1.481 . . . . 0.0 109.979 -165.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HB3' HG11 ' A' ' 67' ' ' VAL . 18.4 tptp -165.14 106.13 0.79 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 56.3 35.31 25.6 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-O 122.065 0.936 . . . . 0.0 109.711 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.04 -13.4 57.08 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.639 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -90.73 117.76 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.9 tt0 -72.4 103.65 3.52 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.206 0.602 . . . . 0.0 110.25 -174.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG11 ' HB3' ' A' ' 62' ' ' LYS . 13.0 m -67.66 -0.7 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 58' ' ' VAL . 5.3 m -67.39 -27.28 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 118.073 0.397 . . . . 0.0 110.526 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -82.05 -16.4 50.26 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.953 0.901 . . . . 0.0 111.118 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.5 -150.34 0.4 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.343 1.057 . . . . 0.0 109.354 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.31 108.37 3.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.442 0.697 . . . . 0.0 111.098 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.25 -42.57 18.59 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.653 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.604 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.8 mmt -78.24 -38.55 42.65 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.36 0.664 . . . . 0.0 112.412 -174.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.22 79.46 1.54 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.553 0.692 . . . . 0.0 111.535 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 t -81.72 -75.43 0.29 Allowed 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.707 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -177.45 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -164.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 77' ' ' LEU . 9.5 mt -72.65 118.31 15.41 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.238 0.926 . . . . 0.0 111.83 -166.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 42.6 m-20 -119.71 173.91 6.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.157 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.3 146.91 52.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.134 0.573 . . . . 0.0 112.277 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 14.86 67.17 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.164 -0.926 . . . . 0.0 114.19 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 2.2 t70 -72.89 179.67 3.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.316 0.558 . . . . 0.0 110.307 -177.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.56 100.08 3.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.047 0.539 . . . . 0.0 110.834 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.2 t -87.77 106.9 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.1 m -91.72 141.88 28.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.57 143.15 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 121.683 0.754 . . . . 0.0 110.189 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 12.8 m-85 -134.92 135.32 22.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 30.4 Cg_endo -61.49 161.92 22.53 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.361 2.708 . . . . 0.0 112.783 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 42.4 Cg_endo -64.08 130.3 26.93 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.052 1.835 . . . . 0.0 112.525 -174.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.09 143.79 10.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.607 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.54 91.05 2.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.817 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.27 29.24 7.26 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.417 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.916 0 CA-C-O 118.512 -1.16 . . . . 0.0 111.707 178.741 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 173.4 46.29 0.05 OUTLIER Glycine 0 C--N 1.347 1.163 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -170.34 146.63 9.99 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 120.088 -0.285 . . . . 0.0 112.498 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -87.29 -86.41 0.16 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . 0.401 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 33.8 m-20 70.26 2.05 3.83 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 152.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 57.74 -81.43 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 160.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.422 ' HE2' ' HA3' ' A' ' -1' ' ' GLY . 10.6 pttp -61.61 -32.0 72.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.241 1.416 . . . . 0.0 114.313 -166.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -159.27 176.26 12.4 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -169.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -79.61 -51.4 9.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.731 1.212 . . . . 0.0 110.728 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -98.17 154.13 17.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.895 0.878 . . . . 0.0 110.32 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 20.7 t70 60.61 100.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.356 1.462 . . . . 0.0 111.265 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.461 ' HB2' ' HG1' ' A' ' 0' ' ' THR . 58.3 pttt -65.06 -45.87 83.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.55 1.14 . . . . 0.0 113.159 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.422 ' HA3' ' HE2' ' A' ' -7' ' ' LYS . . . 52.52 32.49 38.7 Favored Glycine 0 C--N 1.354 1.545 0 O-C-N 123.397 0.436 . . . . 0.0 113.215 -170.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.461 ' HG1' ' HB2' ' A' ' -2' ' ' LYS . 38.0 p -124.9 166.01 17.04 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.183 0.993 . . . . 0.0 110.406 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -141.21 128.87 21.51 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.357 1.063 . . . . 0.0 109.351 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.21 135.72 35.21 Favored 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 123.512 0.725 . . . . 0.0 109.065 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.36 132.62 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.215 0.606 . . . . 0.0 110.105 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 66.0 tt0 -88.82 95.9 10.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.464 HD12 HD22 ' A' ' 37' ' ' LEU . 46.1 mt -92.9 103.79 16.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 95.6 mtt180 -91.3 117.96 30.09 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.642 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.55 141.86 37.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -133.75 159.76 39.62 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.245 0.618 . . . . 0.0 109.563 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 58.3 -130.69 1.32 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.436 1.094 . . . . 0.0 112.1 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.431 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 81.3 m -55.68 -49.19 73.61 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 123.914 0.885 . . . . 0.0 111.188 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -59.78 -27.58 66.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.803 0.441 . . . . 0.0 111.283 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -52.6 27.07 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.605 0.362 . . . . 0.0 111.006 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.13 -21.07 60.79 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.436 0.46 . . . . 0.0 111.652 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.509 HG12 ' HG ' ' A' ' 44' ' ' LEU . 46.1 t -62.76 -53.89 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.444 0.698 . . . . 0.0 110.47 169.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.445 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 93.1 t -73.76 -21.68 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.572 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.95 11.19 62.9 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.699 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -142.54 142.56 32.24 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -95.68 -8.12 35.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.465 0.306 . . . . 0.0 111.737 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 2.1 m -158.47 128.16 5.82 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.491 1.116 . . . . 0.0 108.495 170.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.426 HG12 ' HB2' ' A' ' 5' ' ' LEU . 11.3 pt -119.03 171.03 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.599 0.76 . . . . 0.0 108.999 173.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.05 112.38 20.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.496 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -93.39 177.3 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.647 1.179 . . . . 0.0 109.77 171.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -156.79 105.35 2.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 171.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.93 172.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.46 1.104 . . . . 0.0 108.618 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.88 160.46 30.63 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.415 0.286 . . . . 0.0 110.402 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.7 -14.95 59.47 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -81.31 -16.05 53.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 152.22 43.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.568 0.747 . . . . 0.0 110.712 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.1 p -136.17 -174.49 3.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.834 1.253 . . . . 0.0 108.727 174.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.1 t -50.51 -36.32 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 C-N-CA 124.185 0.994 . . . . 0.0 112.238 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.12 62.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.844 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.43 -30.13 69.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.421 0.688 . . . . 0.0 110.791 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.72 -60.42 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.357 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.6 pp -66.25 -30.09 70.46 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.565 0.346 . . . . 0.0 111.616 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.489 ' HA ' HD11 ' A' ' 49' ' ' ILE . 12.0 tpt180 -50.56 -49.86 55.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.549 0.74 . . . . 0.0 111.042 169.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 35.0 t -76.09 -32.59 59.3 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.05 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.7 mm? -56.77 -36.69 70.11 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.199 0.6 . . . . 0.0 112.597 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.3 pt-20 -73.6 -26.64 60.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.8 62.31 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.303 0.641 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.496 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 16.8 mm-40 -89.52 -58.08 2.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.587 0.755 . . . . 0.0 109.864 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.445 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 97.9 m-85 -102.14 122.2 43.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.32 -171.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.19 -29.12 67.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.599 0.759 . . . . 0.0 111.941 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.8 -4.38 85.33 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.644 0.59 . . . . 0.0 113.47 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.589 ' HB3' HD13 ' A' ' 48' ' ' LEU . 67.2 mt -106.3 -0.98 23.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.479 0.711 . . . . 0.0 111.335 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.89 120.89 14.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.68 -2.5 53.88 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 170.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.9 ptp180 -107.9 4.0 24.87 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.235 1.014 . . . . 0.0 111.122 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.589 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -126.57 -2.24 6.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.186 0.994 . . . . 0.0 110.56 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.489 HD11 ' HA ' ' A' ' 35' ' ' ARG . 27.7 mt -131.53 137.15 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.757 1.223 . . . . 0.0 108.552 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -148.64 114.78 5.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.87 31.17 21.02 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.981 1.312 . . . . 0.0 112.374 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.412 ' O ' ' HE2' ' A' ' 73' ' ' MET . . . 84.39 -10.12 62.39 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.536 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -94.33 -174.84 3.47 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.261 1.031 . . . . 0.0 109.017 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.468 HG12 HD21 ' A' ' 34' ' ' LEU . 27.4 m -64.94 -55.81 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.31 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? 150.84 132.71 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 125.526 1.53 . . . . 0.0 108.492 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.85 135.05 53.5 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 122.947 2.431 . . . . 0.0 111.507 165.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 82.95 -17.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.306 1.442 . . . . 0.0 113.578 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.447 HG23 ' HD3' ' A' ' 88' ' ' PRO . 2.0 p -73.16 139.39 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.582 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.5 m120 -106.12 103.71 13.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.83 131.11 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.162 0.585 . . . . 0.0 109.618 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.5 mp -123.01 143.24 50.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.476 1.11 . . . . 0.0 109.986 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 2.2 tptm -112.98 105.26 13.28 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.45 55.88 8.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.282 1.433 . . . . 0.0 111.994 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.54 -14.34 30.35 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.801 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -97.43 114.07 25.85 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 117.566 0.683 . . . . 0.0 109.212 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.2 tt0 -70.3 112.37 6.58 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 75' ' ' THR . 35.4 m -72.44 -1.27 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 113.397 -174.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 m -70.21 -13.36 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.818 0.447 . . . . 0.0 111.422 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -93.81 -18.78 21.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.635 0.774 . . . . 0.0 110.904 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.96 -152.9 0.52 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.117 0.967 . . . . 0.0 109.076 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.09 112.84 1.66 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.068 0.547 . . . . 0.0 110.956 172.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.33 -46.77 8.72 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.412 ' HE2' ' O ' ' A' ' 52' ' ' GLY . 76.0 mmm -80.32 -38.92 29.68 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.829 0.852 . . . . 0.0 112.32 -172.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.85 74.31 1.46 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.475 0.655 . . . . 0.0 111.48 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.448 HG23 HG13 ' A' ' 67' ' ' VAL . 1.7 t -81.31 -69.94 0.57 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.498 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.402 ' H ' HG21 ' A' ' 75' ' ' THR . . . -177.05 33.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.846 0.858 . . . . 0.0 110.485 -164.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.1 tp -75.66 138.61 41.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.709 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -151.04 -176.13 5.42 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.743 1.217 . . . . 0.0 107.978 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.88 144.43 50.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 118.432 0.56 . . . . 0.0 111.203 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.75 5.17 63.68 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.912 0.768 . . . . 0.0 114.566 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.598 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.9 m-20 -84.35 135.66 34.21 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.241 0.521 . . . . 0.0 112.117 -171.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -92.64 124.6 36.78 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.827 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.7 t -108.1 106.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.5 m -94.34 106.0 17.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.157 0.583 . . . . 0.0 110.186 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 m -106.58 145.46 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.005 0.907 . . . . 0.0 111.039 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 8.2 m-85 -131.23 139.69 36.24 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 175.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 46.4 Cg_endo -65.91 168.49 15.26 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.485 2.79 . . . . 0.0 112.631 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HD3' HG23 ' A' ' 58' ' ' VAL . 74.3 Cg_endo -70.93 129.99 17.21 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.077 1.185 . . . . 0.0 109.372 170.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.3 m -94.88 -10.29 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.095 0.558 . . . . 0.0 110.715 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.96 101.64 4.63 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.54 92.5 0.51 Allowed Glycine 0 C--N 1.346 1.092 0 O-C-N 123.67 0.606 . . . . 0.0 111.823 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.244 0 CA-C-O 118.633 -1.093 . . . . 0.0 112.003 -179.0 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.936 0 CA-C-O 120.112 -0.271 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 80.43 -67.03 3.57 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.305 0.479 . . . . 0.0 112.554 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 98.39 -51.82 1.23 Allowed Glycine 0 C--N 1.346 1.114 0 C-N-CA 123.208 0.432 . . . . 0.0 112.312 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . 0.522 HH21 HG12 ' A' ' 24' ' ' VAL . 32.0 mtp85 -110.79 54.52 0.67 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.716 0.806 . . . . 0.0 109.75 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.93 -32.68 15.18 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.181 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 65.2 -76.58 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.654 1.181 . . . . 0.0 110.918 -172.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' -3' ' ' ASP . 27.0 mtpp 58.96 69.46 0.72 Allowed 'General case' 0 C--N 1.353 0.74 0 C-N-CA 124.457 1.103 . . . . 0.0 110.099 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.52 -68.13 0.34 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.145 -166.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.81 -52.09 6.67 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -162.08 -53.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.868 0.867 . . . . 0.0 109.328 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' -7' ' ' LYS . 13.9 t70 -66.41 144.87 56.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.389 0.676 . . . . 0.0 110.629 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.415 ' HB2' ' HG1' ' A' ' 0' ' ' THR . 24.1 pttm -55.83 -49.66 72.67 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.459 1.104 . . . . 0.0 112.512 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 56.88 53.59 43.11 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 116.417 -0.356 . . . . 0.0 112.709 -172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.415 ' HG1' ' HB2' ' A' ' -2' ' ' LYS . 31.1 p -134.69 142.45 46.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.24 0.543 . . . . 0.0 111.786 -175.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptm -102.94 118.76 37.53 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.476 1.51 . . . . 0.0 110.54 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -86.53 126.49 34.49 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.451 HD12 HD21 ' A' ' 77' ' ' LEU . 27.1 mt -128.46 130.19 47.2 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.288 0.635 . . . . 0.0 110.149 -167.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -88.75 97.74 11.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.42 HD11 HD21 ' A' ' 37' ' ' LEU . 24.3 mt -93.49 103.52 15.71 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 90.0 mtt180 -92.26 117.69 30.14 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.061 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.07 140.1 38.76 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.811 0.844 . . . . 0.0 109.633 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -131.94 158.4 41.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.054 0.542 . . . . 0.0 110.054 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.21 -127.44 1.27 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.069 1.347 . . . . 0.0 111.93 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.36 -47.02 87.87 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.662 0.785 . . . . 0.0 111.204 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -58.06 -29.57 65.51 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.096 0.558 . . . . 0.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.62 -54.32 20.68 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.002 0.521 . . . . 0.0 110.937 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 -20.05 60.43 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 123.62 0.575 . . . . 0.0 111.858 -174.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.467 HG12 ' HG ' ' A' ' 44' ' ' LEU . 41.6 t -60.69 -54.36 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.37 0.668 . . . . 0.0 110.142 168.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.423 HG12 ' HG3' ' A' ' 17' ' ' GLN . 60.4 t -73.26 -21.22 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.367 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.7 11.29 65.53 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.359 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.423 ' HG3' HG12 ' A' ' 15' ' ' VAL . 15.0 mt-30 -140.23 143.46 36.02 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.993 0.917 . . . . 0.0 109.051 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -92.93 -15.09 26.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.492 0.717 . . . . 0.0 111.694 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -156.58 138.06 13.98 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.2 pt -130.99 174.51 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.015 0.926 . . . . 0.0 108.545 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.54 111.92 17.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 163.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.411 ' CH2' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -89.62 176.85 6.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 108.743 169.256 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -155.8 111.74 3.07 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.809 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.522 HG12 HH21 ' A' ' -10' ' ' ARG . 17.0 m -113.62 177.68 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.412 1.085 . . . . 0.0 108.169 174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -59.85 148.95 32.86 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.376 0.535 . . . . 0.0 110.533 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.09 -10.22 59.38 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.77 -20.25 43.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.682 0.793 . . . . 0.0 110.952 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 160.98 23.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.122 0.969 . . . . 0.0 112.377 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -138.39 -176.32 4.42 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.766 1.226 . . . . 0.0 109.437 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.3 t -51.33 -35.84 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.205 1.002 . . . . 0.0 111.471 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.74 -43.54 59.21 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.772 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -64.72 -31.37 72.57 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.447 0.699 . . . . 0.0 110.985 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.22 -60.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.86 0.864 . . . . 0.0 110.63 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.578 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.4 pp -65.62 -30.03 70.69 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.469 0.481 . . . . 0.0 111.173 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.567 ' HA ' HD11 ' A' ' 49' ' ' ILE . 21.9 tpt180 -53.1 -50.51 64.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.681 0.753 . . . . 0.0 111.695 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.8 m -75.27 -31.92 60.88 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.593 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 5' ' ' LEU . 2.5 mm? -56.14 -46.9 79.07 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.323 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.49 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.1 pt-20 -67.78 -26.87 66.31 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.757 0.253 . . . . 0.0 111.486 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.98 -23.93 67.36 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.455 0.472 . . . . 0.0 111.465 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -101.03 -59.55 1.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.158 0.504 . . . . 0.0 110.503 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -86.01 120.72 27.71 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.314 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.56 -33.12 74.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.992 0.917 . . . . 0.0 110.798 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.09 2.85 83.02 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.578 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 48' ' ' LEU . 71.5 mt -115.02 6.15 15.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.352 0.661 . . . . 0.0 110.725 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -72.26 121.45 19.42 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -173.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.58 68.06 Favored Glycine 0 C--N 1.357 1.742 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.504 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 13.5 ptp180 -119.59 -4.78 10.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.031 0.932 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.578 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -119.25 -3.84 10.52 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.189 1.395 . . . . 0.0 109.886 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 35' ' ' ARG . 75.5 mt -132.41 140.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.931 1.293 . . . . 0.0 108.156 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.67 126.96 5.25 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 61.55 30.85 18.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.761 1.224 . . . . 0.0 111.543 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.03 -4.98 56.15 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.666 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -106.59 -174.27 2.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.497 0.719 . . . . 0.0 109.455 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -59.37 -55.67 22.17 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 CA-C-O 117.689 -1.148 . . . . 0.0 112.483 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 12.5 tppt? 150.59 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 125.173 1.389 . . . . 0.0 108.057 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.447 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 11.4 Cg_endo -52.6 124.71 15.86 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.969 2.446 . . . . 0.0 111.947 168.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 74.74 2.59 4.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.639 1.176 . . . . 0.0 113.821 170.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 p -77.63 132.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 19.5 m120 -98.35 103.89 15.88 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.83 141.44 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.574 0.749 . . . . 0.0 109.692 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -131.17 140.62 49.96 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.173 1.389 . . . . 0.0 109.556 -166.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 16.0 tptm -105.46 105.63 15.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 166.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.7 t30 57.12 36.35 27.47 Favored 'General case' 0 CA--C 1.562 1.418 0 O-C-N 124.168 0.918 . . . . 0.0 111.366 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.3 -10.46 74.83 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -94.26 109.96 21.74 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.0 tt0 -68.62 106.25 2.54 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.032 0.533 . . . . 0.0 110.754 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.518 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 16.1 m -69.2 -1.23 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -174.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 m -68.06 -21.74 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-N 117.773 0.261 . . . . 0.0 111.237 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -87.55 -19.4 27.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.339 0.655 . . . . 0.0 110.656 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.0 -153.09 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.382 1.073 . . . . 0.0 109.718 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.73 108.4 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.579 0.752 . . . . 0.0 110.582 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.518 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -71.89 -49.63 22.03 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.589 -0.278 . . . . 0.0 113.122 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.5 -39.68 37.46 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.68 75.6 1.48 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.348 0.594 . . . . 0.0 110.903 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -76.65 -60.79 2.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.239 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.18 33.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.569 1.148 . . . . 0.0 109.657 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.451 HD21 HD12 ' A' ' 3' ' ' LEU . 42.5 tp -74.98 114.84 13.92 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -120.1 -176.7 3.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.676 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -66.5 144.14 56.65 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.364 0.666 . . . . 0.0 111.101 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.92 8.97 85.22 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.946 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.576 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 70.4 m-20 -97.75 144.56 27.25 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.786 0.834 . . . . 0.0 111.599 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.28 141.96 27.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.67 0.788 . . . . 0.0 111.116 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.08 107.39 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.232 1.013 . . . . 0.0 108.311 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.642 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 49.4 m -90.6 139.05 31.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.691 0.796 . . . . 0.0 109.268 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.16 142.43 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.124 0.874 . . . . 0.0 110.624 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 20.5 m-85 -129.79 135.99 28.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.41 164.02 19.05 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.329 2.686 . . . . 0.0 112.16 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.17 130.51 17.72 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.364 1.376 . . . . 0.0 110.287 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.35 -17.47 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.22 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 63.08 30.03 16.2 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.841 1.257 . . . . 0.0 112.945 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.85 50.87 4.47 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 122.957 0.313 . . . . 0.0 112.955 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.326 0 CA-C-O 118.924 -0.931 . . . . 0.0 111.86 -178.767 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' -4' ' ' ASP . . . . . . . . 0 N--CA 1.478 1.46 0 CA-C-O 119.557 -0.58 . . . . 0.0 111.745 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -179.34 -35.6 0.06 OUTLIER Glycine 0 C--N 1.347 1.188 0 CA-C-N 117.175 0.488 . . . . 0.0 112.653 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 134.78 129.12 2.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 15.9 mtm-85 69.38 36.45 2.28 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.394 1.077 . . . . 0.0 110.166 -171.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.74 -24.64 33.45 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.948 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 65.9 10.81 7.2 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 125.518 1.527 . . . . 0.0 112.128 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -151.5 178.11 9.64 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.025 0.93 . . . . 0.0 110.624 -163.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.65 -38.72 92.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.231 1.012 . . . . 0.0 111.392 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -158.25 -155.85 0.52 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.261 -174.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . 0.413 ' O ' ' HA2' ' A' ' -13' ' ' GLY . 17.5 m-20 70.69 168.9 0.31 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.357 1.463 . . . . 0.0 111.346 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -62.19 -44.42 96.63 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -176.91 -54.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.437 1.495 . . . . 0.0 108.76 166.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 61.76 39.96 98.15 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.775 0.672 . . . . 0.0 112.058 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 43.5 p -122.72 148.62 45.1 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.041 0.936 . . . . 0.0 109.007 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -122.71 146.03 47.86 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.506 0.722 . . . . 0.0 109.944 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.57 135.2 33.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 HD21 ' A' ' 77' ' ' LEU . 20.6 mt -134.12 133.54 41.2 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.32 0.648 . . . . 0.0 109.399 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -88.89 107.79 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 37' ' ' LEU . 24.6 mt -94.79 104.03 15.93 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 92.4 mtt180 -92.05 118.13 30.5 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.825 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.7 139.6 40.03 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.807 0.843 . . . . 0.0 109.283 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.43 154.95 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.195 0.598 . . . . 0.0 109.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 61.85 -128.9 0.72 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.813 1.245 . . . . 0.0 112.074 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.3 m -62.39 -41.5 98.69 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 123.731 0.813 . . . . 0.0 111.381 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -63.33 -25.18 68.18 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.225 0.61 . . . . 0.0 111.383 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -71.55 -53.18 14.63 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.411 0.684 . . . . 0.0 111.189 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -71.18 -23.37 62.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.013 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.495 HG11 ' HG ' ' A' ' 44' ' ' LEU . 19.8 t -60.87 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.555 0.693 . . . . 0.0 111.043 170.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.74 -21.97 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.323 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.48 12.48 77.22 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.567 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -143.36 143.82 31.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.774 1.229 . . . . 0.0 109.016 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -94.62 -18.47 21.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.622 0.369 . . . . 0.0 111.732 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -154.86 127.96 8.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.899 0.88 . . . . 0.0 108.663 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.17 170.02 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.955 0.902 . . . . 0.0 109.086 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.82 112.35 20.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -96.93 179.67 4.87 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 108.848 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -157.06 106.17 2.19 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.15 179.97 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.427 1.091 . . . . 0.0 108.391 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.71 150.14 24.31 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.489 0.715 . . . . 0.0 111.511 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.91 -20.82 62.45 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.149 0.579 . . . . 0.0 111.741 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.89 -23.82 20.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.238 0.615 . . . . 0.0 110.724 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.29 128.06 35.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.465 0.306 . . . . 0.0 110.286 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.2 p -107.25 -174.68 2.59 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.496 0.719 . . . . 0.0 111.175 -172.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 78.9 t -51.85 -38.24 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.164 0.985 . . . . 0.0 112.25 -173.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -64.44 -42.39 97.62 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 123.728 0.643 . . . . 0.0 113.27 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -69.24 -30.42 68.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.57 0.748 . . . . 0.0 110.956 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.0 t -64.88 -60.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.476 0.71 . . . . 0.0 110.452 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.472 HD21 HG12 ' A' ' 54' ' ' VAL . 1.9 pp -63.94 -30.3 71.39 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.183 0.447 . . . . 0.0 111.337 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.511 ' HA ' HD13 ' A' ' 49' ' ' ILE . 8.8 tpt85 -53.71 -47.02 70.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.046 0.538 . . . . 0.0 110.831 169.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 m -74.84 -32.94 62.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.22 0.608 . . . . 0.0 111.78 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.5 HD22 HD11 ' A' ' 5' ' ' LEU . 3.9 mm? -58.18 -35.36 71.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -78.57 -25.91 45.46 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.173 0.442 . . . . 0.0 111.394 176.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -16.07 62.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.652 0.781 . . . . 0.0 111.513 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -100.87 -59.36 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.404 0.681 . . . . 0.0 110.181 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.07 119.47 34.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.676 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.09 -30.29 70.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.858 0.463 . . . . 0.0 110.599 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -72.22 -12.28 76.03 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.597 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.604 ' HB3' HD12 ' A' ' 48' ' ' LEU . 97.7 mt -109.84 -0.43 18.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 111.026 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -62.02 121.08 12.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.444 0.698 . . . . 0.0 112.433 -172.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.12 -22.87 3.43 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -91.18 10.69 26.01 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.393 1.077 . . . . 0.0 111.856 -173.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -130.0 -5.98 4.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.34 1.056 . . . . 0.0 110.9 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 35' ' ' ARG . 67.4 mt -131.78 130.6 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.676 1.19 . . . . 0.0 108.195 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.37 126.13 22.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.951 0.5 . . . . 0.0 110.0 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.1 t70 54.81 31.33 15.39 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.552 1.141 . . . . 0.0 112.315 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.41 -13.74 53.94 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.692 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.35 -176.96 3.45 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.815 0.846 . . . . 0.0 109.008 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.472 HG12 HD21 ' A' ' 34' ' ' LEU . 16.6 m -64.47 -56.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.836 -1.078 . . . . 0.0 112.333 -173.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? 155.17 133.14 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 124.705 1.202 . . . . 0.0 109.287 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.79 134.48 47.13 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.519 2.812 . . . . 0.0 111.383 168.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 77.85 -15.11 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.778 1.631 . . . . 0.0 113.52 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.13 145.37 13.0 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -114.24 103.88 11.54 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.05 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.071 0.948 . . . . 0.0 108.663 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -117.15 151.51 36.7 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 20.8 tptp -124.24 104.37 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.392 1.477 . . . . 0.0 107.203 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 50.75 38.63 20.0 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.648 1.179 . . . . 0.0 111.15 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.1 80.82 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.374 -0.83 . . . . 0.0 115.107 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -103.61 110.15 22.1 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 118.021 0.911 . . . . 0.0 109.424 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.4 tt0 -66.55 112.28 4.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.497 0.719 . . . . 0.0 110.885 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.557 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 31.0 m -68.01 -0.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.41 -18.18 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 118.182 0.446 . . . . 0.0 110.669 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -92.73 -10.52 36.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.141 0.976 . . . . 0.0 111.396 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.66 -155.67 0.62 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.019 0.928 . . . . 0.0 109.081 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -66.92 111.01 3.56 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.008 0.523 . . . . 0.0 111.492 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.557 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -73.21 -50.32 12.89 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.223 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.49 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.5 mmt -71.15 -36.56 72.09 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.576 0.75 . . . . 0.0 112.79 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.39 81.67 1.41 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.749 0.785 . . . . 0.0 111.525 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -79.37 0.14 Allowed 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.961 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.96 33.11 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.132 0.573 . . . . 0.0 110.035 -168.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.518 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 18.0 tp -74.72 123.25 24.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.928 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.69 168.08 17.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.98 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.92 135.16 55.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.124 0.57 . . . . 0.0 111.29 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.26 18.97 73.04 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.54 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.12 169.98 12.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.736 0.414 . . . . 0.0 110.092 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.48 98.45 4.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.415 0.686 . . . . 0.0 110.519 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -86.36 107.88 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.65 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 53.6 m -87.04 152.23 22.56 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.91 0.484 . . . . 0.0 109.934 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m -144.56 146.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-O 121.635 0.731 . . . . 0.0 109.939 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 11.3 m-85 -136.81 140.34 31.56 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.19 169.08 9.84 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.796 2.998 . . . . 0.0 112.501 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.53 129.72 27.52 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 121.159 1.239 . . . . 0.0 110.627 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.4 m -101.84 -3.76 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.384 0.674 . . . . 0.0 111.218 -170.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.46 158.57 44.29 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.712 0.805 . . . . 0.0 110.082 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.88 158.65 35.27 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.392 0 CA-C-O 119.126 -0.819 . . . . 0.0 112.198 179.57 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.066 0 N-CA-C 112.792 -0.123 . . . . 0.0 112.792 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -166.51 84.49 0.1 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -103.06 -146.38 17.06 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 61.09 77.15 0.34 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.595 1.158 . . . . 0.0 112.091 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' -2' ' ' LYS . 29.2 m-20 -89.85 77.03 7.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.929 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . 0.455 ' HA ' HG23 ' A' ' 0' ' ' THR . 4.2 m-30 -87.43 41.63 0.99 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.127 0.571 . . . . 0.0 110.484 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.03 -171.67 3.93 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.777 1.231 . . . . 0.0 110.904 -174.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -83.47 128.44 34.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.176 0.99 . . . . 0.0 111.55 -174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . 0.569 ' N ' ' HZ1' ' A' ' -2' ' ' LYS . 5.2 m-20 -156.49 -170.55 3.38 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.614 1.566 . . . . 0.0 107.906 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.4 -43.78 59.83 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 163.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -140.82 153.73 45.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.816 0.846 . . . . 0.0 109.665 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.647 ' HB3' ' HZ3' ' A' ' -2' ' ' LYS . 0.0 OUTLIER -153.22 -42.31 0.1 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.189 0.996 . . . . 0.0 111.217 -172.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 92.61 1.35 68.51 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.185 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 69.7 p -89.02 142.35 27.71 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.754 0.777 . . . . 0.0 111.092 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 26.9 ptt? -102.84 129.62 49.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 110.583 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.05 136.52 33.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.5 mt -131.82 134.3 45.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 100.32 13.1 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.78 104.16 16.25 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.529 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 52.9 mtp180 -91.0 116.83 29.09 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.757 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.434 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 96.0 m-85 -103.79 138.81 39.88 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 109.241 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -130.77 157.88 41.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.645 0.778 . . . . 0.0 109.072 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.46 -132.72 0.8 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.443 1.097 . . . . 0.0 112.563 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.6 m -58.09 -42.3 85.34 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 124.16 0.984 . . . . 0.0 111.876 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.434 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 11.3 m-30 -62.66 -34.37 76.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.83 0.452 . . . . 0.0 111.224 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -38.38 88.02 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.536 0.523 . . . . 0.0 110.089 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.35 -43.96 84.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.986 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG12 ' HG ' ' A' ' 44' ' ' LEU . 69.4 t -57.22 -51.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.703 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.69 -26.6 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.453 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 11.4 71.25 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.144 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -138.46 145.72 41.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -86.91 -25.01 24.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.05 0.54 . . . . 0.0 112.038 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -156.39 123.13 5.17 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.184 0.993 . . . . 0.0 108.372 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.83 173.39 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.664 0.786 . . . . 0.0 109.353 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.57 112.09 18.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -95.4 177.15 5.93 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.599 1.16 . . . . 0.0 108.689 171.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -157.11 106.79 2.22 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.153 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.24 168.88 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 26.4 t70 -71.75 155.22 40.7 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.93 -14.63 61.91 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.59 0.756 . . . . 0.0 112.708 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -80.14 -16.91 53.9 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.122 0.569 . . . . 0.0 109.909 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.6 163.88 27.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.778 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.1 p -133.48 -175.39 3.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.563 1.145 . . . . 0.0 109.126 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.38 -37.93 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.051 0.94 . . . . 0.0 111.176 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.83 -42.48 69.92 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.567 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.45 -36.38 78.1 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.3 0.64 . . . . 0.0 111.033 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -62.76 -60.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.511 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.482 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.9 -30.45 71.44 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.466 0.306 . . . . 0.0 111.233 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.6 tpt180 -54.71 -49.21 71.26 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.187 0.595 . . . . 0.0 111.603 170.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 m -75.85 -31.27 59.24 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.736 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.03 -46.84 75.31 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.543 0.737 . . . . 0.0 112.373 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.6 pt-20 -65.5 -26.4 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.05 -22.25 62.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.113 0.565 . . . . 0.0 111.211 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -100.36 -59.43 1.71 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.682 0.753 . . . . 0.0 109.413 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -86.83 104.0 15.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.352 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.3 -17.55 63.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.384 0.674 . . . . 0.0 111.329 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -74.99 -12.65 83.21 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.304 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.605 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.6 mt -101.62 0.65 36.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.483 0.713 . . . . 0.0 110.918 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.38 121.35 14.65 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.54 70.42 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.229 -0.896 . . . . 0.0 115.213 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.534 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 2.3 ptp180 -117.91 -12.24 10.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.858 0.863 . . . . 0.0 111.13 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -107.41 -3.27 19.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.41 1.084 . . . . 0.0 110.477 172.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 35' ' ' ARG . 21.1 mt -134.47 136.5 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.911 1.284 . . . . 0.0 109.0 171.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' ' HZ2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -132.47 108.2 8.98 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 167.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 53.56 31.55 12.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.032 0.933 . . . . 0.0 112.903 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.6 2.25 67.68 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.52 -178.88 3.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 164.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.59 -55.54 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.152 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.534 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 14.2 tppt? 150.54 132.27 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.534 0 C-N-CA 125.443 1.497 . . . . 0.0 109.054 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.88 132.85 54.53 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 122.951 2.434 . . . . 0.0 111.679 167.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 78.93 -12.18 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.286 1.434 . . . . 0.0 113.94 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 68' ' ' VAL . 1.2 p -73.18 139.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.607 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.13 104.49 13.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG11 HG12 ' A' ' 85' ' ' VAL . 2.9 m -119.16 119.1 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.487 0.715 . . . . 0.0 109.289 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -112.38 131.24 55.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.491 1.116 . . . . 0.0 110.615 -172.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HB3' HG12 ' A' ' 67' ' ' VAL . 17.2 tptp -107.57 109.51 21.18 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.63 1.572 . . . . 0.0 108.116 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 56.38 35.42 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.763 0.792 . . . . 0.0 110.667 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.0 -0.07 87.49 Favored Glycine 0 CA--C 1.543 1.804 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.617 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -107.47 112.56 25.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.651 0.78 . . . . 0.0 109.913 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.4 tt0 -67.14 105.19 1.62 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.913 0.885 . . . . 0.0 110.98 -173.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 62' ' ' LYS . 17.1 m -69.33 -0.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 58' ' ' VAL . 17.4 m -67.72 -21.19 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 117.924 0.329 . . . . 0.0 111.152 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -84.73 -17.47 38.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.88 0.872 . . . . 0.0 111.204 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -138.15 -151.27 0.38 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.241 1.016 . . . . 0.0 109.769 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' O ' ' HB ' ' A' ' 75' ' ' THR . 1.4 m-20 -63.93 108.5 1.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.026 0.53 . . . . 0.0 111.167 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.25 -42.2 15.65 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.842 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.531 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.3 mmt -77.82 -39.88 42.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.399 0.679 . . . . 0.0 112.334 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.77 77.66 1.47 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.102 0.477 . . . . 0.0 111.461 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 71' ' ' ASP . 4.0 t -81.49 -67.91 0.74 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.003 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 179.84 33.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.346 0.658 . . . . 0.0 111.184 -164.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.453 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 31.0 tp -73.45 135.41 44.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.244 0.545 . . . . 0.0 110.692 -164.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.6 166.19 24.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.998 -165.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 34.4 t70 -65.52 143.6 57.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.382 0.673 . . . . 0.0 111.769 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.33 75.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.627 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.69 137.12 33.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 117.455 0.628 . . . . 0.0 111.249 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -96.39 94.99 7.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.766 0.426 . . . . 0.0 109.953 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 t -86.89 106.36 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.635 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 54.8 m -82.61 150.07 27.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.401 0.681 . . . . 0.0 110.035 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG12 HG11 ' A' ' 60' ' ' VAL . 23.0 m -145.9 141.84 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.601 0.715 . . . . 0.0 109.686 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.607 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 10.9 m-85 -133.68 132.09 21.53 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 22.0 Cg_endo -59.41 165.66 8.94 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.647 2.898 . . . . 0.0 113.256 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.35 130.47 23.96 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 121.532 1.488 . . . . 0.0 110.676 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 m -127.55 128.33 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.027 0.931 . . . . 0.0 108.717 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.16 97.25 4.23 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.439 0.696 . . . . 0.0 109.169 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.06 31.32 0.5 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.201 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.04 0 CA-C-O 118.889 -0.951 . . . . 0.0 111.661 -176.561 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 113.72 64.93 0.44 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -137.04 -149.65 5.65 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -101.09 35.58 2.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.119 0.968 . . . . 0.0 110.271 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.45 126.38 31.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.515 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -105.73 12.55 30.84 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.746 0.819 . . . . 0.0 110.152 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -156.63 161.49 39.9 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.945 0.898 . . . . 0.0 110.068 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.1 -0.91 33.48 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.907 0.883 . . . . 0.0 112.754 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.47 157.21 17.53 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.5 0.72 . . . . 0.0 112.71 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.55 -57.66 11.73 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.861 1.264 . . . . 0.0 110.875 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -82.76 146.33 29.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.349 171.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -25.88 68.51 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.426 0.69 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 61.42 48.01 87.51 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 124.26 0.975 . . . . 0.0 113.277 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 46.5 p -123.64 142.2 51.28 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -123.87 141.81 51.69 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.304 0.642 . . . . 0.0 110.055 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -107.73 113.16 26.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.699 0.399 . . . . 0.0 110.265 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 18.1 mt -102.64 142.09 34.38 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.257 1.023 . . . . 0.0 110.825 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.34 97.06 10.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.39 103.49 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.6 mtp180 -96.07 116.39 28.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.698 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -103.68 137.27 41.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.83 0.852 . . . . 0.0 109.18 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -129.17 159.59 35.54 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.574 0.75 . . . . 0.0 109.102 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.512 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.44 -133.6 1.07 Allowed 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.12 0.968 . . . . 0.0 112.239 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 14' ' ' VAL . 31.3 m -59.89 -40.92 90.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.618 0.767 . . . . 0.0 112.235 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -63.22 -29.08 70.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.772 0.26 . . . . 0.0 111.02 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.509 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 54.4 ttp85 -66.77 -53.58 31.59 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.391 0.676 . . . . 0.0 111.552 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.76 -27.9 67.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.401 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG13 ' HG ' ' A' ' 44' ' ' LEU . 45.6 t -62.19 -53.07 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.593 0.757 . . . . 0.0 111.046 173.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.1 t -70.64 -24.16 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.294 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.51 11.06 71.87 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.587 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -142.53 135.74 28.61 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 21.0 ptmt -83.69 -24.36 31.3 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.539 0.336 . . . . 0.0 111.773 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -155.52 135.69 13.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.2 172.68 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.739 0.816 . . . . 0.0 109.846 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 3' ' ' LEU . 82.8 m-85 -123.18 113.4 18.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.403 0.621 . . . . 0.0 109.51 170.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.426 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -103.01 139.53 38.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.153 1.381 . . . . 0.0 109.51 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -107.95 106.63 16.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.25 -179.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.326 1.05 . . . . 0.0 109.116 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.22 154.75 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.127 0.571 . . . . 0.0 109.894 173.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.36 -37.69 86.64 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.076 0.95 . . . . 0.0 112.25 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.83 -13.04 59.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.42 0.688 . . . . 0.0 110.705 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 142.87 57.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.878 0.471 . . . . 0.0 109.903 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 p -118.83 -176.93 3.2 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.9 t -53.09 -35.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.125 0.97 . . . . 0.0 111.504 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.78 59.64 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.36 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.0 -33.13 72.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.384 0.673 . . . . 0.0 110.804 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.26 -60.38 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.304 1.042 . . . . 0.0 110.946 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.578 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.9 pp -65.33 -30.11 70.92 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 123.239 0.337 . . . . 0.0 111.704 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.524 ' HA ' HD11 ' A' ' 49' ' ' ILE . 1.3 ppt_? -64.49 -36.55 84.55 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.077 0.465 . . . . 0.0 109.994 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.9 m -75.6 -33.67 60.58 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.622 0.769 . . . . 0.0 111.769 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.96 -37.86 88.77 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.064 0.546 . . . . 0.0 112.358 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -70.66 -28.55 64.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.832 0.348 . . . . 0.0 111.609 176.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.94 -24.49 62.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.158 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 12.8 mm-40 -88.13 -59.64 2.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.634 0.731 . . . . 0.0 109.726 174.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 97.1 m-85 -98.45 118.29 34.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.114 -170.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.78 -28.67 68.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.139 0.976 . . . . 0.0 110.654 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.7 -9.55 86.97 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 119.411 -0.661 . . . . 0.0 113.844 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.6 ' HB3' HD13 ' A' ' 48' ' ' LEU . 84.0 mt -95.9 -6.92 38.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.657 0.729 . . . . 0.0 111.127 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.22 124.61 22.62 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.6 0.76 . . . . 0.0 112.906 -171.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.96 8.51 86.81 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 115.135 0.814 . . . . 0.0 115.135 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.3 OUTLIER -125.1 -22.37 4.44 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 117.404 0.602 . . . . 0.0 111.973 -174.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -96.55 -0.23 49.11 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.774 0.43 . . . . 0.0 110.704 172.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.524 HD11 ' HA ' ' A' ' 35' ' ' ARG . 57.4 mt -135.41 145.66 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.173 1.389 . . . . 0.0 108.634 171.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 15.4 tp10 -157.74 127.85 6.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.967 0.907 . . . . 0.0 108.96 168.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.6 t70 56.87 31.31 19.42 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.493 1.14 . . . . 0.0 111.373 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.88 -14.26 38.59 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 114.743 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -94.89 -174.06 3.16 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 117.83 0.815 . . . . 0.0 110.053 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 34' ' ' LEU . 18.2 m -59.93 -54.71 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.772 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HA ' ' HB3' ' A' ' 50' ' ' GLU . 9.6 tppt? 150.44 137.0 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 C-N-CA 126.304 1.841 . . . . 0.0 108.112 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.76 125.6 19.18 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.038 164.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 81.19 -9.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.403 1.481 . . . . 0.0 113.939 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 55' ' ' LYS . 5.2 p -69.52 129.21 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.599 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -94.92 103.27 15.14 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 m -121.55 131.14 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 6.7 mp -123.87 141.73 51.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.065 0.946 . . . . 0.0 110.645 -168.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HE3' HD11 ' A' ' 77' ' ' LEU . 15.0 tptm -111.84 105.14 13.52 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.177 1.391 . . . . 0.0 107.835 168.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.11 35.61 25.25 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.45 1.1 . . . . 0.0 111.402 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.65 -14.21 64.65 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 114.342 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -89.09 107.66 19.16 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.896 0.848 . . . . 0.0 109.595 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.6 tt0 -65.34 106.85 1.46 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.102 0.561 . . . . 0.0 110.024 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.7 m -69.73 -1.71 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.33 -22.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.501 0.591 . . . . 0.0 110.917 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 66' ' ' GLU . 60.0 m-70 -84.05 -12.12 55.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.548 0.739 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.58 -153.04 0.44 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.568 1.147 . . . . 0.0 109.318 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.16 108.46 0.9 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.675 0.39 . . . . 0.0 110.687 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.7 -47.9 14.03 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.371 0.42 . . . . 0.0 112.358 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 90.1 mmm -80.31 -36.78 33.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.307 0.643 . . . . 0.0 112.221 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.98 76.81 1.52 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.906 -0.496 . . . . 0.0 111.715 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 t -81.46 -69.33 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.994 0.518 . . . . 0.0 112.393 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -179.0 34.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.507 0.723 . . . . 0.0 111.064 -163.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 HD11 ' HE3' ' A' ' 62' ' ' LYS . 40.4 tp -74.25 141.45 45.37 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.22 0.608 . . . . 0.0 111.502 -169.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -154.78 175.92 13.12 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.947 0.899 . . . . 0.0 109.567 -170.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.16 143.59 43.18 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.199 0.909 . . . . 0.0 111.78 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.88 2.51 65.31 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.297 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.78 134.9 33.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.781 0.832 . . . . 0.0 110.09 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.38 106.14 17.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.109 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.16 107.23 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.2 m -96.44 106.38 18.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.499 0.72 . . . . 0.0 110.303 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.66 140.78 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 3.5 m-85 -129.6 134.97 26.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 42.3 Cg_endo -65.54 166.19 20.5 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.202 2.602 . . . . 0.0 112.634 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.95 129.86 15.9 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.079 1.186 . . . . 0.0 109.199 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 m -86.65 -9.25 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 122.989 0.516 . . . . 0.0 111.696 -173.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.12 159.73 40.43 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.645 0.778 . . . . 0.0 110.716 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.4 -46.85 0.44 Allowed Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.264 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.944 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 177.027 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 123.37 -145.96 16.26 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 112.178 -0.369 . . . . 0.0 112.178 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -133.53 110.36 0.88 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 56.3 mtt-85 -122.68 113.21 18.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.946 0.898 . . . . 0.0 109.063 176.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . 0.545 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 16.1 t0 -154.27 100.67 2.32 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -75.15 4.99 5.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.449 1.099 . . . . 0.0 113.32 -163.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 133.17 55.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.686 1.194 . . . . 0.0 108.487 169.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.65 100.86 3.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.871 0.468 . . . . 0.0 110.538 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -137.46 27.81 2.78 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 66.91 149.28 0.05 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.968 1.707 . . . . 0.0 112.285 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 62.94 35.75 13.13 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.274 1.029 . . . . 0.0 109.867 -166.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.545 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 0.0 OUTLIER -85.4 -40.95 15.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.239 -176.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 58.15 35.02 75.44 Favored Glycine 0 C--N 1.352 1.424 0 O-C-N 123.756 0.66 . . . . 0.0 112.611 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 47.3 p -112.78 141.25 46.81 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.558 0.743 . . . . 0.0 109.741 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.471 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 24.9 ptt? -104.23 132.23 50.71 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.024 0.93 . . . . 0.0 110.673 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -87.15 135.19 33.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -128.61 136.59 50.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.309 0.643 . . . . 0.0 110.654 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -88.93 95.98 10.53 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.65 103.91 16.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.0 mtp180 -94.34 117.18 29.73 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -103.13 139.71 38.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.777 0.831 . . . . 0.0 109.29 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -133.89 158.86 42.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.379 0.672 . . . . 0.0 109.852 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 87' ' ' PRO . . . 61.02 -130.75 0.78 Allowed 'General case' 0 CA--C 1.565 1.527 0 O-C-N 124.363 1.039 . . . . 0.0 111.37 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.431 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 97.7 m -60.57 -48.08 83.34 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.662 0.665 . . . . 0.0 111.647 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.87 -24.7 53.63 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.817 0.447 . . . . 0.0 111.623 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.418 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -70.43 -53.39 16.63 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.294 0.637 . . . . 0.0 111.027 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 -22.29 59.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.864 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.453 HG12 ' HG ' ' A' ' 44' ' ' LEU . 42.8 t -59.43 -52.82 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.244 0.618 . . . . 0.0 110.342 168.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.444 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 93.8 t -75.13 -22.31 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.51 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.418 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 73.38 11.48 79.83 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.52 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -142.92 146.6 34.17 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.143 0.977 . . . . 0.0 108.58 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -90.12 -19.99 23.65 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.852 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.4 m -155.18 131.99 10.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.03 0.932 . . . . 0.0 108.716 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 pt -123.58 175.38 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.025 0.93 . . . . 0.0 108.64 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.88 112.25 15.76 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 167.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 -178.53 4.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.221 1.409 . . . . 0.0 109.629 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -156.1 111.48 2.95 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.39 174.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.8 p-10 -71.51 158.79 35.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.268 0.94 . . . . 0.0 110.322 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.67 -19.86 61.35 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.388 0.675 . . . . 0.0 112.088 -172.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.85 -21.12 37.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.476 0.31 . . . . 0.0 110.175 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 162.09 28.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.413 0.685 . . . . 0.0 111.216 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -137.86 -174.07 3.68 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.855 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -50.6 -37.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 125.626 1.57 . . . . 0.0 112.107 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.605 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.87 -38.61 65.28 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.299 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -66.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.232 0.613 . . . . 0.0 110.548 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.8 -60.41 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.572 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.87 -30.46 71.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.503 0.321 . . . . 0.0 110.982 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.549 ' HA ' HD11 ' A' ' 49' ' ' ILE . 26.0 tpt85 -52.91 -51.7 60.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.404 0.682 . . . . 0.0 111.507 171.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.1 m -75.99 -32.1 59.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.708 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.3 mm? -52.13 -48.57 64.77 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.723 0.809 . . . . 0.0 112.34 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 3.6 pt-20 -64.95 -26.31 68.25 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.0 -20.22 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.135 0.574 . . . . 0.0 111.104 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.35 -57.9 2.14 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.0 m-85 -91.82 108.55 20.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.84 -173.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.62 -22.0 65.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.353 0.661 . . . . 0.0 111.587 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.496 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.56 -8.68 87.14 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.028 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.647 ' HB3' HD12 ' A' ' 48' ' ' LEU . 88.9 mt -105.14 -6.89 19.46 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.699 0.799 . . . . 0.0 111.041 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.89 122.28 15.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.722 0.809 . . . . 0.0 113.142 -171.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.53 2.84 51.86 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 2.3 ptp180 -113.85 -4.37 13.33 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.647 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -114.5 -2.71 13.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.794 . . . . 0.0 110.357 174.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 35' ' ' ARG . 46.8 mt -135.26 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.99 1.316 . . . . 0.0 109.201 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 19.8 mm-40 -143.69 123.84 13.71 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.119 0.968 . . . . 0.0 109.15 160.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.35 30.87 20.18 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 124.353 1.061 . . . . 0.0 112.109 168.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.86 3.12 88.22 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 114.989 0.756 . . . . 0.0 114.989 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -116.41 -175.44 2.75 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.019 0.928 . . . . 0.0 108.702 170.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 m -63.2 -55.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.876 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 9.6 tppt? 153.22 139.69 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.377 0 C-N-CA 125.091 1.356 . . . . 0.0 109.062 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 22.2 Cg_endo -60.8 128.38 25.44 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.825 2.35 . . . . 0.0 111.928 166.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 77.83 -1.69 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.337 1.455 . . . . 0.0 113.912 171.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 3.1 p -76.4 153.71 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 13.2 m120 -118.24 104.76 11.1 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.8 129.48 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.468 0.707 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 6.9 mp -121.66 140.18 52.62 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.803 1.241 . . . . 0.0 111.899 -166.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.479 ' NZ ' ' HB2' ' A' ' 63' ' ' ASN . 0.5 OUTLIER -119.34 107.56 13.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.824 1.249 . . . . 0.0 108.29 171.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 65.0 t30 60.36 34.78 20.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.666 1.186 . . . . 0.0 110.328 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.87 -14.97 61.81 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.522 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -94.27 111.66 23.4 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.42 0.61 . . . . 0.0 109.896 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.8 tt0 -67.89 108.36 2.99 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.851 0.86 . . . . 0.0 110.886 -173.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.05 -1.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.795 1.638 . . . . 0.0 114.552 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 m -71.16 -23.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.188 0.449 . . . . 0.0 110.582 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 66' ' ' GLU . 74.9 m-70 -88.72 -15.97 33.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.732 0.813 . . . . 0.0 110.828 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.39 -140.7 0.17 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.699 1.199 . . . . 0.0 108.789 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.81 119.02 25.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.746 1.157 . . . . 0.0 110.806 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.29 -43.12 39.87 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.688 0.617 . . . . 0.0 112.817 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.605 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.4 mmt -81.46 -39.95 24.06 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.73 69.26 1.03 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.401 0.62 . . . . 0.0 111.774 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 t -74.49 -67.82 0.59 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.98 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -174.99 33.7 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 110.887 -165.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.11 139.29 42.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.188 0.195 . . . . 0.0 110.851 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 33.9 t70 -144.32 -176.06 4.88 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.729 0.811 . . . . 0.0 108.835 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 30.8 t70 -70.19 147.8 49.4 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.422 0.556 . . . . 0.0 111.852 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.86 66.53 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.386 -0.824 . . . . 0.0 113.301 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 3.6 t0 -94.76 127.65 40.9 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 122.568 0.347 . . . . 0.0 110.608 -168.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.17 115.85 23.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.151 0.58 . . . . 0.0 111.438 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.75 106.99 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.8 m -84.09 147.96 27.08 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -142.45 147.08 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.696 0.76 . . . . 0.0 109.792 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.486 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.8 m-85 -133.82 142.77 44.83 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 9' ' ' ALA . 40.3 Cg_endo -64.82 168.5 13.39 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.222 2.615 . . . . 0.0 111.374 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 48.4 Cg_endo -63.96 128.85 22.89 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 120.645 0.897 . . . . 0.0 111.249 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.68 -17.79 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.177 0.991 . . . . 0.0 109.352 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.15 -7.05 56.56 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.87 0.868 . . . . 0.0 111.311 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 87.82 0.55 Allowed Glycine 0 C--N 1.353 1.473 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 CA-C-O 118.953 -0.915 . . . . 0.0 112.906 -176.769 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.024 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -153.82 24.39 0.72 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.094 -0.402 . . . . 0.0 112.094 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -80.18 144.24 25.79 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -84.93 78.95 9.8 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.373 0.606 . . . . 0.0 109.558 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -91.49 155.51 18.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.347 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -123.49 26.91 7.65 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.696 0.398 . . . . 0.0 111.811 -169.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.59 ' HZ3' ' HB3' ' A' ' -7' ' ' LYS . 0.0 OUTLIER -161.95 121.5 2.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.27 0.628 . . . . 0.0 109.961 -178.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 57.16 -167.72 0.12 Allowed 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 124.737 1.215 . . . . 0.0 112.121 169.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -107.43 -30.96 8.36 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.773 0.829 . . . . 0.0 109.583 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.2 -60.59 2.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.132 0.973 . . . . 0.0 111.776 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -90.85 143.28 26.88 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.144 0.577 . . . . 0.0 111.9 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.524 ' O ' ' HD3' ' A' ' -7' ' ' LYS . 17.0 ptpt -90.3 -42.08 11.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.565 0.746 . . . . 0.0 110.712 176.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 44.9 30.16 2.3 Favored Glycine 0 C--N 1.36 1.905 0 O-C-N 124.43 1.081 . . . . 0.0 115.366 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.518 ' HB ' ' HD2' ' A' ' 23' ' ' ARG . 2.6 p -114.92 150.95 34.89 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.87 0.868 . . . . 0.0 111.26 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.778 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -109.08 121.84 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.788 0.435 . . . . 0.0 110.135 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.51 146.66 28.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.527 0.731 . . . . 0.0 111.153 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 42.9 tt0 -88.72 95.45 10.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.1 103.94 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.677 -0.639 . . . . 0.0 109.47 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 13.1 mtp180 -95.18 117.05 29.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.739 -176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -106.4 135.69 47.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.451 1.101 . . . . 0.0 108.926 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.75 160.46 31.64 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.12 0.568 . . . . 0.0 109.844 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.44 -121.03 1.22 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.994 1.318 . . . . 0.0 112.198 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.522 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 87.9 m -70.37 -44.56 67.83 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.866 0.866 . . . . 0.0 111.329 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -58.8 -28.43 65.97 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.636 0.374 . . . . 0.0 110.962 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 47.6 ttp180 -65.85 -52.17 52.71 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.75 0.656 . . . . 0.0 111.185 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.91 -27.11 60.88 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.481 0.488 . . . . 0.0 111.739 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG13 ' HG ' ' A' ' 44' ' ' LEU . 39.2 t -59.08 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.474 0.709 . . . . 0.0 110.541 170.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 17' ' ' GLN . 96.7 t -74.66 -22.36 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.963 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 11.39 63.35 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.769 0.7 . . . . 0.0 112.891 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.49 ' NE2' HG21 ' A' ' 20' ' ' ILE . 17.3 mt-30 -145.74 138.15 25.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.303 1.041 . . . . 0.0 108.312 -166.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 21.8 ptmt -100.92 -29.22 12.33 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 m -154.9 113.62 3.57 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.49 HG21 ' NE2' ' A' ' 17' ' ' GLN . 26.7 pt -121.63 170.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.205 0.602 . . . . 0.0 110.806 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -111.47 125.21 53.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.4 ' CH2' HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -121.89 123.18 41.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.122 0.969 . . . . 0.0 108.853 -176.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' HD2' ' HB ' ' A' ' 0' ' ' THR . 6.6 tpp85 -83.08 106.95 15.31 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.07 -179.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 0.0 109.526 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.23 159.7 24.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.394 0.677 . . . . 0.0 110.613 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.22 -26.03 68.33 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 110.522 168.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -80.24 -22.94 41.23 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.34 1.056 . . . . 0.0 110.553 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.24 43.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.294 0.637 . . . . 0.0 110.592 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 p -137.75 -174.64 3.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.118 0.967 . . . . 0.0 108.643 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 t -51.09 -35.96 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.996 0.918 . . . . 0.0 111.535 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.6 -45.5 76.38 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.175 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.37 -35.37 78.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.951 0.9 . . . . 0.0 111.113 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.28 -60.79 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.16 0.984 . . . . 0.0 110.805 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.531 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 1.9 pp -67.39 -30.08 69.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.19 0.306 . . . . 0.0 111.404 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.511 ' HA ' HD13 ' A' ' 49' ' ' ILE . 20.8 tpt180 -55.57 -49.74 71.93 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.376 0.608 . . . . 0.0 111.218 170.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -73.96 -32.48 63.49 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.148 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -57.28 -39.05 74.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.441 0.696 . . . . 0.0 112.42 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 7.1 pt-20 -75.67 -28.51 58.73 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 117.874 0.307 . . . . 0.0 111.691 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.64 -34.52 78.42 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.08 0.467 . . . . 0.0 110.467 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -79.0 -59.1 2.91 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.366 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 95.9 m-85 -99.21 122.03 41.85 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.799 -168.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.08 -40.66 96.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.052 0.941 . . . . 0.0 110.926 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 -16.37 64.27 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.323 -0.709 . . . . 0.0 114.218 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.562 ' O ' HD21 ' A' ' 48' ' ' LEU . 64.1 mt -95.39 -13.5 24.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.686 0.795 . . . . 0.0 111.833 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.548 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.07 120.8 9.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.52 -28.14 5.99 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.549 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 12.4 ptm180 -90.89 3.17 55.26 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -168.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.562 HD21 ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -127.15 2.65 6.45 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.355 0.662 . . . . 0.0 110.962 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 35' ' ' ARG . 69.6 mt -135.63 129.13 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.52 1.128 . . . . 0.0 108.352 170.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 1.2 tm-20 -150.62 128.59 11.79 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.0 t70 61.08 30.31 19.4 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.449 1.1 . . . . 0.0 110.85 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.51 -13.55 6.31 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.798 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.78 -173.41 2.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.915 0.886 . . . . 0.0 109.361 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 60' ' ' VAL . 17.0 m -60.23 -57.07 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.536 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.992 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 56' ' ' PRO . 12.8 tppt? 150.39 137.84 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 C-N-CA 124.986 1.314 . . . . 0.0 109.862 -175.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.501 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 42.8 Cg_endo -65.91 141.31 64.27 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 123.435 2.756 . . . . 0.0 111.773 163.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 82.25 -23.78 0.2 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.768 1.627 . . . . 0.0 112.532 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.12 141.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.9 m120 -111.87 104.58 12.89 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 54' ' ' VAL . 2.7 m -115.93 140.64 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.639 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -132.22 146.94 52.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.796 1.239 . . . . 0.0 110.012 -166.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.661 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 17.9 tptm -106.08 104.54 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 164.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.87 41.41 32.05 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.314 1.046 . . . . 0.0 111.838 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.44 -11.53 71.89 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-N 115.244 -0.889 . . . . 0.0 114.551 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -99.87 106.43 18.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tt0 -64.11 114.2 4.02 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.162 0.985 . . . . 0.0 111.63 -170.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.8 m -73.78 -2.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -172.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 m -72.67 -7.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 118.24 0.473 . . . . 0.0 111.361 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -96.69 -16.66 20.81 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.877 0.871 . . . . 0.0 110.958 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.84 -154.01 0.58 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.676 1.19 . . . . 0.0 109.208 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.2 m-20 -61.36 108.59 0.96 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.88 -48.54 33.23 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.484 0.49 . . . . 0.0 112.228 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.9 mmm -80.76 -37.97 29.46 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.003 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.04 66.13 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -172.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -70.09 -70.19 0.31 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.449 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.99 35.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -159.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.78 135.9 43.57 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.644 -0.66 . . . . 0.0 112.566 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.52 175.17 9.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.538 1.535 . . . . 0.0 108.151 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.66 141.26 53.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.771 0.714 . . . . 0.0 111.039 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.75 -15.14 27.34 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.619 -0.718 . . . . 0.0 114.381 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.661 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 50.9 m-20 -69.37 134.15 48.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.313 0.645 . . . . 0.0 111.618 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.21 142.6 27.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.03 107.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 165.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.0 m -94.06 130.12 40.33 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 0.0 109.151 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.437 HG12 HG12 ' A' ' 60' ' ' VAL . 23.0 m -130.53 138.73 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.722 0.692 . . . . 0.0 110.605 -174.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 64.1 m-85 -122.3 135.53 25.59 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.522 ' HG3' ' H ' ' A' ' 10' ' ' THR . 27.4 Cg_endo -58.96 168.04 4.89 Favored 'Trans proline' 0 C--N 1.364 1.369 0 C-N-CA 123.953 3.102 . . . . 0.0 114.075 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.21 130.78 33.59 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.345 2.03 . . . . 0.0 111.374 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.2 t -77.67 103.56 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.65 13.94 9.22 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.957 1.303 . . . . 0.0 112.905 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.33 55.38 0.65 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.124 -179.908 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.384 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 91.55 63.27 1.17 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -152.7 14.12 0.69 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.321 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 39.78 65.55 0.7 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.074 1.35 . . . . 0.0 112.015 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.84 -30.88 4.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.76 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 69.54 10.76 7.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.938 1.295 . . . . 0.0 112.862 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -132.35 -50.39 0.93 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.207 0.603 . . . . 0.0 110.559 -170.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 9.4 t70 69.27 -177.2 0.21 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.953 1.301 . . . . 0.0 110.113 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 26.4 t70 74.12 -73.3 0.1 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.648 1.179 . . . . 0.0 111.223 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -155.69 145.71 21.5 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.94 0.896 . . . . 0.0 108.815 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 13.6 t70 70.59 142.84 0.05 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.383 1.473 . . . . 0.0 111.855 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -110.18 -38.93 5.15 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.849 0.46 . . . . 0.0 111.126 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 58.52 12.74 14.33 Favored Glycine 0 N--CA 1.479 1.545 0 N-CA-C 114.234 0.454 . . . . 0.0 114.234 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 36.8 p -90.29 177.34 6.44 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.994 0.918 . . . . 0.0 110.57 -174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' HE2' HD12 ' A' ' 3' ' ' LEU . 24.8 ptt? -147.21 132.95 18.92 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -83.81 141.11 31.6 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.459 HD12 ' HE2' ' A' ' 1' ' ' MET . 27.5 mt -141.64 129.79 22.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 109.514 -172.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -88.86 101.16 13.77 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 mt -94.98 108.1 20.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 27.9 mtm180 -97.87 117.42 32.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.782 0.833 . . . . 0.0 109.743 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -102.51 135.15 44.66 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.332 1.053 . . . . 0.0 108.877 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -130.69 161.24 32.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.89 0.476 . . . . 0.0 110.069 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.44 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 59.08 -120.9 1.1 Allowed 'General case' 0 CA--C 1.564 1.506 0 O-C-N 124.509 1.131 . . . . 0.0 111.873 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.7 m -71.98 -41.61 67.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.302 0.641 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -60.52 -26.66 67.03 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.579 0.351 . . . . 0.0 110.864 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -47.52 69.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.57 0.748 . . . . 0.0 111.086 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.14 -22.99 59.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.541 HG12 ' HG ' ' A' ' 44' ' ' LEU . 74.8 t -60.33 -55.44 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 171.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.5 -20.42 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.06 11.85 83.98 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.417 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -163.94 158.26 19.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.695 0.798 . . . . 0.0 110.66 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -85.05 -19.67 31.6 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 9.6 m -152.55 147.78 26.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 pt -137.07 174.02 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.399 1.08 . . . . 0.0 108.762 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -122.58 113.16 18.9 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 167.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.405 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -98.49 172.63 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.896 1.279 . . . . 0.0 109.377 171.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -153.68 106.12 2.86 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.291 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.36 173.2 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.22 1.408 . . . . 0.0 108.474 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 34.0 t70 -66.2 161.26 22.43 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.978 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.22 -22.48 59.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.124 0.57 . . . . 0.0 111.745 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -81.0 -16.43 53.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.68 0.392 . . . . 0.0 110.65 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.86 151.49 41.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.324 0.65 . . . . 0.0 109.61 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.4 p -130.39 -174.74 3.43 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.901 0.881 . . . . 0.0 109.954 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.0 t -50.84 -37.04 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 124.578 1.151 . . . . 0.0 111.479 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.87 -39.78 64.5 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.802 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.26 -31.7 71.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.933 0.493 . . . . 0.0 110.52 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.74 -59.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.542 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 54' ' ' VAL . 1.7 pp -64.26 -31.15 72.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.799 0.272 . . . . 0.0 111.093 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.481 ' HA ' HD11 ' A' ' 49' ' ' ILE . 9.1 tpt180 -51.77 -50.25 61.07 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.264 0.554 . . . . 0.0 111.353 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -75.82 -32.02 59.63 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.313 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.94 -39.06 68.48 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.2 pt-20 -73.95 -29.71 62.14 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.65 0.262 . . . . 0.0 111.63 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.69 65.51 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.57 0.748 . . . . 0.0 110.895 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.405 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 21.4 mm-40 -95.39 -58.71 2.06 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.431 1.092 . . . . 0.0 109.944 172.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.89 116.0 28.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.09 -30.49 70.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.953 0.901 . . . . 0.0 110.541 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.9 -20.17 77.49 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.956 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HB3' HD11 ' A' ' 48' ' ' LEU . 63.1 mt -99.3 -1.66 38.41 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.713 0.805 . . . . 0.0 111.842 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.14 120.43 10.31 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.5 -7.64 17.79 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -100.16 4.57 44.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.029 0.914 . . . . 0.0 111.328 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.0 -5.96 8.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.579 1.152 . . . . 0.0 110.605 -177.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 35' ' ' ARG . 55.3 mt -133.02 138.6 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.681 1.193 . . . . 0.0 108.569 169.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 8.5 tp10 -144.9 124.87 13.51 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.649 0.78 . . . . 0.0 109.102 169.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.4 t70 58.95 31.79 21.66 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.432 1.093 . . . . 0.0 111.728 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 73' ' ' MET . . . 87.44 -14.74 57.17 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.168 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.09 -174.44 2.54 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.858 0.863 . . . . 0.0 109.185 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HD22 ' A' ' 34' ' ' LEU . 34.0 m -62.83 -54.97 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 CA-C-O 118.11 -0.947 . . . . 0.0 112.829 -170.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 11.5 tppt? 151.61 139.61 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.388 0 C-N-CA 125.789 1.635 . . . . 0.0 107.879 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.473 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 21.9 Cg_endo -58.58 125.57 18.73 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.83 2.353 . . . . 0.0 111.636 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 73.41 1.4 3.97 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.66 1.184 . . . . 0.0 113.944 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.43 HG22 ' HD3' ' A' ' 88' ' ' PRO . 5.1 p -74.28 117.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.6 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 5.1 m-20 -80.83 103.62 10.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.506 HG13 HG11 ' A' ' 85' ' ' VAL . 2.9 m -123.73 131.98 72.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -175.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.683 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 3.7 mp -121.88 172.14 8.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.254 1.022 . . . . 0.0 111.208 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 16.7 tptp -159.53 108.68 1.84 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.462 ' HB2' ' HZ2' ' A' ' 62' ' ' LYS . 9.7 t-20 54.85 34.42 21.99 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.798 0.839 . . . . 0.0 110.237 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.9 13.98 82.51 Favored Glycine 0 C--N 1.352 1.465 0 N-CA-C 115.005 0.762 . . . . 0.0 115.005 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -119.67 121.25 38.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.797 0.839 . . . . 0.0 108.802 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.6 tt0 -75.91 110.14 10.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.405 0.682 . . . . 0.0 110.677 -171.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.5 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 17.5 m -70.54 -0.96 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -174.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 m -70.25 -16.5 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 118.104 0.411 . . . . 0.0 110.885 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -95.33 1.15 54.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.1 0.96 . . . . 0.0 111.26 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.47 -153.84 0.44 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.795 0.838 . . . . 0.0 109.773 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.54 108.58 0.99 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.0 0.52 . . . . 0.0 111.314 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.5 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -67.37 -50.6 43.29 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.568 0.543 . . . . 0.0 113.627 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.4 ' HE3' ' O ' ' A' ' 52' ' ' GLY . 79.1 mmm -80.48 -39.64 27.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.089 0.556 . . . . 0.0 111.821 -170.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.84 76.62 1.54 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.912 0.863 . . . . 0.0 111.058 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.474 HG21 ' HG2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -81.64 -71.61 0.47 Allowed 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.149 177.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.16 34.67 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.599 0.76 . . . . 0.0 110.931 -163.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.534 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 21.0 tp -73.86 149.89 41.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.991 0.424 . . . . 0.0 110.54 -170.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.5 171.7 19.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 109.297 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.1 p-10 -70.39 146.62 50.29 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.347 0.659 . . . . 0.0 112.059 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.95 16.31 63.88 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.254 -0.885 . . . . 0.0 114.019 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.74 163.15 24.71 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.498 0.649 . . . . 0.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.38 95.33 4.43 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.638 0.732 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.8 t -86.53 138.56 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.919 1.288 . . . . 0.0 109.142 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.683 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 17.9 m -117.25 161.25 19.8 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.459 0.572 . . . . 0.0 110.653 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.506 HG11 HG13 ' A' ' 60' ' ' VAL . 35.3 m -146.79 141.73 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.196 0.998 . . . . 0.0 109.197 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.6 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 7.5 m-85 -135.28 133.7 20.79 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 175.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 23.6 Cg_endo -60.92 155.87 47.22 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.067 2.511 . . . . 0.0 112.565 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HD3' HG22 ' A' ' 58' ' ' VAL . 97.8 Cg_endo -74.33 138.26 24.54 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.565 2.177 . . . . 0.0 111.869 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.31 37.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 121.526 0.679 . . . . 0.0 110.776 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.99 89.93 0.43 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.635 1.174 . . . . 0.0 110.645 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.46 -124.7 0.72 Allowed Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.495 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 119.204 -0.776 . . . . 0.0 112.291 179.7 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.25 -0.34 . . . . 0.0 112.25 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 164.64 -47.87 0.29 Allowed Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 147.03 -160.97 28.39 Favored Glycine 0 N--CA 1.472 1.06 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . 0.489 ' HD2' ' HA3' ' A' ' -1' ' ' GLY . 19.4 mmt180 59.61 -171.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.206 1.002 . . . . 0.0 113.516 169.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' -2' ' ' LYS . 4.0 m-20 -122.98 110.79 15.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.307 1.443 . . . . 0.0 108.804 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . 0.51 ' HA ' HG21 ' A' ' 0' ' ' THR . 15.5 m-85 -86.9 64.13 8.32 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.867 0.841 . . . . 0.0 111.378 -171.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' -9' ' ' ASP . 0.0 OUTLIER -153.86 162.35 41.29 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.521 1.128 . . . . 0.0 109.444 176.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -86.75 120.36 27.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . 0.402 ' H ' ' HD3' ' A' ' -2' ' ' LYS . 35.9 t70 -169.96 172.97 6.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.197 0.999 . . . . 0.0 109.092 -174.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.6 -44.68 81.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.479 0.712 . . . . 0.0 110.513 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -107.17 131.99 53.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.947 0.899 . . . . 0.0 108.9 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' -9' ' ' ASP . 47.6 pttt -167.33 -41.25 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.212 0.605 . . . . 0.0 111.55 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.489 ' HA3' ' HD2' ' A' ' -10' ' ' ARG . . . 60.93 31.74 77.38 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-O 121.21 0.339 . . . . 0.0 112.378 -174.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' -8' ' ' TYR . 54.9 p -120.64 142.12 49.73 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.594 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.0 ptt? -105.34 135.97 45.74 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.823 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.85 129.75 41.71 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.657 0.783 . . . . 0.0 109.005 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 143.78 50.49 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.074 0.397 . . . . 0.0 111.221 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 36.1 tt0 -89.53 101.15 13.83 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.69 104.44 16.54 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 25.4 mtp180 -91.38 118.8 30.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.17 136.06 45.37 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.988 0.915 . . . . 0.0 109.387 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.66 161.56 30.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.083 0.553 . . . . 0.0 109.851 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.45 -129.92 1.33 Allowed 'General case' 0 CA--C 1.561 1.366 0 O-C-N 124.359 1.037 . . . . 0.0 111.238 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -64.04 -40.62 96.71 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 123.394 0.677 . . . . 0.0 111.747 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.478 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -67.54 -49.05 65.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.236 0.615 . . . . 0.0 110.626 -178.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.92 -18.03 60.95 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.82 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.448 HG13 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -66.02 -54.43 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.178 0.513 . . . . 0.0 110.253 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.55 -17.35 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.884 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.478 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 70.71 11.95 69.81 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.536 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -140.07 138.14 35.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.798 1.239 . . . . 0.0 109.146 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -82.68 -21.09 35.05 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.733 0.646 . . . . 0.0 110.707 172.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 11.6 m -154.65 149.81 26.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.628 1.171 . . . . 0.0 108.799 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 15.5 pt -135.26 178.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.129 0.972 . . . . 0.0 109.055 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -125.81 112.22 15.77 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.403 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -96.38 179.1 5.14 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.98 1.312 . . . . 0.0 109.921 174.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.0 ttp-105 -157.23 107.07 2.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.219 0.533 . . . . 0.0 109.942 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.84 176.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.684 1.194 . . . . 0.0 109.141 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -54.3 144.97 18.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.348 1.059 . . . . 0.0 110.014 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.99 -31.86 71.86 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.63 -7.51 59.6 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.593 0.757 . . . . 0.0 111.498 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.73 159.84 29.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.766 0.426 . . . . 0.0 109.853 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.8 p -130.96 179.2 6.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.986 0.515 . . . . 0.0 110.715 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.57 -35.79 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.609 1.164 . . . . 0.0 112.137 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.573 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.71 -37.47 67.01 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.741 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.46 -36.76 84.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.449 0.7 . . . . 0.0 110.927 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.14 -59.98 3.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.612 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD23 HG13 ' A' ' 54' ' ' VAL . 2.5 pp -63.7 -30.45 71.55 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.933 0.333 . . . . 0.0 111.315 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.488 ' HA ' HD13 ' A' ' 49' ' ' ILE . 22.4 tpt180 -53.4 -48.73 68.42 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.004 0.431 . . . . 0.0 111.511 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.21 -32.8 61.29 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.533 0.333 . . . . 0.0 111.547 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 3.1 mm? -56.08 -34.54 66.08 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.6 0.76 . . . . 0.0 112.837 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -76.8 -26.09 54.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.91 -30.75 65.69 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.936 0.494 . . . . 0.0 110.51 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.403 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 15.8 mm-40 -79.79 -58.92 2.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.212 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.4 118.25 36.26 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.718 -169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.09 -28.55 67.45 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.106 0.562 . . . . 0.0 110.192 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.21 -2.29 82.94 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.861 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB3' HD12 ' A' ' 48' ' ' LEU . 87.4 mt -114.65 2.84 14.61 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.578 0.689 . . . . 0.0 110.3 171.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.6 123.62 23.58 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.964 0.505 . . . . 0.0 111.886 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.85 8.19 87.75 Favored Glycine 0 N--CA 1.48 1.625 0 N-CA-C 115.176 0.831 . . . . 0.0 115.176 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.484 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.9 ptp180 -125.96 2.16 7.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.744 0.818 . . . . 0.0 111.422 -173.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.577 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -128.5 -8.89 5.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.427 1.091 . . . . 0.0 110.724 -176.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.488 HD13 ' HA ' ' A' ' 35' ' ' ARG . 31.2 mt -130.26 132.49 65.01 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 C-N-CA 124.867 1.267 . . . . 0.0 108.653 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.32 108.45 8.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.395 0.678 . . . . 0.0 109.798 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.2 t70 57.56 31.29 20.09 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.293 1.037 . . . . 0.0 111.666 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.0 0.66 71.1 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.6 -174.69 2.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.085 0.942 . . . . 0.0 108.721 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG13 HD23 ' A' ' 34' ' ' LEU . 15.0 m -65.1 -56.3 16.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 CA-C-O 117.537 -1.22 . . . . 0.0 112.015 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.2 tppt? 151.18 136.32 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 C-N-CA 124.667 1.187 . . . . 0.0 108.746 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.86 128.12 27.81 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.936 2.424 . . . . 0.0 111.08 164.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 82.42 -14.82 0.73 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.349 1.46 . . . . 0.0 114.251 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -70.12 126.46 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.4 m120 -94.82 103.45 15.34 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -120.68 134.23 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.095 0.474 . . . . 0.0 109.94 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 7.1 mp -119.59 171.68 8.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.885 1.274 . . . . 0.0 111.738 -170.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.57 ' HZ3' ' HB2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -158.16 104.2 1.86 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.776 -177.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.57 ' HB2' ' HZ3' ' A' ' 62' ' ' LYS . 15.3 t-20 56.47 36.47 27.61 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.455 1.102 . . . . 0.0 110.243 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.58 -13.24 67.13 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.719 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -97.41 119.9 36.79 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.413 0.685 . . . . 0.0 109.936 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 25.3 tt0 -79.55 106.47 11.6 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.769 -173.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -68.51 -1.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.374 1.469 . . . . 0.0 114.489 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.47 -21.61 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 117.857 0.299 . . . . 0.0 111.169 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -87.25 -19.34 28.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.979 0.912 . . . . 0.0 110.791 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.81 -139.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.612 1.165 . . . . 0.0 108.423 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.2 109.42 17.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.953 0.797 . . . . 0.0 110.206 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.85 -38.77 65.53 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.354 0.409 . . . . 0.0 112.871 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.573 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.9 mmt -81.58 -37.17 28.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.26 77.57 1.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 t -81.51 -66.5 0.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.27 33.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 -165.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.62 141.81 46.54 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.844 -0.535 . . . . 0.0 111.144 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.43 -175.98 4.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.313 1.045 . . . . 0.0 108.909 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.0 p30 -80.02 148.86 30.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.087 0.555 . . . . 0.0 111.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.67 61.75 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.708 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.34 141.97 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.19 0.596 . . . . 0.0 111.566 -170.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.61 109.84 22.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.88 0.472 . . . . 0.0 110.854 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -100.23 107.09 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.448 0.699 . . . . 0.0 109.285 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 61.4 m -87.07 148.13 25.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.121 0.569 . . . . 0.0 109.934 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 m -143.37 148.31 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.346 0.659 . . . . 0.0 110.241 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 25.5 m-85 -136.7 135.72 20.71 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 23.7 Cg_endo -59.71 164.47 11.5 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 124.012 3.141 . . . . 0.0 113.505 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.0 131.2 31.72 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.297 1.998 . . . . 0.0 112.804 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.82 157.51 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.034 0.934 . . . . 0.0 110.546 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.46 121.84 23.68 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.234 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.47 114.66 0.98 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.941 -0.922 . . . . 0.0 111.079 -179.294 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 112.398 -0.281 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 87.44 170.23 46.28 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -63.34 -52.66 45.18 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . 0.412 ' HE ' ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 50.08 57.26 6.76 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.177 1.391 . . . . 0.0 109.844 176.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 17.1 t70 -136.05 145.35 45.9 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.888 -168.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -107.25 -9.26 16.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.606 0.762 . . . . 0.0 112.26 -161.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.74 179.64 5.08 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 77.72 179.14 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.91 1.684 . . . . 0.0 110.905 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -111.56 -9.53 14.18 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.518 0.727 . . . . 0.0 111.179 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.05 -151.27 0.12 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -65.69 133.09 50.34 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 122.879 0.472 . . . . 0.0 110.328 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 15.8 pttp -153.24 -56.67 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.88 1.272 . . . . 0.0 108.684 -173.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 96.99 59.72 0.99 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 62.8 p -120.63 146.21 46.62 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.235 1.014 . . . . 0.0 109.437 175.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 21.4 ptt? -116.34 133.62 55.81 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.001 0.92 . . . . 0.0 110.976 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.91 132.99 36.08 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.214 1.006 . . . . 0.0 110.139 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.3 mt -132.64 139.07 47.58 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.515 0.726 . . . . 0.0 110.437 -168.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -89.37 102.32 14.99 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.496 HD11 HD23 ' A' ' 37' ' ' LEU . 36.4 mt -93.24 104.07 16.28 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.541 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 12.4 mtp180 -95.58 117.9 31.3 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.993 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.67 138.33 44.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.915 0.886 . . . . 0.0 109.76 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -132.01 156.07 46.9 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.307 0.643 . . . . 0.0 109.32 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.36 -128.12 1.72 Allowed 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.845 1.258 . . . . 0.0 112.818 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 84.8 m -55.92 -49.59 73.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.148 0.979 . . . . 0.0 111.862 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -64.19 -23.12 67.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.685 0.394 . . . . 0.0 111.006 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.593 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -69.21 -48.25 62.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.187 0.595 . . . . 0.0 110.962 178.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -22.78 59.38 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.379 0.424 . . . . 0.0 111.675 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.538 HG13 ' HG ' ' A' ' 44' ' ' LEU . 78.5 t -59.64 -56.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.594 0.711 . . . . 0.0 110.587 170.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.0 t -73.78 -22.07 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.376 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.593 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 71.01 11.05 69.52 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.938 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -142.37 145.33 33.76 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.848 0.859 . . . . 0.0 109.21 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -19.32 29.59 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.572 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 13.6 m -155.0 139.93 17.28 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 162.98 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.129 0.972 . . . . 0.0 108.882 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.0 112.75 24.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -103.37 178.05 4.67 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.447 1.499 . . . . 0.0 109.514 174.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -157.61 110.56 2.46 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.792 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.02 179.89 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.72 150.93 18.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.332 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.89 -35.0 69.62 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.524 1.129 . . . . 0.0 111.438 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' HB3' ' HE ' ' A' ' -10' ' ' ARG . 19.8 t70 -80.93 -13.3 59.02 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.768 0.827 . . . . 0.0 110.375 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 166.96 4.96 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.972 0.909 . . . . 0.0 111.353 172.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.8 p -135.98 -177.62 4.78 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.604 0.762 . . . . 0.0 110.1 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 77' ' ' LEU . 80.2 t -52.01 -37.84 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 C-N-CA 123.8 0.84 . . . . 0.0 110.757 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.63 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.49 -37.98 69.23 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.449 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.89 -29.82 68.18 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.046 0.539 . . . . 0.0 110.624 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.8 t -65.36 -60.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.577 0.751 . . . . 0.0 110.202 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.0 -30.31 71.4 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.794 0.27 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HA ' HD12 ' A' ' 49' ' ' ILE . 19.7 tpt180 -52.83 -46.96 67.99 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.28 0.562 . . . . 0.0 111.388 169.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.5 m -75.03 -32.43 61.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.708 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.496 HD23 HD11 ' A' ' 5' ' ' LEU . 3.5 mm? -59.18 -31.9 69.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.456 ' HB3' HD23 ' A' ' 48' ' ' LEU . 16.6 pt-20 -77.74 -28.48 50.76 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.426 0.557 . . . . 0.0 111.365 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.74 72.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.0 0.52 . . . . 0.0 111.084 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -85.96 -58.8 2.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.506 0.723 . . . . 0.0 110.58 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 95.0 m-85 -95.12 116.32 28.58 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.632 -171.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.99 -32.74 74.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.161 0.985 . . . . 0.0 111.225 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.483 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.69 -5.76 83.91 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.673 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.646 ' HB3' HD11 ' A' ' 48' ' ' LEU . 58.4 mt -106.56 3.04 26.58 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.573 0.687 . . . . 0.0 111.444 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.86 121.04 14.61 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 5.88 59.67 Favored Glycine 0 C--N 1.358 1.782 0 N-CA-C 115.773 1.069 . . . . 0.0 115.773 171.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.7 ptp180 -113.12 5.15 16.95 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.017 0.927 . . . . 0.0 111.337 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -126.27 -8.74 6.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.708 1.203 . . . . 0.0 110.36 -178.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 35' ' ' ARG . 33.5 mt -128.78 137.28 57.7 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 125.266 1.426 . . . . 0.0 108.402 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 16.1 mm-40 -128.9 107.95 10.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.525 0.73 . . . . 0.0 109.416 160.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 52.91 41.56 31.96 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.009 1.323 . . . . 0.0 112.873 171.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -7.1 78.03 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.988 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -110.5 -174.8 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.83 0.815 . . . . 0.0 109.1 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -70.14 -56.39 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.013 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 tppt? 152.49 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.434 0 C-N-CA 124.919 1.288 . . . . 0.0 109.392 -175.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.435 ' HD2' ' HG3' ' A' ' 50' ' ' GLU . 36.5 Cg_endo -63.11 131.91 34.42 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.077 2.518 . . . . 0.0 111.724 166.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 m170 76.73 -2.93 2.61 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 124.859 1.264 . . . . 0.0 113.682 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 1.4 p -75.9 154.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.2 m120 -121.03 103.56 9.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 HG21 ' A' ' 67' ' ' VAL . 4.4 m -117.0 147.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.755 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.1 mp -132.13 172.51 12.3 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.052 1.341 . . . . 0.0 110.375 -163.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 17.6 tptp -157.82 105.33 1.99 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.143 1.377 . . . . 0.0 107.534 -172.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.92 35.02 14.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.484 1.114 . . . . 0.0 110.744 -168.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.76 -14.18 59.06 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.361 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -83.63 116.67 22.73 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.91 0.855 . . . . 0.0 110.087 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 23.0 tt0 -73.85 107.07 5.86 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.068 -171.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.51 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.2 m -75.52 -0.98 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 58' ' ' VAL . 17.1 m -70.62 -14.98 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.946 0.794 . . . . 0.0 111.342 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -85.38 -27.17 26.01 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.628 0.771 . . . . 0.0 110.722 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -130.3 -152.22 0.5 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.119 0.968 . . . . 0.0 109.868 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.28 108.91 1.72 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.206 0.602 . . . . 0.0 111.334 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.51 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.63 -43.1 12.45 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.774 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.63 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.5 mmt -74.52 -39.49 62.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.121 0.569 . . . . 0.0 111.957 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.3 79.02 1.39 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.195 0.521 . . . . 0.0 111.496 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.2 t -81.78 -62.35 1.66 Allowed 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.882 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 176.06 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.67 1.188 . . . . 0.0 110.034 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 30' ' ' VAL . 1.2 tm? -73.91 113.68 11.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.55 0.74 . . . . 0.0 110.727 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.82 -178.19 4.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.229 1.411 . . . . 0.0 109.516 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.2 p-10 -66.42 150.36 49.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 112.362 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.21 13.43 64.75 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.239 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.85 156.99 33.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 117.446 0.623 . . . . 0.0 111.176 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.541 ' HB1' ' HD2' ' A' ' 6' ' ' ARG . . . -115.63 94.31 4.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.438 0.695 . . . . 0.0 109.297 171.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.26 106.37 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 48.9 m -93.11 146.35 23.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.376 0.671 . . . . 0.0 109.718 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 m -140.94 141.79 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.693 0.759 . . . . 0.0 110.199 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.7 m-85 -128.7 136.67 29.5 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.433 ' HG3' ' H ' ' A' ' 10' ' ' THR . 54.5 Cg_endo -62.75 169.37 8.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.165 3.243 . . . . 0.0 112.792 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 12.8 Cg_exo -61.39 128.41 24.83 Favored 'Trans proline' 0 C--N 1.381 2.256 0 N-CA-C 108.962 -1.207 . . . . 0.0 108.962 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 m -86.74 -33.45 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 123.622 0.576 . . . . 0.0 111.697 -166.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.83 105.84 3.87 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 172.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.27 64.67 0.53 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.414 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.904 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 86.09 170.31 46.85 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.447 0.123 . . . . 0.0 112.964 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -72.23 -84.99 0.21 Allowed Glycine 0 C--N 1.344 0.986 0 O-C-N 123.43 0.135 . . . . 0.0 112.83 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -114.79 89.54 3.12 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.687 0.755 . . . . 0.0 109.744 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -123.29 111.67 16.7 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.54 1.136 . . . . 0.0 108.939 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -65.16 -50.94 64.04 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.181 0.515 . . . . 0.0 110.138 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.47 ' HZ1' ' HB3' ' A' ' -7' ' ' LYS . 3.6 mmmp? 69.94 0.75 3.19 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.783 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -67.89 -36.82 80.91 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.04 0.936 . . . . 0.0 111.256 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.35 -67.13 0.42 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.984 0.913 . . . . 0.0 110.754 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 17.3 t70 178.78 -62.27 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' -7' ' ' LYS . 3.3 t70 -83.33 -163.39 0.74 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 163.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -51.89 -40.39 60.58 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.634 0.652 . . . . 0.0 111.286 172.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 61.49 33.05 83.38 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.088 0.868 . . . . 0.0 112.368 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 61.5 p -127.04 145.7 50.62 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.883 0.873 . . . . 0.0 110.849 -173.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.8 ptt? -132.65 145.22 50.9 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.826 0.85 . . . . 0.0 109.443 174.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.33 113.42 26.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.996 0.519 . . . . 0.0 110.473 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.403 HD13 HD12 ' A' ' 77' ' ' LEU . 21.8 mt -104.6 143.53 32.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.858 0.863 . . . . 0.0 111.018 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.53 101.09 13.77 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.58 0.352 . . . . 0.0 110.146 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.2 mt -93.8 105.55 17.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.26 0.552 . . . . 0.0 110.332 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 61.4 mtp180 -91.5 124.18 35.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.62 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -112.32 137.82 49.93 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.561 0.745 . . . . 0.0 109.013 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -132.5 161.16 34.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.874 0.47 . . . . 0.0 110.454 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 56.28 -128.03 1.97 Allowed 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.631 1.172 . . . . 0.0 112.16 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m -59.5 -49.79 76.42 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.778 0.831 . . . . 0.0 111.609 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -59.8 -24.05 63.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.937 0.495 . . . . 0.0 111.352 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 ttp85 -68.71 -51.05 45.7 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.57 -21.85 60.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.529 0.332 . . . . 0.0 111.257 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.431 HG11 ' HG ' ' A' ' 44' ' ' LEU . 76.0 t -61.12 -55.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 0.0 110.07 170.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -77.87 -16.86 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.723 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.56 11.73 62.84 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.088 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -139.75 146.96 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.006 0.922 . . . . 0.0 110.007 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -104.36 -19.04 14.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.013 0.925 . . . . 0.0 110.998 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.5 m -153.74 138.36 16.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.949 0.9 . . . . 0.0 108.971 165.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.8 pt -133.37 178.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.821 0.848 . . . . 0.0 109.734 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -125.09 112.84 16.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.89 132.64 51.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 108.54 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -96.8 112.74 24.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 m -113.61 -179.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.83 166.26 22.62 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.019 0.372 . . . . 0.0 110.548 174.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.63 -31.58 72.86 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.625 0.77 . . . . 0.0 112.377 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.86 -17.16 51.62 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.828 0.451 . . . . 0.0 110.832 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 147.14 37.04 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.724 0.81 . . . . 0.0 112.183 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' A' ' 74' ' ' ALA . 74.5 p -134.03 -174.64 3.6 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.942 0.897 . . . . 0.0 109.097 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.0 t -52.36 -42.06 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.65 0.78 . . . . 0.0 111.464 -175.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.63 94.77 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.363 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.09 -34.43 76.41 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.262 0.553 . . . . 0.0 110.45 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.95 -57.8 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.246 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.625 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.2 pp -70.07 -30.66 67.96 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -64.94 -35.29 80.67 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.715 0.689 . . . . 0.0 110.49 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -75.84 -33.04 60.02 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.422 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -61.89 -39.43 91.95 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.935 0.494 . . . . 0.0 111.722 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 4.8 pt-20 -73.11 -26.26 61.17 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.95 63.72 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.077 0.551 . . . . 0.0 111.328 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -96.5 -59.19 1.87 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.943 0.878 . . . . 0.0 109.306 173.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -95.83 106.95 19.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.094 -171.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.38 -27.04 69.03 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.202 0.601 . . . . 0.0 111.048 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.58 -5.01 62.69 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.826 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.638 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.7 mt -111.3 -6.86 14.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.377 0.671 . . . . 0.0 111.481 172.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.3 120.03 8.51 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.56 5.66 56.51 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -96.62 -32.78 12.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.579 0.751 . . . . 0.0 109.583 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -98.13 2.03 48.15 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.219 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.22 139.0 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.603 1.161 . . . . 0.0 109.469 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.55 129.76 11.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.64 31.11 12.05 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.144 1.378 . . . . 0.0 112.035 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.62 -9.72 41.73 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.127 -0.818 . . . . 0.0 114.76 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -93.67 -174.42 3.46 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.179 0.989 . . . . 0.0 108.902 168.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.479 HG13 HD22 ' A' ' 34' ' ' LEU . 28.6 m -64.14 -55.32 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.417 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HG2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 tppt? 153.6 137.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 C-N-CA 125.175 1.39 . . . . 0.0 109.491 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.27 128.35 29.77 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.665 2.91 . . . . 0.0 111.981 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 76.35 -6.73 1.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.5 1.52 . . . . 0.0 113.874 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.17 141.85 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 18.0 m120 -111.8 104.13 12.43 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.417 HG22 HG11 ' A' ' 54' ' ' VAL . 4.9 m -113.34 136.05 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -127.74 148.53 50.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.036 1.334 . . . . 0.0 110.209 -168.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -112.38 105.43 13.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 59.44 35.87 23.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.059 0.944 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.08 -13.79 65.28 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.765 -0.652 . . . . 0.0 114.247 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -90.45 102.14 14.87 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.6 tt0 -64.79 106.2 1.16 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.859 0.864 . . . . 0.0 111.015 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.87 -1.35 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 66' ' ' GLU . 15.2 m -70.83 -12.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 118.09 0.405 . . . . 0.0 111.554 171.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -93.63 -20.97 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.569 0.748 . . . . 0.0 110.779 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.62 -153.14 0.54 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.604 1.162 . . . . 0.0 109.076 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.442 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.0 m-20 -59.64 109.34 0.89 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.266 0.626 . . . . 0.0 111.116 172.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.98 -46.33 7.15 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 123.321 0.388 . . . . 0.0 112.246 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 89.4 mmm -80.73 -20.16 43.41 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.427 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -161.44 79.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.898 0.317 . . . . 0.0 111.614 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -76.58 -74.97 0.21 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -176.68 35.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.492 0.317 . . . . 0.0 111.572 -164.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.403 HD12 HD13 ' A' ' 3' ' ' LEU . 18.2 mt -73.7 150.13 41.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.553 0.692 . . . . 0.0 112.435 -170.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -154.23 179.7 8.72 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.723 1.609 . . . . 0.0 107.628 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 31.9 t70 -63.99 129.33 39.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.019 0.528 . . . . 0.0 111.906 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.96 6.22 82.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.133 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.01 122.22 27.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.602 0.761 . . . . 0.0 111.413 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.67 125.08 32.19 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.252 0.621 . . . . 0.0 111.734 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.36 107.63 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.684 0.794 . . . . 0.0 109.721 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.666 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.0 m -85.83 152.1 23.28 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.394 0.677 . . . . 0.0 110.191 175.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.49 147.0 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.418 0.628 . . . . 0.0 109.946 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 42.3 m-85 -135.33 134.24 21.14 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 174.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 29.8 Cg_endo -59.42 164.64 10.61 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.841 3.028 . . . . 0.0 114.025 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HG3' ' HG2' ' A' ' 55' ' ' LYS . 15.4 Cg_exo -63.96 130.65 28.16 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.662 2.241 . . . . 0.0 111.166 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.78 122.08 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.685 0.794 . . . . 0.0 110.01 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.76 144.37 41.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.791 0.836 . . . . 0.0 109.962 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.3 -44.48 0.33 Allowed Glycine 0 C--N 1.34 0.783 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.763 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 113.419 0.128 . . . . 0.0 113.419 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -96.26 77.57 0.76 Allowed Glycine 0 C--N 1.348 1.229 0 C-N-CA 123.198 0.428 . . . . 0.0 113.498 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -87.44 -40.79 6.73 Favored Glycine 0 C--N 1.347 1.169 0 C-N-CA 122.796 0.236 . . . . 0.0 112.591 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -77.63 -27.26 51.06 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.749 0.819 . . . . 0.0 111.663 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -83.01 -30.61 27.99 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.094 0.557 . . . . 0.0 110.171 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 70.66 -66.81 0.27 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.478 1.511 . . . . 0.0 111.672 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.23 173.05 6.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.273 1.029 . . . . 0.0 110.962 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -121.76 104.1 9.35 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.064 0.946 . . . . 0.0 108.742 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -161.09 -62.88 0.06 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -85.6 167.73 15.1 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.21 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.38 -21.53 66.66 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.93 0.492 . . . . 0.0 111.729 173.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -153.16 -60.2 0.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.224 1.009 . . . . 0.0 109.861 174.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 57.35 31.13 62.33 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 25' ' ' ASP . 29.7 p -141.51 141.92 33.59 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.684 1.193 . . . . 0.0 110.171 -171.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.501 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 23.7 ptt? -114.63 132.01 56.52 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.581 1.153 . . . . 0.0 110.695 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -84.42 128.57 34.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.275 0.63 . . . . 0.0 109.533 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.476 HD12 ' HE1' ' A' ' 1' ' ' MET . 25.3 mt -127.46 137.08 52.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.475 0.71 . . . . 0.0 110.467 -173.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -89.69 101.54 14.23 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.3 mt -93.33 107.42 19.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtt-85 -96.31 120.45 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.302 1.041 . . . . 0.0 109.778 -176.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.44 134.42 50.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.515 1.126 . . . . 0.0 109.251 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -128.68 162.55 27.09 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.979 0.512 . . . . 0.0 109.904 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 60.8 -122.6 0.91 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.493 1.117 . . . . 0.0 111.497 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.416 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 54.5 m -68.94 -45.77 69.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 111.408 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -57.19 -27.91 62.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.03 0.532 . . . . 0.0 111.335 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -64.57 -53.6 45.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.538 0.735 . . . . 0.0 111.34 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -21.76 60.43 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.345 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.483 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -61.71 -49.99 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.026 0.531 . . . . 0.0 110.606 169.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.94 -15.5 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.728 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.68 83.32 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.049 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -166.93 155.76 10.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.218 1.007 . . . . 0.0 110.156 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -89.75 -13.27 37.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 8.8 m -155.22 147.53 23.85 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.193 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -140.78 172.22 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.61 1.164 . . . . 0.0 108.703 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -118.35 112.78 20.47 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -92.1 -179.19 5.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.832 1.253 . . . . 0.0 108.937 167.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -156.73 110.16 2.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 176.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.363 1.065 . . . . 0.0 108.472 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.429 ' HA ' HG21 ' A' ' 0' ' ' THR . 6.9 t70 -68.76 157.1 37.08 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 122.995 0.518 . . . . 0.0 110.031 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.68 -18.69 60.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.715 0.406 . . . . 0.0 110.728 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.39 -23.83 37.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.297 0.639 . . . . 0.0 109.723 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.52 147.87 47.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.476 0.71 . . . . 0.0 109.668 171.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -132.08 -174.37 3.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.263 1.025 . . . . 0.0 109.8 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.457 ' N ' HD13 ' A' ' 77' ' ' LEU . 2.3 p -50.72 -36.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.644 1.178 . . . . 0.0 112.646 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -71.05 -41.02 61.48 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.379 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 35' ' ' ARG . 17.8 t70 -70.9 -29.49 65.57 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.792 0.296 . . . . 0.0 110.521 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.7 t -59.37 -60.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.455 0.702 . . . . 0.0 109.831 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 HG12 ' A' ' 54' ' ' VAL . 2.4 pp -66.57 -30.76 71.14 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 123.11 0.257 . . . . 0.0 111.334 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.5 tpt180 -56.0 -46.65 78.66 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.36 0.6 . . . . 0.0 111.629 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -75.2 -32.97 61.35 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.356 0.662 . . . . 0.0 111.773 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -56.45 -45.03 81.04 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.701 0.801 . . . . 0.0 112.152 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 9.5 pt-20 -64.16 -29.8 70.9 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.61 0.569 . . . . 0.0 112.283 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.86 -22.67 67.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.957 0.503 . . . . 0.0 111.63 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -97.13 -57.97 2.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.008 0.909 . . . . 0.0 109.169 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.65 105.47 17.84 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.807 -173.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.3 -32.14 72.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.393 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.917 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.642 ' HB3' HD12 ' A' ' 48' ' ' LEU . 81.5 mt -103.09 -11.66 17.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.863 0.865 . . . . 0.0 111.271 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -57.28 121.55 10.41 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.366 0.667 . . . . 0.0 112.517 -173.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.59 -19.93 8.31 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 171.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.76 0.72 57.47 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.466 0.633 . . . . 0.0 111.655 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.642 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -124.02 5.58 8.62 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 110.29 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 35' ' ' ARG . 17.5 mt -140.75 142.47 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 124.639 1.176 . . . . 0.0 109.244 172.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -145.76 116.68 7.76 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.463 0.705 . . . . 0.0 110.125 164.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 55.92 31.56 18.07 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.221 1.008 . . . . 0.0 111.826 172.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.39 82.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -106.9 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.096 0.948 . . . . 0.0 108.785 165.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.513 HG12 HD23 ' A' ' 34' ' ' LEU . 15.8 m -64.29 -55.39 21.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 CA-C-O 117.595 -1.193 . . . . 0.0 112.13 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? 150.02 132.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 C-N-CA 125.212 1.405 . . . . 0.0 107.601 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -61.11 140.61 90.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.727 2.285 . . . . 0.0 111.593 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 90' ' ' ALA . 66.8 m-70 80.16 -21.33 0.33 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.509 1.524 . . . . 0.0 113.504 177.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 p -72.61 152.51 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 15.9 m120 -119.89 103.83 9.67 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.3 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.461 0.704 . . . . 0.0 109.55 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.6 mp -121.12 131.29 54.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.925 1.29 . . . . 0.0 110.725 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -105.59 111.73 24.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.15 0.98 . . . . 0.0 109.057 171.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.4 t30 57.3 34.83 25.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.594 1.158 . . . . 0.0 110.577 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -4.51 86.04 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.41 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -102.37 114.23 28.23 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.944 0.897 . . . . 0.0 109.157 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 18.3 tt0 -70.63 110.26 5.36 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.363 0.665 . . . . 0.0 111.292 -171.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.02 -1.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.2 m -68.3 -19.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.109 0.413 . . . . 0.0 111.527 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -85.39 -16.26 40.42 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.924 0.89 . . . . 0.0 110.963 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.24 -152.72 0.44 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.42 1.088 . . . . 0.0 109.334 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.61 108.2 0.94 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.957 0.503 . . . . 0.0 110.551 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.01 -29.06 24.07 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.794 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.537 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.5 mmt -80.85 -37.94 29.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.503 0.721 . . . . 0.0 112.147 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.78 85.34 1.17 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 t -82.01 -70.79 0.52 Allowed 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.554 0.742 . . . . 0.0 112.271 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 179.77 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.458 1.103 . . . . 0.0 110.209 -163.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.29 114.86 13.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -116.85 179.76 3.92 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.359 0.664 . . . . 0.0 110.433 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 7.8 p-10 -73.09 142.32 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.56 0.744 . . . . 0.0 111.286 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.63 18.3 78.54 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.314 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -96.61 141.78 29.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.439 0.696 . . . . 0.0 111.785 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.54 109.35 22.12 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.167 0.987 . . . . 0.0 110.711 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.13 107.29 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.2 m -83.92 150.49 25.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.77 0.828 . . . . 0.0 110.093 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.12 145.63 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.466 0.706 . . . . 0.0 109.491 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 19.4 m-85 -137.33 135.06 19.02 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 29.3 Cg_endo -61.2 165.61 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 123.96 3.107 . . . . 0.0 113.688 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.8 131.27 30.53 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.608 2.205 . . . . 0.0 112.491 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.8 m -82.58 -26.63 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.46 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.427 ' HB3' ' ND1' ' A' ' 57' ' ' HIS . . . -116.26 125.22 51.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.032 0.533 . . . . 0.0 110.285 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.14 -104.87 0.96 Allowed Glycine 0 C--N 1.345 1.083 0 O-C-N 123.615 0.572 . . . . 0.0 113.272 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.769 0 CA-C-O 119.243 -0.754 . . . . 0.0 111.719 178.603 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -163.94 157.66 29.98 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 116.758 0.279 . . . . 0.0 112.437 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -111.35 -135.72 6.83 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.624 -0.591 . . . . 0.0 111.624 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 -153.68 110.39 3.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.117 0.567 . . . . 0.0 110.664 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . 0.554 ' HB3' HH21 ' A' ' 23' ' ' ARG . 40.0 p-10 -154.68 144.37 21.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.769 0.828 . . . . 0.0 110.166 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -96.0 -47.97 5.89 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.718 0.807 . . . . 0.0 112.07 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 64.06 69.53 0.53 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 125.158 1.536 . . . . 0.0 110.372 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -73.06 -55.6 6.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.63 -172.26 3.0 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.438 166.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.01 -33.93 71.28 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.711 0.805 . . . . 0.0 112.885 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -76.0 -178.47 4.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.068 0.547 . . . . 0.0 111.662 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 0' ' ' THR . 10.2 ptpp? -65.09 -34.51 78.58 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.149 0.98 . . . . 0.0 112.57 -177.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 66.1 34.74 89.18 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.595 -0.275 . . . . 0.0 113.534 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.407 ' H ' ' HG3' ' A' ' -2' ' ' LYS . 1.4 p -148.69 158.61 44.26 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.395 1.078 . . . . 0.0 109.687 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -147.27 145.64 29.47 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.586 0.754 . . . . 0.0 109.495 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -89.3 141.11 28.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.67 138.15 44.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.575 0.75 . . . . 0.0 109.264 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -89.37 104.5 17.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.2 mt -93.72 104.26 16.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 79.9 mtt180 -92.05 117.39 29.79 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.533 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.54 137.59 42.16 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.907 0.883 . . . . 0.0 109.227 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -130.22 160.55 33.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.896 0.478 . . . . 0.0 110.59 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.402 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 57.95 -119.0 1.1 Allowed 'General case' 0 CA--C 1.56 1.332 0 O-C-N 124.783 1.302 . . . . 0.0 112.238 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.519 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 8.6 m -70.99 -47.45 58.78 Favored 'General case' 0 C--N 1.361 1.067 0 CA-C-N 118.415 0.552 . . . . 0.0 110.437 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -58.04 -26.61 62.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.051 0.54 . . . . 0.0 111.056 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -66.55 -54.42 23.85 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.223 0.609 . . . . 0.0 111.386 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -17.64 60.87 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.635 0.585 . . . . 0.0 111.797 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.4 t -63.44 -55.06 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.391 0.676 . . . . 0.0 109.654 169.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.44 -16.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.441 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 17.28 80.23 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.491 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -166.77 150.82 7.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.018 0.927 . . . . 0.0 110.321 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -91.23 -22.21 20.72 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -154.75 136.87 14.73 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -130.03 176.82 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.031 0.933 . . . . 0.0 109.144 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.5 111.44 16.82 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.11 177.4 5.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.001 1.32 . . . . 0.0 109.111 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.554 HH21 ' HB3' ' A' ' -9' ' ' ASP . 55.8 ttt180 -156.54 108.11 2.46 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 m -112.75 179.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.846 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -55.97 148.62 16.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.421 0.688 . . . . 0.0 110.364 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -66.55 -26.1 66.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.517 0.327 . . . . 0.0 111.413 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.45 -24.64 36.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.952 0.501 . . . . 0.0 110.56 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.47 129.2 39.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.345 0.658 . . . . 0.0 111.16 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.1 p -111.92 -172.97 2.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.324 1.049 . . . . 0.0 110.372 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -50.82 -41.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 123.771 0.828 . . . . 0.0 111.804 -170.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.35 94.85 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.65 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.11 -33.26 75.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.264 0.625 . . . . 0.0 111.582 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.03 -59.75 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.675 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.571 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.1 pp -68.89 -30.71 69.27 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.4 ppt_? -67.35 -34.3 77.02 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.907 0.776 . . . . 0.0 111.204 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.1 m -75.58 -32.45 60.36 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.007 175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -59.08 -49.57 77.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.918 0.487 . . . . 0.0 111.213 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -67.25 -25.31 66.02 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -20.84 66.52 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 123.345 0.403 . . . . 0.0 110.973 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -96.91 -58.72 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.782 0.801 . . . . 0.0 109.41 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.85 111.13 22.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.339 -170.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.77 -26.93 67.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.638 0.775 . . . . 0.0 110.116 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.54 -17.48 68.84 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.501 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' HD22 ' A' ' 48' ' ' LEU . 82.4 mt -103.2 -13.98 16.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.888 0.875 . . . . 0.0 111.683 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.16 121.21 10.75 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.28 11.94 79.69 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 11.3 ptm180 -120.58 -21.19 6.84 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.54 0.67 . . . . 0.0 111.318 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -101.85 8.42 41.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.031 0.533 . . . . 0.0 110.219 170.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 35' ' ' ARG . 43.2 mt -140.89 142.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.079 1.351 . . . . 0.0 108.87 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 1.6 tm-20 -154.83 123.69 6.2 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.09 31.04 17.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.413 1.085 . . . . 0.0 111.589 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.57 -4.07 75.36 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.592 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HA ' ' SD ' ' A' ' 73' ' ' MET . 3.7 pt-20 -106.36 -174.07 2.45 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.82 0.81 . . . . 0.0 109.681 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.8 -54.7 30.12 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.165 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? 149.45 137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 C-N-CA 126.503 1.921 . . . . 0.0 106.982 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 18.6 Cg_endo -56.54 129.08 32.81 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.802 2.335 . . . . 0.0 111.174 166.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 76.35 -6.26 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.877 1.271 . . . . 0.0 113.957 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 68' ' ' VAL . 1.9 p -73.69 143.79 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.81 104.69 13.35 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.18 137.25 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.228 0.611 . . . . 0.0 109.599 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.7 mp -126.89 142.73 51.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.835 1.254 . . . . 0.0 110.85 -166.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -114.06 109.21 18.08 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.474 1.11 . . . . 0.0 108.208 166.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.33 35.65 23.26 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.074 0.94 . . . . 0.0 110.349 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.25 -14.7 60.2 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.819 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -87.64 109.03 19.37 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.481 ' HG2' HG23 ' A' ' 68' ' ' VAL . 17.4 tt0 -67.44 105.09 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.453 0.701 . . . . 0.0 110.334 -173.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.48 -1.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.481 HG23 ' HG2' ' A' ' 66' ' ' GLU . 20.2 m -73.7 -10.27 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 122.593 0.357 . . . . 0.0 111.364 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -87.15 -25.54 24.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.534 0.733 . . . . 0.0 110.452 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.22 -150.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.074 0.95 . . . . 0.0 109.808 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.21 107.89 0.54 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.685 0.394 . . . . 0.0 111.055 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -86.22 -30.35 22.74 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.684 0.615 . . . . 0.0 111.954 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.52 ' HA ' ' HE3' ' A' ' 73' ' ' MET . 20.7 mmt -81.45 -34.9 31.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.078 0.551 . . . . 0.0 111.79 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.36 81.48 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 t -81.02 -67.76 0.75 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -173.5 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -163.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.32 144.09 44.65 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.68 -175.08 5.18 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.395 1.478 . . . . 0.0 107.817 -174.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.3 143.08 52.15 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.891 0.476 . . . . 0.0 111.186 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.0 69.6 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 114.806 0.682 . . . . 0.0 114.806 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.99 118.28 22.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.033 0.533 . . . . 0.0 111.665 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.55 104.03 14.19 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.523 0.729 . . . . 0.0 111.147 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 t -93.27 106.56 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 50.8 m -86.95 148.9 25.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.731 0.812 . . . . 0.0 109.539 176.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.42 146.33 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.814 0.816 . . . . 0.0 109.692 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 21.9 m-85 -132.38 144.55 53.51 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 173.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HG3' ' H ' ' A' ' 10' ' ' THR . 34.3 Cg_endo -63.48 169.11 10.22 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.517 2.811 . . . . 0.0 112.124 169.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 38.8 Cg_endo -61.35 130.17 31.03 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 121.218 1.278 . . . . 0.0 110.661 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.6 5.96 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.077 0.551 . . . . 0.0 112.23 -168.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -161.6 -48.22 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.292 1.037 . . . . 0.0 109.122 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.43 -172.16 15.28 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.816 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.325 0 CA-C-O 119.374 -0.681 . . . . 0.0 113.277 178.7 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 77.55 57.07 3.69 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-O 121.195 0.331 . . . . 0.0 112.581 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -89.85 -159.7 35.75 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.268 -0.466 . . . . 0.0 112.404 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . 0.675 ' HD3' ' HD3' ' A' ' 23' ' ' ARG . 95.5 mtt180 -89.75 29.55 1.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.692 0.797 . . . . 0.0 111.068 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -87.24 -60.39 1.99 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.858 0.463 . . . . 0.0 110.425 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 62.73 175.23 0.14 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.232 1.013 . . . . 0.0 111.603 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.5 -156.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 125.307 1.443 . . . . 0.0 113.232 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -106.1 -171.03 1.82 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.696 0.798 . . . . 0.0 109.614 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 30.4 t70 74.02 152.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.261 1.424 . . . . 0.0 112.585 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.59 156.68 25.89 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.505 1.122 . . . . 0.0 111.863 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 68.08 148.63 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.359 1.464 . . . . 0.0 111.419 -172.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -30.1 70.64 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.289 0.636 . . . . 0.0 111.96 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 56.44 30.55 58.82 Favored Glycine 0 N--CA 1.472 1.08 0 O-C-N 123.407 0.442 . . . . 0.0 113.644 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 24.6 p -122.62 142.83 50.23 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.604 1.162 . . . . 0.0 109.566 -177.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.05 136.91 54.88 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.411 1.084 . . . . 0.0 110.068 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -91.74 141.37 28.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.405 0.682 . . . . 0.0 110.14 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.43 138.9 45.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.466 1.106 . . . . 0.0 110.606 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.3 103.98 16.57 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.508 0.723 . . . . 0.0 109.089 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.413 HD11 HD21 ' A' ' 37' ' ' LEU . 29.9 mt -93.31 103.62 15.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 74.7 mtt180 -91.09 119.75 31.49 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.58 1.152 . . . . 0.0 109.434 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -108.11 140.35 41.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.25 1.02 . . . . 0.0 108.759 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -132.38 160.55 36.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.138 0.575 . . . . 0.0 109.585 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 59.72 -125.28 1.18 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.685 1.194 . . . . 0.0 112.706 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 27.6 m -68.02 -46.8 70.19 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.369 0.668 . . . . 0.0 111.14 -178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -57.31 -26.57 61.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.31 0.644 . . . . 0.0 111.633 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.489 ' HD3' ' HG2' ' A' ' 18' ' ' LYS . 7.0 tmm_? -68.66 -53.14 24.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.415 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -18.77 60.59 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.424 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.6 t -64.34 -48.12 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.251 0.548 . . . . 0.0 110.216 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 17' ' ' GLN . 88.4 t -78.87 -21.7 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.863 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.64 20.04 75.34 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.227 -175.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.499 ' HB2' HG13 ' A' ' 15' ' ' VAL . 13.8 mm100 -148.07 139.21 23.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.86 1.264 . . . . 0.0 109.111 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 26.3 mtmt -85.01 -21.32 29.51 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.891 0.744 . . . . 0.0 109.925 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -154.08 148.7 26.35 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.336 1.054 . . . . 0.0 108.814 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -135.84 168.03 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.473 1.109 . . . . 0.0 108.386 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.04 113.16 25.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.425 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -100.15 178.29 4.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.055 1.342 . . . . 0.0 109.373 171.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HD3' ' HD3' ' A' ' -10' ' ' ARG . 18.5 ttt180 -157.44 107.33 2.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.549 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.32 173.21 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.347 1.059 . . . . 0.0 108.229 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.3 p-10 -67.86 160.46 28.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.093 0.473 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.26 -19.69 59.58 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.346 0.659 . . . . 0.0 111.522 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -80.76 -19.34 45.11 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.536 0.734 . . . . 0.0 109.155 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.73 154.65 39.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 0.0 110.775 172.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 p -134.23 -174.7 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.619 1.168 . . . . 0.0 109.862 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.94 -37.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 124.551 1.14 . . . . 0.0 111.878 -175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -68.76 -42.25 80.15 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.298 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.72 -35.15 77.22 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.421 0.688 . . . . 0.0 110.895 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.15 -61.1 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.797 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.15 -30.71 71.65 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.662 0.21 . . . . 0.0 110.728 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -53.68 -48.39 69.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.919 0.487 . . . . 0.0 111.562 172.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.1 m -75.8 -31.61 59.5 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.803 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD21 HD11 ' A' ' 5' ' ' LEU . 2.1 mm? -54.11 -41.08 67.9 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.741 0.816 . . . . 0.0 112.824 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 12.2 pt-20 -71.56 -28.11 63.62 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.13 68.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.102 0.561 . . . . 0.0 110.277 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 4.9 mm-40 -86.04 -59.37 2.32 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.832 0.853 . . . . 0.0 109.783 175.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.2 m-85 -99.58 119.81 38.66 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.672 -168.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.29 -29.01 67.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.791 0.837 . . . . 0.0 110.902 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.87 -0.23 80.68 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.072 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.65 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.6 mt -115.78 1.58 13.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 111.092 173.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.03 122.39 19.28 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.44 76.56 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.555 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 9.8 ptp180 -118.29 4.47 11.89 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.641 0.776 . . . . 0.0 111.827 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.65 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -125.92 -8.08 6.64 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.498 1.119 . . . . 0.0 110.443 -178.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.1 mt -132.73 136.87 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.877 1.271 . . . . 0.0 108.297 167.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -149.64 124.19 9.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.36 31.52 21.01 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.669 1.187 . . . . 0.0 111.937 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.02 -14.46 53.12 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.531 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -99.16 -174.84 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.962 0.881 . . . . 0.0 109.058 171.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.42 -55.11 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 118.104 -0.95 . . . . 0.0 111.723 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.6 tppt? 154.88 135.11 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.037 0 C-N-CA 124.714 1.206 . . . . 0.0 108.956 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 26.7 Cg_endo -60.45 135.55 61.91 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.929 2.419 . . . . 0.0 111.336 165.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 79.45 -12.49 1.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.135 1.374 . . . . 0.0 113.569 174.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 1.9 p -75.81 152.12 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.8 104.12 9.62 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.465 HG21 HG23 ' A' ' 67' ' ' VAL . 5.3 m -122.1 146.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.261 0.624 . . . . 0.0 109.873 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.3 mp -127.64 172.08 11.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.073 1.349 . . . . 0.0 110.971 -167.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 19.4 tptp -162.51 105.58 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 t30 54.99 35.57 24.96 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.053 0.941 . . . . 0.0 110.096 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.03 -14.69 61.36 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.784 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -88.89 118.77 28.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.374 0.67 . . . . 0.0 110.094 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.7 tt0 -72.44 103.01 3.34 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.477 0.486 . . . . 0.0 109.713 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.541 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 14.3 m -69.73 -1.07 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -173.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.3 m -69.91 -16.21 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.31 0.505 . . . . 0.0 111.317 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -91.09 -10.72 40.99 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.383 0.673 . . . . 0.0 111.324 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.84 -152.4 0.42 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.189 0.996 . . . . 0.0 109.595 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.17 108.35 2.65 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.1 0.56 . . . . 0.0 110.409 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.541 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -81.62 -38.59 13.84 Favored Glycine 0 C--N 1.341 0.846 0 O-C-N 123.378 0.424 . . . . 0.0 112.594 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.516 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.8 mmt -80.19 -36.36 35.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 112.647 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.19 77.65 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.432 HG21 ' HG2' ' A' ' 62' ' ' LYS . 1.4 t -82.15 -74.62 0.33 Allowed 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.802 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.22 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.143 0.577 . . . . 0.0 111.472 -161.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 24.3 tp -74.22 144.74 44.59 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.761 0.315 . . . . 0.0 111.347 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -156.21 168.76 26.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.295 1.038 . . . . 0.0 109.464 -168.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.87 149.97 48.56 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.948 0.499 . . . . 0.0 111.839 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.39 63.84 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.841 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -82.74 155.41 24.3 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.169 0.484 . . . . 0.0 109.863 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 99.06 6.68 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 123.287 0.635 . . . . 0.0 109.617 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -86.44 106.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.4 m -90.87 146.5 23.86 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 123.168 0.587 . . . . 0.0 109.506 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.27 144.76 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -128.83 141.19 40.82 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.433 ' HG3' ' H ' ' A' ' 10' ' ' THR . 41.6 Cg_endo -63.79 168.4 11.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.762 2.975 . . . . 0.0 112.519 175.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 15.7 Cg_endo -57.98 129.05 31.3 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 121.234 1.289 . . . . 0.0 111.198 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -80.75 -24.55 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.134 -171.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.69 -36.81 81.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.149 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.35 -54.39 0.5 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.685 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.796 0 CA-C-O 118.929 -0.928 . . . . 0.0 110.814 -177.474 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 177.05 179.47 47.44 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 116.843 0.321 . . . . 0.0 112.53 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -143.77 136.73 7.04 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-O 120.48 -0.067 . . . . 0.0 113.129 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . 0.534 ' HG3' ' H ' ' A' ' -9' ' ' ASP . 3.5 tpm_? -153.37 177.87 10.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.709 1.203 . . . . 0.0 107.891 177.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . 0.534 ' H ' ' HG3' ' A' ' -10' ' ' ARG . 1.5 p30 -144.56 -137.99 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.059 -161.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 71.51 -61.68 0.48 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 126.09 1.756 . . . . 0.0 110.466 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' -5' ' ' ASP . 0.1 OUTLIER -62.56 168.13 3.9 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.853 0.861 . . . . 0.0 111.199 165.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -78.2 -78.88 0.13 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.335 0.254 . . . . 0.0 111.066 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . 0.436 ' HB2' ' HD3' ' A' ' -7' ' ' LYS . 30.2 t70 60.03 -176.75 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.936 0.894 . . . . 0.0 112.249 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.39 -31.48 69.27 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.075 0.95 . . . . 0.0 111.985 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -139.13 140.14 37.83 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.273 0.559 . . . . 0.0 110.461 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -144.97 -62.64 0.35 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.64 1.176 . . . . 0.0 108.61 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 72.82 25.18 74.56 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 121.666 -0.647 . . . . 0.0 112.702 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' -9' ' ' ASP . 73.3 p -97.51 143.46 28.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.828 0.851 . . . . 0.0 110.818 -175.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.9 ptt? -101.72 140.4 36.05 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.781 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -95.22 130.59 41.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.292 0.637 . . . . 0.0 109.797 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 77' ' ' LEU . 24.4 mt -124.44 138.73 54.33 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.646 0.779 . . . . 0.0 110.45 -169.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 45.5 tt0 -89.32 102.64 15.31 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.86 103.7 16.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 30.1 mtm180 -92.32 117.62 30.09 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.393 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.33 138.49 42.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 109.464 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.72 155.38 48.95 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.335 0.654 . . . . 0.0 109.7 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 60.75 -126.75 0.96 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.144 1.378 . . . . 0.0 111.99 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.7 m -63.97 -43.03 96.98 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 123.34 0.656 . . . . 0.0 111.127 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -60.98 -27.69 68.47 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.574 0.35 . . . . 0.0 111.072 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 55.3 ttp180 -67.5 -53.33 29.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.321 0.648 . . . . 0.0 111.396 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -20.42 60.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.111 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.508 HG12 ' HG ' ' A' ' 44' ' ' LEU . 40.6 t -61.5 -47.74 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.559 0.695 . . . . 0.0 110.294 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.75 -20.54 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.905 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.53 16.36 71.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.041 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -143.19 139.4 30.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.553 1.141 . . . . 0.0 109.841 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 22.3 ptmt -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.754 0.659 . . . . 0.0 110.521 172.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -156.92 145.43 19.74 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.465 174.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.12 173.24 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.344 1.057 . . . . 0.0 109.089 172.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -118.73 112.76 20.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.8 -179.64 4.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.276 1.43 . . . . 0.0 109.388 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -157.36 105.75 2.11 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.82 172.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -59.21 148.33 32.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.175 0.59 . . . . 0.0 111.285 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -61.94 -27.31 68.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 111.29 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -80.3 -24.99 39.61 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 110.24 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.89 37.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.02 0.528 . . . . 0.0 109.639 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.3 p -103.14 -173.87 2.42 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.596 0.758 . . . . 0.0 110.799 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 77' ' ' LEU . 87.9 t -50.84 -37.03 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 124.204 1.002 . . . . 0.0 111.493 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.605 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.3 -38.38 71.19 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.97 -31.02 69.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.297 0.639 . . . . 0.0 110.879 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.32 -60.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.172 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.514 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.7 pp -64.63 -30.16 71.18 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.192 0.308 . . . . 0.0 111.204 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' HA ' HD13 ' A' ' 49' ' ' ILE . 16.6 tpt180 -51.41 -49.97 60.57 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.462 0.705 . . . . 0.0 111.242 168.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 m -75.36 -32.31 60.81 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.653 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 3.8 mm? -58.26 -35.31 71.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.187 0.595 . . . . 0.0 112.498 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.493 ' HB3' HD22 ' A' ' 48' ' ' LEU . 7.8 pt-20 -76.84 -27.45 55.12 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.324 0.511 . . . . 0.0 111.673 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.92 64.7 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.776 0.43 . . . . 0.0 111.01 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -90.23 -59.82 2.09 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.574 0.702 . . . . 0.0 110.158 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -92.28 126.54 37.4 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.602 -168.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.99 -35.67 69.55 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.689 0.796 . . . . 0.0 110.023 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.18 -4.19 86.18 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.957 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.591 ' HB3' HD12 ' A' ' 48' ' ' LEU . 56.9 mt -106.82 -3.67 20.12 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.934 0.867 . . . . 0.0 111.485 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.02 121.4 14.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.87 12.02 67.2 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.354 0.902 . . . . 0.0 115.354 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.44 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -118.26 0.44 11.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.005 0.922 . . . . 0.0 110.743 179.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.591 HD12 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -122.8 -5.42 8.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.524 1.13 . . . . 0.0 109.831 177.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 35' ' ' ARG . 37.0 mt -130.67 135.17 60.87 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.108 1.363 . . . . 0.0 108.398 169.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HG2' ' HZ3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -145.84 126.35 14.13 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 166.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 56.11 31.29 17.92 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.604 1.162 . . . . 0.0 111.947 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.01 -14.38 57.32 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.27 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.59 -174.6 2.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.402 HG12 HD21 ' A' ' 34' ' ' LEU . 27.8 m -63.51 -55.88 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.153 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 11.3 tppt? 151.5 137.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.075 0 C-N-CA 125.122 1.369 . . . . 0.0 108.901 -176.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 131.13 31.48 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 C-N-CA 123.042 2.495 . . . . 0.0 111.836 165.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 79.38 -11.72 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.585 1.554 . . . . 0.0 114.167 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -69.34 142.99 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.622 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 16.4 m120 -110.2 103.36 12.04 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG11 HG12 ' A' ' 85' ' ' VAL . 3.7 m -121.3 129.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.537 0.735 . . . . 0.0 109.307 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 2.1 mp -121.06 139.39 53.38 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.435 1.094 . . . . 0.0 110.413 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 12.9 tptm -110.5 114.65 28.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.17 35.12 21.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.032 0.933 . . . . 0.0 110.993 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.05 -4.93 81.79 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.998 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -100.35 116.01 31.32 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 11.3 tt0 -70.28 107.11 3.59 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.635 0.584 . . . . 0.0 109.774 -173.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.71 -1.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.48 -19.35 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 122.662 0.385 . . . . 0.0 111.168 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -90.26 -5.24 56.55 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.668 0.787 . . . . 0.0 111.235 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.01 -149.35 0.29 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 109.327 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.24 108.84 3.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.266 0.626 . . . . 0.0 110.605 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.23 -43.4 20.95 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 122.999 0.187 . . . . 0.0 112.641 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.605 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.6 mmt -76.91 -40.26 47.94 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.195 0.598 . . . . 0.0 111.775 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.37 78.75 1.52 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 t -80.8 -65.99 0.94 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.654 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 175.57 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.918 0.887 . . . . 0.0 110.462 -163.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 30' ' ' VAL . 47.2 tp -73.89 136.64 43.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.639 0.375 . . . . 0.0 110.412 -175.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -149.93 -177.46 5.92 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 122.805 0.442 . . . . 0.0 110.013 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.481 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 33.6 t70 -64.4 144.93 56.81 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.794 0.838 . . . . 0.0 112.917 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.35 -7.19 12.42 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.455 -0.793 . . . . 0.0 114.793 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.456 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 4.9 m-20 -78.44 142.07 37.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.762 0.825 . . . . 0.0 112.431 -169.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -97.64 111.16 23.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.036 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.17 107.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.709 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 12.9 m -85.57 147.04 26.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.985 0.514 . . . . 0.0 109.986 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 HG12 HG11 ' A' ' 60' ' ' VAL . 33.0 m -141.93 140.6 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.602 0.715 . . . . 0.0 109.584 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 6.6 m-85 -129.92 137.79 31.67 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 37.1 Cg_endo -63.44 162.67 26.48 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.151 2.567 . . . . 0.0 112.594 176.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -66.84 130.4 23.1 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 121.509 1.472 . . . . 0.0 111.17 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.6 m -85.08 -11.84 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.127 0.571 . . . . 0.0 110.972 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.28 165.34 27.7 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.35 1.06 . . . . 0.0 109.597 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.98 -59.75 0.07 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.16 174.706 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.39 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 67.81 -136.43 31.24 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 123.043 0.354 . . . . 0.0 112.738 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 74.16 -109.25 2.74 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 27' ' ' ASP . 25.3 mtt180 -146.9 118.8 8.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.565 1.146 . . . . 0.0 108.08 170.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 22.1 t70 -139.8 157.35 45.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.754 1.221 . . . . 0.0 108.826 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -107.17 -43.82 4.51 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.158 0.583 . . . . 0.0 111.633 -170.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.549 ' HD2' ' H ' ' A' ' -6' ' ' ASP . 0.0 OUTLIER -80.27 -53.32 6.75 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -169.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . 0.549 ' H ' ' HD2' ' A' ' -7' ' ' LYS . 37.4 t70 -174.87 -75.06 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.699 0.8 . . . . 0.0 110.175 -174.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 58.29 -171.5 0.11 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.045 0.938 . . . . 0.0 110.635 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -54.8 -41.37 70.52 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.362 0.665 . . . . 0.0 109.833 164.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -151.75 132.53 14.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.283 0.633 . . . . 0.0 109.674 170.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.614 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 13.5 pttm -92.82 -52.78 4.45 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.554 1.142 . . . . 0.0 110.443 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 75.83 16.85 80.39 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 116.565 -0.288 . . . . 0.0 113.329 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 20.9 p -78.56 142.1 37.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.524 0.73 . . . . 0.0 109.654 172.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' HE1' HD22 ' A' ' 3' ' ' LEU . 27.0 ptt? -96.06 143.54 27.12 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.826 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -93.34 126.87 38.69 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.904 0.882 . . . . 0.0 109.046 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.543 HD22 ' HE1' ' A' ' 1' ' ' MET . 0.4 OUTLIER -124.11 148.98 46.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.946 0.498 . . . . 0.0 109.988 -175.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 31.1 tt0 -97.42 113.51 25.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 170.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.2 mt -101.39 112.29 24.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 51.9 mtt180 -99.94 117.17 33.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.187 0.995 . . . . 0.0 108.796 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.55 137.61 45.28 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.952 0.901 . . . . 0.0 109.256 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -131.6 159.7 37.48 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.93 0.492 . . . . 0.0 109.814 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 87' ' ' PRO . . . 59.21 -120.6 1.07 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 124.779 1.232 . . . . 0.0 112.337 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -71.92 -45.41 61.29 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 123.082 0.553 . . . . 0.0 110.442 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -55.34 -30.0 59.42 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.195 0.598 . . . . 0.0 110.972 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HD2' ' HG2' ' A' ' 18' ' ' LYS . 50.8 ttp180 -66.72 -55.24 15.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.84 0.856 . . . . 0.0 111.726 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -16.93 60.91 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.934 -174.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.466 HG13 ' HG ' ' A' ' 44' ' ' LEU . 40.1 t -65.54 -55.87 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.28 0.632 . . . . 0.0 109.689 168.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.2 t -74.54 -17.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.612 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.7 11.61 73.3 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.701 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -139.48 144.29 37.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.198 0.999 . . . . 0.0 109.144 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' HD2' ' A' ' 12' ' ' ARG . 22.0 mtmm -86.31 -21.05 27.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.746 0.419 . . . . 0.0 109.909 174.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 14.7 m -154.05 146.51 24.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.377 1.071 . . . . 0.0 109.216 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 23.2 pt -141.52 170.61 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 109.7 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -112.83 113.07 24.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.47 -179.53 4.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.579 1.151 . . . . 0.0 109.843 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.441 ' HG2' ' HB ' ' A' ' 0' ' ' THR . 60.7 ttp180 -157.4 106.43 2.14 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.829 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.46 169.37 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.215 171.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 27.8 t70 -61.8 154.09 26.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.936 0.494 . . . . 0.0 111.039 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.24 -32.42 71.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.014 0.926 . . . . 0.0 111.833 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' HB2' ' NH2' ' A' ' -10' ' ' ARG . 28.2 t70 -81.01 -22.6 39.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.958 0.903 . . . . 0.0 111.362 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 153.72 37.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.28 0.632 . . . . 0.0 110.66 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -130.48 -175.07 3.53 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 97.8 t -51.81 -37.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.951 0.9 . . . . 0.0 111.648 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.95 65.92 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.005 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.27 -33.79 76.64 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.272 0.629 . . . . 0.0 110.296 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.88 -60.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.813 0.845 . . . . 0.0 110.317 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.484 HD23 HG11 ' A' ' 54' ' ' VAL . 2.6 pp -64.66 -30.74 71.76 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.134 0.424 . . . . 0.0 111.579 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HA ' HD11 ' A' ' 49' ' ' ILE . 17.3 tpt180 -50.96 -48.59 61.0 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.157 0.583 . . . . 0.0 110.956 168.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 m -74.65 -32.5 62.29 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.187 0.595 . . . . 0.0 111.436 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 4.1 mm? -59.74 -34.29 72.76 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 48' ' ' LEU . 5.6 pt-20 -76.89 -28.57 55.41 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.718 0.69 . . . . 0.0 111.124 173.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.05 -32.7 72.37 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.039 0.536 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -83.99 -58.0 2.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.526 0.73 . . . . 0.0 110.474 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -96.38 127.33 42.28 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.587 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.28 -45.68 90.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.131 0.973 . . . . 0.0 110.697 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.11 7.1 54.34 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.423 -0.808 . . . . 0.0 114.021 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.585 ' HB3' HD13 ' A' ' 48' ' ' LEU . 74.3 mt -115.97 5.26 13.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.615 0.707 . . . . 0.0 111.167 172.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -69.89 120.94 16.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.27 -8.09 26.97 Favored Glycine 0 C--N 1.359 1.847 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -100.08 4.13 44.45 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.355 1.062 . . . . 0.0 111.403 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.585 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -128.66 -8.87 5.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.257 1.023 . . . . 0.0 110.855 -177.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.454 HD11 ' HA ' ' A' ' 35' ' ' ARG . 51.5 mt -125.22 132.52 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.598 1.159 . . . . 0.0 107.967 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.17 117.65 13.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.919 0.488 . . . . 0.0 109.731 167.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.2 t70 55.54 30.85 15.98 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.05 -14.83 63.4 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.616 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -97.31 -174.01 2.82 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.883 0.842 . . . . 0.0 108.885 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.484 HG11 HD23 ' A' ' 34' ' ' LEU . 13.8 m -65.5 -56.83 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.788 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 150.81 135.97 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.003 0 C-N-CA 125.078 1.351 . . . . 0.0 109.176 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.49 137.51 51.02 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.84 2.36 . . . . 0.0 110.972 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 77.9 -11.94 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.325 1.45 . . . . 0.0 113.61 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 p -73.56 138.94 20.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.658 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.6 m120 -104.67 103.55 13.21 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.54 HG11 HG11 ' A' ' 85' ' ' VAL . 4.2 m -122.93 135.38 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -126.19 155.62 41.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.349 1.059 . . . . 0.0 110.639 -166.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.509 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 13.3 tptm -123.49 104.51 9.11 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.554 1.142 . . . . 0.0 107.975 169.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 t30 52.64 37.69 24.07 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.062 1.345 . . . . 0.0 111.702 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 19.61 43.79 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.871 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -133.27 105.49 7.01 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 16.0 tt0 -62.85 109.31 1.4 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.331 1.052 . . . . 0.0 110.918 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -69.95 -1.48 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -68.16 -22.53 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 117.935 0.334 . . . . 0.0 110.824 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -86.38 -15.87 39.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.865 0.866 . . . . 0.0 111.151 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.75 -153.14 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.247 1.019 . . . . 0.0 109.289 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.25 113.5 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.077 0.551 . . . . 0.0 110.538 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.3 -50.29 12.79 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.718 0.636 . . . . 0.0 112.734 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.3 mmm -79.94 -36.83 35.7 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.345 0.658 . . . . 0.0 111.692 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.43 77.95 1.65 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.571 0.701 . . . . 0.0 111.008 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.29 -71.4 0.47 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.836 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' H ' HG21 ' A' ' 75' ' ' THR . . . -173.75 28.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.912 0.885 . . . . 0.0 110.962 -164.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -75.33 144.06 42.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.175 0.59 . . . . 0.0 111.574 -168.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -157.51 -176.02 5.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.066 0.546 . . . . 0.0 110.1 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 28.3 t70 -63.88 140.53 58.88 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.035 0.934 . . . . 0.0 111.338 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 -7.09 57.87 Favored Glycine 0 C--N 1.344 1.023 0 O-C-N 123.834 0.709 . . . . 0.0 114.421 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.509 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 78.1 m-20 -79.55 133.9 36.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -170.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.32 105.66 17.63 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.446 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.2 137.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.9 m -118.12 154.83 31.46 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.441 0.564 . . . . 0.0 110.2 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.54 HG11 HG11 ' A' ' 60' ' ' VAL . 34.6 m -145.1 143.92 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.751 0.82 . . . . 0.0 110.152 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.658 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 18.1 m-85 -135.08 133.75 21.08 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.426 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 22.0 Cg_endo -59.89 160.96 19.93 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 123.325 2.684 . . . . 0.0 112.867 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.29 130.67 31.18 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.945 1.764 . . . . 0.0 111.745 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.58 2.61 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.059 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.24 106.17 0.41 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.362 1.065 . . . . 0.0 110.989 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.53 26.41 8.16 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.371 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.352 0 CA-C-O 118.507 -1.163 . . . . 0.0 111.31 -176.634 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 CA-C-O 120.122 -0.266 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -148.4 33.98 1.19 Allowed Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 82.43 -76.1 2.27 Favored Glycine 0 C--N 1.348 1.206 0 C-N-CA 123.233 0.444 . . . . 0.0 112.002 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -110.18 46.77 1.0 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.853 0.835 . . . . 0.0 108.961 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.54 -35.24 73.02 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.835 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 68.13 -6.02 0.81 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.457 1.103 . . . . 0.0 113.268 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' -2' ' ' LYS . 25.1 mtpp -130.39 131.27 45.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.588 0.755 . . . . 0.0 110.855 -166.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.49 -4.72 38.5 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.057 0.943 . . . . 0.0 111.288 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.81 174.85 6.33 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.961 1.304 . . . . 0.0 112.512 -176.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.72 -12.85 61.81 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.071 0.948 . . . . 0.0 111.971 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -127.52 151.97 48.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.923 0.889 . . . . 0.0 109.798 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.457 ' O ' ' HD3' ' A' ' -7' ' ' LYS . 21.6 pttm -66.4 -37.46 85.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.011 1.324 . . . . 0.0 111.179 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 64.95 6.69 26.12 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 34.3 p -121.34 141.39 50.98 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.03 0.932 . . . . 0.0 109.087 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.469 ' HE1' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -113.76 151.44 31.96 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.481 0.712 . . . . 0.0 110.391 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.11 137.96 50.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.602 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.469 HD12 ' HE1' ' A' ' 1' ' ' MET . 11.6 mt -124.23 149.25 46.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.685 0.794 . . . . 0.0 109.855 -176.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -89.2 106.86 18.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.26 112.65 24.57 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 39.8 mtp180 -104.64 118.02 35.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.716 0.806 . . . . 0.0 109.297 -170.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 136.67 45.47 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.924 0.89 . . . . 0.0 109.325 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -132.45 160.74 35.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.79 0.436 . . . . 0.0 110.104 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.06 -117.77 0.82 Allowed 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.892 1.277 . . . . 0.0 112.389 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.536 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 46.7 m -69.69 -47.52 62.91 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 123.632 0.773 . . . . 0.0 110.494 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -59.46 -24.36 63.49 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.986 0.515 . . . . 0.0 111.224 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -50.36 53.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.731 0.813 . . . . 0.0 111.291 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -16.91 60.89 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.537 HG12 ' HG ' ' A' ' 44' ' ' LEU . 72.6 t -65.36 -53.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.626 0.726 . . . . 0.0 110.205 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.85 -16.73 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.633 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.74 11.52 85.15 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.414 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.97 158.84 10.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.84 0.856 . . . . 0.0 110.807 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -94.76 -9.42 34.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.0 m -152.65 143.08 22.63 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.41 175.82 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.223 1.009 . . . . 0.0 109.119 174.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.49 112.96 16.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.36 135.91 44.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.303 1.041 . . . . 0.0 110.038 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -104.13 106.18 16.6 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.1 175.7 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.542 1.137 . . . . 0.0 108.226 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.46 164.52 26.54 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.627 0.371 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -76.95 -15.46 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.53 -24.33 36.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.879 0.472 . . . . 0.0 110.35 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.06 58.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.901 0.881 . . . . 0.0 111.463 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.3 p -128.27 -174.39 3.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.475 1.11 . . . . 0.0 109.725 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.81 -33.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 123.973 0.909 . . . . 0.0 112.093 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.58 -50.05 51.67 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.053 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -61.59 -29.55 70.11 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.174 0.59 . . . . 0.0 111.583 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.45 -60.62 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.31 1.044 . . . . 0.0 110.541 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.3 pp -74.14 -31.06 62.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.2 ppt_? -67.12 -31.85 72.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.67 0.668 . . . . 0.0 111.176 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -76.67 -34.11 58.24 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.607 0.763 . . . . 0.0 112.333 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -59.91 -38.96 83.81 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 122.974 0.509 . . . . 0.0 111.86 -176.449 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -68.28 -37.41 80.64 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.345 0.403 . . . . 0.0 111.765 175.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.54 -28.96 69.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.506 0.723 . . . . 0.0 111.447 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -82.72 -58.83 2.72 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.043 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.22 112.56 24.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.813 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.93 -31.3 70.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.579 0.751 . . . . 0.0 110.55 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -73.31 -6.39 69.56 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.419 -0.809 . . . . 0.0 114.064 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.59 ' HB3' HD11 ' A' ' 48' ' ' LEU . 68.0 mt -113.26 2.29 15.51 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.675 0.738 . . . . 0.0 111.141 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.9 120.74 13.62 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.27 -28.67 2.6 Favored Glycine 0 C--N 1.359 1.826 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 5.6 ptp180 -83.29 9.24 11.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.904 1.282 . . . . 0.0 112.693 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -132.26 9.85 4.45 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.94 0.896 . . . . 0.0 110.931 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.1 mt -141.41 140.75 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.296 1.038 . . . . 0.0 109.315 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HG2' ' HZ1' ' A' ' 55' ' ' LYS . 16.6 mm-40 -139.71 110.41 6.74 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.302 0.641 . . . . 0.0 110.317 163.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t70 56.6 36.14 27.16 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.475 1.11 . . . . 0.0 111.894 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.04 27.52 62.13 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.139 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.63 -177.4 4.17 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 161.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 HD23 ' A' ' 34' ' ' LEU . 17.1 m -66.5 -56.09 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 117.588 -1.196 . . . . 0.0 112.297 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HZ1' ' HG2' ' A' ' 50' ' ' GLU . 5.9 tppt? 149.58 134.27 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.243 0 C-N-CA 126.06 1.744 . . . . 0.0 108.616 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.417 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 19.5 Cg_endo -58.91 133.34 53.02 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.061 2.507 . . . . 0.0 112.184 165.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 81.03 -26.99 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.861 1.664 . . . . 0.0 113.107 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.76 120.44 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -95.41 104.71 16.62 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 85' ' ' VAL . 1.7 m -109.37 146.39 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.287 0.635 . . . . 0.0 109.55 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.5 mp -132.7 170.66 14.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.971 1.308 . . . . 0.0 110.243 -164.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HE2' HD23 ' A' ' 77' ' ' LEU . 20.9 tptp -162.28 105.43 1.14 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 55.82 34.76 24.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.16 0.981 . . . . 0.0 109.832 -171.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.93 -13.58 48.05 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 114.492 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -87.16 119.28 27.23 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.922 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 24.3 tt0 -78.53 104.47 9.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.224 0.61 . . . . 0.0 111.13 -168.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.454 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.1 m -70.87 -1.32 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -170.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.1 m -68.6 -19.78 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.39 0.541 . . . . 0.0 110.898 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -92.53 -29.38 16.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.019 0.927 . . . . 0.0 110.843 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.79 -150.74 0.47 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.143 0.977 . . . . 0.0 109.406 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.04 108.31 2.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.955 0.502 . . . . 0.0 110.955 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.454 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -83.15 -37.79 12.09 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 123.32 0.387 . . . . 0.0 112.273 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.531 ' HA ' ' HE3' ' A' ' 73' ' ' MET . 14.1 mmt -79.73 -38.39 33.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.653 0.781 . . . . 0.0 111.917 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.73 83.96 1.29 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.47 -75.26 0.29 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.724 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.4 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -163.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.448 HD23 ' HE2' ' A' ' 62' ' ' LYS . 15.4 mt -73.68 143.65 46.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.865 0.84 . . . . 0.0 112.554 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -151.1 169.3 22.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.751 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.9 135.07 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 122.13 -0.356 . . . . 0.0 111.217 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 16.58 80.54 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.82 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.2 157.43 21.64 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.421 0.611 . . . . 0.0 109.563 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.75 106.03 11.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.268 0.627 . . . . 0.0 111.143 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -86.92 137.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 69.5 m -118.62 151.82 37.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG13 HG12 ' A' ' 60' ' ' VAL . 10.3 m -142.27 148.3 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 121.404 0.621 . . . . 0.0 110.196 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -136.3 140.71 33.53 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.536 ' HG3' ' H ' ' A' ' 10' ' ' THR . 53.6 Cg_endo -64.28 168.83 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.254 3.303 . . . . 0.0 112.417 174.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.7 129.81 26.05 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.077 1.185 . . . . 0.0 111.385 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.4 m -89.96 1.03 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.508 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.73 111.75 2.57 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.289 1.036 . . . . 0.0 109.333 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 -54.81 6.92 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.8 -1.0 . . . . 0.0 111.312 -178.91 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . 0.47 ' H2 ' ' HA ' ' A' ' -4' ' ' ASP . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -152.99 80.4 0.19 Allowed Glycine 0 C--N 1.344 0.972 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -168.63 51.01 0.22 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . 0.468 HH11 ' HB3' ' A' ' 23' ' ' ARG . 40.3 ttm180 58.61 22.63 10.02 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.526 1.13 . . . . 0.0 111.029 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . 0.571 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 6.2 p-10 -64.53 141.87 58.62 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.046 0.938 . . . . 0.0 112.037 -175.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -104.94 19.12 21.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.709 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.472 ' HZ2' ' HA3' ' A' ' -1' ' ' GLY . 0.0 OUTLIER -128.24 175.17 8.66 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.887 1.275 . . . . 0.0 109.971 -178.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -109.95 -170.08 1.59 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.484 0.713 . . . . 0.0 110.02 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 72.64 -93.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.398 1.479 . . . . 0.0 110.55 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . 0.47 ' HA ' ' H2 ' ' A' ' -13' ' ' GLY . 34.6 t70 -172.03 95.29 0.15 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.431 0.692 . . . . 0.0 109.53 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -176.99 135.6 0.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.577 1.151 . . . . 0.0 108.712 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.571 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 18.7 ptpt -74.96 -53.26 9.28 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.472 ' HA3' ' HZ2' ' A' ' -7' ' ' LYS . . . 44.79 45.57 8.98 Favored Glycine 0 C--N 1.356 1.647 0 O-C-N 123.672 0.607 . . . . 0.0 113.424 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 9.7 p -125.1 147.74 48.86 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.578 0.751 . . . . 0.0 110.016 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' A' ' 26' ' ' ASP . 13.2 ptm -122.31 111.71 17.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.412 1.085 . . . . 0.0 109.722 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.32 121.43 28.87 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 77' ' ' LEU . 21.4 mt -123.93 135.21 53.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.562 0.745 . . . . 0.0 110.027 -169.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.11 98.45 11.77 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.413 HD12 HD21 ' A' ' 37' ' ' LEU . 21.9 mt -94.83 104.8 16.71 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.122 . . . . 0.0 110.529 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 41.3 mtp180 -101.06 117.33 34.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.408 0.683 . . . . 0.0 109.414 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -101.76 140.22 36.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.049 0.939 . . . . 0.0 109.357 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.5 157.11 43.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.096 0.558 . . . . 0.0 110.137 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.66 -122.29 1.09 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.775 1.23 . . . . 0.0 112.861 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.454 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 92.0 m -64.78 -48.07 75.83 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 123.757 0.823 . . . . 0.0 111.042 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -60.03 -24.52 64.59 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.819 0.448 . . . . 0.0 111.467 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -72.46 -47.58 47.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.932 0.493 . . . . 0.0 111.288 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -74.16 -19.11 60.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.53 0.332 . . . . 0.0 111.698 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG12 ' HG ' ' A' ' 44' ' ' LEU . 53.0 t -67.35 -52.55 40.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.67 0.788 . . . . 0.0 110.483 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.486 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 95.6 t -73.88 -22.18 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.526 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.07 11.44 63.66 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.885 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -146.46 136.99 23.97 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -170.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HD2' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -87.71 -14.71 39.09 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -155.5 137.82 14.84 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.709 0.804 . . . . 0.0 109.315 177.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.45 140.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -88.92 112.45 23.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.86 170.97 9.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.55 1.14 . . . . 0.0 108.928 170.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HB3' HH11 ' A' ' -10' ' ' ARG . 65.4 ttt180 -157.02 108.47 2.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.704 0.764 . . . . 0.0 109.466 173.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.57 -179.56 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.766 1.627 . . . . 0.0 108.364 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.99 160.19 30.09 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.412 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 5.3 p-10 -69.83 -8.08 45.33 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.694 0.797 . . . . 0.0 113.043 -170.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.35 -14.44 57.25 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.719 0.807 . . . . 0.0 112.26 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.95 129.47 36.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.696 0.398 . . . . 0.0 111.133 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p -109.63 -179.59 3.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -54.02 -32.66 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.081 0.952 . . . . 0.0 112.368 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.63 -40.51 58.88 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.741 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.7 -32.24 73.41 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.163 0.481 . . . . 0.0 110.45 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.21 -60.08 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.678 0.611 . . . . 0.0 110.408 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD22 HG11 ' A' ' 54' ' ' VAL . 2.6 pp -66.91 -30.08 70.14 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 123.331 0.394 . . . . 0.0 111.166 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HA ' HD13 ' A' ' 49' ' ' ILE . 18.3 tpt85 -56.28 -48.38 76.72 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.061 0.544 . . . . 0.0 111.518 170.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -75.88 -31.75 59.37 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.047 0.539 . . . . 0.0 111.442 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 5' ' ' LEU . 1.5 mm? -56.59 -44.81 81.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.706 0.803 . . . . 0.0 112.406 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -65.68 -25.64 67.42 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.157 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.7 -21.65 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.655 0.597 . . . . 0.0 111.238 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -98.68 -59.09 1.81 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 122.877 0.471 . . . . 0.0 109.781 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 91.9 m-85 -89.66 117.45 28.54 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.882 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.01 -35.39 81.04 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.742 0.817 . . . . 0.0 111.481 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.88 -2.13 75.74 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.754 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.619 ' HB3' HD13 ' A' ' 48' ' ' LEU . 58.0 mt -103.94 -15.57 15.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.46 0.704 . . . . 0.0 110.893 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.48 120.65 9.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.779 0.832 . . . . 0.0 112.59 -171.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.62 74.04 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 115.489 0.955 . . . . 0.0 115.489 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.55 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 3.1 ptp180 -118.71 -0.06 11.37 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.539 0.736 . . . . 0.0 111.713 -176.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.22 -3.05 11.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.738 0.815 . . . . 0.0 110.185 173.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 35' ' ' ARG . 41.2 mt -133.44 137.19 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.019 1.328 . . . . 0.0 108.195 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -135.96 108.39 7.37 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t70 57.92 32.2 21.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.636 1.174 . . . . 0.0 112.557 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.43 1.2 69.17 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 115.084 0.793 . . . . 0.0 115.084 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.08 -174.91 2.63 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 117.849 0.824 . . . . 0.0 109.392 165.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG11 HD22 ' A' ' 34' ' ' LEU . 17.8 m -65.76 -55.42 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.601 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.5 tppt? 150.21 138.09 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 C-N-CA 125.576 1.55 . . . . 0.0 107.956 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.479 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 19.6 Cg_endo -56.07 129.19 33.57 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 123.009 2.473 . . . . 0.0 110.619 166.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 74.86 -4.79 2.29 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.997 1.319 . . . . 0.0 114.28 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -74.99 131.9 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.1 m120 -100.9 103.58 14.76 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.43 137.28 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.267 0.627 . . . . 0.0 109.765 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 7.4 mp -118.87 169.23 10.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.113 1.365 . . . . 0.0 111.09 -169.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -163.77 106.0 0.95 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.478 -177.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.517 ' HB2' ' HZ3' ' A' ' 62' ' ' LYS . 7.5 t-20 59.21 38.12 23.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.188 1.395 . . . . 0.0 109.721 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.96 -14.6 48.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.619 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -93.79 119.12 32.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.445 0.622 . . . . 0.0 109.565 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 22.4 tt0 -75.18 109.46 8.69 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.064 0.459 . . . . 0.0 109.765 -174.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.6 m -71.4 -0.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.72 -19.91 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.186 0.448 . . . . 0.0 110.978 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -88.3 -19.65 26.46 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.737 0.815 . . . . 0.0 110.794 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.34 -148.34 0.36 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.692 1.197 . . . . 0.0 109.262 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.3 108.95 6.46 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.003 0.521 . . . . 0.0 110.57 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.6 -37.64 22.94 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 113.903 0.321 . . . . 0.0 113.903 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 82.8 mmm -81.62 -26.75 34.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.99 85.35 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 118.177 0.444 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.43 HG21 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.81 -73.15 0.4 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.073 0.549 . . . . 0.0 112.192 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.43 ' H ' HG21 ' A' ' 75' ' ' THR . . . -173.19 33.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.815 0.846 . . . . 0.0 110.557 -164.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 3' ' ' LEU . 41.4 tp -74.35 123.54 24.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.495 0.318 . . . . 0.0 110.154 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 7.0 t70 -116.82 178.24 4.41 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.5 147.69 49.09 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.359 0.663 . . . . 0.0 111.035 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.21 10.82 70.06 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.548 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -82.6 177.67 8.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.451 0.701 . . . . 0.0 110.896 -174.228 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.69 109.11 9.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.293 0.637 . . . . 0.0 110.866 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.47 137.65 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 108.734 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 75.3 m -121.04 154.23 36.33 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -142.88 147.64 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.624 0.726 . . . . 0.0 110.141 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 14.9 m-85 -133.51 140.23 36.28 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HG3' ' H ' ' A' ' 10' ' ' THR . 58.7 Cg_endo -66.36 168.38 16.3 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.711 2.94 . . . . 0.0 112.3 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.19 130.71 27.95 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 121.395 1.397 . . . . 0.0 110.869 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.1 m -79.71 -32.41 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.553 -171.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -177.0 129.35 0.17 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.716 1.206 . . . . 0.0 108.889 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.79 49.44 3.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 123.303 0.377 . . . . 0.0 112.947 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.306 0 CA-C-O 118.807 -0.996 . . . . 0.0 112.608 -177.654 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -83.01 64.37 4.33 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -80.7 72.27 2.72 Favored Glycine 0 C--N 1.35 1.331 0 C-N-CA 123.0 0.333 . . . . 0.0 112.347 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -10' ' ' ARG . . . . . 0.55 ' HB2' HH21 ' A' ' 23' ' ' ARG . 2.6 mmp_? -77.81 82.88 4.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.561 0.696 . . . . 0.0 110.447 175.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.58 172.54 12.25 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.379 169.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -124.58 33.79 5.16 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.126 0.489 . . . . 0.0 111.961 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -7' ' ' LYS . . . . . 0.623 ' HG2' ' H ' ' A' ' -6' ' ' ASP . 0.0 OUTLIER -128.6 -69.36 0.72 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' -6' ' ' ASP . . . . . 0.623 ' H ' ' HG2' ' A' ' -7' ' ' LYS . 28.4 t70 173.39 -57.29 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.628 1.571 . . . . 0.0 107.543 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -169.72 -174.81 1.95 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.117 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 25.2 t70 69.92 80.33 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.275 1.03 . . . . 0.0 108.947 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 23.5 t70 67.35 138.19 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.485 1.514 . . . . 0.0 112.281 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -44.91 96.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.402 0.681 . . . . 0.0 111.252 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 48.21 48.9 25.96 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 123.766 0.698 . . . . 0.0 113.566 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 21.3 p -117.32 171.88 7.68 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.184 0.993 . . . . 0.0 110.919 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.6 ptt? -149.86 124.02 9.48 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.773 0.829 . . . . 0.0 109.547 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -85.27 113.65 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.031 0.932 . . . . 0.0 109.107 -175.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.404 HD12 ' HE1' ' A' ' 1' ' ' MET . 27.3 mt -115.46 134.5 55.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.391 0.676 . . . . 0.0 110.931 -171.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 65.1 tt0 -89.17 103.09 15.74 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.8 mt -93.84 105.3 17.33 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.4 mtt180 -91.9 117.0 29.39 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.749 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.431 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m-85 -103.44 136.09 43.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.976 0.91 . . . . 0.0 109.248 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.01 161.41 29.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.225 0.61 . . . . 0.0 109.537 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.459 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.41 -133.27 0.93 Allowed 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.604 1.162 . . . . 0.0 112.354 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.2 m -55.76 -44.03 77.26 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 124.324 1.05 . . . . 0.0 111.819 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.431 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 10.8 m-30 -63.1 -33.09 74.71 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.076 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -41.57 91.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.642 0.377 . . . . 0.0 110.273 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -67.91 -35.86 79.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.806 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.467 HG12 ' HG ' ' A' ' 44' ' ' LEU . 64.6 t -60.46 -56.31 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.257 0.623 . . . . 0.0 110.617 174.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.26 -17.15 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.42 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.98 11.52 70.08 Favored Glycine 0 C--N 1.35 1.313 0 C-N-CA 123.578 0.608 . . . . 0.0 113.682 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -160.7 142.45 12.33 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.232 1.013 . . . . 0.0 110.149 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -85.83 -22.16 27.74 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.952 0.901 . . . . 0.0 113.38 -167.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.2 m -150.18 133.09 16.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 18.1 pt -129.98 171.88 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.997 . . . . 0.0 108.928 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -116.95 112.17 20.63 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 163.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -89.96 -179.05 5.62 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.91 1.284 . . . . 0.0 108.772 164.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.55 HH21 ' HB2' ' A' ' -10' ' ' ARG . 59.8 ttp180 -155.73 113.89 3.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.68 -179.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.52 156.74 35.97 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.723 0.409 . . . . 0.0 110.353 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.56 -24.96 53.56 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.262 0.625 . . . . 0.0 111.049 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.65 -14.39 56.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.86 0.864 . . . . 0.0 110.558 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 166.07 23.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.257 0.623 . . . . 0.0 110.836 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.8 p -132.2 -177.47 4.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.594 0.758 . . . . 0.0 110.815 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.414 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.8 p -57.35 -35.85 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.617 1.167 . . . . 0.0 111.553 175.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.62 -38.52 78.26 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.553 0.533 . . . . 0.0 113.221 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.71 -33.17 75.04 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.284 0.634 . . . . 0.0 110.491 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.0 -60.19 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.702 0.801 . . . . 0.0 110.528 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.0 pp -65.07 -30.61 71.58 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.88 0.309 . . . . 0.0 111.316 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -54.47 -47.31 73.1 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.239 0.616 . . . . 0.0 111.368 170.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 36.1 t -75.9 -32.64 59.74 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.093 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 2.3 mm? -58.04 -35.8 71.84 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.69 0.796 . . . . 0.0 112.954 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -77.79 -30.02 51.11 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 120.737 0.303 . . . . 0.0 111.462 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.19 -26.41 67.39 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.929 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 36' ' ' SER . 6.1 mm-40 -90.76 -56.28 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.026 0.93 . . . . 0.0 110.191 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -95.73 122.66 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.187 -170.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.92 -35.82 81.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.043 0.937 . . . . 0.0 110.774 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.476 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.67 -2.11 90.6 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.919 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.563 ' HB3' HD13 ' A' ' 48' ' ' LEU . 85.0 mt -109.88 5.24 22.33 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.868 0.834 . . . . 0.0 110.885 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.34 121.46 17.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.971 0.508 . . . . 0.0 112.177 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.54 -24.65 6.28 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 12.3 ptp180 -90.25 7.5 37.93 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.69 1.196 . . . . 0.0 112.505 -171.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.563 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.06 -7.1 3.47 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.135 0.974 . . . . 0.0 111.088 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.89 127.7 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.509 1.123 . . . . 0.0 108.416 169.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -127.51 108.84 11.15 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.175 0.59 . . . . 0.0 110.162 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 t70 53.02 39.53 29.63 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.581 1.152 . . . . 0.0 112.007 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.2 -14.53 65.05 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.195 -0.911 . . . . 0.0 115.369 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -102.21 -175.32 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.286 1.043 . . . . 0.0 109.223 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.421 HG13 HD21 ' A' ' 34' ' ' LEU . 15.8 m -69.02 -57.56 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.07 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.486 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 15.4 tppt? 153.74 135.22 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 CA-C-N 119.683 1.129 . . . . 0.0 109.786 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.486 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 17.1 Cg_endo -56.07 135.25 68.9 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 123.319 2.68 . . . . 0.0 111.879 165.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 76.28 -15.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.565 1.546 . . . . 0.0 113.947 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.76 146.36 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.5 m120 -121.13 103.87 9.34 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG11 HG11 ' A' ' 85' ' ' VAL . 3.2 m -116.17 131.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.53 0.732 . . . . 0.0 109.531 -177.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -120.41 133.9 55.35 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.209 1.403 . . . . 0.0 110.297 -171.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -105.62 105.62 15.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 59.32 35.13 23.16 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.097 0.959 . . . . 0.0 111.13 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.92 -14.31 63.7 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.426 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -93.73 105.92 17.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.837 0.855 . . . . 0.0 109.41 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 26.1 tt0 -70.88 104.83 3.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.602 0.761 . . . . 0.0 111.174 -168.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.448 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 23.4 m -71.65 -0.95 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.89 -22.69 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.806 170.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -86.71 -28.55 23.02 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.772 0.829 . . . . 0.0 110.803 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HG ' ' HA ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -117.6 -153.74 0.54 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.383 1.073 . . . . 0.0 109.503 177.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.26 107.89 1.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.888 0.475 . . . . 0.0 110.186 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.448 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -80.2 -34.1 30.58 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.031 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.459 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.7 mmt -82.15 -39.11 23.72 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.2 82.48 1.6 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.29 0.566 . . . . 0.0 111.631 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 t -81.34 -72.87 0.41 Allowed 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.135 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.55 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.955 0.902 . . . . 0.0 110.414 -161.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -74.03 123.0 23.52 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -167.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.71 175.21 5.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.148 0.979 . . . . 0.0 109.989 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 11.1 p-10 -72.89 146.73 45.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.458 0.703 . . . . 0.0 111.949 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 15.15 73.1 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.396 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.31 171.45 13.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.098 0.559 . . . . 0.0 111.332 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.52 94.78 3.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 170.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.89 107.39 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 74.2 m -85.68 155.01 21.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 110.402 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.432 HG11 HG11 ' A' ' 60' ' ' VAL . 32.8 m -146.35 145.49 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 109.673 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 29.9 m-85 -132.38 136.62 28.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 32.5 Cg_endo -61.04 168.91 6.68 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.971 3.114 . . . . 0.0 113.432 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.94 130.33 32.36 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.103 1.202 . . . . 0.0 110.328 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.78 18.64 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.681 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -113.67 155.89 24.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.535 1.134 . . . . 0.0 110.086 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.14 69.29 0.18 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 CA-C-O 119.085 -0.842 . . . . 0.0 112.03 179.584 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 0' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 65.3 p . . . . . 0 C--O 1.244 0.767 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -108.06 167.5 9.95 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.887 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -120.84 133.48 55.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.7 mt -126.13 142.36 51.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.333 0.653 . . . . 0.0 109.945 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 45.5 tt0 -88.73 102.68 15.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.442 HD13 HD21 ' A' ' 37' ' ' LEU . 30.1 mt -93.76 104.0 16.11 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtp85 -94.4 117.83 30.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.775 -176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.4 138.12 43.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.864 0.866 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.28 156.2 48.01 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 109.56 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.458 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.55 -131.24 0.69 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.77 1.228 . . . . 0.0 111.64 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 14' ' ' VAL . 53.2 m -58.38 -46.89 85.46 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 123.346 0.658 . . . . 0.0 111.215 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -58.6 -26.38 63.62 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.042 0.537 . . . . 0.0 111.548 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -70.89 -50.47 34.65 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.096 0.558 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -74.26 -25.62 59.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.375 0.422 . . . . 0.0 111.932 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.552 HG11 ' HG ' ' A' ' 44' ' ' LEU . 48.1 t -59.29 -54.99 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.672 0.789 . . . . 0.0 110.036 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.49 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 94.4 t -72.59 -24.59 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.204 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.06 10.91 62.74 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.017 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -141.32 136.04 31.14 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.49 -22.06 21.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.035 0.534 . . . . 0.0 112.253 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 15.0 m -155.59 134.31 11.91 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 17.4 pt -131.27 176.66 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.209 1.004 . . . . 0.0 109.143 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -125.07 112.84 16.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.71 157.44 15.9 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 0.0 109.436 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -117.94 105.54 12.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.81 172.36 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 16.9 t70 -70.68 157.58 37.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -63.81 -27.74 69.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.06 0.544 . . . . 0.0 111.495 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.24 -23.82 37.77 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.032 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 129.6 40.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 110.586 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -110.81 -179.36 3.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.152 0.581 . . . . 0.0 110.774 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 39.6 t -51.52 -35.78 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.299 1.04 . . . . 0.0 111.981 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -65.81 -41.95 95.37 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 123.865 0.728 . . . . 0.0 114.011 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.81 -37.22 84.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.221 0.608 . . . . 0.0 110.765 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.13 -59.58 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.73 0.812 . . . . 0.0 110.543 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 54' ' ' VAL . 2.5 pp -65.86 -30.46 71.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 117.776 0.262 . . . . 0.0 111.501 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.515 ' HA ' HD11 ' A' ' 49' ' ' ILE . 10.4 tpt180 -54.55 -48.13 72.38 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.147 0.499 . . . . 0.0 110.713 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -75.48 -32.46 60.58 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.865 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -57.28 -39.35 75.51 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.54 0.736 . . . . 0.0 112.683 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 1.4 pp20? -73.53 -29.51 62.5 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 120.664 0.269 . . . . 0.0 111.63 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.18 -22.39 66.92 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.096 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -92.64 -57.71 2.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.777 0.799 . . . . 0.0 109.789 174.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 98.6 m-85 -99.83 116.8 32.74 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.954 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.33 -34.29 77.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.061 0.944 . . . . 0.0 111.052 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.01 -8.66 64.98 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.719 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.669 ' HB3' HD13 ' A' ' 48' ' ' LEU . 57.8 mt -105.54 -9.62 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.851 0.861 . . . . 0.0 111.507 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.87 121.27 10.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.105 0.562 . . . . 0.0 111.953 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.1 -33.85 3.93 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -86.17 2.68 45.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.669 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.34 -5.82 8.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.054 0.941 . . . . 0.0 111.043 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 35' ' ' ARG . 35.0 mt -132.31 128.78 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.499 1.119 . . . . 0.0 108.823 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -129.83 113.04 14.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.063 0.545 . . . . 0.0 109.724 168.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.56 30.7 20.16 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.893 0.877 . . . . 0.0 112.215 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.33 75.01 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.208 -0.774 . . . . 0.0 114.373 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.6 -174.57 2.68 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.085 0.943 . . . . 0.0 109.466 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.556 HG12 HD21 ' A' ' 34' ' ' LEU . 17.5 m -67.47 -56.94 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-O 117.764 -1.112 . . . . 0.0 112.098 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 13.4 tppt? 151.1 139.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 C-N-CA 124.956 1.302 . . . . 0.0 108.923 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 25.5 Cg_endo -59.89 134.08 54.7 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.112 2.542 . . . . 0.0 111.752 167.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 73.48 -14.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.98 1.312 . . . . 0.0 114.441 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.4 p -67.2 136.39 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 15.9 m120 -107.67 103.46 12.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.431 HG23 HG23 ' A' ' 67' ' ' VAL . 3.5 m -120.72 142.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.795 0.838 . . . . 0.0 109.288 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.0 mp -129.19 172.15 11.73 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.403 1.481 . . . . 0.0 109.979 -165.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 67' ' ' VAL . 18.4 tptp -165.14 106.13 0.79 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 56.3 35.31 25.6 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-O 122.065 0.936 . . . . 0.0 109.711 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.04 -13.4 57.08 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.639 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -90.73 117.76 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.9 tt0 -72.4 103.65 3.52 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.206 0.602 . . . . 0.0 110.25 -174.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 62' ' ' LYS . 13.0 m -67.66 -0.7 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 58' ' ' VAL . 5.3 m -67.39 -27.28 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 118.073 0.397 . . . . 0.0 110.526 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -82.05 -16.4 50.26 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.953 0.901 . . . . 0.0 111.118 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.5 -150.34 0.4 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.343 1.057 . . . . 0.0 109.354 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.31 108.37 3.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.442 0.697 . . . . 0.0 111.098 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.25 -42.57 18.59 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.653 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.632 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.8 mmt -78.24 -38.55 42.65 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.36 0.664 . . . . 0.0 112.412 -174.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.22 79.46 1.54 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.553 0.692 . . . . 0.0 111.535 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 t -81.72 -75.43 0.29 Allowed 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.707 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -177.45 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -164.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 77' ' ' LEU . 9.5 mt -72.65 118.31 15.41 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.238 0.926 . . . . 0.0 111.83 -166.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 42.6 m-20 -119.71 173.91 6.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.157 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.3 146.91 52.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.134 0.573 . . . . 0.0 112.277 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 14.86 67.17 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.164 -0.926 . . . . 0.0 114.19 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 2.2 t70 -72.89 179.67 3.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.316 0.558 . . . . 0.0 110.307 -177.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.56 100.08 3.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.047 0.539 . . . . 0.0 110.834 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.2 t -87.77 106.9 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.1 m -91.72 141.88 28.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.57 143.15 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 121.683 0.754 . . . . 0.0 110.189 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.603 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 12.8 m-85 -134.92 135.32 22.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 30.4 Cg_endo -61.49 161.92 22.53 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.361 2.708 . . . . 0.0 112.783 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--N 1.38 2.186 0 C-N-CA 122.052 1.835 . . . . 0.0 112.525 -174.462 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.137 0.494 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -141.21 128.87 21.51 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.357 1.063 . . . . 0.0 109.351 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.21 135.72 35.21 Favored 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 123.512 0.725 . . . . 0.0 109.065 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.36 132.62 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.215 0.606 . . . . 0.0 110.105 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 66.0 tt0 -88.82 95.9 10.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.499 HD13 HD21 ' A' ' 37' ' ' LEU . 46.1 mt -92.9 103.79 16.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 95.6 mtt180 -91.3 117.96 30.09 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.642 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.55 141.86 37.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -133.75 159.76 39.62 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.245 0.618 . . . . 0.0 109.563 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.3 -130.69 1.32 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.436 1.094 . . . . 0.0 112.1 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.404 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 81.3 m -55.68 -49.19 73.61 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 123.914 0.885 . . . . 0.0 111.188 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HE1' ' HD3' ' A' ' 47' ' ' ARG . 12.8 m-30 -59.78 -27.58 66.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.803 0.441 . . . . 0.0 111.283 -177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -52.6 27.07 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.605 0.362 . . . . 0.0 111.006 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.13 -21.07 60.79 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.436 0.46 . . . . 0.0 111.652 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.557 HG11 ' HG ' ' A' ' 44' ' ' LEU . 46.1 t -62.76 -53.89 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.444 0.698 . . . . 0.0 110.47 169.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 93.1 t -73.76 -21.68 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.572 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.95 11.19 62.9 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.699 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -142.54 142.56 32.24 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -95.68 -8.12 35.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.465 0.306 . . . . 0.0 111.737 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 2.1 m -158.47 128.16 5.82 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.491 1.116 . . . . 0.0 108.495 170.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 5' ' ' LEU . 11.3 pt -119.03 171.03 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.599 0.76 . . . . 0.0 108.999 173.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.05 112.38 20.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.531 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -93.39 177.3 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.647 1.179 . . . . 0.0 109.77 171.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -156.79 105.35 2.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 171.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.93 172.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.46 1.104 . . . . 0.0 108.618 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.88 160.46 30.63 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.415 0.286 . . . . 0.0 110.402 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.7 -14.95 59.47 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -81.31 -16.05 53.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 152.22 43.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.568 0.747 . . . . 0.0 110.712 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 33' ' ' VAL . 38.1 p -136.17 -174.49 3.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.834 1.253 . . . . 0.0 108.727 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.1 t -50.51 -36.32 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 C-N-CA 124.185 0.994 . . . . 0.0 112.238 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.12 62.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.844 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.43 -30.13 69.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.421 0.688 . . . . 0.0 110.791 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 29' ' ' THR . 72.8 t -62.72 -60.42 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.357 175.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.6 pp -66.25 -30.09 70.46 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.565 0.346 . . . . 0.0 111.616 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.591 ' HA ' HD11 ' A' ' 49' ' ' ILE . 12.0 tpt180 -50.56 -49.86 55.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.549 0.74 . . . . 0.0 111.042 169.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 35.0 t -76.09 -32.59 59.3 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.05 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.7 mm? -56.77 -36.69 70.11 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.199 0.6 . . . . 0.0 112.597 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.3 pt-20 -73.6 -26.64 60.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.8 62.31 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.303 0.641 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.531 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 16.8 mm-40 -89.52 -58.08 2.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.587 0.755 . . . . 0.0 109.864 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 97.9 m-85 -102.14 122.2 43.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.32 -171.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.19 -29.12 67.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.599 0.759 . . . . 0.0 111.941 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.8 -4.38 85.33 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.644 0.59 . . . . 0.0 113.47 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.603 ' HB3' HD13 ' A' ' 48' ' ' LEU . 67.2 mt -106.3 -0.98 23.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.479 0.711 . . . . 0.0 111.335 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.89 120.89 14.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.68 -2.5 53.88 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 170.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.9 ptp180 -107.9 4.0 24.87 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.235 1.014 . . . . 0.0 111.122 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -126.57 -2.24 6.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.186 0.994 . . . . 0.0 110.56 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.591 HD11 ' HA ' ' A' ' 35' ' ' ARG . 27.7 mt -131.53 137.15 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.757 1.223 . . . . 0.0 108.552 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -148.64 114.78 5.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.87 31.17 21.02 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.981 1.312 . . . . 0.0 112.374 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.39 -10.12 62.39 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.536 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -94.33 -174.84 3.47 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.261 1.031 . . . . 0.0 109.017 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG12 HD21 ' A' ' 34' ' ' LEU . 27.4 m -64.94 -55.81 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.31 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 58' ' ' VAL . 13.7 tppt? 150.84 132.71 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 125.526 1.53 . . . . 0.0 108.492 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 32.8 Cg_endo -61.85 135.05 53.5 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 122.947 2.431 . . . . 0.0 111.507 165.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 82.95 -17.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.306 1.442 . . . . 0.0 113.578 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.477 HG23 ' HD3' ' A' ' 88' ' ' PRO . 2.0 p -73.16 139.39 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.5 m120 -106.12 103.71 13.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.83 131.11 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.162 0.585 . . . . 0.0 109.618 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.5 mp -123.01 143.24 50.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.476 1.11 . . . . 0.0 109.986 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 2.2 tptm -112.98 105.26 13.28 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.45 55.88 8.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.282 1.433 . . . . 0.0 111.994 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.54 -14.34 30.35 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.801 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -97.43 114.07 25.85 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 117.566 0.683 . . . . 0.0 109.212 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.2 tt0 -70.3 112.37 6.58 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 75' ' ' THR . 35.4 m -72.44 -1.27 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 113.397 -174.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 m -70.21 -13.36 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.818 0.447 . . . . 0.0 111.422 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -93.81 -18.78 21.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.635 0.774 . . . . 0.0 110.904 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.96 -152.9 0.52 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.117 0.967 . . . . 0.0 109.076 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 75' ' ' THR . 9.9 m-20 -58.09 112.84 1.66 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.068 0.547 . . . . 0.0 110.956 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.33 -46.77 8.72 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 76.0 mmm -80.32 -38.92 29.68 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.829 0.852 . . . . 0.0 112.32 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.85 74.31 1.46 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.475 0.655 . . . . 0.0 111.48 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.7 t -81.31 -69.94 0.57 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.498 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' H ' HG23 ' A' ' 75' ' ' THR . . . -177.05 33.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.846 0.858 . . . . 0.0 110.485 -164.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.1 tp -75.66 138.61 41.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.709 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -151.04 -176.13 5.42 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.743 1.217 . . . . 0.0 107.978 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.88 144.43 50.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 118.432 0.56 . . . . 0.0 111.203 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.75 5.17 63.68 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.912 0.768 . . . . 0.0 114.566 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.602 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.9 m-20 -84.35 135.66 34.21 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.241 0.521 . . . . 0.0 112.117 -171.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -92.64 124.6 36.78 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.827 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.7 t -108.1 106.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.5 m -94.34 106.0 17.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.157 0.583 . . . . 0.0 110.186 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 m -106.58 145.46 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.005 0.907 . . . . 0.0 111.039 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 8.2 m-85 -131.23 139.69 36.24 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 175.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 46.4 Cg_endo -65.91 168.49 15.26 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.485 2.79 . . . . 0.0 112.631 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HG23 ' A' ' 58' ' ' VAL . 74.3 Cg_endo . . . . . 0 C--N 1.368 1.581 0 C-N-CA 121.077 1.185 . . . . 0.0 109.372 170.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.24 0.543 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptm -102.94 118.76 37.53 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.476 1.51 . . . . 0.0 110.54 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -86.53 126.49 34.49 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.494 HD13 HD21 ' A' ' 77' ' ' LEU . 27.1 mt -128.46 130.19 47.2 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.288 0.635 . . . . 0.0 110.149 -167.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -88.75 97.74 11.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.435 HD13 HD21 ' A' ' 37' ' ' LEU . 24.3 mt -93.49 103.52 15.71 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 90.0 mtt180 -92.26 117.69 30.14 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.061 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.07 140.1 38.76 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.811 0.844 . . . . 0.0 109.633 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -131.94 158.4 41.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.054 0.542 . . . . 0.0 110.054 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.21 -127.44 1.27 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.069 1.347 . . . . 0.0 111.93 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.36 -47.02 87.87 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.662 0.785 . . . . 0.0 111.204 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -58.06 -29.57 65.51 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.096 0.558 . . . . 0.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.62 -54.32 20.68 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.002 0.521 . . . . 0.0 110.937 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 -20.05 60.43 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 123.62 0.575 . . . . 0.0 111.858 -174.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.48 HG11 ' HG ' ' A' ' 44' ' ' LEU . 41.6 t -60.69 -54.36 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.37 0.668 . . . . 0.0 110.142 168.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.416 HG12 ' HG3' ' A' ' 17' ' ' GLN . 60.4 t -73.26 -21.22 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.367 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.7 11.29 65.53 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.359 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.416 ' HG3' HG12 ' A' ' 15' ' ' VAL . 15.0 mt-30 -140.23 143.46 36.02 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.993 0.917 . . . . 0.0 109.051 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -92.93 -15.09 26.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.492 0.717 . . . . 0.0 111.694 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -156.58 138.06 13.98 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.2 pt -130.99 174.51 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.015 0.926 . . . . 0.0 108.545 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.54 111.92 17.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 163.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.426 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -89.62 176.85 6.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 108.743 169.256 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -155.8 111.74 3.07 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.809 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 m -113.62 177.68 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.412 1.085 . . . . 0.0 108.169 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -59.85 148.95 32.86 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.376 0.535 . . . . 0.0 110.533 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.09 -10.22 59.38 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.77 -20.25 43.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.682 0.793 . . . . 0.0 110.952 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 160.98 23.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.122 0.969 . . . . 0.0 112.377 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -138.39 -176.32 4.42 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.766 1.226 . . . . 0.0 109.437 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.3 t -51.33 -35.84 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.205 1.002 . . . . 0.0 111.471 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.74 -43.54 59.21 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.772 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -64.72 -31.37 72.57 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.447 0.699 . . . . 0.0 110.985 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.22 -60.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.86 0.864 . . . . 0.0 110.63 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.4 pp -65.62 -30.03 70.69 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.469 0.481 . . . . 0.0 111.173 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.727 ' HA ' HD11 ' A' ' 49' ' ' ILE . 21.9 tpt180 -53.1 -50.51 64.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.681 0.753 . . . . 0.0 111.695 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.8 m -75.27 -31.92 60.88 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.593 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.435 HD21 HD13 ' A' ' 5' ' ' LEU . 2.5 mm? -56.14 -46.9 79.07 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.323 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.503 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.1 pt-20 -67.78 -26.87 66.31 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.757 0.253 . . . . 0.0 111.486 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.98 -23.93 67.36 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.455 0.472 . . . . 0.0 111.465 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -101.03 -59.55 1.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.158 0.504 . . . . 0.0 110.503 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -86.01 120.72 27.71 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.314 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.56 -33.12 74.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.992 0.917 . . . . 0.0 110.798 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.09 2.85 83.02 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.578 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 48' ' ' LEU . 71.5 mt -115.02 6.15 15.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.352 0.661 . . . . 0.0 110.725 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -72.26 121.45 19.42 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -173.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.58 68.06 Favored Glycine 0 C--N 1.357 1.742 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.524 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 13.5 ptp180 -119.59 -4.78 10.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.031 0.932 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -119.25 -3.84 10.52 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.189 1.395 . . . . 0.0 109.886 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.727 HD11 ' HA ' ' A' ' 35' ' ' ARG . 75.5 mt -132.41 140.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.931 1.293 . . . . 0.0 108.156 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.67 126.96 5.25 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 61.55 30.85 18.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.761 1.224 . . . . 0.0 111.543 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.03 -4.98 56.15 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.666 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -106.59 -174.27 2.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.497 0.719 . . . . 0.0 109.455 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG12 HD21 ' A' ' 34' ' ' LEU . 19.1 m -59.37 -55.67 22.17 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 CA-C-O 117.689 -1.148 . . . . 0.0 112.483 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 12.5 tppt? 150.59 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 125.173 1.389 . . . . 0.0 108.057 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 11.4 Cg_endo -52.6 124.71 15.86 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.969 2.446 . . . . 0.0 111.947 168.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 74.74 2.59 4.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.639 1.176 . . . . 0.0 113.821 170.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 p -77.63 132.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 19.5 m120 -98.35 103.89 15.88 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.83 141.44 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.574 0.749 . . . . 0.0 109.692 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -131.17 140.62 49.96 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.173 1.389 . . . . 0.0 109.556 -166.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.601 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 16.0 tptm -105.46 105.63 15.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 166.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.7 t30 57.12 36.35 27.47 Favored 'General case' 0 CA--C 1.562 1.418 0 O-C-N 124.168 0.918 . . . . 0.0 111.366 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.3 -10.46 74.83 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -94.26 109.96 21.74 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.0 tt0 -68.62 106.25 2.54 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.032 0.533 . . . . 0.0 110.754 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.534 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 16.1 m -69.2 -1.23 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -174.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 m -68.06 -21.74 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-N 117.773 0.261 . . . . 0.0 111.237 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -87.55 -19.4 27.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.339 0.655 . . . . 0.0 110.656 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.0 -153.09 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.382 1.073 . . . . 0.0 109.718 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.73 108.4 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.579 0.752 . . . . 0.0 110.582 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -71.89 -49.63 22.03 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.589 -0.278 . . . . 0.0 113.122 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.5 -39.68 37.46 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.68 75.6 1.48 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.348 0.594 . . . . 0.0 110.903 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -76.65 -60.79 2.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.239 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.18 33.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.569 1.148 . . . . 0.0 109.657 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 3' ' ' LEU . 42.5 tp -74.98 114.84 13.92 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -120.1 -176.7 3.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.676 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -66.5 144.14 56.65 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.364 0.666 . . . . 0.0 111.101 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.92 8.97 85.22 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.946 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.601 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 70.4 m-20 -97.75 144.56 27.25 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.786 0.834 . . . . 0.0 111.599 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.28 141.96 27.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.67 0.788 . . . . 0.0 111.116 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.08 107.39 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.232 1.013 . . . . 0.0 108.311 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.686 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 49.4 m -90.6 139.05 31.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.691 0.796 . . . . 0.0 109.268 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.16 142.43 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.124 0.874 . . . . 0.0 110.624 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 20.5 m-85 -129.79 135.99 28.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.41 164.02 19.05 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.329 2.686 . . . . 0.0 112.16 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.369 1.628 0 C-N-CA 121.364 1.376 . . . . 0.0 110.287 175.744 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -122.71 146.03 47.86 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.506 0.722 . . . . 0.0 109.944 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.57 135.2 33.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.512 HD13 HD21 ' A' ' 77' ' ' LEU . 20.6 mt -134.12 133.54 41.2 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.32 0.648 . . . . 0.0 109.399 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -88.89 107.79 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 37' ' ' LEU . 24.6 mt -94.79 104.03 15.93 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 92.4 mtt180 -92.05 118.13 30.5 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.825 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.7 139.6 40.03 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.807 0.843 . . . . 0.0 109.283 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.43 154.95 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.195 0.598 . . . . 0.0 109.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.85 -128.9 0.72 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.813 1.245 . . . . 0.0 112.074 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.44 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 35.3 m -62.39 -41.5 98.69 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 123.731 0.813 . . . . 0.0 111.381 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -63.33 -25.18 68.18 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.225 0.61 . . . . 0.0 111.383 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -71.55 -53.18 14.63 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.411 0.684 . . . . 0.0 111.189 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 8.9 pt-20 -71.18 -23.37 62.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.013 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG11 ' HG ' ' A' ' 44' ' ' LEU . 19.8 t -60.87 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.555 0.693 . . . . 0.0 111.043 170.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.74 -21.97 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.323 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.48 12.48 77.22 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.567 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -143.36 143.82 31.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.774 1.229 . . . . 0.0 109.016 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -94.62 -18.47 21.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.622 0.369 . . . . 0.0 111.732 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -154.86 127.96 8.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.899 0.88 . . . . 0.0 108.663 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.17 170.02 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.955 0.902 . . . . 0.0 109.086 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.82 112.35 20.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -96.93 179.67 4.87 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 108.848 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -157.06 106.17 2.19 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.15 179.97 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.427 1.091 . . . . 0.0 108.391 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.71 150.14 24.31 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.489 0.715 . . . . 0.0 111.511 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.91 -20.82 62.45 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.149 0.579 . . . . 0.0 111.741 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.89 -23.82 20.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.238 0.615 . . . . 0.0 110.724 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.29 128.06 35.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.465 0.306 . . . . 0.0 110.286 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.2 p -107.25 -174.68 2.59 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.496 0.719 . . . . 0.0 111.175 -172.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 78.9 t -51.85 -38.24 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.164 0.985 . . . . 0.0 112.25 -173.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -64.44 -42.39 97.62 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 123.728 0.643 . . . . 0.0 113.27 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -69.24 -30.42 68.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.57 0.748 . . . . 0.0 110.956 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.0 t -64.88 -60.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.476 0.71 . . . . 0.0 110.452 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.498 HD21 HG12 ' A' ' 54' ' ' VAL . 1.9 pp -63.94 -30.3 71.39 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.183 0.447 . . . . 0.0 111.337 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.568 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.8 tpt85 -53.71 -47.02 70.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.046 0.538 . . . . 0.0 110.831 169.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 m -74.84 -32.94 62.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.22 0.608 . . . . 0.0 111.78 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 5' ' ' LEU . 3.9 mm? -58.18 -35.36 71.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -78.57 -25.91 45.46 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.173 0.442 . . . . 0.0 111.394 176.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -16.07 62.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.652 0.781 . . . . 0.0 111.513 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -100.87 -59.36 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.404 0.681 . . . . 0.0 110.181 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.07 119.47 34.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.676 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.09 -30.29 70.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.858 0.463 . . . . 0.0 110.599 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -72.22 -12.28 76.03 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.597 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 48' ' ' LEU . 97.7 mt -109.84 -0.43 18.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 111.026 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -62.02 121.08 12.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.444 0.698 . . . . 0.0 112.433 -172.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.12 -22.87 3.43 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -91.18 10.69 26.01 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.393 1.077 . . . . 0.0 111.856 -173.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -130.0 -5.98 4.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.34 1.056 . . . . 0.0 110.9 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 35' ' ' ARG . 67.4 mt -131.78 130.6 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.676 1.19 . . . . 0.0 108.195 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.37 126.13 22.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.951 0.5 . . . . 0.0 110.0 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.1 t70 54.81 31.33 15.39 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.552 1.141 . . . . 0.0 112.315 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.41 -13.74 53.94 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.692 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.35 -176.96 3.45 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.815 0.846 . . . . 0.0 109.008 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG12 HD21 ' A' ' 34' ' ' LEU . 16.6 m -64.47 -56.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.836 -1.078 . . . . 0.0 112.333 -173.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? 155.17 133.14 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 124.705 1.202 . . . . 0.0 109.287 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.79 134.48 47.13 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.519 2.812 . . . . 0.0 111.383 168.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 77.85 -15.11 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.778 1.631 . . . . 0.0 113.52 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.13 145.37 13.0 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 83.0 m-20 -114.24 103.88 11.54 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.05 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.071 0.948 . . . . 0.0 108.663 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.706 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -117.15 151.51 36.7 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 20.8 tptp -124.24 104.37 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.392 1.477 . . . . 0.0 107.203 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 50.75 38.63 20.0 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.648 1.179 . . . . 0.0 111.15 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.1 80.82 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.374 -0.83 . . . . 0.0 115.107 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -103.61 110.15 22.1 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 118.021 0.911 . . . . 0.0 109.424 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.4 tt0 -66.55 112.28 4.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.497 0.719 . . . . 0.0 110.885 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.579 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 31.0 m -68.01 -0.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.41 -18.18 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 118.182 0.446 . . . . 0.0 110.669 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -92.73 -10.52 36.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.141 0.976 . . . . 0.0 111.396 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.66 -155.67 0.62 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.019 0.928 . . . . 0.0 109.081 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -66.92 111.01 3.56 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.008 0.523 . . . . 0.0 111.492 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.579 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -73.21 -50.32 12.89 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.223 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.522 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.5 mmt -71.15 -36.56 72.09 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.576 0.75 . . . . 0.0 112.79 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.39 81.67 1.41 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.749 0.785 . . . . 0.0 111.525 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -79.67 -79.37 0.14 Allowed 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.961 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 75' ' ' THR . . . -169.96 33.11 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.132 0.573 . . . . 0.0 110.035 -168.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 18.0 tp -74.72 123.25 24.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.928 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.69 168.08 17.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.98 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.92 135.16 55.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.124 0.57 . . . . 0.0 111.29 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.26 18.97 73.04 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.54 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.12 169.98 12.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.736 0.414 . . . . 0.0 110.092 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.48 98.45 4.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.415 0.686 . . . . 0.0 110.519 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -86.36 107.88 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.706 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 53.6 m -87.04 152.23 22.56 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.91 0.484 . . . . 0.0 109.934 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m -144.56 146.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-O 121.635 0.731 . . . . 0.0 109.939 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.567 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 11.3 m-85 -136.81 140.34 31.56 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HG3' ' H ' ' A' ' 10' ' ' THR . 37.6 Cg_endo -63.19 169.08 9.84 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.796 2.998 . . . . 0.0 112.501 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 C--N 1.379 2.154 0 C-N-CA 121.159 1.239 . . . . 0.0 110.627 177.697 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 0' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 69.7 p . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.247 0.07 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 26.9 ptt? -102.84 129.62 49.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 110.583 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.05 136.52 33.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.421 HD13 HD21 ' A' ' 77' ' ' LEU . 21.5 mt -131.82 134.3 45.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -173.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 100.32 13.1 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.78 104.16 16.25 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 52.9 mtp180 -91.0 116.83 29.09 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.757 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.452 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 96.0 m-85 -103.79 138.81 39.88 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 109.241 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -130.77 157.88 41.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.645 0.778 . . . . 0.0 109.072 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.46 -132.72 0.8 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.443 1.097 . . . . 0.0 112.563 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 14' ' ' VAL . 25.6 m -58.09 -42.3 85.34 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 124.16 0.984 . . . . 0.0 111.876 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 11.3 m-30 -62.66 -34.37 76.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.83 0.452 . . . . 0.0 111.224 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -38.38 88.02 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.536 0.523 . . . . 0.0 110.089 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.35 -43.96 84.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.986 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG11 ' HG ' ' A' ' 44' ' ' LEU . 69.4 t -57.22 -51.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.703 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.69 -26.6 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.453 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 11.4 71.25 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.144 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -138.46 145.72 41.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -86.91 -25.01 24.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.05 0.54 . . . . 0.0 112.038 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -156.39 123.13 5.17 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.184 0.993 . . . . 0.0 108.372 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.83 173.39 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.664 0.786 . . . . 0.0 109.353 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.57 112.09 18.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -95.4 177.15 5.93 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.599 1.16 . . . . 0.0 108.689 171.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -157.11 106.79 2.22 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.153 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.24 168.88 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 26.4 t70 -71.75 155.22 40.7 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.93 -14.63 61.91 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.59 0.756 . . . . 0.0 112.708 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -80.14 -16.91 53.9 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.122 0.569 . . . . 0.0 109.909 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.6 163.88 27.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.778 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.1 p -133.48 -175.39 3.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.563 1.145 . . . . 0.0 109.126 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.38 -37.93 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.051 0.94 . . . . 0.0 111.176 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.562 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.83 -42.48 69.92 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.567 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.45 -36.38 78.1 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.3 0.64 . . . . 0.0 111.033 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -62.76 -60.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.511 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.471 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.9 -30.45 71.44 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.466 0.306 . . . . 0.0 111.233 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.47 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.6 tpt180 -54.71 -49.21 71.26 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.187 0.595 . . . . 0.0 111.603 170.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 m -75.85 -31.27 59.24 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.736 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.03 -46.84 75.31 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.543 0.737 . . . . 0.0 112.373 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.6 pt-20 -65.5 -26.4 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.05 -22.25 62.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.113 0.565 . . . . 0.0 111.211 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -100.36 -59.43 1.71 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.682 0.753 . . . . 0.0 109.413 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -86.83 104.0 15.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.352 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.3 -17.55 63.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.384 0.674 . . . . 0.0 111.329 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -74.99 -12.65 83.21 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.304 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.635 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.6 mt -101.62 0.65 36.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.483 0.713 . . . . 0.0 110.918 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.38 121.35 14.65 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.54 70.42 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.229 -0.896 . . . . 0.0 115.213 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.55 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 2.3 ptp180 -117.91 -12.24 10.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.858 0.863 . . . . 0.0 111.13 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.635 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -107.41 -3.27 19.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.41 1.084 . . . . 0.0 110.477 172.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 35' ' ' ARG . 21.1 mt -134.47 136.5 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.911 1.284 . . . . 0.0 109.0 171.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.47 108.2 8.98 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 167.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 53.56 31.55 12.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.032 0.933 . . . . 0.0 112.903 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.6 2.25 67.68 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.52 -178.88 3.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 164.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.59 -55.54 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.152 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 14.2 tppt? 150.54 132.27 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.534 0 C-N-CA 125.443 1.497 . . . . 0.0 109.054 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.88 132.85 54.53 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 122.951 2.434 . . . . 0.0 111.679 167.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 78.93 -12.18 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.286 1.434 . . . . 0.0 113.94 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 55' ' ' LYS . 1.2 p -73.18 139.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.614 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.13 104.49 13.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 85' ' ' VAL . 2.9 m -119.16 119.1 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.487 0.715 . . . . 0.0 109.289 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -112.38 131.24 55.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.491 1.116 . . . . 0.0 110.615 -172.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 17.2 tptp -107.57 109.51 21.18 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.63 1.572 . . . . 0.0 108.116 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 56.38 35.42 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.763 0.792 . . . . 0.0 110.667 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.0 -0.07 87.49 Favored Glycine 0 CA--C 1.543 1.804 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.617 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -107.47 112.56 25.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.651 0.78 . . . . 0.0 109.913 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.4 tt0 -67.14 105.19 1.62 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.913 0.885 . . . . 0.0 110.98 -173.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 62' ' ' LYS . 17.1 m -69.33 -0.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 58' ' ' VAL . 17.4 m -67.72 -21.19 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 117.924 0.329 . . . . 0.0 111.152 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -84.73 -17.47 38.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.88 0.872 . . . . 0.0 111.204 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -138.15 -151.27 0.38 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.241 1.016 . . . . 0.0 109.769 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 75' ' ' THR . 1.4 m-20 -63.93 108.5 1.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.026 0.53 . . . . 0.0 111.167 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.25 -42.2 15.65 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.842 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.562 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.3 mmt -77.82 -39.88 42.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.399 0.679 . . . . 0.0 112.334 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.77 77.66 1.47 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.102 0.477 . . . . 0.0 111.461 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 71' ' ' ASP . 4.0 t -81.49 -67.91 0.74 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.003 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 75' ' ' THR . . . 179.84 33.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.346 0.658 . . . . 0.0 111.184 -164.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.486 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 31.0 tp -73.45 135.41 44.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.244 0.545 . . . . 0.0 110.692 -164.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.6 166.19 24.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.998 -165.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 34.4 t70 -65.52 143.6 57.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.382 0.673 . . . . 0.0 111.769 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.33 75.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.627 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.69 137.12 33.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 117.455 0.628 . . . . 0.0 111.249 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -96.39 94.99 7.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.766 0.426 . . . . 0.0 109.953 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 t -86.89 106.36 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.659 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 54.8 m -82.61 150.07 27.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.401 0.681 . . . . 0.0 110.035 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 60' ' ' VAL . 23.0 m -145.9 141.84 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.601 0.715 . . . . 0.0 109.686 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 10.9 m-85 -133.68 132.09 21.53 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 22.0 Cg_endo -59.41 165.66 8.94 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.647 2.898 . . . . 0.0 113.256 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--N 1.374 1.884 0 C-N-CA 121.532 1.488 . . . . 0.0 110.676 175.929 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 46.5 p . . . . . 0 C--O 1.237 0.399 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -123.87 141.81 51.69 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.304 0.642 . . . . 0.0 110.055 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -107.73 113.16 26.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.699 0.399 . . . . 0.0 110.265 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.439 HD13 HD21 ' A' ' 77' ' ' LEU . 18.1 mt -102.64 142.09 34.38 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.257 1.023 . . . . 0.0 110.825 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.34 97.06 10.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.39 103.49 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.6 mtp180 -96.07 116.39 28.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.698 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -103.68 137.27 41.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.83 0.852 . . . . 0.0 109.18 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -129.17 159.59 35.54 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.574 0.75 . . . . 0.0 109.102 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.523 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.44 -133.6 1.07 Allowed 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.12 0.968 . . . . 0.0 112.239 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 14' ' ' VAL . 31.3 m -59.89 -40.92 90.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.618 0.767 . . . . 0.0 112.235 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -63.22 -29.08 70.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.772 0.26 . . . . 0.0 111.02 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 54.4 ttp85 -66.77 -53.58 31.59 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.391 0.676 . . . . 0.0 111.552 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.76 -27.9 67.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.401 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.458 HG11 ' HG ' ' A' ' 44' ' ' LEU . 45.6 t -62.19 -53.07 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.593 0.757 . . . . 0.0 111.046 173.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.45 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.1 t -70.64 -24.16 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.294 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.51 11.06 71.87 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.587 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -142.53 135.74 28.61 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 21.0 ptmt -83.69 -24.36 31.3 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.539 0.336 . . . . 0.0 111.773 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -155.52 135.69 13.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.2 172.68 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.739 0.816 . . . . 0.0 109.846 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 3' ' ' LEU . 82.8 m-85 -123.18 113.4 18.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.403 0.621 . . . . 0.0 109.51 170.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.456 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -103.01 139.53 38.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.153 1.381 . . . . 0.0 109.51 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -107.95 106.63 16.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.25 -179.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.326 1.05 . . . . 0.0 109.116 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.22 154.75 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.127 0.571 . . . . 0.0 109.894 173.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.36 -37.69 86.64 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.076 0.95 . . . . 0.0 112.25 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.83 -13.04 59.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.42 0.688 . . . . 0.0 110.705 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 142.87 57.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.878 0.471 . . . . 0.0 109.903 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 p -118.83 -176.93 3.2 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.9 t -53.09 -35.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.125 0.97 . . . . 0.0 111.504 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.78 59.64 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.36 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.0 -33.13 72.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.384 0.673 . . . . 0.0 110.804 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.26 -60.38 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.304 1.042 . . . . 0.0 110.946 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.567 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.9 pp -65.33 -30.11 70.92 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 123.239 0.337 . . . . 0.0 111.704 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.597 ' HA ' HD11 ' A' ' 49' ' ' ILE . 1.3 ppt_? -64.49 -36.55 84.55 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.077 0.465 . . . . 0.0 109.994 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.9 m -75.6 -33.67 60.58 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.622 0.769 . . . . 0.0 111.769 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.96 -37.86 88.77 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.064 0.546 . . . . 0.0 112.358 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -70.66 -28.55 64.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.832 0.348 . . . . 0.0 111.609 176.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.94 -24.49 62.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.158 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 12.8 mm-40 -88.13 -59.64 2.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.634 0.731 . . . . 0.0 109.726 174.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 97.1 m-85 -98.45 118.29 34.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.114 -170.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.78 -28.67 68.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.139 0.976 . . . . 0.0 110.654 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.496 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.7 -9.55 86.97 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 119.411 -0.661 . . . . 0.0 113.844 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.617 ' HB3' HD13 ' A' ' 48' ' ' LEU . 84.0 mt -95.9 -6.92 38.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.657 0.729 . . . . 0.0 111.127 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.22 124.61 22.62 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.6 0.76 . . . . 0.0 112.906 -171.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.96 8.51 86.81 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 115.135 0.814 . . . . 0.0 115.135 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.3 OUTLIER -125.1 -22.37 4.44 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 117.404 0.602 . . . . 0.0 111.973 -174.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -96.55 -0.23 49.11 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.774 0.43 . . . . 0.0 110.704 172.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 35' ' ' ARG . 57.4 mt -135.41 145.66 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.173 1.389 . . . . 0.0 108.634 171.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 15.4 tp10 -157.74 127.85 6.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.967 0.907 . . . . 0.0 108.96 168.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.6 t70 56.87 31.31 19.42 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.493 1.14 . . . . 0.0 111.373 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.88 -14.26 38.59 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 114.743 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -94.89 -174.06 3.16 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 117.83 0.815 . . . . 0.0 110.053 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG12 HD21 ' A' ' 34' ' ' LEU . 18.2 m -59.93 -54.71 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.772 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 50' ' ' GLU . 9.6 tppt? 150.44 137.0 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 C-N-CA 126.304 1.841 . . . . 0.0 108.112 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.76 125.6 19.18 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.038 164.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 81.19 -9.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.403 1.481 . . . . 0.0 113.939 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 55' ' ' LYS . 5.2 p -69.52 129.21 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.609 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -94.92 103.27 15.14 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 m -121.55 131.14 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.489 HD13 ' CE1' ' A' ' 86' ' ' PHE . 6.7 mp -123.87 141.73 51.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.065 0.946 . . . . 0.0 110.645 -168.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HE3' HD12 ' A' ' 77' ' ' LEU . 15.0 tptm -111.84 105.14 13.52 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.177 1.391 . . . . 0.0 107.835 168.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.11 35.61 25.25 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.45 1.1 . . . . 0.0 111.402 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.65 -14.21 64.65 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 114.342 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -89.09 107.66 19.16 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.896 0.848 . . . . 0.0 109.595 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.6 tt0 -65.34 106.85 1.46 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.102 0.561 . . . . 0.0 110.024 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.401 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 23.7 m -69.73 -1.71 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.33 -22.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.501 0.591 . . . . 0.0 110.917 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 66' ' ' GLU . 60.0 m-70 -84.05 -12.12 55.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.548 0.739 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.58 -153.04 0.44 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.568 1.147 . . . . 0.0 109.318 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.16 108.46 0.9 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.675 0.39 . . . . 0.0 110.687 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.401 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -74.7 -47.9 14.03 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.371 0.42 . . . . 0.0 112.358 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 90.1 mmm -80.31 -36.78 33.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.307 0.643 . . . . 0.0 112.221 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.98 76.81 1.52 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.906 -0.496 . . . . 0.0 111.715 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.7 t -81.46 -69.33 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.994 0.518 . . . . 0.0 112.393 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 75' ' ' THR . . . -179.0 34.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.507 0.723 . . . . 0.0 111.064 -163.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.484 HD12 ' HE3' ' A' ' 62' ' ' LYS . 40.4 tp -74.25 141.45 45.37 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.22 0.608 . . . . 0.0 111.502 -169.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -154.78 175.92 13.12 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.947 0.899 . . . . 0.0 109.567 -170.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.16 143.59 43.18 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.199 0.909 . . . . 0.0 111.78 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.88 2.51 65.31 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.297 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.78 134.9 33.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.781 0.832 . . . . 0.0 110.09 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.38 106.14 17.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.109 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.16 107.23 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.2 m -96.44 106.38 18.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.499 0.72 . . . . 0.0 110.303 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.66 140.78 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.609 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 3.5 m-85 -129.6 134.97 26.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 42.3 Cg_endo -65.54 166.19 20.5 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.202 2.602 . . . . 0.0 112.634 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' HG23 ' A' ' 58' ' ' VAL . 73.8 Cg_endo . . . . . 0 C--N 1.366 1.499 0 C-N-CA 121.079 1.186 . . . . 0.0 109.199 170.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 0' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 47.3 p . . . . . 0 C--O 1.234 0.26 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.465 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 24.9 ptt? -104.23 132.23 50.71 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.024 0.93 . . . . 0.0 110.673 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -87.15 135.19 33.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -128.61 136.59 50.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.309 0.643 . . . . 0.0 110.654 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -88.93 95.98 10.53 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.65 103.91 16.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.0 mtp180 -94.34 117.18 29.73 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -103.13 139.71 38.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.777 0.831 . . . . 0.0 109.29 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -133.89 158.86 42.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.379 0.672 . . . . 0.0 109.852 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.554 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.02 -130.75 0.78 Allowed 'General case' 0 CA--C 1.565 1.527 0 O-C-N 124.363 1.039 . . . . 0.0 111.37 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.424 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 97.7 m -60.57 -48.08 83.34 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.662 0.665 . . . . 0.0 111.647 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.87 -24.7 53.63 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.817 0.447 . . . . 0.0 111.623 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.414 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -70.43 -53.39 16.63 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.294 0.637 . . . . 0.0 111.027 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 -22.29 59.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.864 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.477 HG11 ' HG ' ' A' ' 44' ' ' LEU . 42.8 t -59.43 -52.82 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.244 0.618 . . . . 0.0 110.342 168.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 93.8 t -75.13 -22.31 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.51 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 73.38 11.48 79.83 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.52 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -142.92 146.6 34.17 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.143 0.977 . . . . 0.0 108.58 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -90.12 -19.99 23.65 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.852 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.4 m -155.18 131.99 10.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.03 0.932 . . . . 0.0 108.716 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 pt -123.58 175.38 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.025 0.93 . . . . 0.0 108.64 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.88 112.25 15.76 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 167.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 -178.53 4.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.221 1.409 . . . . 0.0 109.629 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -156.1 111.48 2.95 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.39 174.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.8 p-10 -71.51 158.79 35.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.268 0.94 . . . . 0.0 110.322 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.67 -19.86 61.35 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.388 0.675 . . . . 0.0 112.088 -172.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.85 -21.12 37.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.476 0.31 . . . . 0.0 110.175 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 162.09 28.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.413 0.685 . . . . 0.0 111.216 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -137.86 -174.07 3.68 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.855 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -50.6 -37.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 125.626 1.57 . . . . 0.0 112.107 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.635 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.87 -38.61 65.28 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.299 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -66.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.232 0.613 . . . . 0.0 110.548 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.8 -60.41 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.572 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.43 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.87 -30.46 71.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.503 0.321 . . . . 0.0 110.982 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.598 ' HA ' HD11 ' A' ' 49' ' ' ILE . 26.0 tpt85 -52.91 -51.7 60.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.404 0.682 . . . . 0.0 111.507 171.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.1 m -75.99 -32.1 59.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.708 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.3 mm? -52.13 -48.57 64.77 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.723 0.809 . . . . 0.0 112.34 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 3.6 pt-20 -64.95 -26.31 68.25 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.0 -20.22 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.135 0.574 . . . . 0.0 111.104 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.35 -57.9 2.14 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.458 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.0 m-85 -91.82 108.55 20.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.84 -173.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.62 -22.0 65.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.353 0.661 . . . . 0.0 111.587 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.519 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.56 -8.68 87.14 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.028 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.67 ' HB3' HD13 ' A' ' 48' ' ' LEU . 88.9 mt -105.14 -6.89 19.46 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.699 0.799 . . . . 0.0 111.041 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.89 122.28 15.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.722 0.809 . . . . 0.0 113.142 -171.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.53 2.84 51.86 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 2.3 ptp180 -113.85 -4.37 13.33 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.67 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -114.5 -2.71 13.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.794 . . . . 0.0 110.357 174.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 35' ' ' ARG . 46.8 mt -135.26 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.99 1.316 . . . . 0.0 109.201 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 19.8 mm-40 -143.69 123.84 13.71 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.119 0.968 . . . . 0.0 109.15 160.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.35 30.87 20.18 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 124.353 1.061 . . . . 0.0 112.109 168.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.86 3.12 88.22 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 114.989 0.756 . . . . 0.0 114.989 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -116.41 -175.44 2.75 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.019 0.928 . . . . 0.0 108.702 170.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 m -63.2 -55.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.876 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 9.6 tppt? 153.22 139.69 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.377 0 C-N-CA 125.091 1.356 . . . . 0.0 109.062 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 22.2 Cg_endo -60.8 128.38 25.44 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.825 2.35 . . . . 0.0 111.928 166.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 72.1 m80 77.83 -1.69 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.337 1.455 . . . . 0.0 113.912 171.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 3.1 p -76.4 153.71 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 13.2 m120 -118.24 104.76 11.1 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.8 129.48 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.468 0.707 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.9 mp -121.66 140.18 52.62 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.803 1.241 . . . . 0.0 111.899 -166.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 63' ' ' ASN . 0.5 OUTLIER -119.34 107.56 13.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.824 1.249 . . . . 0.0 108.29 171.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.517 ' HB2' ' HZ3' ' A' ' 62' ' ' LYS . 65.0 t30 60.36 34.78 20.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.666 1.186 . . . . 0.0 110.328 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.87 -14.97 61.81 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.522 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HG3' HD21 ' A' ' 70' ' ' LEU . 19.8 tpp180 -94.27 111.66 23.4 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.42 0.61 . . . . 0.0 109.896 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.8 tt0 -67.89 108.36 2.99 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.851 0.86 . . . . 0.0 110.886 -173.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.05 -1.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.795 1.638 . . . . 0.0 114.552 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 m -71.16 -23.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.188 0.449 . . . . 0.0 110.582 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -88.72 -15.97 33.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.732 0.813 . . . . 0.0 110.828 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -135.39 -140.7 0.17 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.699 1.199 . . . . 0.0 108.789 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.81 119.02 25.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.746 1.157 . . . . 0.0 110.806 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.29 -43.12 39.87 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.688 0.617 . . . . 0.0 112.817 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.635 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.4 mmt -81.46 -39.95 24.06 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.73 69.26 1.03 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.401 0.62 . . . . 0.0 111.774 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 t -74.49 -67.82 0.59 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.98 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -174.99 33.7 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 110.887 -165.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.11 139.29 42.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.188 0.195 . . . . 0.0 110.851 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 33.9 t70 -144.32 -176.06 4.88 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.729 0.811 . . . . 0.0 108.835 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 30.8 t70 -70.19 147.8 49.4 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.422 0.556 . . . . 0.0 111.852 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.86 66.53 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.386 -0.824 . . . . 0.0 113.301 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 3.6 t0 -94.76 127.65 40.9 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 122.568 0.347 . . . . 0.0 110.608 -168.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.17 115.85 23.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.151 0.58 . . . . 0.0 111.438 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.75 106.99 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.8 m -84.09 147.96 27.08 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -142.45 147.08 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.696 0.76 . . . . 0.0 109.792 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.8 m-85 -133.82 142.77 44.83 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 40.3 Cg_endo -64.82 168.5 13.39 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.222 2.615 . . . . 0.0 111.374 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 48.4 Cg_endo . . . . . 0 C--N 1.371 1.751 0 C-N-CA 120.645 0.897 . . . . 0.0 111.249 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 0' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 23' ' ' ARG . 2.6 p . . . . . 0 C--O 1.241 0.648 0 CA-C-O 121.285 0.564 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.778 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -109.08 121.84 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.788 0.435 . . . . 0.0 110.135 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.51 146.66 28.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.527 0.731 . . . . 0.0 111.153 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -88.72 95.45 10.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.1 103.94 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.677 -0.639 . . . . 0.0 109.47 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 13.1 mtp180 -95.18 117.05 29.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.739 -176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -106.4 135.69 47.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.451 1.101 . . . . 0.0 108.926 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.75 160.46 31.64 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.12 0.568 . . . . 0.0 109.844 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.44 -121.03 1.22 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.994 1.318 . . . . 0.0 112.198 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.6 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 87.9 m -70.37 -44.56 67.83 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.866 0.866 . . . . 0.0 111.329 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -58.8 -28.43 65.97 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.636 0.374 . . . . 0.0 110.962 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -65.85 -52.17 52.71 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.75 0.656 . . . . 0.0 111.185 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.91 -27.11 60.88 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.481 0.488 . . . . 0.0 111.739 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 44' ' ' LEU . 39.2 t -59.08 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.474 0.709 . . . . 0.0 110.541 170.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 17' ' ' GLN . 96.7 t -74.66 -22.36 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.963 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 11.39 63.35 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.769 0.7 . . . . 0.0 112.891 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HB2' HG12 ' A' ' 15' ' ' VAL . 73.9 mt-30 -145.74 138.15 25.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.303 1.041 . . . . 0.0 108.312 -166.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -100.92 -29.22 12.33 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 m -154.9 113.62 3.57 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.7 pt -121.63 170.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.205 0.602 . . . . 0.0 110.806 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -111.47 125.21 53.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -121.89 123.18 41.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.122 0.969 . . . . 0.0 108.853 -176.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.49 ' HD2' ' HB ' ' A' ' 0' ' ' THR . 6.6 tpp85 -83.08 106.95 15.31 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.07 -179.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 0.0 109.526 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.23 159.7 24.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.394 0.677 . . . . 0.0 110.613 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.22 -26.03 68.33 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 110.522 168.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -80.24 -22.94 41.23 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.34 1.056 . . . . 0.0 110.553 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.24 43.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.294 0.637 . . . . 0.0 110.592 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 p -137.75 -174.64 3.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.118 0.967 . . . . 0.0 108.643 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 t -51.09 -35.96 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.996 0.918 . . . . 0.0 111.535 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA2' ' HE3' ' A' ' 73' ' ' MET . . . -67.6 -45.5 76.38 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.175 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.37 -35.37 78.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.951 0.9 . . . . 0.0 111.113 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.28 -60.79 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.16 0.984 . . . . 0.0 110.805 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.541 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 1.9 pp -67.39 -30.08 69.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.19 0.306 . . . . 0.0 111.404 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HA ' HD11 ' A' ' 49' ' ' ILE . 20.8 tpt180 -55.57 -49.74 71.93 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.376 0.608 . . . . 0.0 111.218 170.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -73.96 -32.48 63.49 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.148 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -57.28 -39.05 74.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.441 0.696 . . . . 0.0 112.42 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.1 pt-20 -75.67 -28.51 58.73 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 117.874 0.307 . . . . 0.0 111.691 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.64 -34.52 78.42 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.08 0.467 . . . . 0.0 110.467 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 15.5 mm-40 -79.0 -59.1 2.91 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.366 175.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 95.9 m-85 -99.21 122.03 41.85 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.799 -168.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.08 -40.66 96.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.052 0.941 . . . . 0.0 110.926 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 -16.37 64.27 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.323 -0.709 . . . . 0.0 114.218 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.567 ' O ' HD22 ' A' ' 48' ' ' LEU . 64.1 mt -95.39 -13.5 24.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.686 0.795 . . . . 0.0 111.833 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.07 120.8 9.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.52 -28.14 5.99 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.549 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 12.4 ptm180 -90.89 3.17 55.26 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -168.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -127.15 2.65 6.45 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.355 0.662 . . . . 0.0 110.962 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.577 HD11 ' HA ' ' A' ' 35' ' ' ARG . 69.6 mt -135.63 129.13 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.52 1.128 . . . . 0.0 108.352 170.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 1.2 tm-20 -150.62 128.59 11.79 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.0 t70 61.08 30.31 19.4 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.449 1.1 . . . . 0.0 110.85 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.51 -13.55 6.31 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.798 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.78 -173.41 2.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.915 0.886 . . . . 0.0 109.361 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 60' ' ' VAL . 17.0 m -60.23 -57.07 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.536 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.992 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 56' ' ' PRO . 12.8 tppt? 150.39 137.84 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 C-N-CA 124.986 1.314 . . . . 0.0 109.862 -175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 42.8 Cg_endo -65.91 141.31 64.27 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 123.435 2.756 . . . . 0.0 111.773 163.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 82.25 -23.78 0.2 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.768 1.627 . . . . 0.0 112.532 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.12 141.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.9 m120 -111.87 104.58 12.89 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 85' ' ' VAL . 2.7 m -115.93 140.64 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.639 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -132.22 146.94 52.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.796 1.239 . . . . 0.0 110.012 -166.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.688 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 17.9 tptm -106.08 104.54 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 164.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.87 41.41 32.05 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.314 1.046 . . . . 0.0 111.838 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.44 -11.53 71.89 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-N 115.244 -0.889 . . . . 0.0 114.551 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -99.87 106.43 18.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tt0 -64.11 114.2 4.02 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.162 0.985 . . . . 0.0 111.63 -170.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.409 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 22.8 m -73.78 -2.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -172.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 m -72.67 -7.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 118.24 0.473 . . . . 0.0 111.361 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -96.69 -16.66 20.81 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.877 0.871 . . . . 0.0 110.958 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.84 -154.01 0.58 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.676 1.19 . . . . 0.0 109.208 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.2 m-20 -61.36 108.59 0.96 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -70.88 -48.54 33.23 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.484 0.49 . . . . 0.0 112.228 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.481 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 73.9 mmm -80.76 -37.97 29.46 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.003 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.04 66.13 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -172.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.412 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -70.09 -70.19 0.31 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.449 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.99 35.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -159.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.78 135.9 43.57 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.644 -0.66 . . . . 0.0 112.566 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.52 175.17 9.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.538 1.535 . . . . 0.0 108.151 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.66 141.26 53.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.771 0.714 . . . . 0.0 111.039 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.75 -15.14 27.34 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.619 -0.718 . . . . 0.0 114.381 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.688 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 50.9 m-20 -69.37 134.15 48.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.313 0.645 . . . . 0.0 111.618 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.21 142.6 27.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.03 107.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 165.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.0 m -94.06 130.12 40.33 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 0.0 109.151 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 60' ' ' VAL . 23.0 m -130.53 138.73 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.722 0.692 . . . . 0.0 110.605 -174.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 64.1 m-85 -122.3 135.53 25.59 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.6 ' HG3' ' H ' ' A' ' 10' ' ' THR . 27.4 Cg_endo -58.96 168.04 4.89 Favored 'Trans proline' 0 C--N 1.364 1.369 0 C-N-CA 123.953 3.102 . . . . 0.0 114.075 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo . . . . . 0 C--N 1.378 2.098 0 C-N-CA 122.345 2.03 . . . . 0.0 111.374 174.1 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 0' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 36.8 p . . . . . 0 C--O 1.241 0.609 0 CA-C-O 120.915 0.388 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 24.8 ptt? -147.21 132.95 18.92 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -83.81 141.11 31.6 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.5 mt -141.64 129.79 22.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 109.514 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -88.86 101.16 13.77 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 mt -94.98 108.1 20.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 27.9 mtm180 -97.87 117.42 32.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.782 0.833 . . . . 0.0 109.743 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -102.51 135.15 44.66 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.332 1.053 . . . . 0.0 108.877 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -130.69 161.24 32.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.89 0.476 . . . . 0.0 110.069 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.08 -120.9 1.1 Allowed 'General case' 0 CA--C 1.564 1.506 0 O-C-N 124.509 1.131 . . . . 0.0 111.873 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 18.7 m -71.98 -41.61 67.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.302 0.641 . . . . 0.0 111.0 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -60.52 -26.66 67.03 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.579 0.351 . . . . 0.0 110.864 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -47.52 69.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.57 0.748 . . . . 0.0 111.086 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.14 -22.99 59.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.625 HG11 ' HG ' ' A' ' 44' ' ' LEU . 74.8 t -60.33 -55.44 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 171.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.5 -20.42 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.06 11.85 83.98 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.417 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -163.94 158.26 19.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.695 0.798 . . . . 0.0 110.66 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -85.05 -19.67 31.6 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 9.6 m -152.55 147.78 26.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 pt -137.07 174.02 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.399 1.08 . . . . 0.0 108.762 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -122.58 113.16 18.9 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 167.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.437 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -98.49 172.63 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.896 1.279 . . . . 0.0 109.377 171.27 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -153.68 106.12 2.86 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.291 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.36 173.2 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.22 1.408 . . . . 0.0 108.474 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 34.0 t70 -66.2 161.26 22.43 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.978 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.22 -22.48 59.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.124 0.57 . . . . 0.0 111.745 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -81.0 -16.43 53.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.68 0.392 . . . . 0.0 110.65 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.86 151.49 41.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.324 0.65 . . . . 0.0 109.61 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.4 p -130.39 -174.74 3.43 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.901 0.881 . . . . 0.0 109.954 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.0 t -50.84 -37.04 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 124.578 1.151 . . . . 0.0 111.479 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.87 -39.78 64.5 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.802 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.26 -31.7 71.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.933 0.493 . . . . 0.0 110.52 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.74 -59.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.542 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.472 HD21 HG12 ' A' ' 54' ' ' VAL . 1.7 pp -64.26 -31.15 72.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.799 0.272 . . . . 0.0 111.093 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.533 ' HA ' HD11 ' A' ' 49' ' ' ILE . 9.1 tpt180 -51.77 -50.25 61.07 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.264 0.554 . . . . 0.0 111.353 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -75.82 -32.02 59.63 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.313 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.94 -39.06 68.48 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.2 pt-20 -73.95 -29.71 62.14 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.65 0.262 . . . . 0.0 111.63 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.69 65.51 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.57 0.748 . . . . 0.0 110.895 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.437 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 21.4 mm-40 -95.39 -58.71 2.06 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.431 1.092 . . . . 0.0 109.944 172.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.89 116.0 28.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.09 -30.49 70.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.953 0.901 . . . . 0.0 110.541 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.9 -20.17 77.49 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.956 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.717 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.1 mt -99.3 -1.66 38.41 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.713 0.805 . . . . 0.0 111.842 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.14 120.43 10.31 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.5 -7.64 17.79 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -100.16 4.57 44.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.029 0.914 . . . . 0.0 111.328 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.717 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.0 -5.96 8.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.579 1.152 . . . . 0.0 110.605 -177.34 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 35' ' ' ARG . 55.3 mt -133.02 138.6 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.681 1.193 . . . . 0.0 108.569 169.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 8.5 tp10 -144.9 124.87 13.51 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.649 0.78 . . . . 0.0 109.102 169.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.4 t70 58.95 31.79 21.66 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.432 1.093 . . . . 0.0 111.728 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.44 -14.74 57.17 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.168 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.09 -174.44 2.54 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.858 0.863 . . . . 0.0 109.185 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.472 HG12 HD21 ' A' ' 34' ' ' LEU . 34.0 m -62.83 -54.97 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 CA-C-O 118.11 -0.947 . . . . 0.0 112.829 -170.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 11.5 tppt? 151.61 139.61 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.388 0 C-N-CA 125.789 1.635 . . . . 0.0 107.879 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.47 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 21.9 Cg_endo -58.58 125.57 18.73 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.83 2.353 . . . . 0.0 111.636 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 73.41 1.4 3.97 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.66 1.184 . . . . 0.0 113.944 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.465 HG23 ' HD3' ' A' ' 88' ' ' PRO . 5.1 p -74.28 117.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 5.1 m-20 -80.83 103.62 10.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 85' ' ' VAL . 2.9 m -123.73 131.98 72.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -175.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 3.7 mp -121.88 172.14 8.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.254 1.022 . . . . 0.0 111.208 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.582 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 16.7 tptp -159.53 108.68 1.84 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 54.85 34.42 21.99 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.798 0.839 . . . . 0.0 110.237 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.9 13.98 82.51 Favored Glycine 0 C--N 1.352 1.465 0 N-CA-C 115.005 0.762 . . . . 0.0 115.005 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -119.67 121.25 38.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.797 0.839 . . . . 0.0 108.802 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.6 tt0 -75.91 110.14 10.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.405 0.682 . . . . 0.0 110.677 -171.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.512 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 17.5 m -70.54 -0.96 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -174.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 m -70.25 -16.5 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 118.104 0.411 . . . . 0.0 110.885 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -95.33 1.15 54.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.1 0.96 . . . . 0.0 111.26 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.47 -153.84 0.44 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.795 0.838 . . . . 0.0 109.773 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.54 108.58 0.99 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.0 0.52 . . . . 0.0 111.314 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -67.37 -50.6 43.29 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.568 0.543 . . . . 0.0 113.627 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 79.1 mmm -80.48 -39.64 27.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.089 0.556 . . . . 0.0 111.821 -170.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.84 76.62 1.54 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.912 0.863 . . . . 0.0 111.058 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.504 HG21 ' HG2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -81.64 -71.61 0.47 Allowed 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.149 177.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 75' ' ' THR . . . -175.16 34.67 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.599 0.76 . . . . 0.0 110.931 -163.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.582 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 21.0 tp -73.86 149.89 41.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.991 0.424 . . . . 0.0 110.54 -170.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.5 171.7 19.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 109.297 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.1 p-10 -70.39 146.62 50.29 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.347 0.659 . . . . 0.0 112.059 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.95 16.31 63.88 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.254 -0.885 . . . . 0.0 114.019 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.74 163.15 24.71 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.498 0.649 . . . . 0.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.38 95.33 4.43 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.638 0.732 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.8 t -86.53 138.56 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.919 1.288 . . . . 0.0 109.142 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 17.9 m -117.25 161.25 19.8 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.459 0.572 . . . . 0.0 110.653 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 60' ' ' VAL . 35.3 m -146.79 141.73 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.196 0.998 . . . . 0.0 109.197 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.63 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 7.5 m-85 -135.28 133.7 20.79 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 175.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.473 ' HG3' ' H ' ' A' ' 10' ' ' THR . 23.6 Cg_endo -60.92 155.87 47.22 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.067 2.511 . . . . 0.0 112.565 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD3' HG23 ' A' ' 58' ' ' VAL . 97.8 Cg_endo . . . . . 0 C--N 1.367 1.536 0 C-N-CA 122.565 2.177 . . . . 0.0 111.869 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 54.9 p . . . . . 0 C--O 1.238 0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.613 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.0 ptt? -105.34 135.97 45.74 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.823 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' TRP . 42.8 tt0 -94.85 129.75 41.71 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.657 0.783 . . . . 0.0 109.005 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 143.78 50.49 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.074 0.397 . . . . 0.0 111.221 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 36.1 tt0 -89.53 101.15 13.83 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.69 104.44 16.54 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 25.4 mtp180 -91.38 118.8 30.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.17 136.06 45.37 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.988 0.915 . . . . 0.0 109.387 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.66 161.56 30.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.083 0.553 . . . . 0.0 109.851 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.491 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.45 -129.92 1.33 Allowed 'General case' 0 CA--C 1.561 1.366 0 O-C-N 124.359 1.037 . . . . 0.0 111.238 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.437 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 4.3 m -64.04 -40.62 96.71 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 123.394 0.677 . . . . 0.0 111.747 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.487 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -67.54 -49.05 65.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.236 0.615 . . . . 0.0 110.626 -178.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.92 -18.03 60.95 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.82 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.465 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -66.02 -54.43 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.178 0.513 . . . . 0.0 110.253 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.55 -17.35 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.884 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.487 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 70.71 11.95 69.81 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.536 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -140.07 138.14 35.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.798 1.239 . . . . 0.0 109.146 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -82.68 -21.09 35.05 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.733 0.646 . . . . 0.0 110.707 172.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 11.6 m -154.65 149.81 26.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.628 1.171 . . . . 0.0 108.799 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 15.5 pt -135.26 178.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.129 0.972 . . . . 0.0 109.055 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -125.81 112.22 15.77 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.434 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -96.38 179.1 5.14 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.98 1.312 . . . . 0.0 109.921 174.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.0 ttp-105 -157.23 107.07 2.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.219 0.533 . . . . 0.0 109.942 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.84 176.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.684 1.194 . . . . 0.0 109.141 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -54.3 144.97 18.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.348 1.059 . . . . 0.0 110.014 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.99 -31.86 71.86 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.63 -7.51 59.6 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.593 0.757 . . . . 0.0 111.498 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.73 159.84 29.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.766 0.426 . . . . 0.0 109.853 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.8 p -130.96 179.2 6.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.986 0.515 . . . . 0.0 110.715 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.57 -35.79 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.609 1.164 . . . . 0.0 112.137 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.597 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.71 -37.47 67.01 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.741 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.46 -36.76 84.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.449 0.7 . . . . 0.0 110.927 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.14 -59.98 3.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.612 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.555 HD21 HG12 ' A' ' 54' ' ' VAL . 2.5 pp -63.7 -30.45 71.55 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.933 0.333 . . . . 0.0 111.315 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HA ' HD11 ' A' ' 49' ' ' ILE . 22.4 tpt180 -53.4 -48.73 68.42 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.004 0.431 . . . . 0.0 111.511 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.21 -32.8 61.29 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.533 0.333 . . . . 0.0 111.547 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 3.1 mm? -56.08 -34.54 66.08 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.6 0.76 . . . . 0.0 112.837 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -76.8 -26.09 54.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.91 -30.75 65.69 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.936 0.494 . . . . 0.0 110.51 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 15.8 mm-40 -79.79 -58.92 2.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.212 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.4 118.25 36.26 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.718 -169.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.09 -28.55 67.45 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.106 0.562 . . . . 0.0 110.192 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.21 -2.29 82.94 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.861 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.59 ' HB3' HD13 ' A' ' 48' ' ' LEU . 87.4 mt -114.65 2.84 14.61 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.578 0.689 . . . . 0.0 110.3 171.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.6 123.62 23.58 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.964 0.505 . . . . 0.0 111.886 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.85 8.19 87.75 Favored Glycine 0 N--CA 1.48 1.625 0 N-CA-C 115.176 0.831 . . . . 0.0 115.176 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.9 ptp180 -125.96 2.16 7.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.744 0.818 . . . . 0.0 111.422 -173.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.59 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -128.5 -8.89 5.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.427 1.091 . . . . 0.0 110.724 -176.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 35' ' ' ARG . 31.2 mt -130.26 132.49 65.01 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 C-N-CA 124.867 1.267 . . . . 0.0 108.653 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.32 108.45 8.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.395 0.678 . . . . 0.0 109.798 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.2 t70 57.56 31.29 20.09 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.293 1.037 . . . . 0.0 111.666 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.0 0.66 71.1 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.6 -174.69 2.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.085 0.942 . . . . 0.0 108.721 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.555 HG12 HD21 ' A' ' 34' ' ' LEU . 15.0 m -65.1 -56.3 16.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 CA-C-O 117.537 -1.22 . . . . 0.0 112.015 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.2 tppt? 151.18 136.32 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 C-N-CA 124.667 1.187 . . . . 0.0 108.746 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.86 128.12 27.81 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.936 2.424 . . . . 0.0 111.08 164.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 82.42 -14.82 0.73 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.349 1.46 . . . . 0.0 114.251 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -70.12 126.46 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.4 m120 -94.82 103.45 15.34 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -120.68 134.23 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.095 0.474 . . . . 0.0 109.94 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.1 mp -119.59 171.68 8.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.885 1.274 . . . . 0.0 111.738 -170.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -158.16 104.2 1.86 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.776 -177.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 15.3 t-20 56.47 36.47 27.61 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.455 1.102 . . . . 0.0 110.243 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.58 -13.24 67.13 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.719 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.406 ' HG3' HD21 ' A' ' 70' ' ' LEU . 7.1 tpp180 -97.41 119.9 36.79 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.413 0.685 . . . . 0.0 109.936 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 25.3 tt0 -79.55 106.47 11.6 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.769 -173.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -68.51 -1.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.374 1.469 . . . . 0.0 114.489 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.47 -21.61 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 117.857 0.299 . . . . 0.0 111.169 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -87.25 -19.34 28.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.979 0.912 . . . . 0.0 110.791 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.406 HD21 ' HG3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -131.81 -139.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.612 1.165 . . . . 0.0 108.423 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.2 109.42 17.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.953 0.797 . . . . 0.0 110.206 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.85 -38.77 65.53 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.354 0.409 . . . . 0.0 112.871 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.597 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.9 mmt -81.58 -37.17 28.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.26 77.57 1.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.4 t -81.51 -66.5 0.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' H ' HG23 ' A' ' 75' ' ' THR . . . -178.27 33.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 -165.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.62 141.81 46.54 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.844 -0.535 . . . . 0.0 111.144 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.43 -175.98 4.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.313 1.045 . . . . 0.0 108.909 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.613 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.0 p30 -80.02 148.86 30.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.087 0.555 . . . . 0.0 111.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.67 61.75 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.708 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.34 141.97 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.19 0.596 . . . . 0.0 111.566 -170.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.61 109.84 22.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.88 0.472 . . . . 0.0 110.854 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -100.23 107.09 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.448 0.699 . . . . 0.0 109.285 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 61.4 m -87.07 148.13 25.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.121 0.569 . . . . 0.0 109.934 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 m -143.37 148.31 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.346 0.659 . . . . 0.0 110.241 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 25.5 m-85 -136.7 135.72 20.71 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 23.7 Cg_endo -59.71 164.47 11.5 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 124.012 3.141 . . . . 0.0 113.505 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.38 2.203 0 C-N-CA 122.297 1.998 . . . . 0.0 112.804 -178.595 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 62.8 p . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 21.4 ptt? -116.34 133.62 55.81 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.001 0.92 . . . . 0.0 110.976 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.91 132.99 36.08 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.214 1.006 . . . . 0.0 110.139 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.3 mt -132.64 139.07 47.58 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.515 0.726 . . . . 0.0 110.437 -168.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -89.37 102.32 14.99 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.543 HD13 HD21 ' A' ' 37' ' ' LEU . 36.4 mt -93.24 104.07 16.28 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.545 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 12.4 mtp180 -95.58 117.9 31.3 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.993 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.67 138.33 44.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.915 0.886 . . . . 0.0 109.76 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -132.01 156.07 46.9 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.307 0.643 . . . . 0.0 109.32 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.36 -128.12 1.72 Allowed 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.845 1.258 . . . . 0.0 112.818 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.521 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 84.8 m -55.92 -49.59 73.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.148 0.979 . . . . 0.0 111.862 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -64.19 -23.12 67.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.685 0.394 . . . . 0.0 111.006 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.606 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -69.21 -48.25 62.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.187 0.595 . . . . 0.0 110.962 178.371 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -22.78 59.38 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.379 0.424 . . . . 0.0 111.675 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 44' ' ' LEU . 78.5 t -59.64 -56.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.594 0.711 . . . . 0.0 110.587 170.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.0 t -73.78 -22.07 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.376 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.606 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 71.01 11.05 69.52 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.938 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -142.37 145.33 33.76 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.848 0.859 . . . . 0.0 109.21 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -86.56 -19.32 29.59 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.572 178.06 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 13.6 m -155.0 139.93 17.28 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 162.98 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.129 0.972 . . . . 0.0 108.882 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.0 112.75 24.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.429 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -103.37 178.05 4.67 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.447 1.499 . . . . 0.0 109.514 174.399 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -157.61 110.56 2.46 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.792 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.02 179.89 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.72 150.93 18.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.332 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.89 -35.0 69.62 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.524 1.129 . . . . 0.0 111.438 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.93 -13.3 59.02 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.768 0.827 . . . . 0.0 110.375 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 166.96 4.96 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.972 0.909 . . . . 0.0 111.353 172.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.8 p -135.98 -177.62 4.78 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.604 0.762 . . . . 0.0 110.1 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 77' ' ' LEU . 80.2 t -52.01 -37.84 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 C-N-CA 123.8 0.84 . . . . 0.0 110.757 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.659 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.49 -37.98 69.23 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.449 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.89 -29.82 68.18 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.046 0.539 . . . . 0.0 110.624 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.8 t -65.36 -60.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.577 0.751 . . . . 0.0 110.202 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.0 -30.31 71.4 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.794 0.27 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 49' ' ' ILE . 19.7 tpt180 -52.83 -46.96 67.99 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.28 0.562 . . . . 0.0 111.388 169.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.5 m -75.03 -32.43 61.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.708 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.543 HD21 HD13 ' A' ' 5' ' ' LEU . 3.5 mm? -59.18 -31.9 69.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB3' HD21 ' A' ' 48' ' ' LEU . 16.6 pt-20 -77.74 -28.48 50.76 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.426 0.557 . . . . 0.0 111.365 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.74 72.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.0 0.52 . . . . 0.0 111.084 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -85.96 -58.8 2.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.506 0.723 . . . . 0.0 110.58 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 95.0 m-85 -95.12 116.32 28.58 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.632 -171.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.99 -32.74 74.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.161 0.985 . . . . 0.0 111.225 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.502 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.69 -5.76 83.91 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.673 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.666 ' HB3' HD13 ' A' ' 48' ' ' LEU . 58.4 mt -106.56 3.04 26.58 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.573 0.687 . . . . 0.0 111.444 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.86 121.04 14.61 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 5.88 59.67 Favored Glycine 0 C--N 1.358 1.782 0 N-CA-C 115.773 1.069 . . . . 0.0 115.773 171.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.7 ptp180 -113.12 5.15 16.95 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.017 0.927 . . . . 0.0 111.337 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.666 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -126.27 -8.74 6.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.708 1.203 . . . . 0.0 110.36 -178.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 35' ' ' ARG . 33.5 mt -128.78 137.28 57.7 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 125.266 1.426 . . . . 0.0 108.402 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 16.1 mm-40 -128.9 107.95 10.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.525 0.73 . . . . 0.0 109.416 160.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 52.91 41.56 31.96 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.009 1.323 . . . . 0.0 112.873 171.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -7.1 78.03 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.988 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -110.5 -174.8 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.83 0.815 . . . . 0.0 109.1 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -70.14 -56.39 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.013 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 tppt? 152.49 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.434 0 C-N-CA 124.919 1.288 . . . . 0.0 109.392 -175.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.458 ' HD2' ' HG3' ' A' ' 50' ' ' GLU . 36.5 Cg_endo -63.11 131.91 34.42 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.077 2.518 . . . . 0.0 111.724 166.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 m170 76.73 -2.93 2.61 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 124.859 1.264 . . . . 0.0 113.682 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.4 p -75.9 154.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 35.8 m-80 -121.03 103.56 9.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 67' ' ' VAL . 4.4 m -117.0 147.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.755 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.1 mp -132.13 172.51 12.3 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.052 1.341 . . . . 0.0 110.375 -163.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.513 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 17.6 tptp -157.82 105.33 1.99 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.143 1.377 . . . . 0.0 107.534 -172.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.92 35.02 14.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.484 1.114 . . . . 0.0 110.744 -168.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.76 -14.18 59.06 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.361 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -83.63 116.67 22.73 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.91 0.855 . . . . 0.0 110.087 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 23.0 tt0 -73.85 107.07 5.86 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.068 -171.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.529 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.2 m -75.52 -0.98 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 58' ' ' VAL . 17.1 m -70.62 -14.98 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.946 0.794 . . . . 0.0 111.342 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -85.38 -27.17 26.01 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.628 0.771 . . . . 0.0 110.722 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -130.3 -152.22 0.5 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.119 0.968 . . . . 0.0 109.868 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.28 108.91 1.72 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.206 0.602 . . . . 0.0 111.334 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.529 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.63 -43.1 12.45 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.774 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.659 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.5 mmt -74.52 -39.49 62.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.121 0.569 . . . . 0.0 111.957 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.3 79.02 1.39 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.195 0.521 . . . . 0.0 111.496 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.419 HG21 ' HG2' ' A' ' 62' ' ' LYS . 2.2 t -81.78 -62.35 1.66 Allowed 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.882 175.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 176.06 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.67 1.188 . . . . 0.0 110.034 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 30' ' ' VAL . 1.2 tm? -73.91 113.68 11.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.55 0.74 . . . . 0.0 110.727 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.82 -178.19 4.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.229 1.411 . . . . 0.0 109.516 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.2 p-10 -66.42 150.36 49.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 112.362 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.21 13.43 64.75 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.239 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.85 156.99 33.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 117.446 0.623 . . . . 0.0 111.176 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 6' ' ' ARG . . . -115.63 94.31 4.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.438 0.695 . . . . 0.0 109.297 171.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.26 106.37 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 48.9 m -93.11 146.35 23.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.376 0.671 . . . . 0.0 109.718 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 m -140.94 141.79 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.693 0.759 . . . . 0.0 110.199 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.7 m-85 -128.7 136.67 29.5 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.521 ' HG3' ' H ' ' A' ' 10' ' ' THR . 54.5 Cg_endo -62.75 169.37 8.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.165 3.243 . . . . 0.0 112.792 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo . . . . . 0 C--N 1.381 2.256 0 N-CA-C 108.962 -1.207 . . . . 0.0 108.962 176.157 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.442 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.8 ptt? -132.65 145.22 50.9 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.826 0.85 . . . . 0.0 109.443 174.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.33 113.42 26.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.996 0.519 . . . . 0.0 110.473 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 77' ' ' LEU . 21.8 mt -104.6 143.53 32.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.858 0.863 . . . . 0.0 111.018 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.53 101.09 13.77 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.58 0.352 . . . . 0.0 110.146 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.2 mt -93.8 105.55 17.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.26 0.552 . . . . 0.0 110.332 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 61.4 mtp180 -91.5 124.18 35.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.62 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -112.32 137.82 49.93 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.561 0.745 . . . . 0.0 109.013 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -132.5 161.16 34.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.874 0.47 . . . . 0.0 110.454 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 56.28 -128.03 1.97 Allowed 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.631 1.172 . . . . 0.0 112.16 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 32.7 m -59.5 -49.79 76.42 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.778 0.831 . . . . 0.0 111.609 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -59.8 -24.05 63.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.937 0.495 . . . . 0.0 111.352 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 ttp85 -68.71 -51.05 45.7 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.57 -21.85 60.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.529 0.332 . . . . 0.0 111.257 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.45 HG11 ' HG ' ' A' ' 44' ' ' LEU . 76.0 t -61.12 -55.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 0.0 110.07 170.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -77.87 -16.86 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.723 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.56 11.73 62.84 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.088 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -139.75 146.96 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.006 0.922 . . . . 0.0 110.007 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -104.36 -19.04 14.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.013 0.925 . . . . 0.0 110.998 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.5 m -153.74 138.36 16.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.949 0.9 . . . . 0.0 108.971 165.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.8 pt -133.37 178.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.821 0.848 . . . . 0.0 109.734 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -125.09 112.84 16.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.89 132.64 51.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 108.54 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -96.8 112.74 24.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 m -113.61 -179.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.83 166.26 22.62 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.019 0.372 . . . . 0.0 110.548 174.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.63 -31.58 72.86 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.625 0.77 . . . . 0.0 112.377 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.86 -17.16 51.62 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.828 0.451 . . . . 0.0 110.832 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 147.14 37.04 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.724 0.81 . . . . 0.0 112.183 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.5 p -134.03 -174.64 3.6 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.942 0.897 . . . . 0.0 109.097 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.0 t -52.36 -42.06 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.65 0.78 . . . . 0.0 111.464 -175.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.63 94.77 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.363 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.09 -34.43 76.41 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.262 0.553 . . . . 0.0 110.45 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.95 -57.8 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.246 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.642 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.2 pp -70.07 -30.66 67.96 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -64.94 -35.29 80.67 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.715 0.689 . . . . 0.0 110.49 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -75.84 -33.04 60.02 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.422 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -61.89 -39.43 91.95 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.935 0.494 . . . . 0.0 111.722 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 4.8 pt-20 -73.11 -26.26 61.17 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.95 63.72 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.077 0.551 . . . . 0.0 111.328 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -96.5 -59.19 1.87 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.943 0.878 . . . . 0.0 109.306 173.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -95.83 106.95 19.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.094 -171.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.38 -27.04 69.03 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.202 0.601 . . . . 0.0 111.048 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.58 -5.01 62.69 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.826 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.668 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.7 mt -111.3 -6.86 14.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.377 0.671 . . . . 0.0 111.481 172.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.3 120.03 8.51 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.56 5.66 56.51 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -96.62 -32.78 12.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.579 0.751 . . . . 0.0 109.583 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -98.13 2.03 48.15 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.219 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.22 139.0 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.603 1.161 . . . . 0.0 109.469 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.55 129.76 11.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.64 31.11 12.05 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.144 1.378 . . . . 0.0 112.035 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.62 -9.72 41.73 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.127 -0.818 . . . . 0.0 114.76 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -93.67 -174.42 3.46 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.179 0.989 . . . . 0.0 108.902 168.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG12 HD21 ' A' ' 34' ' ' LEU . 28.6 m -64.14 -55.32 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.417 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HG2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 tppt? 153.6 137.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 C-N-CA 125.175 1.39 . . . . 0.0 109.491 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.27 128.35 29.77 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.665 2.91 . . . . 0.0 111.981 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 76.35 -6.73 1.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.5 1.52 . . . . 0.0 113.874 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.17 141.85 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 40.6 m-80 -111.8 104.13 12.43 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 85' ' ' VAL . 4.9 m -113.34 136.05 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -127.74 148.53 50.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.036 1.334 . . . . 0.0 110.209 -168.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -112.38 105.43 13.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 59.44 35.87 23.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.059 0.944 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.08 -13.79 65.28 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.765 -0.652 . . . . 0.0 114.247 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -90.45 102.14 14.87 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.6 tt0 -64.79 106.2 1.16 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.859 0.864 . . . . 0.0 111.015 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.87 -1.35 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 66' ' ' GLU . 15.2 m -70.83 -12.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 118.09 0.405 . . . . 0.0 111.554 171.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -93.63 -20.97 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.569 0.748 . . . . 0.0 110.779 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.62 -153.14 0.54 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.604 1.162 . . . . 0.0 109.076 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.0 m-20 -59.64 109.34 0.89 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.266 0.626 . . . . 0.0 111.116 172.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.98 -46.33 7.15 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 123.321 0.388 . . . . 0.0 112.246 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 89.4 mmm -80.73 -20.16 43.41 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.44 79.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.898 0.317 . . . . 0.0 111.614 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -76.58 -74.97 0.21 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' H ' HG23 ' A' ' 75' ' ' THR . . . -176.68 35.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.492 0.317 . . . . 0.0 111.572 -164.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 3' ' ' LEU . 18.2 mt -73.7 150.13 41.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.553 0.692 . . . . 0.0 112.435 -170.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -154.23 179.7 8.72 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.723 1.609 . . . . 0.0 107.628 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 31.9 t70 -63.99 129.33 39.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.019 0.528 . . . . 0.0 111.906 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.96 6.22 82.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.133 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.01 122.22 27.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.602 0.761 . . . . 0.0 111.413 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.67 125.08 32.19 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.252 0.621 . . . . 0.0 111.734 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.36 107.63 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.684 0.794 . . . . 0.0 109.721 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.716 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.0 m -85.83 152.1 23.28 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.394 0.677 . . . . 0.0 110.191 175.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 60' ' ' VAL . 16.2 m -141.49 147.0 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.418 0.628 . . . . 0.0 109.946 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 42.3 m-85 -135.33 134.24 21.14 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 174.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 29.8 Cg_endo -59.42 164.64 10.61 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.841 3.028 . . . . 0.0 114.025 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HG3' ' HG2' ' A' ' 55' ' ' LYS . 15.4 Cg_exo . . . . . 0 C--N 1.38 2.215 0 C-N-CA 122.662 2.241 . . . . 0.0 111.166 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 0' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 25' ' ' ASP . 29.7 p . . . . . 0 C--O 1.238 0.499 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.496 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 23.7 ptt? -114.63 132.01 56.52 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.581 1.153 . . . . 0.0 110.695 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -84.42 128.57 34.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.275 0.63 . . . . 0.0 109.533 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.3 mt -127.46 137.08 52.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.475 0.71 . . . . 0.0 110.467 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -89.69 101.54 14.23 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.435 HD13 HD21 ' A' ' 37' ' ' LEU . 36.3 mt -93.33 107.42 19.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtt-85 -96.31 120.45 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.302 1.041 . . . . 0.0 109.778 -176.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.44 134.42 50.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.515 1.126 . . . . 0.0 109.251 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -128.68 162.55 27.09 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.979 0.512 . . . . 0.0 109.904 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.8 -122.6 0.91 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.493 1.117 . . . . 0.0 111.497 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.514 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 54.5 m -68.94 -45.77 69.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 111.408 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -57.19 -27.91 62.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.03 0.532 . . . . 0.0 111.335 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -64.57 -53.6 45.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.538 0.735 . . . . 0.0 111.34 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -21.76 60.43 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.345 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.511 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -61.71 -49.99 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.026 0.531 . . . . 0.0 110.606 169.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.94 -15.5 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.728 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.68 83.32 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.049 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -166.93 155.76 10.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.218 1.007 . . . . 0.0 110.156 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -89.75 -13.27 37.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 8.8 m -155.22 147.53 23.85 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.193 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -140.78 172.22 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.61 1.164 . . . . 0.0 108.703 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -118.35 112.78 20.47 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -92.1 -179.19 5.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.832 1.253 . . . . 0.0 108.937 167.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -156.73 110.16 2.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 176.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.363 1.065 . . . . 0.0 108.472 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HA ' HG22 ' A' ' 0' ' ' THR . 6.9 t70 -68.76 157.1 37.08 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 122.995 0.518 . . . . 0.0 110.031 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.68 -18.69 60.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.715 0.406 . . . . 0.0 110.728 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.39 -23.83 37.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.297 0.639 . . . . 0.0 109.723 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.52 147.87 47.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.476 0.71 . . . . 0.0 109.668 171.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -132.08 -174.37 3.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.263 1.025 . . . . 0.0 109.8 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.3 p -50.72 -36.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.644 1.178 . . . . 0.0 112.646 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.566 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -71.05 -41.02 61.48 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.379 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.9 -29.49 65.57 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.792 0.296 . . . . 0.0 110.521 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.7 t -59.37 -60.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.455 0.702 . . . . 0.0 109.831 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.575 HD21 HG12 ' A' ' 54' ' ' VAL . 2.4 pp -66.57 -30.76 71.14 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 123.11 0.257 . . . . 0.0 111.334 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.508 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.5 tpt180 -56.0 -46.65 78.66 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.36 0.6 . . . . 0.0 111.629 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -75.2 -32.97 61.35 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.356 0.662 . . . . 0.0 111.773 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -56.45 -45.03 81.04 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.701 0.801 . . . . 0.0 112.152 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 9.5 pt-20 -64.16 -29.8 70.9 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.61 0.569 . . . . 0.0 112.283 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.86 -22.67 67.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.957 0.503 . . . . 0.0 111.63 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -97.13 -57.97 2.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.008 0.909 . . . . 0.0 109.169 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.65 105.47 17.84 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.807 -173.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.3 -32.14 72.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.393 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.917 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.663 ' HB3' HD13 ' A' ' 48' ' ' LEU . 81.5 mt -103.09 -11.66 17.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.863 0.865 . . . . 0.0 111.271 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -57.28 121.55 10.41 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.366 0.667 . . . . 0.0 112.517 -173.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.59 -19.93 8.31 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 171.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.76 0.72 57.47 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.466 0.633 . . . . 0.0 111.655 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -124.02 5.58 8.62 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 110.29 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 35' ' ' ARG . 17.5 mt -140.75 142.47 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 124.639 1.176 . . . . 0.0 109.244 172.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -145.76 116.68 7.76 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.463 0.705 . . . . 0.0 110.125 164.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 55.92 31.56 18.07 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.221 1.008 . . . . 0.0 111.826 172.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.39 82.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -106.9 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.096 0.948 . . . . 0.0 108.785 165.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 34' ' ' LEU . 15.8 m -64.29 -55.39 21.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 CA-C-O 117.595 -1.193 . . . . 0.0 112.13 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? 150.02 132.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 C-N-CA 125.212 1.405 . . . . 0.0 107.601 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -61.11 140.61 90.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.727 2.285 . . . . 0.0 111.593 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 80.16 -21.33 0.33 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.509 1.524 . . . . 0.0 113.504 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.411 HG23 ' HD3' ' A' ' 88' ' ' PRO . 1.1 p -72.61 152.51 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 29.9 m-80 -119.89 103.83 9.67 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.3 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.461 0.704 . . . . 0.0 109.55 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.6 mp -121.12 131.29 54.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.925 1.29 . . . . 0.0 110.725 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HD3' ' HG ' ' A' ' 77' ' ' LEU . 8.4 tptm -105.59 111.73 24.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.15 0.98 . . . . 0.0 109.057 171.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.4 t30 57.3 34.83 25.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.594 1.158 . . . . 0.0 110.577 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -4.51 86.04 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.41 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -102.37 114.23 28.23 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.944 0.897 . . . . 0.0 109.157 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 18.3 tt0 -70.63 110.26 5.36 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.363 0.665 . . . . 0.0 111.292 -171.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.02 -1.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.2 m -68.3 -19.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.109 0.413 . . . . 0.0 111.527 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -85.39 -16.26 40.42 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.924 0.89 . . . . 0.0 110.963 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.24 -152.72 0.44 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.42 1.088 . . . . 0.0 109.334 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.61 108.2 0.94 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.957 0.503 . . . . 0.0 110.551 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.01 -29.06 24.07 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.794 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.566 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.5 mmt -80.85 -37.94 29.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.503 0.721 . . . . 0.0 112.147 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.78 85.34 1.17 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.1 t -82.01 -70.79 0.52 Allowed 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.554 0.742 . . . . 0.0 112.271 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.454 ' H ' HG23 ' A' ' 75' ' ' THR . . . 179.77 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.458 1.103 . . . . 0.0 110.209 -163.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.29 114.86 13.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -116.85 179.76 3.92 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.359 0.664 . . . . 0.0 110.433 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 7.8 p-10 -73.09 142.32 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.56 0.744 . . . . 0.0 111.286 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.63 18.3 78.54 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.314 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -96.61 141.78 29.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.439 0.696 . . . . 0.0 111.785 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.54 109.35 22.12 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.167 0.987 . . . . 0.0 110.711 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.13 107.29 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.2 m -83.92 150.49 25.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.77 0.828 . . . . 0.0 110.093 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.12 145.63 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.466 0.706 . . . . 0.0 109.491 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 19.4 m-85 -137.33 135.06 19.02 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.514 ' HG3' ' H ' ' A' ' 10' ' ' THR . 29.3 Cg_endo -61.2 165.61 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 123.96 3.107 . . . . 0.0 113.688 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 58' ' ' VAL . 41.2 Cg_endo . . . . . 0 C--N 1.378 2.107 0 C-N-CA 122.608 2.205 . . . . 0.0 112.491 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -147.27 145.64 29.47 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.586 0.754 . . . . 0.0 109.495 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -89.3 141.11 28.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.67 138.15 44.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.575 0.75 . . . . 0.0 109.264 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -89.37 104.5 17.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.429 HD13 HD21 ' A' ' 37' ' ' LEU . 28.2 mt -93.72 104.26 16.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 79.9 mtt180 -92.05 117.39 29.79 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.533 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.54 137.59 42.16 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.907 0.883 . . . . 0.0 109.227 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -130.22 160.55 33.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.896 0.478 . . . . 0.0 110.59 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 57.95 -119.0 1.1 Allowed 'General case' 0 CA--C 1.56 1.332 0 O-C-N 124.783 1.302 . . . . 0.0 112.238 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.622 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 8.6 m -70.99 -47.45 58.78 Favored 'General case' 0 C--N 1.361 1.067 0 CA-C-N 118.415 0.552 . . . . 0.0 110.437 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -58.04 -26.61 62.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.051 0.54 . . . . 0.0 111.056 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -66.55 -54.42 23.85 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.223 0.609 . . . . 0.0 111.386 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -17.64 60.87 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.635 0.585 . . . . 0.0 111.797 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.547 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.4 t -63.44 -55.06 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.391 0.676 . . . . 0.0 109.654 169.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.44 -16.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.441 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 17.28 80.23 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.491 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -166.77 150.82 7.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.018 0.927 . . . . 0.0 110.321 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -91.23 -22.21 20.72 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -154.75 136.87 14.73 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -130.03 176.82 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.031 0.933 . . . . 0.0 109.144 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.5 111.44 16.82 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.11 177.4 5.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.001 1.32 . . . . 0.0 109.111 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -156.54 108.11 2.46 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 m -112.75 179.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.846 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -55.97 148.62 16.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.421 0.688 . . . . 0.0 110.364 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -66.55 -26.1 66.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.517 0.327 . . . . 0.0 111.413 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.45 -24.64 36.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.952 0.501 . . . . 0.0 110.56 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.47 129.2 39.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.345 0.658 . . . . 0.0 111.16 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.1 p -111.92 -172.97 2.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.324 1.049 . . . . 0.0 110.372 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -50.82 -41.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 123.771 0.828 . . . . 0.0 111.804 -170.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.402 ' HA2' ' HE2' ' A' ' 73' ' ' MET . . . -65.5 -43.35 94.85 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.65 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.11 -33.26 75.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.264 0.625 . . . . 0.0 111.582 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.03 -59.75 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.675 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.551 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.1 pp -68.89 -30.71 69.27 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.4 ppt_? -67.35 -34.3 77.02 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.907 0.776 . . . . 0.0 111.204 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.1 m -75.58 -32.45 60.36 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.007 175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 5' ' ' LEU . 2.5 mm? -59.08 -49.57 77.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.918 0.487 . . . . 0.0 111.213 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -67.25 -25.31 66.02 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -20.84 66.52 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 123.345 0.403 . . . . 0.0 110.973 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -96.91 -58.72 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.782 0.801 . . . . 0.0 109.41 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.85 111.13 22.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.339 -170.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.77 -26.93 67.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.638 0.775 . . . . 0.0 110.116 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.54 -17.48 68.84 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.501 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' O ' HD22 ' A' ' 48' ' ' LEU . 82.4 mt -103.2 -13.98 16.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.888 0.875 . . . . 0.0 111.683 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.16 121.21 10.75 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.28 11.94 79.69 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 11.3 ptm180 -120.58 -21.19 6.84 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.54 0.67 . . . . 0.0 111.318 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.577 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -101.85 8.42 41.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.031 0.533 . . . . 0.0 110.219 170.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' HA ' ' A' ' 35' ' ' ARG . 43.2 mt -140.89 142.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.079 1.351 . . . . 0.0 108.87 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 1.6 tm-20 -154.83 123.69 6.2 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.09 31.04 17.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.413 1.085 . . . . 0.0 111.589 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.57 -4.07 75.36 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.592 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -106.36 -174.07 2.45 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.82 0.81 . . . . 0.0 109.681 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.406 HG12 HD21 ' A' ' 34' ' ' LEU . 27.6 m -58.8 -54.7 30.12 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.165 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? 149.45 137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 C-N-CA 126.503 1.921 . . . . 0.0 106.982 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 18.6 Cg_endo -56.54 129.08 32.81 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.802 2.335 . . . . 0.0 111.174 166.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 76.35 -6.26 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.877 1.271 . . . . 0.0 113.957 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.445 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.9 p -73.69 143.79 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.81 104.69 13.35 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.18 137.25 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.228 0.611 . . . . 0.0 109.599 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.7 mp -126.89 142.73 51.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.835 1.254 . . . . 0.0 110.85 -166.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -114.06 109.21 18.08 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.474 1.11 . . . . 0.0 108.208 166.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.33 35.65 23.26 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.074 0.94 . . . . 0.0 110.349 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.25 -14.7 60.2 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.819 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -87.64 109.03 19.37 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 68' ' ' VAL . 17.4 tt0 -67.44 105.09 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.453 0.701 . . . . 0.0 110.334 -173.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.48 -1.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 66' ' ' GLU . 20.2 m -73.7 -10.27 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 122.593 0.357 . . . . 0.0 111.364 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -87.15 -25.54 24.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.534 0.733 . . . . 0.0 110.452 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.22 -150.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.074 0.95 . . . . 0.0 109.808 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.21 107.89 0.54 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.685 0.394 . . . . 0.0 111.055 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -86.22 -30.35 22.74 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.684 0.615 . . . . 0.0 111.954 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.402 ' HE2' ' HA2' ' A' ' 31' ' ' GLY . 20.7 mmt -81.45 -34.9 31.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.078 0.551 . . . . 0.0 111.79 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.36 81.48 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 t -81.02 -67.76 0.75 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -173.5 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -163.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.32 144.09 44.65 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.68 -175.08 5.18 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.395 1.478 . . . . 0.0 107.817 -174.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.3 143.08 52.15 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.891 0.476 . . . . 0.0 111.186 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.0 69.6 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 114.806 0.682 . . . . 0.0 114.806 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.99 118.28 22.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.033 0.533 . . . . 0.0 111.665 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.55 104.03 14.19 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.523 0.729 . . . . 0.0 111.147 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 t -93.27 106.56 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 50.8 m -86.95 148.9 25.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.731 0.812 . . . . 0.0 109.539 176.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.42 146.33 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.814 0.816 . . . . 0.0 109.692 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 21.9 m-85 -132.38 144.55 53.51 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 173.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.622 ' HG3' ' H ' ' A' ' 10' ' ' THR . 34.3 Cg_endo -63.48 169.11 10.22 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.517 2.811 . . . . 0.0 112.124 169.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 C--N 1.376 1.995 0 C-N-CA 121.218 1.278 . . . . 0.0 110.661 176.84 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 0' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 24.6 p . . . . . 0 C--O 1.241 0.632 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.05 136.91 54.88 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.411 1.084 . . . . 0.0 110.068 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -91.74 141.37 28.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.405 0.682 . . . . 0.0 110.14 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.43 138.9 45.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.466 1.106 . . . . 0.0 110.606 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.3 103.98 16.57 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.508 0.723 . . . . 0.0 109.089 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD13 HD21 ' A' ' 37' ' ' LEU . 29.9 mt -93.31 103.62 15.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 74.7 mtt180 -91.09 119.75 31.49 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.58 1.152 . . . . 0.0 109.434 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -108.11 140.35 41.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.25 1.02 . . . . 0.0 108.759 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -132.38 160.55 36.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.138 0.575 . . . . 0.0 109.585 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.446 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.72 -125.28 1.18 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.685 1.194 . . . . 0.0 112.706 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.519 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 27.6 m -68.02 -46.8 70.19 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.369 0.668 . . . . 0.0 111.14 -178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -57.31 -26.57 61.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.31 0.644 . . . . 0.0 111.633 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.495 ' HD3' ' HG2' ' A' ' 18' ' ' LYS . 7.0 tmm_? -68.66 -53.14 24.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.415 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -18.77 60.59 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.6 t -64.34 -48.12 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.251 0.548 . . . . 0.0 110.216 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 17' ' ' GLN . 88.4 t -78.87 -21.7 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.863 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.64 20.04 75.34 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.227 -175.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.502 ' HB2' HG12 ' A' ' 15' ' ' VAL . 13.8 mm100 -148.07 139.21 23.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.86 1.264 . . . . 0.0 109.111 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.495 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 26.3 mtmt -85.01 -21.32 29.51 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.891 0.744 . . . . 0.0 109.925 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -154.08 148.7 26.35 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.336 1.054 . . . . 0.0 108.814 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -135.84 168.03 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.473 1.109 . . . . 0.0 108.386 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.04 113.16 25.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.458 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -100.15 178.29 4.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.055 1.342 . . . . 0.0 109.373 171.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -157.44 107.33 2.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.549 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.32 173.21 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.347 1.059 . . . . 0.0 108.229 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.3 p-10 -67.86 160.46 28.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.093 0.473 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.26 -19.69 59.58 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.346 0.659 . . . . 0.0 111.522 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -80.76 -19.34 45.11 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.536 0.734 . . . . 0.0 109.155 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.73 154.65 39.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 0.0 110.775 172.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 p -134.23 -174.7 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.619 1.168 . . . . 0.0 109.862 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.94 -37.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 124.551 1.14 . . . . 0.0 111.878 -175.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.55 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -68.76 -42.25 80.15 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.298 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.72 -35.15 77.22 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.421 0.688 . . . . 0.0 110.895 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.15 -61.1 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.797 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.15 -30.71 71.65 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.662 0.21 . . . . 0.0 110.728 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -53.68 -48.39 69.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.919 0.487 . . . . 0.0 111.562 172.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.1 m -75.8 -31.61 59.5 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.803 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 5' ' ' LEU . 2.1 mm? -54.11 -41.08 67.9 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.741 0.816 . . . . 0.0 112.824 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 12.2 pt-20 -71.56 -28.11 63.62 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.13 68.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.102 0.561 . . . . 0.0 110.277 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.458 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 4.9 mm-40 -86.04 -59.37 2.32 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.832 0.853 . . . . 0.0 109.783 175.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.2 m-85 -99.58 119.81 38.66 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.672 -168.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.29 -29.01 67.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.791 0.837 . . . . 0.0 110.902 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.87 -0.23 80.68 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.072 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.6 mt -115.78 1.58 13.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 111.092 173.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.03 122.39 19.28 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.44 76.56 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 9.8 ptp180 -118.29 4.47 11.89 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.641 0.776 . . . . 0.0 111.827 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -125.92 -8.08 6.64 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.498 1.119 . . . . 0.0 110.443 -178.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.401 ' N ' HD23 ' A' ' 48' ' ' LEU . 15.1 mt -132.73 136.87 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.877 1.271 . . . . 0.0 108.297 167.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.64 124.19 9.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.36 31.52 21.01 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.669 1.187 . . . . 0.0 111.937 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.02 -14.46 53.12 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.531 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -99.16 -174.84 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.962 0.881 . . . . 0.0 109.058 171.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.42 -55.11 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 118.104 -0.95 . . . . 0.0 111.723 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.6 tppt? 154.88 135.11 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.037 0 C-N-CA 124.714 1.206 . . . . 0.0 108.956 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.436 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 26.7 Cg_endo -60.45 135.55 61.91 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.929 2.419 . . . . 0.0 111.336 165.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 79.45 -12.49 1.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.135 1.374 . . . . 0.0 113.569 174.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 1.9 p -75.81 152.12 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.8 104.12 9.62 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.483 HG23 HG23 ' A' ' 67' ' ' VAL . 5.3 m -122.1 146.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.261 0.624 . . . . 0.0 109.873 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.3 mp -127.64 172.08 11.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.073 1.349 . . . . 0.0 110.971 -167.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 19.4 tptp -162.51 105.58 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 t30 54.99 35.57 24.96 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.053 0.941 . . . . 0.0 110.096 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.03 -14.69 61.36 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.784 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -88.89 118.77 28.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.374 0.67 . . . . 0.0 110.094 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.7 tt0 -72.44 103.01 3.34 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.477 0.486 . . . . 0.0 109.713 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.551 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 14.3 m -69.73 -1.07 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -173.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.3 m -69.91 -16.21 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.31 0.505 . . . . 0.0 111.317 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -91.09 -10.72 40.99 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.383 0.673 . . . . 0.0 111.324 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.84 -152.4 0.42 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.189 0.996 . . . . 0.0 109.595 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.17 108.35 2.65 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.1 0.56 . . . . 0.0 110.409 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.551 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -81.62 -38.59 13.84 Favored Glycine 0 C--N 1.341 0.846 0 O-C-N 123.378 0.424 . . . . 0.0 112.594 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.55 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.8 mmt -80.19 -36.36 35.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 112.647 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.19 77.65 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.459 HG21 ' HG2' ' A' ' 62' ' ' LYS . 1.4 t -82.15 -74.62 0.33 Allowed 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.802 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' H ' HG23 ' A' ' 75' ' ' THR . . . -171.22 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.143 0.577 . . . . 0.0 111.472 -161.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.544 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 24.3 tp -74.22 144.74 44.59 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.761 0.315 . . . . 0.0 111.347 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -156.21 168.76 26.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.295 1.038 . . . . 0.0 109.464 -168.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.87 149.97 48.56 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.948 0.499 . . . . 0.0 111.839 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.39 63.84 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.841 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -82.74 155.41 24.3 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.169 0.484 . . . . 0.0 109.863 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 99.06 6.68 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 123.287 0.635 . . . . 0.0 109.617 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -86.44 106.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.4 m -90.87 146.5 23.86 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 123.168 0.587 . . . . 0.0 109.506 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.27 144.76 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -128.83 141.19 40.82 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HG3' ' H ' ' A' ' 10' ' ' THR . 41.6 Cg_endo -63.79 168.4 11.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.762 2.975 . . . . 0.0 112.519 175.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 15.7 Cg_endo . . . . . 0 C--N 1.378 2.088 0 C-N-CA 121.234 1.289 . . . . 0.0 111.198 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 C--O 1.24 0.557 0 CA-C-O 121.107 0.479 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.9 ptt? -101.72 140.4 36.05 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.781 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -95.22 130.59 41.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.292 0.637 . . . . 0.0 109.797 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.486 HD13 HD21 ' A' ' 77' ' ' LEU . 24.4 mt -124.44 138.73 54.33 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.646 0.779 . . . . 0.0 110.45 -169.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 45.5 tt0 -89.32 102.64 15.31 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.411 HD13 HD21 ' A' ' 37' ' ' LEU . 38.7 mt -92.86 103.7 16.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 30.1 mtm180 -92.32 117.62 30.09 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.393 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.33 138.49 42.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 109.464 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.72 155.38 48.95 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.335 0.654 . . . . 0.0 109.7 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.544 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.75 -126.75 0.96 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.144 1.378 . . . . 0.0 111.99 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.422 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 36.7 m -63.97 -43.03 96.98 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 123.34 0.656 . . . . 0.0 111.127 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -60.98 -27.69 68.47 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.574 0.35 . . . . 0.0 111.072 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 55.3 ttp180 -67.5 -53.33 29.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.321 0.648 . . . . 0.0 111.396 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -20.42 60.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.111 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 44' ' ' LEU . 40.6 t -61.5 -47.74 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.559 0.695 . . . . 0.0 110.294 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.75 -20.54 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.905 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.53 16.36 71.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.041 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -143.19 139.4 30.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.553 1.141 . . . . 0.0 109.841 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 22.3 ptmt -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.754 0.659 . . . . 0.0 110.521 172.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -156.92 145.43 19.74 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.465 174.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.12 173.24 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.344 1.057 . . . . 0.0 109.089 172.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -118.73 112.76 20.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.8 -179.64 4.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.276 1.43 . . . . 0.0 109.388 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -157.36 105.75 2.11 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.82 172.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -59.21 148.33 32.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.175 0.59 . . . . 0.0 111.285 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -61.94 -27.31 68.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 111.29 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -80.3 -24.99 39.61 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 110.24 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.89 37.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.02 0.528 . . . . 0.0 109.639 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.3 p -103.14 -173.87 2.42 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.596 0.758 . . . . 0.0 110.799 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 77' ' ' LEU . 87.9 t -50.84 -37.03 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 124.204 1.002 . . . . 0.0 111.493 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.3 -38.38 71.19 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.97 -31.02 69.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.297 0.639 . . . . 0.0 110.879 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.32 -60.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.172 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.506 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.7 pp -64.63 -30.16 71.18 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.192 0.308 . . . . 0.0 111.204 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HA ' HD11 ' A' ' 49' ' ' ILE . 16.6 tpt180 -51.41 -49.97 60.57 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.462 0.705 . . . . 0.0 111.242 168.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 m -75.36 -32.31 60.81 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.653 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.411 HD21 HD13 ' A' ' 5' ' ' LEU . 3.8 mm? -58.26 -35.31 71.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.187 0.595 . . . . 0.0 112.498 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.491 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.8 pt-20 -76.84 -27.45 55.12 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.324 0.511 . . . . 0.0 111.673 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.92 64.7 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.776 0.43 . . . . 0.0 111.01 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -90.23 -59.82 2.09 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.574 0.702 . . . . 0.0 110.158 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -92.28 126.54 37.4 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.602 -168.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.99 -35.67 69.55 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.689 0.796 . . . . 0.0 110.023 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.18 -4.19 86.18 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.957 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.605 ' HB3' HD13 ' A' ' 48' ' ' LEU . 56.9 mt -106.82 -3.67 20.12 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.934 0.867 . . . . 0.0 111.485 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.02 121.4 14.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.87 12.02 67.2 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.354 0.902 . . . . 0.0 115.354 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -118.26 0.44 11.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.005 0.922 . . . . 0.0 110.743 179.146 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -122.8 -5.42 8.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.524 1.13 . . . . 0.0 109.831 177.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 35' ' ' ARG . 37.0 mt -130.67 135.17 60.87 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.108 1.363 . . . . 0.0 108.398 169.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.84 126.35 14.13 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 166.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 56.11 31.29 17.92 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.604 1.162 . . . . 0.0 111.947 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.01 -14.38 57.32 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.27 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.59 -174.6 2.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 34' ' ' LEU . 27.8 m -63.51 -55.88 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.153 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 11.3 tppt? 151.5 137.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.075 0 C-N-CA 125.122 1.369 . . . . 0.0 108.901 -176.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 131.13 31.48 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 C-N-CA 123.042 2.495 . . . . 0.0 111.836 165.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 79.38 -11.72 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.585 1.554 . . . . 0.0 114.167 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -69.34 142.99 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 16.4 m120 -110.2 103.36 12.04 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 85' ' ' VAL . 3.7 m -121.3 129.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.537 0.735 . . . . 0.0 109.307 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.727 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 2.1 mp -121.06 139.39 53.38 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.435 1.094 . . . . 0.0 110.413 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 12.9 tptm -110.5 114.65 28.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.17 35.12 21.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.032 0.933 . . . . 0.0 110.993 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.05 -4.93 81.79 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.998 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -100.35 116.01 31.32 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 11.3 tt0 -70.28 107.11 3.59 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.635 0.584 . . . . 0.0 109.774 -173.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.71 -1.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.48 -19.35 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 122.662 0.385 . . . . 0.0 111.168 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -90.26 -5.24 56.55 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.668 0.787 . . . . 0.0 111.235 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.01 -149.35 0.29 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 109.327 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.24 108.84 3.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.266 0.626 . . . . 0.0 110.605 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.23 -43.4 20.95 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 122.999 0.187 . . . . 0.0 112.641 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.632 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.6 mmt -76.91 -40.26 47.94 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.195 0.598 . . . . 0.0 111.775 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.37 78.75 1.52 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 t -80.8 -65.99 0.94 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.654 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 175.57 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.918 0.887 . . . . 0.0 110.462 -163.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.486 HD21 HD13 ' A' ' 3' ' ' LEU . 47.2 tp -73.89 136.64 43.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.639 0.375 . . . . 0.0 110.412 -175.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -149.93 -177.46 5.92 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 122.805 0.442 . . . . 0.0 110.013 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 33.6 t70 -64.4 144.93 56.81 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.794 0.838 . . . . 0.0 112.917 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.35 -7.19 12.42 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.455 -0.793 . . . . 0.0 114.793 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.475 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 4.9 m-20 -78.44 142.07 37.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.762 0.825 . . . . 0.0 112.431 -169.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -97.64 111.16 23.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.036 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.17 107.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.727 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 12.9 m -85.57 147.04 26.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.985 0.514 . . . . 0.0 109.986 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 60' ' ' VAL . 33.0 m -141.93 140.6 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.602 0.715 . . . . 0.0 109.584 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.644 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 6.6 m-85 -129.92 137.79 31.67 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 37.1 Cg_endo -63.44 162.67 26.48 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.151 2.567 . . . . 0.0 112.594 176.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 C--N 1.37 1.68 0 C-N-CA 121.509 1.472 . . . . 0.0 111.17 177.864 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 0' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 20.9 p . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.465 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 27.0 ptt? -96.06 143.54 27.12 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.826 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -93.34 126.87 38.69 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.904 0.882 . . . . 0.0 109.046 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.426 HD11 HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -124.11 148.98 46.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.946 0.498 . . . . 0.0 109.988 -175.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 31.1 tt0 -97.42 113.51 25.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 170.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.2 mt -101.39 112.29 24.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 51.9 mtt180 -99.94 117.17 33.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.187 0.995 . . . . 0.0 108.796 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.55 137.61 45.28 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.952 0.901 . . . . 0.0 109.256 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -131.6 159.7 37.48 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.93 0.492 . . . . 0.0 109.814 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.21 -120.6 1.07 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 124.779 1.232 . . . . 0.0 112.337 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.481 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 26.2 m -71.92 -45.41 61.29 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 123.082 0.553 . . . . 0.0 110.442 -178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -55.34 -30.0 59.42 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.195 0.598 . . . . 0.0 110.972 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HD2' ' HG2' ' A' ' 18' ' ' LYS . 50.8 ttp180 -66.72 -55.24 15.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.84 0.856 . . . . 0.0 111.726 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -16.93 60.91 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.934 -174.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.49 HG11 ' HG ' ' A' ' 44' ' ' LEU . 40.1 t -65.54 -55.87 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.28 0.632 . . . . 0.0 109.689 168.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.2 t -74.54 -17.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.612 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.7 11.61 73.3 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.701 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -139.48 144.29 37.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.198 0.999 . . . . 0.0 109.144 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.522 ' HG2' ' HD2' ' A' ' 12' ' ' ARG . 22.0 mtmm -86.31 -21.05 27.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.746 0.419 . . . . 0.0 109.909 174.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 14.7 m -154.05 146.51 24.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.377 1.071 . . . . 0.0 109.216 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 23.2 pt -141.52 170.61 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 109.7 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -112.83 113.07 24.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.47 -179.53 4.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.579 1.151 . . . . 0.0 109.843 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG2' ' HB ' ' A' ' 0' ' ' THR . 60.7 ttp180 -157.4 106.43 2.14 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.829 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 3' ' ' LEU . 27.2 m -114.46 169.37 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.215 171.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 27.8 t70 -61.8 154.09 26.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.936 0.494 . . . . 0.0 111.039 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.24 -32.42 71.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.014 0.926 . . . . 0.0 111.833 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -81.01 -22.6 39.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.958 0.903 . . . . 0.0 111.362 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 153.72 37.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.28 0.632 . . . . 0.0 110.66 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -130.48 -175.07 3.53 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 97.8 t -51.81 -37.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.951 0.9 . . . . 0.0 111.648 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.95 65.92 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.005 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.27 -33.79 76.64 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.272 0.629 . . . . 0.0 110.296 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.88 -60.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.813 0.845 . . . . 0.0 110.317 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.508 HD21 HG12 ' A' ' 54' ' ' VAL . 2.6 pp -64.66 -30.74 71.76 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.134 0.424 . . . . 0.0 111.579 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HA ' HD11 ' A' ' 49' ' ' ILE . 17.3 tpt180 -50.96 -48.59 61.0 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.157 0.583 . . . . 0.0 110.956 168.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 m -74.65 -32.5 62.29 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.187 0.595 . . . . 0.0 111.436 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 4.1 mm? -59.74 -34.29 72.76 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' A' ' 48' ' ' LEU . 5.6 pt-20 -76.89 -28.57 55.41 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.718 0.69 . . . . 0.0 111.124 173.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.05 -32.7 72.37 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.039 0.536 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -83.99 -58.0 2.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.526 0.73 . . . . 0.0 110.474 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -96.38 127.33 42.28 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.587 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.28 -45.68 90.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.131 0.973 . . . . 0.0 110.697 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.11 7.1 54.34 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.423 -0.808 . . . . 0.0 114.021 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.588 ' HB3' HD13 ' A' ' 48' ' ' LEU . 74.3 mt -115.97 5.26 13.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.615 0.707 . . . . 0.0 111.167 172.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -69.89 120.94 16.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.27 -8.09 26.97 Favored Glycine 0 C--N 1.359 1.847 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -100.08 4.13 44.45 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.355 1.062 . . . . 0.0 111.403 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -128.66 -8.87 5.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.257 1.023 . . . . 0.0 110.855 -177.204 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.479 HD11 ' HA ' ' A' ' 35' ' ' ARG . 51.5 mt -125.22 132.52 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.598 1.159 . . . . 0.0 107.967 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.17 117.65 13.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.919 0.488 . . . . 0.0 109.731 167.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.2 t70 55.54 30.85 15.98 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.05 -14.83 63.4 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.616 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -97.31 -174.01 2.82 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.883 0.842 . . . . 0.0 108.885 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG12 HD21 ' A' ' 34' ' ' LEU . 13.8 m -65.5 -56.83 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.788 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 150.81 135.97 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.003 0 C-N-CA 125.078 1.351 . . . . 0.0 109.176 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.49 137.51 51.02 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.84 2.36 . . . . 0.0 110.972 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 77.9 -11.94 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.325 1.45 . . . . 0.0 113.61 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 p -73.56 138.94 20.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.666 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.6 m120 -104.67 103.55 13.21 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 85' ' ' VAL . 4.2 m -122.93 135.38 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.624 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -126.19 155.62 41.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.349 1.059 . . . . 0.0 110.639 -166.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 13.3 tptm -123.49 104.51 9.11 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.554 1.142 . . . . 0.0 107.975 169.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 t30 52.64 37.69 24.07 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.062 1.345 . . . . 0.0 111.702 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 19.61 43.79 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.871 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -133.27 105.49 7.01 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 16.0 tt0 -62.85 109.31 1.4 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.331 1.052 . . . . 0.0 110.918 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 31.3 m -69.95 -1.48 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -172.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -68.16 -22.53 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 117.935 0.334 . . . . 0.0 110.824 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -86.38 -15.87 39.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.865 0.866 . . . . 0.0 111.151 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.75 -153.14 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.247 1.019 . . . . 0.0 109.289 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.25 113.5 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.077 0.551 . . . . 0.0 110.538 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -73.3 -50.29 12.79 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.718 0.636 . . . . 0.0 112.734 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.3 mmm -79.94 -36.83 35.7 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.345 0.658 . . . . 0.0 111.692 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.43 77.95 1.65 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.571 0.701 . . . . 0.0 111.008 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.29 -71.4 0.47 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.836 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.477 ' H ' HG23 ' A' ' 75' ' ' THR . . . -173.75 28.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.912 0.885 . . . . 0.0 110.962 -164.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -75.33 144.06 42.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.175 0.59 . . . . 0.0 111.574 -168.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -157.51 -176.02 5.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.066 0.546 . . . . 0.0 110.1 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 28.3 t70 -63.88 140.53 58.88 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.035 0.934 . . . . 0.0 111.338 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 -7.09 57.87 Favored Glycine 0 C--N 1.344 1.023 0 O-C-N 123.834 0.709 . . . . 0.0 114.421 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.52 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 78.1 m-20 -79.55 133.9 36.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -170.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.32 105.66 17.63 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.446 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.2 137.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.624 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.9 m -118.12 154.83 31.46 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.441 0.564 . . . . 0.0 110.2 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 60' ' ' VAL . 34.6 m -145.1 143.92 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.751 0.82 . . . . 0.0 110.152 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.666 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 18.1 m-85 -135.08 133.75 21.08 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HG3' ' H ' ' A' ' 10' ' ' THR . 22.0 Cg_endo -59.89 160.96 19.93 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 123.325 2.684 . . . . 0.0 112.867 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 C--N 1.377 2.059 0 C-N-CA 121.945 1.764 . . . . 0.0 111.745 -178.664 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 34.3 p . . . . . 0 C--O 1.241 0.624 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.76 151.44 31.96 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.481 0.712 . . . . 0.0 110.391 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.11 137.96 50.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.602 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.23 149.25 46.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.685 0.794 . . . . 0.0 109.855 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -89.2 106.86 18.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.26 112.65 24.57 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 39.8 mtp180 -104.64 118.02 35.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.716 0.806 . . . . 0.0 109.297 -170.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 136.67 45.47 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.924 0.89 . . . . 0.0 109.325 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -132.45 160.74 35.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.79 0.436 . . . . 0.0 110.104 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.06 -117.77 0.82 Allowed 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.892 1.277 . . . . 0.0 112.389 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.626 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 46.7 m -69.69 -47.52 62.91 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 123.632 0.773 . . . . 0.0 110.494 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -59.46 -24.36 63.49 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.986 0.515 . . . . 0.0 111.224 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -50.36 53.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.731 0.813 . . . . 0.0 111.291 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -16.91 60.89 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.595 HG11 ' HG ' ' A' ' 44' ' ' LEU . 72.6 t -65.36 -53.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.626 0.726 . . . . 0.0 110.205 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.85 -16.73 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.633 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.74 11.52 85.15 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.414 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.97 158.84 10.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.84 0.856 . . . . 0.0 110.807 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -94.76 -9.42 34.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.0 m -152.65 143.08 22.63 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.41 175.82 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.223 1.009 . . . . 0.0 109.119 174.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.49 112.96 16.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.36 135.91 44.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.303 1.041 . . . . 0.0 110.038 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -104.13 106.18 16.6 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.1 175.7 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.542 1.137 . . . . 0.0 108.226 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.46 164.52 26.54 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.627 0.371 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -76.95 -15.46 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.53 -24.33 36.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.879 0.472 . . . . 0.0 110.35 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.06 58.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.901 0.881 . . . . 0.0 111.463 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.3 p -128.27 -174.39 3.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.475 1.11 . . . . 0.0 109.725 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.81 -33.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 123.973 0.909 . . . . 0.0 112.093 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' HA2' ' HE1' ' A' ' 73' ' ' MET . . . -66.58 -50.05 51.67 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.053 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -61.59 -29.55 70.11 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.174 0.59 . . . . 0.0 111.583 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.45 -60.62 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.31 1.044 . . . . 0.0 110.541 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.3 pp -74.14 -31.06 62.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.2 ppt_? -67.12 -31.85 72.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.67 0.668 . . . . 0.0 111.176 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -76.67 -34.11 58.24 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.607 0.763 . . . . 0.0 112.333 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -59.91 -38.96 83.81 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 122.974 0.509 . . . . 0.0 111.86 -176.449 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -68.28 -37.41 80.64 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.345 0.403 . . . . 0.0 111.765 175.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.54 -28.96 69.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.506 0.723 . . . . 0.0 111.447 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -82.72 -58.83 2.72 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.043 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.22 112.56 24.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.813 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.93 -31.3 70.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.579 0.751 . . . . 0.0 110.55 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -73.31 -6.39 69.56 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.419 -0.809 . . . . 0.0 114.064 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HB3' HD13 ' A' ' 48' ' ' LEU . 68.0 mt -113.26 2.29 15.51 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.675 0.738 . . . . 0.0 111.141 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.9 120.74 13.62 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.27 -28.67 2.6 Favored Glycine 0 C--N 1.359 1.826 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 5.6 ptp180 -83.29 9.24 11.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.904 1.282 . . . . 0.0 112.693 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -132.26 9.85 4.45 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.94 0.896 . . . . 0.0 110.931 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 35' ' ' ARG . 61.1 mt -141.41 140.75 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.296 1.038 . . . . 0.0 109.315 175.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 55' ' ' LYS . 16.6 mm-40 -139.71 110.41 6.74 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.302 0.641 . . . . 0.0 110.317 163.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t70 56.6 36.14 27.16 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.475 1.11 . . . . 0.0 111.894 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.04 27.52 62.13 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.139 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.63 -177.4 4.17 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 161.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.495 HG12 HD21 ' A' ' 34' ' ' LEU . 17.1 m -66.5 -56.09 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 117.588 -1.196 . . . . 0.0 112.297 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HD3' ' HG2' ' A' ' 50' ' ' GLU . 5.9 tppt? 149.58 134.27 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.243 0 C-N-CA 126.06 1.744 . . . . 0.0 108.616 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.427 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 19.5 Cg_endo -58.91 133.34 53.02 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.061 2.507 . . . . 0.0 112.184 165.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 81.03 -26.99 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.861 1.664 . . . . 0.0 113.107 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.76 120.44 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -95.41 104.71 16.62 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 85' ' ' VAL . 1.7 m -109.37 146.39 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.287 0.635 . . . . 0.0 109.55 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.5 mp -132.7 170.66 14.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.971 1.308 . . . . 0.0 110.243 -164.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE2' HD23 ' A' ' 77' ' ' LEU . 20.9 tptp -162.28 105.43 1.14 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 55.82 34.76 24.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.16 0.981 . . . . 0.0 109.832 -171.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.93 -13.58 48.05 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 114.492 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -87.16 119.28 27.23 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.922 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 24.3 tt0 -78.53 104.47 9.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.224 0.61 . . . . 0.0 111.13 -168.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.469 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.1 m -70.87 -1.32 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -170.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.1 m -68.6 -19.78 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.39 0.541 . . . . 0.0 110.898 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -92.53 -29.38 16.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.019 0.927 . . . . 0.0 110.843 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.79 -150.74 0.47 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.143 0.977 . . . . 0.0 109.406 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.04 108.31 2.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.955 0.502 . . . . 0.0 110.955 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -83.15 -37.79 12.09 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 123.32 0.387 . . . . 0.0 112.273 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.518 ' HE1' ' HA2' ' A' ' 31' ' ' GLY . 14.1 mmt -79.73 -38.39 33.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.653 0.781 . . . . 0.0 111.917 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.73 83.96 1.29 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.47 -75.26 0.29 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.724 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.4 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -163.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.475 HD23 ' HE2' ' A' ' 62' ' ' LYS . 15.4 mt -73.68 143.65 46.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.865 0.84 . . . . 0.0 112.554 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -151.1 169.3 22.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.751 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.9 135.07 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 122.13 -0.356 . . . . 0.0 111.217 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 16.58 80.54 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.82 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.2 157.43 21.64 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.421 0.611 . . . . 0.0 109.563 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.75 106.03 11.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.268 0.627 . . . . 0.0 111.143 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.405 HG22 HD21 ' A' ' 77' ' ' LEU . 47.6 t -86.92 137.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.622 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 69.5 m -118.62 151.82 37.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 60' ' ' VAL . 10.3 m -142.27 148.3 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 121.404 0.621 . . . . 0.0 110.196 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -136.3 140.71 33.53 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.626 ' HG3' ' H ' ' A' ' 10' ' ' THR . 53.6 Cg_endo -64.28 168.83 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.254 3.303 . . . . 0.0 112.417 174.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 C--N 1.382 2.329 0 C-N-CA 121.077 1.185 . . . . 0.0 111.385 -178.725 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.198 0.523 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.431 ' SD ' ' HA ' ' A' ' 26' ' ' ASP . 13.2 ptm -122.31 111.71 17.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.412 1.085 . . . . 0.0 109.722 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.32 121.43 28.87 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.542 HD13 HD21 ' A' ' 77' ' ' LEU . 21.4 mt -123.93 135.21 53.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.562 0.745 . . . . 0.0 110.027 -169.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.11 98.45 11.77 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD13 HD21 ' A' ' 37' ' ' LEU . 21.9 mt -94.83 104.8 16.71 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.122 . . . . 0.0 110.529 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 41.3 mtp180 -101.06 117.33 34.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.408 0.683 . . . . 0.0 109.414 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -101.76 140.22 36.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.049 0.939 . . . . 0.0 109.357 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.5 157.11 43.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.096 0.558 . . . . 0.0 110.137 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.66 -122.29 1.09 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.775 1.23 . . . . 0.0 112.861 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.539 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 92.0 m -64.78 -48.07 75.83 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 123.757 0.823 . . . . 0.0 111.042 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -60.03 -24.52 64.59 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.819 0.448 . . . . 0.0 111.467 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 13' ' ' GLU . 7.8 tmm_? -72.46 -47.58 47.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.932 0.493 . . . . 0.0 111.288 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 1.1 pp20? -74.16 -19.11 60.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.53 0.332 . . . . 0.0 111.698 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.558 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.0 t -67.35 -52.55 40.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.67 0.788 . . . . 0.0 110.483 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 95.6 t -73.88 -22.18 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.526 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.07 11.44 63.66 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.885 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -146.46 136.99 23.97 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -170.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HD2' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -87.71 -14.71 39.09 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -155.5 137.82 14.84 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.709 0.804 . . . . 0.0 109.315 177.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.45 140.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -88.92 112.45 23.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.86 170.97 9.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.55 1.14 . . . . 0.0 108.928 170.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -157.02 108.47 2.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.704 0.764 . . . . 0.0 109.466 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.57 -179.56 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.766 1.627 . . . . 0.0 108.364 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.99 160.19 30.09 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.431 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 5.3 p-10 -69.83 -8.08 45.33 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.694 0.797 . . . . 0.0 113.043 -170.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.35 -14.44 57.25 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.719 0.807 . . . . 0.0 112.26 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.95 129.47 36.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.696 0.398 . . . . 0.0 111.133 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p -109.63 -179.59 3.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -54.02 -32.66 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.081 0.952 . . . . 0.0 112.368 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.63 -40.51 58.88 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.741 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.7 -32.24 73.41 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.163 0.481 . . . . 0.0 110.45 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.21 -60.08 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.678 0.611 . . . . 0.0 110.408 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.493 HD21 HG12 ' A' ' 54' ' ' VAL . 2.6 pp -66.91 -30.08 70.14 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 123.331 0.394 . . . . 0.0 111.166 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.3 tpt85 -56.28 -48.38 76.72 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.061 0.544 . . . . 0.0 111.518 170.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -75.88 -31.75 59.37 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.047 0.539 . . . . 0.0 111.442 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 5' ' ' LEU . 1.5 mm? -56.59 -44.81 81.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.706 0.803 . . . . 0.0 112.406 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.501 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.68 -25.64 67.42 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.157 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.7 -21.65 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.655 0.597 . . . . 0.0 111.238 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -98.68 -59.09 1.81 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 122.877 0.471 . . . . 0.0 109.781 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.499 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 91.9 m-85 -89.66 117.45 28.54 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.882 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.01 -35.39 81.04 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.742 0.817 . . . . 0.0 111.481 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.88 -2.13 75.74 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.754 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.663 ' HB3' HD13 ' A' ' 48' ' ' LEU . 58.0 mt -103.94 -15.57 15.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.46 0.704 . . . . 0.0 110.893 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.48 120.65 9.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.779 0.832 . . . . 0.0 112.59 -171.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.62 74.04 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 115.489 0.955 . . . . 0.0 115.489 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 3.1 ptp180 -118.71 -0.06 11.37 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.539 0.736 . . . . 0.0 111.713 -176.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.22 -3.05 11.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.738 0.815 . . . . 0.0 110.185 173.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 35' ' ' ARG . 41.2 mt -133.44 137.19 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.019 1.328 . . . . 0.0 108.195 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -135.96 108.39 7.37 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t70 57.92 32.2 21.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.636 1.174 . . . . 0.0 112.557 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.43 1.2 69.17 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 115.084 0.793 . . . . 0.0 115.084 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.08 -174.91 2.63 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 117.849 0.824 . . . . 0.0 109.392 165.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.493 HG12 HD21 ' A' ' 34' ' ' LEU . 17.8 m -65.76 -55.42 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.601 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.5 tppt? 150.21 138.09 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 C-N-CA 125.576 1.55 . . . . 0.0 107.956 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.455 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 19.6 Cg_endo -56.07 129.19 33.57 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 123.009 2.473 . . . . 0.0 110.619 166.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 74.86 -4.79 2.29 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.997 1.319 . . . . 0.0 114.28 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -74.99 131.9 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 34.4 m-80 -100.9 103.58 14.76 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.43 137.28 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.267 0.627 . . . . 0.0 109.765 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 7.4 mp -118.87 169.23 10.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.113 1.365 . . . . 0.0 111.09 -169.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -163.77 106.0 0.95 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.478 -177.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.481 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 7.5 t-20 59.21 38.12 23.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.188 1.395 . . . . 0.0 109.721 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.96 -14.6 48.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.619 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -93.79 119.12 32.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.445 0.622 . . . . 0.0 109.565 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 22.4 tt0 -75.18 109.46 8.69 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.064 0.459 . . . . 0.0 109.765 -174.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 20.6 m -71.4 -0.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.72 -19.91 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.186 0.448 . . . . 0.0 110.978 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -88.3 -19.65 26.46 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.737 0.815 . . . . 0.0 110.794 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.34 -148.34 0.36 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.692 1.197 . . . . 0.0 109.262 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.3 108.95 6.46 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.003 0.521 . . . . 0.0 110.57 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -79.6 -37.64 22.94 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 113.903 0.321 . . . . 0.0 113.903 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 82.8 mmm -81.62 -26.75 34.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.99 85.35 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 118.177 0.444 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.81 -73.15 0.4 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.073 0.549 . . . . 0.0 112.192 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' H ' HG23 ' A' ' 75' ' ' THR . . . -173.19 33.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.815 0.846 . . . . 0.0 110.557 -164.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.542 HD21 HD13 ' A' ' 3' ' ' LEU . 41.4 tp -74.35 123.54 24.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.495 0.318 . . . . 0.0 110.154 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 7.0 t70 -116.82 178.24 4.41 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.5 147.69 49.09 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.359 0.663 . . . . 0.0 111.035 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.21 10.82 70.06 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.548 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -82.6 177.67 8.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.451 0.701 . . . . 0.0 110.896 -174.228 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.69 109.11 9.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.293 0.637 . . . . 0.0 110.866 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.47 137.65 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 108.734 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 75.3 m -121.04 154.23 36.33 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -142.88 147.64 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.624 0.726 . . . . 0.0 110.141 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 14.9 m-85 -133.51 140.23 36.28 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HG3' ' H ' ' A' ' 10' ' ' THR . 58.7 Cg_endo -66.36 168.38 16.3 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.711 2.94 . . . . 0.0 112.3 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 C--N 1.377 2.04 0 C-N-CA 121.395 1.397 . . . . 0.0 110.869 177.001 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.244 0.77 0 CA-C-O 120.974 0.416 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.6 ptt? -149.86 124.02 9.48 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.773 0.829 . . . . 0.0 109.547 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -85.27 113.65 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.031 0.932 . . . . 0.0 109.107 -175.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.3 mt -115.46 134.5 55.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.391 0.676 . . . . 0.0 110.931 -171.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 65.1 tt0 -89.17 103.09 15.74 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.8 mt -93.84 105.3 17.33 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.4 mtt180 -91.9 117.0 29.39 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.749 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.444 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m-85 -103.44 136.09 43.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.976 0.91 . . . . 0.0 109.248 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.01 161.41 29.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.225 0.61 . . . . 0.0 109.537 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.41 -133.27 0.93 Allowed 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.604 1.162 . . . . 0.0 112.354 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 14' ' ' VAL . 57.2 m -55.76 -44.03 77.26 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 124.324 1.05 . . . . 0.0 111.819 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 10.8 m-30 -63.1 -33.09 74.71 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.076 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -41.57 91.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.642 0.377 . . . . 0.0 110.273 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -67.91 -35.86 79.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.806 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.493 HG11 ' HG ' ' A' ' 44' ' ' LEU . 64.6 t -60.46 -56.31 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.257 0.623 . . . . 0.0 110.617 174.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.26 -17.15 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.42 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.98 11.52 70.08 Favored Glycine 0 C--N 1.35 1.313 0 C-N-CA 123.578 0.608 . . . . 0.0 113.682 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -160.7 142.45 12.33 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.232 1.013 . . . . 0.0 110.149 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -85.83 -22.16 27.74 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.952 0.901 . . . . 0.0 113.38 -167.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.2 m -150.18 133.09 16.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 18.1 pt -129.98 171.88 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.997 . . . . 0.0 108.928 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -116.95 112.17 20.63 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 163.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -89.96 -179.05 5.62 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.91 1.284 . . . . 0.0 108.772 164.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -155.73 113.89 3.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.68 -179.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.52 156.74 35.97 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.723 0.409 . . . . 0.0 110.353 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.56 -24.96 53.56 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.262 0.625 . . . . 0.0 111.049 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.65 -14.39 56.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.86 0.864 . . . . 0.0 110.558 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 166.07 23.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.257 0.623 . . . . 0.0 110.836 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.8 p -132.2 -177.47 4.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.594 0.758 . . . . 0.0 110.815 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.35 -35.85 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.617 1.167 . . . . 0.0 111.553 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.483 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.62 -38.52 78.26 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.553 0.533 . . . . 0.0 113.221 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.71 -33.17 75.04 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.284 0.634 . . . . 0.0 110.491 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.0 -60.19 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.702 0.801 . . . . 0.0 110.528 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 54' ' ' VAL . 2.0 pp -65.07 -30.61 71.58 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.88 0.309 . . . . 0.0 111.316 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -54.47 -47.31 73.1 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.239 0.616 . . . . 0.0 111.368 170.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 36.1 t -75.9 -32.64 59.74 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.093 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 2.3 mm? -58.04 -35.8 71.84 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.69 0.796 . . . . 0.0 112.954 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -77.79 -30.02 51.11 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 120.737 0.303 . . . . 0.0 111.462 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.19 -26.41 67.39 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.929 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 36' ' ' SER . 6.1 mm-40 -90.76 -56.28 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.026 0.93 . . . . 0.0 110.191 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -95.73 122.66 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.187 -170.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.92 -35.82 81.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.043 0.937 . . . . 0.0 110.774 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.67 -2.11 90.6 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.919 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB3' HD13 ' A' ' 48' ' ' LEU . 85.0 mt -109.88 5.24 22.33 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.868 0.834 . . . . 0.0 110.885 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.34 121.46 17.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.971 0.508 . . . . 0.0 112.177 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.54 -24.65 6.28 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 12.3 ptp180 -90.25 7.5 37.93 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.69 1.196 . . . . 0.0 112.505 -171.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.06 -7.1 3.47 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.135 0.974 . . . . 0.0 111.088 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.89 127.7 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.509 1.123 . . . . 0.0 108.416 169.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -127.51 108.84 11.15 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.175 0.59 . . . . 0.0 110.162 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 t70 53.02 39.53 29.63 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.581 1.152 . . . . 0.0 112.007 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.2 -14.53 65.05 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.195 -0.911 . . . . 0.0 115.369 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -102.21 -175.32 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.286 1.043 . . . . 0.0 109.223 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG12 HD21 ' A' ' 34' ' ' LEU . 15.8 m -69.02 -57.56 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.07 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 15.4 tppt? 153.74 135.22 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 CA-C-N 119.683 1.129 . . . . 0.0 109.786 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 17.1 Cg_endo -56.07 135.25 68.9 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 123.319 2.68 . . . . 0.0 111.879 165.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 76.28 -15.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.565 1.546 . . . . 0.0 113.947 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.76 146.36 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.5 m120 -121.13 103.87 9.34 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG12 HG12 ' A' ' 85' ' ' VAL . 3.2 m -116.17 131.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.53 0.732 . . . . 0.0 109.531 -177.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -120.41 133.9 55.35 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.209 1.403 . . . . 0.0 110.297 -171.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 16.8 tptp -105.62 105.62 15.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 59.32 35.13 23.16 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.097 0.959 . . . . 0.0 111.13 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.92 -14.31 63.7 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.426 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -93.73 105.92 17.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.837 0.855 . . . . 0.0 109.41 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 26.1 tt0 -70.88 104.83 3.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.602 0.761 . . . . 0.0 111.174 -168.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 23.4 m -71.65 -0.95 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.89 -22.69 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.806 170.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -86.71 -28.55 23.02 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.772 0.829 . . . . 0.0 110.803 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.6 -153.74 0.54 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.383 1.073 . . . . 0.0 109.503 177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.26 107.89 1.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.888 0.475 . . . . 0.0 110.186 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.472 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -80.2 -34.1 30.58 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.031 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.483 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.7 mmt -82.15 -39.11 23.72 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.2 82.48 1.6 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.29 0.566 . . . . 0.0 111.631 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 76' ' ' ALA . 2.1 t -81.34 -72.87 0.41 Allowed 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.135 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' H ' HG23 ' A' ' 75' ' ' THR . . . 174.55 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.955 0.902 . . . . 0.0 110.414 -161.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -74.03 123.0 23.52 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -167.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.71 175.21 5.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.148 0.979 . . . . 0.0 109.989 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 11.1 p-10 -72.89 146.73 45.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.458 0.703 . . . . 0.0 111.949 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 15.15 73.1 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.396 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.31 171.45 13.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.098 0.559 . . . . 0.0 111.332 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.52 94.78 3.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 170.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.89 107.39 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 74.2 m -85.68 155.01 21.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 110.402 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 HG12 ' A' ' 60' ' ' VAL . 32.8 m -146.35 145.49 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 109.673 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 29.9 m-85 -132.38 136.62 28.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 32.5 Cg_endo -61.04 168.91 6.68 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.971 3.114 . . . . 0.0 113.432 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 C--N 1.376 2.016 0 C-N-CA 121.103 1.202 . . . . 0.0 110.328 172.929 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.561 0 N-CA-C 112.124 -0.39 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -85.51 161.26 35.21 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.202 -0.359 . . . . 0.0 112.202 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -87.03 -174.25 48.98 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-O 119.804 -0.442 . . . . 0.0 112.262 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? 57.46 87.51 0.06 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.731 1.213 . . . . 0.0 109.708 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -9' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' -2' ' ' LYS . 13.0 m-20 -130.28 37.4 3.88 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.926 0.891 . . . . 0.0 110.261 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -8' ' ' TYR . . . . . 0.563 ' HA ' HG21 ' A' ' 0' ' ' THR . 1.7 m-85 -84.81 69.26 10.7 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 122.034 0.921 . . . . 0.0 110.991 -169.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 179.98 7.76 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.272 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -6' ' ' ASP . . . . . 0.435 ' HA ' ' HE2' ' A' ' -2' ' ' LYS . 23.1 t70 -101.48 169.03 9.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 27.9 t70 72.68 150.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.841 1.256 . . . . 0.0 111.722 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.37 -178.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.006 0.922 . . . . 0.0 110.443 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.73 135.5 46.81 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.463 -0.773 . . . . 0.0 109.492 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.575 ' HG2' ' H ' ' A' ' 0' ' ' THR . 0.0 OUTLIER -167.46 -35.95 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.621 0.768 . . . . 0.0 110.068 -178.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 69.51 29.92 71.32 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.781 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.575 ' H ' ' HG2' ' A' ' -2' ' ' LYS . 65.3 p -88.55 141.57 28.41 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -108.06 167.5 9.95 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.887 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -120.84 133.48 55.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.7 mt -126.13 142.36 51.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.333 0.653 . . . . 0.0 109.945 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 45.5 tt0 -88.73 102.68 15.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.442 HD13 HD21 ' A' ' 37' ' ' LEU . 30.1 mt -93.76 104.0 16.11 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtp85 -94.4 117.83 30.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.775 -176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.4 138.12 43.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.864 0.866 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.28 156.2 48.01 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 109.56 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.458 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.55 -131.24 0.69 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.77 1.228 . . . . 0.0 111.64 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 14' ' ' VAL . 53.2 m -58.38 -46.89 85.46 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 123.346 0.658 . . . . 0.0 111.215 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -58.6 -26.38 63.62 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.042 0.537 . . . . 0.0 111.548 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -70.89 -50.47 34.65 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.096 0.558 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -74.26 -25.62 59.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.375 0.422 . . . . 0.0 111.932 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.552 HG11 ' HG ' ' A' ' 44' ' ' LEU . 48.1 t -59.29 -54.99 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.672 0.789 . . . . 0.0 110.036 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.49 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 94.4 t -72.59 -24.59 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.204 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.06 10.91 62.74 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.017 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -141.32 136.04 31.14 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.49 -22.06 21.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.035 0.534 . . . . 0.0 112.253 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 15.0 m -155.59 134.31 11.91 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 17.4 pt -131.27 176.66 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.209 1.004 . . . . 0.0 109.143 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -125.07 112.84 16.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.71 157.44 15.9 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 0.0 109.436 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -117.94 105.54 12.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.81 172.36 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 16.9 t70 -70.68 157.58 37.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -63.81 -27.74 69.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.06 0.544 . . . . 0.0 111.495 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.24 -23.82 37.77 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.032 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 129.6 40.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 110.586 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -110.81 -179.36 3.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.152 0.581 . . . . 0.0 110.774 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 39.6 t -51.52 -35.78 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.299 1.04 . . . . 0.0 111.981 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -65.81 -41.95 95.37 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 123.865 0.728 . . . . 0.0 114.011 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.81 -37.22 84.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.221 0.608 . . . . 0.0 110.765 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.13 -59.58 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.73 0.812 . . . . 0.0 110.543 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 54' ' ' VAL . 2.5 pp -65.86 -30.46 71.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 117.776 0.262 . . . . 0.0 111.501 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.515 ' HA ' HD11 ' A' ' 49' ' ' ILE . 10.4 tpt180 -54.55 -48.13 72.38 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.147 0.499 . . . . 0.0 110.713 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -75.48 -32.46 60.58 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.865 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -57.28 -39.35 75.51 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.54 0.736 . . . . 0.0 112.683 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 1.4 pp20? -73.53 -29.51 62.5 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 120.664 0.269 . . . . 0.0 111.63 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.18 -22.39 66.92 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.096 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -92.64 -57.71 2.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.777 0.799 . . . . 0.0 109.789 174.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 98.6 m-85 -99.83 116.8 32.74 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.954 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.33 -34.29 77.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.061 0.944 . . . . 0.0 111.052 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.01 -8.66 64.98 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.719 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.669 ' HB3' HD13 ' A' ' 48' ' ' LEU . 57.8 mt -105.54 -9.62 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.851 0.861 . . . . 0.0 111.507 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.87 121.27 10.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.105 0.562 . . . . 0.0 111.953 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.1 -33.85 3.93 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -86.17 2.68 45.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.669 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.34 -5.82 8.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.054 0.941 . . . . 0.0 111.043 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 35' ' ' ARG . 35.0 mt -132.31 128.78 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.499 1.119 . . . . 0.0 108.823 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -129.83 113.04 14.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.063 0.545 . . . . 0.0 109.724 168.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.56 30.7 20.16 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.893 0.877 . . . . 0.0 112.215 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.33 75.01 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.208 -0.774 . . . . 0.0 114.373 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.6 -174.57 2.68 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.085 0.943 . . . . 0.0 109.466 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.556 HG12 HD21 ' A' ' 34' ' ' LEU . 17.5 m -67.47 -56.94 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-O 117.764 -1.112 . . . . 0.0 112.098 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 13.4 tppt? 151.1 139.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 C-N-CA 124.956 1.302 . . . . 0.0 108.923 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 25.5 Cg_endo -59.89 134.08 54.7 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.112 2.542 . . . . 0.0 111.752 167.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 73.48 -14.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.98 1.312 . . . . 0.0 114.441 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.4 p -67.2 136.39 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 15.9 m120 -107.67 103.46 12.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.431 HG23 HG23 ' A' ' 67' ' ' VAL . 3.5 m -120.72 142.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.795 0.838 . . . . 0.0 109.288 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.0 mp -129.19 172.15 11.73 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.403 1.481 . . . . 0.0 109.979 -165.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 67' ' ' VAL . 18.4 tptp -165.14 106.13 0.79 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 56.3 35.31 25.6 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-O 122.065 0.936 . . . . 0.0 109.711 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.04 -13.4 57.08 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.639 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -90.73 117.76 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.9 tt0 -72.4 103.65 3.52 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.206 0.602 . . . . 0.0 110.25 -174.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 62' ' ' LYS . 13.0 m -67.66 -0.7 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 58' ' ' VAL . 5.3 m -67.39 -27.28 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 118.073 0.397 . . . . 0.0 110.526 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -82.05 -16.4 50.26 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.953 0.901 . . . . 0.0 111.118 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.5 -150.34 0.4 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.343 1.057 . . . . 0.0 109.354 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.31 108.37 3.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.442 0.697 . . . . 0.0 111.098 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.25 -42.57 18.59 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.653 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.632 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.8 mmt -78.24 -38.55 42.65 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.36 0.664 . . . . 0.0 112.412 -174.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.22 79.46 1.54 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.553 0.692 . . . . 0.0 111.535 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 t -81.72 -75.43 0.29 Allowed 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.707 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -177.45 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -164.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 77' ' ' LEU . 9.5 mt -72.65 118.31 15.41 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.238 0.926 . . . . 0.0 111.83 -166.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 42.6 m-20 -119.71 173.91 6.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.157 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.3 146.91 52.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.134 0.573 . . . . 0.0 112.277 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 14.86 67.17 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.164 -0.926 . . . . 0.0 114.19 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 2.2 t70 -72.89 179.67 3.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.316 0.558 . . . . 0.0 110.307 -177.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.56 100.08 3.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.047 0.539 . . . . 0.0 110.834 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.2 t -87.77 106.9 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.1 m -91.72 141.88 28.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.57 143.15 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 121.683 0.754 . . . . 0.0 110.189 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.603 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 12.8 m-85 -134.92 135.32 22.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 30.4 Cg_endo -61.49 161.92 22.53 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.361 2.708 . . . . 0.0 112.783 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.08 130.3 26.93 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.052 1.835 . . . . 0.0 112.525 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.09 143.79 10.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.607 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.54 91.05 2.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.817 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.27 29.24 7.26 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.417 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.916 0 CA-C-O 118.512 -1.16 . . . . 0.0 111.707 178.741 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 173.4 46.29 0.05 OUTLIER Glycine 0 C--N 1.347 1.163 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -170.34 146.63 9.99 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 120.088 -0.285 . . . . 0.0 112.498 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -87.29 -86.41 0.16 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 70.26 2.05 3.83 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 152.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 57.74 -81.43 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 160.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -7' ' ' LYS . . . . . 0.448 ' HE2' ' HA3' ' A' ' -1' ' ' GLY . 10.6 pttp -61.61 -32.0 72.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.241 1.416 . . . . 0.0 114.313 -166.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -159.27 176.26 12.4 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -169.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -79.61 -51.4 9.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.731 1.212 . . . . 0.0 110.728 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -98.17 154.13 17.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.895 0.878 . . . . 0.0 110.32 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 20.7 t70 60.61 100.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.356 1.462 . . . . 0.0 111.265 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -65.06 -45.87 83.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.55 1.14 . . . . 0.0 113.159 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' -7' ' ' LYS . . . 52.52 32.49 38.7 Favored Glycine 0 C--N 1.354 1.545 0 O-C-N 123.397 0.436 . . . . 0.0 113.215 -170.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 38.0 p -124.9 166.01 17.04 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.183 0.993 . . . . 0.0 110.406 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -141.21 128.87 21.51 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.357 1.063 . . . . 0.0 109.351 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.21 135.72 35.21 Favored 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 123.512 0.725 . . . . 0.0 109.065 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.36 132.62 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.215 0.606 . . . . 0.0 110.105 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 66.0 tt0 -88.82 95.9 10.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.499 HD13 HD21 ' A' ' 37' ' ' LEU . 46.1 mt -92.9 103.79 16.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 95.6 mtt180 -91.3 117.96 30.09 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.642 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.55 141.86 37.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -133.75 159.76 39.62 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.245 0.618 . . . . 0.0 109.563 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.3 -130.69 1.32 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.436 1.094 . . . . 0.0 112.1 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.404 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 81.3 m -55.68 -49.19 73.61 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 123.914 0.885 . . . . 0.0 111.188 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HE1' ' HD3' ' A' ' 47' ' ' ARG . 12.8 m-30 -59.78 -27.58 66.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.803 0.441 . . . . 0.0 111.283 -177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -52.6 27.07 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.605 0.362 . . . . 0.0 111.006 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.13 -21.07 60.79 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.436 0.46 . . . . 0.0 111.652 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.557 HG11 ' HG ' ' A' ' 44' ' ' LEU . 46.1 t -62.76 -53.89 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.444 0.698 . . . . 0.0 110.47 169.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 93.1 t -73.76 -21.68 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.572 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.95 11.19 62.9 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.699 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -142.54 142.56 32.24 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -95.68 -8.12 35.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.465 0.306 . . . . 0.0 111.737 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 2.1 m -158.47 128.16 5.82 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.491 1.116 . . . . 0.0 108.495 170.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 5' ' ' LEU . 11.3 pt -119.03 171.03 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.599 0.76 . . . . 0.0 108.999 173.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.05 112.38 20.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.531 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -93.39 177.3 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.647 1.179 . . . . 0.0 109.77 171.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -156.79 105.35 2.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 171.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.93 172.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.46 1.104 . . . . 0.0 108.618 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.88 160.46 30.63 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.415 0.286 . . . . 0.0 110.402 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.7 -14.95 59.47 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -81.31 -16.05 53.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 152.22 43.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.568 0.747 . . . . 0.0 110.712 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 33' ' ' VAL . 38.1 p -136.17 -174.49 3.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.834 1.253 . . . . 0.0 108.727 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.1 t -50.51 -36.32 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 C-N-CA 124.185 0.994 . . . . 0.0 112.238 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.12 62.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.844 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.43 -30.13 69.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.421 0.688 . . . . 0.0 110.791 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 29' ' ' THR . 72.8 t -62.72 -60.42 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.357 175.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.6 pp -66.25 -30.09 70.46 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.565 0.346 . . . . 0.0 111.616 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.591 ' HA ' HD11 ' A' ' 49' ' ' ILE . 12.0 tpt180 -50.56 -49.86 55.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.549 0.74 . . . . 0.0 111.042 169.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 35.0 t -76.09 -32.59 59.3 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.05 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.7 mm? -56.77 -36.69 70.11 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.199 0.6 . . . . 0.0 112.597 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.3 pt-20 -73.6 -26.64 60.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.8 62.31 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.303 0.641 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.531 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 16.8 mm-40 -89.52 -58.08 2.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.587 0.755 . . . . 0.0 109.864 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 97.9 m-85 -102.14 122.2 43.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.32 -171.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.19 -29.12 67.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.599 0.759 . . . . 0.0 111.941 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.8 -4.38 85.33 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.644 0.59 . . . . 0.0 113.47 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.603 ' HB3' HD13 ' A' ' 48' ' ' LEU . 67.2 mt -106.3 -0.98 23.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.479 0.711 . . . . 0.0 111.335 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.89 120.89 14.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.68 -2.5 53.88 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 170.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.9 ptp180 -107.9 4.0 24.87 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.235 1.014 . . . . 0.0 111.122 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -126.57 -2.24 6.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.186 0.994 . . . . 0.0 110.56 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.591 HD11 ' HA ' ' A' ' 35' ' ' ARG . 27.7 mt -131.53 137.15 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.757 1.223 . . . . 0.0 108.552 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -148.64 114.78 5.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.87 31.17 21.02 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.981 1.312 . . . . 0.0 112.374 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.39 -10.12 62.39 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.536 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -94.33 -174.84 3.47 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.261 1.031 . . . . 0.0 109.017 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG12 HD21 ' A' ' 34' ' ' LEU . 27.4 m -64.94 -55.81 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.31 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 58' ' ' VAL . 13.7 tppt? 150.84 132.71 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 125.526 1.53 . . . . 0.0 108.492 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 32.8 Cg_endo -61.85 135.05 53.5 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 122.947 2.431 . . . . 0.0 111.507 165.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 82.95 -17.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.306 1.442 . . . . 0.0 113.578 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.477 HG23 ' HD3' ' A' ' 88' ' ' PRO . 2.0 p -73.16 139.39 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.5 m120 -106.12 103.71 13.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.83 131.11 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.162 0.585 . . . . 0.0 109.618 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.5 mp -123.01 143.24 50.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.476 1.11 . . . . 0.0 109.986 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 2.2 tptm -112.98 105.26 13.28 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.45 55.88 8.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.282 1.433 . . . . 0.0 111.994 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.54 -14.34 30.35 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.801 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -97.43 114.07 25.85 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 117.566 0.683 . . . . 0.0 109.212 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.2 tt0 -70.3 112.37 6.58 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 75' ' ' THR . 35.4 m -72.44 -1.27 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 113.397 -174.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 m -70.21 -13.36 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.818 0.447 . . . . 0.0 111.422 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -93.81 -18.78 21.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.635 0.774 . . . . 0.0 110.904 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.96 -152.9 0.52 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.117 0.967 . . . . 0.0 109.076 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 75' ' ' THR . 9.9 m-20 -58.09 112.84 1.66 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.068 0.547 . . . . 0.0 110.956 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.33 -46.77 8.72 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 76.0 mmm -80.32 -38.92 29.68 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.829 0.852 . . . . 0.0 112.32 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.85 74.31 1.46 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.475 0.655 . . . . 0.0 111.48 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.7 t -81.31 -69.94 0.57 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.498 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' H ' HG23 ' A' ' 75' ' ' THR . . . -177.05 33.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.846 0.858 . . . . 0.0 110.485 -164.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.1 tp -75.66 138.61 41.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.709 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -151.04 -176.13 5.42 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.743 1.217 . . . . 0.0 107.978 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.88 144.43 50.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 118.432 0.56 . . . . 0.0 111.203 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.75 5.17 63.68 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.912 0.768 . . . . 0.0 114.566 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.602 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.9 m-20 -84.35 135.66 34.21 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.241 0.521 . . . . 0.0 112.117 -171.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -92.64 124.6 36.78 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.827 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.7 t -108.1 106.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.5 m -94.34 106.0 17.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.157 0.583 . . . . 0.0 110.186 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 m -106.58 145.46 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.005 0.907 . . . . 0.0 111.039 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 8.2 m-85 -131.23 139.69 36.24 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 175.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 46.4 Cg_endo -65.91 168.49 15.26 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.485 2.79 . . . . 0.0 112.631 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HG23 ' A' ' 58' ' ' VAL . 74.3 Cg_endo -70.93 129.99 17.21 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.077 1.185 . . . . 0.0 109.372 170.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.3 m -94.88 -10.29 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.095 0.558 . . . . 0.0 110.715 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.96 101.64 4.63 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.54 92.5 0.51 Allowed Glycine 0 C--N 1.346 1.092 0 O-C-N 123.67 0.606 . . . . 0.0 111.823 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.244 0 CA-C-O 118.633 -1.093 . . . . 0.0 112.003 -179.0 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.936 0 CA-C-O 120.112 -0.271 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 80.43 -67.03 3.57 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.305 0.479 . . . . 0.0 112.554 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 98.39 -51.82 1.23 Allowed Glycine 0 C--N 1.346 1.114 0 C-N-CA 123.208 0.432 . . . . 0.0 112.312 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -10' ' ' ARG . . . . . 0.526 HH21 HG12 ' A' ' 24' ' ' VAL . 32.0 mtp85 -110.79 54.52 0.67 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.716 0.806 . . . . 0.0 109.75 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.93 -32.68 15.18 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.181 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 65.2 -76.58 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.654 1.181 . . . . 0.0 110.918 -172.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -7' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' -3' ' ' ASP . 27.0 mtpp 58.96 69.46 0.72 Allowed 'General case' 0 C--N 1.353 0.74 0 C-N-CA 124.457 1.103 . . . . 0.0 110.099 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.52 -68.13 0.34 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.145 -166.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.81 -52.09 6.67 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -162.08 -53.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.868 0.867 . . . . 0.0 109.328 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' -7' ' ' LYS . 13.9 t70 -66.41 144.87 56.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.389 0.676 . . . . 0.0 110.629 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.83 -49.66 72.67 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.459 1.104 . . . . 0.0 112.512 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 56.88 53.59 43.11 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 116.417 -0.356 . . . . 0.0 112.709 -172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 31.1 p -134.69 142.45 46.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.24 0.543 . . . . 0.0 111.786 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptm -102.94 118.76 37.53 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.476 1.51 . . . . 0.0 110.54 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -86.53 126.49 34.49 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.494 HD13 HD21 ' A' ' 77' ' ' LEU . 27.1 mt -128.46 130.19 47.2 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.288 0.635 . . . . 0.0 110.149 -167.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -88.75 97.74 11.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.435 HD13 HD21 ' A' ' 37' ' ' LEU . 24.3 mt -93.49 103.52 15.71 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 90.0 mtt180 -92.26 117.69 30.14 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.061 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.07 140.1 38.76 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.811 0.844 . . . . 0.0 109.633 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -131.94 158.4 41.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.054 0.542 . . . . 0.0 110.054 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.21 -127.44 1.27 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.069 1.347 . . . . 0.0 111.93 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.36 -47.02 87.87 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.662 0.785 . . . . 0.0 111.204 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -58.06 -29.57 65.51 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.096 0.558 . . . . 0.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.62 -54.32 20.68 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.002 0.521 . . . . 0.0 110.937 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 -20.05 60.43 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 123.62 0.575 . . . . 0.0 111.858 -174.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.48 HG11 ' HG ' ' A' ' 44' ' ' LEU . 41.6 t -60.69 -54.36 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.37 0.668 . . . . 0.0 110.142 168.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.416 HG12 ' HG3' ' A' ' 17' ' ' GLN . 60.4 t -73.26 -21.22 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.367 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.7 11.29 65.53 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.359 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.416 ' HG3' HG12 ' A' ' 15' ' ' VAL . 15.0 mt-30 -140.23 143.46 36.02 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.993 0.917 . . . . 0.0 109.051 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -92.93 -15.09 26.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.492 0.717 . . . . 0.0 111.694 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -156.58 138.06 13.98 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.2 pt -130.99 174.51 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.015 0.926 . . . . 0.0 108.545 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.54 111.92 17.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 163.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.426 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -89.62 176.85 6.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 108.743 169.256 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -155.8 111.74 3.07 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.809 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.526 HG12 HH21 ' A' ' -10' ' ' ARG . 17.0 m -113.62 177.68 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.412 1.085 . . . . 0.0 108.169 174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -59.85 148.95 32.86 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.376 0.535 . . . . 0.0 110.533 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.09 -10.22 59.38 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.77 -20.25 43.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.682 0.793 . . . . 0.0 110.952 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 160.98 23.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.122 0.969 . . . . 0.0 112.377 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -138.39 -176.32 4.42 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.766 1.226 . . . . 0.0 109.437 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.3 t -51.33 -35.84 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.205 1.002 . . . . 0.0 111.471 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.74 -43.54 59.21 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.772 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -64.72 -31.37 72.57 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.447 0.699 . . . . 0.0 110.985 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.22 -60.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.86 0.864 . . . . 0.0 110.63 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.4 pp -65.62 -30.03 70.69 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.469 0.481 . . . . 0.0 111.173 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.727 ' HA ' HD11 ' A' ' 49' ' ' ILE . 21.9 tpt180 -53.1 -50.51 64.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.681 0.753 . . . . 0.0 111.695 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.8 m -75.27 -31.92 60.88 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.593 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.435 HD21 HD13 ' A' ' 5' ' ' LEU . 2.5 mm? -56.14 -46.9 79.07 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.323 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.503 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.1 pt-20 -67.78 -26.87 66.31 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.757 0.253 . . . . 0.0 111.486 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.98 -23.93 67.36 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.455 0.472 . . . . 0.0 111.465 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -101.03 -59.55 1.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.158 0.504 . . . . 0.0 110.503 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -86.01 120.72 27.71 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.314 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.56 -33.12 74.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.992 0.917 . . . . 0.0 110.798 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.09 2.85 83.02 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.578 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 48' ' ' LEU . 71.5 mt -115.02 6.15 15.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.352 0.661 . . . . 0.0 110.725 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -72.26 121.45 19.42 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -173.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.58 68.06 Favored Glycine 0 C--N 1.357 1.742 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.524 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 13.5 ptp180 -119.59 -4.78 10.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.031 0.932 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -119.25 -3.84 10.52 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.189 1.395 . . . . 0.0 109.886 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.727 HD11 ' HA ' ' A' ' 35' ' ' ARG . 75.5 mt -132.41 140.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.931 1.293 . . . . 0.0 108.156 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.67 126.96 5.25 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 61.55 30.85 18.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.761 1.224 . . . . 0.0 111.543 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.03 -4.98 56.15 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.666 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -106.59 -174.27 2.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.497 0.719 . . . . 0.0 109.455 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG12 HD21 ' A' ' 34' ' ' LEU . 19.1 m -59.37 -55.67 22.17 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 CA-C-O 117.689 -1.148 . . . . 0.0 112.483 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 12.5 tppt? 150.59 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 125.173 1.389 . . . . 0.0 108.057 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 11.4 Cg_endo -52.6 124.71 15.86 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.969 2.446 . . . . 0.0 111.947 168.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 74.74 2.59 4.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.639 1.176 . . . . 0.0 113.821 170.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 p -77.63 132.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 19.5 m120 -98.35 103.89 15.88 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.83 141.44 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.574 0.749 . . . . 0.0 109.692 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -131.17 140.62 49.96 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.173 1.389 . . . . 0.0 109.556 -166.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.601 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 16.0 tptm -105.46 105.63 15.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 166.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.7 t30 57.12 36.35 27.47 Favored 'General case' 0 CA--C 1.562 1.418 0 O-C-N 124.168 0.918 . . . . 0.0 111.366 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.3 -10.46 74.83 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -94.26 109.96 21.74 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.0 tt0 -68.62 106.25 2.54 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.032 0.533 . . . . 0.0 110.754 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.534 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 16.1 m -69.2 -1.23 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -174.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 m -68.06 -21.74 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-N 117.773 0.261 . . . . 0.0 111.237 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -87.55 -19.4 27.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.339 0.655 . . . . 0.0 110.656 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.0 -153.09 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.382 1.073 . . . . 0.0 109.718 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.73 108.4 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.579 0.752 . . . . 0.0 110.582 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -71.89 -49.63 22.03 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.589 -0.278 . . . . 0.0 113.122 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.5 -39.68 37.46 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.68 75.6 1.48 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.348 0.594 . . . . 0.0 110.903 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -76.65 -60.79 2.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.239 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.18 33.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.569 1.148 . . . . 0.0 109.657 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 3' ' ' LEU . 42.5 tp -74.98 114.84 13.92 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -120.1 -176.7 3.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.676 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -66.5 144.14 56.65 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.364 0.666 . . . . 0.0 111.101 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.92 8.97 85.22 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.946 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.601 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 70.4 m-20 -97.75 144.56 27.25 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.786 0.834 . . . . 0.0 111.599 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.28 141.96 27.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.67 0.788 . . . . 0.0 111.116 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.08 107.39 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.232 1.013 . . . . 0.0 108.311 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.686 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 49.4 m -90.6 139.05 31.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.691 0.796 . . . . 0.0 109.268 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.16 142.43 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.124 0.874 . . . . 0.0 110.624 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 20.5 m-85 -129.79 135.99 28.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.41 164.02 19.05 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.329 2.686 . . . . 0.0 112.16 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.17 130.51 17.72 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.364 1.376 . . . . 0.0 110.287 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.35 -17.47 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.22 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 63.08 30.03 16.2 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.841 1.257 . . . . 0.0 112.945 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.85 50.87 4.47 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 122.957 0.313 . . . . 0.0 112.955 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.326 0 CA-C-O 118.924 -0.931 . . . . 0.0 111.86 -178.767 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -13' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' -4' ' ' ASP . . . . . . . . 0 N--CA 1.478 1.46 0 CA-C-O 119.557 -0.58 . . . . 0.0 111.745 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -179.34 -35.6 0.06 OUTLIER Glycine 0 C--N 1.347 1.188 0 CA-C-N 117.175 0.488 . . . . 0.0 112.653 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 134.78 129.12 2.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 15.9 mtm-85 69.38 36.45 2.28 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.394 1.077 . . . . 0.0 110.166 -171.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.74 -24.64 33.45 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.948 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 65.9 10.81 7.2 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 125.518 1.527 . . . . 0.0 112.128 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -151.5 178.11 9.64 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.025 0.93 . . . . 0.0 110.624 -163.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.65 -38.72 92.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.231 1.012 . . . . 0.0 111.392 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -158.25 -155.85 0.52 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.261 -174.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -4' ' ' ASP . . . . . 0.432 ' O ' ' HA2' ' A' ' -13' ' ' GLY . 17.5 m-20 70.69 168.9 0.31 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.357 1.463 . . . . 0.0 111.346 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -62.19 -44.42 96.63 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -176.91 -54.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.437 1.495 . . . . 0.0 108.76 166.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 61.76 39.96 98.15 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.775 0.672 . . . . 0.0 112.058 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 43.5 p -122.72 148.62 45.1 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.041 0.936 . . . . 0.0 109.007 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -122.71 146.03 47.86 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.506 0.722 . . . . 0.0 109.944 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.57 135.2 33.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.512 HD13 HD21 ' A' ' 77' ' ' LEU . 20.6 mt -134.12 133.54 41.2 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.32 0.648 . . . . 0.0 109.399 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -88.89 107.79 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 37' ' ' LEU . 24.6 mt -94.79 104.03 15.93 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 92.4 mtt180 -92.05 118.13 30.5 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.825 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.7 139.6 40.03 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.807 0.843 . . . . 0.0 109.283 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.43 154.95 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.195 0.598 . . . . 0.0 109.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.85 -128.9 0.72 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.813 1.245 . . . . 0.0 112.074 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.44 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 35.3 m -62.39 -41.5 98.69 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 123.731 0.813 . . . . 0.0 111.381 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -63.33 -25.18 68.18 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.225 0.61 . . . . 0.0 111.383 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -71.55 -53.18 14.63 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.411 0.684 . . . . 0.0 111.189 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 8.9 pt-20 -71.18 -23.37 62.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.013 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG11 ' HG ' ' A' ' 44' ' ' LEU . 19.8 t -60.87 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.555 0.693 . . . . 0.0 111.043 170.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.74 -21.97 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.323 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.48 12.48 77.22 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.567 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -143.36 143.82 31.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.774 1.229 . . . . 0.0 109.016 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -94.62 -18.47 21.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.622 0.369 . . . . 0.0 111.732 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -154.86 127.96 8.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.899 0.88 . . . . 0.0 108.663 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.17 170.02 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.955 0.902 . . . . 0.0 109.086 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.82 112.35 20.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -96.93 179.67 4.87 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 108.848 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -157.06 106.17 2.19 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.15 179.97 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.427 1.091 . . . . 0.0 108.391 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.71 150.14 24.31 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.489 0.715 . . . . 0.0 111.511 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.91 -20.82 62.45 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.149 0.579 . . . . 0.0 111.741 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.89 -23.82 20.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.238 0.615 . . . . 0.0 110.724 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.29 128.06 35.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.465 0.306 . . . . 0.0 110.286 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.2 p -107.25 -174.68 2.59 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.496 0.719 . . . . 0.0 111.175 -172.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 78.9 t -51.85 -38.24 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.164 0.985 . . . . 0.0 112.25 -173.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -64.44 -42.39 97.62 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 123.728 0.643 . . . . 0.0 113.27 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -69.24 -30.42 68.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.57 0.748 . . . . 0.0 110.956 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.0 t -64.88 -60.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.476 0.71 . . . . 0.0 110.452 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.498 HD21 HG12 ' A' ' 54' ' ' VAL . 1.9 pp -63.94 -30.3 71.39 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.183 0.447 . . . . 0.0 111.337 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.568 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.8 tpt85 -53.71 -47.02 70.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.046 0.538 . . . . 0.0 110.831 169.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 m -74.84 -32.94 62.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.22 0.608 . . . . 0.0 111.78 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 5' ' ' LEU . 3.9 mm? -58.18 -35.36 71.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -78.57 -25.91 45.46 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.173 0.442 . . . . 0.0 111.394 176.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -16.07 62.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.652 0.781 . . . . 0.0 111.513 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -100.87 -59.36 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.404 0.681 . . . . 0.0 110.181 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.07 119.47 34.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.676 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.09 -30.29 70.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.858 0.463 . . . . 0.0 110.599 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -72.22 -12.28 76.03 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.597 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 48' ' ' LEU . 97.7 mt -109.84 -0.43 18.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 111.026 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -62.02 121.08 12.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.444 0.698 . . . . 0.0 112.433 -172.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.12 -22.87 3.43 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -91.18 10.69 26.01 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.393 1.077 . . . . 0.0 111.856 -173.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -130.0 -5.98 4.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.34 1.056 . . . . 0.0 110.9 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 35' ' ' ARG . 67.4 mt -131.78 130.6 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.676 1.19 . . . . 0.0 108.195 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.37 126.13 22.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.951 0.5 . . . . 0.0 110.0 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.1 t70 54.81 31.33 15.39 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.552 1.141 . . . . 0.0 112.315 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.41 -13.74 53.94 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.692 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.35 -176.96 3.45 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.815 0.846 . . . . 0.0 109.008 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG12 HD21 ' A' ' 34' ' ' LEU . 16.6 m -64.47 -56.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.836 -1.078 . . . . 0.0 112.333 -173.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? 155.17 133.14 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 124.705 1.202 . . . . 0.0 109.287 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.79 134.48 47.13 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.519 2.812 . . . . 0.0 111.383 168.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 77.85 -15.11 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.778 1.631 . . . . 0.0 113.52 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.13 145.37 13.0 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -114.24 103.88 11.54 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.05 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.071 0.948 . . . . 0.0 108.663 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.706 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -117.15 151.51 36.7 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 20.8 tptp -124.24 104.37 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.392 1.477 . . . . 0.0 107.203 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 50.75 38.63 20.0 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.648 1.179 . . . . 0.0 111.15 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.1 80.82 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.374 -0.83 . . . . 0.0 115.107 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -103.61 110.15 22.1 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 118.021 0.911 . . . . 0.0 109.424 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.4 tt0 -66.55 112.28 4.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.497 0.719 . . . . 0.0 110.885 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.579 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 31.0 m -68.01 -0.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.41 -18.18 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 118.182 0.446 . . . . 0.0 110.669 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -92.73 -10.52 36.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.141 0.976 . . . . 0.0 111.396 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.66 -155.67 0.62 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.019 0.928 . . . . 0.0 109.081 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -66.92 111.01 3.56 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.008 0.523 . . . . 0.0 111.492 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.579 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -73.21 -50.32 12.89 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.223 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.522 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.5 mmt -71.15 -36.56 72.09 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.576 0.75 . . . . 0.0 112.79 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.39 81.67 1.41 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.749 0.785 . . . . 0.0 111.525 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -79.67 -79.37 0.14 Allowed 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.961 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 75' ' ' THR . . . -169.96 33.11 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.132 0.573 . . . . 0.0 110.035 -168.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 18.0 tp -74.72 123.25 24.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.928 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.69 168.08 17.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.98 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.92 135.16 55.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.124 0.57 . . . . 0.0 111.29 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.26 18.97 73.04 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.54 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.12 169.98 12.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.736 0.414 . . . . 0.0 110.092 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.48 98.45 4.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.415 0.686 . . . . 0.0 110.519 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -86.36 107.88 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.706 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 53.6 m -87.04 152.23 22.56 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.91 0.484 . . . . 0.0 109.934 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m -144.56 146.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-O 121.635 0.731 . . . . 0.0 109.939 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.567 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 11.3 m-85 -136.81 140.34 31.56 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HG3' ' H ' ' A' ' 10' ' ' THR . 37.6 Cg_endo -63.19 169.08 9.84 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.796 2.998 . . . . 0.0 112.501 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.53 129.72 27.52 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 121.159 1.239 . . . . 0.0 110.627 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.4 m -101.84 -3.76 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.384 0.674 . . . . 0.0 111.218 -170.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.46 158.57 44.29 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.712 0.805 . . . . 0.0 110.082 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.88 158.65 35.27 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.392 0 CA-C-O 119.126 -0.819 . . . . 0.0 112.198 179.57 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.066 0 N-CA-C 112.792 -0.123 . . . . 0.0 112.792 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -166.51 84.49 0.1 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -103.06 -146.38 17.06 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 61.09 77.15 0.34 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.595 1.158 . . . . 0.0 112.091 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -9' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' -2' ' ' LYS . 29.2 m-20 -89.85 77.03 7.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.929 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' -8' ' ' TYR . . . . . 0.462 ' HA ' HG21 ' A' ' 0' ' ' THR . 4.2 m-30 -87.43 41.63 0.99 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.127 0.571 . . . . 0.0 110.484 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.03 -171.67 3.93 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.777 1.231 . . . . 0.0 110.904 -174.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -83.47 128.44 34.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.176 0.99 . . . . 0.0 111.55 -174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -5' ' ' ASP . . . . . 0.576 ' N ' ' HZ3' ' A' ' -2' ' ' LYS . 5.2 m-20 -156.49 -170.55 3.38 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.614 1.566 . . . . 0.0 107.906 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.4 -43.78 59.83 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 163.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -140.82 153.73 45.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.816 0.846 . . . . 0.0 109.665 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.589 ' HZ2' ' HB3' ' A' ' -2' ' ' LYS . 0.0 OUTLIER -153.22 -42.31 0.1 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.189 0.996 . . . . 0.0 111.217 -172.47 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 92.61 1.35 68.51 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.185 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 69.7 p -89.02 142.35 27.71 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.754 0.777 . . . . 0.0 111.092 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 26.9 ptt? -102.84 129.62 49.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 110.583 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.05 136.52 33.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.421 HD13 HD21 ' A' ' 77' ' ' LEU . 21.5 mt -131.82 134.3 45.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -173.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 100.32 13.1 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.78 104.16 16.25 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 52.9 mtp180 -91.0 116.83 29.09 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.757 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 96.0 m-85 -103.79 138.81 39.88 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 109.241 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -130.77 157.88 41.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.645 0.778 . . . . 0.0 109.072 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.46 -132.72 0.8 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.443 1.097 . . . . 0.0 112.563 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 14' ' ' VAL . 25.6 m -58.09 -42.3 85.34 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 124.16 0.984 . . . . 0.0 111.876 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 11.3 m-30 -62.66 -34.37 76.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.83 0.452 . . . . 0.0 111.224 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -38.38 88.02 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.536 0.523 . . . . 0.0 110.089 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.35 -43.96 84.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.986 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG11 ' HG ' ' A' ' 44' ' ' LEU . 69.4 t -57.22 -51.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.703 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.69 -26.6 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.453 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 11.4 71.25 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.144 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -138.46 145.72 41.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -86.91 -25.01 24.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.05 0.54 . . . . 0.0 112.038 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -156.39 123.13 5.17 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.184 0.993 . . . . 0.0 108.372 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.83 173.39 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.664 0.786 . . . . 0.0 109.353 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.57 112.09 18.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -95.4 177.15 5.93 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.599 1.16 . . . . 0.0 108.689 171.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -157.11 106.79 2.22 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.153 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.24 168.88 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 26.4 t70 -71.75 155.22 40.7 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.93 -14.63 61.91 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.59 0.756 . . . . 0.0 112.708 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -80.14 -16.91 53.9 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.122 0.569 . . . . 0.0 109.909 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.6 163.88 27.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.778 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.1 p -133.48 -175.39 3.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.563 1.145 . . . . 0.0 109.126 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.38 -37.93 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.051 0.94 . . . . 0.0 111.176 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.562 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.83 -42.48 69.92 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.567 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.45 -36.38 78.1 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.3 0.64 . . . . 0.0 111.033 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -62.76 -60.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.511 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.471 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.9 -30.45 71.44 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.466 0.306 . . . . 0.0 111.233 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.47 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.6 tpt180 -54.71 -49.21 71.26 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.187 0.595 . . . . 0.0 111.603 170.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 m -75.85 -31.27 59.24 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.736 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.03 -46.84 75.31 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.543 0.737 . . . . 0.0 112.373 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.6 pt-20 -65.5 -26.4 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.05 -22.25 62.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.113 0.565 . . . . 0.0 111.211 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -100.36 -59.43 1.71 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.682 0.753 . . . . 0.0 109.413 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -86.83 104.0 15.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.352 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.3 -17.55 63.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.384 0.674 . . . . 0.0 111.329 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -74.99 -12.65 83.21 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.304 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.635 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.6 mt -101.62 0.65 36.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.483 0.713 . . . . 0.0 110.918 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.38 121.35 14.65 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.54 70.42 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.229 -0.896 . . . . 0.0 115.213 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.55 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 2.3 ptp180 -117.91 -12.24 10.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.858 0.863 . . . . 0.0 111.13 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.635 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -107.41 -3.27 19.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.41 1.084 . . . . 0.0 110.477 172.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 35' ' ' ARG . 21.1 mt -134.47 136.5 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.911 1.284 . . . . 0.0 109.0 171.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.47 108.2 8.98 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 167.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 53.56 31.55 12.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.032 0.933 . . . . 0.0 112.903 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.6 2.25 67.68 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.52 -178.88 3.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 164.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.59 -55.54 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.152 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 14.2 tppt? 150.54 132.27 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.534 0 C-N-CA 125.443 1.497 . . . . 0.0 109.054 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.88 132.85 54.53 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 122.951 2.434 . . . . 0.0 111.679 167.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 78.93 -12.18 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.286 1.434 . . . . 0.0 113.94 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 55' ' ' LYS . 1.2 p -73.18 139.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.614 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.13 104.49 13.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 85' ' ' VAL . 2.9 m -119.16 119.1 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.487 0.715 . . . . 0.0 109.289 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -112.38 131.24 55.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.491 1.116 . . . . 0.0 110.615 -172.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 17.2 tptp -107.57 109.51 21.18 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.63 1.572 . . . . 0.0 108.116 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 56.38 35.42 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.763 0.792 . . . . 0.0 110.667 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.0 -0.07 87.49 Favored Glycine 0 CA--C 1.543 1.804 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.617 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -107.47 112.56 25.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.651 0.78 . . . . 0.0 109.913 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.4 tt0 -67.14 105.19 1.62 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.913 0.885 . . . . 0.0 110.98 -173.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 62' ' ' LYS . 17.1 m -69.33 -0.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 58' ' ' VAL . 17.4 m -67.72 -21.19 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 117.924 0.329 . . . . 0.0 111.152 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -84.73 -17.47 38.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.88 0.872 . . . . 0.0 111.204 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -138.15 -151.27 0.38 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.241 1.016 . . . . 0.0 109.769 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 75' ' ' THR . 1.4 m-20 -63.93 108.5 1.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.026 0.53 . . . . 0.0 111.167 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.25 -42.2 15.65 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.842 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.562 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.3 mmt -77.82 -39.88 42.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.399 0.679 . . . . 0.0 112.334 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.77 77.66 1.47 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.102 0.477 . . . . 0.0 111.461 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 71' ' ' ASP . 4.0 t -81.49 -67.91 0.74 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.003 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 75' ' ' THR . . . 179.84 33.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.346 0.658 . . . . 0.0 111.184 -164.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.486 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 31.0 tp -73.45 135.41 44.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.244 0.545 . . . . 0.0 110.692 -164.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.6 166.19 24.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.998 -165.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 34.4 t70 -65.52 143.6 57.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.382 0.673 . . . . 0.0 111.769 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.33 75.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.627 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.69 137.12 33.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 117.455 0.628 . . . . 0.0 111.249 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -96.39 94.99 7.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.766 0.426 . . . . 0.0 109.953 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 t -86.89 106.36 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.659 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 54.8 m -82.61 150.07 27.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.401 0.681 . . . . 0.0 110.035 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 60' ' ' VAL . 23.0 m -145.9 141.84 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.601 0.715 . . . . 0.0 109.686 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 10.9 m-85 -133.68 132.09 21.53 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 22.0 Cg_endo -59.41 165.66 8.94 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.647 2.898 . . . . 0.0 113.256 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.35 130.47 23.96 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 121.532 1.488 . . . . 0.0 110.676 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 m -127.55 128.33 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.027 0.931 . . . . 0.0 108.717 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.16 97.25 4.23 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.439 0.696 . . . . 0.0 109.169 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.06 31.32 0.5 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.201 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.04 0 CA-C-O 118.889 -0.951 . . . . 0.0 111.661 -176.561 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 113.72 64.93 0.44 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -137.04 -149.65 5.65 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -101.09 35.58 2.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.119 0.968 . . . . 0.0 110.271 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.45 126.38 31.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.515 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -105.73 12.55 30.84 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.746 0.819 . . . . 0.0 110.152 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -156.63 161.49 39.9 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.945 0.898 . . . . 0.0 110.068 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.1 -0.91 33.48 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.907 0.883 . . . . 0.0 112.754 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.47 157.21 17.53 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.5 0.72 . . . . 0.0 112.71 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.55 -57.66 11.73 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.861 1.264 . . . . 0.0 110.875 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -82.76 146.33 29.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.349 171.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -25.88 68.51 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.426 0.69 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 61.42 48.01 87.51 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 124.26 0.975 . . . . 0.0 113.277 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 46.5 p -123.64 142.2 51.28 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -123.87 141.81 51.69 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.304 0.642 . . . . 0.0 110.055 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -107.73 113.16 26.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.699 0.399 . . . . 0.0 110.265 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.439 HD13 HD21 ' A' ' 77' ' ' LEU . 18.1 mt -102.64 142.09 34.38 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.257 1.023 . . . . 0.0 110.825 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.34 97.06 10.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.39 103.49 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.6 mtp180 -96.07 116.39 28.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.698 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -103.68 137.27 41.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.83 0.852 . . . . 0.0 109.18 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -129.17 159.59 35.54 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.574 0.75 . . . . 0.0 109.102 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.44 -133.6 1.07 Allowed 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.12 0.968 . . . . 0.0 112.239 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 14' ' ' VAL . 31.3 m -59.89 -40.92 90.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.618 0.767 . . . . 0.0 112.235 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -63.22 -29.08 70.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.772 0.26 . . . . 0.0 111.02 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 54.4 ttp85 -66.77 -53.58 31.59 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.391 0.676 . . . . 0.0 111.552 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.76 -27.9 67.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.401 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.458 HG11 ' HG ' ' A' ' 44' ' ' LEU . 45.6 t -62.19 -53.07 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.593 0.757 . . . . 0.0 111.046 173.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.45 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.1 t -70.64 -24.16 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.294 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.51 11.06 71.87 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.587 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -142.53 135.74 28.61 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 21.0 ptmt -83.69 -24.36 31.3 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.539 0.336 . . . . 0.0 111.773 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -155.52 135.69 13.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.2 172.68 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.739 0.816 . . . . 0.0 109.846 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 3' ' ' LEU . 82.8 m-85 -123.18 113.4 18.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.403 0.621 . . . . 0.0 109.51 170.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.456 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -103.01 139.53 38.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.153 1.381 . . . . 0.0 109.51 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -107.95 106.63 16.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.25 -179.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.326 1.05 . . . . 0.0 109.116 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.22 154.75 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.127 0.571 . . . . 0.0 109.894 173.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.36 -37.69 86.64 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.076 0.95 . . . . 0.0 112.25 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.83 -13.04 59.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.42 0.688 . . . . 0.0 110.705 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 142.87 57.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.878 0.471 . . . . 0.0 109.903 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 p -118.83 -176.93 3.2 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.9 t -53.09 -35.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.125 0.97 . . . . 0.0 111.504 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.78 59.64 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.36 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.0 -33.13 72.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.384 0.673 . . . . 0.0 110.804 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.26 -60.38 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.304 1.042 . . . . 0.0 110.946 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.567 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.9 pp -65.33 -30.11 70.92 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 123.239 0.337 . . . . 0.0 111.704 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.597 ' HA ' HD11 ' A' ' 49' ' ' ILE . 1.3 ppt_? -64.49 -36.55 84.55 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.077 0.465 . . . . 0.0 109.994 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.9 m -75.6 -33.67 60.58 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.622 0.769 . . . . 0.0 111.769 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.96 -37.86 88.77 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.064 0.546 . . . . 0.0 112.358 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -70.66 -28.55 64.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.832 0.348 . . . . 0.0 111.609 176.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.94 -24.49 62.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.158 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 12.8 mm-40 -88.13 -59.64 2.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.634 0.731 . . . . 0.0 109.726 174.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 97.1 m-85 -98.45 118.29 34.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.114 -170.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.78 -28.67 68.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.139 0.976 . . . . 0.0 110.654 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.496 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.7 -9.55 86.97 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 119.411 -0.661 . . . . 0.0 113.844 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.617 ' HB3' HD13 ' A' ' 48' ' ' LEU . 84.0 mt -95.9 -6.92 38.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.657 0.729 . . . . 0.0 111.127 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.22 124.61 22.62 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.6 0.76 . . . . 0.0 112.906 -171.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.96 8.51 86.81 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 115.135 0.814 . . . . 0.0 115.135 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.3 OUTLIER -125.1 -22.37 4.44 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 117.404 0.602 . . . . 0.0 111.973 -174.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -96.55 -0.23 49.11 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.774 0.43 . . . . 0.0 110.704 172.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 35' ' ' ARG . 57.4 mt -135.41 145.66 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.173 1.389 . . . . 0.0 108.634 171.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 15.4 tp10 -157.74 127.85 6.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.967 0.907 . . . . 0.0 108.96 168.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.6 t70 56.87 31.31 19.42 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.493 1.14 . . . . 0.0 111.373 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.88 -14.26 38.59 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 114.743 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -94.89 -174.06 3.16 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 117.83 0.815 . . . . 0.0 110.053 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG12 HD21 ' A' ' 34' ' ' LEU . 18.2 m -59.93 -54.71 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.772 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 50' ' ' GLU . 9.6 tppt? 150.44 137.0 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 C-N-CA 126.304 1.841 . . . . 0.0 108.112 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.76 125.6 19.18 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.038 164.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 81.19 -9.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.403 1.481 . . . . 0.0 113.939 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 55' ' ' LYS . 5.2 p -69.52 129.21 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.609 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -94.92 103.27 15.14 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 m -121.55 131.14 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.489 HD13 ' CE1' ' A' ' 86' ' ' PHE . 6.7 mp -123.87 141.73 51.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.065 0.946 . . . . 0.0 110.645 -168.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HE3' HD12 ' A' ' 77' ' ' LEU . 15.0 tptm -111.84 105.14 13.52 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.177 1.391 . . . . 0.0 107.835 168.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.11 35.61 25.25 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.45 1.1 . . . . 0.0 111.402 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.65 -14.21 64.65 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 114.342 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -89.09 107.66 19.16 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.896 0.848 . . . . 0.0 109.595 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.6 tt0 -65.34 106.85 1.46 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.102 0.561 . . . . 0.0 110.024 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.401 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 23.7 m -69.73 -1.71 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.33 -22.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.501 0.591 . . . . 0.0 110.917 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 66' ' ' GLU . 60.0 m-70 -84.05 -12.12 55.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.548 0.739 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.58 -153.04 0.44 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.568 1.147 . . . . 0.0 109.318 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.16 108.46 0.9 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.675 0.39 . . . . 0.0 110.687 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.401 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -74.7 -47.9 14.03 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.371 0.42 . . . . 0.0 112.358 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 90.1 mmm -80.31 -36.78 33.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.307 0.643 . . . . 0.0 112.221 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.98 76.81 1.52 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.906 -0.496 . . . . 0.0 111.715 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.7 t -81.46 -69.33 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.994 0.518 . . . . 0.0 112.393 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 75' ' ' THR . . . -179.0 34.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.507 0.723 . . . . 0.0 111.064 -163.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.484 HD12 ' HE3' ' A' ' 62' ' ' LYS . 40.4 tp -74.25 141.45 45.37 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.22 0.608 . . . . 0.0 111.502 -169.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -154.78 175.92 13.12 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.947 0.899 . . . . 0.0 109.567 -170.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.16 143.59 43.18 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.199 0.909 . . . . 0.0 111.78 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.88 2.51 65.31 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.297 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.78 134.9 33.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.781 0.832 . . . . 0.0 110.09 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.38 106.14 17.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.109 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.16 107.23 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.2 m -96.44 106.38 18.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.499 0.72 . . . . 0.0 110.303 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.66 140.78 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.609 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 3.5 m-85 -129.6 134.97 26.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 42.3 Cg_endo -65.54 166.19 20.5 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.202 2.602 . . . . 0.0 112.634 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' HG23 ' A' ' 58' ' ' VAL . 73.8 Cg_endo -71.95 129.86 15.9 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.079 1.186 . . . . 0.0 109.199 170.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 m -86.65 -9.25 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 122.989 0.516 . . . . 0.0 111.696 -173.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.12 159.73 40.43 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.645 0.778 . . . . 0.0 110.716 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.4 -46.85 0.44 Allowed Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.264 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.944 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 177.027 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 123.37 -145.96 16.26 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 112.178 -0.369 . . . . 0.0 112.178 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -133.53 110.36 0.88 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 56.3 mtt-85 -122.68 113.21 18.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.946 0.898 . . . . 0.0 109.063 176.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -9' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 16.1 t0 -154.27 100.67 2.32 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -75.15 4.99 5.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.449 1.099 . . . . 0.0 113.32 -163.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 133.17 55.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.686 1.194 . . . . 0.0 108.487 169.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.65 100.86 3.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.871 0.468 . . . . 0.0 110.538 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -137.46 27.81 2.78 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 66.91 149.28 0.05 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.968 1.707 . . . . 0.0 112.285 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 62.94 35.75 13.13 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.274 1.029 . . . . 0.0 109.867 -166.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.601 ' HD3' ' H ' ' A' ' -2' ' ' LYS . 0.0 OUTLIER -85.4 -40.95 15.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.239 -176.273 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 58.15 35.02 75.44 Favored Glycine 0 C--N 1.352 1.424 0 O-C-N 123.756 0.66 . . . . 0.0 112.611 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 47.3 p -112.78 141.25 46.81 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.558 0.743 . . . . 0.0 109.741 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.465 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 24.9 ptt? -104.23 132.23 50.71 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.024 0.93 . . . . 0.0 110.673 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -87.15 135.19 33.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -128.61 136.59 50.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.309 0.643 . . . . 0.0 110.654 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -88.93 95.98 10.53 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.65 103.91 16.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.0 mtp180 -94.34 117.18 29.73 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -103.13 139.71 38.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.777 0.831 . . . . 0.0 109.29 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -133.89 158.86 42.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.379 0.672 . . . . 0.0 109.852 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.554 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.02 -130.75 0.78 Allowed 'General case' 0 CA--C 1.565 1.527 0 O-C-N 124.363 1.039 . . . . 0.0 111.37 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.424 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 97.7 m -60.57 -48.08 83.34 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.662 0.665 . . . . 0.0 111.647 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.87 -24.7 53.63 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.817 0.447 . . . . 0.0 111.623 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.414 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -70.43 -53.39 16.63 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.294 0.637 . . . . 0.0 111.027 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 -22.29 59.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.864 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.477 HG11 ' HG ' ' A' ' 44' ' ' LEU . 42.8 t -59.43 -52.82 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.244 0.618 . . . . 0.0 110.342 168.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 93.8 t -75.13 -22.31 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.51 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 73.38 11.48 79.83 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.52 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -142.92 146.6 34.17 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.143 0.977 . . . . 0.0 108.58 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -90.12 -19.99 23.65 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.852 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.4 m -155.18 131.99 10.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.03 0.932 . . . . 0.0 108.716 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 pt -123.58 175.38 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.025 0.93 . . . . 0.0 108.64 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.88 112.25 15.76 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 167.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 -178.53 4.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.221 1.409 . . . . 0.0 109.629 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -156.1 111.48 2.95 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.39 174.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.8 p-10 -71.51 158.79 35.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.268 0.94 . . . . 0.0 110.322 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.67 -19.86 61.35 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.388 0.675 . . . . 0.0 112.088 -172.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.85 -21.12 37.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.476 0.31 . . . . 0.0 110.175 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 162.09 28.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.413 0.685 . . . . 0.0 111.216 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -137.86 -174.07 3.68 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.855 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -50.6 -37.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 125.626 1.57 . . . . 0.0 112.107 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.635 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.87 -38.61 65.28 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.299 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -66.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.232 0.613 . . . . 0.0 110.548 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.8 -60.41 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.572 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.43 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.87 -30.46 71.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.503 0.321 . . . . 0.0 110.982 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.598 ' HA ' HD11 ' A' ' 49' ' ' ILE . 26.0 tpt85 -52.91 -51.7 60.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.404 0.682 . . . . 0.0 111.507 171.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.1 m -75.99 -32.1 59.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.708 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.3 mm? -52.13 -48.57 64.77 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.723 0.809 . . . . 0.0 112.34 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 3.6 pt-20 -64.95 -26.31 68.25 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.0 -20.22 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.135 0.574 . . . . 0.0 111.104 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.35 -57.9 2.14 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.458 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.0 m-85 -91.82 108.55 20.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.84 -173.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.62 -22.0 65.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.353 0.661 . . . . 0.0 111.587 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.519 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.56 -8.68 87.14 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.028 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.67 ' HB3' HD13 ' A' ' 48' ' ' LEU . 88.9 mt -105.14 -6.89 19.46 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.699 0.799 . . . . 0.0 111.041 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.89 122.28 15.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.722 0.809 . . . . 0.0 113.142 -171.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.53 2.84 51.86 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 2.3 ptp180 -113.85 -4.37 13.33 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.67 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -114.5 -2.71 13.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.794 . . . . 0.0 110.357 174.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 35' ' ' ARG . 46.8 mt -135.26 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.99 1.316 . . . . 0.0 109.201 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 19.8 mm-40 -143.69 123.84 13.71 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.119 0.968 . . . . 0.0 109.15 160.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.35 30.87 20.18 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 124.353 1.061 . . . . 0.0 112.109 168.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.86 3.12 88.22 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 114.989 0.756 . . . . 0.0 114.989 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -116.41 -175.44 2.75 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.019 0.928 . . . . 0.0 108.702 170.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 m -63.2 -55.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.876 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 9.6 tppt? 153.22 139.69 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.377 0 C-N-CA 125.091 1.356 . . . . 0.0 109.062 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 22.2 Cg_endo -60.8 128.38 25.44 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.825 2.35 . . . . 0.0 111.928 166.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 77.83 -1.69 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.337 1.455 . . . . 0.0 113.912 171.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 3.1 p -76.4 153.71 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 13.2 m120 -118.24 104.76 11.1 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.8 129.48 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.468 0.707 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.9 mp -121.66 140.18 52.62 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.803 1.241 . . . . 0.0 111.899 -166.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 63' ' ' ASN . 0.5 OUTLIER -119.34 107.56 13.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.824 1.249 . . . . 0.0 108.29 171.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.517 ' HB2' ' HZ3' ' A' ' 62' ' ' LYS . 65.0 t30 60.36 34.78 20.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.666 1.186 . . . . 0.0 110.328 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.87 -14.97 61.81 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.522 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HG3' HD21 ' A' ' 70' ' ' LEU . 19.8 tpp180 -94.27 111.66 23.4 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.42 0.61 . . . . 0.0 109.896 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.8 tt0 -67.89 108.36 2.99 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.851 0.86 . . . . 0.0 110.886 -173.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.05 -1.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.795 1.638 . . . . 0.0 114.552 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 m -71.16 -23.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.188 0.449 . . . . 0.0 110.582 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -88.72 -15.97 33.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.732 0.813 . . . . 0.0 110.828 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -135.39 -140.7 0.17 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.699 1.199 . . . . 0.0 108.789 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.81 119.02 25.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.746 1.157 . . . . 0.0 110.806 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.29 -43.12 39.87 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.688 0.617 . . . . 0.0 112.817 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.635 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.4 mmt -81.46 -39.95 24.06 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.73 69.26 1.03 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.401 0.62 . . . . 0.0 111.774 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 t -74.49 -67.82 0.59 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.98 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -174.99 33.7 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 110.887 -165.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.11 139.29 42.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.188 0.195 . . . . 0.0 110.851 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 33.9 t70 -144.32 -176.06 4.88 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.729 0.811 . . . . 0.0 108.835 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 30.8 t70 -70.19 147.8 49.4 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.422 0.556 . . . . 0.0 111.852 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.86 66.53 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.386 -0.824 . . . . 0.0 113.301 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 3.6 t0 -94.76 127.65 40.9 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 122.568 0.347 . . . . 0.0 110.608 -168.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.17 115.85 23.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.151 0.58 . . . . 0.0 111.438 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.75 106.99 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.8 m -84.09 147.96 27.08 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -142.45 147.08 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.696 0.76 . . . . 0.0 109.792 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.8 m-85 -133.82 142.77 44.83 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 40.3 Cg_endo -64.82 168.5 13.39 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.222 2.615 . . . . 0.0 111.374 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 48.4 Cg_endo -63.96 128.85 22.89 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 120.645 0.897 . . . . 0.0 111.249 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.68 -17.79 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.177 0.991 . . . . 0.0 109.352 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.15 -7.05 56.56 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.87 0.868 . . . . 0.0 111.311 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 87.82 0.55 Allowed Glycine 0 C--N 1.353 1.473 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 CA-C-O 118.953 -0.915 . . . . 0.0 112.906 -176.769 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.024 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -153.82 24.39 0.72 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.094 -0.402 . . . . 0.0 112.094 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -80.18 144.24 25.79 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -84.93 78.95 9.8 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.373 0.606 . . . . 0.0 109.558 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -91.49 155.51 18.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.347 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -123.49 26.91 7.65 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.696 0.398 . . . . 0.0 111.811 -169.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -7' ' ' LYS . . . . . 0.536 ' HD3' ' O ' ' A' ' -2' ' ' LYS . 0.0 OUTLIER -161.95 121.5 2.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.27 0.628 . . . . 0.0 109.961 -178.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 57.16 -167.72 0.12 Allowed 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 124.737 1.215 . . . . 0.0 112.121 169.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -107.43 -30.96 8.36 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.773 0.829 . . . . 0.0 109.583 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.2 -60.59 2.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.132 0.973 . . . . 0.0 111.776 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -90.85 143.28 26.88 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.144 0.577 . . . . 0.0 111.9 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.536 ' O ' ' HD3' ' A' ' -7' ' ' LYS . 17.0 ptpt -90.3 -42.08 11.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.565 0.746 . . . . 0.0 110.712 176.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 44.9 30.16 2.3 Favored Glycine 0 C--N 1.36 1.905 0 O-C-N 124.43 1.081 . . . . 0.0 115.366 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 23' ' ' ARG . 2.6 p -114.92 150.95 34.89 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.87 0.868 . . . . 0.0 111.26 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.778 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -109.08 121.84 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.788 0.435 . . . . 0.0 110.135 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.51 146.66 28.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.527 0.731 . . . . 0.0 111.153 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -88.72 95.45 10.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.1 103.94 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.677 -0.639 . . . . 0.0 109.47 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 13.1 mtp180 -95.18 117.05 29.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.739 -176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -106.4 135.69 47.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.451 1.101 . . . . 0.0 108.926 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.75 160.46 31.64 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.12 0.568 . . . . 0.0 109.844 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.44 -121.03 1.22 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.994 1.318 . . . . 0.0 112.198 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.6 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 87.9 m -70.37 -44.56 67.83 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.866 0.866 . . . . 0.0 111.329 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -58.8 -28.43 65.97 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.636 0.374 . . . . 0.0 110.962 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -65.85 -52.17 52.71 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.75 0.656 . . . . 0.0 111.185 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.91 -27.11 60.88 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.481 0.488 . . . . 0.0 111.739 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 44' ' ' LEU . 39.2 t -59.08 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.474 0.709 . . . . 0.0 110.541 170.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 17' ' ' GLN . 96.7 t -74.66 -22.36 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.963 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 11.39 63.35 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.769 0.7 . . . . 0.0 112.891 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HB2' HG12 ' A' ' 15' ' ' VAL . 73.9 mt-30 -145.74 138.15 25.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.303 1.041 . . . . 0.0 108.312 -166.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -100.92 -29.22 12.33 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 m -154.9 113.62 3.57 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.7 pt -121.63 170.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.205 0.602 . . . . 0.0 110.806 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -111.47 125.21 53.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -121.89 123.18 41.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.122 0.969 . . . . 0.0 108.853 -176.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.49 ' HD2' ' HB ' ' A' ' 0' ' ' THR . 6.6 tpp85 -83.08 106.95 15.31 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.07 -179.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 0.0 109.526 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.23 159.7 24.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.394 0.677 . . . . 0.0 110.613 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.22 -26.03 68.33 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 110.522 168.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -80.24 -22.94 41.23 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.34 1.056 . . . . 0.0 110.553 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.24 43.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.294 0.637 . . . . 0.0 110.592 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 p -137.75 -174.64 3.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.118 0.967 . . . . 0.0 108.643 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 t -51.09 -35.96 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.996 0.918 . . . . 0.0 111.535 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA2' ' HE3' ' A' ' 73' ' ' MET . . . -67.6 -45.5 76.38 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.175 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.37 -35.37 78.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.951 0.9 . . . . 0.0 111.113 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.28 -60.79 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.16 0.984 . . . . 0.0 110.805 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.541 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 1.9 pp -67.39 -30.08 69.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.19 0.306 . . . . 0.0 111.404 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HA ' HD11 ' A' ' 49' ' ' ILE . 20.8 tpt180 -55.57 -49.74 71.93 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.376 0.608 . . . . 0.0 111.218 170.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -73.96 -32.48 63.49 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.148 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -57.28 -39.05 74.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.441 0.696 . . . . 0.0 112.42 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.1 pt-20 -75.67 -28.51 58.73 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 117.874 0.307 . . . . 0.0 111.691 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.64 -34.52 78.42 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.08 0.467 . . . . 0.0 110.467 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 15.5 mm-40 -79.0 -59.1 2.91 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.366 175.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 95.9 m-85 -99.21 122.03 41.85 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.799 -168.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.08 -40.66 96.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.052 0.941 . . . . 0.0 110.926 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 -16.37 64.27 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.323 -0.709 . . . . 0.0 114.218 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.567 ' O ' HD22 ' A' ' 48' ' ' LEU . 64.1 mt -95.39 -13.5 24.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.686 0.795 . . . . 0.0 111.833 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.07 120.8 9.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.52 -28.14 5.99 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.549 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 12.4 ptm180 -90.89 3.17 55.26 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -168.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -127.15 2.65 6.45 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.355 0.662 . . . . 0.0 110.962 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.577 HD11 ' HA ' ' A' ' 35' ' ' ARG . 69.6 mt -135.63 129.13 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.52 1.128 . . . . 0.0 108.352 170.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 1.2 tm-20 -150.62 128.59 11.79 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.0 t70 61.08 30.31 19.4 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.449 1.1 . . . . 0.0 110.85 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.51 -13.55 6.31 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.798 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.78 -173.41 2.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.915 0.886 . . . . 0.0 109.361 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 60' ' ' VAL . 17.0 m -60.23 -57.07 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.536 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.992 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 56' ' ' PRO . 12.8 tppt? 150.39 137.84 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 C-N-CA 124.986 1.314 . . . . 0.0 109.862 -175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 42.8 Cg_endo -65.91 141.31 64.27 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 123.435 2.756 . . . . 0.0 111.773 163.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 82.25 -23.78 0.2 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.768 1.627 . . . . 0.0 112.532 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.12 141.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.9 m120 -111.87 104.58 12.89 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 85' ' ' VAL . 2.7 m -115.93 140.64 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.639 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -132.22 146.94 52.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.796 1.239 . . . . 0.0 110.012 -166.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.688 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 17.9 tptm -106.08 104.54 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 164.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.87 41.41 32.05 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.314 1.046 . . . . 0.0 111.838 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.44 -11.53 71.89 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-N 115.244 -0.889 . . . . 0.0 114.551 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -99.87 106.43 18.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tt0 -64.11 114.2 4.02 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.162 0.985 . . . . 0.0 111.63 -170.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.409 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 22.8 m -73.78 -2.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -172.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 m -72.67 -7.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 118.24 0.473 . . . . 0.0 111.361 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -96.69 -16.66 20.81 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.877 0.871 . . . . 0.0 110.958 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.84 -154.01 0.58 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.676 1.19 . . . . 0.0 109.208 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.2 m-20 -61.36 108.59 0.96 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -70.88 -48.54 33.23 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.484 0.49 . . . . 0.0 112.228 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.481 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 73.9 mmm -80.76 -37.97 29.46 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.003 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.04 66.13 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -172.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.412 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -70.09 -70.19 0.31 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.449 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.99 35.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -159.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.78 135.9 43.57 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.644 -0.66 . . . . 0.0 112.566 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.52 175.17 9.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.538 1.535 . . . . 0.0 108.151 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.66 141.26 53.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.771 0.714 . . . . 0.0 111.039 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.75 -15.14 27.34 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.619 -0.718 . . . . 0.0 114.381 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.688 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 50.9 m-20 -69.37 134.15 48.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.313 0.645 . . . . 0.0 111.618 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.21 142.6 27.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.03 107.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 165.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.0 m -94.06 130.12 40.33 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 0.0 109.151 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 60' ' ' VAL . 23.0 m -130.53 138.73 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.722 0.692 . . . . 0.0 110.605 -174.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 64.1 m-85 -122.3 135.53 25.59 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.6 ' HG3' ' H ' ' A' ' 10' ' ' THR . 27.4 Cg_endo -58.96 168.04 4.89 Favored 'Trans proline' 0 C--N 1.364 1.369 0 C-N-CA 123.953 3.102 . . . . 0.0 114.075 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.21 130.78 33.59 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.345 2.03 . . . . 0.0 111.374 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.2 t -77.67 103.56 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.65 13.94 9.22 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.957 1.303 . . . . 0.0 112.905 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.33 55.38 0.65 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.124 -179.908 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.384 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 91.55 63.27 1.17 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -152.7 14.12 0.69 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.321 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 39.78 65.55 0.7 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.074 1.35 . . . . 0.0 112.015 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.84 -30.88 4.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.76 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 69.54 10.76 7.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.938 1.295 . . . . 0.0 112.862 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -132.35 -50.39 0.93 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.207 0.603 . . . . 0.0 110.559 -170.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 9.4 t70 69.27 -177.2 0.21 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.953 1.301 . . . . 0.0 110.113 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 26.4 t70 74.12 -73.3 0.1 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.648 1.179 . . . . 0.0 111.223 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -155.69 145.71 21.5 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.94 0.896 . . . . 0.0 108.815 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 13.6 t70 70.59 142.84 0.05 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.383 1.473 . . . . 0.0 111.855 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -110.18 -38.93 5.15 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.849 0.46 . . . . 0.0 111.126 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 58.52 12.74 14.33 Favored Glycine 0 N--CA 1.479 1.545 0 N-CA-C 114.234 0.454 . . . . 0.0 114.234 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 36.8 p -90.29 177.34 6.44 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.994 0.918 . . . . 0.0 110.57 -174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 24.8 ptt? -147.21 132.95 18.92 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -83.81 141.11 31.6 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.5 mt -141.64 129.79 22.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 109.514 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -88.86 101.16 13.77 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 mt -94.98 108.1 20.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 27.9 mtm180 -97.87 117.42 32.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.782 0.833 . . . . 0.0 109.743 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -102.51 135.15 44.66 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.332 1.053 . . . . 0.0 108.877 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -130.69 161.24 32.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.89 0.476 . . . . 0.0 110.069 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.08 -120.9 1.1 Allowed 'General case' 0 CA--C 1.564 1.506 0 O-C-N 124.509 1.131 . . . . 0.0 111.873 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 18.7 m -71.98 -41.61 67.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.302 0.641 . . . . 0.0 111.0 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -60.52 -26.66 67.03 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.579 0.351 . . . . 0.0 110.864 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -47.52 69.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.57 0.748 . . . . 0.0 111.086 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.14 -22.99 59.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.625 HG11 ' HG ' ' A' ' 44' ' ' LEU . 74.8 t -60.33 -55.44 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 171.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.5 -20.42 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.06 11.85 83.98 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.417 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -163.94 158.26 19.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.695 0.798 . . . . 0.0 110.66 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -85.05 -19.67 31.6 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 9.6 m -152.55 147.78 26.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 pt -137.07 174.02 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.399 1.08 . . . . 0.0 108.762 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -122.58 113.16 18.9 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 167.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.437 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -98.49 172.63 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.896 1.279 . . . . 0.0 109.377 171.27 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -153.68 106.12 2.86 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.291 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.36 173.2 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.22 1.408 . . . . 0.0 108.474 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 34.0 t70 -66.2 161.26 22.43 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.978 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.22 -22.48 59.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.124 0.57 . . . . 0.0 111.745 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -81.0 -16.43 53.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.68 0.392 . . . . 0.0 110.65 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.86 151.49 41.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.324 0.65 . . . . 0.0 109.61 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.4 p -130.39 -174.74 3.43 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.901 0.881 . . . . 0.0 109.954 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.0 t -50.84 -37.04 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 124.578 1.151 . . . . 0.0 111.479 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.87 -39.78 64.5 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.802 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.26 -31.7 71.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.933 0.493 . . . . 0.0 110.52 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.74 -59.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.542 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.472 HD21 HG12 ' A' ' 54' ' ' VAL . 1.7 pp -64.26 -31.15 72.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.799 0.272 . . . . 0.0 111.093 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.533 ' HA ' HD11 ' A' ' 49' ' ' ILE . 9.1 tpt180 -51.77 -50.25 61.07 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.264 0.554 . . . . 0.0 111.353 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -75.82 -32.02 59.63 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.313 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.94 -39.06 68.48 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.2 pt-20 -73.95 -29.71 62.14 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.65 0.262 . . . . 0.0 111.63 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.69 65.51 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.57 0.748 . . . . 0.0 110.895 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.437 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 21.4 mm-40 -95.39 -58.71 2.06 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.431 1.092 . . . . 0.0 109.944 172.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.89 116.0 28.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.09 -30.49 70.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.953 0.901 . . . . 0.0 110.541 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.9 -20.17 77.49 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.956 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.717 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.1 mt -99.3 -1.66 38.41 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.713 0.805 . . . . 0.0 111.842 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.14 120.43 10.31 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.5 -7.64 17.79 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -100.16 4.57 44.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.029 0.914 . . . . 0.0 111.328 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.717 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.0 -5.96 8.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.579 1.152 . . . . 0.0 110.605 -177.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 35' ' ' ARG . 55.3 mt -133.02 138.6 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.681 1.193 . . . . 0.0 108.569 169.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 8.5 tp10 -144.9 124.87 13.51 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.649 0.78 . . . . 0.0 109.102 169.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.4 t70 58.95 31.79 21.66 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.432 1.093 . . . . 0.0 111.728 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.44 -14.74 57.17 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.168 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.09 -174.44 2.54 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.858 0.863 . . . . 0.0 109.185 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.472 HG12 HD21 ' A' ' 34' ' ' LEU . 34.0 m -62.83 -54.97 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 CA-C-O 118.11 -0.947 . . . . 0.0 112.829 -170.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 11.5 tppt? 151.61 139.61 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.388 0 C-N-CA 125.789 1.635 . . . . 0.0 107.879 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.47 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 21.9 Cg_endo -58.58 125.57 18.73 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.83 2.353 . . . . 0.0 111.636 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 73.41 1.4 3.97 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.66 1.184 . . . . 0.0 113.944 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.465 HG23 ' HD3' ' A' ' 88' ' ' PRO . 5.1 p -74.28 117.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 5.1 m-20 -80.83 103.62 10.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 85' ' ' VAL . 2.9 m -123.73 131.98 72.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -175.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 3.7 mp -121.88 172.14 8.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.254 1.022 . . . . 0.0 111.208 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.582 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 16.7 tptp -159.53 108.68 1.84 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 54.85 34.42 21.99 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.798 0.839 . . . . 0.0 110.237 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.9 13.98 82.51 Favored Glycine 0 C--N 1.352 1.465 0 N-CA-C 115.005 0.762 . . . . 0.0 115.005 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -119.67 121.25 38.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.797 0.839 . . . . 0.0 108.802 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.6 tt0 -75.91 110.14 10.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.405 0.682 . . . . 0.0 110.677 -171.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.512 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 17.5 m -70.54 -0.96 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -174.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 m -70.25 -16.5 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 118.104 0.411 . . . . 0.0 110.885 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -95.33 1.15 54.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.1 0.96 . . . . 0.0 111.26 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.47 -153.84 0.44 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.795 0.838 . . . . 0.0 109.773 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.54 108.58 0.99 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.0 0.52 . . . . 0.0 111.314 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -67.37 -50.6 43.29 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.568 0.543 . . . . 0.0 113.627 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 79.1 mmm -80.48 -39.64 27.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.089 0.556 . . . . 0.0 111.821 -170.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.84 76.62 1.54 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.912 0.863 . . . . 0.0 111.058 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.504 HG21 ' HG2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -81.64 -71.61 0.47 Allowed 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.149 177.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 75' ' ' THR . . . -175.16 34.67 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.599 0.76 . . . . 0.0 110.931 -163.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.582 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 21.0 tp -73.86 149.89 41.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.991 0.424 . . . . 0.0 110.54 -170.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.5 171.7 19.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 109.297 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.1 p-10 -70.39 146.62 50.29 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.347 0.659 . . . . 0.0 112.059 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.95 16.31 63.88 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.254 -0.885 . . . . 0.0 114.019 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.74 163.15 24.71 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.498 0.649 . . . . 0.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.38 95.33 4.43 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.638 0.732 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.8 t -86.53 138.56 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.919 1.288 . . . . 0.0 109.142 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 17.9 m -117.25 161.25 19.8 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.459 0.572 . . . . 0.0 110.653 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 60' ' ' VAL . 35.3 m -146.79 141.73 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.196 0.998 . . . . 0.0 109.197 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.63 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 7.5 m-85 -135.28 133.7 20.79 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 175.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.473 ' HG3' ' H ' ' A' ' 10' ' ' THR . 23.6 Cg_endo -60.92 155.87 47.22 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.067 2.511 . . . . 0.0 112.565 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD3' HG23 ' A' ' 58' ' ' VAL . 97.8 Cg_endo -74.33 138.26 24.54 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.565 2.177 . . . . 0.0 111.869 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.31 37.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 121.526 0.679 . . . . 0.0 110.776 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.99 89.93 0.43 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.635 1.174 . . . . 0.0 110.645 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.46 -124.7 0.72 Allowed Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.495 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 119.204 -0.776 . . . . 0.0 112.291 179.7 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.25 -0.34 . . . . 0.0 112.25 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 164.64 -47.87 0.29 Allowed Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 147.03 -160.97 28.39 Favored Glycine 0 N--CA 1.472 1.06 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -10' ' ' ARG . . . . . 0.491 ' HD2' ' HA3' ' A' ' -1' ' ' GLY . 19.4 mmt180 59.61 -171.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.206 1.002 . . . . 0.0 113.516 169.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -9' ' ' ASP . . . . . 0.565 ' HB2' ' HA ' ' A' ' -2' ' ' LYS . 4.0 m-20 -122.98 110.79 15.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.307 1.443 . . . . 0.0 108.804 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -8' ' ' TYR . . . . . 0.524 ' HA ' HG21 ' A' ' 0' ' ' THR . 15.5 m-85 -86.9 64.13 8.32 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.867 0.841 . . . . 0.0 111.378 -171.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -7' ' ' LYS . . . . . 0.525 ' HE3' ' HB3' ' A' ' -9' ' ' ASP . 0.0 OUTLIER -153.86 162.35 41.29 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.521 1.128 . . . . 0.0 109.444 176.083 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -86.75 120.36 27.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -5' ' ' ASP . . . . . 0.422 ' H ' ' HD3' ' A' ' -2' ' ' LYS . 35.9 t70 -169.96 172.97 6.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.197 0.999 . . . . 0.0 109.092 -174.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.6 -44.68 81.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.479 0.712 . . . . 0.0 110.513 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -107.17 131.99 53.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.947 0.899 . . . . 0.0 108.9 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' -9' ' ' ASP . 47.6 pttt -167.33 -41.25 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.212 0.605 . . . . 0.0 111.55 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.491 ' HA3' ' HD2' ' A' ' -10' ' ' ARG . . . 60.93 31.74 77.38 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-O 121.21 0.339 . . . . 0.0 112.378 -174.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' -8' ' ' TYR . 54.9 p -120.64 142.12 49.73 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.613 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.0 ptt? -105.34 135.97 45.74 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.823 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' TRP . 42.8 tt0 -94.85 129.75 41.71 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.657 0.783 . . . . 0.0 109.005 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 143.78 50.49 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.074 0.397 . . . . 0.0 111.221 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 36.1 tt0 -89.53 101.15 13.83 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.69 104.44 16.54 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 25.4 mtp180 -91.38 118.8 30.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.17 136.06 45.37 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.988 0.915 . . . . 0.0 109.387 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.66 161.56 30.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.083 0.553 . . . . 0.0 109.851 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.491 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.45 -129.92 1.33 Allowed 'General case' 0 CA--C 1.561 1.366 0 O-C-N 124.359 1.037 . . . . 0.0 111.238 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.437 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 4.3 m -64.04 -40.62 96.71 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 123.394 0.677 . . . . 0.0 111.747 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.487 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -67.54 -49.05 65.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.236 0.615 . . . . 0.0 110.626 -178.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.92 -18.03 60.95 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.82 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.465 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -66.02 -54.43 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.178 0.513 . . . . 0.0 110.253 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.55 -17.35 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.884 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.487 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 70.71 11.95 69.81 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.536 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -140.07 138.14 35.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.798 1.239 . . . . 0.0 109.146 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -82.68 -21.09 35.05 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.733 0.646 . . . . 0.0 110.707 172.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 11.6 m -154.65 149.81 26.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.628 1.171 . . . . 0.0 108.799 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 15.5 pt -135.26 178.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.129 0.972 . . . . 0.0 109.055 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -125.81 112.22 15.77 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.434 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -96.38 179.1 5.14 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.98 1.312 . . . . 0.0 109.921 174.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.0 ttp-105 -157.23 107.07 2.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.219 0.533 . . . . 0.0 109.942 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.84 176.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.684 1.194 . . . . 0.0 109.141 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -54.3 144.97 18.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.348 1.059 . . . . 0.0 110.014 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.99 -31.86 71.86 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.63 -7.51 59.6 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.593 0.757 . . . . 0.0 111.498 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.73 159.84 29.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.766 0.426 . . . . 0.0 109.853 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.8 p -130.96 179.2 6.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.986 0.515 . . . . 0.0 110.715 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.57 -35.79 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.609 1.164 . . . . 0.0 112.137 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.597 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.71 -37.47 67.01 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.741 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.46 -36.76 84.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.449 0.7 . . . . 0.0 110.927 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.14 -59.98 3.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.612 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.555 HD21 HG12 ' A' ' 54' ' ' VAL . 2.5 pp -63.7 -30.45 71.55 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.933 0.333 . . . . 0.0 111.315 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HA ' HD11 ' A' ' 49' ' ' ILE . 22.4 tpt180 -53.4 -48.73 68.42 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.004 0.431 . . . . 0.0 111.511 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.21 -32.8 61.29 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.533 0.333 . . . . 0.0 111.547 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 3.1 mm? -56.08 -34.54 66.08 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.6 0.76 . . . . 0.0 112.837 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -76.8 -26.09 54.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.91 -30.75 65.69 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.936 0.494 . . . . 0.0 110.51 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 15.8 mm-40 -79.79 -58.92 2.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.212 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.4 118.25 36.26 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.718 -169.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.09 -28.55 67.45 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.106 0.562 . . . . 0.0 110.192 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.21 -2.29 82.94 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.861 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.59 ' HB3' HD13 ' A' ' 48' ' ' LEU . 87.4 mt -114.65 2.84 14.61 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.578 0.689 . . . . 0.0 110.3 171.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.6 123.62 23.58 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.964 0.505 . . . . 0.0 111.886 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.85 8.19 87.75 Favored Glycine 0 N--CA 1.48 1.625 0 N-CA-C 115.176 0.831 . . . . 0.0 115.176 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.9 ptp180 -125.96 2.16 7.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.744 0.818 . . . . 0.0 111.422 -173.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.59 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -128.5 -8.89 5.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.427 1.091 . . . . 0.0 110.724 -176.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 35' ' ' ARG . 31.2 mt -130.26 132.49 65.01 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 C-N-CA 124.867 1.267 . . . . 0.0 108.653 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.32 108.45 8.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.395 0.678 . . . . 0.0 109.798 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.2 t70 57.56 31.29 20.09 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.293 1.037 . . . . 0.0 111.666 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.0 0.66 71.1 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.6 -174.69 2.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.085 0.942 . . . . 0.0 108.721 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.555 HG12 HD21 ' A' ' 34' ' ' LEU . 15.0 m -65.1 -56.3 16.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 CA-C-O 117.537 -1.22 . . . . 0.0 112.015 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.2 tppt? 151.18 136.32 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 C-N-CA 124.667 1.187 . . . . 0.0 108.746 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.86 128.12 27.81 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.936 2.424 . . . . 0.0 111.08 164.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 82.42 -14.82 0.73 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.349 1.46 . . . . 0.0 114.251 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -70.12 126.46 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.4 m120 -94.82 103.45 15.34 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -120.68 134.23 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.095 0.474 . . . . 0.0 109.94 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.1 mp -119.59 171.68 8.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.885 1.274 . . . . 0.0 111.738 -170.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -158.16 104.2 1.86 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.776 -177.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 15.3 t-20 56.47 36.47 27.61 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.455 1.102 . . . . 0.0 110.243 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.58 -13.24 67.13 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.719 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.406 ' HG3' HD21 ' A' ' 70' ' ' LEU . 7.1 tpp180 -97.41 119.9 36.79 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.413 0.685 . . . . 0.0 109.936 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 25.3 tt0 -79.55 106.47 11.6 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.769 -173.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -68.51 -1.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.374 1.469 . . . . 0.0 114.489 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.47 -21.61 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 117.857 0.299 . . . . 0.0 111.169 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -87.25 -19.34 28.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.979 0.912 . . . . 0.0 110.791 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.406 HD21 ' HG3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -131.81 -139.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.612 1.165 . . . . 0.0 108.423 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.2 109.42 17.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.953 0.797 . . . . 0.0 110.206 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.85 -38.77 65.53 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.354 0.409 . . . . 0.0 112.871 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.597 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.9 mmt -81.58 -37.17 28.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.26 77.57 1.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.4 t -81.51 -66.5 0.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' H ' HG23 ' A' ' 75' ' ' THR . . . -178.27 33.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 -165.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.62 141.81 46.54 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.844 -0.535 . . . . 0.0 111.144 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.43 -175.98 4.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.313 1.045 . . . . 0.0 108.909 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.613 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.0 p30 -80.02 148.86 30.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.087 0.555 . . . . 0.0 111.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.67 61.75 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.708 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.34 141.97 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.19 0.596 . . . . 0.0 111.566 -170.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.61 109.84 22.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.88 0.472 . . . . 0.0 110.854 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -100.23 107.09 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.448 0.699 . . . . 0.0 109.285 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 61.4 m -87.07 148.13 25.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.121 0.569 . . . . 0.0 109.934 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 m -143.37 148.31 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.346 0.659 . . . . 0.0 110.241 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 25.5 m-85 -136.7 135.72 20.71 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 23.7 Cg_endo -59.71 164.47 11.5 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 124.012 3.141 . . . . 0.0 113.505 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.0 131.2 31.72 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.297 1.998 . . . . 0.0 112.804 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.82 157.51 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.034 0.934 . . . . 0.0 110.546 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.46 121.84 23.68 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.234 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.47 114.66 0.98 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.941 -0.922 . . . . 0.0 111.079 -179.294 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 112.398 -0.281 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 87.44 170.23 46.28 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -63.34 -52.66 45.18 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -10' ' ' ARG . . . . . 0.473 ' HE ' ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 50.08 57.26 6.76 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.177 1.391 . . . . 0.0 109.844 176.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' -9' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 17.1 t70 -136.05 145.35 45.9 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.888 -168.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -107.25 -9.26 16.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.606 0.762 . . . . 0.0 112.26 -161.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.74 179.64 5.08 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 77.72 179.14 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.91 1.684 . . . . 0.0 110.905 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -111.56 -9.53 14.18 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.518 0.727 . . . . 0.0 111.179 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.05 -151.27 0.12 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -65.69 133.09 50.34 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 122.879 0.472 . . . . 0.0 110.328 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 15.8 pttp -153.24 -56.67 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.88 1.272 . . . . 0.0 108.684 -173.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 96.99 59.72 0.99 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 62.8 p -120.63 146.21 46.62 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.235 1.014 . . . . 0.0 109.437 175.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 21.4 ptt? -116.34 133.62 55.81 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.001 0.92 . . . . 0.0 110.976 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.91 132.99 36.08 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.214 1.006 . . . . 0.0 110.139 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.3 mt -132.64 139.07 47.58 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.515 0.726 . . . . 0.0 110.437 -168.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -89.37 102.32 14.99 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.543 HD13 HD21 ' A' ' 37' ' ' LEU . 36.4 mt -93.24 104.07 16.28 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.545 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 12.4 mtp180 -95.58 117.9 31.3 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.993 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.67 138.33 44.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.915 0.886 . . . . 0.0 109.76 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -132.01 156.07 46.9 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.307 0.643 . . . . 0.0 109.32 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.36 -128.12 1.72 Allowed 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.845 1.258 . . . . 0.0 112.818 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.521 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 84.8 m -55.92 -49.59 73.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.148 0.979 . . . . 0.0 111.862 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -64.19 -23.12 67.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.685 0.394 . . . . 0.0 111.006 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.606 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -69.21 -48.25 62.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.187 0.595 . . . . 0.0 110.962 178.371 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -22.78 59.38 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.379 0.424 . . . . 0.0 111.675 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 44' ' ' LEU . 78.5 t -59.64 -56.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.594 0.711 . . . . 0.0 110.587 170.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.0 t -73.78 -22.07 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.376 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.606 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 71.01 11.05 69.52 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.938 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -142.37 145.33 33.76 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.848 0.859 . . . . 0.0 109.21 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -86.56 -19.32 29.59 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.572 178.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 13.6 m -155.0 139.93 17.28 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 162.98 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.129 0.972 . . . . 0.0 108.882 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.0 112.75 24.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.429 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -103.37 178.05 4.67 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.447 1.499 . . . . 0.0 109.514 174.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -157.61 110.56 2.46 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.792 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.02 179.89 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.72 150.93 18.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.332 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.89 -35.0 69.62 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.524 1.129 . . . . 0.0 111.438 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.473 ' HB3' ' HE ' ' A' ' -10' ' ' ARG . 19.8 t70 -80.93 -13.3 59.02 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.768 0.827 . . . . 0.0 110.375 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 166.96 4.96 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.972 0.909 . . . . 0.0 111.353 172.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.8 p -135.98 -177.62 4.78 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.604 0.762 . . . . 0.0 110.1 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 77' ' ' LEU . 80.2 t -52.01 -37.84 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 C-N-CA 123.8 0.84 . . . . 0.0 110.757 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.659 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.49 -37.98 69.23 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.449 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.89 -29.82 68.18 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.046 0.539 . . . . 0.0 110.624 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.8 t -65.36 -60.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.577 0.751 . . . . 0.0 110.202 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.0 -30.31 71.4 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.794 0.27 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 49' ' ' ILE . 19.7 tpt180 -52.83 -46.96 67.99 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.28 0.562 . . . . 0.0 111.388 169.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.5 m -75.03 -32.43 61.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.708 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.543 HD21 HD13 ' A' ' 5' ' ' LEU . 3.5 mm? -59.18 -31.9 69.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB3' HD21 ' A' ' 48' ' ' LEU . 16.6 pt-20 -77.74 -28.48 50.76 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.426 0.557 . . . . 0.0 111.365 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.74 72.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.0 0.52 . . . . 0.0 111.084 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -85.96 -58.8 2.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.506 0.723 . . . . 0.0 110.58 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 95.0 m-85 -95.12 116.32 28.58 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.632 -171.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.99 -32.74 74.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.161 0.985 . . . . 0.0 111.225 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.502 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.69 -5.76 83.91 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.673 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.666 ' HB3' HD13 ' A' ' 48' ' ' LEU . 58.4 mt -106.56 3.04 26.58 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.573 0.687 . . . . 0.0 111.444 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.86 121.04 14.61 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 5.88 59.67 Favored Glycine 0 C--N 1.358 1.782 0 N-CA-C 115.773 1.069 . . . . 0.0 115.773 171.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.7 ptp180 -113.12 5.15 16.95 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.017 0.927 . . . . 0.0 111.337 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.666 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -126.27 -8.74 6.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.708 1.203 . . . . 0.0 110.36 -178.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 35' ' ' ARG . 33.5 mt -128.78 137.28 57.7 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 125.266 1.426 . . . . 0.0 108.402 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 16.1 mm-40 -128.9 107.95 10.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.525 0.73 . . . . 0.0 109.416 160.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 52.91 41.56 31.96 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.009 1.323 . . . . 0.0 112.873 171.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -7.1 78.03 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.988 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -110.5 -174.8 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.83 0.815 . . . . 0.0 109.1 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -70.14 -56.39 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.013 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 tppt? 152.49 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.434 0 C-N-CA 124.919 1.288 . . . . 0.0 109.392 -175.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.458 ' HD2' ' HG3' ' A' ' 50' ' ' GLU . 36.5 Cg_endo -63.11 131.91 34.42 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.077 2.518 . . . . 0.0 111.724 166.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 m170 76.73 -2.93 2.61 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 124.859 1.264 . . . . 0.0 113.682 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.4 p -75.9 154.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 35.8 m-80 -121.03 103.56 9.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 67' ' ' VAL . 4.4 m -117.0 147.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.755 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.1 mp -132.13 172.51 12.3 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.052 1.341 . . . . 0.0 110.375 -163.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.513 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 17.6 tptp -157.82 105.33 1.99 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.143 1.377 . . . . 0.0 107.534 -172.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.92 35.02 14.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.484 1.114 . . . . 0.0 110.744 -168.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.76 -14.18 59.06 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.361 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -83.63 116.67 22.73 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.91 0.855 . . . . 0.0 110.087 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 23.0 tt0 -73.85 107.07 5.86 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.068 -171.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.529 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.2 m -75.52 -0.98 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 58' ' ' VAL . 17.1 m -70.62 -14.98 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.946 0.794 . . . . 0.0 111.342 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -85.38 -27.17 26.01 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.628 0.771 . . . . 0.0 110.722 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -130.3 -152.22 0.5 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.119 0.968 . . . . 0.0 109.868 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.28 108.91 1.72 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.206 0.602 . . . . 0.0 111.334 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.529 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.63 -43.1 12.45 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.774 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.659 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.5 mmt -74.52 -39.49 62.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.121 0.569 . . . . 0.0 111.957 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.3 79.02 1.39 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.195 0.521 . . . . 0.0 111.496 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.419 HG21 ' HG2' ' A' ' 62' ' ' LYS . 2.2 t -81.78 -62.35 1.66 Allowed 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.882 175.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 176.06 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.67 1.188 . . . . 0.0 110.034 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 30' ' ' VAL . 1.2 tm? -73.91 113.68 11.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.55 0.74 . . . . 0.0 110.727 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.82 -178.19 4.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.229 1.411 . . . . 0.0 109.516 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.2 p-10 -66.42 150.36 49.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 112.362 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.21 13.43 64.75 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.239 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.85 156.99 33.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 117.446 0.623 . . . . 0.0 111.176 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 6' ' ' ARG . . . -115.63 94.31 4.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.438 0.695 . . . . 0.0 109.297 171.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.26 106.37 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 48.9 m -93.11 146.35 23.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.376 0.671 . . . . 0.0 109.718 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 m -140.94 141.79 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.693 0.759 . . . . 0.0 110.199 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.7 m-85 -128.7 136.67 29.5 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.521 ' HG3' ' H ' ' A' ' 10' ' ' THR . 54.5 Cg_endo -62.75 169.37 8.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.165 3.243 . . . . 0.0 112.792 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -61.39 128.41 24.83 Favored 'Trans proline' 0 C--N 1.381 2.256 0 N-CA-C 108.962 -1.207 . . . . 0.0 108.962 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 m -86.74 -33.45 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 123.622 0.576 . . . . 0.0 111.697 -166.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.83 105.84 3.87 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 172.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.27 64.67 0.53 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.414 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.904 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 86.09 170.31 46.85 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.447 0.123 . . . . 0.0 112.964 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -72.23 -84.99 0.21 Allowed Glycine 0 C--N 1.344 0.986 0 O-C-N 123.43 0.135 . . . . 0.0 112.83 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -114.79 89.54 3.12 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.687 0.755 . . . . 0.0 109.744 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -123.29 111.67 16.7 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.54 1.136 . . . . 0.0 108.939 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -65.16 -50.94 64.04 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.181 0.515 . . . . 0.0 110.138 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -7' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' -3' ' ' ASP . 3.6 mmmp? 69.94 0.75 3.19 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.783 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -67.89 -36.82 80.91 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.04 0.936 . . . . 0.0 111.256 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.35 -67.13 0.42 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.984 0.913 . . . . 0.0 110.754 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 17.3 t70 178.78 -62.27 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' -7' ' ' LYS . 3.3 t70 -83.33 -163.39 0.74 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 163.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.411 ' HG3' ' H ' ' A' ' 0' ' ' THR . 9.0 ptpp? -51.89 -40.39 60.58 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.634 0.652 . . . . 0.0 111.286 172.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 61.49 33.05 83.38 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.088 0.868 . . . . 0.0 112.368 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.411 ' H ' ' HG3' ' A' ' -2' ' ' LYS . 61.5 p -127.04 145.7 50.62 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.883 0.873 . . . . 0.0 110.849 -173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.8 ptt? -132.65 145.22 50.9 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.826 0.85 . . . . 0.0 109.443 174.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.33 113.42 26.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.996 0.519 . . . . 0.0 110.473 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 77' ' ' LEU . 21.8 mt -104.6 143.53 32.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.858 0.863 . . . . 0.0 111.018 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.53 101.09 13.77 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.58 0.352 . . . . 0.0 110.146 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.2 mt -93.8 105.55 17.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.26 0.552 . . . . 0.0 110.332 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 61.4 mtp180 -91.5 124.18 35.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.62 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -112.32 137.82 49.93 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.561 0.745 . . . . 0.0 109.013 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -132.5 161.16 34.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.874 0.47 . . . . 0.0 110.454 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 56.28 -128.03 1.97 Allowed 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.631 1.172 . . . . 0.0 112.16 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 32.7 m -59.5 -49.79 76.42 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.778 0.831 . . . . 0.0 111.609 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -59.8 -24.05 63.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.937 0.495 . . . . 0.0 111.352 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 ttp85 -68.71 -51.05 45.7 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.57 -21.85 60.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.529 0.332 . . . . 0.0 111.257 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.45 HG11 ' HG ' ' A' ' 44' ' ' LEU . 76.0 t -61.12 -55.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 0.0 110.07 170.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -77.87 -16.86 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.723 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.56 11.73 62.84 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.088 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -139.75 146.96 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.006 0.922 . . . . 0.0 110.007 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -104.36 -19.04 14.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.013 0.925 . . . . 0.0 110.998 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.5 m -153.74 138.36 16.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.949 0.9 . . . . 0.0 108.971 165.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.8 pt -133.37 178.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.821 0.848 . . . . 0.0 109.734 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -125.09 112.84 16.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.89 132.64 51.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 108.54 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -96.8 112.74 24.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 m -113.61 -179.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.83 166.26 22.62 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.019 0.372 . . . . 0.0 110.548 174.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.63 -31.58 72.86 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.625 0.77 . . . . 0.0 112.377 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.86 -17.16 51.62 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.828 0.451 . . . . 0.0 110.832 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 147.14 37.04 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.724 0.81 . . . . 0.0 112.183 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.5 p -134.03 -174.64 3.6 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.942 0.897 . . . . 0.0 109.097 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.0 t -52.36 -42.06 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.65 0.78 . . . . 0.0 111.464 -175.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.63 94.77 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.363 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.09 -34.43 76.41 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.262 0.553 . . . . 0.0 110.45 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.95 -57.8 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.246 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.642 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.2 pp -70.07 -30.66 67.96 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -64.94 -35.29 80.67 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.715 0.689 . . . . 0.0 110.49 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -75.84 -33.04 60.02 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.422 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -61.89 -39.43 91.95 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.935 0.494 . . . . 0.0 111.722 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 4.8 pt-20 -73.11 -26.26 61.17 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.95 63.72 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.077 0.551 . . . . 0.0 111.328 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -96.5 -59.19 1.87 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.943 0.878 . . . . 0.0 109.306 173.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -95.83 106.95 19.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.094 -171.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.38 -27.04 69.03 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.202 0.601 . . . . 0.0 111.048 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.58 -5.01 62.69 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.826 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.668 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.7 mt -111.3 -6.86 14.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.377 0.671 . . . . 0.0 111.481 172.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.3 120.03 8.51 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.56 5.66 56.51 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -96.62 -32.78 12.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.579 0.751 . . . . 0.0 109.583 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -98.13 2.03 48.15 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.219 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.22 139.0 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.603 1.161 . . . . 0.0 109.469 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.55 129.76 11.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.64 31.11 12.05 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.144 1.378 . . . . 0.0 112.035 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.62 -9.72 41.73 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.127 -0.818 . . . . 0.0 114.76 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -93.67 -174.42 3.46 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.179 0.989 . . . . 0.0 108.902 168.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.508 HG12 HD21 ' A' ' 34' ' ' LEU . 28.6 m -64.14 -55.32 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.417 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HG2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 tppt? 153.6 137.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 C-N-CA 125.175 1.39 . . . . 0.0 109.491 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.27 128.35 29.77 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.665 2.91 . . . . 0.0 111.981 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 76.35 -6.73 1.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.5 1.52 . . . . 0.0 113.874 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.17 141.85 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 40.6 m-80 -111.8 104.13 12.43 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 85' ' ' VAL . 4.9 m -113.34 136.05 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -127.74 148.53 50.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.036 1.334 . . . . 0.0 110.209 -168.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -112.38 105.43 13.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 59.44 35.87 23.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.059 0.944 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.08 -13.79 65.28 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.765 -0.652 . . . . 0.0 114.247 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -90.45 102.14 14.87 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.6 tt0 -64.79 106.2 1.16 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.859 0.864 . . . . 0.0 111.015 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.87 -1.35 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 66' ' ' GLU . 15.2 m -70.83 -12.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 118.09 0.405 . . . . 0.0 111.554 171.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -93.63 -20.97 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.569 0.748 . . . . 0.0 110.779 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.62 -153.14 0.54 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.604 1.162 . . . . 0.0 109.076 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.0 m-20 -59.64 109.34 0.89 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.266 0.626 . . . . 0.0 111.116 172.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.98 -46.33 7.15 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 123.321 0.388 . . . . 0.0 112.246 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 89.4 mmm -80.73 -20.16 43.41 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.44 79.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.898 0.317 . . . . 0.0 111.614 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -76.58 -74.97 0.21 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' H ' HG23 ' A' ' 75' ' ' THR . . . -176.68 35.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.492 0.317 . . . . 0.0 111.572 -164.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 3' ' ' LEU . 18.2 mt -73.7 150.13 41.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.553 0.692 . . . . 0.0 112.435 -170.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -154.23 179.7 8.72 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.723 1.609 . . . . 0.0 107.628 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 31.9 t70 -63.99 129.33 39.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.019 0.528 . . . . 0.0 111.906 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.96 6.22 82.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.133 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.01 122.22 27.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.602 0.761 . . . . 0.0 111.413 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.67 125.08 32.19 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.252 0.621 . . . . 0.0 111.734 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.36 107.63 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.684 0.794 . . . . 0.0 109.721 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.716 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.0 m -85.83 152.1 23.28 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.394 0.677 . . . . 0.0 110.191 175.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 60' ' ' VAL . 16.2 m -141.49 147.0 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.418 0.628 . . . . 0.0 109.946 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 42.3 m-85 -135.33 134.24 21.14 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 174.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 29.8 Cg_endo -59.42 164.64 10.61 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.841 3.028 . . . . 0.0 114.025 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HG3' ' HG2' ' A' ' 55' ' ' LYS . 15.4 Cg_exo -63.96 130.65 28.16 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.662 2.241 . . . . 0.0 111.166 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.78 122.08 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.685 0.794 . . . . 0.0 110.01 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.76 144.37 41.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.791 0.836 . . . . 0.0 109.962 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.3 -44.48 0.33 Allowed Glycine 0 C--N 1.34 0.783 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.763 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 113.419 0.128 . . . . 0.0 113.419 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -96.26 77.57 0.76 Allowed Glycine 0 C--N 1.348 1.229 0 C-N-CA 123.198 0.428 . . . . 0.0 113.498 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -87.44 -40.79 6.73 Favored Glycine 0 C--N 1.347 1.169 0 C-N-CA 122.796 0.236 . . . . 0.0 112.591 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -77.63 -27.26 51.06 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.749 0.819 . . . . 0.0 111.663 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -83.01 -30.61 27.99 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.094 0.557 . . . . 0.0 110.171 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 70.66 -66.81 0.27 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.478 1.511 . . . . 0.0 111.672 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.23 173.05 6.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.273 1.029 . . . . 0.0 110.962 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -121.76 104.1 9.35 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.064 0.946 . . . . 0.0 108.742 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -161.09 -62.88 0.06 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -85.6 167.73 15.1 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.21 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.38 -21.53 66.66 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.93 0.492 . . . . 0.0 111.729 173.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -153.16 -60.2 0.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.224 1.009 . . . . 0.0 109.861 174.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 57.35 31.13 62.33 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 25' ' ' ASP . 29.7 p -141.51 141.92 33.59 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.684 1.193 . . . . 0.0 110.171 -171.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 23.7 ptt? -114.63 132.01 56.52 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.581 1.153 . . . . 0.0 110.695 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -84.42 128.57 34.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.275 0.63 . . . . 0.0 109.533 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.3 mt -127.46 137.08 52.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.475 0.71 . . . . 0.0 110.467 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -89.69 101.54 14.23 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.435 HD13 HD21 ' A' ' 37' ' ' LEU . 36.3 mt -93.33 107.42 19.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtt-85 -96.31 120.45 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.302 1.041 . . . . 0.0 109.778 -176.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.44 134.42 50.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.515 1.126 . . . . 0.0 109.251 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -128.68 162.55 27.09 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.979 0.512 . . . . 0.0 109.904 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.8 -122.6 0.91 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.493 1.117 . . . . 0.0 111.497 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.514 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 54.5 m -68.94 -45.77 69.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 111.408 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -57.19 -27.91 62.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.03 0.532 . . . . 0.0 111.335 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -64.57 -53.6 45.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.538 0.735 . . . . 0.0 111.34 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -21.76 60.43 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.345 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.511 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -61.71 -49.99 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.026 0.531 . . . . 0.0 110.606 169.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.94 -15.5 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.728 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.68 83.32 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.049 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -166.93 155.76 10.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.218 1.007 . . . . 0.0 110.156 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -89.75 -13.27 37.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 8.8 m -155.22 147.53 23.85 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.193 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -140.78 172.22 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.61 1.164 . . . . 0.0 108.703 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -118.35 112.78 20.47 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -92.1 -179.19 5.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.832 1.253 . . . . 0.0 108.937 167.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -156.73 110.16 2.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 176.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.363 1.065 . . . . 0.0 108.472 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HA ' HG22 ' A' ' 0' ' ' THR . 6.9 t70 -68.76 157.1 37.08 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 122.995 0.518 . . . . 0.0 110.031 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.68 -18.69 60.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.715 0.406 . . . . 0.0 110.728 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.39 -23.83 37.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.297 0.639 . . . . 0.0 109.723 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.52 147.87 47.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.476 0.71 . . . . 0.0 109.668 171.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -132.08 -174.37 3.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.263 1.025 . . . . 0.0 109.8 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.3 p -50.72 -36.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.644 1.178 . . . . 0.0 112.646 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.566 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -71.05 -41.02 61.48 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.379 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.9 -29.49 65.57 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.792 0.296 . . . . 0.0 110.521 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.7 t -59.37 -60.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.455 0.702 . . . . 0.0 109.831 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.575 HD21 HG12 ' A' ' 54' ' ' VAL . 2.4 pp -66.57 -30.76 71.14 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 123.11 0.257 . . . . 0.0 111.334 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.508 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.5 tpt180 -56.0 -46.65 78.66 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.36 0.6 . . . . 0.0 111.629 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -75.2 -32.97 61.35 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.356 0.662 . . . . 0.0 111.773 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -56.45 -45.03 81.04 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.701 0.801 . . . . 0.0 112.152 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 9.5 pt-20 -64.16 -29.8 70.9 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.61 0.569 . . . . 0.0 112.283 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.86 -22.67 67.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.957 0.503 . . . . 0.0 111.63 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -97.13 -57.97 2.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.008 0.909 . . . . 0.0 109.169 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.65 105.47 17.84 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.807 -173.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.3 -32.14 72.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.393 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.917 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.663 ' HB3' HD13 ' A' ' 48' ' ' LEU . 81.5 mt -103.09 -11.66 17.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.863 0.865 . . . . 0.0 111.271 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -57.28 121.55 10.41 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.366 0.667 . . . . 0.0 112.517 -173.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.59 -19.93 8.31 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 171.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.76 0.72 57.47 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.466 0.633 . . . . 0.0 111.655 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -124.02 5.58 8.62 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 110.29 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 35' ' ' ARG . 17.5 mt -140.75 142.47 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 124.639 1.176 . . . . 0.0 109.244 172.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -145.76 116.68 7.76 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.463 0.705 . . . . 0.0 110.125 164.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 55.92 31.56 18.07 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.221 1.008 . . . . 0.0 111.826 172.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.39 82.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -106.9 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.096 0.948 . . . . 0.0 108.785 165.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 34' ' ' LEU . 15.8 m -64.29 -55.39 21.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 CA-C-O 117.595 -1.193 . . . . 0.0 112.13 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? 150.02 132.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 C-N-CA 125.212 1.405 . . . . 0.0 107.601 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -61.11 140.61 90.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.727 2.285 . . . . 0.0 111.593 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.423 ' ND1' ' HB3' ' A' ' 90' ' ' ALA . 66.8 m-70 80.16 -21.33 0.33 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.509 1.524 . . . . 0.0 113.504 177.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG23 ' HD3' ' A' ' 88' ' ' PRO . 1.1 p -72.61 152.51 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 29.9 m-80 -119.89 103.83 9.67 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.3 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.461 0.704 . . . . 0.0 109.55 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.6 mp -121.12 131.29 54.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.925 1.29 . . . . 0.0 110.725 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HD3' ' HG ' ' A' ' 77' ' ' LEU . 8.4 tptm -105.59 111.73 24.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.15 0.98 . . . . 0.0 109.057 171.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.4 t30 57.3 34.83 25.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.594 1.158 . . . . 0.0 110.577 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -4.51 86.04 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.41 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -102.37 114.23 28.23 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.944 0.897 . . . . 0.0 109.157 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 18.3 tt0 -70.63 110.26 5.36 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.363 0.665 . . . . 0.0 111.292 -171.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.02 -1.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.2 m -68.3 -19.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.109 0.413 . . . . 0.0 111.527 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -85.39 -16.26 40.42 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.924 0.89 . . . . 0.0 110.963 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.24 -152.72 0.44 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.42 1.088 . . . . 0.0 109.334 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.61 108.2 0.94 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.957 0.503 . . . . 0.0 110.551 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.01 -29.06 24.07 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.794 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.566 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.5 mmt -80.85 -37.94 29.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.503 0.721 . . . . 0.0 112.147 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.78 85.34 1.17 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.1 t -82.01 -70.79 0.52 Allowed 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.554 0.742 . . . . 0.0 112.271 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' H ' HG23 ' A' ' 75' ' ' THR . . . 179.77 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.458 1.103 . . . . 0.0 110.209 -163.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.29 114.86 13.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -116.85 179.76 3.92 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.359 0.664 . . . . 0.0 110.433 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 7.8 p-10 -73.09 142.32 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.56 0.744 . . . . 0.0 111.286 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.63 18.3 78.54 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.314 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -96.61 141.78 29.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.439 0.696 . . . . 0.0 111.785 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.54 109.35 22.12 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.167 0.987 . . . . 0.0 110.711 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.13 107.29 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.2 m -83.92 150.49 25.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.77 0.828 . . . . 0.0 110.093 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.12 145.63 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.466 0.706 . . . . 0.0 109.491 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 19.4 m-85 -137.33 135.06 19.02 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.514 ' HG3' ' H ' ' A' ' 10' ' ' THR . 29.3 Cg_endo -61.2 165.61 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 123.96 3.107 . . . . 0.0 113.688 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 58' ' ' VAL . 41.2 Cg_endo -63.8 131.27 30.53 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.608 2.205 . . . . 0.0 112.491 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.8 m -82.58 -26.63 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.46 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.423 ' HB3' ' ND1' ' A' ' 57' ' ' HIS . . . -116.26 125.22 51.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.032 0.533 . . . . 0.0 110.285 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.14 -104.87 0.96 Allowed Glycine 0 C--N 1.345 1.083 0 O-C-N 123.615 0.572 . . . . 0.0 113.272 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.769 0 CA-C-O 119.243 -0.754 . . . . 0.0 111.719 178.603 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -163.94 157.66 29.98 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 116.758 0.279 . . . . 0.0 112.437 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -111.35 -135.72 6.83 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.624 -0.591 . . . . 0.0 111.624 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 -153.68 110.39 3.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.117 0.567 . . . . 0.0 110.664 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -9' ' ' ASP . . . . . 0.573 ' HB3' HH21 ' A' ' 23' ' ' ARG . 40.0 p-10 -154.68 144.37 21.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.769 0.828 . . . . 0.0 110.166 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -96.0 -47.97 5.89 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.718 0.807 . . . . 0.0 112.07 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 64.06 69.53 0.53 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 125.158 1.536 . . . . 0.0 110.372 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -73.06 -55.6 6.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.63 -172.26 3.0 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.438 166.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.01 -33.93 71.28 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.711 0.805 . . . . 0.0 112.885 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -76.0 -178.47 4.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.068 0.547 . . . . 0.0 111.662 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 0' ' ' THR . 10.2 ptpp? -65.09 -34.51 78.58 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.149 0.98 . . . . 0.0 112.57 -177.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 66.1 34.74 89.18 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.595 -0.275 . . . . 0.0 113.534 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.455 ' H ' ' HG3' ' A' ' -2' ' ' LYS . 1.4 p -148.69 158.61 44.26 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.395 1.078 . . . . 0.0 109.687 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -147.27 145.64 29.47 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.586 0.754 . . . . 0.0 109.495 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -89.3 141.11 28.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.67 138.15 44.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.575 0.75 . . . . 0.0 109.264 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -89.37 104.5 17.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.429 HD13 HD21 ' A' ' 37' ' ' LEU . 28.2 mt -93.72 104.26 16.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 79.9 mtt180 -92.05 117.39 29.79 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.533 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.54 137.59 42.16 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.907 0.883 . . . . 0.0 109.227 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -130.22 160.55 33.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.896 0.478 . . . . 0.0 110.59 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 57.95 -119.0 1.1 Allowed 'General case' 0 CA--C 1.56 1.332 0 O-C-N 124.783 1.302 . . . . 0.0 112.238 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.622 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 8.6 m -70.99 -47.45 58.78 Favored 'General case' 0 C--N 1.361 1.067 0 CA-C-N 118.415 0.552 . . . . 0.0 110.437 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -58.04 -26.61 62.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.051 0.54 . . . . 0.0 111.056 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -66.55 -54.42 23.85 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.223 0.609 . . . . 0.0 111.386 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -17.64 60.87 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.635 0.585 . . . . 0.0 111.797 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.547 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.4 t -63.44 -55.06 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.391 0.676 . . . . 0.0 109.654 169.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.44 -16.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.441 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 17.28 80.23 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.491 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -166.77 150.82 7.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.018 0.927 . . . . 0.0 110.321 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -91.23 -22.21 20.72 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -154.75 136.87 14.73 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -130.03 176.82 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.031 0.933 . . . . 0.0 109.144 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.5 111.44 16.82 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.11 177.4 5.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.001 1.32 . . . . 0.0 109.111 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.573 HH21 ' HB3' ' A' ' -9' ' ' ASP . 55.8 ttt180 -156.54 108.11 2.46 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 m -112.75 179.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.846 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -55.97 148.62 16.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.421 0.688 . . . . 0.0 110.364 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -66.55 -26.1 66.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.517 0.327 . . . . 0.0 111.413 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.45 -24.64 36.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.952 0.501 . . . . 0.0 110.56 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.47 129.2 39.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.345 0.658 . . . . 0.0 111.16 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.1 p -111.92 -172.97 2.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.324 1.049 . . . . 0.0 110.372 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -50.82 -41.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 123.771 0.828 . . . . 0.0 111.804 -170.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' HA2' ' HE2' ' A' ' 73' ' ' MET . . . -65.5 -43.35 94.85 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.65 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.11 -33.26 75.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.264 0.625 . . . . 0.0 111.582 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.03 -59.75 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.675 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.551 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.1 pp -68.89 -30.71 69.27 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.4 ppt_? -67.35 -34.3 77.02 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.907 0.776 . . . . 0.0 111.204 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.1 m -75.58 -32.45 60.36 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.007 175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 5' ' ' LEU . 2.5 mm? -59.08 -49.57 77.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.918 0.487 . . . . 0.0 111.213 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -67.25 -25.31 66.02 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -20.84 66.52 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 123.345 0.403 . . . . 0.0 110.973 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -96.91 -58.72 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.782 0.801 . . . . 0.0 109.41 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.85 111.13 22.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.339 -170.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.77 -26.93 67.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.638 0.775 . . . . 0.0 110.116 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.54 -17.48 68.84 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.501 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' O ' HD22 ' A' ' 48' ' ' LEU . 82.4 mt -103.2 -13.98 16.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.888 0.875 . . . . 0.0 111.683 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.16 121.21 10.75 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.28 11.94 79.69 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 11.3 ptm180 -120.58 -21.19 6.84 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.54 0.67 . . . . 0.0 111.318 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.577 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -101.85 8.42 41.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.031 0.533 . . . . 0.0 110.219 170.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' HA ' ' A' ' 35' ' ' ARG . 43.2 mt -140.89 142.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.079 1.351 . . . . 0.0 108.87 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 1.6 tm-20 -154.83 123.69 6.2 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.09 31.04 17.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.413 1.085 . . . . 0.0 111.589 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.57 -4.07 75.36 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.592 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -106.36 -174.07 2.45 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.82 0.81 . . . . 0.0 109.681 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.406 HG12 HD21 ' A' ' 34' ' ' LEU . 27.6 m -58.8 -54.7 30.12 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.165 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? 149.45 137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 C-N-CA 126.503 1.921 . . . . 0.0 106.982 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 18.6 Cg_endo -56.54 129.08 32.81 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.802 2.335 . . . . 0.0 111.174 166.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 76.35 -6.26 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.877 1.271 . . . . 0.0 113.957 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.445 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.9 p -73.69 143.79 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.81 104.69 13.35 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.18 137.25 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.228 0.611 . . . . 0.0 109.599 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.7 mp -126.89 142.73 51.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.835 1.254 . . . . 0.0 110.85 -166.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -114.06 109.21 18.08 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.474 1.11 . . . . 0.0 108.208 166.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.33 35.65 23.26 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.074 0.94 . . . . 0.0 110.349 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.25 -14.7 60.2 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.819 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -87.64 109.03 19.37 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 68' ' ' VAL . 17.4 tt0 -67.44 105.09 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.453 0.701 . . . . 0.0 110.334 -173.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.48 -1.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 66' ' ' GLU . 20.2 m -73.7 -10.27 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 122.593 0.357 . . . . 0.0 111.364 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -87.15 -25.54 24.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.534 0.733 . . . . 0.0 110.452 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.22 -150.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.074 0.95 . . . . 0.0 109.808 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.21 107.89 0.54 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.685 0.394 . . . . 0.0 111.055 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -86.22 -30.35 22.74 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.684 0.615 . . . . 0.0 111.954 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.402 ' HE2' ' HA2' ' A' ' 31' ' ' GLY . 20.7 mmt -81.45 -34.9 31.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.078 0.551 . . . . 0.0 111.79 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.36 81.48 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 t -81.02 -67.76 0.75 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -173.5 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -163.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.32 144.09 44.65 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.68 -175.08 5.18 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.395 1.478 . . . . 0.0 107.817 -174.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.3 143.08 52.15 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.891 0.476 . . . . 0.0 111.186 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.0 69.6 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 114.806 0.682 . . . . 0.0 114.806 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.99 118.28 22.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.033 0.533 . . . . 0.0 111.665 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.55 104.03 14.19 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.523 0.729 . . . . 0.0 111.147 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 t -93.27 106.56 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 50.8 m -86.95 148.9 25.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.731 0.812 . . . . 0.0 109.539 176.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.42 146.33 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.814 0.816 . . . . 0.0 109.692 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 21.9 m-85 -132.38 144.55 53.51 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 173.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.622 ' HG3' ' H ' ' A' ' 10' ' ' THR . 34.3 Cg_endo -63.48 169.11 10.22 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.517 2.811 . . . . 0.0 112.124 169.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.35 130.17 31.03 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 121.218 1.278 . . . . 0.0 110.661 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.6 5.96 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.077 0.551 . . . . 0.0 112.23 -168.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -161.6 -48.22 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.292 1.037 . . . . 0.0 109.122 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.43 -172.16 15.28 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.816 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.325 0 CA-C-O 119.374 -0.681 . . . . 0.0 113.277 178.7 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 77.55 57.07 3.69 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-O 121.195 0.331 . . . . 0.0 112.581 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -89.85 -159.7 35.75 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.268 -0.466 . . . . 0.0 112.404 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -10' ' ' ARG . . . . . 0.697 ' HD3' ' HD3' ' A' ' 23' ' ' ARG . 95.5 mtt180 -89.75 29.55 1.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.692 0.797 . . . . 0.0 111.068 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -87.24 -60.39 1.99 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.858 0.463 . . . . 0.0 110.425 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 62.73 175.23 0.14 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.232 1.013 . . . . 0.0 111.603 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.5 -156.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 125.307 1.443 . . . . 0.0 113.232 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -106.1 -171.03 1.82 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.696 0.798 . . . . 0.0 109.614 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 30.4 t70 74.02 152.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.261 1.424 . . . . 0.0 112.585 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.59 156.68 25.89 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.505 1.122 . . . . 0.0 111.863 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 68.08 148.63 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.359 1.464 . . . . 0.0 111.419 -172.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' -2' ' ' LYS . 0.0 OUTLIER -65.89 -30.1 70.64 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.289 0.636 . . . . 0.0 111.96 -178.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 56.44 30.55 58.82 Favored Glycine 0 N--CA 1.472 1.08 0 O-C-N 123.407 0.442 . . . . 0.0 113.644 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 24.6 p -122.62 142.83 50.23 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.604 1.162 . . . . 0.0 109.566 -177.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.05 136.91 54.88 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.411 1.084 . . . . 0.0 110.068 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -91.74 141.37 28.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.405 0.682 . . . . 0.0 110.14 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.43 138.9 45.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.466 1.106 . . . . 0.0 110.606 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.3 103.98 16.57 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.508 0.723 . . . . 0.0 109.089 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD13 HD21 ' A' ' 37' ' ' LEU . 29.9 mt -93.31 103.62 15.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 74.7 mtt180 -91.09 119.75 31.49 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.58 1.152 . . . . 0.0 109.434 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -108.11 140.35 41.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.25 1.02 . . . . 0.0 108.759 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -132.38 160.55 36.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.138 0.575 . . . . 0.0 109.585 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.446 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.72 -125.28 1.18 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.685 1.194 . . . . 0.0 112.706 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.519 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 27.6 m -68.02 -46.8 70.19 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.369 0.668 . . . . 0.0 111.14 -178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -57.31 -26.57 61.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.31 0.644 . . . . 0.0 111.633 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.495 ' HD3' ' HG2' ' A' ' 18' ' ' LYS . 7.0 tmm_? -68.66 -53.14 24.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.415 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -18.77 60.59 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.6 t -64.34 -48.12 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.251 0.548 . . . . 0.0 110.216 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 17' ' ' GLN . 88.4 t -78.87 -21.7 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.863 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.64 20.04 75.34 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.227 -175.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.502 ' HB2' HG12 ' A' ' 15' ' ' VAL . 13.8 mm100 -148.07 139.21 23.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.86 1.264 . . . . 0.0 109.111 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.495 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 26.3 mtmt -85.01 -21.32 29.51 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.891 0.744 . . . . 0.0 109.925 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -154.08 148.7 26.35 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.336 1.054 . . . . 0.0 108.814 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -135.84 168.03 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.473 1.109 . . . . 0.0 108.386 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.04 113.16 25.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.458 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -100.15 178.29 4.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.055 1.342 . . . . 0.0 109.373 171.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.697 ' HD3' ' HD3' ' A' ' -10' ' ' ARG . 18.5 ttt180 -157.44 107.33 2.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.549 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.32 173.21 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.347 1.059 . . . . 0.0 108.229 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.3 p-10 -67.86 160.46 28.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.093 0.473 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.26 -19.69 59.58 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.346 0.659 . . . . 0.0 111.522 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -80.76 -19.34 45.11 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.536 0.734 . . . . 0.0 109.155 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.73 154.65 39.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 0.0 110.775 172.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 p -134.23 -174.7 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.619 1.168 . . . . 0.0 109.862 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.94 -37.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 124.551 1.14 . . . . 0.0 111.878 -175.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.55 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -68.76 -42.25 80.15 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.298 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.72 -35.15 77.22 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.421 0.688 . . . . 0.0 110.895 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.15 -61.1 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.797 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.15 -30.71 71.65 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.662 0.21 . . . . 0.0 110.728 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -53.68 -48.39 69.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.919 0.487 . . . . 0.0 111.562 172.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.1 m -75.8 -31.61 59.5 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.803 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 5' ' ' LEU . 2.1 mm? -54.11 -41.08 67.9 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.741 0.816 . . . . 0.0 112.824 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 12.2 pt-20 -71.56 -28.11 63.62 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.13 68.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.102 0.561 . . . . 0.0 110.277 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.458 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 4.9 mm-40 -86.04 -59.37 2.32 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.832 0.853 . . . . 0.0 109.783 175.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.2 m-85 -99.58 119.81 38.66 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.672 -168.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.29 -29.01 67.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.791 0.837 . . . . 0.0 110.902 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.87 -0.23 80.68 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.072 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.6 mt -115.78 1.58 13.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 111.092 173.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.03 122.39 19.28 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.44 76.56 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 9.8 ptp180 -118.29 4.47 11.89 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.641 0.776 . . . . 0.0 111.827 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -125.92 -8.08 6.64 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.498 1.119 . . . . 0.0 110.443 -178.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.401 ' N ' HD23 ' A' ' 48' ' ' LEU . 15.1 mt -132.73 136.87 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.877 1.271 . . . . 0.0 108.297 167.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.64 124.19 9.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.36 31.52 21.01 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.669 1.187 . . . . 0.0 111.937 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.02 -14.46 53.12 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.531 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -99.16 -174.84 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.962 0.881 . . . . 0.0 109.058 171.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.42 -55.11 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 118.104 -0.95 . . . . 0.0 111.723 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.6 tppt? 154.88 135.11 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.037 0 C-N-CA 124.714 1.206 . . . . 0.0 108.956 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.436 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 26.7 Cg_endo -60.45 135.55 61.91 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.929 2.419 . . . . 0.0 111.336 165.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 79.45 -12.49 1.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.135 1.374 . . . . 0.0 113.569 174.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 1.9 p -75.81 152.12 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.8 104.12 9.62 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.483 HG23 HG23 ' A' ' 67' ' ' VAL . 5.3 m -122.1 146.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.261 0.624 . . . . 0.0 109.873 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.3 mp -127.64 172.08 11.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.073 1.349 . . . . 0.0 110.971 -167.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 19.4 tptp -162.51 105.58 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 t30 54.99 35.57 24.96 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.053 0.941 . . . . 0.0 110.096 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.03 -14.69 61.36 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.784 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -88.89 118.77 28.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.374 0.67 . . . . 0.0 110.094 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.7 tt0 -72.44 103.01 3.34 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.477 0.486 . . . . 0.0 109.713 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 14.3 m -69.73 -1.07 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -173.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.3 m -69.91 -16.21 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.31 0.505 . . . . 0.0 111.317 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -91.09 -10.72 40.99 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.383 0.673 . . . . 0.0 111.324 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.84 -152.4 0.42 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.189 0.996 . . . . 0.0 109.595 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.17 108.35 2.65 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.1 0.56 . . . . 0.0 110.409 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.551 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -81.62 -38.59 13.84 Favored Glycine 0 C--N 1.341 0.846 0 O-C-N 123.378 0.424 . . . . 0.0 112.594 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.55 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.8 mmt -80.19 -36.36 35.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 112.647 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.19 77.65 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.459 HG21 ' HG2' ' A' ' 62' ' ' LYS . 1.4 t -82.15 -74.62 0.33 Allowed 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.802 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' H ' HG23 ' A' ' 75' ' ' THR . . . -171.22 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.143 0.577 . . . . 0.0 111.472 -161.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.544 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 24.3 tp -74.22 144.74 44.59 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.761 0.315 . . . . 0.0 111.347 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -156.21 168.76 26.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.295 1.038 . . . . 0.0 109.464 -168.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.87 149.97 48.56 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.948 0.499 . . . . 0.0 111.839 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.39 63.84 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.841 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -82.74 155.41 24.3 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.169 0.484 . . . . 0.0 109.863 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 99.06 6.68 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 123.287 0.635 . . . . 0.0 109.617 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -86.44 106.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.4 m -90.87 146.5 23.86 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 123.168 0.587 . . . . 0.0 109.506 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.27 144.76 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -128.83 141.19 40.82 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HG3' ' H ' ' A' ' 10' ' ' THR . 41.6 Cg_endo -63.79 168.4 11.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.762 2.975 . . . . 0.0 112.519 175.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 15.7 Cg_endo -57.98 129.05 31.3 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 121.234 1.289 . . . . 0.0 111.198 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -80.75 -24.55 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.134 -171.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.69 -36.81 81.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.149 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.35 -54.39 0.5 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.685 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.796 0 CA-C-O 118.929 -0.928 . . . . 0.0 110.814 -177.474 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 177.05 179.47 47.44 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 116.843 0.321 . . . . 0.0 112.53 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -143.77 136.73 7.04 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-O 120.48 -0.067 . . . . 0.0 113.129 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -10' ' ' ARG . . . . . 0.518 ' HG3' ' H ' ' A' ' -9' ' ' ASP . 3.5 tpm_? -153.37 177.87 10.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.709 1.203 . . . . 0.0 107.891 177.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' -9' ' ' ASP . . . . . 0.518 ' H ' ' HG3' ' A' ' -10' ' ' ARG . 1.5 p30 -144.56 -137.99 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.059 -161.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 71.51 -61.68 0.48 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 126.09 1.756 . . . . 0.0 110.466 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -7' ' ' LYS . . . . . 0.465 ' HD3' ' HB2' ' A' ' -5' ' ' ASP . 0.1 OUTLIER -62.56 168.13 3.9 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.853 0.861 . . . . 0.0 111.199 165.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -78.2 -78.88 0.13 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.335 0.254 . . . . 0.0 111.066 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -5' ' ' ASP . . . . . 0.465 ' HB2' ' HD3' ' A' ' -7' ' ' LYS . 30.2 t70 60.03 -176.75 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.936 0.894 . . . . 0.0 112.249 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.39 -31.48 69.27 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.075 0.95 . . . . 0.0 111.985 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -139.13 140.14 37.83 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.273 0.559 . . . . 0.0 110.461 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.406 ' HG3' ' H ' ' A' ' 0' ' ' THR . 22.1 pttm -144.97 -62.64 0.35 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.64 1.176 . . . . 0.0 108.61 175.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 72.82 25.18 74.56 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 121.666 -0.647 . . . . 0.0 112.702 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' -9' ' ' ASP . 73.3 p -97.51 143.46 28.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.828 0.851 . . . . 0.0 110.818 -175.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.9 ptt? -101.72 140.4 36.05 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.781 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -95.22 130.59 41.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.292 0.637 . . . . 0.0 109.797 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.486 HD13 HD21 ' A' ' 77' ' ' LEU . 24.4 mt -124.44 138.73 54.33 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.646 0.779 . . . . 0.0 110.45 -169.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 45.5 tt0 -89.32 102.64 15.31 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD13 HD21 ' A' ' 37' ' ' LEU . 38.7 mt -92.86 103.7 16.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 30.1 mtm180 -92.32 117.62 30.09 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.393 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.33 138.49 42.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 109.464 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.72 155.38 48.95 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.335 0.654 . . . . 0.0 109.7 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.544 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.75 -126.75 0.96 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.144 1.378 . . . . 0.0 111.99 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.422 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 36.7 m -63.97 -43.03 96.98 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 123.34 0.656 . . . . 0.0 111.127 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -60.98 -27.69 68.47 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.574 0.35 . . . . 0.0 111.072 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 55.3 ttp180 -67.5 -53.33 29.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.321 0.648 . . . . 0.0 111.396 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -20.42 60.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.111 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 44' ' ' LEU . 40.6 t -61.5 -47.74 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.559 0.695 . . . . 0.0 110.294 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.75 -20.54 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.905 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.53 16.36 71.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.041 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -143.19 139.4 30.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.553 1.141 . . . . 0.0 109.841 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 22.3 ptmt -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.754 0.659 . . . . 0.0 110.521 172.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -156.92 145.43 19.74 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.465 174.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.12 173.24 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.344 1.057 . . . . 0.0 109.089 172.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -118.73 112.76 20.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.8 -179.64 4.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.276 1.43 . . . . 0.0 109.388 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -157.36 105.75 2.11 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.82 172.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -59.21 148.33 32.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.175 0.59 . . . . 0.0 111.285 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -61.94 -27.31 68.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 111.29 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -80.3 -24.99 39.61 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 110.24 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.89 37.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.02 0.528 . . . . 0.0 109.639 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.3 p -103.14 -173.87 2.42 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.596 0.758 . . . . 0.0 110.799 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 77' ' ' LEU . 87.9 t -50.84 -37.03 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 124.204 1.002 . . . . 0.0 111.493 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.3 -38.38 71.19 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.97 -31.02 69.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.297 0.639 . . . . 0.0 110.879 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.32 -60.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.172 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.506 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.7 pp -64.63 -30.16 71.18 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.192 0.308 . . . . 0.0 111.204 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HA ' HD11 ' A' ' 49' ' ' ILE . 16.6 tpt180 -51.41 -49.97 60.57 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.462 0.705 . . . . 0.0 111.242 168.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 m -75.36 -32.31 60.81 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.653 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.411 HD21 HD13 ' A' ' 5' ' ' LEU . 3.8 mm? -58.26 -35.31 71.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.187 0.595 . . . . 0.0 112.498 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.491 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.8 pt-20 -76.84 -27.45 55.12 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.324 0.511 . . . . 0.0 111.673 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.92 64.7 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.776 0.43 . . . . 0.0 111.01 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -90.23 -59.82 2.09 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.574 0.702 . . . . 0.0 110.158 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -92.28 126.54 37.4 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.602 -168.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.99 -35.67 69.55 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.689 0.796 . . . . 0.0 110.023 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.18 -4.19 86.18 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.957 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.605 ' HB3' HD13 ' A' ' 48' ' ' LEU . 56.9 mt -106.82 -3.67 20.12 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.934 0.867 . . . . 0.0 111.485 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.02 121.4 14.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.87 12.02 67.2 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.354 0.902 . . . . 0.0 115.354 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -118.26 0.44 11.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.005 0.922 . . . . 0.0 110.743 179.146 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -122.8 -5.42 8.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.524 1.13 . . . . 0.0 109.831 177.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 35' ' ' ARG . 37.0 mt -130.67 135.17 60.87 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.108 1.363 . . . . 0.0 108.398 169.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.84 126.35 14.13 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 166.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 56.11 31.29 17.92 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.604 1.162 . . . . 0.0 111.947 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.01 -14.38 57.32 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.27 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.59 -174.6 2.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 34' ' ' LEU . 27.8 m -63.51 -55.88 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.153 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 11.3 tppt? 151.5 137.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.075 0 C-N-CA 125.122 1.369 . . . . 0.0 108.901 -176.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 131.13 31.48 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 C-N-CA 123.042 2.495 . . . . 0.0 111.836 165.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 79.38 -11.72 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.585 1.554 . . . . 0.0 114.167 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -69.34 142.99 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 16.4 m120 -110.2 103.36 12.04 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 85' ' ' VAL . 3.7 m -121.3 129.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.537 0.735 . . . . 0.0 109.307 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.727 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 2.1 mp -121.06 139.39 53.38 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.435 1.094 . . . . 0.0 110.413 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 12.9 tptm -110.5 114.65 28.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.17 35.12 21.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.032 0.933 . . . . 0.0 110.993 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.05 -4.93 81.79 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.998 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -100.35 116.01 31.32 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 11.3 tt0 -70.28 107.11 3.59 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.635 0.584 . . . . 0.0 109.774 -173.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.71 -1.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.48 -19.35 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 122.662 0.385 . . . . 0.0 111.168 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -90.26 -5.24 56.55 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.668 0.787 . . . . 0.0 111.235 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.01 -149.35 0.29 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 109.327 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.24 108.84 3.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.266 0.626 . . . . 0.0 110.605 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.23 -43.4 20.95 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 122.999 0.187 . . . . 0.0 112.641 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.632 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.6 mmt -76.91 -40.26 47.94 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.195 0.598 . . . . 0.0 111.775 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.37 78.75 1.52 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 t -80.8 -65.99 0.94 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.654 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 175.57 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.918 0.887 . . . . 0.0 110.462 -163.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.486 HD21 HD13 ' A' ' 3' ' ' LEU . 47.2 tp -73.89 136.64 43.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.639 0.375 . . . . 0.0 110.412 -175.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -149.93 -177.46 5.92 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 122.805 0.442 . . . . 0.0 110.013 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 33.6 t70 -64.4 144.93 56.81 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.794 0.838 . . . . 0.0 112.917 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.35 -7.19 12.42 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.455 -0.793 . . . . 0.0 114.793 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.475 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 4.9 m-20 -78.44 142.07 37.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.762 0.825 . . . . 0.0 112.431 -169.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -97.64 111.16 23.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.036 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.17 107.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.727 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 12.9 m -85.57 147.04 26.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.985 0.514 . . . . 0.0 109.986 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 60' ' ' VAL . 33.0 m -141.93 140.6 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.602 0.715 . . . . 0.0 109.584 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.644 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 6.6 m-85 -129.92 137.79 31.67 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 37.1 Cg_endo -63.44 162.67 26.48 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.151 2.567 . . . . 0.0 112.594 176.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -66.84 130.4 23.1 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 121.509 1.472 . . . . 0.0 111.17 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.6 m -85.08 -11.84 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.127 0.571 . . . . 0.0 110.972 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.28 165.34 27.7 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.35 1.06 . . . . 0.0 109.597 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.98 -59.75 0.07 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.16 174.706 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.39 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 67.81 -136.43 31.24 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 123.043 0.354 . . . . 0.0 112.738 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 74.16 -109.25 2.74 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -10' ' ' ARG . . . . . 0.404 ' NH2' ' HB2' ' A' ' 27' ' ' ASP . 25.3 mtt180 -146.9 118.8 8.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.565 1.146 . . . . 0.0 108.08 170.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -9' ' ' ASP . . . . . 0.622 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 22.1 t70 -139.8 157.35 45.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.754 1.221 . . . . 0.0 108.826 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -107.17 -43.82 4.51 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.158 0.583 . . . . 0.0 111.633 -170.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -7' ' ' LYS . . . . . 0.629 ' HD2' ' H ' ' A' ' -6' ' ' ASP . 0.0 OUTLIER -80.27 -53.32 6.75 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -169.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' -6' ' ' ASP . . . . . 0.629 ' H ' ' HD2' ' A' ' -7' ' ' LYS . 37.4 t70 -174.87 -75.06 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.699 0.8 . . . . 0.0 110.175 -174.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 58.29 -171.5 0.11 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.045 0.938 . . . . 0.0 110.635 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -54.8 -41.37 70.52 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.362 0.665 . . . . 0.0 109.833 164.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -151.75 132.53 14.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.283 0.633 . . . . 0.0 109.674 170.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 13.5 pttm -92.82 -52.78 4.45 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.554 1.142 . . . . 0.0 110.443 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 75.83 16.85 80.39 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 116.565 -0.288 . . . . 0.0 113.329 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 20.9 p -78.56 142.1 37.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.524 0.73 . . . . 0.0 109.654 172.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.465 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 27.0 ptt? -96.06 143.54 27.12 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.826 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -93.34 126.87 38.69 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.904 0.882 . . . . 0.0 109.046 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.426 HD11 HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -124.11 148.98 46.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.946 0.498 . . . . 0.0 109.988 -175.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 31.1 tt0 -97.42 113.51 25.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 170.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.2 mt -101.39 112.29 24.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 51.9 mtt180 -99.94 117.17 33.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.187 0.995 . . . . 0.0 108.796 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.55 137.61 45.28 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.952 0.901 . . . . 0.0 109.256 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -131.6 159.7 37.48 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.93 0.492 . . . . 0.0 109.814 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.21 -120.6 1.07 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 124.779 1.232 . . . . 0.0 112.337 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.481 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 26.2 m -71.92 -45.41 61.29 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 123.082 0.553 . . . . 0.0 110.442 -178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -55.34 -30.0 59.42 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.195 0.598 . . . . 0.0 110.972 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HD2' ' HG2' ' A' ' 18' ' ' LYS . 50.8 ttp180 -66.72 -55.24 15.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.84 0.856 . . . . 0.0 111.726 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -16.93 60.91 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.934 -174.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG11 ' HG ' ' A' ' 44' ' ' LEU . 40.1 t -65.54 -55.87 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.28 0.632 . . . . 0.0 109.689 168.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.2 t -74.54 -17.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.612 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.7 11.61 73.3 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.701 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -139.48 144.29 37.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.198 0.999 . . . . 0.0 109.144 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.522 ' HG2' ' HD2' ' A' ' 12' ' ' ARG . 22.0 mtmm -86.31 -21.05 27.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.746 0.419 . . . . 0.0 109.909 174.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 14.7 m -154.05 146.51 24.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.377 1.071 . . . . 0.0 109.216 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 23.2 pt -141.52 170.61 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 109.7 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -112.83 113.07 24.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.47 -179.53 4.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.579 1.151 . . . . 0.0 109.843 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG2' ' HB ' ' A' ' 0' ' ' THR . 60.7 ttp180 -157.4 106.43 2.14 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.829 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 3' ' ' LEU . 27.2 m -114.46 169.37 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.215 171.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 27.8 t70 -61.8 154.09 26.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.936 0.494 . . . . 0.0 111.039 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.24 -32.42 71.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.014 0.926 . . . . 0.0 111.833 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.404 ' HB2' ' NH2' ' A' ' -10' ' ' ARG . 28.2 t70 -81.01 -22.6 39.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.958 0.903 . . . . 0.0 111.362 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 153.72 37.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.28 0.632 . . . . 0.0 110.66 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -130.48 -175.07 3.53 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 97.8 t -51.81 -37.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.951 0.9 . . . . 0.0 111.648 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.95 65.92 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.005 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.27 -33.79 76.64 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.272 0.629 . . . . 0.0 110.296 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.88 -60.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.813 0.845 . . . . 0.0 110.317 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.508 HD21 HG12 ' A' ' 54' ' ' VAL . 2.6 pp -64.66 -30.74 71.76 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.134 0.424 . . . . 0.0 111.579 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HA ' HD11 ' A' ' 49' ' ' ILE . 17.3 tpt180 -50.96 -48.59 61.0 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.157 0.583 . . . . 0.0 110.956 168.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 m -74.65 -32.5 62.29 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.187 0.595 . . . . 0.0 111.436 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 4.1 mm? -59.74 -34.29 72.76 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' A' ' 48' ' ' LEU . 5.6 pt-20 -76.89 -28.57 55.41 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.718 0.69 . . . . 0.0 111.124 173.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.05 -32.7 72.37 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.039 0.536 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -83.99 -58.0 2.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.526 0.73 . . . . 0.0 110.474 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -96.38 127.33 42.28 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.587 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.28 -45.68 90.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.131 0.973 . . . . 0.0 110.697 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.11 7.1 54.34 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.423 -0.808 . . . . 0.0 114.021 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.588 ' HB3' HD13 ' A' ' 48' ' ' LEU . 74.3 mt -115.97 5.26 13.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.615 0.707 . . . . 0.0 111.167 172.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -69.89 120.94 16.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.27 -8.09 26.97 Favored Glycine 0 C--N 1.359 1.847 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -100.08 4.13 44.45 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.355 1.062 . . . . 0.0 111.403 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -128.66 -8.87 5.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.257 1.023 . . . . 0.0 110.855 -177.204 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.479 HD11 ' HA ' ' A' ' 35' ' ' ARG . 51.5 mt -125.22 132.52 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.598 1.159 . . . . 0.0 107.967 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.17 117.65 13.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.919 0.488 . . . . 0.0 109.731 167.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.2 t70 55.54 30.85 15.98 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.05 -14.83 63.4 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.616 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -97.31 -174.01 2.82 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.883 0.842 . . . . 0.0 108.885 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.508 HG12 HD21 ' A' ' 34' ' ' LEU . 13.8 m -65.5 -56.83 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.788 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 150.81 135.97 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.003 0 C-N-CA 125.078 1.351 . . . . 0.0 109.176 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.49 137.51 51.02 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.84 2.36 . . . . 0.0 110.972 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 77.9 -11.94 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.325 1.45 . . . . 0.0 113.61 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 p -73.56 138.94 20.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.666 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.6 m120 -104.67 103.55 13.21 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 85' ' ' VAL . 4.2 m -122.93 135.38 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.624 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -126.19 155.62 41.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.349 1.059 . . . . 0.0 110.639 -166.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 13.3 tptm -123.49 104.51 9.11 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.554 1.142 . . . . 0.0 107.975 169.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 t30 52.64 37.69 24.07 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.062 1.345 . . . . 0.0 111.702 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 19.61 43.79 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.871 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -133.27 105.49 7.01 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 16.0 tt0 -62.85 109.31 1.4 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.331 1.052 . . . . 0.0 110.918 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 31.3 m -69.95 -1.48 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -172.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -68.16 -22.53 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 117.935 0.334 . . . . 0.0 110.824 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -86.38 -15.87 39.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.865 0.866 . . . . 0.0 111.151 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.75 -153.14 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.247 1.019 . . . . 0.0 109.289 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.25 113.5 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.077 0.551 . . . . 0.0 110.538 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -73.3 -50.29 12.79 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.718 0.636 . . . . 0.0 112.734 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.3 mmm -79.94 -36.83 35.7 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.345 0.658 . . . . 0.0 111.692 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.43 77.95 1.65 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.571 0.701 . . . . 0.0 111.008 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.29 -71.4 0.47 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.836 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.477 ' H ' HG23 ' A' ' 75' ' ' THR . . . -173.75 28.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.912 0.885 . . . . 0.0 110.962 -164.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -75.33 144.06 42.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.175 0.59 . . . . 0.0 111.574 -168.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -157.51 -176.02 5.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.066 0.546 . . . . 0.0 110.1 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 28.3 t70 -63.88 140.53 58.88 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.035 0.934 . . . . 0.0 111.338 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 -7.09 57.87 Favored Glycine 0 C--N 1.344 1.023 0 O-C-N 123.834 0.709 . . . . 0.0 114.421 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.52 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 78.1 m-20 -79.55 133.9 36.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -170.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.32 105.66 17.63 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.446 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.2 137.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.624 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.9 m -118.12 154.83 31.46 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.441 0.564 . . . . 0.0 110.2 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 60' ' ' VAL . 34.6 m -145.1 143.92 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.751 0.82 . . . . 0.0 110.152 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.666 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 18.1 m-85 -135.08 133.75 21.08 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HG3' ' H ' ' A' ' 10' ' ' THR . 22.0 Cg_endo -59.89 160.96 19.93 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 123.325 2.684 . . . . 0.0 112.867 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.29 130.67 31.18 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.945 1.764 . . . . 0.0 111.745 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.58 2.61 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.059 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.24 106.17 0.41 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.362 1.065 . . . . 0.0 110.989 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.53 26.41 8.16 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.371 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.352 0 CA-C-O 118.507 -1.163 . . . . 0.0 111.31 -176.634 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 CA-C-O 120.122 -0.266 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -148.4 33.98 1.19 Allowed Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 82.43 -76.1 2.27 Favored Glycine 0 C--N 1.348 1.206 0 C-N-CA 123.233 0.444 . . . . 0.0 112.002 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -110.18 46.77 1.0 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.853 0.835 . . . . 0.0 108.961 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.54 -35.24 73.02 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.835 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 68.13 -6.02 0.81 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.457 1.103 . . . . 0.0 113.268 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -7' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' -2' ' ' LYS . 25.1 mtpp -130.39 131.27 45.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.588 0.755 . . . . 0.0 110.855 -166.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.49 -4.72 38.5 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.057 0.943 . . . . 0.0 111.288 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.81 174.85 6.33 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.961 1.304 . . . . 0.0 112.512 -176.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.72 -12.85 61.81 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.071 0.948 . . . . 0.0 111.971 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -127.52 151.97 48.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.923 0.889 . . . . 0.0 109.798 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' -7' ' ' LYS . 21.6 pttm -66.4 -37.46 85.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.011 1.324 . . . . 0.0 111.179 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 64.95 6.69 26.12 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 34.3 p -121.34 141.39 50.98 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.03 0.932 . . . . 0.0 109.087 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.76 151.44 31.96 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.481 0.712 . . . . 0.0 110.391 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.11 137.96 50.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.602 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.23 149.25 46.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.685 0.794 . . . . 0.0 109.855 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -89.2 106.86 18.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.26 112.65 24.57 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 39.8 mtp180 -104.64 118.02 35.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.716 0.806 . . . . 0.0 109.297 -170.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 136.67 45.47 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.924 0.89 . . . . 0.0 109.325 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -132.45 160.74 35.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.79 0.436 . . . . 0.0 110.104 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.06 -117.77 0.82 Allowed 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.892 1.277 . . . . 0.0 112.389 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.626 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 46.7 m -69.69 -47.52 62.91 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 123.632 0.773 . . . . 0.0 110.494 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -59.46 -24.36 63.49 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.986 0.515 . . . . 0.0 111.224 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -50.36 53.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.731 0.813 . . . . 0.0 111.291 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -16.91 60.89 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.595 HG11 ' HG ' ' A' ' 44' ' ' LEU . 72.6 t -65.36 -53.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.626 0.726 . . . . 0.0 110.205 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.85 -16.73 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.633 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.74 11.52 85.15 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.414 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.97 158.84 10.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.84 0.856 . . . . 0.0 110.807 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -94.76 -9.42 34.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.0 m -152.65 143.08 22.63 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.41 175.82 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.223 1.009 . . . . 0.0 109.119 174.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.49 112.96 16.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.36 135.91 44.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.303 1.041 . . . . 0.0 110.038 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -104.13 106.18 16.6 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.1 175.7 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.542 1.137 . . . . 0.0 108.226 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.46 164.52 26.54 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.627 0.371 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -76.95 -15.46 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.53 -24.33 36.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.879 0.472 . . . . 0.0 110.35 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.06 58.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.901 0.881 . . . . 0.0 111.463 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.3 p -128.27 -174.39 3.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.475 1.11 . . . . 0.0 109.725 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.81 -33.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 123.973 0.909 . . . . 0.0 112.093 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' HA2' ' HE1' ' A' ' 73' ' ' MET . . . -66.58 -50.05 51.67 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.053 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -61.59 -29.55 70.11 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.174 0.59 . . . . 0.0 111.583 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.45 -60.62 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.31 1.044 . . . . 0.0 110.541 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.3 pp -74.14 -31.06 62.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.2 ppt_? -67.12 -31.85 72.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.67 0.668 . . . . 0.0 111.176 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -76.67 -34.11 58.24 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.607 0.763 . . . . 0.0 112.333 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -59.91 -38.96 83.81 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 122.974 0.509 . . . . 0.0 111.86 -176.449 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -68.28 -37.41 80.64 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.345 0.403 . . . . 0.0 111.765 175.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.54 -28.96 69.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.506 0.723 . . . . 0.0 111.447 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -82.72 -58.83 2.72 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.043 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.22 112.56 24.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.813 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.93 -31.3 70.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.579 0.751 . . . . 0.0 110.55 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -73.31 -6.39 69.56 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.419 -0.809 . . . . 0.0 114.064 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HB3' HD13 ' A' ' 48' ' ' LEU . 68.0 mt -113.26 2.29 15.51 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.675 0.738 . . . . 0.0 111.141 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.9 120.74 13.62 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.27 -28.67 2.6 Favored Glycine 0 C--N 1.359 1.826 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 5.6 ptp180 -83.29 9.24 11.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.904 1.282 . . . . 0.0 112.693 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -132.26 9.85 4.45 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.94 0.896 . . . . 0.0 110.931 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 35' ' ' ARG . 61.1 mt -141.41 140.75 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.296 1.038 . . . . 0.0 109.315 175.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 55' ' ' LYS . 16.6 mm-40 -139.71 110.41 6.74 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.302 0.641 . . . . 0.0 110.317 163.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t70 56.6 36.14 27.16 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.475 1.11 . . . . 0.0 111.894 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.04 27.52 62.13 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.139 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.63 -177.4 4.17 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 161.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.495 HG12 HD21 ' A' ' 34' ' ' LEU . 17.1 m -66.5 -56.09 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 117.588 -1.196 . . . . 0.0 112.297 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HD3' ' HG2' ' A' ' 50' ' ' GLU . 5.9 tppt? 149.58 134.27 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.243 0 C-N-CA 126.06 1.744 . . . . 0.0 108.616 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 19.5 Cg_endo -58.91 133.34 53.02 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.061 2.507 . . . . 0.0 112.184 165.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 81.03 -26.99 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.861 1.664 . . . . 0.0 113.107 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.76 120.44 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -95.41 104.71 16.62 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 85' ' ' VAL . 1.7 m -109.37 146.39 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.287 0.635 . . . . 0.0 109.55 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.5 mp -132.7 170.66 14.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.971 1.308 . . . . 0.0 110.243 -164.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE2' HD23 ' A' ' 77' ' ' LEU . 20.9 tptp -162.28 105.43 1.14 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 55.82 34.76 24.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.16 0.981 . . . . 0.0 109.832 -171.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.93 -13.58 48.05 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 114.492 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -87.16 119.28 27.23 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.922 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 24.3 tt0 -78.53 104.47 9.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.224 0.61 . . . . 0.0 111.13 -168.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.469 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.1 m -70.87 -1.32 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -170.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.1 m -68.6 -19.78 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.39 0.541 . . . . 0.0 110.898 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -92.53 -29.38 16.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.019 0.927 . . . . 0.0 110.843 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.79 -150.74 0.47 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.143 0.977 . . . . 0.0 109.406 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.04 108.31 2.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.955 0.502 . . . . 0.0 110.955 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -83.15 -37.79 12.09 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 123.32 0.387 . . . . 0.0 112.273 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.518 ' HE1' ' HA2' ' A' ' 31' ' ' GLY . 14.1 mmt -79.73 -38.39 33.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.653 0.781 . . . . 0.0 111.917 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.73 83.96 1.29 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.47 -75.26 0.29 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.724 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.4 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -163.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.475 HD23 ' HE2' ' A' ' 62' ' ' LYS . 15.4 mt -73.68 143.65 46.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.865 0.84 . . . . 0.0 112.554 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -151.1 169.3 22.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.751 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.9 135.07 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 122.13 -0.356 . . . . 0.0 111.217 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 16.58 80.54 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.82 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.2 157.43 21.64 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.421 0.611 . . . . 0.0 109.563 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.75 106.03 11.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.268 0.627 . . . . 0.0 111.143 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.405 HG22 HD21 ' A' ' 77' ' ' LEU . 47.6 t -86.92 137.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.622 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 69.5 m -118.62 151.82 37.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 60' ' ' VAL . 10.3 m -142.27 148.3 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 121.404 0.621 . . . . 0.0 110.196 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -136.3 140.71 33.53 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.626 ' HG3' ' H ' ' A' ' 10' ' ' THR . 53.6 Cg_endo -64.28 168.83 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.254 3.303 . . . . 0.0 112.417 174.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.7 129.81 26.05 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.077 1.185 . . . . 0.0 111.385 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.4 m -89.96 1.03 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.508 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.73 111.75 2.57 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.289 1.036 . . . . 0.0 109.333 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 -54.81 6.92 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.8 -1.0 . . . . 0.0 111.312 -178.91 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -152.99 80.4 0.19 Allowed Glycine 0 C--N 1.344 0.972 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -168.63 51.01 0.22 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -10' ' ' ARG . . . . . 0.493 HH11 ' HB3' ' A' ' 23' ' ' ARG . 40.3 ttm180 58.61 22.63 10.02 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.526 1.13 . . . . 0.0 111.029 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' -9' ' ' ASP . . . . . 0.563 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 6.2 p-10 -64.53 141.87 58.62 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.046 0.938 . . . . 0.0 112.037 -175.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -104.94 19.12 21.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.709 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 175.17 8.66 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.887 1.275 . . . . 0.0 109.971 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -109.95 -170.08 1.59 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.484 0.713 . . . . 0.0 110.02 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 72.64 -93.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.398 1.479 . . . . 0.0 110.55 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -172.03 95.29 0.15 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.431 0.692 . . . . 0.0 109.53 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -176.99 135.6 0.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.577 1.151 . . . . 0.0 108.712 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 18.7 ptpt -74.96 -53.26 9.28 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.403 ' N ' ' HG3' ' A' ' -2' ' ' LYS . . . 44.79 45.57 8.98 Favored Glycine 0 C--N 1.356 1.647 0 O-C-N 123.672 0.607 . . . . 0.0 113.424 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 9.7 p -125.1 147.74 48.86 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.578 0.751 . . . . 0.0 110.016 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' SD ' ' HA ' ' A' ' 26' ' ' ASP . 13.2 ptm -122.31 111.71 17.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.412 1.085 . . . . 0.0 109.722 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.32 121.43 28.87 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.542 HD13 HD21 ' A' ' 77' ' ' LEU . 21.4 mt -123.93 135.21 53.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.562 0.745 . . . . 0.0 110.027 -169.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.11 98.45 11.77 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD13 HD21 ' A' ' 37' ' ' LEU . 21.9 mt -94.83 104.8 16.71 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.122 . . . . 0.0 110.529 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 41.3 mtp180 -101.06 117.33 34.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.408 0.683 . . . . 0.0 109.414 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -101.76 140.22 36.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.049 0.939 . . . . 0.0 109.357 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.5 157.11 43.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.096 0.558 . . . . 0.0 110.137 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.66 -122.29 1.09 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.775 1.23 . . . . 0.0 112.861 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.539 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 92.0 m -64.78 -48.07 75.83 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 123.757 0.823 . . . . 0.0 111.042 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -60.03 -24.52 64.59 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.819 0.448 . . . . 0.0 111.467 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 13' ' ' GLU . 7.8 tmm_? -72.46 -47.58 47.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.932 0.493 . . . . 0.0 111.288 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 1.1 pp20? -74.16 -19.11 60.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.53 0.332 . . . . 0.0 111.698 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.558 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.0 t -67.35 -52.55 40.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.67 0.788 . . . . 0.0 110.483 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 95.6 t -73.88 -22.18 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.526 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.07 11.44 63.66 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.885 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -146.46 136.99 23.97 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -170.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HD2' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -87.71 -14.71 39.09 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -155.5 137.82 14.84 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.709 0.804 . . . . 0.0 109.315 177.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.45 140.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -88.92 112.45 23.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.86 170.97 9.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.55 1.14 . . . . 0.0 108.928 170.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.493 ' HB3' HH11 ' A' ' -10' ' ' ARG . 65.4 ttt180 -157.02 108.47 2.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.704 0.764 . . . . 0.0 109.466 173.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.57 -179.56 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.766 1.627 . . . . 0.0 108.364 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.99 160.19 30.09 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.431 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 5.3 p-10 -69.83 -8.08 45.33 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.694 0.797 . . . . 0.0 113.043 -170.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.35 -14.44 57.25 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.719 0.807 . . . . 0.0 112.26 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.95 129.47 36.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.696 0.398 . . . . 0.0 111.133 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p -109.63 -179.59 3.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -54.02 -32.66 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.081 0.952 . . . . 0.0 112.368 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.63 -40.51 58.88 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.741 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.7 -32.24 73.41 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.163 0.481 . . . . 0.0 110.45 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.21 -60.08 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.678 0.611 . . . . 0.0 110.408 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.493 HD21 HG12 ' A' ' 54' ' ' VAL . 2.6 pp -66.91 -30.08 70.14 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 123.331 0.394 . . . . 0.0 111.166 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.3 tpt85 -56.28 -48.38 76.72 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.061 0.544 . . . . 0.0 111.518 170.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -75.88 -31.75 59.37 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.047 0.539 . . . . 0.0 111.442 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 5' ' ' LEU . 1.5 mm? -56.59 -44.81 81.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.706 0.803 . . . . 0.0 112.406 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.501 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.68 -25.64 67.42 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.157 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.7 -21.65 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.655 0.597 . . . . 0.0 111.238 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -98.68 -59.09 1.81 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 122.877 0.471 . . . . 0.0 109.781 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.499 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 91.9 m-85 -89.66 117.45 28.54 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.882 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.01 -35.39 81.04 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.742 0.817 . . . . 0.0 111.481 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.88 -2.13 75.74 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.754 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.663 ' HB3' HD13 ' A' ' 48' ' ' LEU . 58.0 mt -103.94 -15.57 15.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.46 0.704 . . . . 0.0 110.893 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.48 120.65 9.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.779 0.832 . . . . 0.0 112.59 -171.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.62 74.04 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 115.489 0.955 . . . . 0.0 115.489 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 3.1 ptp180 -118.71 -0.06 11.37 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.539 0.736 . . . . 0.0 111.713 -176.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.22 -3.05 11.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.738 0.815 . . . . 0.0 110.185 173.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 35' ' ' ARG . 41.2 mt -133.44 137.19 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.019 1.328 . . . . 0.0 108.195 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -135.96 108.39 7.37 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t70 57.92 32.2 21.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.636 1.174 . . . . 0.0 112.557 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.43 1.2 69.17 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 115.084 0.793 . . . . 0.0 115.084 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.08 -174.91 2.63 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 117.849 0.824 . . . . 0.0 109.392 165.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.493 HG12 HD21 ' A' ' 34' ' ' LEU . 17.8 m -65.76 -55.42 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.601 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.5 tppt? 150.21 138.09 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 C-N-CA 125.576 1.55 . . . . 0.0 107.956 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.455 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 19.6 Cg_endo -56.07 129.19 33.57 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 123.009 2.473 . . . . 0.0 110.619 166.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 74.86 -4.79 2.29 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.997 1.319 . . . . 0.0 114.28 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -74.99 131.9 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.1 m120 -100.9 103.58 14.76 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.43 137.28 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.267 0.627 . . . . 0.0 109.765 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 7.4 mp -118.87 169.23 10.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.113 1.365 . . . . 0.0 111.09 -169.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -163.77 106.0 0.95 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.478 -177.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.481 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 7.5 t-20 59.21 38.12 23.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.188 1.395 . . . . 0.0 109.721 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.96 -14.6 48.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.619 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -93.79 119.12 32.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.445 0.622 . . . . 0.0 109.565 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 22.4 tt0 -75.18 109.46 8.69 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.064 0.459 . . . . 0.0 109.765 -174.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 20.6 m -71.4 -0.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.72 -19.91 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.186 0.448 . . . . 0.0 110.978 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -88.3 -19.65 26.46 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.737 0.815 . . . . 0.0 110.794 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.34 -148.34 0.36 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.692 1.197 . . . . 0.0 109.262 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.3 108.95 6.46 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.003 0.521 . . . . 0.0 110.57 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -79.6 -37.64 22.94 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 113.903 0.321 . . . . 0.0 113.903 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 82.8 mmm -81.62 -26.75 34.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.99 85.35 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 118.177 0.444 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.81 -73.15 0.4 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.073 0.549 . . . . 0.0 112.192 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' H ' HG23 ' A' ' 75' ' ' THR . . . -173.19 33.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.815 0.846 . . . . 0.0 110.557 -164.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.542 HD21 HD13 ' A' ' 3' ' ' LEU . 41.4 tp -74.35 123.54 24.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.495 0.318 . . . . 0.0 110.154 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 7.0 t70 -116.82 178.24 4.41 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.5 147.69 49.09 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.359 0.663 . . . . 0.0 111.035 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.21 10.82 70.06 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.548 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -82.6 177.67 8.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.451 0.701 . . . . 0.0 110.896 -174.228 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.69 109.11 9.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.293 0.637 . . . . 0.0 110.866 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.47 137.65 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 108.734 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 75.3 m -121.04 154.23 36.33 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -142.88 147.64 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.624 0.726 . . . . 0.0 110.141 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 14.9 m-85 -133.51 140.23 36.28 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HG3' ' H ' ' A' ' 10' ' ' THR . 58.7 Cg_endo -66.36 168.38 16.3 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.711 2.94 . . . . 0.0 112.3 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.19 130.71 27.95 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 121.395 1.397 . . . . 0.0 110.869 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.1 m -79.71 -32.41 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.553 -171.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -177.0 129.35 0.17 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.716 1.206 . . . . 0.0 108.889 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.79 49.44 3.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 123.303 0.377 . . . . 0.0 112.947 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.306 0 CA-C-O 118.807 -0.996 . . . . 0.0 112.608 -177.654 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -83.01 64.37 4.33 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -80.7 72.27 2.72 Favored Glycine 0 C--N 1.35 1.331 0 C-N-CA 123.0 0.333 . . . . 0.0 112.347 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -10' ' ' ARG . . . . . 0.559 ' HB2' HH21 ' A' ' 23' ' ' ARG . 2.6 mmp_? -77.81 82.88 4.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.561 0.696 . . . . 0.0 110.447 175.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' -9' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 5.2 p-10 -83.58 172.54 12.25 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.379 169.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -124.58 33.79 5.16 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.126 0.489 . . . . 0.0 111.961 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -7' ' ' LYS . . . . . 0.632 ' HG2' ' H ' ' A' ' -6' ' ' ASP . 0.0 OUTLIER -128.6 -69.36 0.72 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.42 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' -6' ' ' ASP . . . . . 0.632 ' H ' ' HG2' ' A' ' -7' ' ' LYS . 28.4 t70 173.39 -57.29 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.628 1.571 . . . . 0.0 107.543 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -169.72 -174.81 1.95 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.117 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 25.2 t70 69.92 80.33 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.275 1.03 . . . . 0.0 108.947 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 23.5 t70 67.35 138.19 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.485 1.514 . . . . 0.0 112.281 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 0.2 OUTLIER -61.65 -44.91 96.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.402 0.681 . . . . 0.0 111.252 178.241 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 48.21 48.9 25.96 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 123.766 0.698 . . . . 0.0 113.566 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 21.3 p -117.32 171.88 7.68 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.184 0.993 . . . . 0.0 110.919 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.6 ptt? -149.86 124.02 9.48 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.773 0.829 . . . . 0.0 109.547 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -85.27 113.65 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.031 0.932 . . . . 0.0 109.107 -175.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.3 mt -115.46 134.5 55.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.391 0.676 . . . . 0.0 110.931 -171.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 65.1 tt0 -89.17 103.09 15.74 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.8 mt -93.84 105.3 17.33 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.4 mtt180 -91.9 117.0 29.39 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.749 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.444 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m-85 -103.44 136.09 43.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.976 0.91 . . . . 0.0 109.248 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.01 161.41 29.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.225 0.61 . . . . 0.0 109.537 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.41 -133.27 0.93 Allowed 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.604 1.162 . . . . 0.0 112.354 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 14' ' ' VAL . 57.2 m -55.76 -44.03 77.26 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 124.324 1.05 . . . . 0.0 111.819 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 10.8 m-30 -63.1 -33.09 74.71 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.076 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -41.57 91.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.642 0.377 . . . . 0.0 110.273 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -67.91 -35.86 79.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.806 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.493 HG11 ' HG ' ' A' ' 44' ' ' LEU . 64.6 t -60.46 -56.31 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.257 0.623 . . . . 0.0 110.617 174.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.26 -17.15 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.42 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.98 11.52 70.08 Favored Glycine 0 C--N 1.35 1.313 0 C-N-CA 123.578 0.608 . . . . 0.0 113.682 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -160.7 142.45 12.33 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.232 1.013 . . . . 0.0 110.149 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -85.83 -22.16 27.74 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.952 0.901 . . . . 0.0 113.38 -167.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.2 m -150.18 133.09 16.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 18.1 pt -129.98 171.88 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.997 . . . . 0.0 108.928 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -116.95 112.17 20.63 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 163.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -89.96 -179.05 5.62 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.91 1.284 . . . . 0.0 108.772 164.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.559 HH21 ' HB2' ' A' ' -10' ' ' ARG . 59.8 ttp180 -155.73 113.89 3.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.68 -179.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.52 156.74 35.97 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.723 0.409 . . . . 0.0 110.353 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.56 -24.96 53.56 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.262 0.625 . . . . 0.0 111.049 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.65 -14.39 56.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.86 0.864 . . . . 0.0 110.558 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 166.07 23.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.257 0.623 . . . . 0.0 110.836 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.8 p -132.2 -177.47 4.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.594 0.758 . . . . 0.0 110.815 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.35 -35.85 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.617 1.167 . . . . 0.0 111.553 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.62 -38.52 78.26 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.553 0.533 . . . . 0.0 113.221 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.71 -33.17 75.04 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.284 0.634 . . . . 0.0 110.491 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.0 -60.19 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.702 0.801 . . . . 0.0 110.528 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 54' ' ' VAL . 2.0 pp -65.07 -30.61 71.58 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.88 0.309 . . . . 0.0 111.316 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -54.47 -47.31 73.1 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.239 0.616 . . . . 0.0 111.368 170.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 36.1 t -75.9 -32.64 59.74 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.093 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 2.3 mm? -58.04 -35.8 71.84 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.69 0.796 . . . . 0.0 112.954 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -77.79 -30.02 51.11 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 120.737 0.303 . . . . 0.0 111.462 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.19 -26.41 67.39 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.929 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 36' ' ' SER . 6.1 mm-40 -90.76 -56.28 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.026 0.93 . . . . 0.0 110.191 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -95.73 122.66 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.187 -170.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.92 -35.82 81.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.043 0.937 . . . . 0.0 110.774 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.67 -2.11 90.6 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.919 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB3' HD13 ' A' ' 48' ' ' LEU . 85.0 mt -109.88 5.24 22.33 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.868 0.834 . . . . 0.0 110.885 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.34 121.46 17.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.971 0.508 . . . . 0.0 112.177 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.54 -24.65 6.28 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 12.3 ptp180 -90.25 7.5 37.93 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.69 1.196 . . . . 0.0 112.505 -171.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.06 -7.1 3.47 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.135 0.974 . . . . 0.0 111.088 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.89 127.7 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.509 1.123 . . . . 0.0 108.416 169.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -127.51 108.84 11.15 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.175 0.59 . . . . 0.0 110.162 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 t70 53.02 39.53 29.63 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.581 1.152 . . . . 0.0 112.007 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.2 -14.53 65.05 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.195 -0.911 . . . . 0.0 115.369 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -102.21 -175.32 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.286 1.043 . . . . 0.0 109.223 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG12 HD21 ' A' ' 34' ' ' LEU . 15.8 m -69.02 -57.56 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.07 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 15.4 tppt? 153.74 135.22 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 CA-C-N 119.683 1.129 . . . . 0.0 109.786 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 17.1 Cg_endo -56.07 135.25 68.9 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 123.319 2.68 . . . . 0.0 111.879 165.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 76.28 -15.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.565 1.546 . . . . 0.0 113.947 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.76 146.36 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.5 m120 -121.13 103.87 9.34 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG12 HG12 ' A' ' 85' ' ' VAL . 3.2 m -116.17 131.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.53 0.732 . . . . 0.0 109.531 -177.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -120.41 133.9 55.35 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.209 1.403 . . . . 0.0 110.297 -171.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 16.8 tptp -105.62 105.62 15.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 59.32 35.13 23.16 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.097 0.959 . . . . 0.0 111.13 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.92 -14.31 63.7 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.426 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -93.73 105.92 17.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.837 0.855 . . . . 0.0 109.41 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 26.1 tt0 -70.88 104.83 3.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.602 0.761 . . . . 0.0 111.174 -168.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 23.4 m -71.65 -0.95 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.89 -22.69 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.806 170.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -86.71 -28.55 23.02 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.772 0.829 . . . . 0.0 110.803 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.6 -153.74 0.54 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.383 1.073 . . . . 0.0 109.503 177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.26 107.89 1.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.888 0.475 . . . . 0.0 110.186 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.472 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -80.2 -34.1 30.58 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.031 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.483 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.7 mmt -82.15 -39.11 23.72 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.2 82.48 1.6 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.29 0.566 . . . . 0.0 111.631 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 76' ' ' ALA . 2.1 t -81.34 -72.87 0.41 Allowed 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.135 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' H ' HG23 ' A' ' 75' ' ' THR . . . 174.55 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.955 0.902 . . . . 0.0 110.414 -161.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -74.03 123.0 23.52 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -167.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.71 175.21 5.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.148 0.979 . . . . 0.0 109.989 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 11.1 p-10 -72.89 146.73 45.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.458 0.703 . . . . 0.0 111.949 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 15.15 73.1 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.396 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.31 171.45 13.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.098 0.559 . . . . 0.0 111.332 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.52 94.78 3.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 170.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.89 107.39 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 74.2 m -85.68 155.01 21.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 110.402 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 HG12 ' A' ' 60' ' ' VAL . 32.8 m -146.35 145.49 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 109.673 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 29.9 m-85 -132.38 136.62 28.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 32.5 Cg_endo -61.04 168.91 6.68 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.971 3.114 . . . . 0.0 113.432 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.94 130.33 32.36 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.103 1.202 . . . . 0.0 110.328 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.78 18.64 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.681 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -113.67 155.89 24.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.535 1.134 . . . . 0.0 110.086 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.14 69.29 0.18 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 CA-C-O 119.085 -0.842 . . . . 0.0 112.03 179.584 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 65.3 p . . . . . 0 C--O 1.244 0.767 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -108.06 167.5 9.95 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.887 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -120.84 133.48 55.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.7 mt -126.13 142.36 51.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.333 0.653 . . . . 0.0 109.945 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 45.5 tt0 -88.73 102.68 15.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.442 HD13 HD21 ' A' ' 37' ' ' LEU . 30.1 mt -93.76 104.0 16.11 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtp85 -94.4 117.83 30.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.775 -176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.4 138.12 43.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.864 0.866 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.28 156.2 48.01 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 109.56 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.458 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.55 -131.24 0.69 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.77 1.228 . . . . 0.0 111.64 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 14' ' ' VAL . 53.2 m -58.38 -46.89 85.46 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 123.346 0.658 . . . . 0.0 111.215 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -58.6 -26.38 63.62 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.042 0.537 . . . . 0.0 111.548 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -70.89 -50.47 34.65 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.096 0.558 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -74.26 -25.62 59.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.375 0.422 . . . . 0.0 111.932 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.552 HG11 ' HG ' ' A' ' 44' ' ' LEU . 48.1 t -59.29 -54.99 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.672 0.789 . . . . 0.0 110.036 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.49 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 94.4 t -72.59 -24.59 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.204 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.06 10.91 62.74 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.017 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -141.32 136.04 31.14 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.49 -22.06 21.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.035 0.534 . . . . 0.0 112.253 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 15.0 m -155.59 134.31 11.91 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 17.4 pt -131.27 176.66 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.209 1.004 . . . . 0.0 109.143 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -125.07 112.84 16.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.71 157.44 15.9 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 0.0 109.436 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -117.94 105.54 12.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.81 172.36 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 16.9 t70 -70.68 157.58 37.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -63.81 -27.74 69.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.06 0.544 . . . . 0.0 111.495 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.24 -23.82 37.77 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.032 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 129.6 40.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 110.586 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -110.81 -179.36 3.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.152 0.581 . . . . 0.0 110.774 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 39.6 t -51.52 -35.78 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.299 1.04 . . . . 0.0 111.981 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -65.81 -41.95 95.37 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 123.865 0.728 . . . . 0.0 114.011 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.81 -37.22 84.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.221 0.608 . . . . 0.0 110.765 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.13 -59.58 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.73 0.812 . . . . 0.0 110.543 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 54' ' ' VAL . 2.5 pp -65.86 -30.46 71.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 117.776 0.262 . . . . 0.0 111.501 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.515 ' HA ' HD11 ' A' ' 49' ' ' ILE . 10.4 tpt180 -54.55 -48.13 72.38 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.147 0.499 . . . . 0.0 110.713 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -75.48 -32.46 60.58 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.865 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -57.28 -39.35 75.51 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.54 0.736 . . . . 0.0 112.683 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 1.4 pp20? -73.53 -29.51 62.5 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 120.664 0.269 . . . . 0.0 111.63 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.18 -22.39 66.92 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.096 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -92.64 -57.71 2.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.777 0.799 . . . . 0.0 109.789 174.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 98.6 m-85 -99.83 116.8 32.74 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.954 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.33 -34.29 77.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.061 0.944 . . . . 0.0 111.052 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.01 -8.66 64.98 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.719 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.669 ' HB3' HD13 ' A' ' 48' ' ' LEU . 57.8 mt -105.54 -9.62 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.851 0.861 . . . . 0.0 111.507 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.87 121.27 10.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.105 0.562 . . . . 0.0 111.953 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.1 -33.85 3.93 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -86.17 2.68 45.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.669 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.34 -5.82 8.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.054 0.941 . . . . 0.0 111.043 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 35' ' ' ARG . 35.0 mt -132.31 128.78 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.499 1.119 . . . . 0.0 108.823 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -129.83 113.04 14.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.063 0.545 . . . . 0.0 109.724 168.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.56 30.7 20.16 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.893 0.877 . . . . 0.0 112.215 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.33 75.01 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.208 -0.774 . . . . 0.0 114.373 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.6 -174.57 2.68 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.085 0.943 . . . . 0.0 109.466 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.556 HG12 HD21 ' A' ' 34' ' ' LEU . 17.5 m -67.47 -56.94 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-O 117.764 -1.112 . . . . 0.0 112.098 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 13.4 tppt? 151.1 139.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 C-N-CA 124.956 1.302 . . . . 0.0 108.923 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 25.5 Cg_endo -59.89 134.08 54.7 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.112 2.542 . . . . 0.0 111.752 167.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 73.48 -14.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.98 1.312 . . . . 0.0 114.441 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.4 p -67.2 136.39 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 15.9 m120 -107.67 103.46 12.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.431 HG23 HG23 ' A' ' 67' ' ' VAL . 3.5 m -120.72 142.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.795 0.838 . . . . 0.0 109.288 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.0 mp -129.19 172.15 11.73 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.403 1.481 . . . . 0.0 109.979 -165.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 67' ' ' VAL . 18.4 tptp -165.14 106.13 0.79 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 56.3 35.31 25.6 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-O 122.065 0.936 . . . . 0.0 109.711 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.04 -13.4 57.08 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.639 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -90.73 117.76 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.9 tt0 -72.4 103.65 3.52 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.206 0.602 . . . . 0.0 110.25 -174.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 62' ' ' LYS . 13.0 m -67.66 -0.7 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 58' ' ' VAL . 5.3 m -67.39 -27.28 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 118.073 0.397 . . . . 0.0 110.526 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -82.05 -16.4 50.26 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.953 0.901 . . . . 0.0 111.118 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.5 -150.34 0.4 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.343 1.057 . . . . 0.0 109.354 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.31 108.37 3.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.442 0.697 . . . . 0.0 111.098 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.25 -42.57 18.59 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.653 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.632 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.8 mmt -78.24 -38.55 42.65 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.36 0.664 . . . . 0.0 112.412 -174.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.22 79.46 1.54 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.553 0.692 . . . . 0.0 111.535 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 t -81.72 -75.43 0.29 Allowed 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.707 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -177.45 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -164.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 77' ' ' LEU . 9.5 mt -72.65 118.31 15.41 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.238 0.926 . . . . 0.0 111.83 -166.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 42.6 m-20 -119.71 173.91 6.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.157 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.3 146.91 52.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.134 0.573 . . . . 0.0 112.277 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 14.86 67.17 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.164 -0.926 . . . . 0.0 114.19 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 2.2 t70 -72.89 179.67 3.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.316 0.558 . . . . 0.0 110.307 -177.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.56 100.08 3.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.047 0.539 . . . . 0.0 110.834 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.2 t -87.77 106.9 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.1 m -91.72 141.88 28.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.57 143.15 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 121.683 0.754 . . . . 0.0 110.189 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.603 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 12.8 m-85 -134.92 135.32 22.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 30.4 Cg_endo -61.49 161.92 22.53 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.361 2.708 . . . . 0.0 112.783 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--N 1.38 2.186 0 C-N-CA 122.052 1.835 . . . . 0.0 112.525 -174.462 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.137 0.494 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -141.21 128.87 21.51 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.357 1.063 . . . . 0.0 109.351 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.21 135.72 35.21 Favored 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 123.512 0.725 . . . . 0.0 109.065 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.36 132.62 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.215 0.606 . . . . 0.0 110.105 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 66.0 tt0 -88.82 95.9 10.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.499 HD13 HD21 ' A' ' 37' ' ' LEU . 46.1 mt -92.9 103.79 16.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 95.6 mtt180 -91.3 117.96 30.09 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.642 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.55 141.86 37.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -133.75 159.76 39.62 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.245 0.618 . . . . 0.0 109.563 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.3 -130.69 1.32 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.436 1.094 . . . . 0.0 112.1 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.404 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 81.3 m -55.68 -49.19 73.61 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 123.914 0.885 . . . . 0.0 111.188 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HE1' ' HD3' ' A' ' 47' ' ' ARG . 12.8 m-30 -59.78 -27.58 66.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.803 0.441 . . . . 0.0 111.283 -177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -52.6 27.07 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.605 0.362 . . . . 0.0 111.006 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.13 -21.07 60.79 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.436 0.46 . . . . 0.0 111.652 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.557 HG11 ' HG ' ' A' ' 44' ' ' LEU . 46.1 t -62.76 -53.89 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.444 0.698 . . . . 0.0 110.47 169.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 93.1 t -73.76 -21.68 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.572 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.95 11.19 62.9 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.699 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -142.54 142.56 32.24 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -95.68 -8.12 35.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.465 0.306 . . . . 0.0 111.737 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 2.1 m -158.47 128.16 5.82 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.491 1.116 . . . . 0.0 108.495 170.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 5' ' ' LEU . 11.3 pt -119.03 171.03 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.599 0.76 . . . . 0.0 108.999 173.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.05 112.38 20.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.531 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -93.39 177.3 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.647 1.179 . . . . 0.0 109.77 171.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -156.79 105.35 2.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 171.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.93 172.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.46 1.104 . . . . 0.0 108.618 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.88 160.46 30.63 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.415 0.286 . . . . 0.0 110.402 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.7 -14.95 59.47 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -81.31 -16.05 53.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 152.22 43.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.568 0.747 . . . . 0.0 110.712 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 33' ' ' VAL . 38.1 p -136.17 -174.49 3.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.834 1.253 . . . . 0.0 108.727 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.1 t -50.51 -36.32 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 C-N-CA 124.185 0.994 . . . . 0.0 112.238 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.12 62.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.844 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.43 -30.13 69.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.421 0.688 . . . . 0.0 110.791 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 29' ' ' THR . 72.8 t -62.72 -60.42 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.357 175.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.6 pp -66.25 -30.09 70.46 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.565 0.346 . . . . 0.0 111.616 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.591 ' HA ' HD11 ' A' ' 49' ' ' ILE . 12.0 tpt180 -50.56 -49.86 55.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.549 0.74 . . . . 0.0 111.042 169.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 35.0 t -76.09 -32.59 59.3 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.05 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.7 mm? -56.77 -36.69 70.11 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.199 0.6 . . . . 0.0 112.597 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.3 pt-20 -73.6 -26.64 60.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.8 62.31 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.303 0.641 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.531 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 16.8 mm-40 -89.52 -58.08 2.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.587 0.755 . . . . 0.0 109.864 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 97.9 m-85 -102.14 122.2 43.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.32 -171.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.19 -29.12 67.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.599 0.759 . . . . 0.0 111.941 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.8 -4.38 85.33 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.644 0.59 . . . . 0.0 113.47 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.603 ' HB3' HD13 ' A' ' 48' ' ' LEU . 67.2 mt -106.3 -0.98 23.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.479 0.711 . . . . 0.0 111.335 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.89 120.89 14.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.68 -2.5 53.88 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 170.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.9 ptp180 -107.9 4.0 24.87 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.235 1.014 . . . . 0.0 111.122 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -126.57 -2.24 6.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.186 0.994 . . . . 0.0 110.56 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.591 HD11 ' HA ' ' A' ' 35' ' ' ARG . 27.7 mt -131.53 137.15 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.757 1.223 . . . . 0.0 108.552 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -148.64 114.78 5.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.87 31.17 21.02 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.981 1.312 . . . . 0.0 112.374 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.39 -10.12 62.39 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.536 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -94.33 -174.84 3.47 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.261 1.031 . . . . 0.0 109.017 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG12 HD21 ' A' ' 34' ' ' LEU . 27.4 m -64.94 -55.81 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.31 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 58' ' ' VAL . 13.7 tppt? 150.84 132.71 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 125.526 1.53 . . . . 0.0 108.492 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 32.8 Cg_endo -61.85 135.05 53.5 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 122.947 2.431 . . . . 0.0 111.507 165.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 82.95 -17.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.306 1.442 . . . . 0.0 113.578 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.477 HG23 ' HD3' ' A' ' 88' ' ' PRO . 2.0 p -73.16 139.39 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.5 m120 -106.12 103.71 13.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.83 131.11 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.162 0.585 . . . . 0.0 109.618 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.5 mp -123.01 143.24 50.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.476 1.11 . . . . 0.0 109.986 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 2.2 tptm -112.98 105.26 13.28 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.45 55.88 8.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.282 1.433 . . . . 0.0 111.994 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.54 -14.34 30.35 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.801 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -97.43 114.07 25.85 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 117.566 0.683 . . . . 0.0 109.212 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.2 tt0 -70.3 112.37 6.58 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 75' ' ' THR . 35.4 m -72.44 -1.27 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 113.397 -174.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 m -70.21 -13.36 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.818 0.447 . . . . 0.0 111.422 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -93.81 -18.78 21.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.635 0.774 . . . . 0.0 110.904 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.96 -152.9 0.52 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.117 0.967 . . . . 0.0 109.076 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 75' ' ' THR . 9.9 m-20 -58.09 112.84 1.66 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.068 0.547 . . . . 0.0 110.956 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.33 -46.77 8.72 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 76.0 mmm -80.32 -38.92 29.68 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.829 0.852 . . . . 0.0 112.32 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.85 74.31 1.46 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.475 0.655 . . . . 0.0 111.48 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.7 t -81.31 -69.94 0.57 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.498 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' H ' HG23 ' A' ' 75' ' ' THR . . . -177.05 33.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.846 0.858 . . . . 0.0 110.485 -164.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.1 tp -75.66 138.61 41.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.709 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -151.04 -176.13 5.42 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.743 1.217 . . . . 0.0 107.978 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.88 144.43 50.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 118.432 0.56 . . . . 0.0 111.203 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.75 5.17 63.68 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.912 0.768 . . . . 0.0 114.566 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.602 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.9 m-20 -84.35 135.66 34.21 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.241 0.521 . . . . 0.0 112.117 -171.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -92.64 124.6 36.78 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.827 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.7 t -108.1 106.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.5 m -94.34 106.0 17.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.157 0.583 . . . . 0.0 110.186 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 m -106.58 145.46 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.005 0.907 . . . . 0.0 111.039 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 8.2 m-85 -131.23 139.69 36.24 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 175.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 46.4 Cg_endo -65.91 168.49 15.26 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.485 2.79 . . . . 0.0 112.631 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HG23 ' A' ' 58' ' ' VAL . 74.3 Cg_endo . . . . . 0 C--N 1.368 1.581 0 C-N-CA 121.077 1.185 . . . . 0.0 109.372 170.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.24 0.543 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptm -102.94 118.76 37.53 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.476 1.51 . . . . 0.0 110.54 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -86.53 126.49 34.49 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.494 HD13 HD21 ' A' ' 77' ' ' LEU . 27.1 mt -128.46 130.19 47.2 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.288 0.635 . . . . 0.0 110.149 -167.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -88.75 97.74 11.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.435 HD13 HD21 ' A' ' 37' ' ' LEU . 24.3 mt -93.49 103.52 15.71 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 90.0 mtt180 -92.26 117.69 30.14 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.061 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.07 140.1 38.76 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.811 0.844 . . . . 0.0 109.633 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -131.94 158.4 41.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.054 0.542 . . . . 0.0 110.054 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.21 -127.44 1.27 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.069 1.347 . . . . 0.0 111.93 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.36 -47.02 87.87 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.662 0.785 . . . . 0.0 111.204 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -58.06 -29.57 65.51 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.096 0.558 . . . . 0.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.62 -54.32 20.68 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.002 0.521 . . . . 0.0 110.937 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 -20.05 60.43 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 123.62 0.575 . . . . 0.0 111.858 -174.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.48 HG11 ' HG ' ' A' ' 44' ' ' LEU . 41.6 t -60.69 -54.36 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.37 0.668 . . . . 0.0 110.142 168.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.416 HG12 ' HG3' ' A' ' 17' ' ' GLN . 60.4 t -73.26 -21.22 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.367 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.7 11.29 65.53 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.359 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.416 ' HG3' HG12 ' A' ' 15' ' ' VAL . 15.0 mt-30 -140.23 143.46 36.02 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.993 0.917 . . . . 0.0 109.051 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -92.93 -15.09 26.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.492 0.717 . . . . 0.0 111.694 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -156.58 138.06 13.98 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.2 pt -130.99 174.51 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.015 0.926 . . . . 0.0 108.545 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.54 111.92 17.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 163.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.426 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -89.62 176.85 6.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 108.743 169.256 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -155.8 111.74 3.07 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.809 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 m -113.62 177.68 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.412 1.085 . . . . 0.0 108.169 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -59.85 148.95 32.86 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.376 0.535 . . . . 0.0 110.533 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.09 -10.22 59.38 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.77 -20.25 43.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.682 0.793 . . . . 0.0 110.952 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 160.98 23.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.122 0.969 . . . . 0.0 112.377 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -138.39 -176.32 4.42 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.766 1.226 . . . . 0.0 109.437 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.3 t -51.33 -35.84 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.205 1.002 . . . . 0.0 111.471 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.74 -43.54 59.21 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.772 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -64.72 -31.37 72.57 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.447 0.699 . . . . 0.0 110.985 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.22 -60.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.86 0.864 . . . . 0.0 110.63 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.4 pp -65.62 -30.03 70.69 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.469 0.481 . . . . 0.0 111.173 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.727 ' HA ' HD11 ' A' ' 49' ' ' ILE . 21.9 tpt180 -53.1 -50.51 64.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.681 0.753 . . . . 0.0 111.695 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.8 m -75.27 -31.92 60.88 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.593 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.435 HD21 HD13 ' A' ' 5' ' ' LEU . 2.5 mm? -56.14 -46.9 79.07 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.323 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.503 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.1 pt-20 -67.78 -26.87 66.31 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.757 0.253 . . . . 0.0 111.486 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.98 -23.93 67.36 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.455 0.472 . . . . 0.0 111.465 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -101.03 -59.55 1.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.158 0.504 . . . . 0.0 110.503 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -86.01 120.72 27.71 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.314 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.56 -33.12 74.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.992 0.917 . . . . 0.0 110.798 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.09 2.85 83.02 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.578 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 48' ' ' LEU . 71.5 mt -115.02 6.15 15.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.352 0.661 . . . . 0.0 110.725 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -72.26 121.45 19.42 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -173.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.58 68.06 Favored Glycine 0 C--N 1.357 1.742 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.524 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 13.5 ptp180 -119.59 -4.78 10.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.031 0.932 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -119.25 -3.84 10.52 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.189 1.395 . . . . 0.0 109.886 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.727 HD11 ' HA ' ' A' ' 35' ' ' ARG . 75.5 mt -132.41 140.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.931 1.293 . . . . 0.0 108.156 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.67 126.96 5.25 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 61.55 30.85 18.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.761 1.224 . . . . 0.0 111.543 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.03 -4.98 56.15 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.666 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -106.59 -174.27 2.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.497 0.719 . . . . 0.0 109.455 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG12 HD21 ' A' ' 34' ' ' LEU . 19.1 m -59.37 -55.67 22.17 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 CA-C-O 117.689 -1.148 . . . . 0.0 112.483 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 12.5 tppt? 150.59 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 125.173 1.389 . . . . 0.0 108.057 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 11.4 Cg_endo -52.6 124.71 15.86 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.969 2.446 . . . . 0.0 111.947 168.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 74.74 2.59 4.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.639 1.176 . . . . 0.0 113.821 170.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 p -77.63 132.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 19.5 m120 -98.35 103.89 15.88 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.83 141.44 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.574 0.749 . . . . 0.0 109.692 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -131.17 140.62 49.96 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.173 1.389 . . . . 0.0 109.556 -166.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.601 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 16.0 tptm -105.46 105.63 15.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 166.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.7 t30 57.12 36.35 27.47 Favored 'General case' 0 CA--C 1.562 1.418 0 O-C-N 124.168 0.918 . . . . 0.0 111.366 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.3 -10.46 74.83 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -94.26 109.96 21.74 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.0 tt0 -68.62 106.25 2.54 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.032 0.533 . . . . 0.0 110.754 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.534 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 16.1 m -69.2 -1.23 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -174.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 m -68.06 -21.74 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-N 117.773 0.261 . . . . 0.0 111.237 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -87.55 -19.4 27.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.339 0.655 . . . . 0.0 110.656 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.0 -153.09 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.382 1.073 . . . . 0.0 109.718 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.73 108.4 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.579 0.752 . . . . 0.0 110.582 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -71.89 -49.63 22.03 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.589 -0.278 . . . . 0.0 113.122 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.5 -39.68 37.46 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.68 75.6 1.48 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.348 0.594 . . . . 0.0 110.903 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -76.65 -60.79 2.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.239 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.18 33.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.569 1.148 . . . . 0.0 109.657 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 3' ' ' LEU . 42.5 tp -74.98 114.84 13.92 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -120.1 -176.7 3.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.676 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -66.5 144.14 56.65 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.364 0.666 . . . . 0.0 111.101 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.92 8.97 85.22 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.946 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.601 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 70.4 m-20 -97.75 144.56 27.25 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.786 0.834 . . . . 0.0 111.599 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.28 141.96 27.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.67 0.788 . . . . 0.0 111.116 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.08 107.39 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.232 1.013 . . . . 0.0 108.311 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.686 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 49.4 m -90.6 139.05 31.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.691 0.796 . . . . 0.0 109.268 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.16 142.43 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.124 0.874 . . . . 0.0 110.624 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 20.5 m-85 -129.79 135.99 28.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.41 164.02 19.05 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.329 2.686 . . . . 0.0 112.16 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.369 1.628 0 C-N-CA 121.364 1.376 . . . . 0.0 110.287 175.744 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 C--O 1.237 0.436 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -122.71 146.03 47.86 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.506 0.722 . . . . 0.0 109.944 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.57 135.2 33.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.512 HD13 HD21 ' A' ' 77' ' ' LEU . 20.6 mt -134.12 133.54 41.2 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.32 0.648 . . . . 0.0 109.399 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -88.89 107.79 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 37' ' ' LEU . 24.6 mt -94.79 104.03 15.93 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 92.4 mtt180 -92.05 118.13 30.5 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.825 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.7 139.6 40.03 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.807 0.843 . . . . 0.0 109.283 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.43 154.95 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.195 0.598 . . . . 0.0 109.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.85 -128.9 0.72 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.813 1.245 . . . . 0.0 112.074 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.44 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 35.3 m -62.39 -41.5 98.69 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 123.731 0.813 . . . . 0.0 111.381 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -63.33 -25.18 68.18 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.225 0.61 . . . . 0.0 111.383 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -71.55 -53.18 14.63 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.411 0.684 . . . . 0.0 111.189 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 8.9 pt-20 -71.18 -23.37 62.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.013 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG11 ' HG ' ' A' ' 44' ' ' LEU . 19.8 t -60.87 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.555 0.693 . . . . 0.0 111.043 170.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.74 -21.97 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.323 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.48 12.48 77.22 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.567 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -143.36 143.82 31.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.774 1.229 . . . . 0.0 109.016 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -94.62 -18.47 21.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.622 0.369 . . . . 0.0 111.732 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -154.86 127.96 8.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.899 0.88 . . . . 0.0 108.663 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.17 170.02 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.955 0.902 . . . . 0.0 109.086 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.82 112.35 20.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -96.93 179.67 4.87 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 108.848 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -157.06 106.17 2.19 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.15 179.97 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.427 1.091 . . . . 0.0 108.391 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.71 150.14 24.31 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.489 0.715 . . . . 0.0 111.511 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.91 -20.82 62.45 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.149 0.579 . . . . 0.0 111.741 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.89 -23.82 20.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.238 0.615 . . . . 0.0 110.724 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.29 128.06 35.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.465 0.306 . . . . 0.0 110.286 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.2 p -107.25 -174.68 2.59 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.496 0.719 . . . . 0.0 111.175 -172.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 78.9 t -51.85 -38.24 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.164 0.985 . . . . 0.0 112.25 -173.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -64.44 -42.39 97.62 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 123.728 0.643 . . . . 0.0 113.27 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -69.24 -30.42 68.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.57 0.748 . . . . 0.0 110.956 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.0 t -64.88 -60.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.476 0.71 . . . . 0.0 110.452 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.498 HD21 HG12 ' A' ' 54' ' ' VAL . 1.9 pp -63.94 -30.3 71.39 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.183 0.447 . . . . 0.0 111.337 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.568 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.8 tpt85 -53.71 -47.02 70.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.046 0.538 . . . . 0.0 110.831 169.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 m -74.84 -32.94 62.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.22 0.608 . . . . 0.0 111.78 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 5' ' ' LEU . 3.9 mm? -58.18 -35.36 71.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -78.57 -25.91 45.46 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.173 0.442 . . . . 0.0 111.394 176.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -16.07 62.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.652 0.781 . . . . 0.0 111.513 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -100.87 -59.36 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.404 0.681 . . . . 0.0 110.181 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.07 119.47 34.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.676 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.09 -30.29 70.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.858 0.463 . . . . 0.0 110.599 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -72.22 -12.28 76.03 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.597 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 48' ' ' LEU . 97.7 mt -109.84 -0.43 18.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 111.026 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -62.02 121.08 12.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.444 0.698 . . . . 0.0 112.433 -172.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.12 -22.87 3.43 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -91.18 10.69 26.01 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.393 1.077 . . . . 0.0 111.856 -173.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -130.0 -5.98 4.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.34 1.056 . . . . 0.0 110.9 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 35' ' ' ARG . 67.4 mt -131.78 130.6 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.676 1.19 . . . . 0.0 108.195 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.37 126.13 22.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.951 0.5 . . . . 0.0 110.0 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.1 t70 54.81 31.33 15.39 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.552 1.141 . . . . 0.0 112.315 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.41 -13.74 53.94 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.692 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.35 -176.96 3.45 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.815 0.846 . . . . 0.0 109.008 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG12 HD21 ' A' ' 34' ' ' LEU . 16.6 m -64.47 -56.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.836 -1.078 . . . . 0.0 112.333 -173.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? 155.17 133.14 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 124.705 1.202 . . . . 0.0 109.287 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.79 134.48 47.13 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.519 2.812 . . . . 0.0 111.383 168.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 77.85 -15.11 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.778 1.631 . . . . 0.0 113.52 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.13 145.37 13.0 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -114.24 103.88 11.54 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.05 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.071 0.948 . . . . 0.0 108.663 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.706 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -117.15 151.51 36.7 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 20.8 tptp -124.24 104.37 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.392 1.477 . . . . 0.0 107.203 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 50.75 38.63 20.0 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.648 1.179 . . . . 0.0 111.15 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.1 80.82 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.374 -0.83 . . . . 0.0 115.107 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -103.61 110.15 22.1 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 118.021 0.911 . . . . 0.0 109.424 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.4 tt0 -66.55 112.28 4.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.497 0.719 . . . . 0.0 110.885 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.579 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 31.0 m -68.01 -0.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.41 -18.18 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 118.182 0.446 . . . . 0.0 110.669 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -92.73 -10.52 36.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.141 0.976 . . . . 0.0 111.396 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.66 -155.67 0.62 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.019 0.928 . . . . 0.0 109.081 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -66.92 111.01 3.56 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.008 0.523 . . . . 0.0 111.492 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.579 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -73.21 -50.32 12.89 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.223 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.522 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.5 mmt -71.15 -36.56 72.09 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.576 0.75 . . . . 0.0 112.79 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.39 81.67 1.41 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.749 0.785 . . . . 0.0 111.525 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -79.67 -79.37 0.14 Allowed 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.961 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 75' ' ' THR . . . -169.96 33.11 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.132 0.573 . . . . 0.0 110.035 -168.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 18.0 tp -74.72 123.25 24.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.928 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.69 168.08 17.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.98 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.92 135.16 55.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.124 0.57 . . . . 0.0 111.29 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.26 18.97 73.04 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.54 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.12 169.98 12.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.736 0.414 . . . . 0.0 110.092 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.48 98.45 4.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.415 0.686 . . . . 0.0 110.519 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -86.36 107.88 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.706 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 53.6 m -87.04 152.23 22.56 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.91 0.484 . . . . 0.0 109.934 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m -144.56 146.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-O 121.635 0.731 . . . . 0.0 109.939 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.567 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 11.3 m-85 -136.81 140.34 31.56 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HG3' ' H ' ' A' ' 10' ' ' THR . 37.6 Cg_endo -63.19 169.08 9.84 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.796 2.998 . . . . 0.0 112.501 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 C--N 1.379 2.154 0 C-N-CA 121.159 1.239 . . . . 0.0 110.627 177.697 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 69.7 p . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.247 0.07 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 26.9 ptt? -102.84 129.62 49.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 110.583 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.05 136.52 33.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.421 HD13 HD21 ' A' ' 77' ' ' LEU . 21.5 mt -131.82 134.3 45.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -173.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 100.32 13.1 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.78 104.16 16.25 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 52.9 mtp180 -91.0 116.83 29.09 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.757 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.452 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 96.0 m-85 -103.79 138.81 39.88 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 109.241 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -130.77 157.88 41.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.645 0.778 . . . . 0.0 109.072 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.46 -132.72 0.8 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.443 1.097 . . . . 0.0 112.563 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 14' ' ' VAL . 25.6 m -58.09 -42.3 85.34 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 124.16 0.984 . . . . 0.0 111.876 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 11.3 m-30 -62.66 -34.37 76.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.83 0.452 . . . . 0.0 111.224 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -38.38 88.02 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.536 0.523 . . . . 0.0 110.089 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.35 -43.96 84.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.986 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG11 ' HG ' ' A' ' 44' ' ' LEU . 69.4 t -57.22 -51.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.703 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.69 -26.6 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.453 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 11.4 71.25 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.144 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -138.46 145.72 41.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -86.91 -25.01 24.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.05 0.54 . . . . 0.0 112.038 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -156.39 123.13 5.17 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.184 0.993 . . . . 0.0 108.372 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.83 173.39 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.664 0.786 . . . . 0.0 109.353 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.57 112.09 18.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -95.4 177.15 5.93 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.599 1.16 . . . . 0.0 108.689 171.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -157.11 106.79 2.22 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.153 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.24 168.88 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 26.4 t70 -71.75 155.22 40.7 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.93 -14.63 61.91 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.59 0.756 . . . . 0.0 112.708 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -80.14 -16.91 53.9 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.122 0.569 . . . . 0.0 109.909 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.6 163.88 27.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.778 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.1 p -133.48 -175.39 3.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.563 1.145 . . . . 0.0 109.126 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.38 -37.93 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.051 0.94 . . . . 0.0 111.176 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.562 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.83 -42.48 69.92 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.567 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.45 -36.38 78.1 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.3 0.64 . . . . 0.0 111.033 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -62.76 -60.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.511 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.471 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.9 -30.45 71.44 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.466 0.306 . . . . 0.0 111.233 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.47 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.6 tpt180 -54.71 -49.21 71.26 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.187 0.595 . . . . 0.0 111.603 170.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 m -75.85 -31.27 59.24 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.736 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.03 -46.84 75.31 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.543 0.737 . . . . 0.0 112.373 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.6 pt-20 -65.5 -26.4 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.05 -22.25 62.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.113 0.565 . . . . 0.0 111.211 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -100.36 -59.43 1.71 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.682 0.753 . . . . 0.0 109.413 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -86.83 104.0 15.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.352 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.3 -17.55 63.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.384 0.674 . . . . 0.0 111.329 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -74.99 -12.65 83.21 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.304 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.635 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.6 mt -101.62 0.65 36.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.483 0.713 . . . . 0.0 110.918 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.38 121.35 14.65 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.54 70.42 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.229 -0.896 . . . . 0.0 115.213 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.55 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 2.3 ptp180 -117.91 -12.24 10.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.858 0.863 . . . . 0.0 111.13 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.635 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -107.41 -3.27 19.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.41 1.084 . . . . 0.0 110.477 172.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 35' ' ' ARG . 21.1 mt -134.47 136.5 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.911 1.284 . . . . 0.0 109.0 171.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.47 108.2 8.98 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 167.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 53.56 31.55 12.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.032 0.933 . . . . 0.0 112.903 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.6 2.25 67.68 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.52 -178.88 3.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 164.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.59 -55.54 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.152 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 14.2 tppt? 150.54 132.27 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.534 0 C-N-CA 125.443 1.497 . . . . 0.0 109.054 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.88 132.85 54.53 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 122.951 2.434 . . . . 0.0 111.679 167.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 78.93 -12.18 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.286 1.434 . . . . 0.0 113.94 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 55' ' ' LYS . 1.2 p -73.18 139.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.614 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.13 104.49 13.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 85' ' ' VAL . 2.9 m -119.16 119.1 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.487 0.715 . . . . 0.0 109.289 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -112.38 131.24 55.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.491 1.116 . . . . 0.0 110.615 -172.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 17.2 tptp -107.57 109.51 21.18 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.63 1.572 . . . . 0.0 108.116 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 56.38 35.42 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.763 0.792 . . . . 0.0 110.667 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.0 -0.07 87.49 Favored Glycine 0 CA--C 1.543 1.804 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.617 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -107.47 112.56 25.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.651 0.78 . . . . 0.0 109.913 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.4 tt0 -67.14 105.19 1.62 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.913 0.885 . . . . 0.0 110.98 -173.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 62' ' ' LYS . 17.1 m -69.33 -0.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 58' ' ' VAL . 17.4 m -67.72 -21.19 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 117.924 0.329 . . . . 0.0 111.152 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -84.73 -17.47 38.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.88 0.872 . . . . 0.0 111.204 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -138.15 -151.27 0.38 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.241 1.016 . . . . 0.0 109.769 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 75' ' ' THR . 1.4 m-20 -63.93 108.5 1.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.026 0.53 . . . . 0.0 111.167 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.25 -42.2 15.65 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.842 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.562 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.3 mmt -77.82 -39.88 42.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.399 0.679 . . . . 0.0 112.334 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.77 77.66 1.47 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.102 0.477 . . . . 0.0 111.461 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 71' ' ' ASP . 4.0 t -81.49 -67.91 0.74 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.003 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 75' ' ' THR . . . 179.84 33.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.346 0.658 . . . . 0.0 111.184 -164.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.486 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 31.0 tp -73.45 135.41 44.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.244 0.545 . . . . 0.0 110.692 -164.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.6 166.19 24.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.998 -165.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 34.4 t70 -65.52 143.6 57.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.382 0.673 . . . . 0.0 111.769 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.33 75.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.627 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.69 137.12 33.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 117.455 0.628 . . . . 0.0 111.249 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -96.39 94.99 7.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.766 0.426 . . . . 0.0 109.953 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 t -86.89 106.36 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.659 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 54.8 m -82.61 150.07 27.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.401 0.681 . . . . 0.0 110.035 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 60' ' ' VAL . 23.0 m -145.9 141.84 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.601 0.715 . . . . 0.0 109.686 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 10.9 m-85 -133.68 132.09 21.53 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 22.0 Cg_endo -59.41 165.66 8.94 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.647 2.898 . . . . 0.0 113.256 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--N 1.374 1.884 0 C-N-CA 121.532 1.488 . . . . 0.0 110.676 175.929 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 46.5 p . . . . . 0 C--O 1.237 0.399 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -123.87 141.81 51.69 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.304 0.642 . . . . 0.0 110.055 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -107.73 113.16 26.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.699 0.399 . . . . 0.0 110.265 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.439 HD13 HD21 ' A' ' 77' ' ' LEU . 18.1 mt -102.64 142.09 34.38 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.257 1.023 . . . . 0.0 110.825 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.34 97.06 10.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.39 103.49 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.6 mtp180 -96.07 116.39 28.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.698 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -103.68 137.27 41.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.83 0.852 . . . . 0.0 109.18 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -129.17 159.59 35.54 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.574 0.75 . . . . 0.0 109.102 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.523 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.44 -133.6 1.07 Allowed 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.12 0.968 . . . . 0.0 112.239 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 14' ' ' VAL . 31.3 m -59.89 -40.92 90.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.618 0.767 . . . . 0.0 112.235 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -63.22 -29.08 70.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.772 0.26 . . . . 0.0 111.02 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 54.4 ttp85 -66.77 -53.58 31.59 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.391 0.676 . . . . 0.0 111.552 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.76 -27.9 67.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.401 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.458 HG11 ' HG ' ' A' ' 44' ' ' LEU . 45.6 t -62.19 -53.07 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.593 0.757 . . . . 0.0 111.046 173.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.45 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.1 t -70.64 -24.16 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.294 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.51 11.06 71.87 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.587 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -142.53 135.74 28.61 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 21.0 ptmt -83.69 -24.36 31.3 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.539 0.336 . . . . 0.0 111.773 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -155.52 135.69 13.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.2 172.68 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.739 0.816 . . . . 0.0 109.846 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 3' ' ' LEU . 82.8 m-85 -123.18 113.4 18.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.403 0.621 . . . . 0.0 109.51 170.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.456 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -103.01 139.53 38.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.153 1.381 . . . . 0.0 109.51 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -107.95 106.63 16.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.25 -179.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.326 1.05 . . . . 0.0 109.116 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.22 154.75 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.127 0.571 . . . . 0.0 109.894 173.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.36 -37.69 86.64 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.076 0.95 . . . . 0.0 112.25 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.83 -13.04 59.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.42 0.688 . . . . 0.0 110.705 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 142.87 57.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.878 0.471 . . . . 0.0 109.903 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 p -118.83 -176.93 3.2 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.9 t -53.09 -35.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.125 0.97 . . . . 0.0 111.504 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.78 59.64 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.36 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.0 -33.13 72.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.384 0.673 . . . . 0.0 110.804 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.26 -60.38 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.304 1.042 . . . . 0.0 110.946 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.567 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.9 pp -65.33 -30.11 70.92 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 123.239 0.337 . . . . 0.0 111.704 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.597 ' HA ' HD11 ' A' ' 49' ' ' ILE . 1.3 ppt_? -64.49 -36.55 84.55 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.077 0.465 . . . . 0.0 109.994 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.9 m -75.6 -33.67 60.58 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.622 0.769 . . . . 0.0 111.769 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.96 -37.86 88.77 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.064 0.546 . . . . 0.0 112.358 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -70.66 -28.55 64.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.832 0.348 . . . . 0.0 111.609 176.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.94 -24.49 62.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.158 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 12.8 mm-40 -88.13 -59.64 2.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.634 0.731 . . . . 0.0 109.726 174.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 97.1 m-85 -98.45 118.29 34.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.114 -170.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.78 -28.67 68.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.139 0.976 . . . . 0.0 110.654 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.496 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.7 -9.55 86.97 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 119.411 -0.661 . . . . 0.0 113.844 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.617 ' HB3' HD13 ' A' ' 48' ' ' LEU . 84.0 mt -95.9 -6.92 38.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.657 0.729 . . . . 0.0 111.127 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.22 124.61 22.62 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.6 0.76 . . . . 0.0 112.906 -171.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.96 8.51 86.81 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 115.135 0.814 . . . . 0.0 115.135 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.3 OUTLIER -125.1 -22.37 4.44 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 117.404 0.602 . . . . 0.0 111.973 -174.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -96.55 -0.23 49.11 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.774 0.43 . . . . 0.0 110.704 172.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 35' ' ' ARG . 57.4 mt -135.41 145.66 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.173 1.389 . . . . 0.0 108.634 171.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 15.4 tp10 -157.74 127.85 6.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.967 0.907 . . . . 0.0 108.96 168.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.6 t70 56.87 31.31 19.42 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.493 1.14 . . . . 0.0 111.373 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.88 -14.26 38.59 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 114.743 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -94.89 -174.06 3.16 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 117.83 0.815 . . . . 0.0 110.053 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG12 HD21 ' A' ' 34' ' ' LEU . 18.2 m -59.93 -54.71 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.772 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 50' ' ' GLU . 9.6 tppt? 150.44 137.0 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 C-N-CA 126.304 1.841 . . . . 0.0 108.112 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.76 125.6 19.18 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.038 164.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 81.19 -9.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.403 1.481 . . . . 0.0 113.939 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 55' ' ' LYS . 5.2 p -69.52 129.21 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.609 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -94.92 103.27 15.14 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 m -121.55 131.14 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.489 HD13 ' CE1' ' A' ' 86' ' ' PHE . 6.7 mp -123.87 141.73 51.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.065 0.946 . . . . 0.0 110.645 -168.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HE3' HD12 ' A' ' 77' ' ' LEU . 15.0 tptm -111.84 105.14 13.52 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.177 1.391 . . . . 0.0 107.835 168.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.11 35.61 25.25 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.45 1.1 . . . . 0.0 111.402 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.65 -14.21 64.65 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 114.342 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -89.09 107.66 19.16 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.896 0.848 . . . . 0.0 109.595 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.6 tt0 -65.34 106.85 1.46 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.102 0.561 . . . . 0.0 110.024 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.401 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 23.7 m -69.73 -1.71 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.33 -22.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.501 0.591 . . . . 0.0 110.917 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 66' ' ' GLU . 60.0 m-70 -84.05 -12.12 55.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.548 0.739 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.58 -153.04 0.44 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.568 1.147 . . . . 0.0 109.318 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.16 108.46 0.9 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.675 0.39 . . . . 0.0 110.687 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.401 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -74.7 -47.9 14.03 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.371 0.42 . . . . 0.0 112.358 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 90.1 mmm -80.31 -36.78 33.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.307 0.643 . . . . 0.0 112.221 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.98 76.81 1.52 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.906 -0.496 . . . . 0.0 111.715 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.7 t -81.46 -69.33 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.994 0.518 . . . . 0.0 112.393 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 75' ' ' THR . . . -179.0 34.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.507 0.723 . . . . 0.0 111.064 -163.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.484 HD12 ' HE3' ' A' ' 62' ' ' LYS . 40.4 tp -74.25 141.45 45.37 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.22 0.608 . . . . 0.0 111.502 -169.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -154.78 175.92 13.12 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.947 0.899 . . . . 0.0 109.567 -170.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.16 143.59 43.18 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.199 0.909 . . . . 0.0 111.78 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.88 2.51 65.31 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.297 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.78 134.9 33.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.781 0.832 . . . . 0.0 110.09 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.38 106.14 17.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.109 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.16 107.23 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.2 m -96.44 106.38 18.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.499 0.72 . . . . 0.0 110.303 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.66 140.78 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.609 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 3.5 m-85 -129.6 134.97 26.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 42.3 Cg_endo -65.54 166.19 20.5 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.202 2.602 . . . . 0.0 112.634 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' HG23 ' A' ' 58' ' ' VAL . 73.8 Cg_endo . . . . . 0 C--N 1.366 1.499 0 C-N-CA 121.079 1.186 . . . . 0.0 109.199 170.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 47.3 p . . . . . 0 C--O 1.234 0.26 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.465 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 24.9 ptt? -104.23 132.23 50.71 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.024 0.93 . . . . 0.0 110.673 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -87.15 135.19 33.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -128.61 136.59 50.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.309 0.643 . . . . 0.0 110.654 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -88.93 95.98 10.53 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.65 103.91 16.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.0 mtp180 -94.34 117.18 29.73 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -103.13 139.71 38.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.777 0.831 . . . . 0.0 109.29 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -133.89 158.86 42.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.379 0.672 . . . . 0.0 109.852 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.554 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.02 -130.75 0.78 Allowed 'General case' 0 CA--C 1.565 1.527 0 O-C-N 124.363 1.039 . . . . 0.0 111.37 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.424 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 97.7 m -60.57 -48.08 83.34 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.662 0.665 . . . . 0.0 111.647 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.87 -24.7 53.63 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.817 0.447 . . . . 0.0 111.623 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.414 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -70.43 -53.39 16.63 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.294 0.637 . . . . 0.0 111.027 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 -22.29 59.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.864 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.477 HG11 ' HG ' ' A' ' 44' ' ' LEU . 42.8 t -59.43 -52.82 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.244 0.618 . . . . 0.0 110.342 168.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 93.8 t -75.13 -22.31 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.51 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 73.38 11.48 79.83 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.52 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -142.92 146.6 34.17 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.143 0.977 . . . . 0.0 108.58 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -90.12 -19.99 23.65 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.852 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.4 m -155.18 131.99 10.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.03 0.932 . . . . 0.0 108.716 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 pt -123.58 175.38 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.025 0.93 . . . . 0.0 108.64 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.88 112.25 15.76 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 167.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 -178.53 4.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.221 1.409 . . . . 0.0 109.629 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -156.1 111.48 2.95 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.39 174.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.8 p-10 -71.51 158.79 35.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.268 0.94 . . . . 0.0 110.322 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.67 -19.86 61.35 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.388 0.675 . . . . 0.0 112.088 -172.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.85 -21.12 37.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.476 0.31 . . . . 0.0 110.175 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 162.09 28.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.413 0.685 . . . . 0.0 111.216 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -137.86 -174.07 3.68 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.855 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -50.6 -37.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 125.626 1.57 . . . . 0.0 112.107 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.635 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.87 -38.61 65.28 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.299 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -66.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.232 0.613 . . . . 0.0 110.548 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.8 -60.41 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.572 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.43 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.87 -30.46 71.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.503 0.321 . . . . 0.0 110.982 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.598 ' HA ' HD11 ' A' ' 49' ' ' ILE . 26.0 tpt85 -52.91 -51.7 60.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.404 0.682 . . . . 0.0 111.507 171.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.1 m -75.99 -32.1 59.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.708 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.3 mm? -52.13 -48.57 64.77 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.723 0.809 . . . . 0.0 112.34 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 3.6 pt-20 -64.95 -26.31 68.25 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.0 -20.22 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.135 0.574 . . . . 0.0 111.104 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.35 -57.9 2.14 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.458 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.0 m-85 -91.82 108.55 20.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.84 -173.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.62 -22.0 65.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.353 0.661 . . . . 0.0 111.587 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.519 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.56 -8.68 87.14 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.028 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.67 ' HB3' HD13 ' A' ' 48' ' ' LEU . 88.9 mt -105.14 -6.89 19.46 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.699 0.799 . . . . 0.0 111.041 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.89 122.28 15.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.722 0.809 . . . . 0.0 113.142 -171.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.53 2.84 51.86 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 2.3 ptp180 -113.85 -4.37 13.33 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.67 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -114.5 -2.71 13.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.794 . . . . 0.0 110.357 174.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 35' ' ' ARG . 46.8 mt -135.26 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.99 1.316 . . . . 0.0 109.201 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 19.8 mm-40 -143.69 123.84 13.71 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.119 0.968 . . . . 0.0 109.15 160.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.35 30.87 20.18 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 124.353 1.061 . . . . 0.0 112.109 168.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.86 3.12 88.22 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 114.989 0.756 . . . . 0.0 114.989 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -116.41 -175.44 2.75 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.019 0.928 . . . . 0.0 108.702 170.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 m -63.2 -55.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.876 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 9.6 tppt? 153.22 139.69 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.377 0 C-N-CA 125.091 1.356 . . . . 0.0 109.062 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 22.2 Cg_endo -60.8 128.38 25.44 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.825 2.35 . . . . 0.0 111.928 166.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 77.83 -1.69 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.337 1.455 . . . . 0.0 113.912 171.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 3.1 p -76.4 153.71 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 13.2 m120 -118.24 104.76 11.1 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.8 129.48 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.468 0.707 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.9 mp -121.66 140.18 52.62 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.803 1.241 . . . . 0.0 111.899 -166.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 63' ' ' ASN . 0.5 OUTLIER -119.34 107.56 13.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.824 1.249 . . . . 0.0 108.29 171.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.517 ' HB2' ' HZ3' ' A' ' 62' ' ' LYS . 65.0 t30 60.36 34.78 20.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.666 1.186 . . . . 0.0 110.328 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.87 -14.97 61.81 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.522 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HG3' HD21 ' A' ' 70' ' ' LEU . 19.8 tpp180 -94.27 111.66 23.4 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.42 0.61 . . . . 0.0 109.896 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.8 tt0 -67.89 108.36 2.99 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.851 0.86 . . . . 0.0 110.886 -173.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.05 -1.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.795 1.638 . . . . 0.0 114.552 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 m -71.16 -23.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.188 0.449 . . . . 0.0 110.582 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.434 ' CD2' ' HB3' ' A' ' 66' ' ' GLU . 74.9 m-70 -88.72 -15.97 33.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.732 0.813 . . . . 0.0 110.828 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -135.39 -140.7 0.17 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.699 1.199 . . . . 0.0 108.789 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.81 119.02 25.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.746 1.157 . . . . 0.0 110.806 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.29 -43.12 39.87 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.688 0.617 . . . . 0.0 112.817 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.635 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.4 mmt -81.46 -39.95 24.06 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.73 69.26 1.03 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.401 0.62 . . . . 0.0 111.774 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 t -74.49 -67.82 0.59 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.98 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -174.99 33.7 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 110.887 -165.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.11 139.29 42.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.188 0.195 . . . . 0.0 110.851 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 33.9 t70 -144.32 -176.06 4.88 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.729 0.811 . . . . 0.0 108.835 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 30.8 t70 -70.19 147.8 49.4 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.422 0.556 . . . . 0.0 111.852 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.86 66.53 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.386 -0.824 . . . . 0.0 113.301 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 3.6 t0 -94.76 127.65 40.9 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 122.568 0.347 . . . . 0.0 110.608 -168.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.17 115.85 23.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.151 0.58 . . . . 0.0 111.438 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.75 106.99 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.8 m -84.09 147.96 27.08 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -142.45 147.08 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.696 0.76 . . . . 0.0 109.792 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.8 m-85 -133.82 142.77 44.83 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 40.3 Cg_endo -64.82 168.5 13.39 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.222 2.615 . . . . 0.0 111.374 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 48.4 Cg_endo . . . . . 0 C--N 1.371 1.751 0 C-N-CA 120.645 0.897 . . . . 0.0 111.249 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 23' ' ' ARG . 2.6 p . . . . . 0 C--O 1.241 0.648 0 CA-C-O 121.285 0.564 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.778 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -109.08 121.84 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.788 0.435 . . . . 0.0 110.135 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.51 146.66 28.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.527 0.731 . . . . 0.0 111.153 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -88.72 95.45 10.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.1 103.94 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.677 -0.639 . . . . 0.0 109.47 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 13.1 mtp180 -95.18 117.05 29.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.739 -176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -106.4 135.69 47.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.451 1.101 . . . . 0.0 108.926 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.75 160.46 31.64 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.12 0.568 . . . . 0.0 109.844 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.44 -121.03 1.22 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.994 1.318 . . . . 0.0 112.198 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.6 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 87.9 m -70.37 -44.56 67.83 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.866 0.866 . . . . 0.0 111.329 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -58.8 -28.43 65.97 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.636 0.374 . . . . 0.0 110.962 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -65.85 -52.17 52.71 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.75 0.656 . . . . 0.0 111.185 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.91 -27.11 60.88 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.481 0.488 . . . . 0.0 111.739 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 44' ' ' LEU . 39.2 t -59.08 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.474 0.709 . . . . 0.0 110.541 170.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 17' ' ' GLN . 96.7 t -74.66 -22.36 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.963 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 11.39 63.35 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.769 0.7 . . . . 0.0 112.891 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HB2' HG12 ' A' ' 15' ' ' VAL . 17.3 mt-30 -145.74 138.15 25.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.303 1.041 . . . . 0.0 108.312 -166.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -100.92 -29.22 12.33 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 m -154.9 113.62 3.57 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.485 HG21 ' NE2' ' A' ' 17' ' ' GLN . 26.7 pt -121.63 170.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.205 0.602 . . . . 0.0 110.806 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -111.47 125.21 53.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -121.89 123.18 41.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.122 0.969 . . . . 0.0 108.853 -176.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.49 ' HD2' ' HB ' ' A' ' 0' ' ' THR . 6.6 tpp85 -83.08 106.95 15.31 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.07 -179.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 0.0 109.526 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.23 159.7 24.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.394 0.677 . . . . 0.0 110.613 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.22 -26.03 68.33 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 110.522 168.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -80.24 -22.94 41.23 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.34 1.056 . . . . 0.0 110.553 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.24 43.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.294 0.637 . . . . 0.0 110.592 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 p -137.75 -174.64 3.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.118 0.967 . . . . 0.0 108.643 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 t -51.09 -35.96 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.996 0.918 . . . . 0.0 111.535 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA2' ' HE3' ' A' ' 73' ' ' MET . . . -67.6 -45.5 76.38 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.175 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.37 -35.37 78.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.951 0.9 . . . . 0.0 111.113 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.28 -60.79 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.16 0.984 . . . . 0.0 110.805 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.541 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 1.9 pp -67.39 -30.08 69.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.19 0.306 . . . . 0.0 111.404 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HA ' HD11 ' A' ' 49' ' ' ILE . 20.8 tpt180 -55.57 -49.74 71.93 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.376 0.608 . . . . 0.0 111.218 170.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -73.96 -32.48 63.49 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.148 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -57.28 -39.05 74.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.441 0.696 . . . . 0.0 112.42 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.1 pt-20 -75.67 -28.51 58.73 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 117.874 0.307 . . . . 0.0 111.691 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.64 -34.52 78.42 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.08 0.467 . . . . 0.0 110.467 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 15.5 mm-40 -79.0 -59.1 2.91 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.366 175.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 95.9 m-85 -99.21 122.03 41.85 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.799 -168.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.08 -40.66 96.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.052 0.941 . . . . 0.0 110.926 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 -16.37 64.27 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.323 -0.709 . . . . 0.0 114.218 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.567 ' O ' HD22 ' A' ' 48' ' ' LEU . 64.1 mt -95.39 -13.5 24.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.686 0.795 . . . . 0.0 111.833 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.07 120.8 9.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.52 -28.14 5.99 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.549 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 12.4 ptm180 -90.89 3.17 55.26 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -168.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -127.15 2.65 6.45 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.355 0.662 . . . . 0.0 110.962 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.577 HD11 ' HA ' ' A' ' 35' ' ' ARG . 69.6 mt -135.63 129.13 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.52 1.128 . . . . 0.0 108.352 170.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 1.2 tm-20 -150.62 128.59 11.79 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.0 t70 61.08 30.31 19.4 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.449 1.1 . . . . 0.0 110.85 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.51 -13.55 6.31 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.798 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.78 -173.41 2.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.915 0.886 . . . . 0.0 109.361 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 60' ' ' VAL . 17.0 m -60.23 -57.07 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.536 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.992 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 56' ' ' PRO . 12.8 tppt? 150.39 137.84 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 C-N-CA 124.986 1.314 . . . . 0.0 109.862 -175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 42.8 Cg_endo -65.91 141.31 64.27 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 123.435 2.756 . . . . 0.0 111.773 163.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 82.25 -23.78 0.2 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.768 1.627 . . . . 0.0 112.532 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.12 141.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.9 m120 -111.87 104.58 12.89 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 85' ' ' VAL . 2.7 m -115.93 140.64 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.639 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -132.22 146.94 52.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.796 1.239 . . . . 0.0 110.012 -166.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.688 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 17.9 tptm -106.08 104.54 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 164.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.87 41.41 32.05 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.314 1.046 . . . . 0.0 111.838 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.44 -11.53 71.89 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-N 115.244 -0.889 . . . . 0.0 114.551 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -99.87 106.43 18.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tt0 -64.11 114.2 4.02 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.162 0.985 . . . . 0.0 111.63 -170.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.409 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 22.8 m -73.78 -2.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -172.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 m -72.67 -7.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 118.24 0.473 . . . . 0.0 111.361 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -96.69 -16.66 20.81 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.877 0.871 . . . . 0.0 110.958 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.84 -154.01 0.58 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.676 1.19 . . . . 0.0 109.208 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.2 m-20 -61.36 108.59 0.96 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -70.88 -48.54 33.23 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.484 0.49 . . . . 0.0 112.228 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.481 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 73.9 mmm -80.76 -37.97 29.46 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.003 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.04 66.13 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -172.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.412 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -70.09 -70.19 0.31 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.449 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.99 35.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -159.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.78 135.9 43.57 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.644 -0.66 . . . . 0.0 112.566 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.52 175.17 9.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.538 1.535 . . . . 0.0 108.151 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.66 141.26 53.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.771 0.714 . . . . 0.0 111.039 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.75 -15.14 27.34 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.619 -0.718 . . . . 0.0 114.381 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.688 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 50.9 m-20 -69.37 134.15 48.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.313 0.645 . . . . 0.0 111.618 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.21 142.6 27.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.03 107.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 165.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.0 m -94.06 130.12 40.33 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 0.0 109.151 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 60' ' ' VAL . 23.0 m -130.53 138.73 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.722 0.692 . . . . 0.0 110.605 -174.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 64.1 m-85 -122.3 135.53 25.59 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.6 ' HG3' ' H ' ' A' ' 10' ' ' THR . 27.4 Cg_endo -58.96 168.04 4.89 Favored 'Trans proline' 0 C--N 1.364 1.369 0 C-N-CA 123.953 3.102 . . . . 0.0 114.075 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo . . . . . 0 C--N 1.378 2.098 0 C-N-CA 122.345 2.03 . . . . 0.0 111.374 174.1 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 36.8 p . . . . . 0 C--O 1.241 0.609 0 CA-C-O 120.915 0.388 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 24.8 ptt? -147.21 132.95 18.92 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -83.81 141.11 31.6 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.5 mt -141.64 129.79 22.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 109.514 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -88.86 101.16 13.77 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 mt -94.98 108.1 20.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 27.9 mtm180 -97.87 117.42 32.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.782 0.833 . . . . 0.0 109.743 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -102.51 135.15 44.66 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.332 1.053 . . . . 0.0 108.877 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -130.69 161.24 32.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.89 0.476 . . . . 0.0 110.069 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.08 -120.9 1.1 Allowed 'General case' 0 CA--C 1.564 1.506 0 O-C-N 124.509 1.131 . . . . 0.0 111.873 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 18.7 m -71.98 -41.61 67.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.302 0.641 . . . . 0.0 111.0 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -60.52 -26.66 67.03 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.579 0.351 . . . . 0.0 110.864 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -47.52 69.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.57 0.748 . . . . 0.0 111.086 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.14 -22.99 59.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.625 HG11 ' HG ' ' A' ' 44' ' ' LEU . 74.8 t -60.33 -55.44 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 171.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.5 -20.42 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.06 11.85 83.98 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.417 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -163.94 158.26 19.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.695 0.798 . . . . 0.0 110.66 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -85.05 -19.67 31.6 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 9.6 m -152.55 147.78 26.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 pt -137.07 174.02 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.399 1.08 . . . . 0.0 108.762 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -122.58 113.16 18.9 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 167.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.437 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -98.49 172.63 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.896 1.279 . . . . 0.0 109.377 171.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -153.68 106.12 2.86 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.291 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.36 173.2 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.22 1.408 . . . . 0.0 108.474 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 34.0 t70 -66.2 161.26 22.43 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.978 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.22 -22.48 59.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.124 0.57 . . . . 0.0 111.745 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -81.0 -16.43 53.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.68 0.392 . . . . 0.0 110.65 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.86 151.49 41.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.324 0.65 . . . . 0.0 109.61 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.4 p -130.39 -174.74 3.43 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.901 0.881 . . . . 0.0 109.954 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.0 t -50.84 -37.04 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 124.578 1.151 . . . . 0.0 111.479 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.87 -39.78 64.5 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.802 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.26 -31.7 71.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.933 0.493 . . . . 0.0 110.52 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.74 -59.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.542 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.472 HD21 HG12 ' A' ' 54' ' ' VAL . 1.7 pp -64.26 -31.15 72.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.799 0.272 . . . . 0.0 111.093 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.533 ' HA ' HD11 ' A' ' 49' ' ' ILE . 9.1 tpt180 -51.77 -50.25 61.07 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.264 0.554 . . . . 0.0 111.353 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -75.82 -32.02 59.63 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.313 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.94 -39.06 68.48 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.2 pt-20 -73.95 -29.71 62.14 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.65 0.262 . . . . 0.0 111.63 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.69 65.51 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.57 0.748 . . . . 0.0 110.895 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.437 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 21.4 mm-40 -95.39 -58.71 2.06 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.431 1.092 . . . . 0.0 109.944 172.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.89 116.0 28.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.09 -30.49 70.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.953 0.901 . . . . 0.0 110.541 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.9 -20.17 77.49 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.956 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.717 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.1 mt -99.3 -1.66 38.41 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.713 0.805 . . . . 0.0 111.842 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.14 120.43 10.31 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.5 -7.64 17.79 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -100.16 4.57 44.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.029 0.914 . . . . 0.0 111.328 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.717 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.0 -5.96 8.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.579 1.152 . . . . 0.0 110.605 -177.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 35' ' ' ARG . 55.3 mt -133.02 138.6 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.681 1.193 . . . . 0.0 108.569 169.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 8.5 tp10 -144.9 124.87 13.51 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.649 0.78 . . . . 0.0 109.102 169.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.4 t70 58.95 31.79 21.66 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.432 1.093 . . . . 0.0 111.728 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.44 -14.74 57.17 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.168 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.09 -174.44 2.54 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.858 0.863 . . . . 0.0 109.185 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.472 HG12 HD21 ' A' ' 34' ' ' LEU . 34.0 m -62.83 -54.97 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 CA-C-O 118.11 -0.947 . . . . 0.0 112.829 -170.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 11.5 tppt? 151.61 139.61 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.388 0 C-N-CA 125.789 1.635 . . . . 0.0 107.879 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.47 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 21.9 Cg_endo -58.58 125.57 18.73 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.83 2.353 . . . . 0.0 111.636 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 73.41 1.4 3.97 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.66 1.184 . . . . 0.0 113.944 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.465 HG23 ' HD3' ' A' ' 88' ' ' PRO . 5.1 p -74.28 117.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 5.1 m-20 -80.83 103.62 10.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 85' ' ' VAL . 2.9 m -123.73 131.98 72.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -175.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 3.7 mp -121.88 172.14 8.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.254 1.022 . . . . 0.0 111.208 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.582 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 16.7 tptp -159.53 108.68 1.84 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 54.85 34.42 21.99 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.798 0.839 . . . . 0.0 110.237 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.9 13.98 82.51 Favored Glycine 0 C--N 1.352 1.465 0 N-CA-C 115.005 0.762 . . . . 0.0 115.005 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -119.67 121.25 38.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.797 0.839 . . . . 0.0 108.802 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.6 tt0 -75.91 110.14 10.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.405 0.682 . . . . 0.0 110.677 -171.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.512 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 17.5 m -70.54 -0.96 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -174.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 m -70.25 -16.5 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 118.104 0.411 . . . . 0.0 110.885 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -95.33 1.15 54.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.1 0.96 . . . . 0.0 111.26 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.47 -153.84 0.44 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.795 0.838 . . . . 0.0 109.773 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.54 108.58 0.99 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.0 0.52 . . . . 0.0 111.314 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -67.37 -50.6 43.29 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.568 0.543 . . . . 0.0 113.627 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 79.1 mmm -80.48 -39.64 27.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.089 0.556 . . . . 0.0 111.821 -170.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.84 76.62 1.54 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.912 0.863 . . . . 0.0 111.058 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.504 HG21 ' HG2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -81.64 -71.61 0.47 Allowed 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.149 177.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 75' ' ' THR . . . -175.16 34.67 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.599 0.76 . . . . 0.0 110.931 -163.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.582 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 21.0 tp -73.86 149.89 41.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.991 0.424 . . . . 0.0 110.54 -170.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.5 171.7 19.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 109.297 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.1 p-10 -70.39 146.62 50.29 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.347 0.659 . . . . 0.0 112.059 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.95 16.31 63.88 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.254 -0.885 . . . . 0.0 114.019 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.74 163.15 24.71 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.498 0.649 . . . . 0.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.38 95.33 4.43 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.638 0.732 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.8 t -86.53 138.56 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.919 1.288 . . . . 0.0 109.142 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 17.9 m -117.25 161.25 19.8 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.459 0.572 . . . . 0.0 110.653 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 60' ' ' VAL . 35.3 m -146.79 141.73 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.196 0.998 . . . . 0.0 109.197 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.63 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 7.5 m-85 -135.28 133.7 20.79 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 175.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.473 ' HG3' ' H ' ' A' ' 10' ' ' THR . 23.6 Cg_endo -60.92 155.87 47.22 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.067 2.511 . . . . 0.0 112.565 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD3' HG23 ' A' ' 58' ' ' VAL . 97.8 Cg_endo . . . . . 0 C--N 1.367 1.536 0 C-N-CA 122.565 2.177 . . . . 0.0 111.869 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 54.9 p . . . . . 0 C--O 1.238 0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.613 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.0 ptt? -105.34 135.97 45.74 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.823 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' TRP . 42.8 tt0 -94.85 129.75 41.71 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.657 0.783 . . . . 0.0 109.005 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 143.78 50.49 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.074 0.397 . . . . 0.0 111.221 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 36.1 tt0 -89.53 101.15 13.83 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.69 104.44 16.54 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 25.4 mtp180 -91.38 118.8 30.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.17 136.06 45.37 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.988 0.915 . . . . 0.0 109.387 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.66 161.56 30.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.083 0.553 . . . . 0.0 109.851 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.491 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.45 -129.92 1.33 Allowed 'General case' 0 CA--C 1.561 1.366 0 O-C-N 124.359 1.037 . . . . 0.0 111.238 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.437 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 4.3 m -64.04 -40.62 96.71 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 123.394 0.677 . . . . 0.0 111.747 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.487 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -67.54 -49.05 65.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.236 0.615 . . . . 0.0 110.626 -178.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.92 -18.03 60.95 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.82 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.465 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -66.02 -54.43 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.178 0.513 . . . . 0.0 110.253 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.55 -17.35 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.884 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.487 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 70.71 11.95 69.81 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.536 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -140.07 138.14 35.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.798 1.239 . . . . 0.0 109.146 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -82.68 -21.09 35.05 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.733 0.646 . . . . 0.0 110.707 172.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 11.6 m -154.65 149.81 26.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.628 1.171 . . . . 0.0 108.799 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 15.5 pt -135.26 178.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.129 0.972 . . . . 0.0 109.055 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -125.81 112.22 15.77 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.434 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -96.38 179.1 5.14 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.98 1.312 . . . . 0.0 109.921 174.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.0 ttp-105 -157.23 107.07 2.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.219 0.533 . . . . 0.0 109.942 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.84 176.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.684 1.194 . . . . 0.0 109.141 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -54.3 144.97 18.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.348 1.059 . . . . 0.0 110.014 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.99 -31.86 71.86 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.63 -7.51 59.6 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.593 0.757 . . . . 0.0 111.498 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.73 159.84 29.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.766 0.426 . . . . 0.0 109.853 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.8 p -130.96 179.2 6.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.986 0.515 . . . . 0.0 110.715 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.57 -35.79 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.609 1.164 . . . . 0.0 112.137 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.597 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.71 -37.47 67.01 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.741 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.46 -36.76 84.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.449 0.7 . . . . 0.0 110.927 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.14 -59.98 3.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.612 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.555 HD21 HG12 ' A' ' 54' ' ' VAL . 2.5 pp -63.7 -30.45 71.55 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.933 0.333 . . . . 0.0 111.315 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HA ' HD11 ' A' ' 49' ' ' ILE . 22.4 tpt180 -53.4 -48.73 68.42 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.004 0.431 . . . . 0.0 111.511 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.21 -32.8 61.29 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.533 0.333 . . . . 0.0 111.547 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 3.1 mm? -56.08 -34.54 66.08 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.6 0.76 . . . . 0.0 112.837 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -76.8 -26.09 54.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.91 -30.75 65.69 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.936 0.494 . . . . 0.0 110.51 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 15.8 mm-40 -79.79 -58.92 2.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.212 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.4 118.25 36.26 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.718 -169.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.09 -28.55 67.45 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.106 0.562 . . . . 0.0 110.192 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.21 -2.29 82.94 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.861 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.59 ' HB3' HD13 ' A' ' 48' ' ' LEU . 87.4 mt -114.65 2.84 14.61 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.578 0.689 . . . . 0.0 110.3 171.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.6 123.62 23.58 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.964 0.505 . . . . 0.0 111.886 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.85 8.19 87.75 Favored Glycine 0 N--CA 1.48 1.625 0 N-CA-C 115.176 0.831 . . . . 0.0 115.176 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.9 ptp180 -125.96 2.16 7.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.744 0.818 . . . . 0.0 111.422 -173.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.59 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -128.5 -8.89 5.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.427 1.091 . . . . 0.0 110.724 -176.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 35' ' ' ARG . 31.2 mt -130.26 132.49 65.01 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 C-N-CA 124.867 1.267 . . . . 0.0 108.653 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.32 108.45 8.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.395 0.678 . . . . 0.0 109.798 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.2 t70 57.56 31.29 20.09 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.293 1.037 . . . . 0.0 111.666 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.0 0.66 71.1 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.6 -174.69 2.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.085 0.942 . . . . 0.0 108.721 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.555 HG12 HD21 ' A' ' 34' ' ' LEU . 15.0 m -65.1 -56.3 16.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 CA-C-O 117.537 -1.22 . . . . 0.0 112.015 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.2 tppt? 151.18 136.32 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 C-N-CA 124.667 1.187 . . . . 0.0 108.746 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.86 128.12 27.81 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.936 2.424 . . . . 0.0 111.08 164.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 82.42 -14.82 0.73 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.349 1.46 . . . . 0.0 114.251 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -70.12 126.46 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.4 m120 -94.82 103.45 15.34 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -120.68 134.23 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.095 0.474 . . . . 0.0 109.94 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.1 mp -119.59 171.68 8.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.885 1.274 . . . . 0.0 111.738 -170.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -158.16 104.2 1.86 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.776 -177.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 15.3 t-20 56.47 36.47 27.61 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.455 1.102 . . . . 0.0 110.243 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.58 -13.24 67.13 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.719 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.406 ' HG3' HD21 ' A' ' 70' ' ' LEU . 7.1 tpp180 -97.41 119.9 36.79 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.413 0.685 . . . . 0.0 109.936 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 25.3 tt0 -79.55 106.47 11.6 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.769 -173.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -68.51 -1.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.374 1.469 . . . . 0.0 114.489 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.47 -21.61 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 117.857 0.299 . . . . 0.0 111.169 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -87.25 -19.34 28.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.979 0.912 . . . . 0.0 110.791 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.406 HD21 ' HG3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -131.81 -139.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.612 1.165 . . . . 0.0 108.423 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.2 109.42 17.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.953 0.797 . . . . 0.0 110.206 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.85 -38.77 65.53 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.354 0.409 . . . . 0.0 112.871 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.597 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.9 mmt -81.58 -37.17 28.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.26 77.57 1.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.4 t -81.51 -66.5 0.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' H ' HG23 ' A' ' 75' ' ' THR . . . -178.27 33.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 -165.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.62 141.81 46.54 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.844 -0.535 . . . . 0.0 111.144 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.43 -175.98 4.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.313 1.045 . . . . 0.0 108.909 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.613 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.0 p30 -80.02 148.86 30.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.087 0.555 . . . . 0.0 111.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.67 61.75 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.708 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.34 141.97 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.19 0.596 . . . . 0.0 111.566 -170.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.61 109.84 22.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.88 0.472 . . . . 0.0 110.854 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -100.23 107.09 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.448 0.699 . . . . 0.0 109.285 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 61.4 m -87.07 148.13 25.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.121 0.569 . . . . 0.0 109.934 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 m -143.37 148.31 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.346 0.659 . . . . 0.0 110.241 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 25.5 m-85 -136.7 135.72 20.71 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 23.7 Cg_endo -59.71 164.47 11.5 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 124.012 3.141 . . . . 0.0 113.505 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.38 2.203 0 C-N-CA 122.297 1.998 . . . . 0.0 112.804 -178.595 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 62.8 p . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 21.4 ptt? -116.34 133.62 55.81 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.001 0.92 . . . . 0.0 110.976 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.91 132.99 36.08 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.214 1.006 . . . . 0.0 110.139 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.3 mt -132.64 139.07 47.58 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.515 0.726 . . . . 0.0 110.437 -168.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -89.37 102.32 14.99 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.543 HD13 HD21 ' A' ' 37' ' ' LEU . 36.4 mt -93.24 104.07 16.28 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.545 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 12.4 mtp180 -95.58 117.9 31.3 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.993 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.67 138.33 44.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.915 0.886 . . . . 0.0 109.76 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -132.01 156.07 46.9 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.307 0.643 . . . . 0.0 109.32 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.36 -128.12 1.72 Allowed 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.845 1.258 . . . . 0.0 112.818 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.521 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 84.8 m -55.92 -49.59 73.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.148 0.979 . . . . 0.0 111.862 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -64.19 -23.12 67.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.685 0.394 . . . . 0.0 111.006 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.606 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -69.21 -48.25 62.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.187 0.595 . . . . 0.0 110.962 178.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -22.78 59.38 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.379 0.424 . . . . 0.0 111.675 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 44' ' ' LEU . 78.5 t -59.64 -56.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.594 0.711 . . . . 0.0 110.587 170.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.0 t -73.78 -22.07 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.376 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.606 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 71.01 11.05 69.52 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.938 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -142.37 145.33 33.76 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.848 0.859 . . . . 0.0 109.21 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -86.56 -19.32 29.59 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.572 178.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 13.6 m -155.0 139.93 17.28 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 162.98 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.129 0.972 . . . . 0.0 108.882 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.0 112.75 24.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.429 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -103.37 178.05 4.67 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.447 1.499 . . . . 0.0 109.514 174.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -157.61 110.56 2.46 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.792 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.02 179.89 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.72 150.93 18.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.332 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.89 -35.0 69.62 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.524 1.129 . . . . 0.0 111.438 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.93 -13.3 59.02 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.768 0.827 . . . . 0.0 110.375 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 166.96 4.96 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.972 0.909 . . . . 0.0 111.353 172.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.8 p -135.98 -177.62 4.78 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.604 0.762 . . . . 0.0 110.1 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 77' ' ' LEU . 80.2 t -52.01 -37.84 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 C-N-CA 123.8 0.84 . . . . 0.0 110.757 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.659 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.49 -37.98 69.23 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.449 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.89 -29.82 68.18 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.046 0.539 . . . . 0.0 110.624 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.8 t -65.36 -60.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.577 0.751 . . . . 0.0 110.202 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.0 -30.31 71.4 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.794 0.27 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 49' ' ' ILE . 19.7 tpt180 -52.83 -46.96 67.99 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.28 0.562 . . . . 0.0 111.388 169.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.5 m -75.03 -32.43 61.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.708 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.543 HD21 HD13 ' A' ' 5' ' ' LEU . 3.5 mm? -59.18 -31.9 69.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB3' HD21 ' A' ' 48' ' ' LEU . 16.6 pt-20 -77.74 -28.48 50.76 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.426 0.557 . . . . 0.0 111.365 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.74 72.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.0 0.52 . . . . 0.0 111.084 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -85.96 -58.8 2.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.506 0.723 . . . . 0.0 110.58 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 95.0 m-85 -95.12 116.32 28.58 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.632 -171.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.99 -32.74 74.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.161 0.985 . . . . 0.0 111.225 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.502 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.69 -5.76 83.91 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.673 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.666 ' HB3' HD13 ' A' ' 48' ' ' LEU . 58.4 mt -106.56 3.04 26.58 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.573 0.687 . . . . 0.0 111.444 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.86 121.04 14.61 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 5.88 59.67 Favored Glycine 0 C--N 1.358 1.782 0 N-CA-C 115.773 1.069 . . . . 0.0 115.773 171.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.7 ptp180 -113.12 5.15 16.95 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.017 0.927 . . . . 0.0 111.337 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.666 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -126.27 -8.74 6.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.708 1.203 . . . . 0.0 110.36 -178.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 35' ' ' ARG . 33.5 mt -128.78 137.28 57.7 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 125.266 1.426 . . . . 0.0 108.402 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 16.1 mm-40 -128.9 107.95 10.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.525 0.73 . . . . 0.0 109.416 160.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 52.91 41.56 31.96 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.009 1.323 . . . . 0.0 112.873 171.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -7.1 78.03 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.988 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -110.5 -174.8 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.83 0.815 . . . . 0.0 109.1 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -70.14 -56.39 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.013 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 tppt? 152.49 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.434 0 C-N-CA 124.919 1.288 . . . . 0.0 109.392 -175.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.458 ' HD2' ' HG3' ' A' ' 50' ' ' GLU . 36.5 Cg_endo -63.11 131.91 34.42 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.077 2.518 . . . . 0.0 111.724 166.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 m170 76.73 -2.93 2.61 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 124.859 1.264 . . . . 0.0 113.682 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.4 p -75.9 154.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.2 m120 -121.03 103.56 9.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 67' ' ' VAL . 4.4 m -117.0 147.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.755 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.1 mp -132.13 172.51 12.3 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.052 1.341 . . . . 0.0 110.375 -163.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.513 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 17.6 tptp -157.82 105.33 1.99 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.143 1.377 . . . . 0.0 107.534 -172.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.92 35.02 14.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.484 1.114 . . . . 0.0 110.744 -168.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.76 -14.18 59.06 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.361 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -83.63 116.67 22.73 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.91 0.855 . . . . 0.0 110.087 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 23.0 tt0 -73.85 107.07 5.86 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.068 -171.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.529 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.2 m -75.52 -0.98 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 58' ' ' VAL . 17.1 m -70.62 -14.98 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.946 0.794 . . . . 0.0 111.342 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -85.38 -27.17 26.01 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.628 0.771 . . . . 0.0 110.722 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -130.3 -152.22 0.5 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.119 0.968 . . . . 0.0 109.868 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.28 108.91 1.72 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.206 0.602 . . . . 0.0 111.334 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.529 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.63 -43.1 12.45 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.774 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.659 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.5 mmt -74.52 -39.49 62.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.121 0.569 . . . . 0.0 111.957 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.3 79.02 1.39 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.195 0.521 . . . . 0.0 111.496 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.419 HG21 ' HG2' ' A' ' 62' ' ' LYS . 2.2 t -81.78 -62.35 1.66 Allowed 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.882 175.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 176.06 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.67 1.188 . . . . 0.0 110.034 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 30' ' ' VAL . 1.2 tm? -73.91 113.68 11.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.55 0.74 . . . . 0.0 110.727 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.82 -178.19 4.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.229 1.411 . . . . 0.0 109.516 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.2 p-10 -66.42 150.36 49.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 112.362 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.21 13.43 64.75 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.239 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.85 156.99 33.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 117.446 0.623 . . . . 0.0 111.176 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 6' ' ' ARG . . . -115.63 94.31 4.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.438 0.695 . . . . 0.0 109.297 171.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.26 106.37 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 48.9 m -93.11 146.35 23.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.376 0.671 . . . . 0.0 109.718 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 m -140.94 141.79 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.693 0.759 . . . . 0.0 110.199 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.7 m-85 -128.7 136.67 29.5 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.521 ' HG3' ' H ' ' A' ' 10' ' ' THR . 54.5 Cg_endo -62.75 169.37 8.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.165 3.243 . . . . 0.0 112.792 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo . . . . . 0 C--N 1.381 2.256 0 N-CA-C 108.962 -1.207 . . . . 0.0 108.962 176.157 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.442 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.8 ptt? -132.65 145.22 50.9 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.826 0.85 . . . . 0.0 109.443 174.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.33 113.42 26.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.996 0.519 . . . . 0.0 110.473 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 77' ' ' LEU . 21.8 mt -104.6 143.53 32.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.858 0.863 . . . . 0.0 111.018 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.53 101.09 13.77 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.58 0.352 . . . . 0.0 110.146 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.2 mt -93.8 105.55 17.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.26 0.552 . . . . 0.0 110.332 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 61.4 mtp180 -91.5 124.18 35.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.62 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -112.32 137.82 49.93 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.561 0.745 . . . . 0.0 109.013 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -132.5 161.16 34.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.874 0.47 . . . . 0.0 110.454 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 56.28 -128.03 1.97 Allowed 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.631 1.172 . . . . 0.0 112.16 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 32.7 m -59.5 -49.79 76.42 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.778 0.831 . . . . 0.0 111.609 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -59.8 -24.05 63.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.937 0.495 . . . . 0.0 111.352 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 ttp85 -68.71 -51.05 45.7 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.57 -21.85 60.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.529 0.332 . . . . 0.0 111.257 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.45 HG11 ' HG ' ' A' ' 44' ' ' LEU . 76.0 t -61.12 -55.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 0.0 110.07 170.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -77.87 -16.86 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.723 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.56 11.73 62.84 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.088 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -139.75 146.96 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.006 0.922 . . . . 0.0 110.007 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -104.36 -19.04 14.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.013 0.925 . . . . 0.0 110.998 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.5 m -153.74 138.36 16.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.949 0.9 . . . . 0.0 108.971 165.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.8 pt -133.37 178.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.821 0.848 . . . . 0.0 109.734 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -125.09 112.84 16.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.89 132.64 51.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 108.54 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -96.8 112.74 24.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 m -113.61 -179.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.83 166.26 22.62 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.019 0.372 . . . . 0.0 110.548 174.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.63 -31.58 72.86 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.625 0.77 . . . . 0.0 112.377 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.86 -17.16 51.62 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.828 0.451 . . . . 0.0 110.832 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 147.14 37.04 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.724 0.81 . . . . 0.0 112.183 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.5 p -134.03 -174.64 3.6 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.942 0.897 . . . . 0.0 109.097 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.0 t -52.36 -42.06 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.65 0.78 . . . . 0.0 111.464 -175.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.63 94.77 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.363 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.09 -34.43 76.41 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.262 0.553 . . . . 0.0 110.45 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.95 -57.8 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.246 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.642 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.2 pp -70.07 -30.66 67.96 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -64.94 -35.29 80.67 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.715 0.689 . . . . 0.0 110.49 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -75.84 -33.04 60.02 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.422 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -61.89 -39.43 91.95 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.935 0.494 . . . . 0.0 111.722 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 4.8 pt-20 -73.11 -26.26 61.17 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.95 63.72 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.077 0.551 . . . . 0.0 111.328 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -96.5 -59.19 1.87 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.943 0.878 . . . . 0.0 109.306 173.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -95.83 106.95 19.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.094 -171.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.38 -27.04 69.03 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.202 0.601 . . . . 0.0 111.048 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.58 -5.01 62.69 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.826 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.668 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.7 mt -111.3 -6.86 14.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.377 0.671 . . . . 0.0 111.481 172.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.3 120.03 8.51 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.56 5.66 56.51 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -96.62 -32.78 12.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.579 0.751 . . . . 0.0 109.583 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -98.13 2.03 48.15 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.219 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.22 139.0 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.603 1.161 . . . . 0.0 109.469 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.55 129.76 11.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.64 31.11 12.05 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.144 1.378 . . . . 0.0 112.035 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.62 -9.72 41.73 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.127 -0.818 . . . . 0.0 114.76 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -93.67 -174.42 3.46 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.179 0.989 . . . . 0.0 108.902 168.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG12 HD21 ' A' ' 34' ' ' LEU . 28.6 m -64.14 -55.32 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.417 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HG2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 tppt? 153.6 137.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 C-N-CA 125.175 1.39 . . . . 0.0 109.491 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.27 128.35 29.77 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.665 2.91 . . . . 0.0 111.981 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 76.35 -6.73 1.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.5 1.52 . . . . 0.0 113.874 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.17 141.85 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 18.0 m120 -111.8 104.13 12.43 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 85' ' ' VAL . 4.9 m -113.34 136.05 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -127.74 148.53 50.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.036 1.334 . . . . 0.0 110.209 -168.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -112.38 105.43 13.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 59.44 35.87 23.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.059 0.944 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.08 -13.79 65.28 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.765 -0.652 . . . . 0.0 114.247 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -90.45 102.14 14.87 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.6 tt0 -64.79 106.2 1.16 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.859 0.864 . . . . 0.0 111.015 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.87 -1.35 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 66' ' ' GLU . 15.2 m -70.83 -12.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 118.09 0.405 . . . . 0.0 111.554 171.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.411 ' HD2' ' HB3' ' A' ' 66' ' ' GLU . 93.6 m-70 -93.63 -20.97 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.569 0.748 . . . . 0.0 110.779 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.62 -153.14 0.54 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.604 1.162 . . . . 0.0 109.076 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.0 m-20 -59.64 109.34 0.89 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.266 0.626 . . . . 0.0 111.116 172.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.98 -46.33 7.15 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 123.321 0.388 . . . . 0.0 112.246 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 89.4 mmm -80.73 -20.16 43.41 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.44 79.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.898 0.317 . . . . 0.0 111.614 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -76.58 -74.97 0.21 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' H ' HG23 ' A' ' 75' ' ' THR . . . -176.68 35.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.492 0.317 . . . . 0.0 111.572 -164.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 3' ' ' LEU . 18.2 mt -73.7 150.13 41.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.553 0.692 . . . . 0.0 112.435 -170.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -154.23 179.7 8.72 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.723 1.609 . . . . 0.0 107.628 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 31.9 t70 -63.99 129.33 39.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.019 0.528 . . . . 0.0 111.906 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.96 6.22 82.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.133 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.01 122.22 27.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.602 0.761 . . . . 0.0 111.413 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.67 125.08 32.19 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.252 0.621 . . . . 0.0 111.734 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.36 107.63 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.684 0.794 . . . . 0.0 109.721 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.716 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.0 m -85.83 152.1 23.28 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.394 0.677 . . . . 0.0 110.191 175.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 60' ' ' VAL . 16.2 m -141.49 147.0 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.418 0.628 . . . . 0.0 109.946 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 42.3 m-85 -135.33 134.24 21.14 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 174.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 29.8 Cg_endo -59.42 164.64 10.61 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.841 3.028 . . . . 0.0 114.025 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HG3' ' HG2' ' A' ' 55' ' ' LYS . 15.4 Cg_exo . . . . . 0 C--N 1.38 2.215 0 C-N-CA 122.662 2.241 . . . . 0.0 111.166 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 25' ' ' ASP . 29.7 p . . . . . 0 C--O 1.238 0.499 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.496 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 23.7 ptt? -114.63 132.01 56.52 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.581 1.153 . . . . 0.0 110.695 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -84.42 128.57 34.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.275 0.63 . . . . 0.0 109.533 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.3 mt -127.46 137.08 52.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.475 0.71 . . . . 0.0 110.467 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -89.69 101.54 14.23 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.435 HD13 HD21 ' A' ' 37' ' ' LEU . 36.3 mt -93.33 107.42 19.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtt-85 -96.31 120.45 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.302 1.041 . . . . 0.0 109.778 -176.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.44 134.42 50.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.515 1.126 . . . . 0.0 109.251 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -128.68 162.55 27.09 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.979 0.512 . . . . 0.0 109.904 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.8 -122.6 0.91 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.493 1.117 . . . . 0.0 111.497 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.514 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 54.5 m -68.94 -45.77 69.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 111.408 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -57.19 -27.91 62.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.03 0.532 . . . . 0.0 111.335 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -64.57 -53.6 45.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.538 0.735 . . . . 0.0 111.34 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -21.76 60.43 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.345 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.511 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -61.71 -49.99 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.026 0.531 . . . . 0.0 110.606 169.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.94 -15.5 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.728 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.68 83.32 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.049 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -166.93 155.76 10.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.218 1.007 . . . . 0.0 110.156 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -89.75 -13.27 37.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 8.8 m -155.22 147.53 23.85 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.193 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -140.78 172.22 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.61 1.164 . . . . 0.0 108.703 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -118.35 112.78 20.47 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -92.1 -179.19 5.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.832 1.253 . . . . 0.0 108.937 167.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -156.73 110.16 2.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 176.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.363 1.065 . . . . 0.0 108.472 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HA ' HG22 ' A' ' 0' ' ' THR . 6.9 t70 -68.76 157.1 37.08 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 122.995 0.518 . . . . 0.0 110.031 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.68 -18.69 60.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.715 0.406 . . . . 0.0 110.728 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.39 -23.83 37.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.297 0.639 . . . . 0.0 109.723 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.52 147.87 47.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.476 0.71 . . . . 0.0 109.668 171.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -132.08 -174.37 3.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.263 1.025 . . . . 0.0 109.8 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.3 p -50.72 -36.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.644 1.178 . . . . 0.0 112.646 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.566 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -71.05 -41.02 61.48 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.379 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.9 -29.49 65.57 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.792 0.296 . . . . 0.0 110.521 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.7 t -59.37 -60.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.455 0.702 . . . . 0.0 109.831 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.575 HD21 HG12 ' A' ' 54' ' ' VAL . 2.4 pp -66.57 -30.76 71.14 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 123.11 0.257 . . . . 0.0 111.334 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.508 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.5 tpt180 -56.0 -46.65 78.66 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.36 0.6 . . . . 0.0 111.629 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -75.2 -32.97 61.35 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.356 0.662 . . . . 0.0 111.773 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -56.45 -45.03 81.04 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.701 0.801 . . . . 0.0 112.152 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 9.5 pt-20 -64.16 -29.8 70.9 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.61 0.569 . . . . 0.0 112.283 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.86 -22.67 67.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.957 0.503 . . . . 0.0 111.63 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -97.13 -57.97 2.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.008 0.909 . . . . 0.0 109.169 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.65 105.47 17.84 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.807 -173.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.3 -32.14 72.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.393 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.917 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.663 ' HB3' HD13 ' A' ' 48' ' ' LEU . 81.5 mt -103.09 -11.66 17.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.863 0.865 . . . . 0.0 111.271 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -57.28 121.55 10.41 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.366 0.667 . . . . 0.0 112.517 -173.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.59 -19.93 8.31 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 171.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.76 0.72 57.47 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.466 0.633 . . . . 0.0 111.655 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -124.02 5.58 8.62 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 110.29 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 35' ' ' ARG . 17.5 mt -140.75 142.47 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 124.639 1.176 . . . . 0.0 109.244 172.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -145.76 116.68 7.76 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.463 0.705 . . . . 0.0 110.125 164.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 55.92 31.56 18.07 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.221 1.008 . . . . 0.0 111.826 172.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.39 82.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -106.9 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.096 0.948 . . . . 0.0 108.785 165.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 34' ' ' LEU . 15.8 m -64.29 -55.39 21.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 CA-C-O 117.595 -1.193 . . . . 0.0 112.13 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? 150.02 132.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 C-N-CA 125.212 1.405 . . . . 0.0 107.601 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -61.11 140.61 90.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.727 2.285 . . . . 0.0 111.593 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 80.16 -21.33 0.33 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.509 1.524 . . . . 0.0 113.504 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.411 HG23 ' HD3' ' A' ' 88' ' ' PRO . 1.1 p -72.61 152.51 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 15.9 m120 -119.89 103.83 9.67 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.3 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.461 0.704 . . . . 0.0 109.55 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.6 mp -121.12 131.29 54.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.925 1.29 . . . . 0.0 110.725 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HD3' ' HG ' ' A' ' 77' ' ' LEU . 8.4 tptm -105.59 111.73 24.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.15 0.98 . . . . 0.0 109.057 171.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.4 t30 57.3 34.83 25.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.594 1.158 . . . . 0.0 110.577 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -4.51 86.04 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.41 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -102.37 114.23 28.23 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.944 0.897 . . . . 0.0 109.157 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 18.3 tt0 -70.63 110.26 5.36 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.363 0.665 . . . . 0.0 111.292 -171.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.02 -1.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.2 m -68.3 -19.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.109 0.413 . . . . 0.0 111.527 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -85.39 -16.26 40.42 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.924 0.89 . . . . 0.0 110.963 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.24 -152.72 0.44 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.42 1.088 . . . . 0.0 109.334 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.61 108.2 0.94 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.957 0.503 . . . . 0.0 110.551 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.01 -29.06 24.07 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.794 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.566 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.5 mmt -80.85 -37.94 29.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.503 0.721 . . . . 0.0 112.147 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.78 85.34 1.17 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.1 t -82.01 -70.79 0.52 Allowed 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.554 0.742 . . . . 0.0 112.271 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.454 ' H ' HG23 ' A' ' 75' ' ' THR . . . 179.77 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.458 1.103 . . . . 0.0 110.209 -163.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.29 114.86 13.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -116.85 179.76 3.92 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.359 0.664 . . . . 0.0 110.433 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 7.8 p-10 -73.09 142.32 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.56 0.744 . . . . 0.0 111.286 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.63 18.3 78.54 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.314 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -96.61 141.78 29.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.439 0.696 . . . . 0.0 111.785 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.54 109.35 22.12 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.167 0.987 . . . . 0.0 110.711 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.13 107.29 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.2 m -83.92 150.49 25.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.77 0.828 . . . . 0.0 110.093 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.12 145.63 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.466 0.706 . . . . 0.0 109.491 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 19.4 m-85 -137.33 135.06 19.02 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.514 ' HG3' ' H ' ' A' ' 10' ' ' THR . 29.3 Cg_endo -61.2 165.61 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 123.96 3.107 . . . . 0.0 113.688 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 58' ' ' VAL . 41.2 Cg_endo . . . . . 0 C--N 1.378 2.107 0 C-N-CA 122.608 2.205 . . . . 0.0 112.491 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -147.27 145.64 29.47 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.586 0.754 . . . . 0.0 109.495 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -89.3 141.11 28.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.67 138.15 44.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.575 0.75 . . . . 0.0 109.264 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -89.37 104.5 17.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.429 HD13 HD21 ' A' ' 37' ' ' LEU . 28.2 mt -93.72 104.26 16.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 79.9 mtt180 -92.05 117.39 29.79 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.533 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.54 137.59 42.16 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.907 0.883 . . . . 0.0 109.227 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -130.22 160.55 33.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.896 0.478 . . . . 0.0 110.59 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 57.95 -119.0 1.1 Allowed 'General case' 0 CA--C 1.56 1.332 0 O-C-N 124.783 1.302 . . . . 0.0 112.238 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.622 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 8.6 m -70.99 -47.45 58.78 Favored 'General case' 0 C--N 1.361 1.067 0 CA-C-N 118.415 0.552 . . . . 0.0 110.437 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -58.04 -26.61 62.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.051 0.54 . . . . 0.0 111.056 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -66.55 -54.42 23.85 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.223 0.609 . . . . 0.0 111.386 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -17.64 60.87 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.635 0.585 . . . . 0.0 111.797 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.547 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.4 t -63.44 -55.06 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.391 0.676 . . . . 0.0 109.654 169.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.44 -16.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.441 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 17.28 80.23 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.491 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -166.77 150.82 7.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.018 0.927 . . . . 0.0 110.321 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -91.23 -22.21 20.72 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -154.75 136.87 14.73 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -130.03 176.82 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.031 0.933 . . . . 0.0 109.144 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.5 111.44 16.82 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.11 177.4 5.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.001 1.32 . . . . 0.0 109.111 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -156.54 108.11 2.46 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 m -112.75 179.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.846 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -55.97 148.62 16.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.421 0.688 . . . . 0.0 110.364 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -66.55 -26.1 66.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.517 0.327 . . . . 0.0 111.413 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.45 -24.64 36.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.952 0.501 . . . . 0.0 110.56 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.47 129.2 39.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.345 0.658 . . . . 0.0 111.16 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.1 p -111.92 -172.97 2.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.324 1.049 . . . . 0.0 110.372 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -50.82 -41.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 123.771 0.828 . . . . 0.0 111.804 -170.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.402 ' HA2' ' HE2' ' A' ' 73' ' ' MET . . . -65.5 -43.35 94.85 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.65 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.11 -33.26 75.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.264 0.625 . . . . 0.0 111.582 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.03 -59.75 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.675 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.551 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.1 pp -68.89 -30.71 69.27 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.4 ppt_? -67.35 -34.3 77.02 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.907 0.776 . . . . 0.0 111.204 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.1 m -75.58 -32.45 60.36 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.007 175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 5' ' ' LEU . 2.5 mm? -59.08 -49.57 77.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.918 0.487 . . . . 0.0 111.213 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -67.25 -25.31 66.02 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -20.84 66.52 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 123.345 0.403 . . . . 0.0 110.973 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -96.91 -58.72 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.782 0.801 . . . . 0.0 109.41 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.85 111.13 22.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.339 -170.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.77 -26.93 67.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.638 0.775 . . . . 0.0 110.116 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.54 -17.48 68.84 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.501 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' O ' HD22 ' A' ' 48' ' ' LEU . 82.4 mt -103.2 -13.98 16.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.888 0.875 . . . . 0.0 111.683 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.16 121.21 10.75 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.28 11.94 79.69 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 11.3 ptm180 -120.58 -21.19 6.84 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.54 0.67 . . . . 0.0 111.318 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.577 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -101.85 8.42 41.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.031 0.533 . . . . 0.0 110.219 170.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' HA ' ' A' ' 35' ' ' ARG . 43.2 mt -140.89 142.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.079 1.351 . . . . 0.0 108.87 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 1.6 tm-20 -154.83 123.69 6.2 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.09 31.04 17.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.413 1.085 . . . . 0.0 111.589 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.57 -4.07 75.36 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.592 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -106.36 -174.07 2.45 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.82 0.81 . . . . 0.0 109.681 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.406 HG12 HD21 ' A' ' 34' ' ' LEU . 27.6 m -58.8 -54.7 30.12 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.165 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? 149.45 137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 C-N-CA 126.503 1.921 . . . . 0.0 106.982 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 18.6 Cg_endo -56.54 129.08 32.81 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.802 2.335 . . . . 0.0 111.174 166.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 76.35 -6.26 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.877 1.271 . . . . 0.0 113.957 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.445 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.9 p -73.69 143.79 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.81 104.69 13.35 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.18 137.25 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.228 0.611 . . . . 0.0 109.599 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.7 mp -126.89 142.73 51.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.835 1.254 . . . . 0.0 110.85 -166.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -114.06 109.21 18.08 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.474 1.11 . . . . 0.0 108.208 166.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.33 35.65 23.26 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.074 0.94 . . . . 0.0 110.349 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.25 -14.7 60.2 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.819 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -87.64 109.03 19.37 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 68' ' ' VAL . 17.4 tt0 -67.44 105.09 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.453 0.701 . . . . 0.0 110.334 -173.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.48 -1.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 66' ' ' GLU . 20.2 m -73.7 -10.27 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 122.593 0.357 . . . . 0.0 111.364 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -87.15 -25.54 24.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.534 0.733 . . . . 0.0 110.452 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.22 -150.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.074 0.95 . . . . 0.0 109.808 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.21 107.89 0.54 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.685 0.394 . . . . 0.0 111.055 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -86.22 -30.35 22.74 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.684 0.615 . . . . 0.0 111.954 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.402 ' HE2' ' HA2' ' A' ' 31' ' ' GLY . 20.7 mmt -81.45 -34.9 31.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.078 0.551 . . . . 0.0 111.79 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.36 81.48 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 t -81.02 -67.76 0.75 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -173.5 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -163.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.32 144.09 44.65 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.68 -175.08 5.18 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.395 1.478 . . . . 0.0 107.817 -174.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.3 143.08 52.15 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.891 0.476 . . . . 0.0 111.186 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.0 69.6 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 114.806 0.682 . . . . 0.0 114.806 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.99 118.28 22.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.033 0.533 . . . . 0.0 111.665 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.55 104.03 14.19 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.523 0.729 . . . . 0.0 111.147 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 t -93.27 106.56 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 50.8 m -86.95 148.9 25.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.731 0.812 . . . . 0.0 109.539 176.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.42 146.33 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.814 0.816 . . . . 0.0 109.692 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 21.9 m-85 -132.38 144.55 53.51 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 173.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.622 ' HG3' ' H ' ' A' ' 10' ' ' THR . 34.3 Cg_endo -63.48 169.11 10.22 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.517 2.811 . . . . 0.0 112.124 169.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 C--N 1.376 1.995 0 C-N-CA 121.218 1.278 . . . . 0.0 110.661 176.84 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 24.6 p . . . . . 0 C--O 1.241 0.632 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.05 136.91 54.88 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.411 1.084 . . . . 0.0 110.068 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -91.74 141.37 28.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.405 0.682 . . . . 0.0 110.14 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.43 138.9 45.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.466 1.106 . . . . 0.0 110.606 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.3 103.98 16.57 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.508 0.723 . . . . 0.0 109.089 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD13 HD21 ' A' ' 37' ' ' LEU . 29.9 mt -93.31 103.62 15.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 74.7 mtt180 -91.09 119.75 31.49 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.58 1.152 . . . . 0.0 109.434 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -108.11 140.35 41.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.25 1.02 . . . . 0.0 108.759 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -132.38 160.55 36.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.138 0.575 . . . . 0.0 109.585 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.446 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.72 -125.28 1.18 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.685 1.194 . . . . 0.0 112.706 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.519 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 27.6 m -68.02 -46.8 70.19 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.369 0.668 . . . . 0.0 111.14 -178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -57.31 -26.57 61.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.31 0.644 . . . . 0.0 111.633 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.495 ' HD3' ' HG2' ' A' ' 18' ' ' LYS . 7.0 tmm_? -68.66 -53.14 24.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.415 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -18.77 60.59 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.6 t -64.34 -48.12 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.251 0.548 . . . . 0.0 110.216 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 17' ' ' GLN . 88.4 t -78.87 -21.7 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.863 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.64 20.04 75.34 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.227 -175.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.502 ' HB2' HG12 ' A' ' 15' ' ' VAL . 13.8 mm100 -148.07 139.21 23.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.86 1.264 . . . . 0.0 109.111 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.495 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 26.3 mtmt -85.01 -21.32 29.51 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.891 0.744 . . . . 0.0 109.925 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -154.08 148.7 26.35 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.336 1.054 . . . . 0.0 108.814 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -135.84 168.03 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.473 1.109 . . . . 0.0 108.386 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.04 113.16 25.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.458 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -100.15 178.29 4.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.055 1.342 . . . . 0.0 109.373 171.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -157.44 107.33 2.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.549 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.32 173.21 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.347 1.059 . . . . 0.0 108.229 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.3 p-10 -67.86 160.46 28.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.093 0.473 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.26 -19.69 59.58 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.346 0.659 . . . . 0.0 111.522 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -80.76 -19.34 45.11 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.536 0.734 . . . . 0.0 109.155 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.73 154.65 39.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 0.0 110.775 172.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 p -134.23 -174.7 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.619 1.168 . . . . 0.0 109.862 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.94 -37.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 124.551 1.14 . . . . 0.0 111.878 -175.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.55 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -68.76 -42.25 80.15 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.298 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.72 -35.15 77.22 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.421 0.688 . . . . 0.0 110.895 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.15 -61.1 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.797 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.15 -30.71 71.65 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.662 0.21 . . . . 0.0 110.728 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -53.68 -48.39 69.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.919 0.487 . . . . 0.0 111.562 172.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.1 m -75.8 -31.61 59.5 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.803 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 5' ' ' LEU . 2.1 mm? -54.11 -41.08 67.9 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.741 0.816 . . . . 0.0 112.824 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 12.2 pt-20 -71.56 -28.11 63.62 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.13 68.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.102 0.561 . . . . 0.0 110.277 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.458 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 4.9 mm-40 -86.04 -59.37 2.32 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.832 0.853 . . . . 0.0 109.783 175.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.2 m-85 -99.58 119.81 38.66 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.672 -168.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.29 -29.01 67.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.791 0.837 . . . . 0.0 110.902 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.87 -0.23 80.68 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.072 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.6 mt -115.78 1.58 13.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 111.092 173.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.03 122.39 19.28 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.44 76.56 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 9.8 ptp180 -118.29 4.47 11.89 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.641 0.776 . . . . 0.0 111.827 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -125.92 -8.08 6.64 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.498 1.119 . . . . 0.0 110.443 -178.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.401 ' N ' HD23 ' A' ' 48' ' ' LEU . 15.1 mt -132.73 136.87 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.877 1.271 . . . . 0.0 108.297 167.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.64 124.19 9.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.36 31.52 21.01 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.669 1.187 . . . . 0.0 111.937 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.02 -14.46 53.12 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.531 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -99.16 -174.84 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.962 0.881 . . . . 0.0 109.058 171.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.42 -55.11 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 118.104 -0.95 . . . . 0.0 111.723 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.6 tppt? 154.88 135.11 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.037 0 C-N-CA 124.714 1.206 . . . . 0.0 108.956 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.436 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 26.7 Cg_endo -60.45 135.55 61.91 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.929 2.419 . . . . 0.0 111.336 165.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 79.45 -12.49 1.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.135 1.374 . . . . 0.0 113.569 174.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 1.9 p -75.81 152.12 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.8 104.12 9.62 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.483 HG23 HG23 ' A' ' 67' ' ' VAL . 5.3 m -122.1 146.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.261 0.624 . . . . 0.0 109.873 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.3 mp -127.64 172.08 11.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.073 1.349 . . . . 0.0 110.971 -167.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 19.4 tptp -162.51 105.58 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 t30 54.99 35.57 24.96 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.053 0.941 . . . . 0.0 110.096 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.03 -14.69 61.36 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.784 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -88.89 118.77 28.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.374 0.67 . . . . 0.0 110.094 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.7 tt0 -72.44 103.01 3.34 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.477 0.486 . . . . 0.0 109.713 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.551 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 14.3 m -69.73 -1.07 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -173.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.3 m -69.91 -16.21 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.31 0.505 . . . . 0.0 111.317 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -91.09 -10.72 40.99 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.383 0.673 . . . . 0.0 111.324 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.84 -152.4 0.42 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.189 0.996 . . . . 0.0 109.595 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.17 108.35 2.65 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.1 0.56 . . . . 0.0 110.409 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.551 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -81.62 -38.59 13.84 Favored Glycine 0 C--N 1.341 0.846 0 O-C-N 123.378 0.424 . . . . 0.0 112.594 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.55 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.8 mmt -80.19 -36.36 35.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 112.647 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.19 77.65 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.459 HG21 ' HG2' ' A' ' 62' ' ' LYS . 1.4 t -82.15 -74.62 0.33 Allowed 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.802 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' H ' HG23 ' A' ' 75' ' ' THR . . . -171.22 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.143 0.577 . . . . 0.0 111.472 -161.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.544 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 24.3 tp -74.22 144.74 44.59 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.761 0.315 . . . . 0.0 111.347 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -156.21 168.76 26.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.295 1.038 . . . . 0.0 109.464 -168.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.87 149.97 48.56 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.948 0.499 . . . . 0.0 111.839 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.39 63.84 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.841 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -82.74 155.41 24.3 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.169 0.484 . . . . 0.0 109.863 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 99.06 6.68 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 123.287 0.635 . . . . 0.0 109.617 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -86.44 106.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.4 m -90.87 146.5 23.86 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 123.168 0.587 . . . . 0.0 109.506 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.27 144.76 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -128.83 141.19 40.82 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HG3' ' H ' ' A' ' 10' ' ' THR . 41.6 Cg_endo -63.79 168.4 11.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.762 2.975 . . . . 0.0 112.519 175.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 15.7 Cg_endo . . . . . 0 C--N 1.378 2.088 0 C-N-CA 121.234 1.289 . . . . 0.0 111.198 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 C--O 1.24 0.557 0 CA-C-O 121.107 0.479 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.9 ptt? -101.72 140.4 36.05 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.781 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -95.22 130.59 41.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.292 0.637 . . . . 0.0 109.797 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.486 HD13 HD21 ' A' ' 77' ' ' LEU . 24.4 mt -124.44 138.73 54.33 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.646 0.779 . . . . 0.0 110.45 -169.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 45.5 tt0 -89.32 102.64 15.31 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.411 HD13 HD21 ' A' ' 37' ' ' LEU . 38.7 mt -92.86 103.7 16.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 30.1 mtm180 -92.32 117.62 30.09 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.393 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.33 138.49 42.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 109.464 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.72 155.38 48.95 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.335 0.654 . . . . 0.0 109.7 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.544 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.75 -126.75 0.96 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.144 1.378 . . . . 0.0 111.99 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.422 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 36.7 m -63.97 -43.03 96.98 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 123.34 0.656 . . . . 0.0 111.127 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -60.98 -27.69 68.47 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.574 0.35 . . . . 0.0 111.072 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 55.3 ttp180 -67.5 -53.33 29.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.321 0.648 . . . . 0.0 111.396 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -20.42 60.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.111 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 44' ' ' LEU . 40.6 t -61.5 -47.74 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.559 0.695 . . . . 0.0 110.294 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.75 -20.54 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.905 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.53 16.36 71.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.041 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -143.19 139.4 30.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.553 1.141 . . . . 0.0 109.841 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 22.3 ptmt -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.754 0.659 . . . . 0.0 110.521 172.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -156.92 145.43 19.74 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.465 174.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.12 173.24 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.344 1.057 . . . . 0.0 109.089 172.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -118.73 112.76 20.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.8 -179.64 4.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.276 1.43 . . . . 0.0 109.388 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -157.36 105.75 2.11 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.82 172.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -59.21 148.33 32.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.175 0.59 . . . . 0.0 111.285 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -61.94 -27.31 68.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 111.29 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -80.3 -24.99 39.61 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 110.24 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.89 37.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.02 0.528 . . . . 0.0 109.639 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.3 p -103.14 -173.87 2.42 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.596 0.758 . . . . 0.0 110.799 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 77' ' ' LEU . 87.9 t -50.84 -37.03 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 124.204 1.002 . . . . 0.0 111.493 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.3 -38.38 71.19 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.97 -31.02 69.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.297 0.639 . . . . 0.0 110.879 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.32 -60.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.172 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.506 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.7 pp -64.63 -30.16 71.18 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.192 0.308 . . . . 0.0 111.204 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HA ' HD11 ' A' ' 49' ' ' ILE . 16.6 tpt180 -51.41 -49.97 60.57 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.462 0.705 . . . . 0.0 111.242 168.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 m -75.36 -32.31 60.81 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.653 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 3.8 mm? -58.26 -35.31 71.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.187 0.595 . . . . 0.0 112.498 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.491 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.8 pt-20 -76.84 -27.45 55.12 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.324 0.511 . . . . 0.0 111.673 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.92 64.7 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.776 0.43 . . . . 0.0 111.01 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -90.23 -59.82 2.09 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.574 0.702 . . . . 0.0 110.158 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -92.28 126.54 37.4 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.602 -168.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.99 -35.67 69.55 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.689 0.796 . . . . 0.0 110.023 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.18 -4.19 86.18 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.957 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.605 ' HB3' HD13 ' A' ' 48' ' ' LEU . 56.9 mt -106.82 -3.67 20.12 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.934 0.867 . . . . 0.0 111.485 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.02 121.4 14.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.87 12.02 67.2 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.354 0.902 . . . . 0.0 115.354 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -118.26 0.44 11.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.005 0.922 . . . . 0.0 110.743 179.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -122.8 -5.42 8.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.524 1.13 . . . . 0.0 109.831 177.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 35' ' ' ARG . 37.0 mt -130.67 135.17 60.87 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.108 1.363 . . . . 0.0 108.398 169.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.84 126.35 14.13 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 166.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 56.11 31.29 17.92 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.604 1.162 . . . . 0.0 111.947 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.01 -14.38 57.32 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.27 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.59 -174.6 2.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 34' ' ' LEU . 27.8 m -63.51 -55.88 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.153 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 11.3 tppt? 151.5 137.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.075 0 C-N-CA 125.122 1.369 . . . . 0.0 108.901 -176.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 131.13 31.48 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 C-N-CA 123.042 2.495 . . . . 0.0 111.836 165.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 79.38 -11.72 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.585 1.554 . . . . 0.0 114.167 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -69.34 142.99 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 16.4 m120 -110.2 103.36 12.04 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 85' ' ' VAL . 3.7 m -121.3 129.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.537 0.735 . . . . 0.0 109.307 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.727 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 2.1 mp -121.06 139.39 53.38 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.435 1.094 . . . . 0.0 110.413 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 12.9 tptm -110.5 114.65 28.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.17 35.12 21.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.032 0.933 . . . . 0.0 110.993 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.05 -4.93 81.79 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.998 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -100.35 116.01 31.32 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 11.3 tt0 -70.28 107.11 3.59 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.635 0.584 . . . . 0.0 109.774 -173.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.71 -1.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.48 -19.35 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 122.662 0.385 . . . . 0.0 111.168 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -90.26 -5.24 56.55 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.668 0.787 . . . . 0.0 111.235 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.01 -149.35 0.29 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 109.327 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.24 108.84 3.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.266 0.626 . . . . 0.0 110.605 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.23 -43.4 20.95 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 122.999 0.187 . . . . 0.0 112.641 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.632 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.6 mmt -76.91 -40.26 47.94 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.195 0.598 . . . . 0.0 111.775 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.37 78.75 1.52 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 t -80.8 -65.99 0.94 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.654 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 175.57 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.918 0.887 . . . . 0.0 110.462 -163.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.486 HD21 HD13 ' A' ' 3' ' ' LEU . 47.2 tp -73.89 136.64 43.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.639 0.375 . . . . 0.0 110.412 -175.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -149.93 -177.46 5.92 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 122.805 0.442 . . . . 0.0 110.013 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 33.6 t70 -64.4 144.93 56.81 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.794 0.838 . . . . 0.0 112.917 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.35 -7.19 12.42 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.455 -0.793 . . . . 0.0 114.793 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.475 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 4.9 m-20 -78.44 142.07 37.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.762 0.825 . . . . 0.0 112.431 -169.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -97.64 111.16 23.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.036 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.17 107.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.727 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 12.9 m -85.57 147.04 26.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.985 0.514 . . . . 0.0 109.986 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 60' ' ' VAL . 33.0 m -141.93 140.6 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.602 0.715 . . . . 0.0 109.584 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.644 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 6.6 m-85 -129.92 137.79 31.67 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 37.1 Cg_endo -63.44 162.67 26.48 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.151 2.567 . . . . 0.0 112.594 176.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 C--N 1.37 1.68 0 C-N-CA 121.509 1.472 . . . . 0.0 111.17 177.864 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 20.9 p . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.465 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 27.0 ptt? -96.06 143.54 27.12 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.826 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -93.34 126.87 38.69 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.904 0.882 . . . . 0.0 109.046 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.426 HD11 HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -124.11 148.98 46.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.946 0.498 . . . . 0.0 109.988 -175.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 31.1 tt0 -97.42 113.51 25.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 170.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.2 mt -101.39 112.29 24.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 51.9 mtt180 -99.94 117.17 33.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.187 0.995 . . . . 0.0 108.796 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.55 137.61 45.28 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.952 0.901 . . . . 0.0 109.256 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -131.6 159.7 37.48 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.93 0.492 . . . . 0.0 109.814 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.21 -120.6 1.07 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 124.779 1.232 . . . . 0.0 112.337 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.481 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 26.2 m -71.92 -45.41 61.29 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 123.082 0.553 . . . . 0.0 110.442 -178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -55.34 -30.0 59.42 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.195 0.598 . . . . 0.0 110.972 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HD2' ' HG2' ' A' ' 18' ' ' LYS . 50.8 ttp180 -66.72 -55.24 15.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.84 0.856 . . . . 0.0 111.726 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -16.93 60.91 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.934 -174.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.49 HG11 ' HG ' ' A' ' 44' ' ' LEU . 40.1 t -65.54 -55.87 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.28 0.632 . . . . 0.0 109.689 168.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.2 t -74.54 -17.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.612 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.7 11.61 73.3 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.701 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -139.48 144.29 37.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.198 0.999 . . . . 0.0 109.144 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.522 ' HG2' ' HD2' ' A' ' 12' ' ' ARG . 22.0 mtmm -86.31 -21.05 27.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.746 0.419 . . . . 0.0 109.909 174.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 14.7 m -154.05 146.51 24.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.377 1.071 . . . . 0.0 109.216 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 23.2 pt -141.52 170.61 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 109.7 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -112.83 113.07 24.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.47 -179.53 4.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.579 1.151 . . . . 0.0 109.843 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG2' ' HB ' ' A' ' 0' ' ' THR . 60.7 ttp180 -157.4 106.43 2.14 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.829 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 3' ' ' LEU . 27.2 m -114.46 169.37 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.215 171.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 27.8 t70 -61.8 154.09 26.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.936 0.494 . . . . 0.0 111.039 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.24 -32.42 71.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.014 0.926 . . . . 0.0 111.833 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -81.01 -22.6 39.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.958 0.903 . . . . 0.0 111.362 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 153.72 37.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.28 0.632 . . . . 0.0 110.66 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -130.48 -175.07 3.53 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 97.8 t -51.81 -37.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.951 0.9 . . . . 0.0 111.648 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.95 65.92 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.005 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.27 -33.79 76.64 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.272 0.629 . . . . 0.0 110.296 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.88 -60.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.813 0.845 . . . . 0.0 110.317 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.508 HD21 HG12 ' A' ' 54' ' ' VAL . 2.6 pp -64.66 -30.74 71.76 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.134 0.424 . . . . 0.0 111.579 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HA ' HD11 ' A' ' 49' ' ' ILE . 17.3 tpt180 -50.96 -48.59 61.0 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.157 0.583 . . . . 0.0 110.956 168.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 m -74.65 -32.5 62.29 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.187 0.595 . . . . 0.0 111.436 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 4.1 mm? -59.74 -34.29 72.76 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' A' ' 48' ' ' LEU . 5.6 pt-20 -76.89 -28.57 55.41 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.718 0.69 . . . . 0.0 111.124 173.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.05 -32.7 72.37 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.039 0.536 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -83.99 -58.0 2.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.526 0.73 . . . . 0.0 110.474 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -96.38 127.33 42.28 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.587 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.28 -45.68 90.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.131 0.973 . . . . 0.0 110.697 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.11 7.1 54.34 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.423 -0.808 . . . . 0.0 114.021 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.588 ' HB3' HD13 ' A' ' 48' ' ' LEU . 74.3 mt -115.97 5.26 13.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.615 0.707 . . . . 0.0 111.167 172.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -69.89 120.94 16.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.27 -8.09 26.97 Favored Glycine 0 C--N 1.359 1.847 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -100.08 4.13 44.45 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.355 1.062 . . . . 0.0 111.403 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -128.66 -8.87 5.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.257 1.023 . . . . 0.0 110.855 -177.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.479 HD11 ' HA ' ' A' ' 35' ' ' ARG . 51.5 mt -125.22 132.52 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.598 1.159 . . . . 0.0 107.967 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.17 117.65 13.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.919 0.488 . . . . 0.0 109.731 167.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.2 t70 55.54 30.85 15.98 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.05 -14.83 63.4 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.616 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -97.31 -174.01 2.82 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.883 0.842 . . . . 0.0 108.885 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG12 HD21 ' A' ' 34' ' ' LEU . 13.8 m -65.5 -56.83 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.788 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 150.81 135.97 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.003 0 C-N-CA 125.078 1.351 . . . . 0.0 109.176 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.49 137.51 51.02 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.84 2.36 . . . . 0.0 110.972 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 77.9 -11.94 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.325 1.45 . . . . 0.0 113.61 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 p -73.56 138.94 20.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.666 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.6 m120 -104.67 103.55 13.21 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 85' ' ' VAL . 4.2 m -122.93 135.38 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.624 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -126.19 155.62 41.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.349 1.059 . . . . 0.0 110.639 -166.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 13.3 tptm -123.49 104.51 9.11 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.554 1.142 . . . . 0.0 107.975 169.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 t30 52.64 37.69 24.07 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.062 1.345 . . . . 0.0 111.702 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 19.61 43.79 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.871 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -133.27 105.49 7.01 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 16.0 tt0 -62.85 109.31 1.4 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.331 1.052 . . . . 0.0 110.918 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 31.3 m -69.95 -1.48 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -172.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -68.16 -22.53 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 117.935 0.334 . . . . 0.0 110.824 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -86.38 -15.87 39.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.865 0.866 . . . . 0.0 111.151 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.75 -153.14 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.247 1.019 . . . . 0.0 109.289 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.25 113.5 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.077 0.551 . . . . 0.0 110.538 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -73.3 -50.29 12.79 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.718 0.636 . . . . 0.0 112.734 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.3 mmm -79.94 -36.83 35.7 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.345 0.658 . . . . 0.0 111.692 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.43 77.95 1.65 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.571 0.701 . . . . 0.0 111.008 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.29 -71.4 0.47 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.836 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.477 ' H ' HG23 ' A' ' 75' ' ' THR . . . -173.75 28.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.912 0.885 . . . . 0.0 110.962 -164.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -75.33 144.06 42.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.175 0.59 . . . . 0.0 111.574 -168.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -157.51 -176.02 5.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.066 0.546 . . . . 0.0 110.1 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 28.3 t70 -63.88 140.53 58.88 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.035 0.934 . . . . 0.0 111.338 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 -7.09 57.87 Favored Glycine 0 C--N 1.344 1.023 0 O-C-N 123.834 0.709 . . . . 0.0 114.421 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.52 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 78.1 m-20 -79.55 133.9 36.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -170.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.32 105.66 17.63 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.446 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.2 137.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.624 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.9 m -118.12 154.83 31.46 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.441 0.564 . . . . 0.0 110.2 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 60' ' ' VAL . 34.6 m -145.1 143.92 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.751 0.82 . . . . 0.0 110.152 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.666 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 18.1 m-85 -135.08 133.75 21.08 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HG3' ' H ' ' A' ' 10' ' ' THR . 22.0 Cg_endo -59.89 160.96 19.93 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 123.325 2.684 . . . . 0.0 112.867 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 C--N 1.377 2.059 0 C-N-CA 121.945 1.764 . . . . 0.0 111.745 -178.664 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 34.3 p . . . . . 0 C--O 1.241 0.624 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.76 151.44 31.96 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.481 0.712 . . . . 0.0 110.391 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.11 137.96 50.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.602 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.23 149.25 46.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.685 0.794 . . . . 0.0 109.855 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -89.2 106.86 18.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.26 112.65 24.57 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 39.8 mtp180 -104.64 118.02 35.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.716 0.806 . . . . 0.0 109.297 -170.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 136.67 45.47 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.924 0.89 . . . . 0.0 109.325 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -132.45 160.74 35.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.79 0.436 . . . . 0.0 110.104 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.06 -117.77 0.82 Allowed 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.892 1.277 . . . . 0.0 112.389 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.626 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 46.7 m -69.69 -47.52 62.91 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 123.632 0.773 . . . . 0.0 110.494 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -59.46 -24.36 63.49 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.986 0.515 . . . . 0.0 111.224 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -50.36 53.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.731 0.813 . . . . 0.0 111.291 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -16.91 60.89 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.595 HG11 ' HG ' ' A' ' 44' ' ' LEU . 72.6 t -65.36 -53.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.626 0.726 . . . . 0.0 110.205 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.85 -16.73 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.633 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.74 11.52 85.15 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.414 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.97 158.84 10.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.84 0.856 . . . . 0.0 110.807 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -94.76 -9.42 34.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.0 m -152.65 143.08 22.63 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.41 175.82 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.223 1.009 . . . . 0.0 109.119 174.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.49 112.96 16.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.36 135.91 44.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.303 1.041 . . . . 0.0 110.038 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -104.13 106.18 16.6 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.1 175.7 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.542 1.137 . . . . 0.0 108.226 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.46 164.52 26.54 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.627 0.371 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -76.95 -15.46 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.53 -24.33 36.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.879 0.472 . . . . 0.0 110.35 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.06 58.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.901 0.881 . . . . 0.0 111.463 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.3 p -128.27 -174.39 3.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.475 1.11 . . . . 0.0 109.725 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.81 -33.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 123.973 0.909 . . . . 0.0 112.093 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' HA2' ' HE1' ' A' ' 73' ' ' MET . . . -66.58 -50.05 51.67 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.053 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -61.59 -29.55 70.11 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.174 0.59 . . . . 0.0 111.583 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.45 -60.62 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.31 1.044 . . . . 0.0 110.541 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.3 pp -74.14 -31.06 62.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.2 ppt_? -67.12 -31.85 72.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.67 0.668 . . . . 0.0 111.176 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -76.67 -34.11 58.24 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.607 0.763 . . . . 0.0 112.333 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -59.91 -38.96 83.81 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 122.974 0.509 . . . . 0.0 111.86 -176.449 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -68.28 -37.41 80.64 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.345 0.403 . . . . 0.0 111.765 175.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.54 -28.96 69.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.506 0.723 . . . . 0.0 111.447 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -82.72 -58.83 2.72 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.043 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.22 112.56 24.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.813 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.93 -31.3 70.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.579 0.751 . . . . 0.0 110.55 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -73.31 -6.39 69.56 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.419 -0.809 . . . . 0.0 114.064 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HB3' HD13 ' A' ' 48' ' ' LEU . 68.0 mt -113.26 2.29 15.51 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.675 0.738 . . . . 0.0 111.141 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.9 120.74 13.62 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.27 -28.67 2.6 Favored Glycine 0 C--N 1.359 1.826 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 5.6 ptp180 -83.29 9.24 11.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.904 1.282 . . . . 0.0 112.693 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -132.26 9.85 4.45 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.94 0.896 . . . . 0.0 110.931 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 35' ' ' ARG . 61.1 mt -141.41 140.75 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.296 1.038 . . . . 0.0 109.315 175.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 55' ' ' LYS . 16.6 mm-40 -139.71 110.41 6.74 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.302 0.641 . . . . 0.0 110.317 163.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t70 56.6 36.14 27.16 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.475 1.11 . . . . 0.0 111.894 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.04 27.52 62.13 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.139 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.63 -177.4 4.17 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 161.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.495 HG12 HD21 ' A' ' 34' ' ' LEU . 17.1 m -66.5 -56.09 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 117.588 -1.196 . . . . 0.0 112.297 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HD3' ' HG2' ' A' ' 50' ' ' GLU . 5.9 tppt? 149.58 134.27 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.243 0 C-N-CA 126.06 1.744 . . . . 0.0 108.616 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.427 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 19.5 Cg_endo -58.91 133.34 53.02 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.061 2.507 . . . . 0.0 112.184 165.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 81.03 -26.99 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.861 1.664 . . . . 0.0 113.107 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.76 120.44 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -95.41 104.71 16.62 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 85' ' ' VAL . 1.7 m -109.37 146.39 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.287 0.635 . . . . 0.0 109.55 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.5 mp -132.7 170.66 14.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.971 1.308 . . . . 0.0 110.243 -164.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE2' HD23 ' A' ' 77' ' ' LEU . 20.9 tptp -162.28 105.43 1.14 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 55.82 34.76 24.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.16 0.981 . . . . 0.0 109.832 -171.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.93 -13.58 48.05 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 114.492 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -87.16 119.28 27.23 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.922 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 24.3 tt0 -78.53 104.47 9.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.224 0.61 . . . . 0.0 111.13 -168.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.469 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.1 m -70.87 -1.32 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -170.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.1 m -68.6 -19.78 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.39 0.541 . . . . 0.0 110.898 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -92.53 -29.38 16.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.019 0.927 . . . . 0.0 110.843 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.79 -150.74 0.47 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.143 0.977 . . . . 0.0 109.406 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.04 108.31 2.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.955 0.502 . . . . 0.0 110.955 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -83.15 -37.79 12.09 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 123.32 0.387 . . . . 0.0 112.273 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.518 ' HE1' ' HA2' ' A' ' 31' ' ' GLY . 14.1 mmt -79.73 -38.39 33.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.653 0.781 . . . . 0.0 111.917 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.73 83.96 1.29 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.47 -75.26 0.29 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.724 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.4 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -163.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.475 HD23 ' HE2' ' A' ' 62' ' ' LYS . 15.4 mt -73.68 143.65 46.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.865 0.84 . . . . 0.0 112.554 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -151.1 169.3 22.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.751 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.9 135.07 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 122.13 -0.356 . . . . 0.0 111.217 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 16.58 80.54 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.82 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.2 157.43 21.64 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.421 0.611 . . . . 0.0 109.563 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.75 106.03 11.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.268 0.627 . . . . 0.0 111.143 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.405 HG22 HD21 ' A' ' 77' ' ' LEU . 47.6 t -86.92 137.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.622 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 69.5 m -118.62 151.82 37.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 60' ' ' VAL . 10.3 m -142.27 148.3 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 121.404 0.621 . . . . 0.0 110.196 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -136.3 140.71 33.53 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.626 ' HG3' ' H ' ' A' ' 10' ' ' THR . 53.6 Cg_endo -64.28 168.83 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.254 3.303 . . . . 0.0 112.417 174.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 C--N 1.382 2.329 0 C-N-CA 121.077 1.185 . . . . 0.0 111.385 -178.725 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.198 0.523 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.431 ' SD ' ' HA ' ' A' ' 26' ' ' ASP . 13.2 ptm -122.31 111.71 17.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.412 1.085 . . . . 0.0 109.722 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.32 121.43 28.87 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.542 HD13 HD21 ' A' ' 77' ' ' LEU . 21.4 mt -123.93 135.21 53.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.562 0.745 . . . . 0.0 110.027 -169.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.11 98.45 11.77 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD13 HD21 ' A' ' 37' ' ' LEU . 21.9 mt -94.83 104.8 16.71 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.122 . . . . 0.0 110.529 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 41.3 mtp180 -101.06 117.33 34.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.408 0.683 . . . . 0.0 109.414 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -101.76 140.22 36.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.049 0.939 . . . . 0.0 109.357 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.5 157.11 43.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.096 0.558 . . . . 0.0 110.137 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.66 -122.29 1.09 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.775 1.23 . . . . 0.0 112.861 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.539 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 92.0 m -64.78 -48.07 75.83 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 123.757 0.823 . . . . 0.0 111.042 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -60.03 -24.52 64.59 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.819 0.448 . . . . 0.0 111.467 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 13' ' ' GLU . 7.8 tmm_? -72.46 -47.58 47.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.932 0.493 . . . . 0.0 111.288 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 1.1 pp20? -74.16 -19.11 60.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.53 0.332 . . . . 0.0 111.698 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.558 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.0 t -67.35 -52.55 40.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.67 0.788 . . . . 0.0 110.483 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 95.6 t -73.88 -22.18 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.526 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.07 11.44 63.66 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.885 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -146.46 136.99 23.97 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -170.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HD2' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -87.71 -14.71 39.09 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -155.5 137.82 14.84 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.709 0.804 . . . . 0.0 109.315 177.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.45 140.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -88.92 112.45 23.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.86 170.97 9.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.55 1.14 . . . . 0.0 108.928 170.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -157.02 108.47 2.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.704 0.764 . . . . 0.0 109.466 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.57 -179.56 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.766 1.627 . . . . 0.0 108.364 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.99 160.19 30.09 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.431 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 5.3 p-10 -69.83 -8.08 45.33 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.694 0.797 . . . . 0.0 113.043 -170.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.35 -14.44 57.25 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.719 0.807 . . . . 0.0 112.26 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.95 129.47 36.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.696 0.398 . . . . 0.0 111.133 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p -109.63 -179.59 3.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -54.02 -32.66 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.081 0.952 . . . . 0.0 112.368 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.63 -40.51 58.88 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.741 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.7 -32.24 73.41 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.163 0.481 . . . . 0.0 110.45 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.21 -60.08 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.678 0.611 . . . . 0.0 110.408 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.493 HD21 HG12 ' A' ' 54' ' ' VAL . 2.6 pp -66.91 -30.08 70.14 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 123.331 0.394 . . . . 0.0 111.166 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.3 tpt85 -56.28 -48.38 76.72 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.061 0.544 . . . . 0.0 111.518 170.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -75.88 -31.75 59.37 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.047 0.539 . . . . 0.0 111.442 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 5' ' ' LEU . 1.5 mm? -56.59 -44.81 81.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.706 0.803 . . . . 0.0 112.406 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.501 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.68 -25.64 67.42 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.157 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.7 -21.65 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.655 0.597 . . . . 0.0 111.238 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -98.68 -59.09 1.81 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 122.877 0.471 . . . . 0.0 109.781 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.499 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 91.9 m-85 -89.66 117.45 28.54 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.882 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.01 -35.39 81.04 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.742 0.817 . . . . 0.0 111.481 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.88 -2.13 75.74 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.754 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.663 ' HB3' HD13 ' A' ' 48' ' ' LEU . 58.0 mt -103.94 -15.57 15.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.46 0.704 . . . . 0.0 110.893 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.48 120.65 9.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.779 0.832 . . . . 0.0 112.59 -171.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.62 74.04 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 115.489 0.955 . . . . 0.0 115.489 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 3.1 ptp180 -118.71 -0.06 11.37 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.539 0.736 . . . . 0.0 111.713 -176.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.22 -3.05 11.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.738 0.815 . . . . 0.0 110.185 173.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 35' ' ' ARG . 41.2 mt -133.44 137.19 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.019 1.328 . . . . 0.0 108.195 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -135.96 108.39 7.37 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t70 57.92 32.2 21.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.636 1.174 . . . . 0.0 112.557 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.43 1.2 69.17 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 115.084 0.793 . . . . 0.0 115.084 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.08 -174.91 2.63 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 117.849 0.824 . . . . 0.0 109.392 165.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.493 HG12 HD21 ' A' ' 34' ' ' LEU . 17.8 m -65.76 -55.42 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.601 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.5 tppt? 150.21 138.09 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 C-N-CA 125.576 1.55 . . . . 0.0 107.956 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.455 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 19.6 Cg_endo -56.07 129.19 33.57 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 123.009 2.473 . . . . 0.0 110.619 166.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 74.86 -4.79 2.29 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.997 1.319 . . . . 0.0 114.28 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -74.99 131.9 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.1 m120 -100.9 103.58 14.76 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.43 137.28 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.267 0.627 . . . . 0.0 109.765 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 7.4 mp -118.87 169.23 10.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.113 1.365 . . . . 0.0 111.09 -169.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -163.77 106.0 0.95 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.478 -177.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.481 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 7.5 t-20 59.21 38.12 23.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.188 1.395 . . . . 0.0 109.721 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.96 -14.6 48.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.619 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -93.79 119.12 32.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.445 0.622 . . . . 0.0 109.565 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 22.4 tt0 -75.18 109.46 8.69 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.064 0.459 . . . . 0.0 109.765 -174.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 20.6 m -71.4 -0.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.72 -19.91 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.186 0.448 . . . . 0.0 110.978 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -88.3 -19.65 26.46 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.737 0.815 . . . . 0.0 110.794 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.34 -148.34 0.36 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.692 1.197 . . . . 0.0 109.262 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.3 108.95 6.46 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.003 0.521 . . . . 0.0 110.57 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -79.6 -37.64 22.94 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 113.903 0.321 . . . . 0.0 113.903 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 82.8 mmm -81.62 -26.75 34.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.99 85.35 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 118.177 0.444 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.81 -73.15 0.4 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.073 0.549 . . . . 0.0 112.192 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' H ' HG23 ' A' ' 75' ' ' THR . . . -173.19 33.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.815 0.846 . . . . 0.0 110.557 -164.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.542 HD21 HD13 ' A' ' 3' ' ' LEU . 41.4 tp -74.35 123.54 24.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.495 0.318 . . . . 0.0 110.154 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 7.0 t70 -116.82 178.24 4.41 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.5 147.69 49.09 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.359 0.663 . . . . 0.0 111.035 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.21 10.82 70.06 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.548 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -82.6 177.67 8.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.451 0.701 . . . . 0.0 110.896 -174.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.69 109.11 9.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.293 0.637 . . . . 0.0 110.866 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.47 137.65 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 108.734 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 75.3 m -121.04 154.23 36.33 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -142.88 147.64 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.624 0.726 . . . . 0.0 110.141 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 14.9 m-85 -133.51 140.23 36.28 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HG3' ' H ' ' A' ' 10' ' ' THR . 58.7 Cg_endo -66.36 168.38 16.3 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.711 2.94 . . . . 0.0 112.3 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 C--N 1.377 2.04 0 C-N-CA 121.395 1.397 . . . . 0.0 110.869 177.001 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.244 0.77 0 CA-C-O 120.974 0.416 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.6 ptt? -149.86 124.02 9.48 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.773 0.829 . . . . 0.0 109.547 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -85.27 113.65 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.031 0.932 . . . . 0.0 109.107 -175.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.3 mt -115.46 134.5 55.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.391 0.676 . . . . 0.0 110.931 -171.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 65.1 tt0 -89.17 103.09 15.74 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.8 mt -93.84 105.3 17.33 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.4 mtt180 -91.9 117.0 29.39 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.749 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.444 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m-85 -103.44 136.09 43.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.976 0.91 . . . . 0.0 109.248 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.01 161.41 29.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.225 0.61 . . . . 0.0 109.537 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.41 -133.27 0.93 Allowed 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.604 1.162 . . . . 0.0 112.354 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 14' ' ' VAL . 57.2 m -55.76 -44.03 77.26 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 124.324 1.05 . . . . 0.0 111.819 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 10.8 m-30 -63.1 -33.09 74.71 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.076 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -41.57 91.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.642 0.377 . . . . 0.0 110.273 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -67.91 -35.86 79.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.806 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.493 HG11 ' HG ' ' A' ' 44' ' ' LEU . 64.6 t -60.46 -56.31 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.257 0.623 . . . . 0.0 110.617 174.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.26 -17.15 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.42 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.98 11.52 70.08 Favored Glycine 0 C--N 1.35 1.313 0 C-N-CA 123.578 0.608 . . . . 0.0 113.682 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -160.7 142.45 12.33 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.232 1.013 . . . . 0.0 110.149 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -85.83 -22.16 27.74 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.952 0.901 . . . . 0.0 113.38 -167.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.2 m -150.18 133.09 16.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 18.1 pt -129.98 171.88 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.997 . . . . 0.0 108.928 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -116.95 112.17 20.63 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 163.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -89.96 -179.05 5.62 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.91 1.284 . . . . 0.0 108.772 164.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -155.73 113.89 3.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.68 -179.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.52 156.74 35.97 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.723 0.409 . . . . 0.0 110.353 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.56 -24.96 53.56 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.262 0.625 . . . . 0.0 111.049 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.65 -14.39 56.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.86 0.864 . . . . 0.0 110.558 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 166.07 23.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.257 0.623 . . . . 0.0 110.836 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.8 p -132.2 -177.47 4.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.594 0.758 . . . . 0.0 110.815 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.35 -35.85 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.617 1.167 . . . . 0.0 111.553 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.483 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.62 -38.52 78.26 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.553 0.533 . . . . 0.0 113.221 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.71 -33.17 75.04 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.284 0.634 . . . . 0.0 110.491 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.0 -60.19 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.702 0.801 . . . . 0.0 110.528 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 54' ' ' VAL . 2.0 pp -65.07 -30.61 71.58 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.88 0.309 . . . . 0.0 111.316 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -54.47 -47.31 73.1 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.239 0.616 . . . . 0.0 111.368 170.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 36.1 t -75.9 -32.64 59.74 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.093 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 2.3 mm? -58.04 -35.8 71.84 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.69 0.796 . . . . 0.0 112.954 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -77.79 -30.02 51.11 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 120.737 0.303 . . . . 0.0 111.462 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.19 -26.41 67.39 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.929 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 36' ' ' SER . 6.1 mm-40 -90.76 -56.28 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.026 0.93 . . . . 0.0 110.191 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -95.73 122.66 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.187 -170.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.92 -35.82 81.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.043 0.937 . . . . 0.0 110.774 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.67 -2.11 90.6 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.919 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB3' HD13 ' A' ' 48' ' ' LEU . 85.0 mt -109.88 5.24 22.33 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.868 0.834 . . . . 0.0 110.885 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.34 121.46 17.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.971 0.508 . . . . 0.0 112.177 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.54 -24.65 6.28 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 12.3 ptp180 -90.25 7.5 37.93 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.69 1.196 . . . . 0.0 112.505 -171.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.06 -7.1 3.47 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.135 0.974 . . . . 0.0 111.088 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.89 127.7 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.509 1.123 . . . . 0.0 108.416 169.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -127.51 108.84 11.15 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.175 0.59 . . . . 0.0 110.162 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 t70 53.02 39.53 29.63 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.581 1.152 . . . . 0.0 112.007 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.2 -14.53 65.05 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.195 -0.911 . . . . 0.0 115.369 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -102.21 -175.32 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.286 1.043 . . . . 0.0 109.223 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG12 HD21 ' A' ' 34' ' ' LEU . 15.8 m -69.02 -57.56 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.07 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 15.4 tppt? 153.74 135.22 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 CA-C-N 119.683 1.129 . . . . 0.0 109.786 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 17.1 Cg_endo -56.07 135.25 68.9 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 123.319 2.68 . . . . 0.0 111.879 165.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 76.28 -15.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.565 1.546 . . . . 0.0 113.947 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.76 146.36 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.5 m120 -121.13 103.87 9.34 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG12 HG12 ' A' ' 85' ' ' VAL . 3.2 m -116.17 131.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.53 0.732 . . . . 0.0 109.531 -177.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -120.41 133.9 55.35 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.209 1.403 . . . . 0.0 110.297 -171.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 16.8 tptp -105.62 105.62 15.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 59.32 35.13 23.16 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.097 0.959 . . . . 0.0 111.13 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.92 -14.31 63.7 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.426 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -93.73 105.92 17.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.837 0.855 . . . . 0.0 109.41 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 26.1 tt0 -70.88 104.83 3.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.602 0.761 . . . . 0.0 111.174 -168.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 23.4 m -71.65 -0.95 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.89 -22.69 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.806 170.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -86.71 -28.55 23.02 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.772 0.829 . . . . 0.0 110.803 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.6 -153.74 0.54 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.383 1.073 . . . . 0.0 109.503 177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.26 107.89 1.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.888 0.475 . . . . 0.0 110.186 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.472 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -80.2 -34.1 30.58 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.031 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.483 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.7 mmt -82.15 -39.11 23.72 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.2 82.48 1.6 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.29 0.566 . . . . 0.0 111.631 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 76' ' ' ALA . 2.1 t -81.34 -72.87 0.41 Allowed 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.135 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' H ' HG23 ' A' ' 75' ' ' THR . . . 174.55 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.955 0.902 . . . . 0.0 110.414 -161.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -74.03 123.0 23.52 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -167.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.71 175.21 5.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.148 0.979 . . . . 0.0 109.989 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 11.1 p-10 -72.89 146.73 45.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.458 0.703 . . . . 0.0 111.949 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 15.15 73.1 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.396 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.31 171.45 13.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.098 0.559 . . . . 0.0 111.332 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.52 94.78 3.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 170.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.89 107.39 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 74.2 m -85.68 155.01 21.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 110.402 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 HG12 ' A' ' 60' ' ' VAL . 32.8 m -146.35 145.49 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 109.673 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 29.9 m-85 -132.38 136.62 28.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 32.5 Cg_endo -61.04 168.91 6.68 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.971 3.114 . . . . 0.0 113.432 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 C--N 1.376 2.016 0 C-N-CA 121.103 1.202 . . . . 0.0 110.328 172.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.561 0 N-CA-C 112.124 -0.39 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -85.51 161.26 35.21 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.202 -0.359 . . . . 0.0 112.202 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -87.03 -174.25 48.98 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-O 119.804 -0.442 . . . . 0.0 112.262 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? 57.46 87.51 0.06 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.731 1.213 . . . . 0.0 109.708 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' -2' ' ' LYS . 13.0 m-20 -130.28 37.4 3.88 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.926 0.891 . . . . 0.0 110.261 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . 0.563 ' HA ' HG21 ' A' ' 0' ' ' THR . 1.7 m-85 -84.81 69.26 10.7 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 122.034 0.921 . . . . 0.0 110.991 -169.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 179.98 7.76 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.272 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . 0.435 ' HA ' ' HE2' ' A' ' -2' ' ' LYS . 23.1 t70 -101.48 169.03 9.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 27.9 t70 72.68 150.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.841 1.256 . . . . 0.0 111.722 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.37 -178.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.006 0.922 . . . . 0.0 110.443 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.73 135.5 46.81 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.463 -0.773 . . . . 0.0 109.492 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.575 ' HG2' ' H ' ' A' ' 0' ' ' THR . 0.0 OUTLIER -167.46 -35.95 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.621 0.768 . . . . 0.0 110.068 -178.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 69.51 29.92 71.32 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.781 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.575 ' H ' ' HG2' ' A' ' -2' ' ' LYS . 65.3 p -88.55 141.57 28.41 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -108.06 167.5 9.95 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.073 0.949 . . . . 0.0 108.887 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -120.84 133.48 55.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.7 mt -126.13 142.36 51.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.333 0.653 . . . . 0.0 109.945 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 45.5 tt0 -88.73 102.68 15.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.442 HD13 HD21 ' A' ' 37' ' ' LEU . 30.1 mt -93.76 104.0 16.11 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtp85 -94.4 117.83 30.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.775 -176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -106.4 138.12 43.15 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.864 0.866 . . . . 0.0 109.456 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.28 156.2 48.01 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 109.56 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.458 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.55 -131.24 0.69 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.77 1.228 . . . . 0.0 111.64 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 14' ' ' VAL . 53.2 m -58.38 -46.89 85.46 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 123.346 0.658 . . . . 0.0 111.215 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -58.6 -26.38 63.62 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.042 0.537 . . . . 0.0 111.548 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -70.89 -50.47 34.65 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.096 0.558 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -74.26 -25.62 59.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.375 0.422 . . . . 0.0 111.932 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.552 HG11 ' HG ' ' A' ' 44' ' ' LEU . 48.1 t -59.29 -54.99 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.672 0.789 . . . . 0.0 110.036 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.49 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 94.4 t -72.59 -24.59 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.204 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.06 10.91 62.74 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.017 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -141.32 136.04 31.14 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.49 -22.06 21.55 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.035 0.534 . . . . 0.0 112.253 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 15.0 m -155.59 134.31 11.91 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 17.4 pt -131.27 176.66 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.209 1.004 . . . . 0.0 109.143 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -125.07 112.84 16.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.71 157.44 15.9 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 0.0 109.436 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -117.94 105.54 12.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.81 172.36 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 16.9 t70 -70.68 157.58 37.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -63.81 -27.74 69.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.06 0.544 . . . . 0.0 111.495 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -81.24 -23.82 37.77 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.032 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 129.6 40.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 110.586 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -110.81 -179.36 3.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.152 0.581 . . . . 0.0 110.774 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 39.6 t -51.52 -35.78 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.299 1.04 . . . . 0.0 111.981 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -65.81 -41.95 95.37 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 123.865 0.728 . . . . 0.0 114.011 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.81 -37.22 84.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.221 0.608 . . . . 0.0 110.765 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.13 -59.58 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.73 0.812 . . . . 0.0 110.543 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 54' ' ' VAL . 2.5 pp -65.86 -30.46 71.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 117.776 0.262 . . . . 0.0 111.501 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.515 ' HA ' HD11 ' A' ' 49' ' ' ILE . 10.4 tpt180 -54.55 -48.13 72.38 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.147 0.499 . . . . 0.0 110.713 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -75.48 -32.46 60.58 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.865 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -57.28 -39.35 75.51 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.54 0.736 . . . . 0.0 112.683 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 1.4 pp20? -73.53 -29.51 62.5 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 120.664 0.269 . . . . 0.0 111.63 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.18 -22.39 66.92 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.096 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -92.64 -57.71 2.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.777 0.799 . . . . 0.0 109.789 174.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 98.6 m-85 -99.83 116.8 32.74 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.954 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.33 -34.29 77.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.061 0.944 . . . . 0.0 111.052 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.01 -8.66 64.98 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.719 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.669 ' HB3' HD13 ' A' ' 48' ' ' LEU . 57.8 mt -105.54 -9.62 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.851 0.861 . . . . 0.0 111.507 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.87 121.27 10.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.105 0.562 . . . . 0.0 111.953 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.1 -33.85 3.93 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -86.17 2.68 45.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.669 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.34 -5.82 8.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.054 0.941 . . . . 0.0 111.043 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 35' ' ' ARG . 35.0 mt -132.31 128.78 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.499 1.119 . . . . 0.0 108.823 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -129.83 113.04 14.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.063 0.545 . . . . 0.0 109.724 168.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 58.56 30.7 20.16 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.893 0.877 . . . . 0.0 112.215 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.33 75.01 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.208 -0.774 . . . . 0.0 114.373 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.6 -174.57 2.68 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.085 0.943 . . . . 0.0 109.466 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.556 HG12 HD21 ' A' ' 34' ' ' LEU . 17.5 m -67.47 -56.94 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-O 117.764 -1.112 . . . . 0.0 112.098 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 13.4 tppt? 151.1 139.2 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 C-N-CA 124.956 1.302 . . . . 0.0 108.923 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 25.5 Cg_endo -59.89 134.08 54.7 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.112 2.542 . . . . 0.0 111.752 167.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 73.48 -14.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.98 1.312 . . . . 0.0 114.441 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.4 p -67.2 136.39 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 15.9 m120 -107.67 103.46 12.76 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.431 HG23 HG23 ' A' ' 67' ' ' VAL . 3.5 m -120.72 142.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.795 0.838 . . . . 0.0 109.288 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.0 mp -129.19 172.15 11.73 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.403 1.481 . . . . 0.0 109.979 -165.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 67' ' ' VAL . 18.4 tptp -165.14 106.13 0.79 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 56.3 35.31 25.6 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-O 122.065 0.936 . . . . 0.0 109.711 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.04 -13.4 57.08 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.639 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -90.73 117.76 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.9 tt0 -72.4 103.65 3.52 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.206 0.602 . . . . 0.0 110.25 -174.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 62' ' ' LYS . 13.0 m -67.66 -0.7 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 58' ' ' VAL . 5.3 m -67.39 -27.28 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 118.073 0.397 . . . . 0.0 110.526 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -82.05 -16.4 50.26 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.953 0.901 . . . . 0.0 111.118 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.5 -150.34 0.4 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.343 1.057 . . . . 0.0 109.354 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.31 108.37 3.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.442 0.697 . . . . 0.0 111.098 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.25 -42.57 18.59 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.653 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.632 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.8 mmt -78.24 -38.55 42.65 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.36 0.664 . . . . 0.0 112.412 -174.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.22 79.46 1.54 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.553 0.692 . . . . 0.0 111.535 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 t -81.72 -75.43 0.29 Allowed 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.707 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -177.45 34.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -164.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 77' ' ' LEU . 9.5 mt -72.65 118.31 15.41 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.238 0.926 . . . . 0.0 111.83 -166.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 42.6 m-20 -119.71 173.91 6.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.157 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.3 146.91 52.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.134 0.573 . . . . 0.0 112.277 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 14.86 67.17 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.164 -0.926 . . . . 0.0 114.19 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 2.2 t70 -72.89 179.67 3.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.316 0.558 . . . . 0.0 110.307 -177.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.56 100.08 3.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.047 0.539 . . . . 0.0 110.834 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.2 t -87.77 106.9 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.1 m -91.72 141.88 28.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.57 143.15 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 121.683 0.754 . . . . 0.0 110.189 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.603 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 12.8 m-85 -134.92 135.32 22.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 30.4 Cg_endo -61.49 161.92 22.53 Favored 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 123.361 2.708 . . . . 0.0 112.783 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.08 130.3 26.93 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.052 1.835 . . . . 0.0 112.525 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.09 143.79 10.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.607 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.54 91.05 2.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.817 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.27 29.24 7.26 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.417 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.916 0 CA-C-O 118.512 -1.16 . . . . 0.0 111.707 178.741 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 173.4 46.29 0.05 OUTLIER Glycine 0 C--N 1.347 1.163 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -170.34 146.63 9.99 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 120.088 -0.285 . . . . 0.0 112.498 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -87.29 -86.41 0.16 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 70.26 2.05 3.83 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 152.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 57.74 -81.43 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 160.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . 0.448 ' HE2' ' HA3' ' A' ' -1' ' ' GLY . 10.6 pttp -61.61 -32.0 72.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.241 1.416 . . . . 0.0 114.313 -166.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -159.27 176.26 12.4 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -169.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -79.61 -51.4 9.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.731 1.212 . . . . 0.0 110.728 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -98.17 154.13 17.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.895 0.878 . . . . 0.0 110.32 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 20.7 t70 60.61 100.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.356 1.462 . . . . 0.0 111.265 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -65.06 -45.87 83.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.55 1.14 . . . . 0.0 113.159 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' -7' ' ' LYS . . . 52.52 32.49 38.7 Favored Glycine 0 C--N 1.354 1.545 0 O-C-N 123.397 0.436 . . . . 0.0 113.215 -170.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 38.0 p -124.9 166.01 17.04 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.183 0.993 . . . . 0.0 110.406 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -141.21 128.87 21.51 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.357 1.063 . . . . 0.0 109.351 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.21 135.72 35.21 Favored 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 123.512 0.725 . . . . 0.0 109.065 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.36 132.62 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.215 0.606 . . . . 0.0 110.105 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 66.0 tt0 -88.82 95.9 10.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.499 HD13 HD21 ' A' ' 37' ' ' LEU . 46.1 mt -92.9 103.79 16.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 95.6 mtt180 -91.3 117.96 30.09 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.642 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.55 141.86 37.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -133.75 159.76 39.62 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.245 0.618 . . . . 0.0 109.563 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.3 -130.69 1.32 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.436 1.094 . . . . 0.0 112.1 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.404 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 81.3 m -55.68 -49.19 73.61 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 123.914 0.885 . . . . 0.0 111.188 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HE1' ' HD3' ' A' ' 47' ' ' ARG . 12.8 m-30 -59.78 -27.58 66.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.803 0.441 . . . . 0.0 111.283 -177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -52.6 27.07 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.605 0.362 . . . . 0.0 111.006 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.13 -21.07 60.79 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.436 0.46 . . . . 0.0 111.652 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.557 HG11 ' HG ' ' A' ' 44' ' ' LEU . 46.1 t -62.76 -53.89 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.444 0.698 . . . . 0.0 110.47 169.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' CE1' ' A' ' 41' ' ' TYR . 93.1 t -73.76 -21.68 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.572 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.95 11.19 62.9 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.699 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -142.54 142.56 32.24 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -95.68 -8.12 35.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.465 0.306 . . . . 0.0 111.737 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 2.1 m -158.47 128.16 5.82 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.491 1.116 . . . . 0.0 108.495 170.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 5' ' ' LEU . 11.3 pt -119.03 171.03 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.599 0.76 . . . . 0.0 108.999 173.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.05 112.38 20.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.531 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -93.39 177.3 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.647 1.179 . . . . 0.0 109.77 171.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -156.79 105.35 2.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 171.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.93 172.9 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.46 1.104 . . . . 0.0 108.618 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.88 160.46 30.63 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.415 0.286 . . . . 0.0 110.402 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.7 -14.95 59.47 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -81.31 -16.05 53.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.82 152.22 43.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.568 0.747 . . . . 0.0 110.712 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 33' ' ' VAL . 38.1 p -136.17 -174.49 3.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.834 1.253 . . . . 0.0 108.727 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.1 t -50.51 -36.32 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 C-N-CA 124.185 0.994 . . . . 0.0 112.238 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.12 62.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.844 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.43 -30.13 69.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.421 0.688 . . . . 0.0 110.791 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 29' ' ' THR . 72.8 t -62.72 -60.42 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.357 175.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.6 pp -66.25 -30.09 70.46 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.565 0.346 . . . . 0.0 111.616 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.591 ' HA ' HD11 ' A' ' 49' ' ' ILE . 12.0 tpt180 -50.56 -49.86 55.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.549 0.74 . . . . 0.0 111.042 169.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 35.0 t -76.09 -32.59 59.3 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.05 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.7 mm? -56.77 -36.69 70.11 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.199 0.6 . . . . 0.0 112.597 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.3 pt-20 -73.6 -26.64 60.89 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.8 62.31 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.303 0.641 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.531 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 16.8 mm-40 -89.52 -58.08 2.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.587 0.755 . . . . 0.0 109.864 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 97.9 m-85 -102.14 122.2 43.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.32 -171.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.19 -29.12 67.03 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.599 0.759 . . . . 0.0 111.941 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.8 -4.38 85.33 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.644 0.59 . . . . 0.0 113.47 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.603 ' HB3' HD13 ' A' ' 48' ' ' LEU . 67.2 mt -106.3 -0.98 23.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.479 0.711 . . . . 0.0 111.335 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.89 120.89 14.34 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.68 -2.5 53.88 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 170.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.9 ptp180 -107.9 4.0 24.87 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.235 1.014 . . . . 0.0 111.122 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -126.57 -2.24 6.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.186 0.994 . . . . 0.0 110.56 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.591 HD11 ' HA ' ' A' ' 35' ' ' ARG . 27.7 mt -131.53 137.15 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.757 1.223 . . . . 0.0 108.552 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -148.64 114.78 5.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 58.87 31.17 21.02 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.981 1.312 . . . . 0.0 112.374 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.39 -10.12 62.39 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.536 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -94.33 -174.84 3.47 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.261 1.031 . . . . 0.0 109.017 166.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG12 HD21 ' A' ' 34' ' ' LEU . 27.4 m -64.94 -55.81 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.31 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 58' ' ' VAL . 13.7 tppt? 150.84 132.71 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 125.526 1.53 . . . . 0.0 108.492 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 32.8 Cg_endo -61.85 135.05 53.5 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 122.947 2.431 . . . . 0.0 111.507 165.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 82.95 -17.42 0.51 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.306 1.442 . . . . 0.0 113.578 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.477 HG23 ' HD3' ' A' ' 88' ' ' PRO . 2.0 p -73.16 139.39 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.5 m120 -106.12 103.71 13.25 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.83 131.11 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.162 0.585 . . . . 0.0 109.618 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.5 mp -123.01 143.24 50.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.476 1.11 . . . . 0.0 109.986 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 2.2 tptm -112.98 105.26 13.28 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.45 55.88 8.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.282 1.433 . . . . 0.0 111.994 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.54 -14.34 30.35 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.801 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -97.43 114.07 25.85 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 117.566 0.683 . . . . 0.0 109.212 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.2 tt0 -70.3 112.37 6.58 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 75' ' ' THR . 35.4 m -72.44 -1.27 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 113.397 -174.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 m -70.21 -13.36 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.818 0.447 . . . . 0.0 111.422 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -93.81 -18.78 21.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.635 0.774 . . . . 0.0 110.904 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -131.96 -152.9 0.52 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.117 0.967 . . . . 0.0 109.076 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 75' ' ' THR . 9.9 m-20 -58.09 112.84 1.66 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.068 0.547 . . . . 0.0 110.956 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.33 -46.77 8.72 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 176.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 76.0 mmm -80.32 -38.92 29.68 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.829 0.852 . . . . 0.0 112.32 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.85 74.31 1.46 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.475 0.655 . . . . 0.0 111.48 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.7 t -81.31 -69.94 0.57 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.498 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' H ' HG23 ' A' ' 75' ' ' THR . . . -177.05 33.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.846 0.858 . . . . 0.0 110.485 -164.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.1 tp -75.66 138.61 41.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.709 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -151.04 -176.13 5.42 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.743 1.217 . . . . 0.0 107.978 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.88 144.43 50.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 118.432 0.56 . . . . 0.0 111.203 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.75 5.17 63.68 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.912 0.768 . . . . 0.0 114.566 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.602 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.9 m-20 -84.35 135.66 34.21 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 117.241 0.521 . . . . 0.0 112.117 -171.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -92.64 124.6 36.78 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.827 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.7 t -108.1 106.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.5 m -94.34 106.0 17.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.157 0.583 . . . . 0.0 110.186 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 m -106.58 145.46 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.005 0.907 . . . . 0.0 111.039 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 8.2 m-85 -131.23 139.69 36.24 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 175.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 46.4 Cg_endo -65.91 168.49 15.26 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.485 2.79 . . . . 0.0 112.631 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HG23 ' A' ' 58' ' ' VAL . 74.3 Cg_endo -70.93 129.99 17.21 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.077 1.185 . . . . 0.0 109.372 170.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.3 m -94.88 -10.29 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.095 0.558 . . . . 0.0 110.715 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.96 101.64 4.63 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.54 92.5 0.51 Allowed Glycine 0 C--N 1.346 1.092 0 O-C-N 123.67 0.606 . . . . 0.0 111.823 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.244 0 CA-C-O 118.633 -1.093 . . . . 0.0 112.003 -179.0 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.936 0 CA-C-O 120.112 -0.271 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 80.43 -67.03 3.57 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.305 0.479 . . . . 0.0 112.554 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 98.39 -51.82 1.23 Allowed Glycine 0 C--N 1.346 1.114 0 C-N-CA 123.208 0.432 . . . . 0.0 112.312 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . 0.526 HH21 HG12 ' A' ' 24' ' ' VAL . 32.0 mtp85 -110.79 54.52 0.67 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.716 0.806 . . . . 0.0 109.75 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.93 -32.68 15.18 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.181 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 65.2 -76.58 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.654 1.181 . . . . 0.0 110.918 -172.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' -3' ' ' ASP . 27.0 mtpp 58.96 69.46 0.72 Allowed 'General case' 0 C--N 1.353 0.74 0 C-N-CA 124.457 1.103 . . . . 0.0 110.099 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.52 -68.13 0.34 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.145 -166.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.81 -52.09 6.67 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -162.08 -53.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.868 0.867 . . . . 0.0 109.328 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' -7' ' ' LYS . 13.9 t70 -66.41 144.87 56.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.389 0.676 . . . . 0.0 110.629 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.83 -49.66 72.67 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.459 1.104 . . . . 0.0 112.512 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 56.88 53.59 43.11 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 116.417 -0.356 . . . . 0.0 112.709 -172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 31.1 p -134.69 142.45 46.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.24 0.543 . . . . 0.0 111.786 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptm -102.94 118.76 37.53 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.476 1.51 . . . . 0.0 110.54 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -86.53 126.49 34.49 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.494 HD13 HD21 ' A' ' 77' ' ' LEU . 27.1 mt -128.46 130.19 47.2 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.288 0.635 . . . . 0.0 110.149 -167.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -88.75 97.74 11.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.435 HD13 HD21 ' A' ' 37' ' ' LEU . 24.3 mt -93.49 103.52 15.71 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 90.0 mtt180 -92.26 117.69 30.14 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.061 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.07 140.1 38.76 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.811 0.844 . . . . 0.0 109.633 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -131.94 158.4 41.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.054 0.542 . . . . 0.0 110.054 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.21 -127.44 1.27 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.069 1.347 . . . . 0.0 111.93 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.36 -47.02 87.87 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.662 0.785 . . . . 0.0 111.204 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -58.06 -29.57 65.51 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.096 0.558 . . . . 0.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.62 -54.32 20.68 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.002 0.521 . . . . 0.0 110.937 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 -20.05 60.43 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 123.62 0.575 . . . . 0.0 111.858 -174.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.48 HG11 ' HG ' ' A' ' 44' ' ' LEU . 41.6 t -60.69 -54.36 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.37 0.668 . . . . 0.0 110.142 168.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.416 HG12 ' HG3' ' A' ' 17' ' ' GLN . 60.4 t -73.26 -21.22 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.367 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.7 11.29 65.53 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.359 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.416 ' HG3' HG12 ' A' ' 15' ' ' VAL . 15.0 mt-30 -140.23 143.46 36.02 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.993 0.917 . . . . 0.0 109.051 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -92.93 -15.09 26.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.492 0.717 . . . . 0.0 111.694 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -156.58 138.06 13.98 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.2 pt -130.99 174.51 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.015 0.926 . . . . 0.0 108.545 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.54 111.92 17.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 163.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.426 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -89.62 176.85 6.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 108.743 169.256 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -155.8 111.74 3.07 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.809 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.526 HG12 HH21 ' A' ' -10' ' ' ARG . 17.0 m -113.62 177.68 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.412 1.085 . . . . 0.0 108.169 174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -59.85 148.95 32.86 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.376 0.535 . . . . 0.0 110.533 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.09 -10.22 59.38 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.77 -20.25 43.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.682 0.793 . . . . 0.0 110.952 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 160.98 23.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.122 0.969 . . . . 0.0 112.377 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -138.39 -176.32 4.42 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.766 1.226 . . . . 0.0 109.437 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.3 t -51.33 -35.84 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.205 1.002 . . . . 0.0 111.471 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.74 -43.54 59.21 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.772 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -64.72 -31.37 72.57 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.447 0.699 . . . . 0.0 110.985 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.22 -60.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.86 0.864 . . . . 0.0 110.63 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.4 pp -65.62 -30.03 70.69 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.469 0.481 . . . . 0.0 111.173 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.727 ' HA ' HD11 ' A' ' 49' ' ' ILE . 21.9 tpt180 -53.1 -50.51 64.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.681 0.753 . . . . 0.0 111.695 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.8 m -75.27 -31.92 60.88 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.593 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.435 HD21 HD13 ' A' ' 5' ' ' LEU . 2.5 mm? -56.14 -46.9 79.07 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.323 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.503 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.1 pt-20 -67.78 -26.87 66.31 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.757 0.253 . . . . 0.0 111.486 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.98 -23.93 67.36 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.455 0.472 . . . . 0.0 111.465 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -101.03 -59.55 1.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.158 0.504 . . . . 0.0 110.503 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -86.01 120.72 27.71 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.314 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.56 -33.12 74.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.992 0.917 . . . . 0.0 110.798 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.09 2.85 83.02 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.578 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 48' ' ' LEU . 71.5 mt -115.02 6.15 15.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.352 0.661 . . . . 0.0 110.725 171.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -72.26 121.45 19.42 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -173.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.58 68.06 Favored Glycine 0 C--N 1.357 1.742 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.524 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 13.5 ptp180 -119.59 -4.78 10.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.031 0.932 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -119.25 -3.84 10.52 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.189 1.395 . . . . 0.0 109.886 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.727 HD11 ' HA ' ' A' ' 35' ' ' ARG . 75.5 mt -132.41 140.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.931 1.293 . . . . 0.0 108.156 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.67 126.96 5.25 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 61.55 30.85 18.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.761 1.224 . . . . 0.0 111.543 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.03 -4.98 56.15 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.666 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -106.59 -174.27 2.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.497 0.719 . . . . 0.0 109.455 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG12 HD21 ' A' ' 34' ' ' LEU . 19.1 m -59.37 -55.67 22.17 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 CA-C-O 117.689 -1.148 . . . . 0.0 112.483 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 12.5 tppt? 150.59 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 125.173 1.389 . . . . 0.0 108.057 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 11.4 Cg_endo -52.6 124.71 15.86 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.969 2.446 . . . . 0.0 111.947 168.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 74.74 2.59 4.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.639 1.176 . . . . 0.0 113.821 170.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 p -77.63 132.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 19.5 m120 -98.35 103.89 15.88 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.83 141.44 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.574 0.749 . . . . 0.0 109.692 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -131.17 140.62 49.96 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.173 1.389 . . . . 0.0 109.556 -166.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.601 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 16.0 tptm -105.46 105.63 15.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 166.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.7 t30 57.12 36.35 27.47 Favored 'General case' 0 CA--C 1.562 1.418 0 O-C-N 124.168 0.918 . . . . 0.0 111.366 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.3 -10.46 74.83 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -94.26 109.96 21.74 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.0 tt0 -68.62 106.25 2.54 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.032 0.533 . . . . 0.0 110.754 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.534 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 16.1 m -69.2 -1.23 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -174.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 m -68.06 -21.74 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-N 117.773 0.261 . . . . 0.0 111.237 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -87.55 -19.4 27.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.339 0.655 . . . . 0.0 110.656 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.0 -153.09 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.382 1.073 . . . . 0.0 109.718 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.73 108.4 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.579 0.752 . . . . 0.0 110.582 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -71.89 -49.63 22.03 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.589 -0.278 . . . . 0.0 113.122 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.5 -39.68 37.46 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.68 75.6 1.48 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.348 0.594 . . . . 0.0 110.903 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 t -76.65 -60.79 2.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.239 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.18 33.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.569 1.148 . . . . 0.0 109.657 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 3' ' ' LEU . 42.5 tp -74.98 114.84 13.92 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -120.1 -176.7 3.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.676 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -66.5 144.14 56.65 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.364 0.666 . . . . 0.0 111.101 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.92 8.97 85.22 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.946 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.601 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 70.4 m-20 -97.75 144.56 27.25 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.786 0.834 . . . . 0.0 111.599 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.28 141.96 27.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.67 0.788 . . . . 0.0 111.116 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.08 107.39 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.232 1.013 . . . . 0.0 108.311 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.686 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 49.4 m -90.6 139.05 31.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.691 0.796 . . . . 0.0 109.268 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.16 142.43 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.124 0.874 . . . . 0.0 110.624 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 20.5 m-85 -129.79 135.99 28.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.41 164.02 19.05 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.329 2.686 . . . . 0.0 112.16 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.17 130.51 17.72 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.364 1.376 . . . . 0.0 110.287 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.35 -17.47 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.22 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 63.08 30.03 16.2 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.841 1.257 . . . . 0.0 112.945 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.85 50.87 4.47 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 122.957 0.313 . . . . 0.0 112.955 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.326 0 CA-C-O 118.924 -0.931 . . . . 0.0 111.86 -178.767 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' -4' ' ' ASP . . . . . . . . 0 N--CA 1.478 1.46 0 CA-C-O 119.557 -0.58 . . . . 0.0 111.745 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -179.34 -35.6 0.06 OUTLIER Glycine 0 C--N 1.347 1.188 0 CA-C-N 117.175 0.488 . . . . 0.0 112.653 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 134.78 129.12 2.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 15.9 mtm-85 69.38 36.45 2.28 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.394 1.077 . . . . 0.0 110.166 -171.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.74 -24.64 33.45 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.948 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 65.9 10.81 7.2 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 125.518 1.527 . . . . 0.0 112.128 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -151.5 178.11 9.64 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.025 0.93 . . . . 0.0 110.624 -163.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.65 -38.72 92.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.231 1.012 . . . . 0.0 111.392 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -158.25 -155.85 0.52 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.261 -174.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . 0.432 ' O ' ' HA2' ' A' ' -13' ' ' GLY . 17.5 m-20 70.69 168.9 0.31 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.357 1.463 . . . . 0.0 111.346 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -62.19 -44.42 96.63 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -176.91 -54.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.437 1.495 . . . . 0.0 108.76 166.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 61.76 39.96 98.15 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.775 0.672 . . . . 0.0 112.058 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 43.5 p -122.72 148.62 45.1 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.041 0.936 . . . . 0.0 109.007 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -122.71 146.03 47.86 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.506 0.722 . . . . 0.0 109.944 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.57 135.2 33.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.512 HD13 HD21 ' A' ' 77' ' ' LEU . 20.6 mt -134.12 133.54 41.2 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.32 0.648 . . . . 0.0 109.399 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -88.89 107.79 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 37' ' ' LEU . 24.6 mt -94.79 104.03 15.93 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 92.4 mtt180 -92.05 118.13 30.5 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.825 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.7 139.6 40.03 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.807 0.843 . . . . 0.0 109.283 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.43 154.95 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.195 0.598 . . . . 0.0 109.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.85 -128.9 0.72 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.813 1.245 . . . . 0.0 112.074 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.44 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 35.3 m -62.39 -41.5 98.69 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 123.731 0.813 . . . . 0.0 111.381 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -63.33 -25.18 68.18 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.225 0.61 . . . . 0.0 111.383 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -71.55 -53.18 14.63 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.411 0.684 . . . . 0.0 111.189 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 8.9 pt-20 -71.18 -23.37 62.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.013 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG11 ' HG ' ' A' ' 44' ' ' LEU . 19.8 t -60.87 -48.59 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.555 0.693 . . . . 0.0 111.043 170.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.74 -21.97 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.323 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.48 12.48 77.22 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.567 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -143.36 143.82 31.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.774 1.229 . . . . 0.0 109.016 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -94.62 -18.47 21.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.622 0.369 . . . . 0.0 111.732 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -154.86 127.96 8.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.899 0.88 . . . . 0.0 108.663 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.17 170.02 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.955 0.902 . . . . 0.0 109.086 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.82 112.35 20.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -96.93 179.67 4.87 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 108.848 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -157.06 106.17 2.19 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.15 179.97 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.427 1.091 . . . . 0.0 108.391 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.71 150.14 24.31 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.489 0.715 . . . . 0.0 111.511 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.91 -20.82 62.45 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.149 0.579 . . . . 0.0 111.741 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.89 -23.82 20.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.238 0.615 . . . . 0.0 110.724 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.29 128.06 35.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.465 0.306 . . . . 0.0 110.286 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.2 p -107.25 -174.68 2.59 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.496 0.719 . . . . 0.0 111.175 -172.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 78.9 t -51.85 -38.24 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.164 0.985 . . . . 0.0 112.25 -173.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -64.44 -42.39 97.62 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 123.728 0.643 . . . . 0.0 113.27 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -69.24 -30.42 68.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.57 0.748 . . . . 0.0 110.956 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.0 t -64.88 -60.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.476 0.71 . . . . 0.0 110.452 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.498 HD21 HG12 ' A' ' 54' ' ' VAL . 1.9 pp -63.94 -30.3 71.39 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.183 0.447 . . . . 0.0 111.337 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.568 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.8 tpt85 -53.71 -47.02 70.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.046 0.538 . . . . 0.0 110.831 169.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 m -74.84 -32.94 62.06 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.22 0.608 . . . . 0.0 111.78 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 5' ' ' LEU . 3.9 mm? -58.18 -35.36 71.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -78.57 -25.91 45.46 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.173 0.442 . . . . 0.0 111.394 176.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -16.07 62.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.652 0.781 . . . . 0.0 111.513 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -100.87 -59.36 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.404 0.681 . . . . 0.0 110.181 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.07 119.47 34.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.676 -169.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.09 -30.29 70.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.858 0.463 . . . . 0.0 110.599 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -72.22 -12.28 76.03 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.597 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 48' ' ' LEU . 97.7 mt -109.84 -0.43 18.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 111.026 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -62.02 121.08 12.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.444 0.698 . . . . 0.0 112.433 -172.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.12 -22.87 3.43 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -91.18 10.69 26.01 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.393 1.077 . . . . 0.0 111.856 -173.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -130.0 -5.98 4.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.34 1.056 . . . . 0.0 110.9 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 35' ' ' ARG . 67.4 mt -131.78 130.6 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.676 1.19 . . . . 0.0 108.195 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.37 126.13 22.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.951 0.5 . . . . 0.0 110.0 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.1 t70 54.81 31.33 15.39 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.552 1.141 . . . . 0.0 112.315 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.41 -13.74 53.94 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.692 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -99.35 -176.96 3.45 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.815 0.846 . . . . 0.0 109.008 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG12 HD21 ' A' ' 34' ' ' LEU . 16.6 m -64.47 -56.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.836 -1.078 . . . . 0.0 112.333 -173.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? 155.17 133.14 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 124.705 1.202 . . . . 0.0 109.287 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.79 134.48 47.13 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.519 2.812 . . . . 0.0 111.383 168.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 77.85 -15.11 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.778 1.631 . . . . 0.0 113.52 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.13 145.37 13.0 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -114.24 103.88 11.54 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.05 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.071 0.948 . . . . 0.0 108.663 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.706 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -117.15 151.51 36.7 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 20.8 tptp -124.24 104.37 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.392 1.477 . . . . 0.0 107.203 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 50.75 38.63 20.0 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.648 1.179 . . . . 0.0 111.15 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.1 80.82 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.374 -0.83 . . . . 0.0 115.107 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -103.61 110.15 22.1 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 118.021 0.911 . . . . 0.0 109.424 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.4 tt0 -66.55 112.28 4.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.497 0.719 . . . . 0.0 110.885 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.579 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 31.0 m -68.01 -0.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -174.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 m -70.41 -18.18 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 118.182 0.446 . . . . 0.0 110.669 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -92.73 -10.52 36.77 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.141 0.976 . . . . 0.0 111.396 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.66 -155.67 0.62 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.019 0.928 . . . . 0.0 109.081 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -66.92 111.01 3.56 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.008 0.523 . . . . 0.0 111.492 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.579 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -73.21 -50.32 12.89 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.223 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.522 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.5 mmt -71.15 -36.56 72.09 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.576 0.75 . . . . 0.0 112.79 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.39 81.67 1.41 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.749 0.785 . . . . 0.0 111.525 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -79.67 -79.37 0.14 Allowed 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.961 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 75' ' ' THR . . . -169.96 33.11 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.132 0.573 . . . . 0.0 110.035 -168.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 18.0 tp -74.72 123.25 24.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.928 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.69 168.08 17.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.98 -170.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.92 135.16 55.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.124 0.57 . . . . 0.0 111.29 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.26 18.97 73.04 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.54 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.12 169.98 12.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.736 0.414 . . . . 0.0 110.092 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.48 98.45 4.52 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.415 0.686 . . . . 0.0 110.519 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -86.36 107.88 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.706 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 53.6 m -87.04 152.23 22.56 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.91 0.484 . . . . 0.0 109.934 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.0 m -144.56 146.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-O 121.635 0.731 . . . . 0.0 109.939 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.567 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 11.3 m-85 -136.81 140.34 31.56 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HG3' ' H ' ' A' ' 10' ' ' THR . 37.6 Cg_endo -63.19 169.08 9.84 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.796 2.998 . . . . 0.0 112.501 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.53 129.72 27.52 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 121.159 1.239 . . . . 0.0 110.627 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.4 m -101.84 -3.76 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.384 0.674 . . . . 0.0 111.218 -170.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.46 158.57 44.29 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.712 0.805 . . . . 0.0 110.082 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.88 158.65 35.27 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.392 0 CA-C-O 119.126 -0.819 . . . . 0.0 112.198 179.57 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.066 0 N-CA-C 112.792 -0.123 . . . . 0.0 112.792 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -166.51 84.49 0.1 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -103.06 -146.38 17.06 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 61.09 77.15 0.34 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.595 1.158 . . . . 0.0 112.091 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' -2' ' ' LYS . 29.2 m-20 -89.85 77.03 7.06 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.929 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . 0.462 ' HA ' HG21 ' A' ' 0' ' ' THR . 4.2 m-30 -87.43 41.63 0.99 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.127 0.571 . . . . 0.0 110.484 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.03 -171.67 3.93 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.777 1.231 . . . . 0.0 110.904 -174.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -83.47 128.44 34.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.176 0.99 . . . . 0.0 111.55 -174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . 0.576 ' N ' ' HZ3' ' A' ' -2' ' ' LYS . 5.2 m-20 -156.49 -170.55 3.38 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.614 1.566 . . . . 0.0 107.906 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.4 -43.78 59.83 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 163.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -140.82 153.73 45.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.816 0.846 . . . . 0.0 109.665 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.589 ' HB3' ' HZ2' ' A' ' -2' ' ' LYS . 0.0 OUTLIER -153.22 -42.31 0.1 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.189 0.996 . . . . 0.0 111.217 -172.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 92.61 1.35 68.51 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.185 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 69.7 p -89.02 142.35 27.71 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.754 0.777 . . . . 0.0 111.092 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 26.9 ptt? -102.84 129.62 49.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 110.583 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.05 136.52 33.21 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.421 HD13 HD21 ' A' ' 77' ' ' LEU . 21.5 mt -131.82 134.3 45.63 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -173.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 100.32 13.1 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.78 104.16 16.25 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 52.9 mtp180 -91.0 116.83 29.09 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.757 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 96.0 m-85 -103.79 138.81 39.88 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 109.241 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -130.77 157.88 41.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.645 0.778 . . . . 0.0 109.072 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.46 -132.72 0.8 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.443 1.097 . . . . 0.0 112.563 176.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 14' ' ' VAL . 25.6 m -58.09 -42.3 85.34 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 124.16 0.984 . . . . 0.0 111.876 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 11.3 m-30 -62.66 -34.37 76.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.83 0.452 . . . . 0.0 111.224 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -38.38 88.02 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.536 0.523 . . . . 0.0 110.089 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.35 -43.96 84.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.986 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG11 ' HG ' ' A' ' 44' ' ' LEU . 69.4 t -57.22 -51.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.703 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.69 -26.6 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.453 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 11.4 71.25 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.144 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -138.46 145.72 41.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -86.91 -25.01 24.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.05 0.54 . . . . 0.0 112.038 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -156.39 123.13 5.17 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.184 0.993 . . . . 0.0 108.372 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.83 173.39 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.664 0.786 . . . . 0.0 109.353 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.57 112.09 18.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -95.4 177.15 5.93 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.599 1.16 . . . . 0.0 108.689 171.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -157.11 106.79 2.22 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.153 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.24 168.88 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 26.4 t70 -71.75 155.22 40.7 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.93 -14.63 61.91 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.59 0.756 . . . . 0.0 112.708 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -80.14 -16.91 53.9 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.122 0.569 . . . . 0.0 109.909 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.6 163.88 27.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.778 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.1 p -133.48 -175.39 3.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.563 1.145 . . . . 0.0 109.126 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.38 -37.93 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.051 0.94 . . . . 0.0 111.176 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.562 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.83 -42.48 69.92 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.567 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.45 -36.38 78.1 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.3 0.64 . . . . 0.0 111.033 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.5 t -62.76 -60.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.511 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.471 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.9 -30.45 71.44 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.466 0.306 . . . . 0.0 111.233 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.47 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.6 tpt180 -54.71 -49.21 71.26 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.187 0.595 . . . . 0.0 111.603 170.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 m -75.85 -31.27 59.24 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.736 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.03 -46.84 75.31 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.543 0.737 . . . . 0.0 112.373 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.6 pt-20 -65.5 -26.4 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.05 -22.25 62.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.113 0.565 . . . . 0.0 111.211 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -100.36 -59.43 1.71 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.682 0.753 . . . . 0.0 109.413 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -86.83 104.0 15.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.352 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.3 -17.55 63.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.384 0.674 . . . . 0.0 111.329 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -74.99 -12.65 83.21 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.304 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.635 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.6 mt -101.62 0.65 36.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.483 0.713 . . . . 0.0 110.918 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.38 121.35 14.65 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.54 70.42 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.229 -0.896 . . . . 0.0 115.213 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.55 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 2.3 ptp180 -117.91 -12.24 10.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.858 0.863 . . . . 0.0 111.13 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.635 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -107.41 -3.27 19.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.41 1.084 . . . . 0.0 110.477 172.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 35' ' ' ARG . 21.1 mt -134.47 136.5 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.911 1.284 . . . . 0.0 109.0 171.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.47 108.2 8.98 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 167.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 53.56 31.55 12.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.032 0.933 . . . . 0.0 112.903 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.6 2.25 67.68 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.52 -178.88 3.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 164.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.59 -55.54 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.152 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 14.2 tppt? 150.54 132.27 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.534 0 C-N-CA 125.443 1.497 . . . . 0.0 109.054 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.88 132.85 54.53 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 122.951 2.434 . . . . 0.0 111.679 167.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 78.93 -12.18 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.286 1.434 . . . . 0.0 113.94 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 55' ' ' LYS . 1.2 p -73.18 139.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.614 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.13 104.49 13.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 85' ' ' VAL . 2.9 m -119.16 119.1 59.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.487 0.715 . . . . 0.0 109.289 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -112.38 131.24 55.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.491 1.116 . . . . 0.0 110.615 -172.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 17.2 tptp -107.57 109.51 21.18 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.63 1.572 . . . . 0.0 108.116 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 56.38 35.42 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.763 0.792 . . . . 0.0 110.667 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.0 -0.07 87.49 Favored Glycine 0 CA--C 1.543 1.804 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.617 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -107.47 112.56 25.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.651 0.78 . . . . 0.0 109.913 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 10.4 tt0 -67.14 105.19 1.62 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.913 0.885 . . . . 0.0 110.98 -173.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 62' ' ' LYS . 17.1 m -69.33 -0.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 58' ' ' VAL . 17.4 m -67.72 -21.19 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 117.924 0.329 . . . . 0.0 111.152 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -84.73 -17.47 38.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.88 0.872 . . . . 0.0 111.204 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -138.15 -151.27 0.38 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.241 1.016 . . . . 0.0 109.769 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 75' ' ' THR . 1.4 m-20 -63.93 108.5 1.5 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.026 0.53 . . . . 0.0 111.167 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.25 -42.2 15.65 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.842 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.562 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.3 mmt -77.82 -39.88 42.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.399 0.679 . . . . 0.0 112.334 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.77 77.66 1.47 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.102 0.477 . . . . 0.0 111.461 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 71' ' ' ASP . 4.0 t -81.49 -67.91 0.74 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.003 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 75' ' ' THR . . . 179.84 33.77 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.346 0.658 . . . . 0.0 111.184 -164.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.486 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 31.0 tp -73.45 135.41 44.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.244 0.545 . . . . 0.0 110.692 -164.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.6 166.19 24.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.998 -165.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 34.4 t70 -65.52 143.6 57.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.382 0.673 . . . . 0.0 111.769 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 18.33 75.02 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.627 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.69 137.12 33.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 117.455 0.628 . . . . 0.0 111.249 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -96.39 94.99 7.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.766 0.426 . . . . 0.0 109.953 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 t -86.89 106.36 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.659 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 54.8 m -82.61 150.07 27.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.401 0.681 . . . . 0.0 110.035 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 60' ' ' VAL . 23.0 m -145.9 141.84 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.601 0.715 . . . . 0.0 109.686 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 10.9 m-85 -133.68 132.09 21.53 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 22.0 Cg_endo -59.41 165.66 8.94 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.647 2.898 . . . . 0.0 113.256 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.35 130.47 23.96 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 121.532 1.488 . . . . 0.0 110.676 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 m -127.55 128.33 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.027 0.931 . . . . 0.0 108.717 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.16 97.25 4.23 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.439 0.696 . . . . 0.0 109.169 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.06 31.32 0.5 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.201 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.04 0 CA-C-O 118.889 -0.951 . . . . 0.0 111.661 -176.561 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 113.72 64.93 0.44 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -137.04 -149.65 5.65 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -101.09 35.58 2.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.119 0.968 . . . . 0.0 110.271 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.45 126.38 31.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.515 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -105.73 12.55 30.84 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.746 0.819 . . . . 0.0 110.152 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -156.63 161.49 39.9 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.945 0.898 . . . . 0.0 110.068 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.1 -0.91 33.48 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.907 0.883 . . . . 0.0 112.754 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.47 157.21 17.53 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.5 0.72 . . . . 0.0 112.71 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.55 -57.66 11.73 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.861 1.264 . . . . 0.0 110.875 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -82.76 146.33 29.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.349 171.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -25.88 68.51 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.426 0.69 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 61.42 48.01 87.51 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 124.26 0.975 . . . . 0.0 113.277 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 46.5 p -123.64 142.2 51.28 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -123.87 141.81 51.69 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.304 0.642 . . . . 0.0 110.055 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -107.73 113.16 26.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.699 0.399 . . . . 0.0 110.265 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.439 HD13 HD21 ' A' ' 77' ' ' LEU . 18.1 mt -102.64 142.09 34.38 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.257 1.023 . . . . 0.0 110.825 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.34 97.06 10.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.39 103.49 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.6 mtp180 -96.07 116.39 28.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.698 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -103.68 137.27 41.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.83 0.852 . . . . 0.0 109.18 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -129.17 159.59 35.54 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.574 0.75 . . . . 0.0 109.102 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.44 -133.6 1.07 Allowed 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.12 0.968 . . . . 0.0 112.239 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 14' ' ' VAL . 31.3 m -59.89 -40.92 90.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.618 0.767 . . . . 0.0 112.235 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -63.22 -29.08 70.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.772 0.26 . . . . 0.0 111.02 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 54.4 ttp85 -66.77 -53.58 31.59 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.391 0.676 . . . . 0.0 111.552 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.76 -27.9 67.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.401 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.458 HG11 ' HG ' ' A' ' 44' ' ' LEU . 45.6 t -62.19 -53.07 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.593 0.757 . . . . 0.0 111.046 173.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.45 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.1 t -70.64 -24.16 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.294 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.51 11.06 71.87 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.587 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -142.53 135.74 28.61 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 21.0 ptmt -83.69 -24.36 31.3 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.539 0.336 . . . . 0.0 111.773 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.3 m -155.52 135.69 13.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.2 172.68 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.739 0.816 . . . . 0.0 109.846 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 3' ' ' LEU . 82.8 m-85 -123.18 113.4 18.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.403 0.621 . . . . 0.0 109.51 170.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.456 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -103.01 139.53 38.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.153 1.381 . . . . 0.0 109.51 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -107.95 106.63 16.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.25 -179.44 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.326 1.05 . . . . 0.0 109.116 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.22 154.75 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.127 0.571 . . . . 0.0 109.894 173.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.36 -37.69 86.64 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.076 0.95 . . . . 0.0 112.25 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.83 -13.04 59.3 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.42 0.688 . . . . 0.0 110.705 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 142.87 57.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.878 0.471 . . . . 0.0 109.903 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 p -118.83 -176.93 3.2 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.9 t -53.09 -35.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.125 0.97 . . . . 0.0 111.504 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.59 -43.78 59.64 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.36 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.0 -33.13 72.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.384 0.673 . . . . 0.0 110.804 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -66.26 -60.38 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.304 1.042 . . . . 0.0 110.946 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.567 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.9 pp -65.33 -30.11 70.92 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 123.239 0.337 . . . . 0.0 111.704 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.597 ' HA ' HD11 ' A' ' 49' ' ' ILE . 1.3 ppt_? -64.49 -36.55 84.55 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.077 0.465 . . . . 0.0 109.994 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.9 m -75.6 -33.67 60.58 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.622 0.769 . . . . 0.0 111.769 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.96 -37.86 88.77 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.064 0.546 . . . . 0.0 112.358 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -70.66 -28.55 64.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.832 0.348 . . . . 0.0 111.609 176.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.94 -24.49 62.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.158 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 12.8 mm-40 -88.13 -59.64 2.19 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.634 0.731 . . . . 0.0 109.726 174.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 97.1 m-85 -98.45 118.29 34.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.114 -170.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.78 -28.67 68.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.139 0.976 . . . . 0.0 110.654 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.496 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.7 -9.55 86.97 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 119.411 -0.661 . . . . 0.0 113.844 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.617 ' HB3' HD13 ' A' ' 48' ' ' LEU . 84.0 mt -95.9 -6.92 38.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.657 0.729 . . . . 0.0 111.127 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.22 124.61 22.62 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.6 0.76 . . . . 0.0 112.906 -171.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.96 8.51 86.81 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 115.135 0.814 . . . . 0.0 115.135 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.3 OUTLIER -125.1 -22.37 4.44 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 117.404 0.602 . . . . 0.0 111.973 -174.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -96.55 -0.23 49.11 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.774 0.43 . . . . 0.0 110.704 172.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 35' ' ' ARG . 57.4 mt -135.41 145.66 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.173 1.389 . . . . 0.0 108.634 171.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 15.4 tp10 -157.74 127.85 6.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.967 0.907 . . . . 0.0 108.96 168.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.6 t70 56.87 31.31 19.42 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.493 1.14 . . . . 0.0 111.373 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.88 -14.26 38.59 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 114.743 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -94.89 -174.06 3.16 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 117.83 0.815 . . . . 0.0 110.053 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG12 HD21 ' A' ' 34' ' ' LEU . 18.2 m -59.93 -54.71 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.772 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 50' ' ' GLU . 9.6 tppt? 150.44 137.0 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 C-N-CA 126.304 1.841 . . . . 0.0 108.112 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.76 125.6 19.18 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.777 2.318 . . . . 0.0 112.038 164.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 81.19 -9.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.403 1.481 . . . . 0.0 113.939 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 55' ' ' LYS . 5.2 p -69.52 129.21 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.609 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.3 m120 -94.92 103.27 15.14 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 m -121.55 131.14 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.489 HD13 ' CE1' ' A' ' 86' ' ' PHE . 6.7 mp -123.87 141.73 51.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.065 0.946 . . . . 0.0 110.645 -168.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HE3' HD12 ' A' ' 77' ' ' LEU . 15.0 tptm -111.84 105.14 13.52 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.177 1.391 . . . . 0.0 107.835 168.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.11 35.61 25.25 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.45 1.1 . . . . 0.0 111.402 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.65 -14.21 64.65 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 114.342 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -89.09 107.66 19.16 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.896 0.848 . . . . 0.0 109.595 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.6 tt0 -65.34 106.85 1.46 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.102 0.561 . . . . 0.0 110.024 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.401 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 23.7 m -69.73 -1.71 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.33 -22.68 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 118.501 0.591 . . . . 0.0 110.917 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 66' ' ' GLU . 60.0 m-70 -84.05 -12.12 55.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.548 0.739 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.58 -153.04 0.44 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.568 1.147 . . . . 0.0 109.318 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.16 108.46 0.9 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.675 0.39 . . . . 0.0 110.687 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.401 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -74.7 -47.9 14.03 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.371 0.42 . . . . 0.0 112.358 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 90.1 mmm -80.31 -36.78 33.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.307 0.643 . . . . 0.0 112.221 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.98 76.81 1.52 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.906 -0.496 . . . . 0.0 111.715 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.7 t -81.46 -69.33 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.994 0.518 . . . . 0.0 112.393 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 75' ' ' THR . . . -179.0 34.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.507 0.723 . . . . 0.0 111.064 -163.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.484 HD12 ' HE3' ' A' ' 62' ' ' LYS . 40.4 tp -74.25 141.45 45.37 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.22 0.608 . . . . 0.0 111.502 -169.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -154.78 175.92 13.12 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.947 0.899 . . . . 0.0 109.567 -170.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.16 143.59 43.18 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.199 0.909 . . . . 0.0 111.78 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.88 2.51 65.31 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.297 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.78 134.9 33.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.781 0.832 . . . . 0.0 110.09 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.38 106.14 17.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.109 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.16 107.23 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 68.2 m -96.44 106.38 18.61 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.499 0.72 . . . . 0.0 110.303 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.66 140.78 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.609 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 3.5 m-85 -129.6 134.97 26.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 42.3 Cg_endo -65.54 166.19 20.5 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.202 2.602 . . . . 0.0 112.634 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' HG23 ' A' ' 58' ' ' VAL . 73.8 Cg_endo -71.95 129.86 15.9 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.079 1.186 . . . . 0.0 109.199 170.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 m -86.65 -9.25 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 122.989 0.516 . . . . 0.0 111.696 -173.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.12 159.73 40.43 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.645 0.778 . . . . 0.0 110.716 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.4 -46.85 0.44 Allowed Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.264 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.944 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 177.027 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 123.37 -145.96 16.26 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 112.178 -0.369 . . . . 0.0 112.178 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -133.53 110.36 0.88 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 56.3 mtt-85 -122.68 113.21 18.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.946 0.898 . . . . 0.0 109.063 176.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 16.1 t0 -154.27 100.67 2.32 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -75.15 4.99 5.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.449 1.099 . . . . 0.0 113.32 -163.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 133.17 55.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.686 1.194 . . . . 0.0 108.487 169.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.65 100.86 3.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.871 0.468 . . . . 0.0 110.538 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -137.46 27.81 2.78 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 66.91 149.28 0.05 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.968 1.707 . . . . 0.0 112.285 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 62.94 35.75 13.13 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.274 1.029 . . . . 0.0 109.867 -166.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.601 ' HD3' ' H ' ' A' ' -2' ' ' LYS . 0.0 OUTLIER -85.4 -40.95 15.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.239 -176.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 58.15 35.02 75.44 Favored Glycine 0 C--N 1.352 1.424 0 O-C-N 123.756 0.66 . . . . 0.0 112.611 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 47.3 p -112.78 141.25 46.81 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.558 0.743 . . . . 0.0 109.741 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.465 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 24.9 ptt? -104.23 132.23 50.71 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.024 0.93 . . . . 0.0 110.673 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -87.15 135.19 33.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -128.61 136.59 50.89 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.309 0.643 . . . . 0.0 110.654 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -88.93 95.98 10.53 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.65 103.91 16.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.571 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 5.0 mtp180 -94.34 117.18 29.73 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -103.13 139.71 38.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.777 0.831 . . . . 0.0 109.29 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -133.89 158.86 42.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.379 0.672 . . . . 0.0 109.852 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.554 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 61.02 -130.75 0.78 Allowed 'General case' 0 CA--C 1.565 1.527 0 O-C-N 124.363 1.039 . . . . 0.0 111.37 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.424 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 97.7 m -60.57 -48.08 83.34 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.662 0.665 . . . . 0.0 111.647 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.87 -24.7 53.63 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.817 0.447 . . . . 0.0 111.623 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.414 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -70.43 -53.39 16.63 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.294 0.637 . . . . 0.0 111.027 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 -22.29 59.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.864 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.477 HG11 ' HG ' ' A' ' 44' ' ' LEU . 42.8 t -59.43 -52.82 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.244 0.618 . . . . 0.0 110.342 168.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 93.8 t -75.13 -22.31 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.51 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 73.38 11.48 79.83 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.52 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -142.92 146.6 34.17 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.143 0.977 . . . . 0.0 108.58 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -90.12 -19.99 23.65 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.852 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.4 m -155.18 131.99 10.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.03 0.932 . . . . 0.0 108.716 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 pt -123.58 175.38 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.025 0.93 . . . . 0.0 108.64 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.88 112.25 15.76 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 167.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 -178.53 4.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.221 1.409 . . . . 0.0 109.629 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -156.1 111.48 2.95 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.39 174.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.8 p-10 -71.51 158.79 35.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.268 0.94 . . . . 0.0 110.322 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.67 -19.86 61.35 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.388 0.675 . . . . 0.0 112.088 -172.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.85 -21.12 37.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.476 0.31 . . . . 0.0 110.175 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 162.09 28.15 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.413 0.685 . . . . 0.0 111.216 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -137.86 -174.07 3.68 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.855 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -50.6 -37.6 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 125.626 1.57 . . . . 0.0 112.107 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.635 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.87 -38.61 65.28 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.299 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -66.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.232 0.613 . . . . 0.0 110.548 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.8 -60.41 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.572 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.43 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.6 pp -64.87 -30.46 71.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.503 0.321 . . . . 0.0 110.982 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.598 ' HA ' HD11 ' A' ' 49' ' ' ILE . 26.0 tpt85 -52.91 -51.7 60.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.404 0.682 . . . . 0.0 111.507 171.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.1 m -75.99 -32.1 59.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.708 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.3 mm? -52.13 -48.57 64.77 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.723 0.809 . . . . 0.0 112.34 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 3.6 pt-20 -64.95 -26.31 68.25 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.0 -20.22 65.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.135 0.574 . . . . 0.0 111.104 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.35 -57.9 2.14 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.458 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.0 m-85 -91.82 108.55 20.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.84 -173.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.62 -22.0 65.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.353 0.661 . . . . 0.0 111.587 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.519 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -77.56 -8.68 87.14 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.028 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.67 ' HB3' HD13 ' A' ' 48' ' ' LEU . 88.9 mt -105.14 -6.89 19.46 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.699 0.799 . . . . 0.0 111.041 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.89 122.28 15.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.722 0.809 . . . . 0.0 113.142 -171.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.53 2.84 51.86 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 115.343 0.897 . . . . 0.0 115.343 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 2.3 ptp180 -113.85 -4.37 13.33 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.67 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -114.5 -2.71 13.11 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.794 . . . . 0.0 110.357 174.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 35' ' ' ARG . 46.8 mt -135.26 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.99 1.316 . . . . 0.0 109.201 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 19.8 mm-40 -143.69 123.84 13.71 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.119 0.968 . . . . 0.0 109.15 160.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.35 30.87 20.18 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 124.353 1.061 . . . . 0.0 112.109 168.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.86 3.12 88.22 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 114.989 0.756 . . . . 0.0 114.989 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -116.41 -175.44 2.75 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.019 0.928 . . . . 0.0 108.702 170.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 m -63.2 -55.75 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.876 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 9.6 tppt? 153.22 139.69 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.377 0 C-N-CA 125.091 1.356 . . . . 0.0 109.062 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 22.2 Cg_endo -60.8 128.38 25.44 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.825 2.35 . . . . 0.0 111.928 166.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 77.83 -1.69 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.337 1.455 . . . . 0.0 113.912 171.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 3.1 p -76.4 153.71 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 13.2 m120 -118.24 104.76 11.1 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.8 129.48 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.468 0.707 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.9 mp -121.66 140.18 52.62 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.803 1.241 . . . . 0.0 111.899 -166.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 63' ' ' ASN . 0.5 OUTLIER -119.34 107.56 13.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.824 1.249 . . . . 0.0 108.29 171.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.517 ' HB2' ' HZ3' ' A' ' 62' ' ' LYS . 65.0 t30 60.36 34.78 20.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.666 1.186 . . . . 0.0 110.328 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.87 -14.97 61.81 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.522 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HG3' HD21 ' A' ' 70' ' ' LEU . 19.8 tpp180 -94.27 111.66 23.4 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.42 0.61 . . . . 0.0 109.896 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.8 tt0 -67.89 108.36 2.99 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.851 0.86 . . . . 0.0 110.886 -173.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.05 -1.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.795 1.638 . . . . 0.0 114.552 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 m -71.16 -23.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.188 0.449 . . . . 0.0 110.582 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.434 ' CD2' ' HB3' ' A' ' 66' ' ' GLU . 74.9 m-70 -88.72 -15.97 33.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.732 0.813 . . . . 0.0 110.828 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -135.39 -140.7 0.17 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.699 1.199 . . . . 0.0 108.789 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.81 119.02 25.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.746 1.157 . . . . 0.0 110.806 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.29 -43.12 39.87 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.688 0.617 . . . . 0.0 112.817 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.635 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 9.4 mmt -81.46 -39.95 24.06 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.73 69.26 1.03 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.401 0.62 . . . . 0.0 111.774 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 t -74.49 -67.82 0.59 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.98 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -174.99 33.7 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 110.887 -165.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.11 139.29 42.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.188 0.195 . . . . 0.0 110.851 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 33.9 t70 -144.32 -176.06 4.88 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.729 0.811 . . . . 0.0 108.835 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 30.8 t70 -70.19 147.8 49.4 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.422 0.556 . . . . 0.0 111.852 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.86 66.53 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.386 -0.824 . . . . 0.0 113.301 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 3.6 t0 -94.76 127.65 40.9 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 122.568 0.347 . . . . 0.0 110.608 -168.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.17 115.85 23.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.151 0.58 . . . . 0.0 111.438 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.75 106.99 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.8 m -84.09 147.96 27.08 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -142.45 147.08 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.696 0.76 . . . . 0.0 109.792 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.8 m-85 -133.82 142.77 44.83 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 40.3 Cg_endo -64.82 168.5 13.39 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.222 2.615 . . . . 0.0 111.374 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 48.4 Cg_endo -63.96 128.85 22.89 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 120.645 0.897 . . . . 0.0 111.249 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.68 -17.79 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.177 0.991 . . . . 0.0 109.352 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.15 -7.05 56.56 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.87 0.868 . . . . 0.0 111.311 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 87.82 0.55 Allowed Glycine 0 C--N 1.353 1.473 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 CA-C-O 118.953 -0.915 . . . . 0.0 112.906 -176.769 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.024 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -153.82 24.39 0.72 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.094 -0.402 . . . . 0.0 112.094 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -80.18 144.24 25.79 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -84.93 78.95 9.8 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.373 0.606 . . . . 0.0 109.558 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -91.49 155.51 18.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.347 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -123.49 26.91 7.65 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.696 0.398 . . . . 0.0 111.811 -169.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . 0.536 ' HD3' ' O ' ' A' ' -2' ' ' LYS . 0.0 OUTLIER -161.95 121.5 2.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.27 0.628 . . . . 0.0 109.961 -178.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 57.16 -167.72 0.12 Allowed 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 124.737 1.215 . . . . 0.0 112.121 169.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -107.43 -30.96 8.36 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.773 0.829 . . . . 0.0 109.583 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.2 -60.59 2.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.132 0.973 . . . . 0.0 111.776 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -90.85 143.28 26.88 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.144 0.577 . . . . 0.0 111.9 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.536 ' O ' ' HD3' ' A' ' -7' ' ' LYS . 17.0 ptpt -90.3 -42.08 11.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.565 0.746 . . . . 0.0 110.712 176.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 44.9 30.16 2.3 Favored Glycine 0 C--N 1.36 1.905 0 O-C-N 124.43 1.081 . . . . 0.0 115.366 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 23' ' ' ARG . 2.6 p -114.92 150.95 34.89 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.87 0.868 . . . . 0.0 111.26 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.778 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -109.08 121.84 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.788 0.435 . . . . 0.0 110.135 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 mt -103.51 146.66 28.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.527 0.731 . . . . 0.0 111.153 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -88.72 95.45 10.27 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.1 103.94 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.677 -0.639 . . . . 0.0 109.47 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 13.1 mtp180 -95.18 117.05 29.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.739 -176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -106.4 135.69 47.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.451 1.101 . . . . 0.0 108.926 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.75 160.46 31.64 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.12 0.568 . . . . 0.0 109.844 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.44 -121.03 1.22 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.994 1.318 . . . . 0.0 112.198 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.6 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 87.9 m -70.37 -44.56 67.83 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.866 0.866 . . . . 0.0 111.329 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -58.8 -28.43 65.97 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.636 0.374 . . . . 0.0 110.962 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -65.85 -52.17 52.71 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.75 0.656 . . . . 0.0 111.185 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.91 -27.11 60.88 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.481 0.488 . . . . 0.0 111.739 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 44' ' ' LEU . 39.2 t -59.08 -51.87 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.474 0.709 . . . . 0.0 110.541 170.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 17' ' ' GLN . 96.7 t -74.66 -22.36 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.963 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 11.39 63.35 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.769 0.7 . . . . 0.0 112.891 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HB2' HG12 ' A' ' 15' ' ' VAL . 17.3 mt-30 -145.74 138.15 25.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.303 1.041 . . . . 0.0 108.312 -166.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -100.92 -29.22 12.33 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -168.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 m -154.9 113.62 3.57 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.485 HG21 ' NE2' ' A' ' 17' ' ' GLN . 26.7 pt -121.63 170.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.205 0.602 . . . . 0.0 110.806 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -111.47 125.21 53.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -121.89 123.18 41.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.122 0.969 . . . . 0.0 108.853 -176.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.49 ' HD2' ' HB ' ' A' ' 0' ' ' THR . 6.6 tpp85 -83.08 106.95 15.31 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.07 -179.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 0.0 109.526 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -81.23 159.7 24.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.394 0.677 . . . . 0.0 110.613 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.22 -26.03 68.33 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 110.522 168.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -80.24 -22.94 41.23 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.34 1.056 . . . . 0.0 110.553 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.24 43.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.294 0.637 . . . . 0.0 110.592 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 p -137.75 -174.64 3.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.118 0.967 . . . . 0.0 108.643 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 t -51.09 -35.96 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.996 0.918 . . . . 0.0 111.535 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA2' ' HE3' ' A' ' 73' ' ' MET . . . -67.6 -45.5 76.38 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.175 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.37 -35.37 78.94 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.951 0.9 . . . . 0.0 111.113 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.28 -60.79 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.16 0.984 . . . . 0.0 110.805 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.541 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 1.9 pp -67.39 -30.08 69.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.19 0.306 . . . . 0.0 111.404 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HA ' HD11 ' A' ' 49' ' ' ILE . 20.8 tpt180 -55.57 -49.74 71.93 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.376 0.608 . . . . 0.0 111.218 170.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -73.96 -32.48 63.49 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.148 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -57.28 -39.05 74.9 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.441 0.696 . . . . 0.0 112.42 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.1 pt-20 -75.67 -28.51 58.73 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 117.874 0.307 . . . . 0.0 111.691 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.64 -34.52 78.42 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.08 0.467 . . . . 0.0 110.467 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 15.5 mm-40 -79.0 -59.1 2.91 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.366 175.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 15' ' ' VAL . 95.9 m-85 -99.21 122.03 41.85 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.799 -168.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.08 -40.66 96.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.052 0.941 . . . . 0.0 110.926 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 -16.37 64.27 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.323 -0.709 . . . . 0.0 114.218 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.567 ' O ' HD22 ' A' ' 48' ' ' LEU . 64.1 mt -95.39 -13.5 24.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.686 0.795 . . . . 0.0 111.833 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -58.07 120.8 9.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.52 -28.14 5.99 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 114.549 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 12.4 ptm180 -90.89 3.17 55.26 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -168.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -127.15 2.65 6.45 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.355 0.662 . . . . 0.0 110.962 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.577 HD11 ' HA ' ' A' ' 35' ' ' ARG . 69.6 mt -135.63 129.13 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.52 1.128 . . . . 0.0 108.352 170.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 1.2 tm-20 -150.62 128.59 11.79 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.0 t70 61.08 30.31 19.4 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.449 1.1 . . . . 0.0 110.85 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.51 -13.55 6.31 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.798 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.78 -173.41 2.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.915 0.886 . . . . 0.0 109.361 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 60' ' ' VAL . 17.0 m -60.23 -57.07 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.536 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.992 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 56' ' ' PRO . 12.8 tppt? 150.39 137.84 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 C-N-CA 124.986 1.314 . . . . 0.0 109.862 -175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 42.8 Cg_endo -65.91 141.31 64.27 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 123.435 2.756 . . . . 0.0 111.773 163.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 82.25 -23.78 0.2 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.768 1.627 . . . . 0.0 112.532 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.12 141.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.9 m120 -111.87 104.58 12.89 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 85' ' ' VAL . 2.7 m -115.93 140.64 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.639 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -132.22 146.94 52.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.796 1.239 . . . . 0.0 110.012 -166.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.688 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 17.9 tptm -106.08 104.54 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 164.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 53.87 41.41 32.05 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.314 1.046 . . . . 0.0 111.838 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.44 -11.53 71.89 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-N 115.244 -0.889 . . . . 0.0 114.551 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -99.87 106.43 18.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tt0 -64.11 114.2 4.02 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.162 0.985 . . . . 0.0 111.63 -170.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.409 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 22.8 m -73.78 -2.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -172.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 m -72.67 -7.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 118.24 0.473 . . . . 0.0 111.361 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -96.69 -16.66 20.81 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.877 0.871 . . . . 0.0 110.958 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.84 -154.01 0.58 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.676 1.19 . . . . 0.0 109.208 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.2 m-20 -61.36 108.59 0.96 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -70.88 -48.54 33.23 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.484 0.49 . . . . 0.0 112.228 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.481 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 73.9 mmm -80.76 -37.97 29.46 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.003 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.04 66.13 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -172.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.412 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -70.09 -70.19 0.31 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.449 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.99 35.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -159.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.78 135.9 43.57 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.644 -0.66 . . . . 0.0 112.566 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.52 175.17 9.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.538 1.535 . . . . 0.0 108.151 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.66 141.26 53.64 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.771 0.714 . . . . 0.0 111.039 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.75 -15.14 27.34 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.619 -0.718 . . . . 0.0 114.381 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.688 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 50.9 m-20 -69.37 134.15 48.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.313 0.645 . . . . 0.0 111.618 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.21 142.6 27.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.03 107.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 165.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 70.0 m -94.06 130.12 40.33 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 0.0 109.151 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 60' ' ' VAL . 23.0 m -130.53 138.73 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 118.722 0.692 . . . . 0.0 110.605 -174.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 64.1 m-85 -122.3 135.53 25.59 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.6 ' HG3' ' H ' ' A' ' 10' ' ' THR . 27.4 Cg_endo -58.96 168.04 4.89 Favored 'Trans proline' 0 C--N 1.364 1.369 0 C-N-CA 123.953 3.102 . . . . 0.0 114.075 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.21 130.78 33.59 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.345 2.03 . . . . 0.0 111.374 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.2 t -77.67 103.56 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.65 13.94 9.22 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.957 1.303 . . . . 0.0 112.905 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.33 55.38 0.65 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.124 -179.908 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.384 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 91.55 63.27 1.17 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -152.7 14.12 0.69 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.321 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 39.78 65.55 0.7 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.074 1.35 . . . . 0.0 112.015 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.84 -30.88 4.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.76 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 69.54 10.76 7.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.938 1.295 . . . . 0.0 112.862 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -132.35 -50.39 0.93 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.207 0.603 . . . . 0.0 110.559 -170.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 9.4 t70 69.27 -177.2 0.21 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.953 1.301 . . . . 0.0 110.113 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 26.4 t70 74.12 -73.3 0.1 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.648 1.179 . . . . 0.0 111.223 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -155.69 145.71 21.5 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.94 0.896 . . . . 0.0 108.815 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 13.6 t70 70.59 142.84 0.05 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.383 1.473 . . . . 0.0 111.855 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -110.18 -38.93 5.15 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.849 0.46 . . . . 0.0 111.126 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 58.52 12.74 14.33 Favored Glycine 0 N--CA 1.479 1.545 0 N-CA-C 114.234 0.454 . . . . 0.0 114.234 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 36.8 p -90.29 177.34 6.44 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.994 0.918 . . . . 0.0 110.57 -174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 24.8 ptt? -147.21 132.95 18.92 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -83.81 141.11 31.6 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.5 mt -141.64 129.79 22.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 109.514 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -88.86 101.16 13.77 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 mt -94.98 108.1 20.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 27.9 mtm180 -97.87 117.42 32.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.782 0.833 . . . . 0.0 109.743 -175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -102.51 135.15 44.66 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.332 1.053 . . . . 0.0 108.877 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -130.69 161.24 32.09 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.89 0.476 . . . . 0.0 110.069 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.08 -120.9 1.1 Allowed 'General case' 0 CA--C 1.564 1.506 0 O-C-N 124.509 1.131 . . . . 0.0 111.873 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 18.7 m -71.98 -41.61 67.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.302 0.641 . . . . 0.0 111.0 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -60.52 -26.66 67.03 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.579 0.351 . . . . 0.0 110.864 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -47.52 69.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.57 0.748 . . . . 0.0 111.086 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.14 -22.99 59.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.625 HG11 ' HG ' ' A' ' 44' ' ' LEU . 74.8 t -60.33 -55.44 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 171.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.5 -20.42 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.931 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.06 11.85 83.98 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.417 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -163.94 158.26 19.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.695 0.798 . . . . 0.0 110.66 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -85.05 -19.67 31.6 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 9.6 m -152.55 147.78 26.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 pt -137.07 174.02 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.399 1.08 . . . . 0.0 108.762 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -122.58 113.16 18.9 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 167.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.437 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -98.49 172.63 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.896 1.279 . . . . 0.0 109.377 171.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -153.68 106.12 2.86 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.291 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.36 173.2 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.22 1.408 . . . . 0.0 108.474 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 34.0 t70 -66.2 161.26 22.43 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.978 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.22 -22.48 59.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.124 0.57 . . . . 0.0 111.745 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -81.0 -16.43 53.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.68 0.392 . . . . 0.0 110.65 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.86 151.49 41.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.324 0.65 . . . . 0.0 109.61 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.4 p -130.39 -174.74 3.43 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.901 0.881 . . . . 0.0 109.954 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.0 t -50.84 -37.04 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 124.578 1.151 . . . . 0.0 111.479 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.87 -39.78 64.5 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.802 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.26 -31.7 71.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.933 0.493 . . . . 0.0 110.52 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.74 -59.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.542 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.472 HD21 HG12 ' A' ' 54' ' ' VAL . 1.7 pp -64.26 -31.15 72.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.799 0.272 . . . . 0.0 111.093 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.533 ' HA ' HD11 ' A' ' 49' ' ' ILE . 9.1 tpt180 -51.77 -50.25 61.07 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.264 0.554 . . . . 0.0 111.353 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -75.82 -32.02 59.63 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.313 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.94 -39.06 68.48 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 10.2 pt-20 -73.95 -29.71 62.14 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.65 0.262 . . . . 0.0 111.63 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.69 65.51 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.57 0.748 . . . . 0.0 110.895 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.437 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 21.4 mm-40 -95.39 -58.71 2.06 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.431 1.092 . . . . 0.0 109.944 172.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.89 116.0 28.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.09 -30.49 70.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.953 0.901 . . . . 0.0 110.541 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.9 -20.17 77.49 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.956 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.717 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.1 mt -99.3 -1.66 38.41 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.713 0.805 . . . . 0.0 111.842 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -61.14 120.43 10.31 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.5 -7.64 17.79 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -100.16 4.57 44.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.029 0.914 . . . . 0.0 111.328 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.717 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -123.0 -5.96 8.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.579 1.152 . . . . 0.0 110.605 -177.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 35' ' ' ARG . 55.3 mt -133.02 138.6 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.681 1.193 . . . . 0.0 108.569 169.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 8.5 tp10 -144.9 124.87 13.51 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.649 0.78 . . . . 0.0 109.102 169.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.4 t70 58.95 31.79 21.66 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.432 1.093 . . . . 0.0 111.728 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.44 -14.74 57.17 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.168 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.09 -174.44 2.54 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.858 0.863 . . . . 0.0 109.185 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.472 HG12 HD21 ' A' ' 34' ' ' LEU . 34.0 m -62.83 -54.97 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 CA-C-O 118.11 -0.947 . . . . 0.0 112.829 -170.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 11.5 tppt? 151.61 139.61 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.388 0 C-N-CA 125.789 1.635 . . . . 0.0 107.879 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.47 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 21.9 Cg_endo -58.58 125.57 18.73 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.83 2.353 . . . . 0.0 111.636 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 73.41 1.4 3.97 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.66 1.184 . . . . 0.0 113.944 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.465 HG23 ' HD3' ' A' ' 88' ' ' PRO . 5.1 p -74.28 117.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 5.1 m-20 -80.83 103.62 10.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 85' ' ' VAL . 2.9 m -123.73 131.98 72.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -175.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 3.7 mp -121.88 172.14 8.4 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.254 1.022 . . . . 0.0 111.208 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.582 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 16.7 tptp -159.53 108.68 1.84 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 54.85 34.42 21.99 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.798 0.839 . . . . 0.0 110.237 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.9 13.98 82.51 Favored Glycine 0 C--N 1.352 1.465 0 N-CA-C 115.005 0.762 . . . . 0.0 115.005 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -119.67 121.25 38.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.797 0.839 . . . . 0.0 108.802 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 14.6 tt0 -75.91 110.14 10.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.405 0.682 . . . . 0.0 110.677 -171.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.512 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 17.5 m -70.54 -0.96 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -174.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 m -70.25 -16.5 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 118.104 0.411 . . . . 0.0 110.885 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -95.33 1.15 54.28 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.1 0.96 . . . . 0.0 111.26 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.47 -153.84 0.44 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.795 0.838 . . . . 0.0 109.773 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.54 108.58 0.99 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.0 0.52 . . . . 0.0 111.314 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -67.37 -50.6 43.29 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.568 0.543 . . . . 0.0 113.627 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 79.1 mmm -80.48 -39.64 27.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.089 0.556 . . . . 0.0 111.821 -170.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.84 76.62 1.54 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.912 0.863 . . . . 0.0 111.058 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.504 HG21 ' HG2' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -81.64 -71.61 0.47 Allowed 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.149 177.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 75' ' ' THR . . . -175.16 34.67 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.599 0.76 . . . . 0.0 110.931 -163.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.582 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 21.0 tp -73.86 149.89 41.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.991 0.424 . . . . 0.0 110.54 -170.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.5 171.7 19.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 109.297 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.1 p-10 -70.39 146.62 50.29 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.347 0.659 . . . . 0.0 112.059 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.95 16.31 63.88 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.254 -0.885 . . . . 0.0 114.019 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.74 163.15 24.71 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.498 0.649 . . . . 0.0 109.998 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.38 95.33 4.43 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.638 0.732 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.8 t -86.53 138.56 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.919 1.288 . . . . 0.0 109.142 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 17.9 m -117.25 161.25 19.8 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.459 0.572 . . . . 0.0 110.653 175.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 60' ' ' VAL . 35.3 m -146.79 141.73 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.196 0.998 . . . . 0.0 109.197 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.63 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 7.5 m-85 -135.28 133.7 20.79 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 175.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.473 ' HG3' ' H ' ' A' ' 10' ' ' THR . 23.6 Cg_endo -60.92 155.87 47.22 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.067 2.511 . . . . 0.0 112.565 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD3' HG23 ' A' ' 58' ' ' VAL . 97.8 Cg_endo -74.33 138.26 24.54 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.565 2.177 . . . . 0.0 111.869 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.31 37.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 121.526 0.679 . . . . 0.0 110.776 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.99 89.93 0.43 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.635 1.174 . . . . 0.0 110.645 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.46 -124.7 0.72 Allowed Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.495 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 119.204 -0.776 . . . . 0.0 112.291 179.7 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.25 -0.34 . . . . 0.0 112.25 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 164.64 -47.87 0.29 Allowed Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 147.03 -160.97 28.39 Favored Glycine 0 N--CA 1.472 1.06 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . 0.491 ' HD2' ' HA3' ' A' ' -1' ' ' GLY . 19.4 mmt180 59.61 -171.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.206 1.002 . . . . 0.0 113.516 169.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . 0.565 ' HB2' ' HA ' ' A' ' -2' ' ' LYS . 4.0 m-20 -122.98 110.79 15.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.307 1.443 . . . . 0.0 108.804 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . 0.524 ' HA ' HG21 ' A' ' 0' ' ' THR . 15.5 m-85 -86.9 64.13 8.32 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.867 0.841 . . . . 0.0 111.378 -171.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . 0.525 ' HE3' ' HB3' ' A' ' -9' ' ' ASP . 0.0 OUTLIER -153.86 162.35 41.29 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.521 1.128 . . . . 0.0 109.444 176.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -86.75 120.36 27.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . 0.422 ' H ' ' HD3' ' A' ' -2' ' ' LYS . 35.9 t70 -169.96 172.97 6.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.197 0.999 . . . . 0.0 109.092 -174.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.6 -44.68 81.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.479 0.712 . . . . 0.0 110.513 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -107.17 131.99 53.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.947 0.899 . . . . 0.0 108.9 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' -9' ' ' ASP . 47.6 pttt -167.33 -41.25 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.212 0.605 . . . . 0.0 111.55 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.491 ' HA3' ' HD2' ' A' ' -10' ' ' ARG . . . 60.93 31.74 77.38 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-O 121.21 0.339 . . . . 0.0 112.378 -174.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' -8' ' ' TYR . 54.9 p -120.64 142.12 49.73 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.613 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.0 ptt? -105.34 135.97 45.74 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.823 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' TRP . 42.8 tt0 -94.85 129.75 41.71 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.657 0.783 . . . . 0.0 109.005 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 143.78 50.49 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.074 0.397 . . . . 0.0 111.221 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 36.1 tt0 -89.53 101.15 13.83 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.69 104.44 16.54 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 25.4 mtp180 -91.38 118.8 30.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.17 136.06 45.37 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.988 0.915 . . . . 0.0 109.387 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.66 161.56 30.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.083 0.553 . . . . 0.0 109.851 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.491 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 58.45 -129.92 1.33 Allowed 'General case' 0 CA--C 1.561 1.366 0 O-C-N 124.359 1.037 . . . . 0.0 111.238 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.437 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 4.3 m -64.04 -40.62 96.71 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 123.394 0.677 . . . . 0.0 111.747 -176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.487 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -67.54 -49.05 65.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.236 0.615 . . . . 0.0 110.626 -178.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.92 -18.03 60.95 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.82 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.465 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -66.02 -54.43 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.178 0.513 . . . . 0.0 110.253 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.55 -17.35 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.884 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.487 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 70.71 11.95 69.81 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.536 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -140.07 138.14 35.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.798 1.239 . . . . 0.0 109.146 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -82.68 -21.09 35.05 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.733 0.646 . . . . 0.0 110.707 172.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 11.6 m -154.65 149.81 26.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.628 1.171 . . . . 0.0 108.799 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 15.5 pt -135.26 178.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.129 0.972 . . . . 0.0 109.055 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -125.81 112.22 15.77 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.434 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.7 OUTLIER -96.38 179.1 5.14 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.98 1.312 . . . . 0.0 109.921 174.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.0 ttp-105 -157.23 107.07 2.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.219 0.533 . . . . 0.0 109.942 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.84 176.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.684 1.194 . . . . 0.0 109.141 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -54.3 144.97 18.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.348 1.059 . . . . 0.0 110.014 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.99 -31.86 71.86 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.63 -7.51 59.6 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.593 0.757 . . . . 0.0 111.498 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.73 159.84 29.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.766 0.426 . . . . 0.0 109.853 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.8 p -130.96 179.2 6.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.986 0.515 . . . . 0.0 110.715 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.57 -35.79 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.609 1.164 . . . . 0.0 112.137 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.597 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.71 -37.47 67.01 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.741 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.46 -36.76 84.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.449 0.7 . . . . 0.0 110.927 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.14 -59.98 3.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.612 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.555 HD21 HG12 ' A' ' 54' ' ' VAL . 2.5 pp -63.7 -30.45 71.55 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.933 0.333 . . . . 0.0 111.315 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HA ' HD11 ' A' ' 49' ' ' ILE . 22.4 tpt180 -53.4 -48.73 68.42 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.004 0.431 . . . . 0.0 111.511 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.21 -32.8 61.29 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.533 0.333 . . . . 0.0 111.547 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 3.1 mm? -56.08 -34.54 66.08 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.6 0.76 . . . . 0.0 112.837 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -76.8 -26.09 54.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.91 -30.75 65.69 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.936 0.494 . . . . 0.0 110.51 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 15.8 mm-40 -79.79 -58.92 2.94 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.212 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.4 118.25 36.26 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.718 -169.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.09 -28.55 67.45 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.106 0.562 . . . . 0.0 110.192 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.21 -2.29 82.94 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.861 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.59 ' HB3' HD13 ' A' ' 48' ' ' LEU . 87.4 mt -114.65 2.84 14.61 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.578 0.689 . . . . 0.0 110.3 171.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.6 123.62 23.58 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.964 0.505 . . . . 0.0 111.886 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.85 8.19 87.75 Favored Glycine 0 N--CA 1.48 1.625 0 N-CA-C 115.176 0.831 . . . . 0.0 115.176 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 11.9 ptp180 -125.96 2.16 7.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.744 0.818 . . . . 0.0 111.422 -173.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.59 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -128.5 -8.89 5.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.427 1.091 . . . . 0.0 110.724 -176.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 35' ' ' ARG . 31.2 mt -130.26 132.49 65.01 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 C-N-CA 124.867 1.267 . . . . 0.0 108.653 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -134.32 108.45 8.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.395 0.678 . . . . 0.0 109.798 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.2 t70 57.56 31.29 20.09 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.293 1.037 . . . . 0.0 111.666 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.0 0.66 71.1 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.6 -174.69 2.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.085 0.942 . . . . 0.0 108.721 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.555 HG12 HD21 ' A' ' 34' ' ' LEU . 15.0 m -65.1 -56.3 16.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 CA-C-O 117.537 -1.22 . . . . 0.0 112.015 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.2 tppt? 151.18 136.32 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 C-N-CA 124.667 1.187 . . . . 0.0 108.746 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.86 128.12 27.81 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 122.936 2.424 . . . . 0.0 111.08 164.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 82.42 -14.82 0.73 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.349 1.46 . . . . 0.0 114.251 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 p -70.12 126.46 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.4 m120 -94.82 103.45 15.34 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -120.68 134.23 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.095 0.474 . . . . 0.0 109.94 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.1 mp -119.59 171.68 8.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.885 1.274 . . . . 0.0 111.738 -170.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -158.16 104.2 1.86 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.776 -177.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 15.3 t-20 56.47 36.47 27.61 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.455 1.102 . . . . 0.0 110.243 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.58 -13.24 67.13 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.719 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.406 ' HG3' HD21 ' A' ' 70' ' ' LEU . 7.1 tpp180 -97.41 119.9 36.79 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.413 0.685 . . . . 0.0 109.936 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 25.3 tt0 -79.55 106.47 11.6 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.769 -173.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -68.51 -1.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.374 1.469 . . . . 0.0 114.489 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.47 -21.61 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 117.857 0.299 . . . . 0.0 111.169 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -87.25 -19.34 28.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.979 0.912 . . . . 0.0 110.791 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.406 HD21 ' HG3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -131.81 -139.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.612 1.165 . . . . 0.0 108.423 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.2 109.42 17.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.953 0.797 . . . . 0.0 110.206 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.85 -38.77 65.53 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.354 0.409 . . . . 0.0 112.871 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.597 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.9 mmt -81.58 -37.17 28.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.26 77.57 1.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.4 t -81.51 -66.5 0.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' H ' HG23 ' A' ' 75' ' ' THR . . . -178.27 33.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.808 0.843 . . . . 0.0 111.067 -165.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.62 141.81 46.54 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.844 -0.535 . . . . 0.0 111.144 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.43 -175.98 4.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.313 1.045 . . . . 0.0 108.909 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.613 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.0 p30 -80.02 148.86 30.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.087 0.555 . . . . 0.0 111.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.67 61.75 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.708 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.34 141.97 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.19 0.596 . . . . 0.0 111.566 -170.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.61 109.84 22.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.88 0.472 . . . . 0.0 110.854 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -100.23 107.09 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.448 0.699 . . . . 0.0 109.285 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 61.4 m -87.07 148.13 25.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.121 0.569 . . . . 0.0 109.934 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 m -143.37 148.31 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.346 0.659 . . . . 0.0 110.241 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 25.5 m-85 -136.7 135.72 20.71 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 23.7 Cg_endo -59.71 164.47 11.5 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 124.012 3.141 . . . . 0.0 113.505 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.0 131.2 31.72 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.297 1.998 . . . . 0.0 112.804 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.82 157.51 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.034 0.934 . . . . 0.0 110.546 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.46 121.84 23.68 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.234 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.47 114.66 0.98 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.941 -0.922 . . . . 0.0 111.079 -179.294 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 112.398 -0.281 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 87.44 170.23 46.28 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -63.34 -52.66 45.18 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . 0.473 ' HE ' ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 50.08 57.26 6.76 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.177 1.391 . . . . 0.0 109.844 176.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 17.1 t70 -136.05 145.35 45.9 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.888 -168.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -107.25 -9.26 16.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.606 0.762 . . . . 0.0 112.26 -161.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.74 179.64 5.08 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -172.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 77.72 179.14 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.91 1.684 . . . . 0.0 110.905 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -111.56 -9.53 14.18 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.518 0.727 . . . . 0.0 111.179 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.05 -151.27 0.12 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -65.69 133.09 50.34 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 122.879 0.472 . . . . 0.0 110.328 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 15.8 pttp -153.24 -56.67 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.88 1.272 . . . . 0.0 108.684 -173.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 96.99 59.72 0.99 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 62.8 p -120.63 146.21 46.62 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.235 1.014 . . . . 0.0 109.437 175.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 21.4 ptt? -116.34 133.62 55.81 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.001 0.92 . . . . 0.0 110.976 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.91 132.99 36.08 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.214 1.006 . . . . 0.0 110.139 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.3 mt -132.64 139.07 47.58 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.515 0.726 . . . . 0.0 110.437 -168.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -89.37 102.32 14.99 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.543 HD13 HD21 ' A' ' 37' ' ' LEU . 36.4 mt -93.24 104.07 16.28 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.545 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 12.4 mtp180 -95.58 117.9 31.3 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.993 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.67 138.33 44.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.915 0.886 . . . . 0.0 109.76 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -132.01 156.07 46.9 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.307 0.643 . . . . 0.0 109.32 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.36 -128.12 1.72 Allowed 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 124.845 1.258 . . . . 0.0 112.818 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.521 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 84.8 m -55.92 -49.59 73.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.148 0.979 . . . . 0.0 111.862 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -64.19 -23.12 67.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.685 0.394 . . . . 0.0 111.006 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.606 HH21 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -69.21 -48.25 62.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.187 0.595 . . . . 0.0 110.962 178.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -22.78 59.38 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.379 0.424 . . . . 0.0 111.675 -175.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 44' ' ' LEU . 78.5 t -59.64 -56.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.594 0.711 . . . . 0.0 110.587 170.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 96.0 t -73.78 -22.07 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.376 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.606 ' HA2' HH21 ' A' ' 12' ' ' ARG . . . 71.01 11.05 69.52 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.938 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -142.37 145.33 33.76 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.848 0.859 . . . . 0.0 109.21 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -86.56 -19.32 29.59 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.572 178.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 13.6 m -155.0 139.93 17.28 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 162.98 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.129 0.972 . . . . 0.0 108.882 174.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -110.0 112.75 24.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.429 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -103.37 178.05 4.67 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.447 1.499 . . . . 0.0 109.514 174.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -157.61 110.56 2.46 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.792 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.02 179.89 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.72 150.93 18.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.332 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.89 -35.0 69.62 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.524 1.129 . . . . 0.0 111.438 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.473 ' HB3' ' HE ' ' A' ' -10' ' ' ARG . 19.8 t70 -80.93 -13.3 59.02 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.768 0.827 . . . . 0.0 110.375 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.77 166.96 4.96 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.972 0.909 . . . . 0.0 111.353 172.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.8 p -135.98 -177.62 4.78 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.604 0.762 . . . . 0.0 110.1 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 77' ' ' LEU . 80.2 t -52.01 -37.84 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 C-N-CA 123.8 0.84 . . . . 0.0 110.757 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.659 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.49 -37.98 69.23 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.449 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.89 -29.82 68.18 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.046 0.539 . . . . 0.0 110.624 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.8 t -65.36 -60.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.577 0.751 . . . . 0.0 110.202 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.0 -30.31 71.4 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.794 0.27 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 49' ' ' ILE . 19.7 tpt180 -52.83 -46.96 67.99 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.28 0.562 . . . . 0.0 111.388 169.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.5 m -75.03 -32.43 61.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.708 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.543 HD21 HD13 ' A' ' 5' ' ' LEU . 3.5 mm? -59.18 -31.9 69.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB3' HD21 ' A' ' 48' ' ' LEU . 16.6 pt-20 -77.74 -28.48 50.76 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.426 0.557 . . . . 0.0 111.365 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.74 72.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.0 0.52 . . . . 0.0 111.084 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -85.96 -58.8 2.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.506 0.723 . . . . 0.0 110.58 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 95.0 m-85 -95.12 116.32 28.58 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.632 -171.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.99 -32.74 74.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.161 0.985 . . . . 0.0 111.225 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.502 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.69 -5.76 83.91 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.673 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.666 ' HB3' HD13 ' A' ' 48' ' ' LEU . 58.4 mt -106.56 3.04 26.58 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.573 0.687 . . . . 0.0 111.444 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -66.86 121.04 14.61 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 5.88 59.67 Favored Glycine 0 C--N 1.358 1.782 0 N-CA-C 115.773 1.069 . . . . 0.0 115.773 171.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 1.7 ptp180 -113.12 5.15 16.95 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.017 0.927 . . . . 0.0 111.337 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.666 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -126.27 -8.74 6.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.708 1.203 . . . . 0.0 110.36 -178.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 35' ' ' ARG . 33.5 mt -128.78 137.28 57.7 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 125.266 1.426 . . . . 0.0 108.402 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 55' ' ' LYS . 16.1 mm-40 -128.9 107.95 10.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.525 0.73 . . . . 0.0 109.416 160.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 52.91 41.56 31.96 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.009 1.323 . . . . 0.0 112.873 171.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -7.1 78.03 Favored Glycine 0 N--CA 1.47 0.927 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.988 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -110.5 -174.8 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.83 0.815 . . . . 0.0 109.1 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -70.14 -56.39 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.013 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 50' ' ' GLU . 10.8 tppt? 152.49 135.92 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.434 0 C-N-CA 124.919 1.288 . . . . 0.0 109.392 -175.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.458 ' HD2' ' HG3' ' A' ' 50' ' ' GLU . 36.5 Cg_endo -63.11 131.91 34.42 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.077 2.518 . . . . 0.0 111.724 166.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 m170 76.73 -2.93 2.61 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 124.859 1.264 . . . . 0.0 113.682 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.4 p -75.9 154.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.2 m120 -121.03 103.56 9.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 67' ' ' VAL . 4.4 m -117.0 147.71 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.755 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 7.1 mp -132.13 172.51 12.3 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.052 1.341 . . . . 0.0 110.375 -163.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.513 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 17.6 tptp -157.82 105.33 1.99 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.143 1.377 . . . . 0.0 107.534 -172.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.92 35.02 14.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.484 1.114 . . . . 0.0 110.744 -168.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.76 -14.18 59.06 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.361 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -83.63 116.67 22.73 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.91 0.855 . . . . 0.0 110.087 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 23.0 tt0 -73.85 107.07 5.86 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.068 -171.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.529 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.2 m -75.52 -0.98 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 58' ' ' VAL . 17.1 m -70.62 -14.98 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.946 0.794 . . . . 0.0 111.342 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -85.38 -27.17 26.01 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.628 0.771 . . . . 0.0 110.722 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -130.3 -152.22 0.5 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.119 0.968 . . . . 0.0 109.868 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.28 108.91 1.72 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.206 0.602 . . . . 0.0 111.334 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.529 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -78.63 -43.1 12.45 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.774 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.659 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.5 mmt -74.52 -39.49 62.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.121 0.569 . . . . 0.0 111.957 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.3 79.02 1.39 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.195 0.521 . . . . 0.0 111.496 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.419 HG21 ' HG2' ' A' ' 62' ' ' LYS . 2.2 t -81.78 -62.35 1.66 Allowed 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.882 175.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 176.06 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.67 1.188 . . . . 0.0 110.034 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 30' ' ' VAL . 1.2 tm? -73.91 113.68 11.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.55 0.74 . . . . 0.0 110.727 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.82 -178.19 4.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.229 1.411 . . . . 0.0 109.516 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.2 p-10 -66.42 150.36 49.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 112.362 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.21 13.43 64.75 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.239 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.85 156.99 33.87 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 117.446 0.623 . . . . 0.0 111.176 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 6' ' ' ARG . . . -115.63 94.31 4.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.438 0.695 . . . . 0.0 109.297 171.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.26 106.37 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 48.9 m -93.11 146.35 23.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.376 0.671 . . . . 0.0 109.718 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 m -140.94 141.79 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.693 0.759 . . . . 0.0 110.199 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 17.7 m-85 -128.7 136.67 29.5 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.521 ' HG3' ' H ' ' A' ' 10' ' ' THR . 54.5 Cg_endo -62.75 169.37 8.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.165 3.243 . . . . 0.0 112.792 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -61.39 128.41 24.83 Favored 'Trans proline' 0 C--N 1.381 2.256 0 N-CA-C 108.962 -1.207 . . . . 0.0 108.962 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 m -86.74 -33.45 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 123.622 0.576 . . . . 0.0 111.697 -166.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.83 105.84 3.87 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 172.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.27 64.67 0.53 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.414 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.904 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 86.09 170.31 46.85 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.447 0.123 . . . . 0.0 112.964 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -72.23 -84.99 0.21 Allowed Glycine 0 C--N 1.344 0.986 0 O-C-N 123.43 0.135 . . . . 0.0 112.83 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -114.79 89.54 3.12 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.687 0.755 . . . . 0.0 109.744 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -123.29 111.67 16.7 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.54 1.136 . . . . 0.0 108.939 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -65.16 -50.94 64.04 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.181 0.515 . . . . 0.0 110.138 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' -3' ' ' ASP . 3.6 mmmp? 69.94 0.75 3.19 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.783 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -67.89 -36.82 80.91 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.04 0.936 . . . . 0.0 111.256 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.35 -67.13 0.42 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.984 0.913 . . . . 0.0 110.754 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 17.3 t70 178.78 -62.27 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' -7' ' ' LYS . 3.3 t70 -83.33 -163.39 0.74 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 163.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.411 ' HG3' ' H ' ' A' ' 0' ' ' THR . 9.0 ptpp? -51.89 -40.39 60.58 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.634 0.652 . . . . 0.0 111.286 172.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 61.49 33.05 83.38 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.088 0.868 . . . . 0.0 112.368 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.411 ' H ' ' HG3' ' A' ' -2' ' ' LYS . 61.5 p -127.04 145.7 50.62 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.883 0.873 . . . . 0.0 110.849 -173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.8 ptt? -132.65 145.22 50.9 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.826 0.85 . . . . 0.0 109.443 174.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -107.33 113.42 26.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.996 0.519 . . . . 0.0 110.473 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 77' ' ' LEU . 21.8 mt -104.6 143.53 32.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.858 0.863 . . . . 0.0 111.018 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.53 101.09 13.77 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.58 0.352 . . . . 0.0 110.146 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.2 mt -93.8 105.55 17.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.26 0.552 . . . . 0.0 110.332 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 61.4 mtp180 -91.5 124.18 35.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.62 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -112.32 137.82 49.93 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.561 0.745 . . . . 0.0 109.013 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -132.5 161.16 34.46 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.874 0.47 . . . . 0.0 110.454 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 56.28 -128.03 1.97 Allowed 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.631 1.172 . . . . 0.0 112.16 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 32.7 m -59.5 -49.79 76.42 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.778 0.831 . . . . 0.0 111.609 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -59.8 -24.05 63.8 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.937 0.495 . . . . 0.0 111.352 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.4 ttp85 -68.71 -51.05 45.7 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -73.57 -21.85 60.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.529 0.332 . . . . 0.0 111.257 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.45 HG11 ' HG ' ' A' ' 44' ' ' LEU . 76.0 t -61.12 -55.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 0.0 110.07 170.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -77.87 -16.86 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.723 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.56 11.73 62.84 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.088 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -139.75 146.96 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.006 0.922 . . . . 0.0 110.007 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -104.36 -19.04 14.2 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.013 0.925 . . . . 0.0 110.998 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.5 m -153.74 138.36 16.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.949 0.9 . . . . 0.0 108.971 165.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.8 pt -133.37 178.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.821 0.848 . . . . 0.0 109.734 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -125.09 112.84 16.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 170.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.89 132.64 51.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 108.54 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -96.8 112.74 24.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 m -113.61 -179.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.83 166.26 22.62 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.019 0.372 . . . . 0.0 110.548 174.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.63 -31.58 72.86 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.625 0.77 . . . . 0.0 112.377 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.86 -17.16 51.62 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.828 0.451 . . . . 0.0 110.832 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 147.14 37.04 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.724 0.81 . . . . 0.0 112.183 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.5 p -134.03 -174.64 3.6 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.942 0.897 . . . . 0.0 109.097 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.0 t -52.36 -42.06 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.65 0.78 . . . . 0.0 111.464 -175.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.63 94.77 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.363 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.09 -34.43 76.41 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.262 0.553 . . . . 0.0 110.45 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.95 -57.8 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.246 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.642 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.2 pp -70.07 -30.66 67.96 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -64.94 -35.29 80.67 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.715 0.689 . . . . 0.0 110.49 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -75.84 -33.04 60.02 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.422 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.5 mm? -61.89 -39.43 91.95 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.935 0.494 . . . . 0.0 111.722 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 4.8 pt-20 -73.11 -26.26 61.17 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.95 63.72 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.077 0.551 . . . . 0.0 111.328 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -96.5 -59.19 1.87 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.943 0.878 . . . . 0.0 109.306 173.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -95.83 106.95 19.15 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.094 -171.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.38 -27.04 69.03 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.202 0.601 . . . . 0.0 111.048 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.58 -5.01 62.69 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.826 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.668 ' HB3' HD13 ' A' ' 48' ' ' LEU . 92.7 mt -111.3 -6.86 14.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.377 0.671 . . . . 0.0 111.481 172.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.3 120.03 8.51 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -168.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.56 5.66 56.51 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -96.62 -32.78 12.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.579 0.751 . . . . 0.0 109.583 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -98.13 2.03 48.15 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.219 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -133.22 139.0 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.603 1.161 . . . . 0.0 109.469 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.55 129.76 11.21 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.64 31.11 12.05 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.144 1.378 . . . . 0.0 112.035 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.62 -9.72 41.73 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.127 -0.818 . . . . 0.0 114.76 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -93.67 -174.42 3.46 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.179 0.989 . . . . 0.0 108.902 168.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.508 HG12 HD21 ' A' ' 34' ' ' LEU . 28.6 m -64.14 -55.32 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 117.638 -1.172 . . . . 0.0 111.417 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HG2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 tppt? 153.6 137.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 C-N-CA 125.175 1.39 . . . . 0.0 109.491 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.27 128.35 29.77 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.665 2.91 . . . . 0.0 111.981 165.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 76.35 -6.73 1.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.5 1.52 . . . . 0.0 113.874 174.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.17 141.85 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 18.0 m120 -111.8 104.13 12.43 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 85' ' ' VAL . 4.9 m -113.34 136.05 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 5.9 mp -127.74 148.53 50.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.036 1.334 . . . . 0.0 110.209 -168.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -112.38 105.43 13.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 59.44 35.87 23.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.059 0.944 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.08 -13.79 65.28 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.765 -0.652 . . . . 0.0 114.247 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -90.45 102.14 14.87 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 19.6 tt0 -64.79 106.2 1.16 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.859 0.864 . . . . 0.0 111.015 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.87 -1.35 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 66' ' ' GLU . 15.2 m -70.83 -12.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 118.09 0.405 . . . . 0.0 111.554 171.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.411 ' HD2' ' HB3' ' A' ' 66' ' ' GLU . 93.6 m-70 -93.63 -20.97 19.69 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.569 0.748 . . . . 0.0 110.779 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.62 -153.14 0.54 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.604 1.162 . . . . 0.0 109.076 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.0 m-20 -59.64 109.34 0.89 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.266 0.626 . . . . 0.0 111.116 172.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.98 -46.33 7.15 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 123.321 0.388 . . . . 0.0 112.246 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 89.4 mmm -80.73 -20.16 43.41 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.44 79.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.898 0.317 . . . . 0.0 111.614 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 71' ' ' ASP . 3.0 t -76.58 -74.97 0.21 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' H ' HG23 ' A' ' 75' ' ' THR . . . -176.68 35.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.492 0.317 . . . . 0.0 111.572 -164.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 3' ' ' LEU . 18.2 mt -73.7 150.13 41.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.553 0.692 . . . . 0.0 112.435 -170.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -154.23 179.7 8.72 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.723 1.609 . . . . 0.0 107.628 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 31.9 t70 -63.99 129.33 39.6 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.019 0.528 . . . . 0.0 111.906 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.96 6.22 82.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.133 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -81.01 122.22 27.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.602 0.761 . . . . 0.0 111.413 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.67 125.08 32.19 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.252 0.621 . . . . 0.0 111.734 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.36 107.63 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.684 0.794 . . . . 0.0 109.721 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.716 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.0 m -85.83 152.1 23.28 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.394 0.677 . . . . 0.0 110.191 175.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 60' ' ' VAL . 16.2 m -141.49 147.0 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.418 0.628 . . . . 0.0 109.946 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 42.3 m-85 -135.33 134.24 21.14 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 174.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 29.8 Cg_endo -59.42 164.64 10.61 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.841 3.028 . . . . 0.0 114.025 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HG3' ' HG2' ' A' ' 55' ' ' LYS . 15.4 Cg_exo -63.96 130.65 28.16 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.662 2.241 . . . . 0.0 111.166 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.78 122.08 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.685 0.794 . . . . 0.0 110.01 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.76 144.37 41.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.791 0.836 . . . . 0.0 109.962 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.3 -44.48 0.33 Allowed Glycine 0 C--N 1.34 0.783 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.763 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 113.419 0.128 . . . . 0.0 113.419 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -96.26 77.57 0.76 Allowed Glycine 0 C--N 1.348 1.229 0 C-N-CA 123.198 0.428 . . . . 0.0 113.498 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -87.44 -40.79 6.73 Favored Glycine 0 C--N 1.347 1.169 0 C-N-CA 122.796 0.236 . . . . 0.0 112.591 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -77.63 -27.26 51.06 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.749 0.819 . . . . 0.0 111.663 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -83.01 -30.61 27.99 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.094 0.557 . . . . 0.0 110.171 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 70.66 -66.81 0.27 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.478 1.511 . . . . 0.0 111.672 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.23 173.05 6.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.273 1.029 . . . . 0.0 110.962 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -121.76 104.1 9.35 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.064 0.946 . . . . 0.0 108.742 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -161.09 -62.88 0.06 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -85.6 167.73 15.1 Favored 'General case' 0 C--O 1.246 0.915 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.21 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.38 -21.53 66.66 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.93 0.492 . . . . 0.0 111.729 173.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -153.16 -60.2 0.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.224 1.009 . . . . 0.0 109.861 174.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 57.35 31.13 62.33 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 25' ' ' ASP . 29.7 p -141.51 141.92 33.59 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.684 1.193 . . . . 0.0 110.171 -171.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 23.7 ptt? -114.63 132.01 56.52 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.581 1.153 . . . . 0.0 110.695 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -84.42 128.57 34.66 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.275 0.63 . . . . 0.0 109.533 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.3 mt -127.46 137.08 52.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.475 0.71 . . . . 0.0 110.467 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -89.69 101.54 14.23 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.435 HD13 HD21 ' A' ' 37' ' ' LEU . 36.3 mt -93.33 107.42 19.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.5 mtt-85 -96.31 120.45 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.302 1.041 . . . . 0.0 109.778 -176.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.44 134.42 50.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.515 1.126 . . . . 0.0 109.251 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -128.68 162.55 27.09 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.979 0.512 . . . . 0.0 109.904 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.8 -122.6 0.91 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.493 1.117 . . . . 0.0 111.497 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.514 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 54.5 m -68.94 -45.77 69.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 111.408 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -57.19 -27.91 62.36 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.03 0.532 . . . . 0.0 111.335 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -64.57 -53.6 45.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.538 0.735 . . . . 0.0 111.34 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -21.76 60.43 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.345 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.511 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.9 t -61.71 -49.99 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.026 0.531 . . . . 0.0 110.606 169.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.94 -15.5 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.728 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.68 83.32 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.049 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -166.93 155.76 10.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.218 1.007 . . . . 0.0 110.156 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -89.75 -13.27 37.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 8.8 m -155.22 147.53 23.85 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.193 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -140.78 172.22 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.61 1.164 . . . . 0.0 108.703 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -118.35 112.78 20.47 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -92.1 -179.19 5.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.832 1.253 . . . . 0.0 108.937 167.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -156.73 110.16 2.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 176.57 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.363 1.065 . . . . 0.0 108.472 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HA ' HG22 ' A' ' 0' ' ' THR . 6.9 t70 -68.76 157.1 37.08 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 122.995 0.518 . . . . 0.0 110.031 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.68 -18.69 60.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.715 0.406 . . . . 0.0 110.728 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.39 -23.83 37.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.297 0.639 . . . . 0.0 109.723 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.52 147.87 47.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.476 0.71 . . . . 0.0 109.668 171.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -132.08 -174.37 3.41 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.263 1.025 . . . . 0.0 109.8 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.3 p -50.72 -36.46 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.644 1.178 . . . . 0.0 112.646 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.566 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -71.05 -41.02 61.48 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.379 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.9 -29.49 65.57 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.792 0.296 . . . . 0.0 110.521 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.7 t -59.37 -60.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.455 0.702 . . . . 0.0 109.831 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.575 HD21 HG12 ' A' ' 54' ' ' VAL . 2.4 pp -66.57 -30.76 71.14 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 123.11 0.257 . . . . 0.0 111.334 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.508 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.5 tpt180 -56.0 -46.65 78.66 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.36 0.6 . . . . 0.0 111.629 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -75.2 -32.97 61.35 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.356 0.662 . . . . 0.0 111.773 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 1.6 mm? -56.45 -45.03 81.04 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.701 0.801 . . . . 0.0 112.152 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 9.5 pt-20 -64.16 -29.8 70.9 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.61 0.569 . . . . 0.0 112.283 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.86 -22.67 67.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.957 0.503 . . . . 0.0 111.63 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -97.13 -57.97 2.13 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.008 0.909 . . . . 0.0 109.169 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.65 105.47 17.84 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.807 -173.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.3 -32.14 72.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.393 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.917 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.663 ' HB3' HD13 ' A' ' 48' ' ' LEU . 81.5 mt -103.09 -11.66 17.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.863 0.865 . . . . 0.0 111.271 175.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -57.28 121.55 10.41 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.366 0.667 . . . . 0.0 112.517 -173.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.59 -19.93 8.31 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 171.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.76 0.72 57.47 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.466 0.633 . . . . 0.0 111.655 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -124.02 5.58 8.62 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.333 1.053 . . . . 0.0 110.29 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 35' ' ' ARG . 17.5 mt -140.75 142.47 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 124.639 1.176 . . . . 0.0 109.244 172.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -145.76 116.68 7.76 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.463 0.705 . . . . 0.0 110.125 164.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 55.92 31.56 18.07 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.221 1.008 . . . . 0.0 111.826 172.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.84 6.39 82.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -106.9 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.096 0.948 . . . . 0.0 108.785 165.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 34' ' ' LEU . 15.8 m -64.29 -55.39 21.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.836 0 CA-C-O 117.595 -1.193 . . . . 0.0 112.13 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? 150.02 132.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 C-N-CA 125.212 1.405 . . . . 0.0 107.601 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -61.11 140.61 90.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.727 2.285 . . . . 0.0 111.593 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.423 ' ND1' ' HB3' ' A' ' 90' ' ' ALA . 66.8 m-70 80.16 -21.33 0.33 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.509 1.524 . . . . 0.0 113.504 177.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG23 ' HD3' ' A' ' 88' ' ' PRO . 1.1 p -72.61 152.51 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 15.9 m120 -119.89 103.83 9.67 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.3 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.461 0.704 . . . . 0.0 109.55 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.6 mp -121.12 131.29 54.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.925 1.29 . . . . 0.0 110.725 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HD3' ' HG ' ' A' ' 77' ' ' LEU . 8.4 tptm -105.59 111.73 24.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.15 0.98 . . . . 0.0 109.057 171.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.4 t30 57.3 34.83 25.3 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.594 1.158 . . . . 0.0 110.577 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -4.51 86.04 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.41 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -102.37 114.23 28.23 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.944 0.897 . . . . 0.0 109.157 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 18.3 tt0 -70.63 110.26 5.36 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.363 0.665 . . . . 0.0 111.292 -171.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.02 -1.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.2 m -68.3 -19.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.109 0.413 . . . . 0.0 111.527 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -85.39 -16.26 40.42 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.924 0.89 . . . . 0.0 110.963 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.24 -152.72 0.44 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.42 1.088 . . . . 0.0 109.334 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.61 108.2 0.94 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.957 0.503 . . . . 0.0 110.551 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.01 -29.06 24.07 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.794 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.566 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 4.5 mmt -80.85 -37.94 29.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.503 0.721 . . . . 0.0 112.147 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.78 85.34 1.17 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 76' ' ' ALA . 3.1 t -82.01 -70.79 0.52 Allowed 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.554 0.742 . . . . 0.0 112.271 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' H ' HG23 ' A' ' 75' ' ' THR . . . 179.77 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.458 1.103 . . . . 0.0 110.209 -163.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.29 114.86 13.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -116.85 179.76 3.92 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.359 0.664 . . . . 0.0 110.433 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 7.8 p-10 -73.09 142.32 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.56 0.744 . . . . 0.0 111.286 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.63 18.3 78.54 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.314 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -96.61 141.78 29.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.439 0.696 . . . . 0.0 111.785 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.54 109.35 22.12 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.167 0.987 . . . . 0.0 110.711 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.0 t -95.13 107.29 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.2 m -83.92 150.49 25.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.77 0.828 . . . . 0.0 110.093 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.12 145.63 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.466 0.706 . . . . 0.0 109.491 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 19.4 m-85 -137.33 135.06 19.02 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.514 ' HG3' ' H ' ' A' ' 10' ' ' THR . 29.3 Cg_endo -61.2 165.61 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 123.96 3.107 . . . . 0.0 113.688 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 58' ' ' VAL . 41.2 Cg_endo -63.8 131.27 30.53 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.608 2.205 . . . . 0.0 112.491 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.8 m -82.58 -26.63 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.46 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.423 ' HB3' ' ND1' ' A' ' 57' ' ' HIS . . . -116.26 125.22 51.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.032 0.533 . . . . 0.0 110.285 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.14 -104.87 0.96 Allowed Glycine 0 C--N 1.345 1.083 0 O-C-N 123.615 0.572 . . . . 0.0 113.272 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.769 0 CA-C-O 119.243 -0.754 . . . . 0.0 111.719 178.603 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -163.94 157.66 29.98 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 116.758 0.279 . . . . 0.0 112.437 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -111.35 -135.72 6.83 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.624 -0.591 . . . . 0.0 111.624 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 -153.68 110.39 3.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.117 0.567 . . . . 0.0 110.664 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . 0.573 ' HB3' HH21 ' A' ' 23' ' ' ARG . 40.0 p-10 -154.68 144.37 21.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.769 0.828 . . . . 0.0 110.166 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -96.0 -47.97 5.89 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.718 0.807 . . . . 0.0 112.07 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 64.06 69.53 0.53 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 125.158 1.536 . . . . 0.0 110.372 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -73.06 -55.6 6.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.63 -172.26 3.0 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.438 166.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.01 -33.93 71.28 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.711 0.805 . . . . 0.0 112.885 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -76.0 -178.47 4.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.068 0.547 . . . . 0.0 111.662 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 0' ' ' THR . 10.2 ptpp? -65.09 -34.51 78.58 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.149 0.98 . . . . 0.0 112.57 -177.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 66.1 34.74 89.18 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.595 -0.275 . . . . 0.0 113.534 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.455 ' H ' ' HG3' ' A' ' -2' ' ' LYS . 1.4 p -148.69 158.61 44.26 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.395 1.078 . . . . 0.0 109.687 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -147.27 145.64 29.47 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.586 0.754 . . . . 0.0 109.495 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -89.3 141.11 28.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.67 138.15 44.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.575 0.75 . . . . 0.0 109.264 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -89.37 104.5 17.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.429 HD13 HD21 ' A' ' 37' ' ' LEU . 28.2 mt -93.72 104.26 16.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 79.9 mtt180 -92.05 117.39 29.79 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.533 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.54 137.59 42.16 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.907 0.883 . . . . 0.0 109.227 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -130.22 160.55 33.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.896 0.478 . . . . 0.0 110.59 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 57.95 -119.0 1.1 Allowed 'General case' 0 CA--C 1.56 1.332 0 O-C-N 124.783 1.302 . . . . 0.0 112.238 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.622 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 8.6 m -70.99 -47.45 58.78 Favored 'General case' 0 C--N 1.361 1.067 0 CA-C-N 118.415 0.552 . . . . 0.0 110.437 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -58.04 -26.61 62.68 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.051 0.54 . . . . 0.0 111.056 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -66.55 -54.42 23.85 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.223 0.609 . . . . 0.0 111.386 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -17.64 60.87 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.635 0.585 . . . . 0.0 111.797 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.547 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.4 t -63.44 -55.06 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.391 0.676 . . . . 0.0 109.654 169.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.44 -16.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.441 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 17.28 80.23 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.491 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -166.77 150.82 7.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.018 0.927 . . . . 0.0 110.321 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -91.23 -22.21 20.72 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.7 m -154.75 136.87 14.73 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -130.03 176.82 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.031 0.933 . . . . 0.0 109.144 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.5 111.44 16.82 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -96.11 177.4 5.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.001 1.32 . . . . 0.0 109.111 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.573 HH21 ' HB3' ' A' ' -9' ' ' ASP . 55.8 ttt180 -156.54 108.11 2.46 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 m -112.75 179.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.846 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -55.97 148.62 16.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.421 0.688 . . . . 0.0 110.364 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -66.55 -26.1 66.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.517 0.327 . . . . 0.0 111.413 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.45 -24.64 36.71 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.952 0.501 . . . . 0.0 110.56 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.47 129.2 39.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.345 0.658 . . . . 0.0 111.16 -174.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.1 p -111.92 -172.97 2.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.324 1.049 . . . . 0.0 110.372 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -50.82 -41.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 123.771 0.828 . . . . 0.0 111.804 -170.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' HA2' ' HE2' ' A' ' 73' ' ' MET . . . -65.5 -43.35 94.85 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.65 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.11 -33.26 75.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.264 0.625 . . . . 0.0 111.582 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.03 -59.75 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.675 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.551 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 3.1 pp -68.89 -30.71 69.27 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.4 ppt_? -67.35 -34.3 77.02 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.907 0.776 . . . . 0.0 111.204 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.1 m -75.58 -32.45 60.36 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.007 175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 5' ' ' LEU . 2.5 mm? -59.08 -49.57 77.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.918 0.487 . . . . 0.0 111.213 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -67.25 -25.31 66.02 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -20.84 66.52 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 123.345 0.403 . . . . 0.0 110.973 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -96.91 -58.72 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.782 0.801 . . . . 0.0 109.41 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -90.85 111.13 22.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.339 -170.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.77 -26.93 67.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.638 0.775 . . . . 0.0 110.116 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.54 -17.48 68.84 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.501 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' O ' HD22 ' A' ' 48' ' ' LEU . 82.4 mt -103.2 -13.98 16.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.888 0.875 . . . . 0.0 111.683 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.16 121.21 10.75 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.28 11.94 79.69 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 11.3 ptm180 -120.58 -21.19 6.84 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.54 0.67 . . . . 0.0 111.318 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.577 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -101.85 8.42 41.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.031 0.533 . . . . 0.0 110.219 170.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' HA ' ' A' ' 35' ' ' ARG . 43.2 mt -140.89 142.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.079 1.351 . . . . 0.0 108.87 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 1.6 tm-20 -154.83 123.69 6.2 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.09 31.04 17.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.413 1.085 . . . . 0.0 111.589 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.57 -4.07 75.36 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.592 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -106.36 -174.07 2.45 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.82 0.81 . . . . 0.0 109.681 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.406 HG12 HD21 ' A' ' 34' ' ' LEU . 27.6 m -58.8 -54.7 30.12 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.165 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? 149.45 137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 C-N-CA 126.503 1.921 . . . . 0.0 106.982 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 18.6 Cg_endo -56.54 129.08 32.81 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.802 2.335 . . . . 0.0 111.174 166.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 76.35 -6.26 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.877 1.271 . . . . 0.0 113.957 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.445 ' O ' HG11 ' A' ' 68' ' ' VAL . 1.9 p -73.69 143.79 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 m120 -110.81 104.69 13.35 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.18 137.25 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.228 0.611 . . . . 0.0 109.599 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.7 mp -126.89 142.73 51.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.835 1.254 . . . . 0.0 110.85 -166.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -114.06 109.21 18.08 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.474 1.11 . . . . 0.0 108.208 166.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.33 35.65 23.26 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.074 0.94 . . . . 0.0 110.349 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.25 -14.7 60.2 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.819 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 -87.64 109.03 19.37 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 68' ' ' VAL . 17.4 tt0 -67.44 105.09 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.453 0.701 . . . . 0.0 110.334 -173.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -70.48 -1.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 66' ' ' GLU . 20.2 m -73.7 -10.27 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 122.593 0.357 . . . . 0.0 111.364 171.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -87.15 -25.54 24.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.534 0.733 . . . . 0.0 110.452 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.22 -150.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.074 0.95 . . . . 0.0 109.808 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.21 107.89 0.54 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.685 0.394 . . . . 0.0 111.055 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -86.22 -30.35 22.74 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.684 0.615 . . . . 0.0 111.954 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.402 ' HE2' ' HA2' ' A' ' 31' ' ' GLY . 20.7 mmt -81.45 -34.9 31.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.078 0.551 . . . . 0.0 111.79 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.36 81.48 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 t -81.02 -67.76 0.75 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -173.5 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -163.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.32 144.09 44.65 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.68 -175.08 5.18 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.395 1.478 . . . . 0.0 107.817 -174.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.3 143.08 52.15 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.891 0.476 . . . . 0.0 111.186 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.0 69.6 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 114.806 0.682 . . . . 0.0 114.806 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.99 118.28 22.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.033 0.533 . . . . 0.0 111.665 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.55 104.03 14.19 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.523 0.729 . . . . 0.0 111.147 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 t -93.27 106.56 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 50.8 m -86.95 148.9 25.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.731 0.812 . . . . 0.0 109.539 176.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.42 146.33 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.814 0.816 . . . . 0.0 109.692 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 21.9 m-85 -132.38 144.55 53.51 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 173.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.622 ' HG3' ' H ' ' A' ' 10' ' ' THR . 34.3 Cg_endo -63.48 169.11 10.22 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.517 2.811 . . . . 0.0 112.124 169.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.35 130.17 31.03 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 121.218 1.278 . . . . 0.0 110.661 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.6 5.96 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.077 0.551 . . . . 0.0 112.23 -168.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -161.6 -48.22 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.292 1.037 . . . . 0.0 109.122 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.43 -172.16 15.28 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.816 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.325 0 CA-C-O 119.374 -0.681 . . . . 0.0 113.277 178.7 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 77.55 57.07 3.69 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-O 121.195 0.331 . . . . 0.0 112.581 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -89.85 -159.7 35.75 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.268 -0.466 . . . . 0.0 112.404 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . 0.697 ' HD3' ' HD3' ' A' ' 23' ' ' ARG . 95.5 mtt180 -89.75 29.55 1.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.692 0.797 . . . . 0.0 111.068 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -87.24 -60.39 1.99 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.858 0.463 . . . . 0.0 110.425 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 62.73 175.23 0.14 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.232 1.013 . . . . 0.0 111.603 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.5 -156.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 125.307 1.443 . . . . 0.0 113.232 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -106.1 -171.03 1.82 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.696 0.798 . . . . 0.0 109.614 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 30.4 t70 74.02 152.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.261 1.424 . . . . 0.0 112.585 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.59 156.68 25.89 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.505 1.122 . . . . 0.0 111.863 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 68.08 148.63 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.359 1.464 . . . . 0.0 111.419 -172.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' -2' ' ' LYS . 0.0 OUTLIER -65.89 -30.1 70.64 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.289 0.636 . . . . 0.0 111.96 -178.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 56.44 30.55 58.82 Favored Glycine 0 N--CA 1.472 1.08 0 O-C-N 123.407 0.442 . . . . 0.0 113.644 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 24.6 p -122.62 142.83 50.23 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.604 1.162 . . . . 0.0 109.566 -177.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.05 136.91 54.88 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.411 1.084 . . . . 0.0 110.068 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -91.74 141.37 28.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.405 0.682 . . . . 0.0 110.14 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.43 138.9 45.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.466 1.106 . . . . 0.0 110.606 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.3 103.98 16.57 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.508 0.723 . . . . 0.0 109.089 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD13 HD21 ' A' ' 37' ' ' LEU . 29.9 mt -93.31 103.62 15.84 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 74.7 mtt180 -91.09 119.75 31.49 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.58 1.152 . . . . 0.0 109.434 -178.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -108.11 140.35 41.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.25 1.02 . . . . 0.0 108.759 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -132.38 160.55 36.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.138 0.575 . . . . 0.0 109.585 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.446 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.72 -125.28 1.18 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.685 1.194 . . . . 0.0 112.706 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.519 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 27.6 m -68.02 -46.8 70.19 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.369 0.668 . . . . 0.0 111.14 -178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -57.31 -26.57 61.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.31 0.644 . . . . 0.0 111.633 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.495 ' HD3' ' HG2' ' A' ' 18' ' ' LYS . 7.0 tmm_? -68.66 -53.14 24.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.415 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -18.77 60.59 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG11 ' HG ' ' A' ' 44' ' ' LEU . 55.6 t -64.34 -48.12 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.251 0.548 . . . . 0.0 110.216 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 17' ' ' GLN . 88.4 t -78.87 -21.7 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.863 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.64 20.04 75.34 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.227 -175.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.502 ' HB2' HG12 ' A' ' 15' ' ' VAL . 13.8 mm100 -148.07 139.21 23.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.86 1.264 . . . . 0.0 109.111 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.495 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 26.3 mtmt -85.01 -21.32 29.51 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.891 0.744 . . . . 0.0 109.925 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -154.08 148.7 26.35 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.336 1.054 . . . . 0.0 108.814 171.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -135.84 168.03 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.473 1.109 . . . . 0.0 108.386 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.04 113.16 25.05 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.458 ' HZ2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -100.15 178.29 4.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.055 1.342 . . . . 0.0 109.373 171.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.697 ' HD3' ' HD3' ' A' ' -10' ' ' ARG . 18.5 ttt180 -157.44 107.33 2.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.549 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.32 173.21 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.347 1.059 . . . . 0.0 108.229 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 6.3 p-10 -67.86 160.46 28.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.093 0.473 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.26 -19.69 59.58 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.346 0.659 . . . . 0.0 111.522 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -80.76 -19.34 45.11 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.536 0.734 . . . . 0.0 109.155 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.73 154.65 39.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 0.0 110.775 172.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 p -134.23 -174.7 3.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.619 1.168 . . . . 0.0 109.862 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.94 -37.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 124.551 1.14 . . . . 0.0 111.878 -175.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.55 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -68.76 -42.25 80.15 Favored Glycine 0 C--N 1.336 0.528 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.298 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.72 -35.15 77.22 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.421 0.688 . . . . 0.0 110.895 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.15 -61.1 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.797 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pp -65.15 -30.71 71.65 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 117.662 0.21 . . . . 0.0 110.728 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -53.68 -48.39 69.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.919 0.487 . . . . 0.0 111.562 172.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.1 m -75.8 -31.61 59.5 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.803 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 5' ' ' LEU . 2.1 mm? -54.11 -41.08 67.9 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.741 0.816 . . . . 0.0 112.824 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 12.2 pt-20 -71.56 -28.11 63.62 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.13 68.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.102 0.561 . . . . 0.0 110.277 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.458 ' HG3' ' HZ2' ' A' ' 22' ' ' TRP . 4.9 mm-40 -86.04 -59.37 2.32 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.832 0.853 . . . . 0.0 109.783 175.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 89.2 m-85 -99.58 119.81 38.66 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.672 -168.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.29 -29.01 67.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.791 0.837 . . . . 0.0 110.902 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.87 -0.23 80.68 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.072 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.6 mt -115.78 1.58 13.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 111.092 173.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.03 122.39 19.28 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.44 76.56 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 9.8 ptp180 -118.29 4.47 11.89 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.641 0.776 . . . . 0.0 111.827 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -125.92 -8.08 6.64 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.498 1.119 . . . . 0.0 110.443 -178.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.401 ' N ' HD23 ' A' ' 48' ' ' LEU . 15.1 mt -132.73 136.87 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.877 1.271 . . . . 0.0 108.297 167.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.64 124.19 9.72 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.36 31.52 21.01 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.669 1.187 . . . . 0.0 111.937 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.02 -14.46 53.12 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.531 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -99.16 -174.84 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.962 0.881 . . . . 0.0 109.058 171.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.42 -55.11 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 118.104 -0.95 . . . . 0.0 111.723 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.6 tppt? 154.88 135.11 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.037 0 C-N-CA 124.714 1.206 . . . . 0.0 108.956 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.436 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 26.7 Cg_endo -60.45 135.55 61.91 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.929 2.419 . . . . 0.0 111.336 165.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 79.45 -12.49 1.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.135 1.374 . . . . 0.0 113.569 174.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 1.9 p -75.81 152.12 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -120.8 104.12 9.62 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.483 HG23 HG23 ' A' ' 67' ' ' VAL . 5.3 m -122.1 146.04 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.261 0.624 . . . . 0.0 109.873 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.3 mp -127.64 172.08 11.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.073 1.349 . . . . 0.0 110.971 -167.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 19.4 tptp -162.51 105.58 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 t30 54.99 35.57 24.96 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.053 0.941 . . . . 0.0 110.096 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.03 -14.69 61.36 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.784 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -88.89 118.77 28.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.374 0.67 . . . . 0.0 110.094 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 21.7 tt0 -72.44 103.01 3.34 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.477 0.486 . . . . 0.0 109.713 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 14.3 m -69.73 -1.07 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -173.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.3 m -69.91 -16.21 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.31 0.505 . . . . 0.0 111.317 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -91.09 -10.72 40.99 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.383 0.673 . . . . 0.0 111.324 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.84 -152.4 0.42 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.189 0.996 . . . . 0.0 109.595 -176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.17 108.35 2.65 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.1 0.56 . . . . 0.0 110.409 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.551 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -81.62 -38.59 13.84 Favored Glycine 0 C--N 1.341 0.846 0 O-C-N 123.378 0.424 . . . . 0.0 112.594 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.55 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 11.8 mmt -80.19 -36.36 35.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 112.647 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.19 77.65 1.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.459 HG21 ' HG2' ' A' ' 62' ' ' LYS . 1.4 t -82.15 -74.62 0.33 Allowed 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.802 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' H ' HG23 ' A' ' 75' ' ' THR . . . -171.22 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.143 0.577 . . . . 0.0 111.472 -161.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.544 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 24.3 tp -74.22 144.74 44.59 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.761 0.315 . . . . 0.0 111.347 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -156.21 168.76 26.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.295 1.038 . . . . 0.0 109.464 -168.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.87 149.97 48.56 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.948 0.499 . . . . 0.0 111.839 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.39 63.84 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.841 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -82.74 155.41 24.3 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.169 0.484 . . . . 0.0 109.863 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 99.06 6.68 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 123.287 0.635 . . . . 0.0 109.617 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -86.44 106.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 67.4 m -90.87 146.5 23.86 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 123.168 0.587 . . . . 0.0 109.506 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.27 144.76 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -128.83 141.19 40.82 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HG3' ' H ' ' A' ' 10' ' ' THR . 41.6 Cg_endo -63.79 168.4 11.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.762 2.975 . . . . 0.0 112.519 175.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 15.7 Cg_endo -57.98 129.05 31.3 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 121.234 1.289 . . . . 0.0 111.198 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -80.75 -24.55 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.134 -171.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.69 -36.81 81.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.149 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.35 -54.39 0.5 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.685 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.796 0 CA-C-O 118.929 -0.928 . . . . 0.0 110.814 -177.474 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 177.05 179.47 47.44 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 116.843 0.321 . . . . 0.0 112.53 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -143.77 136.73 7.04 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-O 120.48 -0.067 . . . . 0.0 113.129 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . 0.518 ' HG3' ' H ' ' A' ' -9' ' ' ASP . 3.5 tpm_? -153.37 177.87 10.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.709 1.203 . . . . 0.0 107.891 177.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . 0.518 ' H ' ' HG3' ' A' ' -10' ' ' ARG . 1.5 p30 -144.56 -137.99 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.059 -161.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 71.51 -61.68 0.48 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 126.09 1.756 . . . . 0.0 110.466 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . 0.465 ' HD3' ' HB2' ' A' ' -5' ' ' ASP . 0.1 OUTLIER -62.56 168.13 3.9 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.853 0.861 . . . . 0.0 111.199 165.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -78.2 -78.88 0.13 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.335 0.254 . . . . 0.0 111.066 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . 0.465 ' HB2' ' HD3' ' A' ' -7' ' ' LYS . 30.2 t70 60.03 -176.75 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.936 0.894 . . . . 0.0 112.249 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.39 -31.48 69.27 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.075 0.95 . . . . 0.0 111.985 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -139.13 140.14 37.83 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.273 0.559 . . . . 0.0 110.461 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.406 ' HG3' ' H ' ' A' ' 0' ' ' THR . 22.1 pttm -144.97 -62.64 0.35 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.64 1.176 . . . . 0.0 108.61 175.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 72.82 25.18 74.56 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 121.666 -0.647 . . . . 0.0 112.702 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' -9' ' ' ASP . 73.3 p -97.51 143.46 28.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.828 0.851 . . . . 0.0 110.818 -175.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.9 ptt? -101.72 140.4 36.05 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.781 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -95.22 130.59 41.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.292 0.637 . . . . 0.0 109.797 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.486 HD13 HD21 ' A' ' 77' ' ' LEU . 24.4 mt -124.44 138.73 54.33 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.646 0.779 . . . . 0.0 110.45 -169.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 45.5 tt0 -89.32 102.64 15.31 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD13 HD21 ' A' ' 37' ' ' LEU . 38.7 mt -92.86 103.7 16.02 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 30.1 mtm180 -92.32 117.62 30.09 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.393 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.33 138.49 42.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 109.464 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.72 155.38 48.95 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.335 0.654 . . . . 0.0 109.7 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.544 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 60.75 -126.75 0.96 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.144 1.378 . . . . 0.0 111.99 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.422 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 36.7 m -63.97 -43.03 96.98 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 123.34 0.656 . . . . 0.0 111.127 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -60.98 -27.69 68.47 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.574 0.35 . . . . 0.0 111.072 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 18' ' ' LYS . 55.3 ttp180 -67.5 -53.33 29.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.321 0.648 . . . . 0.0 111.396 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -20.42 60.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.111 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 44' ' ' LEU . 40.6 t -61.5 -47.74 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.559 0.695 . . . . 0.0 110.294 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.75 -20.54 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.905 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.53 16.36 71.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.041 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -143.19 139.4 30.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.553 1.141 . . . . 0.0 109.841 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 22.3 ptmt -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.754 0.659 . . . . 0.0 110.521 172.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.1 m -156.92 145.43 19.74 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.465 174.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.12 173.24 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.344 1.057 . . . . 0.0 109.089 172.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -118.73 112.76 20.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.8 -179.64 4.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.276 1.43 . . . . 0.0 109.388 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.9 ttp-105 -157.36 105.75 2.11 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.82 172.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -59.21 148.33 32.14 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.175 0.59 . . . . 0.0 111.285 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -61.94 -27.31 68.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 111.29 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -80.3 -24.99 39.61 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 110.24 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.89 37.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.02 0.528 . . . . 0.0 109.639 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.3 p -103.14 -173.87 2.42 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.596 0.758 . . . . 0.0 110.799 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 77' ' ' LEU . 87.9 t -50.84 -37.03 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 124.204 1.002 . . . . 0.0 111.493 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.632 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -70.3 -38.38 71.19 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.97 -31.02 69.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.297 0.639 . . . . 0.0 110.879 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.32 -60.87 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.172 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.506 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 2.7 pp -64.63 -30.16 71.18 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.192 0.308 . . . . 0.0 111.204 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HA ' HD11 ' A' ' 49' ' ' ILE . 16.6 tpt180 -51.41 -49.97 60.57 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.462 0.705 . . . . 0.0 111.242 168.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 m -75.36 -32.31 60.81 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.653 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 3.8 mm? -58.26 -35.31 71.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.187 0.595 . . . . 0.0 112.498 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.491 ' HB3' HD21 ' A' ' 48' ' ' LEU . 7.8 pt-20 -76.84 -27.45 55.12 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.324 0.511 . . . . 0.0 111.673 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.92 64.7 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 122.776 0.43 . . . . 0.0 111.01 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -90.23 -59.82 2.09 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.574 0.702 . . . . 0.0 110.158 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -92.28 126.54 37.4 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.602 -168.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.99 -35.67 69.55 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.689 0.796 . . . . 0.0 110.023 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.18 -4.19 86.18 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.957 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.605 ' HB3' HD13 ' A' ' 48' ' ' LEU . 56.9 mt -106.82 -3.67 20.12 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.934 0.867 . . . . 0.0 111.485 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.02 121.4 14.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.87 12.02 67.2 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.354 0.902 . . . . 0.0 115.354 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -118.26 0.44 11.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.005 0.922 . . . . 0.0 110.743 179.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -122.8 -5.42 8.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.524 1.13 . . . . 0.0 109.831 177.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 35' ' ' ARG . 37.0 mt -130.67 135.17 60.87 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 125.108 1.363 . . . . 0.0 108.398 169.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.84 126.35 14.13 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 166.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 56.11 31.29 17.92 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.604 1.162 . . . . 0.0 111.947 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.01 -14.38 57.32 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.27 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.59 -174.6 2.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 34' ' ' LEU . 27.8 m -63.51 -55.88 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.153 -173.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 11.3 tppt? 151.5 137.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.075 0 C-N-CA 125.122 1.369 . . . . 0.0 108.901 -176.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 131.13 31.48 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 C-N-CA 123.042 2.495 . . . . 0.0 111.836 165.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 79.38 -11.72 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.585 1.554 . . . . 0.0 114.167 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 p -69.34 142.99 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 16.4 m120 -110.2 103.36 12.04 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 85' ' ' VAL . 3.7 m -121.3 129.16 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.537 0.735 . . . . 0.0 109.307 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.727 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 2.1 mp -121.06 139.39 53.38 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.435 1.094 . . . . 0.0 110.413 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 12.9 tptm -110.5 114.65 28.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.17 35.12 21.1 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.032 0.933 . . . . 0.0 110.993 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.05 -4.93 81.79 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.998 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -100.35 116.01 31.32 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 11.3 tt0 -70.28 107.11 3.59 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.635 0.584 . . . . 0.0 109.774 -173.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.71 -1.12 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.48 -19.35 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 122.662 0.385 . . . . 0.0 111.168 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -90.26 -5.24 56.55 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.668 0.787 . . . . 0.0 111.235 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.01 -149.35 0.29 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.435 1.094 . . . . 0.0 109.327 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.24 108.84 3.33 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.266 0.626 . . . . 0.0 110.605 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.23 -43.4 20.95 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 122.999 0.187 . . . . 0.0 112.641 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.632 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 6.6 mmt -76.91 -40.26 47.94 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.195 0.598 . . . . 0.0 111.775 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.37 78.75 1.52 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.144 0.497 . . . . 0.0 111.273 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 t -80.8 -65.99 0.94 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.654 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 175.57 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.918 0.887 . . . . 0.0 110.462 -163.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.486 HD21 HD13 ' A' ' 3' ' ' LEU . 47.2 tp -73.89 136.64 43.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.639 0.375 . . . . 0.0 110.412 -175.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -149.93 -177.46 5.92 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 122.805 0.442 . . . . 0.0 110.013 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 33.6 t70 -64.4 144.93 56.81 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.794 0.838 . . . . 0.0 112.917 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.35 -7.19 12.42 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.455 -0.793 . . . . 0.0 114.793 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.475 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 4.9 m-20 -78.44 142.07 37.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.762 0.825 . . . . 0.0 112.431 -169.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' GLU . . . -97.64 111.16 23.55 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.036 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.17 107.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.727 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 12.9 m -85.57 147.04 26.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.985 0.514 . . . . 0.0 109.986 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 60' ' ' VAL . 33.0 m -141.93 140.6 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.602 0.715 . . . . 0.0 109.584 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.644 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 6.6 m-85 -129.92 137.79 31.67 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 37.1 Cg_endo -63.44 162.67 26.48 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.151 2.567 . . . . 0.0 112.594 176.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -66.84 130.4 23.1 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 121.509 1.472 . . . . 0.0 111.17 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.6 m -85.08 -11.84 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.127 0.571 . . . . 0.0 110.972 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.28 165.34 27.7 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.35 1.06 . . . . 0.0 109.597 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.98 -59.75 0.07 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.16 174.706 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.39 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . 67.81 -136.43 31.24 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 123.043 0.354 . . . . 0.0 112.738 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 74.16 -109.25 2.74 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . 0.404 ' NH2' ' HB2' ' A' ' 27' ' ' ASP . 25.3 mtt180 -146.9 118.8 8.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.565 1.146 . . . . 0.0 108.08 170.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . 0.622 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 22.1 t70 -139.8 157.35 45.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.754 1.221 . . . . 0.0 108.826 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -107.17 -43.82 4.51 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.158 0.583 . . . . 0.0 111.633 -170.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . 0.629 ' HD2' ' H ' ' A' ' -6' ' ' ASP . 0.0 OUTLIER -80.27 -53.32 6.75 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -169.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . 0.629 ' H ' ' HD2' ' A' ' -7' ' ' LYS . 37.4 t70 -174.87 -75.06 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.699 0.8 . . . . 0.0 110.175 -174.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 58.29 -171.5 0.11 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.045 0.938 . . . . 0.0 110.635 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -54.8 -41.37 70.52 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.362 0.665 . . . . 0.0 109.833 164.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -151.75 132.53 14.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.283 0.633 . . . . 0.0 109.674 170.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 13.5 pttm -92.82 -52.78 4.45 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.554 1.142 . . . . 0.0 110.443 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 75.83 16.85 80.39 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 116.565 -0.288 . . . . 0.0 113.329 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 20.9 p -78.56 142.1 37.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.524 0.73 . . . . 0.0 109.654 172.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.465 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 27.0 ptt? -96.06 143.54 27.12 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.826 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -93.34 126.87 38.69 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.904 0.882 . . . . 0.0 109.046 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.426 HD11 HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -124.11 148.98 46.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.946 0.498 . . . . 0.0 109.988 -175.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 31.1 tt0 -97.42 113.51 25.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 170.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.2 mt -101.39 112.29 24.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 51.9 mtt180 -99.94 117.17 33.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.187 0.995 . . . . 0.0 108.796 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.55 137.61 45.28 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.952 0.901 . . . . 0.0 109.256 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -131.6 159.7 37.48 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.93 0.492 . . . . 0.0 109.814 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.21 -120.6 1.07 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 124.779 1.232 . . . . 0.0 112.337 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.481 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 26.2 m -71.92 -45.41 61.29 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 123.082 0.553 . . . . 0.0 110.442 -178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -55.34 -30.0 59.42 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.195 0.598 . . . . 0.0 110.972 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HD2' ' HG2' ' A' ' 18' ' ' LYS . 50.8 ttp180 -66.72 -55.24 15.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.84 0.856 . . . . 0.0 111.726 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -16.93 60.91 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.934 -174.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG11 ' HG ' ' A' ' 44' ' ' LEU . 40.1 t -65.54 -55.87 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.28 0.632 . . . . 0.0 109.689 168.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.2 t -74.54 -17.88 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.612 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.7 11.61 73.3 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.701 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -139.48 144.29 37.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.198 0.999 . . . . 0.0 109.144 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.522 ' HG2' ' HD2' ' A' ' 12' ' ' ARG . 22.0 mtmm -86.31 -21.05 27.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.746 0.419 . . . . 0.0 109.909 174.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 14.7 m -154.05 146.51 24.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.377 1.071 . . . . 0.0 109.216 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 23.2 pt -141.52 170.61 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 109.7 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -112.83 113.07 24.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 165.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.47 -179.53 4.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.579 1.151 . . . . 0.0 109.843 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG2' ' HB ' ' A' ' 0' ' ' THR . 60.7 ttp180 -157.4 106.43 2.14 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.829 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 3' ' ' LEU . 27.2 m -114.46 169.37 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.215 171.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 0' ' ' THR . 27.8 t70 -61.8 154.09 26.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.936 0.494 . . . . 0.0 111.039 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.24 -32.42 71.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.014 0.926 . . . . 0.0 111.833 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.404 ' HB2' ' NH2' ' A' ' -10' ' ' ARG . 28.2 t70 -81.01 -22.6 39.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.958 0.903 . . . . 0.0 111.362 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 153.72 37.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.28 0.632 . . . . 0.0 110.66 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -130.48 -175.07 3.53 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 97.8 t -51.81 -37.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.951 0.9 . . . . 0.0 111.648 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.95 65.92 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.005 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.27 -33.79 76.64 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.272 0.629 . . . . 0.0 110.296 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.88 -60.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.813 0.845 . . . . 0.0 110.317 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.508 HD21 HG12 ' A' ' 54' ' ' VAL . 2.6 pp -64.66 -30.74 71.76 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.134 0.424 . . . . 0.0 111.579 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HA ' HD11 ' A' ' 49' ' ' ILE . 17.3 tpt180 -50.96 -48.59 61.0 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.157 0.583 . . . . 0.0 110.956 168.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.5 m -74.65 -32.5 62.29 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.187 0.595 . . . . 0.0 111.436 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 4.1 mm? -59.74 -34.29 72.76 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' A' ' 48' ' ' LEU . 5.6 pt-20 -76.89 -28.57 55.41 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.718 0.69 . . . . 0.0 111.124 173.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.05 -32.7 72.37 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.039 0.536 . . . . 0.0 111.121 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -83.99 -58.0 2.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.526 0.73 . . . . 0.0 110.474 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -96.38 127.33 42.28 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.587 -168.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.28 -45.68 90.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.131 0.973 . . . . 0.0 110.697 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.11 7.1 54.34 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.423 -0.808 . . . . 0.0 114.021 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.588 ' HB3' HD13 ' A' ' 48' ' ' LEU . 74.3 mt -115.97 5.26 13.92 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.615 0.707 . . . . 0.0 111.167 172.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -69.89 120.94 16.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.27 -8.09 26.97 Favored Glycine 0 C--N 1.359 1.847 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -100.08 4.13 44.45 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.355 1.062 . . . . 0.0 111.403 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -128.66 -8.87 5.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.257 1.023 . . . . 0.0 110.855 -177.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.479 HD11 ' HA ' ' A' ' 35' ' ' ARG . 51.5 mt -125.22 132.52 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.598 1.159 . . . . 0.0 107.967 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.17 117.65 13.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.919 0.488 . . . . 0.0 109.731 167.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.2 t70 55.54 30.85 15.98 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.05 -14.83 63.4 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.616 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -97.31 -174.01 2.82 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.883 0.842 . . . . 0.0 108.885 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.508 HG12 HD21 ' A' ' 34' ' ' LEU . 13.8 m -65.5 -56.83 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.788 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 150.81 135.97 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.003 0 C-N-CA 125.078 1.351 . . . . 0.0 109.176 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.49 137.51 51.02 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.84 2.36 . . . . 0.0 110.972 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 77.9 -11.94 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.325 1.45 . . . . 0.0 113.61 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 p -73.56 138.94 20.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.666 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 14.6 m120 -104.67 103.55 13.21 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 85' ' ' VAL . 4.2 m -122.93 135.38 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.624 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 4.5 mp -126.19 155.62 41.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.349 1.059 . . . . 0.0 110.639 -166.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HE3' ' HB3' ' A' ' 81' ' ' ASP . 13.3 tptm -123.49 104.51 9.11 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.554 1.142 . . . . 0.0 107.975 169.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 t30 52.64 37.69 24.07 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 125.062 1.345 . . . . 0.0 111.702 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 19.61 43.79 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.871 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -133.27 105.49 7.01 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 16.0 tt0 -62.85 109.31 1.4 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.331 1.052 . . . . 0.0 110.918 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 31.3 m -69.95 -1.48 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -172.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -68.16 -22.53 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 117.935 0.334 . . . . 0.0 110.824 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -86.38 -15.87 39.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.865 0.866 . . . . 0.0 111.151 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.75 -153.14 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.247 1.019 . . . . 0.0 109.289 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.25 113.5 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.077 0.551 . . . . 0.0 110.538 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -73.3 -50.29 12.79 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.718 0.636 . . . . 0.0 112.734 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.3 mmm -79.94 -36.83 35.7 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.345 0.658 . . . . 0.0 111.692 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.43 77.95 1.65 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.571 0.701 . . . . 0.0 111.008 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.29 -71.4 0.47 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.836 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.477 ' H ' HG23 ' A' ' 75' ' ' THR . . . -173.75 28.08 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.912 0.885 . . . . 0.0 110.962 -164.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.9 tp -75.33 144.06 42.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.175 0.59 . . . . 0.0 111.574 -168.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -157.51 -176.02 5.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.066 0.546 . . . . 0.0 110.1 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 28.3 t70 -63.88 140.53 58.88 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.035 0.934 . . . . 0.0 111.338 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 -7.09 57.87 Favored Glycine 0 C--N 1.344 1.023 0 O-C-N 123.834 0.709 . . . . 0.0 114.421 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.52 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 78.1 m-20 -79.55 133.9 36.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -170.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.32 105.66 17.63 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.446 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.2 137.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.624 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 58.9 m -118.12 154.83 31.46 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.441 0.564 . . . . 0.0 110.2 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.585 HG12 HG12 ' A' ' 60' ' ' VAL . 34.6 m -145.1 143.92 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.751 0.82 . . . . 0.0 110.152 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.666 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 18.1 m-85 -135.08 133.75 21.08 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HG3' ' H ' ' A' ' 10' ' ' THR . 22.0 Cg_endo -59.89 160.96 19.93 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 123.325 2.684 . . . . 0.0 112.867 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.29 130.67 31.18 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.945 1.764 . . . . 0.0 111.745 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.58 2.61 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.059 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.24 106.17 0.41 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.362 1.065 . . . . 0.0 110.989 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.53 26.41 8.16 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.371 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.352 0 CA-C-O 118.507 -1.163 . . . . 0.0 111.31 -176.634 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 CA-C-O 120.122 -0.266 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -148.4 33.98 1.19 Allowed Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . 82.43 -76.1 2.27 Favored Glycine 0 C--N 1.348 1.206 0 C-N-CA 123.233 0.444 . . . . 0.0 112.002 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -110.18 46.77 1.0 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.853 0.835 . . . . 0.0 108.961 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.54 -35.24 73.02 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.835 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 68.13 -6.02 0.81 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.457 1.103 . . . . 0.0 113.268 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' -2' ' ' LYS . 25.1 mtpp -130.39 131.27 45.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.588 0.755 . . . . 0.0 110.855 -166.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.49 -4.72 38.5 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.057 0.943 . . . . 0.0 111.288 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.81 174.85 6.33 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.961 1.304 . . . . 0.0 112.512 -176.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.72 -12.85 61.81 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.071 0.948 . . . . 0.0 111.971 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -127.52 151.97 48.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.923 0.889 . . . . 0.0 109.798 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' -7' ' ' LYS . 21.6 pttm -66.4 -37.46 85.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.011 1.324 . . . . 0.0 111.179 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 64.95 6.69 26.12 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 34.3 p -121.34 141.39 50.98 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.03 0.932 . . . . 0.0 109.087 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.76 151.44 31.96 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.481 0.712 . . . . 0.0 110.391 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.11 137.96 50.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.602 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.23 149.25 46.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.685 0.794 . . . . 0.0 109.855 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -89.2 106.86 18.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.26 112.65 24.57 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 39.8 mtp180 -104.64 118.02 35.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.716 0.806 . . . . 0.0 109.297 -170.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 136.67 45.47 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.924 0.89 . . . . 0.0 109.325 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -132.45 160.74 35.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.79 0.436 . . . . 0.0 110.104 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.06 -117.77 0.82 Allowed 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.892 1.277 . . . . 0.0 112.389 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.626 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 46.7 m -69.69 -47.52 62.91 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 123.632 0.773 . . . . 0.0 110.494 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -59.46 -24.36 63.49 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.986 0.515 . . . . 0.0 111.224 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -50.36 53.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.731 0.813 . . . . 0.0 111.291 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -16.91 60.89 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.595 HG11 ' HG ' ' A' ' 44' ' ' LEU . 72.6 t -65.36 -53.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.626 0.726 . . . . 0.0 110.205 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.85 -16.73 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.633 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.74 11.52 85.15 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.414 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.97 158.84 10.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.84 0.856 . . . . 0.0 110.807 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -94.76 -9.42 34.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.0 m -152.65 143.08 22.63 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.41 175.82 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.223 1.009 . . . . 0.0 109.119 174.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.49 112.96 16.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.36 135.91 44.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.303 1.041 . . . . 0.0 110.038 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -104.13 106.18 16.6 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.1 175.7 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.542 1.137 . . . . 0.0 108.226 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.46 164.52 26.54 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.627 0.371 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -76.95 -15.46 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.53 -24.33 36.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.879 0.472 . . . . 0.0 110.35 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.06 58.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.901 0.881 . . . . 0.0 111.463 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.3 p -128.27 -174.39 3.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.475 1.11 . . . . 0.0 109.725 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.81 -33.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 123.973 0.909 . . . . 0.0 112.093 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' HA2' ' HE1' ' A' ' 73' ' ' MET . . . -66.58 -50.05 51.67 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.053 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -61.59 -29.55 70.11 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.174 0.59 . . . . 0.0 111.583 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.45 -60.62 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.31 1.044 . . . . 0.0 110.541 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 2.3 pp -74.14 -31.06 62.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' HD11 ' A' ' 49' ' ' ILE . 8.2 ppt_? -67.12 -31.85 72.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.67 0.668 . . . . 0.0 111.176 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -76.67 -34.11 58.24 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.607 0.763 . . . . 0.0 112.333 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -59.91 -38.96 83.81 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 122.974 0.509 . . . . 0.0 111.86 -176.449 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 5.5 pt-20 -68.28 -37.41 80.64 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.345 0.403 . . . . 0.0 111.765 175.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.54 -28.96 69.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.506 0.723 . . . . 0.0 111.447 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -82.72 -58.83 2.72 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.043 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.22 112.56 24.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.813 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.93 -31.3 70.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.579 0.751 . . . . 0.0 110.55 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -73.31 -6.39 69.56 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.419 -0.809 . . . . 0.0 114.064 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HB3' HD13 ' A' ' 48' ' ' LEU . 68.0 mt -113.26 2.29 15.51 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.675 0.738 . . . . 0.0 111.141 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -65.9 120.74 13.62 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -172.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.27 -28.67 2.6 Favored Glycine 0 C--N 1.359 1.826 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 5.6 ptp180 -83.29 9.24 11.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.904 1.282 . . . . 0.0 112.693 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -132.26 9.85 4.45 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.94 0.896 . . . . 0.0 110.931 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 35' ' ' ARG . 61.1 mt -141.41 140.75 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 124.296 1.038 . . . . 0.0 109.315 175.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 55' ' ' LYS . 16.6 mm-40 -139.71 110.41 6.74 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.302 0.641 . . . . 0.0 110.317 163.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t70 56.6 36.14 27.16 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.475 1.11 . . . . 0.0 111.894 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.04 27.52 62.13 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.139 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.63 -177.4 4.17 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 161.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.495 HG12 HD21 ' A' ' 34' ' ' LEU . 17.1 m -66.5 -56.09 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 CA-C-O 117.588 -1.196 . . . . 0.0 112.297 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HD3' ' HG2' ' A' ' 50' ' ' GLU . 5.9 tppt? 149.58 134.27 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.243 0 C-N-CA 126.06 1.744 . . . . 0.0 108.616 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 19.5 Cg_endo -58.91 133.34 53.02 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.061 2.507 . . . . 0.0 112.184 165.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 81.03 -26.99 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.861 1.664 . . . . 0.0 113.107 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.76 120.44 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -95.41 104.71 16.62 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 85' ' ' VAL . 1.7 m -109.37 146.39 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.287 0.635 . . . . 0.0 109.55 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 8.5 mp -132.7 170.66 14.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.971 1.308 . . . . 0.0 110.243 -164.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE2' HD23 ' A' ' 77' ' ' LEU . 20.9 tptp -162.28 105.43 1.14 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 55.82 34.76 24.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.16 0.981 . . . . 0.0 109.832 -171.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.93 -13.58 48.05 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 114.492 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -87.16 119.28 27.23 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.922 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 24.3 tt0 -78.53 104.47 9.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.224 0.61 . . . . 0.0 111.13 -168.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.469 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 18.1 m -70.87 -1.32 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -170.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.1 m -68.6 -19.78 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.39 0.541 . . . . 0.0 110.898 170.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -92.53 -29.38 16.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.019 0.927 . . . . 0.0 110.843 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.79 -150.74 0.47 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.143 0.977 . . . . 0.0 109.406 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.04 108.31 2.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.955 0.502 . . . . 0.0 110.955 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -83.15 -37.79 12.09 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 123.32 0.387 . . . . 0.0 112.273 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.518 ' HE1' ' HA2' ' A' ' 31' ' ' GLY . 14.1 mmt -79.73 -38.39 33.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.653 0.781 . . . . 0.0 111.917 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.73 83.96 1.29 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.47 -75.26 0.29 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.724 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.4 33.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -163.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.475 HD23 ' HE2' ' A' ' 62' ' ' LYS . 15.4 mt -73.68 143.65 46.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.865 0.84 . . . . 0.0 112.554 -171.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -151.1 169.3 22.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.751 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.9 135.07 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 122.13 -0.356 . . . . 0.0 111.217 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.42 16.58 80.54 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.82 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.2 157.43 21.64 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.421 0.611 . . . . 0.0 109.563 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.75 106.03 11.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.268 0.627 . . . . 0.0 111.143 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.405 HG22 HD21 ' A' ' 77' ' ' LEU . 47.6 t -86.92 137.45 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.622 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 69.5 m -118.62 151.82 37.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 60' ' ' VAL . 10.3 m -142.27 148.3 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 121.404 0.621 . . . . 0.0 110.196 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -136.3 140.71 33.53 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.626 ' HG3' ' H ' ' A' ' 10' ' ' THR . 53.6 Cg_endo -64.28 168.83 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.254 3.303 . . . . 0.0 112.417 174.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.7 129.81 26.05 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.077 1.185 . . . . 0.0 111.385 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.4 m -89.96 1.03 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.508 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.73 111.75 2.57 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.289 1.036 . . . . 0.0 109.333 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 -54.81 6.92 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.8 -1.0 . . . . 0.0 111.312 -178.91 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -152.99 80.4 0.19 Allowed Glycine 0 C--N 1.344 0.972 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -168.63 51.01 0.22 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . 0.493 HH11 ' HB3' ' A' ' 23' ' ' ARG . 40.3 ttm180 58.61 22.63 10.02 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.526 1.13 . . . . 0.0 111.029 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . 0.563 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 6.2 p-10 -64.53 141.87 58.62 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.046 0.938 . . . . 0.0 112.037 -175.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -104.94 19.12 21.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.709 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 175.17 8.66 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.887 1.275 . . . . 0.0 109.971 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -109.95 -170.08 1.59 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.484 0.713 . . . . 0.0 110.02 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 72.64 -93.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.398 1.479 . . . . 0.0 110.55 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -172.03 95.29 0.15 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.431 0.692 . . . . 0.0 109.53 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -176.99 135.6 0.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.577 1.151 . . . . 0.0 108.712 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 18.7 ptpt -74.96 -53.26 9.28 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.403 ' N ' ' HG3' ' A' ' -2' ' ' LYS . . . 44.79 45.57 8.98 Favored Glycine 0 C--N 1.356 1.647 0 O-C-N 123.672 0.607 . . . . 0.0 113.424 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 9.7 p -125.1 147.74 48.86 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.578 0.751 . . . . 0.0 110.016 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' SD ' ' HA ' ' A' ' 26' ' ' ASP . 13.2 ptm -122.31 111.71 17.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.412 1.085 . . . . 0.0 109.722 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.32 121.43 28.87 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.542 HD13 HD21 ' A' ' 77' ' ' LEU . 21.4 mt -123.93 135.21 53.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.562 0.745 . . . . 0.0 110.027 -169.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.11 98.45 11.77 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD13 HD21 ' A' ' 37' ' ' LEU . 21.9 mt -94.83 104.8 16.71 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.122 . . . . 0.0 110.529 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 41.3 mtp180 -101.06 117.33 34.81 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.408 0.683 . . . . 0.0 109.414 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -101.76 140.22 36.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.049 0.939 . . . . 0.0 109.357 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.5 157.11 43.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.096 0.558 . . . . 0.0 110.137 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.66 -122.29 1.09 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.775 1.23 . . . . 0.0 112.861 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.539 ' H ' ' HG3' ' A' ' 87' ' ' PRO . 92.0 m -64.78 -48.07 75.83 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 123.757 0.823 . . . . 0.0 111.042 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -60.03 -24.52 64.59 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.819 0.448 . . . . 0.0 111.467 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 13' ' ' GLU . 7.8 tmm_? -72.46 -47.58 47.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.932 0.493 . . . . 0.0 111.288 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 1.1 pp20? -74.16 -19.11 60.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.53 0.332 . . . . 0.0 111.698 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.558 HG11 ' HG ' ' A' ' 44' ' ' LEU . 53.0 t -67.35 -52.55 40.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.67 0.788 . . . . 0.0 110.483 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 95.6 t -73.88 -22.18 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.526 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.07 11.44 63.66 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.885 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -146.46 136.99 23.97 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -170.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HD2' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -87.71 -14.71 39.09 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 3.3 m -155.5 137.82 14.84 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.709 0.804 . . . . 0.0 109.315 177.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.45 140.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -88.92 112.45 23.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 168.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.86 170.97 9.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.55 1.14 . . . . 0.0 108.928 170.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.493 ' HB3' HH11 ' A' ' -10' ' ' ARG . 65.4 ttt180 -157.02 108.47 2.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.704 0.764 . . . . 0.0 109.466 173.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.57 -179.56 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.766 1.627 . . . . 0.0 108.364 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.99 160.19 30.09 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.431 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 5.3 p-10 -69.83 -8.08 45.33 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.694 0.797 . . . . 0.0 113.043 -170.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.35 -14.44 57.25 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.719 0.807 . . . . 0.0 112.26 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.95 129.47 36.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.696 0.398 . . . . 0.0 111.133 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p -109.63 -179.59 3.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -54.02 -32.66 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.081 0.952 . . . . 0.0 112.368 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.63 -40.51 58.88 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.741 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.7 -32.24 73.41 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.163 0.481 . . . . 0.0 110.45 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.21 -60.08 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.678 0.611 . . . . 0.0 110.408 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.493 HD21 HG12 ' A' ' 54' ' ' VAL . 2.6 pp -66.91 -30.08 70.14 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 123.331 0.394 . . . . 0.0 111.166 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.3 tpt85 -56.28 -48.38 76.72 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.061 0.544 . . . . 0.0 111.518 170.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -75.88 -31.75 59.37 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.047 0.539 . . . . 0.0 111.442 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 5' ' ' LEU . 1.5 mm? -56.59 -44.81 81.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.706 0.803 . . . . 0.0 112.406 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.501 ' HB3' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.68 -25.64 67.42 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.157 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.7 -21.65 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.655 0.597 . . . . 0.0 111.238 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -98.68 -59.09 1.81 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 122.877 0.471 . . . . 0.0 109.781 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.499 ' CE2' ' HA ' ' A' ' 15' ' ' VAL . 91.9 m-85 -89.66 117.45 28.54 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.882 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.01 -35.39 81.04 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.742 0.817 . . . . 0.0 111.481 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -76.88 -2.13 75.74 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.754 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.663 ' HB3' HD13 ' A' ' 48' ' ' LEU . 58.0 mt -103.94 -15.57 15.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.46 0.704 . . . . 0.0 110.893 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -59.48 120.65 9.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.779 0.832 . . . . 0.0 112.59 -171.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.62 74.04 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 115.489 0.955 . . . . 0.0 115.489 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 3.1 ptp180 -118.71 -0.06 11.37 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.539 0.736 . . . . 0.0 111.713 -176.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.22 -3.05 11.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.738 0.815 . . . . 0.0 110.185 173.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 35' ' ' ARG . 41.2 mt -133.44 137.19 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.019 1.328 . . . . 0.0 108.195 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -135.96 108.39 7.37 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t70 57.92 32.2 21.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.636 1.174 . . . . 0.0 112.557 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.43 1.2 69.17 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 115.084 0.793 . . . . 0.0 115.084 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.08 -174.91 2.63 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 117.849 0.824 . . . . 0.0 109.392 165.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.493 HG12 HD21 ' A' ' 34' ' ' LEU . 17.8 m -65.76 -55.42 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.601 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 47' ' ' ARG . 13.5 tppt? 150.21 138.09 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.059 0 C-N-CA 125.576 1.55 . . . . 0.0 107.956 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.455 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 19.6 Cg_endo -56.07 129.19 33.57 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 123.009 2.473 . . . . 0.0 110.619 166.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 74.86 -4.79 2.29 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.997 1.319 . . . . 0.0 114.28 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -74.99 131.9 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 17.1 m120 -100.9 103.58 14.76 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.43 137.28 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 123.267 0.627 . . . . 0.0 109.765 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 7.4 mp -118.87 169.23 10.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.113 1.365 . . . . 0.0 111.09 -169.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -163.77 106.0 0.95 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.478 -177.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.481 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 7.5 t-20 59.21 38.12 23.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.188 1.395 . . . . 0.0 109.721 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.96 -14.6 48.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.619 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -93.79 119.12 32.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.445 0.622 . . . . 0.0 109.565 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 22.4 tt0 -75.18 109.46 8.69 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.064 0.459 . . . . 0.0 109.765 -174.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 20.6 m -71.4 -0.4 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.72 -19.91 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.186 0.448 . . . . 0.0 110.978 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -88.3 -19.65 26.46 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.737 0.815 . . . . 0.0 110.794 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.34 -148.34 0.36 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.692 1.197 . . . . 0.0 109.262 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.3 108.95 6.46 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.003 0.521 . . . . 0.0 110.57 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -79.6 -37.64 22.94 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 113.903 0.321 . . . . 0.0 113.903 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 82.8 mmm -81.62 -26.75 34.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.99 85.35 0.26 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 118.177 0.444 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 76' ' ' ALA . 1.4 t -81.81 -73.15 0.4 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.073 0.549 . . . . 0.0 112.192 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' H ' HG23 ' A' ' 75' ' ' THR . . . -173.19 33.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.815 0.846 . . . . 0.0 110.557 -164.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.542 HD21 HD13 ' A' ' 3' ' ' LEU . 41.4 tp -74.35 123.54 24.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.495 0.318 . . . . 0.0 110.154 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 7.0 t70 -116.82 178.24 4.41 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.5 147.69 49.09 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.359 0.663 . . . . 0.0 111.035 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.21 10.82 70.06 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.548 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -82.6 177.67 8.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.451 0.701 . . . . 0.0 110.896 -174.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.69 109.11 9.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.293 0.637 . . . . 0.0 110.866 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.47 137.65 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 108.734 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 75.3 m -121.04 154.23 36.33 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -142.88 147.64 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.624 0.726 . . . . 0.0 110.141 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 14.9 m-85 -133.51 140.23 36.28 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HG3' ' H ' ' A' ' 10' ' ' THR . 58.7 Cg_endo -66.36 168.38 16.3 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.711 2.94 . . . . 0.0 112.3 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.19 130.71 27.95 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 121.395 1.397 . . . . 0.0 110.869 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.1 m -79.71 -32.41 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.553 -171.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -177.0 129.35 0.17 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.716 1.206 . . . . 0.0 108.889 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.79 49.44 3.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 123.303 0.377 . . . . 0.0 112.947 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.306 0 CA-C-O 118.807 -0.996 . . . . 0.0 112.608 -177.654 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -12' ' ' GLY . . . . . . . . . . . . . . . -83.01 64.37 4.33 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -11' ' ' GLY . . . . . . . . . . . . . . . -80.7 72.27 2.72 Favored Glycine 0 C--N 1.35 1.331 0 C-N-CA 123.0 0.333 . . . . 0.0 112.347 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -10' ' ' ARG . . . . . 0.559 ' HB2' HH21 ' A' ' 23' ' ' ARG . 2.6 mmp_? -77.81 82.88 4.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.561 0.696 . . . . 0.0 110.447 175.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' -9' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' -2' ' ' LYS . 5.2 p-10 -83.58 172.54 12.25 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.379 169.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' -8' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -124.58 33.79 5.16 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.126 0.489 . . . . 0.0 111.961 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -7' ' ' LYS . . . . . 0.632 ' HG2' ' H ' ' A' ' -6' ' ' ASP . 0.0 OUTLIER -128.6 -69.36 0.72 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' -6' ' ' ASP . . . . . 0.632 ' H ' ' HG2' ' A' ' -7' ' ' LYS . 28.4 t70 173.39 -57.29 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.628 1.571 . . . . 0.0 107.543 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' -5' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -169.72 -174.81 1.95 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.117 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' ASP . . . . . . . . . . . . . 25.2 t70 69.92 80.33 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.275 1.03 . . . . 0.0 108.947 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' ASP . . . . . . . . . . . . . 23.5 t70 67.35 138.19 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.485 1.514 . . . . 0.0 112.281 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' -9' ' ' ASP . 0.2 OUTLIER -61.65 -44.91 96.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.402 0.681 . . . . 0.0 111.252 178.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 48.21 48.9 25.96 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 123.766 0.698 . . . . 0.0 113.566 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' THR . . . . . . . . . . . . . 21.3 p -117.32 171.88 7.68 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.184 0.993 . . . . 0.0 110.919 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HA ' ' A' ' 79' ' ' ASP . 25.6 ptt? -149.86 124.02 9.48 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.773 0.829 . . . . 0.0 109.547 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -85.27 113.65 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.031 0.932 . . . . 0.0 109.107 -175.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.3 mt -115.46 134.5 55.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.391 0.676 . . . . 0.0 110.931 -171.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 20' ' ' ILE . 65.1 tt0 -89.17 103.09 15.74 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.8 mt -93.84 105.3 17.33 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 47.4 mtt180 -91.9 117.0 29.39 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.749 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.444 ' HD2' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m-85 -103.44 136.09 43.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.976 0.91 . . . . 0.0 109.248 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.01 161.41 29.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.225 0.61 . . . . 0.0 109.537 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . . . 59.41 -133.27 0.93 Allowed 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.604 1.162 . . . . 0.0 112.354 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 14' ' ' VAL . 57.2 m -55.76 -44.03 77.26 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 124.324 1.05 . . . . 0.0 111.819 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' A' ' 7' ' ' PHE . 10.8 m-30 -63.1 -33.09 74.71 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.076 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -41.57 91.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.642 0.377 . . . . 0.0 110.273 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -67.91 -35.86 79.19 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.806 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.493 HG11 ' HG ' ' A' ' 44' ' ' LEU . 64.6 t -60.46 -56.31 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.257 0.623 . . . . 0.0 110.617 174.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.26 -17.15 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.42 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.98 11.52 70.08 Favored Glycine 0 C--N 1.35 1.313 0 C-N-CA 123.578 0.608 . . . . 0.0 113.682 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -160.7 142.45 12.33 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.232 1.013 . . . . 0.0 110.149 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -85.83 -22.16 27.74 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.952 0.901 . . . . 0.0 113.38 -167.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 4.2 m -150.18 133.09 16.06 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 18.1 pt -129.98 171.88 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.997 . . . . 0.0 108.928 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -116.95 112.17 20.63 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 163.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CH2' HD22 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -89.96 -179.05 5.62 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.91 1.284 . . . . 0.0 108.772 164.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.559 HH21 ' HB2' ' A' ' -10' ' ' ARG . 59.8 ttp180 -155.73 113.89 3.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.68 -179.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.52 156.74 35.97 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.723 0.409 . . . . 0.0 110.353 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.56 -24.96 53.56 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.262 0.625 . . . . 0.0 111.049 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.65 -14.39 56.73 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.86 0.864 . . . . 0.0 110.558 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 166.07 23.3 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.257 0.623 . . . . 0.0 110.836 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.8 p -132.2 -177.47 4.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.594 0.758 . . . . 0.0 110.815 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.35 -35.85 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.617 1.167 . . . . 0.0 111.553 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' HA3' ' SD ' ' A' ' 73' ' ' MET . . . -69.62 -38.52 78.26 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.553 0.533 . . . . 0.0 113.221 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.71 -33.17 75.04 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.284 0.634 . . . . 0.0 110.491 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.0 -60.19 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.702 0.801 . . . . 0.0 110.528 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 54' ' ' VAL . 2.0 pp -65.07 -30.61 71.58 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.88 0.309 . . . . 0.0 111.316 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -54.47 -47.31 73.1 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.239 0.616 . . . . 0.0 111.368 170.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 36.1 t -75.9 -32.64 59.74 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.093 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 2.3 mm? -58.04 -35.8 71.84 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.69 0.796 . . . . 0.0 112.954 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -77.79 -30.02 51.11 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 120.737 0.303 . . . . 0.0 111.462 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.19 -26.41 67.39 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.929 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 36' ' ' SER . 6.1 mm-40 -90.76 -56.28 3.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.026 0.93 . . . . 0.0 110.191 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -95.73 122.66 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.187 -170.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.92 -35.82 81.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.043 0.937 . . . . 0.0 110.774 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.67 -2.11 90.6 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.919 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB3' HD13 ' A' ' 48' ' ' LEU . 85.0 mt -109.88 5.24 22.33 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.868 0.834 . . . . 0.0 110.885 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 38' ' ' GLU . . . -70.34 121.46 17.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.971 0.508 . . . . 0.0 112.177 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.54 -24.65 6.28 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 12.3 ptp180 -90.25 7.5 37.93 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.69 1.196 . . . . 0.0 112.505 -171.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.06 -7.1 3.47 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.135 0.974 . . . . 0.0 111.088 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.89 127.7 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.509 1.123 . . . . 0.0 108.416 169.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -127.51 108.84 11.15 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.175 0.59 . . . . 0.0 110.162 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 t70 53.02 39.53 29.63 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.581 1.152 . . . . 0.0 112.007 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.2 -14.53 65.05 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.195 -0.911 . . . . 0.0 115.369 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -102.21 -175.32 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.286 1.043 . . . . 0.0 109.223 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG12 HD21 ' A' ' 34' ' ' LEU . 15.8 m -69.02 -57.56 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.07 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HD3' ' HD2' ' A' ' 56' ' ' PRO . 15.4 tppt? 153.74 135.22 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 CA-C-N 119.683 1.129 . . . . 0.0 109.786 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' HD3' ' A' ' 55' ' ' LYS . 17.1 Cg_endo -56.07 135.25 68.9 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 123.319 2.68 . . . . 0.0 111.879 165.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 76.28 -15.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.565 1.546 . . . . 0.0 113.947 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.76 146.36 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 20.5 m120 -121.13 103.87 9.34 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG12 HG12 ' A' ' 85' ' ' VAL . 3.2 m -116.17 131.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.53 0.732 . . . . 0.0 109.531 -177.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 6.1 mp -120.41 133.9 55.35 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.209 1.403 . . . . 0.0 110.297 -171.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 16.8 tptp -105.62 105.62 15.74 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 59.32 35.13 23.16 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.097 0.959 . . . . 0.0 111.13 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.92 -14.31 63.7 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.426 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -93.73 105.92 17.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.837 0.855 . . . . 0.0 109.41 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 26.1 tt0 -70.88 104.83 3.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.602 0.761 . . . . 0.0 111.174 -168.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 23.4 m -71.65 -0.95 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.89 -22.69 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.806 170.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -86.71 -28.55 23.02 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.772 0.829 . . . . 0.0 110.803 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.6 -153.74 0.54 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.383 1.073 . . . . 0.0 109.503 177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.26 107.89 1.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.888 0.475 . . . . 0.0 110.186 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.472 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -80.2 -34.1 30.58 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.031 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.483 ' SD ' ' HA3' ' A' ' 31' ' ' GLY . 8.7 mmt -82.15 -39.11 23.72 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.2 82.48 1.6 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.29 0.566 . . . . 0.0 111.631 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 76' ' ' ALA . 2.1 t -81.34 -72.87 0.41 Allowed 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.135 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' H ' HG23 ' A' ' 75' ' ' THR . . . 174.55 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.955 0.902 . . . . 0.0 110.414 -161.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -74.03 123.0 23.52 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -167.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.71 175.21 5.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.148 0.979 . . . . 0.0 109.989 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 11.1 p-10 -72.89 146.73 45.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.458 0.703 . . . . 0.0 111.949 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 15.15 73.1 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.396 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.31 171.45 13.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.098 0.559 . . . . 0.0 111.332 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.52 94.78 3.84 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 170.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.89 107.39 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 74.2 m -85.68 155.01 21.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 110.402 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 HG12 ' A' ' 60' ' ' VAL . 32.8 m -146.35 145.49 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.676 0.79 . . . . 0.0 109.673 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . 29.9 m-85 -132.38 136.62 28.33 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 32.5 Cg_endo -61.04 168.91 6.68 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.971 3.114 . . . . 0.0 113.432 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.94 130.33 32.36 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.103 1.202 . . . . 0.0 110.328 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.78 18.64 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.681 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -113.67 155.89 24.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.535 1.134 . . . . 0.0 110.086 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.14 69.29 0.18 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 CA-C-O 119.085 -0.842 . . . . 0.0 112.03 179.584 . . . . . . . . 0 0 . 1 stop_ save_